Citrus Sinensis ID: 017246
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 375 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.909 | 0.747 | 0.601 | 1e-127 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.914 | 0.828 | 0.595 | 1e-123 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.912 | 0.808 | 0.549 | 1e-116 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.773 | 0.680 | 0.554 | 2e-93 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.781 | 0.594 | 0.539 | 8e-92 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.778 | 0.685 | 0.537 | 2e-91 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.789 | 0.604 | 0.524 | 2e-89 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.813 | 0.784 | 0.5 | 2e-88 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.778 | 0.712 | 0.536 | 3e-87 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.837 | 0.762 | 0.477 | 3e-86 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 220/366 (60%), Positives = 265/366 (72%), Gaps = 25/366 (6%)
Query: 1 MSCFSCLTRQTKDTKVDIDDAPRSKSRYSSESSENG-------------KGNGGKEKS-- 45
M CFSC + +D++ + + S + N K NGG ++
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 46 ---------GARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHE 95
A +F FRELA AT NF +GEGGFG+VYKGRL+S GQ+VA+KQL+
Sbjct: 61 LPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRN 120
Query: 96 GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE 155
GLQG++EF+VEVLMLSLLHH NLV LIGYC GDQRLLVYE+MP+GSLEDHL+DL PD+E
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 180
Query: 156 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215
L WN RMKIA GAA+GLE+LH KANPPVIYRD KS+NILLD F+PKLSDFGLAKLGP
Sbjct: 181 ALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPT 240
Query: 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 275
GD +HVSTRVMGTYGYCAPEYAM+G+LT+KSD+YSFGVV LELITGRKA+D GEQN
Sbjct: 241 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQN 300
Query: 276 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335
LV+W+RP D++KF+ L DP L GR+P R L A+AV +MC+ E+A RPLI D+V AL
Sbjct: 301 LVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360
Query: 336 DYLVSQ 341
YL +Q
Sbjct: 361 SYLANQ 366
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-123, Method: Compositional matrix adjust.
Identities = 215/361 (59%), Positives = 265/361 (73%), Gaps = 18/361 (4%)
Query: 1 MSCFSCLT-RQTKDTKVDIDDA----------------PRSKSRYSSESSENGKGNGGKE 43
M+CFSC + K D D++ P + + ++ N +
Sbjct: 1 MNCFSCFYFHEKKKVPRDSDNSYRRNGEVTGRDNNKTHPENPKTVNEQNKNNDEDKEVTN 60
Query: 44 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQE 102
A++F+FRELA AT+NFR+ LIGEGGFG+VYKG+LE +G +VA+KQL+ GLQG++E
Sbjct: 61 NIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKE 120
Query: 103 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 162
FIVEVLMLSLLHH +LV LIGYC GDQRLLVYEYM GSLEDHL DL PDQ PL W+TR
Sbjct: 121 FIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTR 180
Query: 163 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 222
++IA+GAA GLEYLH KANPPVIYRDLK+ANILLD +FN KLSDFGLAKLGPVGD HVS
Sbjct: 181 IRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVS 240
Query: 223 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282
+RVMGTYGYCAPEY +G+LT KSD+YSFGVVLLELITGR+ +D ++ + EQNLV+W++P
Sbjct: 241 SRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQP 300
Query: 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342
K+ +F L DP L G +P + LN AVAV AMCL EEA RPL++D+V AL +L +
Sbjct: 301 VFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTAP 360
Query: 343 D 343
D
Sbjct: 361 D 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 211/384 (54%), Positives = 267/384 (69%), Gaps = 42/384 (10%)
Query: 1 MSCFSCLTRQTKDTKVDID-----------------DAPRSKSRYSSESSE-------NG 36
M CF C + +K ++ + D D +++ SS+S++ N
Sbjct: 1 MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDVNN 60
Query: 37 KGNGGKEKS-----------------GARSFTFRELAIATRNFREANLIGEGGFGKVYKG 79
+G GKE A++FTF+ELA AT NFR +GEGGFGKV+KG
Sbjct: 61 EGGVGKEDQLSLDVKGLNLNDQVTGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVFKG 120
Query: 80 RLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138
+E Q+VAIKQL+ G+QG +EF+VEVL LSL H NLV LIG+C GDQRLLVYEYM
Sbjct: 121 TIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYM 180
Query: 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 198
P GSLEDHL+ L ++PL WNTRMKIA GAARGLEYLH + PPVIYRDLK +NILL
Sbjct: 181 PQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGE 240
Query: 199 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 258
D+ PKLSDFGLAK+GP GD THVSTRVMGTYGYCAP+YAM+G+LT KSDIYSFGVVLLEL
Sbjct: 241 DYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 300
Query: 259 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCL 318
ITGRKA+D +K + +QNLV W+RP KD++ F +VDPLL G+YP R L A+A++AMC+
Sbjct: 301 ITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCV 360
Query: 319 NEEANFRPLINDIVVALDYLVSQR 342
E+ RP+++D+V+AL++L S +
Sbjct: 361 QEQPTMRPVVSDVVLALNFLASSK 384
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 168/303 (55%), Positives = 219/303 (72%), Gaps = 13/303 (4%)
Query: 48 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNHEGL 97
++FTF EL AT+NFR+ NL+GEGGFG V+KG ++ SG +VA+KQL EG
Sbjct: 72 KAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGF 131
Query: 98 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 157
QGH+E++ EV L L H NLV L+GYC G+ RLLVYE+MP GSLE+HL+ +PL
Sbjct: 132 QGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF--RRGAQPL 189
Query: 158 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
+W RMK+AVGAA+GL +LH +A VIYRD K+ANILLD DFN KLSDFGLAK GP GD
Sbjct: 190 TWAIRMKVAVGAAKGLTFLH-EAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGD 248
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 277
NTHVST+V+GT+GY APEY +G+LT KSD+YSFGVVLLELI+GR+AMD S G E +LV
Sbjct: 249 NTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLV 308
Query: 278 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337
W+ P+L D++K ++D L G+YP++ A + CLN +A RP +++++V L+
Sbjct: 309 DWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQ 368
Query: 338 LVS 340
L S
Sbjct: 369 LES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (864), Expect = 8e-92, Method: Compositional matrix adjust.
Identities = 165/306 (53%), Positives = 213/306 (69%), Gaps = 13/306 (4%)
Query: 48 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNHEGL 97
R FTF +L ++TRNFR +L+GEGGFG V+KG +E +G VA+K LN +GL
Sbjct: 128 RKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGL 187
Query: 98 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 157
QGH+E++ E+ L L H NLV L+GYC DQRLLVYE+MP GSLE+HL+ PL
Sbjct: 188 QGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPL 244
Query: 158 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
W+ RMKIA+GAA+GL +LH +A PVIYRD K++NILLD D+N KLSDFGLAK P
Sbjct: 245 PWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEG 304
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 277
THVSTRVMGTYGY APEY M+G LT KSD+YSFGVVLLE++TGR++MD ++ GE NLV
Sbjct: 305 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 364
Query: 278 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337
W+RP L D+++F L+DP L G + + + A CL+ + RP ++D+V AL
Sbjct: 365 EWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKP 424
Query: 338 LVSQRD 343
L +D
Sbjct: 425 LPHLKD 430
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 164/305 (53%), Positives = 218/305 (71%), Gaps = 13/305 (4%)
Query: 48 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNHEGL 97
++FTF EL ATRNFR +L+GEGGFG V+KG ++ SG +VA+K+L EG
Sbjct: 69 KAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGY 128
Query: 98 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 157
QGH+E++ EV L L H NLV L+GYC G+ RLLVYE+MP GSLE+HL+ +PL
Sbjct: 129 QGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF--RRGAQPL 186
Query: 158 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
+W RMK+A+GAA+GL +LH A VIYRD K+ANILLD +FN KLSDFGLAK GP GD
Sbjct: 187 TWAIRMKVAIGAAKGLTFLH-DAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGD 245
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 277
THVST+VMGT+GY APEY +G+LT KSD+YSFGVVLLEL++GR+A+D SK EQ+LV
Sbjct: 246 KTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLV 305
Query: 278 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337
W+ P+L D++K ++D L G+YP++ A ++ CLN +A RP +++++ LD
Sbjct: 306 DWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQ 365
Query: 338 LVSQR 342
L S +
Sbjct: 366 LESTK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 162/309 (52%), Positives = 214/309 (69%), Gaps = 13/309 (4%)
Query: 45 SGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNH 94
S + F+F +L +ATRNFR +L+GEGGFG V+KG +E +G VA+K LN
Sbjct: 119 SHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNP 178
Query: 95 EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 154
+GLQGH+E++ E+ L L H NLV L+GYC DQRLLVYE+MP GSLE+HL+
Sbjct: 179 DGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RS 235
Query: 155 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214
PL W+ RMKIA+GAA+GL +LH +A PVIYRD K++NILLD ++N KLSDFGLAK P
Sbjct: 236 LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAP 295
Query: 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 274
THVSTRVMGTYGY APEY M+G LT KSD+YSFGVVLLE++TGR++MD ++ GE
Sbjct: 296 DEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
Query: 275 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334
NLV W+RP L D+++F L+DP L G + + + A CL+ ++ RP ++++V
Sbjct: 356 NLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEV 415
Query: 335 LDYLVSQRD 343
L L +D
Sbjct: 416 LKPLPHLKD 424
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 325 bits (834), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 160/320 (50%), Positives = 231/320 (72%), Gaps = 15/320 (4%)
Query: 43 EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQL 92
+ + ++F+ EL ATRNFR +++GEGGFG V+KG ++ +G ++A+K+L
Sbjct: 49 QNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRL 108
Query: 93 NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP 152
N EG QGH+E++ E+ L L H NLV LIGYC + RLLVYE+M GSLE+HL+
Sbjct: 109 NQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGT 168
Query: 153 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212
+PLSWNTR+++A+GAARGL +LH A P VIYRD K++NILLD+++N KLSDFGLA+
Sbjct: 169 FYQPLSWNTRVRMALGAARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLSDFGLARD 227
Query: 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 272
GP+GDN+HVSTRVMGT GY APEY +G L++KSD+YSFGVVLLEL++GR+A+D ++ G
Sbjct: 228 GPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVG 287
Query: 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP-RRCLNYAVAVTAM-CLNEEANFRPLIND 330
E NLV W+RP+L ++++ + ++DP L G+Y R L +AV A+ C++ +A RP +N+
Sbjct: 288 EHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALK--IAVLALDCISIDAKSRPTMNE 345
Query: 331 IVVALDYLVSQRDSHPVSRN 350
IV ++ L Q+++ +N
Sbjct: 346 IVKTMEELHIQKEASKEQQN 365
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 162/302 (53%), Positives = 208/302 (68%), Gaps = 10/302 (3%)
Query: 50 FTFRELAIATRNFREANLIGEGGFGKVYKGRLE-------SGQLVAIKQLNHEGLQGHQE 102
FT EL T++FR ++GEGGFG VYKG ++ VA+K LN EGLQGH+E
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 103 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 162
++ EV L L H NLV LIGYC D RLLVYE+M GSLE+HL+ PLSW+ R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLF--RKTTAPLSWSRR 174
Query: 163 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 222
M IA+GAA+GL +LH A PVIYRD K++NILLD+D+ KLSDFGLAK GP GD THVS
Sbjct: 175 MMIALGAAKGLAFLH-NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 223 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282
TRVMGTYGY APEY M+G LT +SD+YSFGVVLLE++TGRK++D ++ EQNLV W+RP
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342
L D++K + ++DP L +Y R A ++ CL++ RPL++D+V L+ L
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTG 353
Query: 343 DS 344
D+
Sbjct: 354 DA 355
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 319 bits (817), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 161/337 (47%), Positives = 221/337 (65%), Gaps = 23/337 (6%)
Query: 48 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNHEGL 97
+SFTF EL ATRNFR +++GEGGFG V+KG ++ +G ++A+K+LN +G
Sbjct: 55 KSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGW 114
Query: 98 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 157
QGHQE++ EV L H NLV LIGYC + RLLVYE+MP GSLE+HL+ +PL
Sbjct: 115 QGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPL 174
Query: 158 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
SW R+K+A+GAA+GL +LH A VIYRD K++NILLD+++N KLSDFGLAK GP GD
Sbjct: 175 SWTLRLKVALGAAKGLAFLH-NAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGD 233
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 277
+HVSTR+MGTYGY APEY +G LT KSD+YS+GVVLLE+++GR+A+D ++ GEQ LV
Sbjct: 234 KSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLV 293
Query: 278 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337
W+RP L +++K ++D L +Y + CL E RP +N++V L++
Sbjct: 294 EWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEH 353
Query: 338 LVSQRDSHPVSRNAGARGVPTSASDVSQGSNSRRSSS 374
+ + + AG R + D+ Q RRS S
Sbjct: 354 IQTLNE-------AGGRNI-----DMVQRRMRRRSDS 378
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 375 | ||||||
| 255539234 | 381 | receptor serine-threonine protein kinase | 0.997 | 0.981 | 0.768 | 1e-166 | |
| 51971074 | 381 | unknown protein [Arabidopsis thaliana] | 0.949 | 0.934 | 0.744 | 1e-162 | |
| 145335950 | 381 | protein kinase-like protein [Arabidopsis | 0.949 | 0.934 | 0.741 | 1e-162 | |
| 297850486 | 381 | protein kinase [Arabidopsis lyrata subsp | 0.949 | 0.934 | 0.741 | 1e-161 | |
| 224061871 | 313 | predicted protein [Populus trichocarpa] | 0.808 | 0.968 | 0.868 | 1e-157 | |
| 359491840 | 401 | PREDICTED: serine/threonine-protein kina | 0.981 | 0.917 | 0.713 | 1e-155 | |
| 297745557 | 433 | unnamed protein product [Vitis vinifera] | 0.981 | 0.849 | 0.713 | 1e-154 | |
| 449485117 | 385 | PREDICTED: serine/threonine-protein kina | 0.949 | 0.924 | 0.731 | 1e-154 | |
| 449455605 | 389 | PREDICTED: serine/threonine-protein kina | 0.949 | 0.915 | 0.723 | 1e-152 | |
| 224086050 | 338 | predicted protein [Populus trichocarpa] | 0.877 | 0.973 | 0.789 | 1e-151 |
| >gi|255539234|ref|XP_002510682.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223551383|gb|EEF52869.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-166, Method: Compositional matrix adjust.
Identities = 289/376 (76%), Positives = 327/376 (86%), Gaps = 2/376 (0%)
Query: 1 MSCFSCLTRQTKDTKVDIDDAPRSKSRYSSESSENGKGNG--GKEKSGARSFTFRELAIA 58
M CFSCL+ KDTK+DI+ PRS S YSS+SS N K NG ++SGA+SFTFRELA+A
Sbjct: 1 MRCFSCLSSHRKDTKIDIESGPRSASLYSSDSSGNAKVNGKDNGKRSGAQSFTFRELAVA 60
Query: 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL 118
T NFRE NLIGEGGFG+VYKGRLESGQ+VA+KQLNH+G+QG QEFIVEVLMLSLLHH NL
Sbjct: 61 TNNFREMNLIGEGGFGRVYKGRLESGQIVAVKQLNHDGVQGFQEFIVEVLMLSLLHHSNL 120
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
VTLIGYCT+GDQRLLVYEYM MGS+EDH++DL+PD+EPL+W+TRMKIA+GAARGLEYLHC
Sbjct: 121 VTLIGYCTAGDQRLLVYEYMQMGSVEDHIFDLDPDKEPLNWSTRMKIAIGAARGLEYLHC 180
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
KANPPVIYRDLKSANILLD DFNPKLSDFGLAKLGPVG+NTHVSTRVMGTYGYCAPEYAM
Sbjct: 181 KANPPVIYRDLKSANILLDTDFNPKLSDFGLAKLGPVGENTHVSTRVMGTYGYCAPEYAM 240
Query: 239 SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298
SGKLTLKSDIYSFGVVLLELITGRKA+D SK GEQNLV+W+RPFLKDQKKF LVDPLL
Sbjct: 241 SGKLTLKSDIYSFGVVLLELITGRKAIDRSKRPGEQNLVAWARPFLKDQKKFYQLVDPLL 300
Query: 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGARGVPT 358
G YPRRCLNYA+A+TAMCL+EEANFRPLI DIVVAL+YL SQ + + G+P
Sbjct: 301 QGCYPRRCLNYAIAITAMCLHEEANFRPLIGDIVVALEYLASQCHGSESNSSQVRSGIPQ 360
Query: 359 SASDVSQGSNSRRSSS 374
S+ ++G+ S+ S
Sbjct: 361 SSMATNRGAVSQEPMS 376
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|51971074|dbj|BAD44229.1| unknown protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1486), Expect = e-162, Method: Compositional matrix adjust.
Identities = 282/379 (74%), Positives = 317/379 (83%), Gaps = 23/379 (6%)
Query: 3 CFSCLTRQTKDTKVDIDDAPRSKSRYSSESSE----------------NGKGNGGKEKSG 46
CFSCL +TKD +VDID+A R SRY ++SS NGK N G
Sbjct: 4 CFSCLNPRTKDIRVDIDNA-RCNSRYQTDSSVHGSDTTGTESISGILVNGKVNSPIPSGG 62
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVE 106
ARSFTF+ELA ATRNFRE NL+GEGGFG+VYKGRL+SGQ+VAIKQLN +GLQG++EFIVE
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNPDGLQGNREFIVE 122
Query: 107 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 166
VLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +QEPLSWNTRMKIA
Sbjct: 123 VLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIA 182
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 226
VGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGPVGD THVSTRVM
Sbjct: 183 VGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVM 242
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286
GTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DL + QGEQNLV+WSRP+LKD
Sbjct: 243 GTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKD 302
Query: 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346
QKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVAL+YL +Q SH
Sbjct: 303 QKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE 362
Query: 347 VSRNAGARGVPTSASDVSQ 365
AR V + + ++S+
Sbjct: 363 ------ARNVSSPSPEISR 375
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145335950|ref|NP_173489.2| protein kinase-like protein [Arabidopsis thaliana] gi|8778594|gb|AAF79602.1|AC027665_3 F5M15.3 [Arabidopsis thaliana] gi|8886951|gb|AAF80637.1|AC069251_30 F2D10.13 [Arabidopsis thaliana] gi|51971194|dbj|BAD44289.1| unknown protein [Arabidopsis thaliana] gi|332191880|gb|AEE30001.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1486), Expect = e-162, Method: Compositional matrix adjust.
Identities = 281/379 (74%), Positives = 317/379 (83%), Gaps = 23/379 (6%)
Query: 3 CFSCLTRQTKDTKVDIDDAPRSKSRYSSESSENGKGNGGKEK----------------SG 46
CFSCL +TKD +VDID+A R SRY ++SS +G G E G
Sbjct: 4 CFSCLNPRTKDIRVDIDNA-RCNSRYQTDSSVHGSDTTGTESISGILVNGKVNSPIPGGG 62
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVE 106
ARSFTF+ELA ATRNFRE NL+GEGGFG+VYKGRL+SGQ+VAIKQLN +GLQG++EFIVE
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNPDGLQGNREFIVE 122
Query: 107 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 166
VLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +QEPLSWNTRMKIA
Sbjct: 123 VLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIA 182
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 226
VGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGPVGD THVSTRVM
Sbjct: 183 VGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVM 242
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286
GTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DL + QGEQNLV+WSRP+LKD
Sbjct: 243 GTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKD 302
Query: 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346
QKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVAL+YL +Q SH
Sbjct: 303 QKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE 362
Query: 347 VSRNAGARGVPTSASDVSQ 365
AR V + + ++S+
Sbjct: 363 ------ARNVSSPSPEISR 375
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297850486|ref|XP_002893124.1| protein kinase [Arabidopsis lyrata subsp. lyrata] gi|297338966|gb|EFH69383.1| protein kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 574 bits (1480), Expect = e-161, Method: Compositional matrix adjust.
Identities = 281/379 (74%), Positives = 317/379 (83%), Gaps = 23/379 (6%)
Query: 3 CFSCLTRQTKDTKVDIDDAPRSKSRYSSESSENGKGNGGKEK----------------SG 46
CFSCL +TKD +VDID+A R SRY ++SS +G G E G
Sbjct: 4 CFSCLNPRTKDIRVDIDNA-RCNSRYQTDSSVHGSDTTGTESISGILVNGKVNSPIPGGG 62
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVE 106
ARSFTF+ELA ATRNFRE NL+GEGGFG+VYKGRL+SGQ+VAIKQLN +GLQG++EFIVE
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNPDGLQGNREFIVE 122
Query: 107 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 166
VLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +QEPLSWNTRMKIA
Sbjct: 123 VLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIA 182
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 226
VGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGPVGD THVSTRVM
Sbjct: 183 VGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVM 242
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286
GTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DLS+ QGEQNLV+WSR +LKD
Sbjct: 243 GTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLSQKQGEQNLVTWSRSYLKD 302
Query: 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346
QKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVAL+YL +Q SH
Sbjct: 303 QKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE 362
Query: 347 VSRNAGARGVPTSASDVSQ 365
AR V + + +V++
Sbjct: 363 ------ARNVSSPSPEVTR 375
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224061871|ref|XP_002300640.1| predicted protein [Populus trichocarpa] gi|222842366|gb|EEE79913.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 265/305 (86%), Positives = 287/305 (94%), Gaps = 2/305 (0%)
Query: 37 KGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEG 96
KG G +E GARSFTFRELA ATRNFRE NLIGEGGFG+VYKGRLE+G++VA+KQLN +G
Sbjct: 1 KGQGAEE--GARSFTFRELAAATRNFREINLIGEGGFGRVYKGRLETGEIVAVKQLNQDG 58
Query: 97 LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP 156
LQGHQEFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLEPD+EP
Sbjct: 59 LQGHQEFIVEVLMLSLLHHSNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLEPDKEP 118
Query: 157 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216
LSW+TRMKIAVGAARGLEYLHCKA+PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG
Sbjct: 119 LSWSTRMKIAVGAARGLEYLHCKADPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 178
Query: 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276
+NTHVSTRVMGTYGYCAPEYAMSGKLT+KSDIYSFGVVLLELITGRKA+D SK GEQNL
Sbjct: 179 ENTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYSFGVVLLELITGRKAIDRSKKPGEQNL 238
Query: 277 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336
V+WSR FLK+QKK+ L DPLL G YPRRCLNYA+A+TAMCLNEEANFRPLI+DI+VAL+
Sbjct: 239 VAWSRAFLKEQKKYCQLADPLLEGCYPRRCLNYAIAITAMCLNEEANFRPLISDILVALE 298
Query: 337 YLVSQ 341
YL SQ
Sbjct: 299 YLASQ 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491840|ref|XP_002271454.2| PREDICTED: serine/threonine-protein kinase PBS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1425), Expect = e-155, Method: Compositional matrix adjust.
Identities = 279/391 (71%), Positives = 314/391 (80%), Gaps = 23/391 (5%)
Query: 1 MSCFSCLTRQTKDTKVDIDD----APRS------------KSRYSSESSENGKGNG---G 41
MSC C++ + +D DD P S + + S +SS+NGKG G G
Sbjct: 1 MSCLPCMSPRKRDVSRIEDDNGTTGPSSSCHSIDDSLGTTRGKGSFDSSDNGKGKGSLNG 60
Query: 42 K---EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ 98
K + + ARSFTFR+LA ATRNF+ NLIGEGGFGKVYKGRL++G++VAIKQLNH+GLQ
Sbjct: 61 KAHPKSNAARSFTFRQLATATRNFKATNLIGEGGFGKVYKGRLDTGEIVAIKQLNHDGLQ 120
Query: 99 GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLS 158
G QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE HL+DL PDQEPL
Sbjct: 121 GFQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMAMGSLEHHLFDLGPDQEPLG 180
Query: 159 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218
WNTR++IAVGAARGLEYLHCKANPPVIYRDLKSANILLDN+FNPKLSDFGLAKLGPVGDN
Sbjct: 181 WNTRIQIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNEFNPKLSDFGLAKLGPVGDN 240
Query: 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 278
THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D SK QGEQNLV+
Sbjct: 241 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAIDTSKRQGEQNLVA 300
Query: 279 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338
WSRPFLKD+KKF+ LVDP L G +P R L++A+A+TAMCL E+ NFRPLI DIVVAL+YL
Sbjct: 301 WSRPFLKDRKKFIQLVDPQLQGNFPVRALHHAIAITAMCLQEQPNFRPLIGDIVVALEYL 360
Query: 339 VSQRDSHPVSRNAGARGVPTSASDVSQGSNS 369
S+ S RN R +S S S+ SNS
Sbjct: 361 ASESHSSEPHRNQ-VRLPSSSPSQGSRNSNS 390
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745557|emb|CBI40722.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 552 bits (1422), Expect = e-154, Method: Compositional matrix adjust.
Identities = 279/391 (71%), Positives = 314/391 (80%), Gaps = 23/391 (5%)
Query: 1 MSCFSCLTRQTKDTKVDIDD----APRS------------KSRYSSESSENGKGNG---G 41
MSC C++ + +D DD P S + + S +SS+NGKG G G
Sbjct: 33 MSCLPCMSPRKRDVSRIEDDNGTTGPSSSCHSIDDSLGTTRGKGSFDSSDNGKGKGSLNG 92
Query: 42 K---EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ 98
K + + ARSFTFR+LA ATRNF+ NLIGEGGFGKVYKGRL++G++VAIKQLNH+GLQ
Sbjct: 93 KAHPKSNAARSFTFRQLATATRNFKATNLIGEGGFGKVYKGRLDTGEIVAIKQLNHDGLQ 152
Query: 99 GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLS 158
G QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE HL+DL PDQEPL
Sbjct: 153 GFQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMAMGSLEHHLFDLGPDQEPLG 212
Query: 159 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218
WNTR++IAVGAARGLEYLHCKANPPVIYRDLKSANILLDN+FNPKLSDFGLAKLGPVGDN
Sbjct: 213 WNTRIQIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNEFNPKLSDFGLAKLGPVGDN 272
Query: 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 278
THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D SK QGEQNLV+
Sbjct: 273 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAIDTSKRQGEQNLVA 332
Query: 279 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338
WSRPFLKD+KKF+ LVDP L G +P R L++A+A+TAMCL E+ NFRPLI DIVVAL+YL
Sbjct: 333 WSRPFLKDRKKFIQLVDPQLQGNFPVRALHHAIAITAMCLQEQPNFRPLIGDIVVALEYL 392
Query: 339 VSQRDSHPVSRNAGARGVPTSASDVSQGSNS 369
S+ S RN R +S S S+ SNS
Sbjct: 393 ASESHSSEPHRNQ-VRLPSSSPSQGSRNSNS 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449485117|ref|XP_004157074.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1415), Expect = e-154, Method: Compositional matrix adjust.
Identities = 270/369 (73%), Positives = 306/369 (82%), Gaps = 13/369 (3%)
Query: 1 MSCFSCLTRQTKD-TKVDIDDAPRSKSRYSSESSENGKGNGGKEKSG-------ARSFTF 52
MSCFSC+ + KD +KV+ID+ R S S+E GKG + + G ARSF F
Sbjct: 1 MSCFSCIRTRCKDASKVEIDNG---SGRGKSYSNETGKGKESQNRGGNNRKCGAARSFPF 57
Query: 53 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL 112
RELA ATR F+E NLIGEGGFG+VYKGRLESGQ+VAIKQLNH+GLQG+QEFIVEVLMLSL
Sbjct: 58 RELATATRGFKEVNLIGEGGFGRVYKGRLESGQIVAIKQLNHDGLQGYQEFIVEVLMLSL 117
Query: 113 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
LHH NLVTLIGYCT GDQRLLVYEYM MGSLE+HL+ L P + PLSWNTR+KIA+GAA+G
Sbjct: 118 LHHSNLVTLIGYCTDGDQRLLVYEYMSMGSLENHLFGLFPKRSPLSWNTRIKIALGAAQG 177
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
LEYLHC ANPPVIYRDLKSANILLD+DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC
Sbjct: 178 LEYLHCTANPPVIYRDLKSANILLDDDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 237
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292
APEYAMSGKLTLKSDIY FGVVLLE+ITGRKA+D +K GEQNLV+WSRPFLKD++KFV
Sbjct: 238 APEYAMSGKLTLKSDIYCFGVVLLEIITGRKAIDTTKKPGEQNLVAWSRPFLKDRRKFVQ 297
Query: 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAG 352
LVDPLL GRYP RCL++A+A+ AMCL E+ FRP+I+DIVVAL+YL SQ SH +
Sbjct: 298 LVDPLLEGRYPLRCLHHAIAIAAMCLQEQPMFRPIISDIVVALEYLASQ--SHASEQPRE 355
Query: 353 ARGVPTSAS 361
G P+ S
Sbjct: 356 GVGSPSKLS 364
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455605|ref|XP_004145543.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 544 bits (1401), Expect = e-152, Method: Compositional matrix adjust.
Identities = 270/373 (72%), Positives = 306/373 (82%), Gaps = 17/373 (4%)
Query: 1 MSCFSCLTRQTKD-TKVDIDDAPRSKSRYSSESSENGKGNGGKEKSG-------ARSFTF 52
MSCFSC+ + KD +KV+ID+ R S S+E GKG + + G ARSF F
Sbjct: 1 MSCFSCIRTRCKDASKVEIDNG---SGRGKSYSNETGKGKESQNRGGNNRKCGAARSFPF 57
Query: 53 RELAIATRNFREANLIGEGGFGKVYKGRLESGQ----LVAIKQLNHEGLQGHQEFIVEVL 108
RELA ATR F+E NLIGEGGFG+VYKGRLESGQ +VAIKQLNH+GLQG+QEFIVEVL
Sbjct: 58 RELATATRGFKEVNLIGEGGFGRVYKGRLESGQGFKEIVAIKQLNHDGLQGYQEFIVEVL 117
Query: 109 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 168
MLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE+HL+ L P + PLSWNTR+KIA+G
Sbjct: 118 MLSLLHHSNLVTLIGYCTDGDQRLLVYEYMSMGSLENHLFGLFPKRSPLSWNTRIKIALG 177
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 228
AA+GLEYLHC ANPPVIYRDLKSANILLD+DFNPKLSDFGLAKLGPVGDNTHVSTRVMGT
Sbjct: 178 AAQGLEYLHCTANPPVIYRDLKSANILLDDDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 237
Query: 229 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288
YGYCAPEYAMSGKLTLKSDIY FGVVLLE+ITGRKA+D +K GEQNLV+WSRPFLKD++
Sbjct: 238 YGYCAPEYAMSGKLTLKSDIYCFGVVLLEIITGRKAIDTTKKPGEQNLVAWSRPFLKDRR 297
Query: 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 348
KFV LVDPLL GRYP RCL++A+A+ AMCL E+ FRP+I+DIVVAL+YL SQ SH
Sbjct: 298 KFVQLVDPLLEGRYPLRCLHHAIAIAAMCLQEQPMFRPIISDIVVALEYLASQ--SHASE 355
Query: 349 RNAGARGVPTSAS 361
+ G P+ S
Sbjct: 356 QPREGVGSPSKLS 368
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086050|ref|XP_002307795.1| predicted protein [Populus trichocarpa] gi|222857244|gb|EEE94791.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1396), Expect = e-151, Method: Compositional matrix adjust.
Identities = 266/337 (78%), Positives = 293/337 (86%), Gaps = 8/337 (2%)
Query: 44 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEF 103
+ GARSFTFRELA ATRNFRE NLIGEGGFG+VYKGRLE+G+LVA+KQLN +GLQG QEF
Sbjct: 3 EDGARSFTFRELAAATRNFREVNLIGEGGFGRVYKGRLETGELVAVKQLNQDGLQGDQEF 62
Query: 104 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 163
IVEVLMLSLLHH NLVTL GYCTSGDQRLLVYEYMPMGSLEDHL+DLEP +EPLSW+TR+
Sbjct: 63 IVEVLMLSLLHHSNLVTLTGYCTSGDQRLLVYEYMPMGSLEDHLFDLEPGKEPLSWSTRI 122
Query: 164 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223
KIAVGAARGLEYLHCKA+PPVIYRDLKSANILLDNDF PKLSDFG+AKLGPVG+NTHVST
Sbjct: 123 KIAVGAARGLEYLHCKADPPVIYRDLKSANILLDNDFQPKLSDFGIAKLGPVGENTHVST 182
Query: 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283
RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D SK GEQNL +WS+PF
Sbjct: 183 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAIDRSKKPGEQNLAAWSQPF 242
Query: 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343
LKDQKK+ L DPLL G YPRRC NYA+A+TAMCLNE+A+FRPLI DI+ AL+YL +Q
Sbjct: 243 LKDQKKYCQLADPLLEGCYPRRCFNYAIAITAMCLNEQASFRPLIGDILGALEYLAAQ-- 300
Query: 344 SHPVSRNAG-ARGVPTSA--SD---VSQGSNSRRSSS 374
H N G RG S+ SD VSQ +SR +S
Sbjct: 301 CHVSEPNTGRVRGTNPSSPYSDRKVVSQERDSRSRAS 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 375 | ||||||
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.933 | 0.918 | 0.734 | 7e-141 | |
| TAIR|locus:2014604 | 381 | AT1G76370 [Arabidopsis thalian | 0.936 | 0.921 | 0.675 | 1.7e-128 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.829 | 0.606 | 0.707 | 3e-117 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.829 | 0.822 | 0.701 | 6.2e-117 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.786 | 0.646 | 0.702 | 1.4e-114 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.792 | 0.717 | 0.687 | 1.6e-109 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.810 | 0.837 | 0.665 | 9e-109 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.778 | 0.756 | 0.653 | 5.8e-105 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.794 | 0.766 | 0.632 | 9.8e-103 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.789 | 0.698 | 0.629 | 9.1e-100 |
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1378 (490.1 bits), Expect = 7.0e-141, P = 7.0e-141
Identities = 269/366 (73%), Positives = 299/366 (81%)
Query: 3 CFSCLTRQTKDTKVDIDDAPXXXXXXXXXXXXXXXXXXXXXXXX---------------A 47
CFSCL +TKD +VDID+A A
Sbjct: 4 CFSCLNPRTKDIRVDIDNARCNSRYQTDSSVHGSDTTGTESISGILVNGKVNSPIPGGGA 63
Query: 48 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEV 107
RSFTF+ELA ATRNFRE NL+GEGGFG+VYKGRL+SGQ+VAIKQLN +GLQG++EFIVEV
Sbjct: 64 RSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNPDGLQGNREFIVEV 123
Query: 108 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 167
LMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +QEPLSWNTRMKIAV
Sbjct: 124 LMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAV 183
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 227
GAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGPVGD THVSTRVMG
Sbjct: 184 GAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMG 243
Query: 228 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287
TYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DL + QGEQNLV+WSRP+LKDQ
Sbjct: 244 TYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQ 303
Query: 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 347
KKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVAL+YL +Q SH
Sbjct: 304 KKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE- 362
Query: 348 SRNAGA 353
+RN +
Sbjct: 363 ARNVSS 368
|
|
| TAIR|locus:2014604 AT1G76370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
Identities = 246/364 (67%), Positives = 283/364 (77%)
Query: 1 MSCFSCLTRQTKDTKVDIDDAPXXXXXXXXXXXXXXXXXXXXXXXX-------------A 47
M CFSCL QT D +++ID A
Sbjct: 1 MRCFSCLNTQTNDMRINIDTLSDLTDYASVATKIDPRGTGSKSGILVNGKVNSPKPGGGA 60
Query: 48 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEV 107
RSFTF+ELA AT+NFRE N+IG+GGFG VYKGRL+SGQ+VAIKQLN +G QG+QEFIVEV
Sbjct: 61 RSFTFKELAAATKNFREGNIIGKGGFGSVYKGRLDSGQVVAIKQLNPDGHQGNQEFIVEV 120
Query: 108 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 167
MLS+ HH NLVTLIGYCTSG QRLLVYEYMPMGSLEDHL+DLEPDQ PLSW TRMKIAV
Sbjct: 121 CMLSVFHHPNLVTLIGYCTSGAQRLLVYEYMPMGSLEDHLFDLEPDQTPLSWYTRMKIAV 180
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 227
GAARG+EYLHCK +P VIYRDLKSANILLD +F+ KLSDFGLAK+GPVG+ THVSTRVMG
Sbjct: 181 GAARGIEYLHCKISPSVIYRDLKSANILLDKEFSVKLSDFGLAKVGPVGNRTHVSTRVMG 240
Query: 228 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287
TYGYCAPEYAMSG+LT+KSDIYSFGVVLLELI+GRKA+DLSK GEQ LV+W+RP+LKD
Sbjct: 241 TYGYCAPEYAMSGRLTIKSDIYSFGVVLLELISGRKAIDLSKPNGEQYLVAWARPYLKDP 300
Query: 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 347
KKF LVDPLL G++ +RCLNYA+++T MCLN+EAN RP I D+VVA +Y+ SQ S+
Sbjct: 301 KKFGLLVDPLLRGKFSKRCLNYAISITEMCLNDEANHRPKIGDVVVAFEYIASQSKSYED 360
Query: 348 SRNA 351
R A
Sbjct: 361 RRTA 364
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1155 (411.6 bits), Expect = 3.0e-117, P = 3.0e-117
Identities = 222/314 (70%), Positives = 261/314 (83%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIV 105
A++FTFRELA AT+NFR L+GEGGFG+VYKGRLE+ GQ+VA+KQL+ GLQG++EF+V
Sbjct: 68 AQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNGLQGNREFLV 127
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
EVLMLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLEDHL+DL PD+EPL W+TRM I
Sbjct: 128 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWSTRMTI 187
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A GAA+GLEYLH KANPPVIYRDLKS+NILL + ++PKLSDFGLAKLGPVGD THVSTRV
Sbjct: 188 AAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTHVSTRV 247
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285
MGTYGYCAPEYAM+G+LTLKSD+YSFGVV LELITGRKA+D ++ GE NLV+W+RP K
Sbjct: 248 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWARPLFK 307
Query: 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR-DS 344
D++KF + DP L GRYP R L A+AV AMCL E+A RPLI D+V AL YL SQ D
Sbjct: 308 DRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTFDP 367
Query: 345 H-PVSRNAGARGVP 357
+ P +N+ + P
Sbjct: 368 NAPSGQNSRSGSGP 381
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1152 (410.6 bits), Expect = 6.2e-117, P = 6.2e-117
Identities = 221/315 (70%), Positives = 259/315 (82%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIV 105
A++FTF ELA ATRNFR+ LIGEGGFG+VYKG L S Q AIKQL+H GLQG++EF+V
Sbjct: 58 AQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLV 117
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
EVLMLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLEDHL+D+ P ++PL WNTRMKI
Sbjct: 118 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKI 177
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A GAA+GLEYLH K PPVIYRDLK +NILLD+D+ PKLSDFGLAKLGPVGD +HVSTRV
Sbjct: 178 AAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRV 237
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285
MGTYGYCAPEYAM+G+LTLKSD+YSFGVVLLE+ITGRKA+D S+ GEQNLV+W+RP K
Sbjct: 238 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLFK 297
Query: 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR-D- 343
D++KF + DP+L G+YP R L A+AV AMC+ E+ N RPLI D+V AL YL SQ+ D
Sbjct: 298 DRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFDP 357
Query: 344 -SHPVSRNAGARGVP 357
+ PV + A G P
Sbjct: 358 LAQPVQGSLFAPGTP 372
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1112 (396.5 bits), Expect = 1.4e-114, Sum P(2) = 1.4e-114
Identities = 208/296 (70%), Positives = 244/296 (82%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIV 105
A +F FRELA AT NF +GEGGFG+VYKGRL+S GQ+VA+KQL+ GLQG++EF+V
Sbjct: 71 AHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLV 130
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
EVLMLSLLHH NLV LIGYC GDQRLLVYE+MP+GSLEDHL+DL PD+E L WN RMKI
Sbjct: 131 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKI 190
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A GAA+GLE+LH KANPPVIYRD KS+NILLD F+PKLSDFGLAKLGP GD +HVSTRV
Sbjct: 191 AAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRV 250
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285
MGTYGYCAPEYAM+G+LT+KSD+YSFGVV LELITGRKA+D GEQNLV+W+RP
Sbjct: 251 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFN 310
Query: 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341
D++KF+ L DP L GR+P R L A+AV +MC+ E+A RPLI D+V AL YL +Q
Sbjct: 311 DRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQ 366
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 1.6e-109, P = 1.6e-109
Identities = 205/298 (68%), Positives = 246/298 (82%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIV 105
A++F+FRELA AT+NFR+ LIGEGGFG+VYKG+LE +G +VA+KQL+ GLQG++EFIV
Sbjct: 64 AQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIV 123
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
EVLMLSLLHH +LV LIGYC GDQRLLVYEYM GSLEDHL DL PDQ PL W+TR++I
Sbjct: 124 EVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRI 183
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A+GAA GLEYLH KANPPVIYRDLK+ANILLD +FN KLSDFGLAKLGPVGD HVS+RV
Sbjct: 184 ALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRV 243
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285
MGTYGYCAPEY +G+LT KSD+YSFGVVLLELITGR+ +D ++ + EQNLV+W++P K
Sbjct: 244 MGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFK 303
Query: 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343
+ +F L DP L G +P + LN AVAV AMCL EEA RPL++D+V AL +L + D
Sbjct: 304 EPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTAPD 361
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1075 (383.5 bits), Expect = 9.0e-109, P = 9.0e-109
Identities = 203/305 (66%), Positives = 246/305 (80%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIV 105
AR FTFRELA AT+NFR+ LIGEGGFG+VYKG+LE+ Q+VA+KQL+ GLQG +EF+V
Sbjct: 32 ARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGLQGQREFLV 91
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
EVLMLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLEDHL DLEP Q+PL WNTR+KI
Sbjct: 92 EVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDWNTRIKI 151
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A+GAA+G+EYLH +A+PPVIYRDLKS+NILLD ++ KLSDFGLAKLGPVGD HVS+RV
Sbjct: 152 ALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTLHVSSRV 211
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285
MGTYGYCAPEY +G LT KSD+YSFGVVLLELI+GR+ +D + EQNLV+W+ P +
Sbjct: 212 MGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTWALPIFR 271
Query: 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 345
D ++ L DPLL G YP + LN A+AV AMCL+EE RPL++D++ AL +L + +S
Sbjct: 272 DPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSFLGASSNSS 331
Query: 346 PVSRN 350
N
Sbjct: 332 NTGSN 336
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1039 (370.8 bits), Expect = 5.8e-105, P = 5.8e-105
Identities = 192/294 (65%), Positives = 241/294 (81%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESG-QLVAIKQLNHEGLQGHQEFIV 105
A FTFREL +AT+NF N +GEGGFG+VYKG++E+ Q+VA+KQL+ G QG++EF+V
Sbjct: 67 AHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLV 126
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE-PLSWNTRMK 164
EV+MLSLLHH NLV L+GYC GDQR+LVYEYM GSLEDHL +L +++ PL W+TRMK
Sbjct: 127 EVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMK 186
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 224
+A GAARGLEYLH A+PPVIYRD K++NILLD +FNPKLSDFGLAK+GP G THVSTR
Sbjct: 187 VAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTR 246
Query: 225 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 284
VMGTYGYCAPEYA++G+LT+KSD+YSFGVV LE+ITGR+ +D +K EQNLV+W+ P
Sbjct: 247 VMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLF 306
Query: 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338
KD++KF + DPLL G+YP + L A+AV AMCL EEA RP+++D+V AL+YL
Sbjct: 307 KDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYL 360
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
Identities = 189/299 (63%), Positives = 243/299 (81%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIV 105
A+SF FRELA AT +FR+ LIGEGGFG+VYKG++E +GQ+VA+KQL+ GLQG++EF+V
Sbjct: 56 AKSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDRNGLQGNREFLV 115
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
E+ LSLLHH NL LIGYC GDQRLLV+E+MP+GSLEDHL D+ Q+PL WN+R++I
Sbjct: 116 EIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRIRI 175
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A+GAA+GLEYLH KANPPVIYRD KS+NILL+ DF+ KLSDFGLAKLG VGD +VS+RV
Sbjct: 176 ALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSSRV 235
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285
+GTYGYCAPEY +G+LT+KSD+YSFGVVLLELITG++ +D ++ EQNLV+W++P +
Sbjct: 236 VGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPIFR 295
Query: 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344
+ +F L DPLL G +P + LN AVA+ AMCL EE RPLI+D+V AL ++ ++ S
Sbjct: 296 EPNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSFMSTETGS 354
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 990 (353.6 bits), Expect = 9.1e-100, P = 9.1e-100
Identities = 187/297 (62%), Positives = 233/297 (78%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIV 105
A++FTF EL+++T NF+ +GEGGFGKVYKG +E Q+VAIKQL+ G QG +EF+V
Sbjct: 83 AQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIKQLDRNGAQGIREFVV 142
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
EVL LSL H NLV LIG+C G QRLLVYEYMP+GSL++HL+DL + PL+WNTRMKI
Sbjct: 143 EVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKI 202
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A GAARGLEYLH PPVIYRDLK +NIL+D ++ KLSDFGLAK+GP G THVSTRV
Sbjct: 203 AAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTRV 262
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285
MGTYGYCAP+YA++G+LT KSD+YSFGVVLLELITGRKA D ++ + Q+LV W+ P K
Sbjct: 263 MGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPLFK 322
Query: 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342
D+K F +VDPLL G YP R L A+A+ AMC+ E+ + RP+I D+V+ALD+L S +
Sbjct: 323 DRKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQPSMRPVIADVVMALDHLASSK 379
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | AT1G20650 | ATP binding / protein kinase/ protein serine/threonine kinase; ATP binding / protein kinase/ protein serine/threonine kinase; FUNCTIONS IN- protein serine/threonine kinase activity, protein kinase activity, ATP binding; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- cellular_component unknown; EXPRESSED IN- 22 plant structures; EXPRESSED DURING- 13 growth stages; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kinase, core (InterPro-IPR000719), Serine/threonine protein kinase-related (InterPro-IPR017442), Protein kinase-like (Int [...] (381 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | AT2G40475 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (193 aa) | • | 0.925 | |||||||
 | AT5G47580 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (748 aa) | • | 0.875 | |||||||
 | ANAC014 | no apical meristem (NAM) family protein; ARABIDOPSIS NAC 014 (ANAC014); FUNCTIONS IN- transcrip [...] (652 aa) | • | 0.621 | |||||||
 | XLG1 | XLG1 (EXTRA-LARGE G-PROTEIN 1); guanyl nucleotide binding / signal transducer; encodes a novel [...] (888 aa) | • | 0.407 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 375 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-58 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-51 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-41 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-31 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 9e-58
Identities = 79/195 (40%), Positives = 111/195 (56%), Gaps = 12/195 (6%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYC 125
+GEGGFG VY R ++G+ VAIK + E +E + E+ +L L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
+ LV EY GSL+D L + E LS + ++I + GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 186 YRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLT 243
+RDLK NILLD+D KL+DFGL+KL + + + ++GT Y APE + G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 244 LKSDIYSFGVVLLEL 258
KSDI+S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-55
Identities = 75/199 (37%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 66 NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIG 123
+GEG FGKVY R ++G+LVAIK + + ++ +E I+ E+ +L L H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
D+ LV EY G L D L E + LEYLH K
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILSALEYLHSK---G 117
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 243
+++RDLK NILLD D + KL+DFGLA+ + ++T V GT Y APE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLGKGYG 174
Query: 244 LKSDIYSFGVVLLELITGR 262
DI+S GV+L EL+TG+
Sbjct: 175 KAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 1e-54
Identities = 76/199 (38%), Positives = 107/199 (53%), Gaps = 12/199 (6%)
Query: 68 IGEGGFGKVYKGRL-----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FG+VYKG L VA+K L + Q +EF+ E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
+G CT + ++V EYMP G L D+L P + LS + + A+ ARG+EYL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK-- 122
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
I+RDL + N L+ + K+SDFGL++ D V + APE GK
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180
Query: 242 LTLKSDIYSFGVVLLELIT 260
T KSD++SFGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 6e-54
Identities = 73/199 (36%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 68 IGEGGFGKVYKGRLE-----SGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FG+VYKG+L+ VA+K L + Q +EF+ E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
+G CT + +V EYM G L +L P LS + + A+ ARG+EYL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK-- 121
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
I+RDL + N L+ + K+SDFGL++ D + APE GK
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179
Query: 242 LTLKSDIYSFGVVLLELIT 260
T KSD++SFGV+L E+ T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 1e-53
Identities = 79/199 (39%), Positives = 107/199 (53%), Gaps = 13/199 (6%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 124
+G G FG VYK + +G++VA+K L E + Q E+ +L L H N+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
D LV EY G L D+L PLS + KIA+ RGLEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAMSGKLT 243
I+RDLK NILLD + K++DFGLAK + ++ ++T V GT Y APE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 244 LKSDIYSFGVVLLELITGR 262
K D++S GV+L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 174 bits (445), Expect = 1e-52
Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 12/200 (6%)
Query: 68 IGEGGFGKVYKGRL-----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FG+VYKG L + VA+K L + +EF+ E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
+G CT G+ +V EYMP G L D L E L+ +++A+ A+G+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
++RDL + N L+ + K+SDFGL++ D + APE GK
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 242 LTLKSDIYSFGVVLLELITG 261
T KSD++SFGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-51
Identities = 72/205 (35%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 66 NLIGEGGFGKVYKGRLESGQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVT 120
+GEG FG+VYKG+L+ VA+K L + + ++F+ E ++ L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHL-----YDLEPDQEPLSWNTRMKIAVGAARGLEY 175
L+G CT + LV EYM G L D+L P++ LS + A+ A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
L K ++RDL + N L+ D K+SDFGL++ D T + APE
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 236 YAMSGKLTLKSDIYSFGVVLLELIT 260
G T KSD++SFGV+L E+ T
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 6e-42
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN-HEGLQGHQEFIV-EVLMLSLLHHDN 117
+ L+G G FG VY ++G+L+A+K + + E + E+ +LS L H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 118 LVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPL--SWNTRMKIAVGAARGL 173
+V G + + EY+ GSL L EP+ + TR + GL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQIL-----EGL 114
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
YLH +++RD+K ANIL+D+D KL+DFG AK + + V GT + A
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELITGR 262
PE + +DI+S G ++E+ TG+
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 80/247 (32%), Positives = 116/247 (46%), Gaps = 34/247 (13%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 120
F IG+GGFG+VYK R +G+ VAIK + E + ++ I E+ +L H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAV---GAARGLEYL 176
G D+ +V E+ GSL+D L + E +IA +GLEYL
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES-------QIAYVCKELLKGLEYL 114
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H +I+RD+K+ANILL +D KL DFGL+ +T ++GT + APE
Sbjct: 115 H-SNG--IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEV 168
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGE---QNLVSWSRPFL 284
K+DI+S G+ +EL G+ KA+ G +N WS F
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEF- 227
Query: 285 KDQKKFV 291
K F+
Sbjct: 228 ---KDFL 231
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 3e-39
Identities = 87/298 (29%), Positives = 142/298 (47%), Gaps = 35/298 (11%)
Query: 60 RNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLL 113
R+ + +GEG FGKV R + +G+ VA+K LNH G + H+ +F E+ +L L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 114 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
H+N+V G C R L+ EY+P GSL D+L ++ ++ + + +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICK 120
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST--RVMGTY 229
G++YL + I+RDL + NIL++++ K+SDFGLAK+ P + + +
Sbjct: 121 GMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL----- 284
Y APE + K + SD++SFGV L EL T G+ + +
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFT----------YGDPSQSPPAEFLRMIGIA 226
Query: 285 KDQKKFVHLVDPLLHG-RYPR--RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339
+ Q L++ L G R PR C + + +C E RP D+++ +D L
Sbjct: 227 QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 77/206 (37%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 61 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 117
N++ +LIG G FG VYKG LE+G VAIKQ++ E + + + + E+ +L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+V IG + D ++ EY GSL + P E L ++ +GL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH 116
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-Y 236
VI+RD+K+ANIL D KL+DFG+A + D + V+GT + APE
Sbjct: 117 ---EQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGR 262
MSG + SDI+S G ++EL+TG
Sbjct: 172 EMSG-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 68 IGEGGFGKVYKGRLESGQ------LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVT 120
+GEG FGKV+ G + LVA+K L ++F E +L+ H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD----------QEPLSWNTRMKIAVGAA 170
G CT GD ++V+EYM G L L PD L+ + ++IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 230
G+ YL A+ ++RDL + N L+ D K+ DFG+++ D V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ PE M K T +SD++SFGVVL E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 25/274 (9%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL-QGHQEFIV-EVLMLSLLHHDN 117
+ IG+G FGKVY R G+L +K+++ + + +E + EV +L L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
++ + +V EY G L + + + +P + V L+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+ +++RD+K NI L ++ KL DFG++K+ + ++ V+GT Y +PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297
+ KSDI+S G VL EL T + + G+ L K + P
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLELA----------LKILKGQYPP 222
Query: 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
+ +Y L V + L ++ RP I I
Sbjct: 223 IPSQYSSE-LRNLV---SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 77/225 (34%), Positives = 113/225 (50%), Gaps = 26/225 (11%)
Query: 54 ELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQL--NHEGLQGHQEFIV 105
E+ ++ F E +GEG FGKVYKG L S VAIK L N E + QEF
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-KVQQEFRQ 57
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPD 153
E ++S L H N+V L+G CT +++EY+ G L + L E
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 154 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213
+ L + + IA+ A G+EYL ++ ++RDL + N L+ K+SDFGL++
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 258
D V ++ + + PE + GK T +SDI+SFGVVL E+
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-32
Identities = 81/222 (36%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEG---LQGHQEFIVEVLML-SLLHHD 116
++R +GEG FG+VY R +LVA+K L + + + F+ E+ +L SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
N+V L + LV EY+ GSLED L + PLS + + I LEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 177 HCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKL----GPVGDNTHVSTRVMGTYGY 231
H K +I+RD+K NILLD + KL DFGLAKL G + + +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 232 CAPEYAMSGKL---TLKSDIYSFGVVLLELITGRKAMDLSKG 270
APE + L + SDI+S G+ L EL+TG + K
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
|
Length = 384 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-32
Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHHDNLVTLI 122
IGEG +G+VYK R ++G+LVA+K++ E + F I E+ +L L H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 123 GYCTSGDQR--LLVYEYMP---MGSLEDHLYDLEPDQEPLSWNTRMK-IAVGAARGLEYL 176
TS + +V+EYM G L+ Q +K GL+YL
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ--------IKCYMKQLLEGLQYL 116
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H +++RD+K +NIL++ND KL+DFGLA+ N+ T + T Y PE
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPEL 172
Query: 237 AM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 275
+ + + + D++S G +L EL G+ +G E
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIF---QGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-32
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 55 LAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH 114
AI ++ + IG+G FG V G GQ VA+K L + Q F+ E +++ L
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLR 58
Query: 115 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
H NLV L+G G+ +V EYM GSL D+L + ++ ++ A+ G+E
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGME 116
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
YL K ++RDL + N+L+ D K+SDFGLAK G S ++ + AP
Sbjct: 117 YLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAP 168
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELIT-GR 262
E K + KSD++SFG++L E+ + GR
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 68/199 (34%), Positives = 109/199 (54%), Gaps = 7/199 (3%)
Query: 62 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121
F +G G FG+V++G ++ VAIK L + L Q+F EV L L H +L++L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
C+ G+ ++ E M GSL L P+ + L + + +A A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQN- 124
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
I+RDL + NIL+ D K++DFGLA+L + ++ ++S+ Y + APE A G
Sbjct: 125 --SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 242 LTLKSDIYSFGVVLLELIT 260
+ KSD++SFG++L E+ T
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 71/202 (35%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIG 123
+G+G FGKV R ++G+L A+K L + + +E + E +LS ++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 124 YCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK-IAVGAARGLEYLHCKA 180
+ + LV EY P G L HL E R + A LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFYAAEIVLALEYLHSLG 113
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
+IYRDLK NILLD D + KL+DFGLAK + + +T GT Y APE +
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 241 KLTLKSDIYSFGVVLLELITGR 262
D +S GV+L E++TG+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 75/211 (35%), Positives = 114/211 (54%), Gaps = 18/211 (8%)
Query: 60 RNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH 114
R+ + +G+G FG V R + +G++VA+K+L H + ++F E+ +L L
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ 63
Query: 115 HDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
HDN+V G C S +R LV EY+P GSL D+ L+ +E L + A +G
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDY---LQKHRERLDHRKLLLYASQICKG 120
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG---TY 229
+EYL K ++RDL + NIL++++ K+ DFGL K+ P D + R G +
Sbjct: 121 MEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIF 176
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
Y APE K ++ SD++SFGVVL EL T
Sbjct: 177 WY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 9e-31
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 68 IGEGGFGKVYKGRL-ESGQLVAIK--QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG- 123
+G+G G VYK R +G++ A+K ++ + Q + E+ L +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ-LLRELKTLRSCESPYVVKCYGA 67
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
+ G+ + V EYM GSL D L + EP+ IA +GL+YLH K +
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVL----AYIARQILKGLDYLHTKRH-- 120
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 242
+I+RD+K +N+L+++ K++DFG++K L D + T V GT Y +PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESY 177
Query: 243 TLKSDIYSFGVVLLELITGR 262
+ +DI+S G+ LLE G+
Sbjct: 178 SYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG+V+ G VA+K L G + F+ E ++ L HD LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ +V EYM GSL D L + + L + +A A G+ YL + I+R
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHR 127
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 244
DL + NIL+ + K++DFGLA+L + D+ + + G + APE A G+ T+
Sbjct: 128 DLAARNILVGENLVCKIADFGLARL--IEDDEYTAR--EGAKFPIKWTAPEAANYGRFTI 183
Query: 245 KSDIYSFGVVLLELIT-GR 262
KSD++SFG++L E++T GR
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 63 REANLIGEGGFGKVYKG-RLESGQLVAIKQLN--HEGLQGHQ---EFIVEVLMLSLLHHD 116
R+ L+G G FG VY+G L+ G A+K+++ +G G + + E+ +LS L H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN-TRMKIAVGAARGLEY 175
N+V +G D + E +P GSL L EP+ TR + GLEY
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEY 117
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-----GTYG 230
LH + ++RD+K ANIL+D + KL+DFG+AK V G+
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPY 166
Query: 231 YCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 262
+ APE G L +DI+S G +LE+ TG+
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 83/249 (33%), Positives = 116/249 (46%), Gaps = 37/249 (14%)
Query: 68 IGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IGEG G+VYK +G+ VAIK++ Q + I E+L++ H N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA--RGLEYLHCKANPPV 184
GD+ +V EYM GSL D + Q + N V +GLEYLH + V
Sbjct: 86 VGDELWVVMEYMDGGSLTDIIT-----QNFVRMNEPQIAYVCREVLQGLEYLHSQ---NV 137
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR--VMGTYGYCAPEYAMSGKL 242
I+RD+KS NILL D + KL+DFG A S R V+GT + APE
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQL----TKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 243 TLKSDIYSFGVVLLELITGR---------KAMDL--SKGQGE-QNLVSWSRPFLKDQKKF 290
K DI+S G++ +E+ G +A+ L +KG +N WS F K F
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF----KDF 249
Query: 291 VHL---VDP 296
++ DP
Sbjct: 250 LNKCLVKDP 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 60 RNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQE-FIVEVLMLSLL 113
R ++ ++GEG FGKV + +G++VA+K L E Q + + E+ +L L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 114 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
+H+N+V G C+ + L+ EY+P+GSL D+L + L+ + A
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICE 118
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH-VSTRVMGTYG 230
G+ YLH + I+RDL + N+LLDND K+ DFGLAK P G + V
Sbjct: 119 GMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290
+ A E K + SD++SFGV L EL+T + + E+ + + Q
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-----GPKQGQMTV 230
Query: 291 VHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
V L++ L G P+ C + C EA FRP ++
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-29
Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 61 NFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDN 117
+F N IG+G FG V+K ++ ++ A+KQ++ + +E I E +L+ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLED--HLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
++ + +V EY G L + P E W + + GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
LH K +++RD+KS N+ LD N K+ D G+AKL + DNT+ + ++GT Y +PE
Sbjct: 117 LHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPE 171
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295
KSD+++ GVVL E TG+ PF D L+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK------------------HPF--DANNQGALIL 211
Query: 296 PLLHGRYPRRCLNYAVAVTAM---CLNEEANFRP 326
++ G +P Y+ + + CL ++ RP
Sbjct: 212 KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 85/284 (29%), Positives = 121/284 (42%), Gaps = 42/284 (14%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FGKV+ + LVA+K L Q+F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE-----------PLSWNTRMKIAVGAA 170
G CT G L+V+EYM G L L PD + L+ + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 230
G+ YL A+ ++RDL + N L+ K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290
+ PE + K T +SDI+SFGVVL E+ T G+Q W Q
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT----------YGKQ---PWY------QLSN 230
Query: 291 VHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
++ + GR PR C A+ C E R +I DI
Sbjct: 231 TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 62 FREANLIGEGGFGKVYKG----RLESGQL-VAIKQLNHE-GLQGHQEFIVEVLMLSLLHH 115
+ ++G G FG VYKG E ++ VAIK L E + ++E + E +++ + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMKIAVGAAR 171
++V L+G C S Q L+ + MP+G L D++ + + Q L+W V A+
Sbjct: 69 PHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNW------CVQIAK 120
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
G+ YL K +++RDL + N+L+ + K++DFGLAKL V + + + +
Sbjct: 121 GMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 263
A E + T KSD++S+GV + EL+T G K
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 17/201 (8%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 122
+GEG +G VYK R ++G++VA+K++ EG+ + E+ +L L H N+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKLL 64
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
+ + LV+EY M L+ +L PLS N I RGL Y H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHSHR-- 118
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 242
+++RDLK NIL++ D KL+DFGLA+ + T+ + V+ T Y APE + K
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEILLGSKH 175
Query: 243 -TLKSDIYSFGVVLLELITGR 262
+ DI+S G + E+ITG+
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 7/196 (3%)
Query: 67 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYC 125
IG+G FG VYKG L+ VA+K ++F+ E +L H N+V LIG C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
+V E +P GSL L + L+ +++++ AA G+EYL K I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTF---LRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 245
+RDL + N L+ + K+SDFG+++ G T + APE G+ T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 246 SDIYSFGVVLLELITG 261
SD++S+G++L E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 120
F +GEG +G VYK E+GQ+VAIK + E QE I E+ +L +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLH 177
G +V EY GS+ D + + + L T +IA +GLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTL---TEEEIAAILYQTLKGLEYLH 116
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
I+RD+K+ NILL+ + KL+DFG++ G + D V+GT + APE
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 238 MSGKLTLKSDIYSFGVVLLELITGR 262
K+DI+S G+ +E+ G+
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 119
F IG+G FG+VYK + Q+VAIK ++ E + E I E+ LS +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYL 176
G G + ++ EY GS D L E IA GLEYL
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDE-------TYIAFILREVLLGLEYL 114
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H + I+RD+K+ANILL + + KL+DFG++ G + +GT + APE
Sbjct: 115 HEEG---KIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 237 AMSGKLTLKSDIYSFGVVLLELITG 261
K+DI+S G+ +EL G
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG+V++G + VA+K L G ++F+ E ++ L H L+ L CT
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ +V E M GSL ++L L + +A A G+ YL + I+R
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 244
DL + N+L+ + K++DFGLA++ + ++ + + G + APE A+ + ++
Sbjct: 128 DLAARNVLVGENNICKVADFGLARV--IKEDIYEARE--GAKFPIKWTAPEAALYNRFSI 183
Query: 245 KSDIYSFGVVLLELIT-GR 262
KSD++SFG++L E++T GR
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIG 123
+G+GGFG+V +++ +G++ A K+L+ + L +G Q + E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANP 182
+ D LV M G L+ H+Y++ EP R A GLE+LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG---EPGFPEARAIFYAAQIICGLEHLH---QR 114
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 242
++YRDLK N+LLD+ N ++SD GLA G GT GY APE
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVY 171
Query: 243 TLKSDIYSFGVVLLELITGR 262
D ++ G L E+I GR
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-26
Identities = 72/197 (36%), Positives = 108/197 (54%), Gaps = 11/197 (5%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG+V+ G VA+K L G + F+ E ++ L HD LV L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ +V EYM GSL D L D + L + +A A G+ Y+ + N I+R
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE-RMN--YIHR 126
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 246
DL+SANIL+ + K++DFGLA+L + DN + + + + APE A+ G+ T+KS
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 247 DIYSFGVVLLELIT-GR 262
D++SFG++L EL+T GR
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 66 NLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLI 122
N IG G FGKVY L++G+L+A+K++ + +E E+ +L LL H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
G ++ + EY G+LE+ L E + + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDE----HVIRVYTLQLLEGLAYLHSHG-- 119
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM----GTYGYCAPEYAM 238
+++RD+K ANI LD++ KL DFG A + +NT + GT Y APE
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 239 SGKLTLK---SDIYSFGVVLLELITGRK 263
GK +DI+S G V+LE+ TG++
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 70/203 (34%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYC 125
IG G VY L + + VAIK+++ E Q + + EV +S +H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANP 182
GD+ LV Y+ GSL D+ P IA +GLEYLH
Sbjct: 69 VVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTH-VSTRVMGTYGYCAPEYAMSG 240
I+RD+K+ NILL D + K++DFG+ A L GD T V +GT + APE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 241 K-LTLKSDIYSFGVVLLELITGR 262
K+DI+SFG+ +EL TG
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 68 IGEGGFGKVYK-GRLESGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIG- 123
IG+G FG V K R G+++ K++++ + Q+ + EV +L L H N+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 124 --------------YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
YC GD L+ + ++ Y +E E W +I
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCK-----KERKY-IE---EEFIW----RILTQL 114
Query: 170 ARGLEYLH--CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 227
L H V++RDLK ANI LD + N KL DFGLAK+ +G ++ + +G
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVG 172
Query: 228 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
T Y +PE KSDI+S G ++ EL
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 73/226 (32%), Positives = 111/226 (49%), Gaps = 24/226 (10%)
Query: 54 ELAIATRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQL-NHEGLQGHQEFIVEV 107
EL ++ F E +GE FGK+YKG L + QLVAIK L + Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 108 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------ 155
+++ LHH N+V L+G T +++EY+ G L + L P +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 156 -PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214
L + IA+ A G+EYL ++ +++DL + NIL+ + K+SD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
D V + + + PE M GK + SDI+SFGVVL E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 87/308 (28%), Positives = 139/308 (45%), Gaps = 40/308 (12%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQL-VAIKQLNHEGLQGHQEFIV 105
++S T ++ + + E N+I G G YKG+ + +K++N I
Sbjct: 680 SKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIA 735
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
+ + L H N+V LIG C S L++EY+ +L + L +L SW R KI
Sbjct: 736 D---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRRKI 785
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A+G A+ L +LHC+ +P V+ +L I++D P L +L G T+
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPG-LLCTDTKC 838
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285
+ Y APE + +T KSDIY FG++L+EL+TG+ D G ++V W+R
Sbjct: 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS 897
Query: 286 DQKKFVHL---VDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336
D HL +DP + + +N A+ TA + RP ND++ L+
Sbjct: 898 D----CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT----DPTARPCANDVLKTLE 949
Query: 337 YLVSQRDS 344
S
Sbjct: 950 SASRSSSS 957
|
Length = 968 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 67/199 (33%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG V+ G+ VAIK + EG +FI E ++ L H NLV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+V EYM G L ++L + + W M V +EYL I+R
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDV--CEAMEYLESNG---FIHR 124
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 244
DL + N L+ D K+SDFGLA+ V D+ + S+ GT + PE + +
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFSS 180
Query: 245 KSDIYSFGVVLLELITGRK 263
KSD++SFGV++ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 66 NLIGEGGFGKVYKGRL-ESGQ---LVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLV 119
+IG G FG+V +GRL G+ VAIK L G Q +F+ E ++ H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
L G T +++ EYM GSL+ L E D + + + + G A G++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGK-FTVGQLVGMLRGIASGMKYL--- 122
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAP 234
+ ++RDL + NIL++++ K+SDFG L +++ + G G + AP
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKG--GKIPIRWTAP 177
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELIT 260
E K T SD++SFG+V+ E+++
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 32/282 (11%)
Query: 68 IGEGGFGKVYKG---RLESGQL---VAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+G+G FG VY+G + G+ VAIK +N + ++ EF+ E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRMKIAVGAARGLE 174
L+G ++G L+V E M G L+ +L P+ E P + +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
YL K ++RDL + N ++ D K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294
E G T KSD++SFGVVL E+ T A +G + ++ F+ D
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLSNEEVLK----FVIDGG------ 238
Query: 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336
H P C + + + MC RP +IV +L
Sbjct: 239 ----HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 50/229 (21%)
Query: 67 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFI-VEVLMLSLL-HHDNLVTL 121
+IGEG F V + E+ + AIK L+ L + +++ +E +L+ L H ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 122 IGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-------- 171
Y T D+ L V EY P G L ++ + R
Sbjct: 68 --YYTFQDEENLYFVLEYAPNGELLQYI------------RKYGSLDEKCTRFYAAEILL 113
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM---- 226
LEYLH K +I+RDLK NILLD D + K++DFG AK L P
Sbjct: 114 ALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 227 -------------GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
GT Y +PE SD+++ G ++ +++TG+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 67 LIGEGGFGKVYKGRLES--GQL--VAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTL 121
+G+G FG V +G + G++ VA+K L + L +F+ E ++ L H+NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEYLHCK 179
G + ++V E P+GSL D L +S + ++IA G+ YL K
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLESK 116
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST---RVMGTYGYCAPEY 236
I+RDL + NILL +D K+ DFGL + P ++ +V +V + +CAPE
Sbjct: 117 R---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171
Query: 237 AMSGKLTLKSDIYSFGVVLLELIT 260
+ + SD++ FGV L E+ T
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG+V+ G VAIK L +G + F+ E ++ L H LV L T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ ++ EYM GSL D L P+ L+ N + +A A G+ ++ K I+R
Sbjct: 73 -EPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHR 126
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 246
DL++ANIL+ K++DFGLA+L + DN + + + APE G T+KS
Sbjct: 127 DLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 247 DIYSFGVVLLELIT-GR 262
D++SFG++L E++T GR
Sbjct: 185 DVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 68 IGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FGKV+ + LVA+K L L ++F E +L+ L H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ------EPLSWNTR------MKIAVGA 169
G C GD ++V+EYM G L L PD +P + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
A G+ YL A+ ++RDL + N L+ + K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ PE M K T +SD++SFGV+L E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 69/211 (32%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 67 LIGEGGFGKVYKG-RLESGQLVAIKQL-----NHEGLQGHQEFIV----EVLMLSLLHHD 116
LIG G FG VY G SG+L+A+KQ+ + + + E+ +L L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
N+V +G D + EY+P GS+ L + +E L N +I +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-----LGPVGDNTHVSTRVMGTYGY 231
H N +I+RD+K ANIL+DN K+SDFG++K N + + G+ +
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
APE T K+DI+S G +++E++TG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 71/198 (35%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IG G +G VYK R + +G+LVAIK + E + E+ ML H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
D+ +V EY GSL+D +Y + + PLS + +GL YLH I+
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIH 124
Query: 187 RDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYA---MSG 240
RD+K ANILL D + KL+DFG+ A+L T ++ R +GT + APE A G
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQL----TAT-IAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 241 KLTLKSDIYSFGVVLLEL 258
K DI++ G+ +EL
Sbjct: 180 GYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV------EVLMLSLLHHDNLVT 120
IGEG +G VYK R +G++VAIK++ + + E+ +L L+H N++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI----KLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCK 179
L+ LV+E+M + LY L D Q L + +GL + H
Sbjct: 63 LLDVFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-S 116
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEY 236
+++RDLK N+L++ + KL+DFGLA+ PV TH V TR Y APE
Sbjct: 117 HG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 237 AM-SGKLTLKSDIYSFGVVLLELITGR 262
+ + DI+S G + EL++ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-24
Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 68 IGEGGFGKVYKG--RLESGQL--VAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLI 122
+G G FG V KG ++SG+ VA+K L E + G +EF+ E +++ L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
G C G+ +LV E P+G L +L P + ++ A G+ YL K
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYA 237
++RDL + N+LL N K+SDFG+++ LG + + G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECI 170
Query: 238 MSGKLTLKSDIYSFGVVLLELIT 260
GK + KSD++S+GV L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 29/210 (13%)
Query: 68 IGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIG 123
I +G +G+V+ + +S G + AIK + + + + E +LS +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 124 YCTSGDQRL-LVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKIA--VGAARGLEYLH 177
Y G + L LV EY+P G SL +++ L+ D R+ IA V A LEYLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED------VARIYIAEIVLA---LEYLH 110
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS------TRVMGTYGY 231
+ +I+RDLK NIL+D++ + KL+DFGL+K+G V +++ R++GT Y
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
APE + + D +S G +L E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 6e-24
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 31/207 (14%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLIG 123
+G G G V K +G+++A+K + E + Q+ I+ ++L + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC--NSPYIVGFYG 66
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
+ + EYM GSL D + + P KIAV +GL YLH K
Sbjct: 67 AFYNNGDISICMEYMDGGSL-DKILKEVQGRIPER--ILGKIAVAVLKGLTYLHEKHK-- 121
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM--------GTYGYCAPE 235
+I+RD+K +NIL+++ KL DFG VS +++ GT Y APE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAPE 169
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGR 262
++KSDI+S G+ L+EL TGR
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 6e-24
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 61 NFREANLIGEGGFGKVYK-GRLESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDN 117
+ + ++G G FG V+ R +LV IKQ+ E + + E +L LL H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMKIAVGAARGL 173
++ ++V EY P G+L +++ L + L + ++ +A L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------L 114
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
++H K +++RDLK+ NILLD K+ DFG++K+ + + T V+GT Y
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYI 168
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 266
+PE KSDI++ G VL EL + ++A +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 6e-24
Identities = 72/197 (36%), Positives = 111/197 (56%), Gaps = 11/197 (5%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G+G FG+V+ G VAIK L G + F+ E ++ L HD LV L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ +V E+M GSL D L E D + L + +A A G+ Y+ + N I+R
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLK--EGDGKYLKLPQLVDMAAQIADGMAYIE-RMN--YIHR 126
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 246
DL++ANIL+ ++ K++DFGLA+L + DN + + + + APE A+ G+ T+KS
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 247 DIYSFGVVLLELIT-GR 262
D++SFG++L EL+T GR
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-23
Identities = 68/197 (34%), Positives = 108/197 (54%), Gaps = 17/197 (8%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
IGEG FG V +G +GQ VA+K + + Q F+ E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ +V E M G+L + L + ++ ++ A G+EYL K +++R
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVG-DNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 246
DL + NIL+ D K+SDFGLA++G +G DN+ + + + APE K + KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178
Query: 247 DIYSFGVVLLELIT-GR 262
D++S+GV+L E+ + GR
Sbjct: 179 DVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 60/196 (30%), Positives = 105/196 (53%), Gaps = 8/196 (4%)
Query: 66 NLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 124
+ +G G +G+VY+G + VA+K L + ++ EF+ E ++ + H NLV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
CT ++ E+M G+L D+L E +++ ++ + +A + +EYL K
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 244
I+RDL + N L+ + K++DFGL++L GD + APE K ++
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 245 KSDIYSFGVVLLELIT 260
KSD+++FGV+L E+ T
Sbjct: 185 KSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-23
Identities = 81/294 (27%), Positives = 137/294 (46%), Gaps = 37/294 (12%)
Query: 62 FREANLIGEGGFGKVY----KGRLE---------SGQ--LVAIKQLNHEGLQ-GHQEFIV 105
+E +GEG FG+V+ +G E GQ LVA+K L + + +F+
Sbjct: 9 LKEK--LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE--------PL 157
E+ ++S L + N++ L+G C S D ++ EYM G L L E + +
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 158 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
S + +AV A G++YL A+ ++RDL + N L+ N + K++DFG+++ GD
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 277
+ R + + A E + GK T SD+++FGV L E+ T K S EQ ++
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VI 242
Query: 278 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
+ F ++Q + ++L L C + + C + + RP N I
Sbjct: 243 ENTGEFFRNQGRQIYLSQTPL-------CPSPVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-23
Identities = 86/294 (29%), Positives = 136/294 (46%), Gaps = 52/294 (17%)
Query: 66 NLIGEGGFGKVYKGRL--ESGQLV--AIKQLNH-EGLQGHQEFIVEVLMLSLLHHDNLVT 120
+IG+G FG VY G L GQ + A+K LN L+ ++F+ E +++ H N+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 121 LIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG----AARGLEY 175
L+G C + L+V YM G L + + + N +K +G A+G+EY
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE-------THNPTVKDLIGFGLQVAKGMEY 113
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK------LGPVGDNTHVSTRVMGTY 229
L A+ ++RDL + N +LD F K++DFGLA+ V ++T V
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK--- 167
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289
+ A E + K T KSD++SFGV+L EL+T R A P D
Sbjct: 168 -WMALESLQTQKFTTKSDVWSFGVLLWELMT-RGA-----------------PPYPDVDS 208
Query: 290 FVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340
F + LL GR P C + V C + + RP +++V ++ + S
Sbjct: 209 F-DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-23
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH-----QEFIVEVLMLSLLH 114
N+R L+G+G FG+VY +++G+ +A+KQ+ + E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 115 HDNLVTLIGYCTSGDQRLLVY-EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
H+ +V G C D+ L ++ EYMP GS++D L L+ K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGV 117
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 232
EYLH +++RD+K ANIL D+ N KL DFG +K L + + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELIT 260
+PE K+D++S G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-23
Identities = 84/300 (28%), Positives = 129/300 (43%), Gaps = 46/300 (15%)
Query: 54 ELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVE 106
E+ ++T F E +GE FGKVYKG L E Q VAIK L + +EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 107 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ------------ 154
+M S L H N+V L+G T +++ Y L + L P
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 155 ---EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211
EP + + I A G+E+L ++ V+++DL + N+L+ + N K+SD GL +
Sbjct: 119 STLEPADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 271
D + + + +PE M GK ++ SDI+S+GVVL E+ + + G
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQPYCGY 230
Query: 272 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
Q+++ R V P P C + + C NE + RP DI
Sbjct: 231 SNQDVIEMIRN---------RQVLPC-----PDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 3e-22
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 68 IGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTL 121
+GEG FGKV R + +G+ VA+K L E H + E+ +L L+H+N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 122 IGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
G CT L+ E++P GSL+++L ++ ++ ++K AV +G++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST----RVMGTYGYCAPE 235
++RDL + N+L++++ K+ DFGL K + + T + Y APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEYYTVKDDLDSPVFWY-APE 182
Query: 236 YAMSGKLTLKSDIYSFGVVLLELIT 260
+ K + SD++SFGV L EL+T
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 79/303 (26%), Positives = 140/303 (46%), Gaps = 46/303 (15%)
Query: 62 FREANLIGEGGFGKVYKGRLESGQ-----------------LVAIKQLNHEGLQ-GHQEF 103
F+E +GEG FG+V+ + + Q LVA+K L + + +F
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66
Query: 104 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEP----- 156
+ EV +LS L N++ L+G C D ++ EYM G L L + L+ +E
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 157 --------LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208
+S+++ + +A+ A G++YL ++ ++RDL + N L+ + K++DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 268
+++ GD + R + + A E + GK T SD+++FGV L E++ K
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243
Query: 269 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 328
+ EQ ++ + F +DQ + V+L R P C + C + + RP
Sbjct: 244 ELTDEQ-VIENAGEFFRDQGRQVYL------FR-PPPCPQGLYELMLQCWSRDCRERPSF 295
Query: 329 NDI 331
+DI
Sbjct: 296 SDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-22
Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG+V+ G + VA+K L G Q F+ E ++ L HD LV L T
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ ++ EYM GSL D L E + L + + A G+ Y+ K I+R
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIHR 127
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY--GYCAPEYAMSGKLTLK 245
DL++AN+L+ K++DFGLA++ + DN + + R + + APE G T+K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARV--IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 246 SDIYSFGVVLLELIT 260
SD++SFG++L E++T
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-22
Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 59 TRNFREANLIGEGGFGKVYKG----RLESGQL-VAIKQL-NHEGLQGHQEFIVEVLMLSL 112
R+ L+G G FG V+KG +S ++ VAIK + + G Q QE +L +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 113 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY----DLEPDQEPLSWNTRMKIAVG 168
L H +V L+G C G LV + P+GSL DH+ L+P Q L+W V
Sbjct: 66 LDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNW------CVQ 117
Query: 169 AARGLEYL--HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 226
A+G+ YL H +++R+L + NILL +D +++DFG+A L D + +
Sbjct: 118 IAKGMYYLEEHR-----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ A E + G+ T +SD++S+GV + E+++
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-22
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI-GYC 125
+G+G FGKVYK + E+G A K + E + ++F+VE+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLE-PDQEPLSWNTRMKIAV---GAARGLEYLHCKAN 181
+L+ E+ G+L+ + +LE EP +I L +LH
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEP-------QIRYVCRQMLEALNFLHSHK- 123
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM--- 238
VI+RDLK+ NILL D + KL+DFG++ + +GT + APE
Sbjct: 124 --VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACET 179
Query: 239 --SGKLTLKSDIYSFGVVLLELITGR 262
K+DI+S G+ L+EL
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 6e-22
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FGKV+ + LVA+K L ++F E +L+ L H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ---------EPLSWNTRMKIAVGAARG 172
G C GD ++V+EYM G L L PD L+ + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
+ YL A+ ++RDL + N L+ + K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELIT 260
PE M K T +SD++S GVVL E+ T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-22
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 39/280 (13%)
Query: 61 NFREANLIGEGGFGKVYK-GRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 117
+F+ +G+G +G VYK RL Q A+K+++ + + ++ + E+ +L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 118 LVTLIGYCTS---GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
+ I Y + G++ +V EY P G L + + ++ + +I + RGL+
Sbjct: 61 I---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
LH + +++RDLKSANILL + K+ D G++K V T +GT Y AP
Sbjct: 118 ALHEQK---ILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKT-QIGTPHYMAP 170
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294
E + KSDI+S G +L E+ T PF + + L
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAP------------------PF--EARSMQDLR 210
Query: 295 DPLLHGRYPRRCLNYAVAVTAMC---LNEEANFRPLINDI 331
+ G+YP Y+ + L + RP + I
Sbjct: 211 YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 8e-22
Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 15/205 (7%)
Query: 60 RNFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDN 117
+ + IG+G G VY + +GQ VAIKQ+N + Q +E I+ E+L++ H N
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPN 77
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+V + GD+ +V EY+ GSL D + + D+ ++ R + + LE+LH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLH 132
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEY 236
VI+RD+KS NILL D + KL+DFG A++ P + + ST V GT + APE
Sbjct: 133 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEV 186
Query: 237 AMSGKLTLKSDIYSFGVVLLELITG 261
K DI+S G++ +E++ G
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 8e-22
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG 123
++GEG +G V K R +G++VAIK+ + + + + EV +L L H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
+ LV+EY+ LE LE L + + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--- 120
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE----YAMS 239
+I+RD+K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNY 179
Query: 240 GKLTLKSDIYSFGVVLLELITGR 262
GK D+++ G ++ EL+ G
Sbjct: 180 GK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 8e-22
Identities = 77/295 (26%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 62 FREANLIGEGGFGKVYKGRLESGQ-----------------LVAIKQLNHEGLQ-GHQEF 103
F+E +GEG FG+V+ E + LVA+K L + + +F
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 104 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP------- 156
+ E+ ++S L N++ L+ C + D ++ EYM G L L EP +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 157 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216
+S++T + +A A G++YL ++ ++RDL + N L+ ++ K++DFG+++ G
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276
D + R + + + E + GK T SD+++FGV L E++T K S+ EQ +
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-V 242
Query: 277 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
+ + F +DQ + V+L P C + + C A RP +I
Sbjct: 243 IENTGEFFRDQGRQVYLPK-------PALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 9e-22
Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG V G+ VAIK + EG EFI E ++ L H+ LV L G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+V EYM G L ++L + +P +++ G+ YL K I+R
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESKQ---FIHR 124
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 244
DL + N L+D+ K+SDFGL++ V D+ + S+ +G+ + PE + K +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFSS 180
Query: 245 KSDIYSFGVVLLELIT 260
KSD+++FGV++ E+ +
Sbjct: 181 KSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 72/202 (35%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 68 IGEGGFGKVYKGRLES-GQLVAIKQL--NHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIG 123
+G GGFG+V +++S + A+K + H G QE I E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 124 YCTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
Y T D++ +Y EY G L L D E + R IA EYLH
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEYLH--- 110
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
N +IYRDLK N+LLD++ KL DFG AK G T GT Y APE ++
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNK 167
Query: 241 KLTLKSDIYSFGVVLLELITGR 262
D +S G++L EL+TGR
Sbjct: 168 GYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 42/217 (19%)
Query: 66 NLIGEGGFGKVYKGR-LESGQLVAIKQ--LNH--EGLQG-HQEFIVEVLMLSLLHHDNLV 119
+GEG + VYK R E+G++VAIK+ L E G + + E+ +L L H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAV 167
L+ LV+E+M DLE D + T
Sbjct: 66 GLLDVFGHKSNINLVFEFME--------TDLEKVIKDKSIVLTPADIKSYMLMT------ 111
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD-NTHVSTRVM 226
RGLEYLH + +++RDLK N+L+ +D KL+DFGLA+ G N ++ +V+
Sbjct: 112 --LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQVV 164
Query: 227 GTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
T Y APE + + D++S G + EL+
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 69/197 (35%), Positives = 107/197 (54%), Gaps = 11/197 (5%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G+G FG+V+ G VAIK L G + F+ E ++ L H+ LV L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ +V EYM GSL D L + L + +A A G+ Y+ + N ++R
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE-RMN--YVHR 126
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 246
DL++ANIL+ + K++DFGLA+L + DN + + + + APE A+ G+ T+KS
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 247 DIYSFGVVLLELIT-GR 262
D++SFG++L EL T GR
Sbjct: 185 DVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-21
Identities = 65/196 (33%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
IG G FG V+ G + VAIK + EG ++FI E ++ L H LV L G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
LV+E+M G L D+ L + S T + + + G+ YL VI+R
Sbjct: 71 RSPICLVFEFMEHGCLSDY---LRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 244
DL + N L+ + K+SDFG+ + V D+ + S+ GT + +PE K +
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSST--GTKFPVKWSSPEVFSFSKYSS 180
Query: 245 KSDIYSFGVVLLELIT 260
KSD++SFGV++ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 68 IGEGGFGKVYKGR---LESGQ---LVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVT 120
IG+G FG+V++ R L + +VA+K L E +F E +++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------------DQEPLSWNTR 162
L+G C G L++EYM G L + L P + PLS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 163 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD----- 217
+ IA A G+ YL + ++RDL + N L+ + K++DFGL++ D
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 218 -NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
N + R M PE + T +SD++++GVVL E+ +
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIG 123
+G+GGFG+V ++ +G+L A K+LN + L +G++ +VE +L+ +H +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
+ LV M G L H+Y+++ + GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 243
+IYRDLK N+LLDND N ++SD GLA + D + GT G+ APE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 244 LKSDIYSFGVVLLELITGR 262
D ++ GV L E+I R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 16/212 (7%)
Query: 61 NFREANLIGEGGFGKVY----KGRLESG--QLVAIKQLNHEGLQGHQ-EFIVEVLMLSLL 113
N +E +G G FG+V+ KG E G LV +K L + Q EF E+ M L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 114 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL-----YDLEPDQEPLSWNTRMKIAVG 168
H N+V L+G C + ++ EY +G L+ L D + PLS ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 228
A G+++L +N ++RDL + N L+ + K+S L+K + +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIP 181
Query: 229 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ APE + KSD++SFGV++ E+ T
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 68 IGEGGFGK--VYKGRLESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIG 123
+G+G FG+ +Y+ R E LV K++N L + E+++LSLL H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 124 YCTSGDQRLLVYEYMPMGSLED---HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
+ + L+ EY G+L D ++E + W + +A + Y+H KA
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW---YLFQIVSA--VSYIH-KA 120
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
+++RD+K+ NI L KL DFG++K+ +G ++ V+GT Y +PE
Sbjct: 121 G--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 241 KLTLKSDIYSFGVVLLELITGRKAMDLS 268
K KSDI++ G VL EL+T ++ D +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNL 118
E + +GEG G V K RL +G + A+K + ++ + E+ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 119 VTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRM------KIAVGAA 170
V G + EY GSL D +Y ++ R+ KIA
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIY-----KKVKKRGGRIGEKVLGKIAESVL 115
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTY 229
+GL YLH + +I+RD+K +NILL KL DFG++ +L T GT
Sbjct: 116 KGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTS 167
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
Y APE ++ SD++S G+ LLE+ R
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 67 LIGEGGFGKVYKG-RLESGQLVAIKQ--LNHEGLQGHQEFIV--------EVLMLSLLHH 115
LIG+G +G+VY + +G+++A+KQ L H E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
N+V +G+ T+ + + EY+P GS+ L +E L ++ GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAY 123
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM---GTYGYC 232
LH K +++RDLK+ N+L+D D K+SDFG++K D+ + + + M G+ +
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNMSMQGSVFWM 177
Query: 233 APEYAMSGK--LTLKSDIYSFGVVLLELITGRK 263
APE S + K DI+S G V+LE+ GR+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 50/289 (17%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV------EVLMLSLLHHDNLV 119
L+GEG +G V K + E+GQ+VAIK+ L+ + +V E+ ML L H+NLV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDH--LYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
LI + LV+E++ DH L DLE L + K RG+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEY 236
+ +I+RD+K NIL+ KL DFG A+ L G+ V T + T Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPEL 171
Query: 237 AMSG-KLTLKSDIYSFGVVLLELITG-----------------RKAMDLSKGQGEQNLVS 278
+ K DI++ G ++ E++TG + +L Q +
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH--QEIFQ 229
Query: 279 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLN-YAVAVTAMCLNEEANFRP 326
+ F + V ++P L R+P+ L+ + + CL + + RP
Sbjct: 230 KNPLFAGMRLPEVKEIEP-LEKRFPK--LSGLVLDLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-21
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 17/211 (8%)
Query: 62 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHE------GLQGHQEFIVEVLMLSLLHH 115
+ + ++G+G +G VY G GQL+A+KQ+ + + +++ EV +L L H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
N+V +G C + + E++P GS+ L P EP+ +I G A Y
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----Y 117
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----LGPVGDNTHVSTRVMGTYGY 231
LH N V++RD+K N++L + KL DFG A+ +G G ++++ + GT +
Sbjct: 118 LH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
APE KSDI+S G + E+ TG+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-21
Identities = 74/280 (26%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 67 LIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTL 121
+IG G FG+V++G L+ VAIK L + Q+F+ E ++ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
G T +++ EYM G+L+ +L D + + ++ G A G++YL ++
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SD 125
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
++RDL + NIL++++ K+SDFGL++ L + T+ ++ + APE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 241 KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHLVDPLLH 299
K T SD++SFG+V+ E+++ GE RP+ + + ++
Sbjct: 186 KFTSASDVWSFGIVMWEVMS----------FGE-------RPYWDMSNHEVMKAINDGFR 228
Query: 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339
P C + + C ++ RP DIV LD L+
Sbjct: 229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 72/229 (31%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 58 ATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQ-LNHEGLQG-HQEFIVEVLMLSLLH 114
R++ +GEG FG+VYK R +++G++VA+K+ L H G + E+ +L L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 115 HDNLVTLIGYC-----TSGDQRLLVYEYMP-M-----GSLEDHLYDLEPDQEPLSWNTRM 163
H N+V LI S +R VY P M G LE+ L Q M
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY----M 121
Query: 164 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL---------GP 214
+ G+ YLH +++RD+K+ANIL+DN K++DFGLA+ G
Sbjct: 122 LQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 215 VGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 262
G T T ++ T Y PE + + T DI+ G V E+ T R
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-21
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 56 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH 115
A+ + + IG+G FG V G G VA+K + ++ Q F+ E +++ L H
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRH 58
Query: 116 DNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
NLV L+G L +V EYM GSL D+L + L + +K ++ +E
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAME 116
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCA 233
YL +AN ++RDL + N+L+ D K+SDFGL K D + + + A
Sbjct: 117 YL--EANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTA 167
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELIT-GR 262
PE K + KSD++SFG++L E+ + GR
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 32/273 (11%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG V+ G+ + VAIK +N EG ++FI E ++ L H LV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+V E+M G L L L Q LS + + + G+EYL + I+R
Sbjct: 71 QKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 246
DL + N L+ + K+SDFG+ + V D+ + S+ + PE K + KS
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 247 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR---YP 303
D++SFGV++ E+ T K PF ++K +V+ + G P
Sbjct: 183 DVWSFGVLMWEVFTEGKM-----------------PF--EKKSNYEVVEMISRGFRLYRP 223
Query: 304 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336
+ V C +E+ RP +++ A+
Sbjct: 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 8/192 (4%)
Query: 67 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYC 125
L+G+G FG+V+KG L+ VA+K + Q + +F+ E +L H N+V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
T QR +Y M + D L L ++ L +K A+ AA G+ YL K I
Sbjct: 62 T---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 245
+RDL + N L+ + K+SDFG+++ G + + + + APE G+ + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSE 174
Query: 246 SDIYSFGVVLLE 257
SD++S+G++L E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 65/223 (29%), Positives = 115/223 (51%), Gaps = 26/223 (11%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIV----EVLMLSLLH 114
+ + N I EG +G VY+ R ++G++VA+K+L + +G F + E+ +L L
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62
Query: 115 HDNLVTL--IGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAAR 171
H N+VT+ + ++ D+ +V EY+ E L L E ++P + + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
G+ +LH +++RDLK++N+LL+N K+ DFGLA+ G T+++ T Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWY 172
Query: 232 CAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGE 273
APE + K + D++S G + EL+T + L G+ E
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP---LFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIV-EVLMLSLLHH 115
+F +G G FG+V R SG+ A+K L+ + E ++ E +L + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 116 DNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--- 171
LV L G D L LV EY+P G L HL + AR
Sbjct: 61 PFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHL------------RKSGRFPEPVARFYA 107
Query: 172 -----GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 226
LEYLH + ++YRDLK N+LLD+D K++DFG AK V T+ +
Sbjct: 108 AQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LC 159
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
GT Y APE +S D ++ G+++ E++ G
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLN---HEGLQGHQEFIVEVLMLSLLHHD 116
+F +IG+G FGKV + ++ ++ A+K +N + + E +L L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 175
LV L + LV + + G L HL E ++K LEY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWICEIVLALEY 115
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
LH K +I+RD+K NILLD + ++DF +A T T GT GY APE
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPE 169
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGRK 263
++ D +S GV E + G++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 122
++G+G FGKV+ L+ + Q AIK L + + + +VE +LSL +T +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 123 GYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
YCT + + V EY+ G L H+ P + +I G L++LH K
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSKG 116
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
++YRDLK NILLD D + K++DFG+ K +GD + GT Y APE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQ 171
Query: 241 KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276
K D +SFGV+L E++ G+ G E+ L
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-20
Identities = 74/199 (37%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIG 123
IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
LV EY +GS D L E ++PL I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLH---SHE 135
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKL-GPVGDNTHVSTRVMGTYGYCAPE--YAM-S 239
I+RD+K+ NILL KL+DFG A L P N+ V GT + APE AM
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFV-----GTPYWMAPEVILAMDE 188
Query: 240 GKLTLKSDIYSFGVVLLEL 258
G+ K D++S G+ +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 17/242 (7%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IGEG G V +G+ VA+K+++ Q + EV+++ H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
GD+ +V E++ G+L D + ++E ++ + + + L +LH + VI+
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHAQG---VIH 138
Query: 187 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 246
RD+KS +ILL +D KLSDFG V ++GT + APE +
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 247 DIYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR 305
DI+S G++++E++ G + Q + + P LK+ K V P L + R
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK----VSPRLRS-FLDR 251
Query: 306 CL 307
L
Sbjct: 252 ML 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLN----HEGLQGHQEFIVEVLMLSLLHHDNLVTLI 122
IGEG G V+K + E+G+ VA+K++ G+ + + E+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP--NQALREIKALQACQHPYVVKLL 65
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGLEYLHCK 179
G +LV EYMP L + L D E P+ + S+ RM + +G+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSY-MRMLL-----KGVAYMHAN 118
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--YA 237
+++RDLK AN+L+ D K++DFGLA+L + S +V T Y APE Y
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174
Query: 238 MSGKLTLKSDIYSFGVVLLELITGR 262
+ K D+++ G + EL+ G
Sbjct: 175 -ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-20
Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG+V+ VA+K + G + F+ E ++ L HD LV L T
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ ++ E+M GSL D L E ++PL + + A G+ ++ + N I+R
Sbjct: 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE-QRN--YIHR 126
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 246
DL++ANIL+ K++DFGLA++ + DN + + + APE G T+KS
Sbjct: 127 DLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 247 DIYSFGVVLLELIT-GR 262
D++SFG++L+E++T GR
Sbjct: 185 DVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-20
Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 10/205 (4%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNL 118
NF++ +GEG + VYKGR +G++VA+K+++ + +G I E+ ++ L H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
V L + ++ +LV+EYM L+ ++ D + L NT +G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCH- 117
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
V++RDLK N+L++ KL+DFGLA+ + NT + V T Y AP+ +
Sbjct: 118 --ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLL 173
Query: 239 SGKLTLKS-DIYSFGVVLLELITGR 262
+ S DI+S G ++ E+ITGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 7e-20
Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 54/305 (17%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQE-FIVEVLM 109
+ + +G G FG+VY+G VA+K L + + F++E L+
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 110 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE---PLSWNTRMKIA 166
+S +H N+V LIG R ++ E M G L+ L + P E L+ + A
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVS 222
A+G +YL I+RD+ + N LL P K++DFG+A+
Sbjct: 123 RDVAKGCKYLEENH---FIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKG 178
Query: 223 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI----------TGRKAMDLSKGQG 272
R M + PE + G T K+D++SFGV+L E+ T ++ M+ G G
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238
Query: 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
+ P+ C + C RP I+
Sbjct: 239 RLD--------------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
Query: 333 VALDY 337
+ Y
Sbjct: 273 ERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 8e-20
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 66 NLIGEGGFGKVYKGRL-------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDN 117
N +G G FG+VY+G VA+K L Q +EF+ E ++S +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP---LSWNTRMKIAVGAARGLE 174
+V L+G C + + ++ E M G L +L D ++ L+ + I + A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 175 YLHCKANPPVIYRDLKSANILL-----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
YL I+RDL + N L+ D D K+ DFGLA+ D +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ APE + GK T +SD++SFGV++ E++T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 67 LIGEGGFGKVYKGRL------ESGQLVAIKQLN---HEGLQGHQEFIVEVLMLSLL-HHD 116
+GEG FG+V K VA+K L E + + + E+ M+ ++ H
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHK 76
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMK 164
N++ L+G CT +V EY G+L D L D P +E L+ +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 224
A ARG+E+L A+ I+RDL + N+L+ D K++DFGLA+ + +
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKT 191
Query: 225 VMG--TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
G + APE T +SD++SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 68 IGEGGFGKVYKG------RLESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVT 120
+G+G FG VY+G + E VAIK +N ++ EF+ E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRMKIAVGAARGLE 174
L+G + G L++ E M G L+ +L L P+ E P S +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
YL+ AN ++RDL + N ++ DF K+ DFG+ + D + + + +P
Sbjct: 134 YLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELIT 260
E G T SD++SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGH--QEFIVEVLMLSLL 113
+ + +G G F Y+ R +++G L+A+KQ+ N Q + E+ +++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 114 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
+H +++ ++G L E+M GS+ L +E + N ++ RGL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGL 116
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLA-KLGPVGDNT-HVSTRVMGTYG 230
YLH +I+RD+K AN+L+D+ +++DFG A +L G +++GT
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+ APE + D++S G V++E+ T +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 71/204 (34%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 124
IGEG +G V+K R E+GQ+VAIK+ + + + + E+ ML L H NLV LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 125 CTSGDQRLLVYEYMPMGSLEDH--LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
+ LV+EY DH L +LE + + + KI + + + H K N
Sbjct: 69 FRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH-KHN- 120
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNT-HVSTRVMGTYGYCAPEYAMS 239
I+RD+K NIL+ KL DFG A++ GP D T +V+TR Y APE +
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL-LV 173
Query: 240 GKLTLKS--DIYSFGVVLLELITG 261
G D+++ G V EL+TG
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 28/207 (13%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHHDNLVTL 121
IGEG +G VYK R +G++VA+K++ L+ E I E+ +L L+H N+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA---VGAARGLEYLHC 178
+ S ++ LV+E++ + L+ ++ D PL+ I +G+ Y H
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYCAPEY 236
V++RDLK N+L+D + KL+DFGLA+ G PV TH V+ T Y APE
Sbjct: 118 HR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEI 170
Query: 237 AMSGKL-TLKSDIYSFGVVLLELITGR 262
+ + + DI+S G + E++ R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFI----VEVLMLSLLHHDNLVTLI 122
+G+G FG VY R E+G+LVAIK++ + +E + V+ L L H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKK-FYSWEECMNLREVKSLR-KLNEHPNIVKLK 64
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE--PLSWNTRMKIAVGAARGLEYLHCKA 180
D+ V+EYM E +LY L D++ P S + I +GL ++H K
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH-KH 118
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN----THVSTRVMGTYGYCAPEY 236
+RDLK N+L+ K++DFGLA+ + +VSTR Y APE
Sbjct: 119 G--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPE- 168
Query: 237 AMSGKLTLKS-------DIYSFGVVLLELITGR 262
+ L+S DI++ G ++ EL T R
Sbjct: 169 -----ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 66 NLIGEGGFGKVYKGRLESGQL---VAIKQLNHEGLQG-HQEFIVEVLMLSLL-HHDNLVT 120
++IGEG FG+V + ++ L AIK L + H++F E+ +L L HH N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYD---LEPD---------QEPLSWNTRMKIAVG 168
L+G C + + EY P G+L D L LE D L+ ++ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 228
A G++YL K I+RDL + N+L+ + K++DFGL++ G+ +V + MG
Sbjct: 128 VATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMGR 179
Query: 229 YG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ A E T KSD++SFGV+L E+++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-19
Identities = 84/295 (28%), Positives = 127/295 (43%), Gaps = 43/295 (14%)
Query: 68 IGEGGFGKVYKG------RLESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVT 120
+G+G FG VY+G + E+ VA+K +N L+ EF+ E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRMKIAVGAARGLE 174
L+G + G L+V E M G L+ +L L P+ E P + +++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
YL+ K ++RDL + N ++ +DF K+ DFG+ + D + + + AP
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294
E G T SD++SFGVVL E IT EQ L KFV
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL------------KFV--- 234
Query: 295 DPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346
+ G Y P C + MC RP +IV L + D HP
Sbjct: 235 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL-----KDDLHP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 3e-19
Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IG+G G V+ + +GQ VAIKQ+N + + I E+L++ L + N+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
GD+ +V EY+ GSL D + + D+ ++ R + + LE+LH VI+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHANQ---VIH 138
Query: 187 RDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 245
RD+KS N+LL D + KL+DFG A++ P + + ST V GT + APE K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 246 SDIYSFGVVLLELITG 261
DI+S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-19
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 66 NLIGEGGFGKVYKGRLESGQL---VAIKQLNHEGLQG-HQEFIVEVLMLSLL-HHDNLVT 120
++IGEG FG+V K R++ L AIK++ + H++F E+ +L L HH N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYD---LEPD---------QEPLSWNTRMKIAVG 168
L+G C L EY P G+L D L LE D LS + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 228
ARG++YL K I+RDL + NIL+ ++ K++DFGL++ G +V + MG
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGR 172
Query: 229 YG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ A E T SD++S+GV+L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 72/214 (33%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 66 NLIGEGGFGKVYKGR-LESGQLVAIKQ--LNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 122
IGEG +G+VYK R ++G+LVA+K+ L++E I E+ +L L+H N+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 123 GYCTSGDQRL----------LVYEYMP---MGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
T L LV+EYM MG LE L D + MK +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI----KSFMKQLL-- 126
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
GL Y H K ++RD+K +NILL+N KL+DFGLA+L ++ + +V+ T
Sbjct: 127 -EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181
Query: 230 GYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 262
Y PE + + D++S G +L EL T +
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 61 NFREANLIGEGGFGKVY------------KGRLESGQ-----LVAIKQLNHEG-LQGHQE 102
NF E +GEG FG+V+ K E+ LVA+K L + ++
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 103 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-------DQE 155
F+ EV +LS L N+ L+G CT ++ EYM G L L + +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 156 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215
LS++T + +A A G+ YL + ++RDL + N L+ ++ K++DFG+++
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
D V R + A E + GK T KSD+++FGV L E++T
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 119
++ LIG G +G VY+G+ + +G++VA+K +N + I EV +LS L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 120 TLIGY--CTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
+ Y RL ++ EY GS+ L P E I+V L L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKY-------ISVIIREVLVAL 114
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
VI+RD+K+ANIL+ N N KL DFG+A L + N+ + +GT + APE
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEV 172
Query: 237 AMSGKL-TLKSDIYSFGVVLLELITG 261
GK K+DI+S G+ + E+ TG
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 73/212 (34%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFI-VEVLML-SLLHHDNLVTLIG 123
+IGEG +GKVYK R ++GQLVAIK ++ +E I E +L +H N+ T G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 124 ------YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+ DQ LV E GS+ D + L + L I RGL YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAP 234
VI+RD+K NILL + KL DFG+ A+L D+T + R +GT + AP
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DST-LGRRNTFIGTPYWMAP 182
Query: 235 EYAMSGK-----LTLKSDIYSFGVVLLELITG 261
E + +SD++S G+ +EL G
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-19
Identities = 80/275 (29%), Positives = 127/275 (46%), Gaps = 29/275 (10%)
Query: 60 RNFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDN 117
F + IG+G FG+VYKG + ++VAIK ++ E + E I E+ +LS
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+ G G + ++ EY+ GS D L +P PL I +GL+YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPG--PLEETYIATILREILKGLDYLH 118
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+ I+RD+K+AN+LL + KL+DFG+A G + D +GT + APE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297
K+DI+S G+ A++L+KG+ + + R K P
Sbjct: 174 KQSAYDFKADIWSLGIT---------AIELAKGEPPNSDLHPMRVLFLIPKN----SPPT 220
Query: 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
L G+Y + + A CLN++ FRP +++
Sbjct: 221 LEGQYSKPFKEFVEA----CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-19
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 61 NFREANLIGEGGFGKVY--KGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 116
+ IGEG FGK+Y K + +S V IK+++ + + + EV++L+ + H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSL-----EDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
N+VT + +V EY G L DQ LSW ++ +
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSWFVQISL------ 112
Query: 172 GLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 230
GL+++H + +++RD+KS NI L N KL DFG+A+ + D+ ++ +GT
Sbjct: 113 GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPY 167
Query: 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
Y +PE + K+DI+S G VL EL T
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-19
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 66 NLIGEGGFGKVYKGRLESGQL---VAIKQLNHEGLQG-HQEFIVEVLMLSLL-HHDNLVT 120
++IGEG FG+V K R++ L AIK++ + H++F E+ +L L HH N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYD---LEPD---------QEPLSWNTRMKIAVG 168
L+G C L EY P G+L D L LE D LS + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 228
ARG++YL K I+RDL + NIL+ ++ K++DFGL++ G +V + MG
Sbjct: 133 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGR 184
Query: 229 YG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ A E T SD++S+GV+L E+++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-19
Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 35/220 (15%)
Query: 68 IGEGGFGKVY--------KGRLESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLL-HHDN 117
+GEG FG+V K + VA+K L + + + I E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHL---------YDLEPDQEP---LSWNTRMKI 165
++ L+G CT ++ EY G+L ++L Y P Q P LS+ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A ARG+EYL A+ I+RDL + N+L+ D K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 226 MGTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
T G + APE T +SD++SFGV+L E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 9e-19
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 67 LIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVT 120
++GEG FG V +G+L S VA+K + + +EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 121 LIGYCTSGDQR------LLVYEYMPMGSLEDHLYD--LEPDQEPLSWNTRMKIAVGAARG 172
LIG C +++ +M G L L L E L T +K V A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD---NTHVSTRVMGTY 229
+EYL +N I+RDL + N +L D ++DFGL+K GD ++ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ A E T KSD+++FGV + E+ T
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 1e-18
Identities = 66/196 (33%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 68 IGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IG+G G VY + +GQ VAIKQ+N + + I E+L++ + N+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
GD+ +V EY+ GSL D + + D+ ++ R + + L++LH VI+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSNQ---VIH 138
Query: 187 RDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 245
RD+KS NILL D + KL+DFG A++ P + + ST V GT + APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 246 SDIYSFGVVLLELITG 261
DI+S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDN 117
F + IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+ G LV EY +GS D L E ++PL + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+ +I+RD+K+ NILL KL DFG A + + +GT + APE
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVI 183
Query: 238 MS---GKLTLKSDIYSFGVVLLEL 258
++ G+ K D++S G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 1e-18
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IG+G G VY + +GQ VAI+Q+N + + I E+L++ + N+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
GD+ +V EY+ GSL D + + D+ ++ R + + LE+LH VI+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSNQ---VIH 139
Query: 187 RDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 245
RD+KS NILL D + KL+DFG A++ P + ++GT + APE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 246 SDIYSFGVVLLELITG 261
DI+S G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 71/247 (28%), Positives = 118/247 (47%), Gaps = 32/247 (12%)
Query: 68 IGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IGEG G V ++S G+LVA+K+++ Q + EV+++ H+N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
GD+ +V E++ G+L D + ++E ++ + + + L LH + VI+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQG---VIH 139
Query: 187 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 246
RD+KS +ILL +D KLSDFG V ++GT + APE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 247 DIYSFGVVLLELITGR---------KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297
DI+S G++++E++ G KAM + + NL P LK+ +H V P
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR----DNL----PPKLKN----LHKVSPS 245
Query: 298 LHGRYPR 304
L G R
Sbjct: 246 LKGFLDR 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 122
++G+G FGKV L+ G+ A+K L + + + +VE +L+L + +T +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 123 GYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--GLEYLHC 178
YCT + + V E++ G L H+ Q+ ++ A GL++LH
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHI------QDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
K +IYRDLK N++LD D + K++DFG+ K GDN ++ GT Y APE
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQ 169
Query: 239 SGKLTLKSDIYSFGVVLLELITGR 262
K T D +SFGV+L E++ G+
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHHDNLVTL 121
IGEG +G VYKGR ++GQ+VA+K++ L+ +E I E+ +L L H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ--EPLSWNTRMKIAVGAARGLEYLHCK 179
+ L++E++ M L+ +L L Q + + + + +G+ + H +
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQIL---QGILFCHSR 120
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM- 238
V++RDLK N+L+DN KL+DFGLA+ G V T + T Y APE +
Sbjct: 121 R---VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 239 SGKLTLKSDIYSFGVVLLELITGR 262
S + + DI+S G + E+ T +
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 22/201 (10%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
+G+G FGKVYK + E+G L A K + + + ++++VE+ +L+ +H +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
+ ++ E+ P G+++ + +L+ EP +I V + LE L + +I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVICRQMLEALQYLHSMKII 132
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAMSGKL 242
+RDLK+ N+LL D + KL+DFG++ N R +GT + APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 243 T-----LKSDIYSFGVVLLEL 258
K+DI+S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 68 IGEGGFGKV-YKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IGEG G V +G+ VA+K+++ Q + EV+++ HH+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
GD+ +V E++ G+L D + ++E ++ + + R L YLH N VI+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH---NQGVIH 141
Query: 187 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 246
RD+KS +ILL +D KLSDFG V ++GT + APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 247 DIYSFGVVLLELITG 261
DI+S G++++E+I G
Sbjct: 200 DIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 68 IGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVT 120
+GEG FGKV K VA+K L ++ + E +L ++H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHL--------------------YDLEPDQEPLSWN 160
L G C+ LL+ EY GSL L Y PD+ L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 161 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220
+ A +RG++YL A +++RDL + N+L+ K+SDFGL++ D+
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
++ + A E T +SD++SFGV+L E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 21/213 (9%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHH 115
NF++ IGEG +G VYK R +G++VA+K++ EG+ I E+ +L L+H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNH 58
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
N+V L+ + ++ LV+E++ L+ + PL + +GL +
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAF 115
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYCA 233
H V++RDLK N+L++ + KL+DFGLA+ G PV TH V+ T Y A
Sbjct: 116 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRA 168
Query: 234 PEYAMSGKL-TLKSDIYSFGVVLLELITGRKAM 265
PE + K + DI+S G + E++T R+A+
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 69/215 (32%), Positives = 116/215 (53%), Gaps = 20/215 (9%)
Query: 62 FREANLIGEGGFGKVYKG-RLESGQLV----AIKQLNHE-GLQGHQEFIVEVLMLSLLHH 115
+ ++G G FG VYKG + G+ V AIK LN G + + EF+ E L+++ + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD---QEPLSWNTRMKIAVGAARG 172
+LV L+G C S +L V + MP G L D++++ + + Q L+W V A+G
Sbjct: 69 PHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKG 121
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
+ YL + +++RDL + N+L+ + + K++DFGLA+L + + + +
Sbjct: 122 MMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 266
A E K T +SD++S+GV + EL+T G K D
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 67 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLL-HHDNLV 119
++G+G FGKV L + +L A+K L + + Q+ VE M L+L H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL--QDDDVECTMTEKRVLALAGKHPFLT 59
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHC 178
L + D+ V EY+ G L H+ EP R + A GL++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLHE 114
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
+ +IYRDLK N+LLD++ + K++DFG+ K G +G T ++ GT Y APE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILS 169
Query: 239 SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276
D ++ GV+L E++ G+ + G E L
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-18
Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 38/285 (13%)
Query: 67 LIGEGGFGKVYKGRLESG----QLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVT 120
+IG G FG+V +GRL+ VAIK L G Q +F+ E ++ H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
L G T +++ E+M G+L+ L + + ++ G A G++YL +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---S 123
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPE 235
++RDL + NIL++++ K+SDFGL++ + D+T T G + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRF--LEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHLV 294
K T SD++S+G+V+ E+ +S G+ RP+ + ++ +
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEV--------MSYGE---------RPYWDMSNQDVINAI 224
Query: 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339
+ P C + C ++ N RP IV LD ++
Sbjct: 225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 68 IGEGGFGKVYKGRLES-GQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGY 124
IG G FG+V+ GRL + VA+K E L +F+ E +L H N+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
CT Q+ +Y M + D L L + L +++ AA G+EYL K
Sbjct: 62 CT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYAMSGKL 242
I+RDL + N L+ K+SDFG+++ D + ST M + APE G+
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 243 TLKSDIYSFGVVLLE 257
+ +SD++SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 4e-18
Identities = 80/273 (29%), Positives = 120/273 (43%), Gaps = 29/273 (10%)
Query: 62 FREANLIGEGGFGKVYKGRLESGQ-LVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 119
F + IG+G FG+V+KG Q +VAIK ++ E + E I E+ +LS +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
G + ++ EY+ GS D L EP PL I +GL+YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPG--PLDETQIATILREILKGLDYLHSE 120
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
I+RD+K+AN+LL KL+DFG+A G + D +GT + APE
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 240 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299
K+DI+S G+ +EL G L+ + P P L
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLE 222
Query: 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
G Y + + A CLN+E +FRP +++
Sbjct: 223 GNYSKPLKEFVEA----CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 66/198 (33%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 68 IGEGGFGKVY-KGRLESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIG 123
IG G FG VY + ++VA+K++++ G Q + Q+ I EV L L H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
LV EY +GS D L E ++PL I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---G 240
+I+RD+K+ NILL KL+DFG A ++ +GT + APE ++ G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEG 195
Query: 241 KLTLKSDIYSFGVVLLEL 258
+ K D++S G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-------FIVEVLMLSL 112
F + N IGEG +G VY+ R SG++VA+K++ + E + E+ +L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD-----NERDGIPISSLREITLLLN 62
Query: 113 LHHDNLVTLIGYCT--SGDQRLLVYEY--MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 168
L H N+V L D LV EY + SL D++ P S + + +
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQ 116
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 228
RGL+YLH +I+RDLK +N+LL + K++DFGLA+ G T + T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVT 171
Query: 229 YGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 262
Y APE + T D+++ G +L EL+ +
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 22/201 (10%)
Query: 68 IGEGGFGKVY--KGRLESGQLVAIKQLNHEGLQGHQEFIVEVL-----MLSLLHHDNLVT 120
I +G FG VY K R +G AIK L + + + V M+ +
Sbjct: 4 ISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAK 61
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
L S D LV EY+ G + L P W + G+E LH +
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAK--QYIAEVVLGVEDLHQRG 117
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
+I+RD+K N+L+D + KL+DFGL++ G + + +GT Y APE +
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGV 168
Query: 241 KLTLKSDIYSFGVVLLELITG 261
SD +S G V+ E + G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSL-LHHDNLVTL 121
++G+G FGKV L+ + + AIK L + + + +VE +L+L H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 122 IGYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
+CT + + V EY+ G L H+ E + +I G L++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK 115
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
+IYRDLK N+LLD D + K++DFG+ K G+ ++ GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 240 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276
K D +SFGV+L E++ G+ G+ E L
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 8e-18
Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDN 117
F + IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+ G LV EY +GS D L E ++PL I GA +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+I+RD+K+ NILL KL+DFG A + ++ +GT + APE
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVI 193
Query: 238 MS---GKLTLKSDIYSFGVVLLEL 258
++ G+ K D++S G+ +EL
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 9e-18
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 68 IGEGGFGKVY--------KGRLESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDN 117
+GEG FG+V K R + VA+K L + + I E+ ++ L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY-------DLEPD-----QEPLSWNTRMKI 165
++ L+G CT ++ EY G+L + L D D +E LS+ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A ARG+EYL + I+RDL + N+L+ D K++DFGLA+ D ++
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ APE T +SD++SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 9e-18
Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDN 117
FR+ ++G+GGFG+V ++ +G++ A K+L + ++ G + E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAAR---GL 173
+V L + D LV M G L+ H+Y++ P E + AA GL
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE------EERALFYAAEILCGL 115
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
E LH + +YRDLK NILLD+ + ++SD GLA P G++ + RV GT GY A
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMA 169
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELITGR 262
PE + + TL D + G ++ E+I G+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 68 IGEGGFGKVY--------KGRLESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDN 117
+GEG FG+V K + VA+K L + + + + E+ M+ ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKI 165
++ L+G CT ++ EY G+L ++L P +E L++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A ARG+EYL A+ I+RDL + N+L+ D K++DFGLA+ D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ APE T +SD++SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 19/196 (9%)
Query: 82 ESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL-VYEY 137
+G VAIK L + + + F E + + L+H N+V L+ + L V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL- 196
+P +L + L L ++ + L+ L C N +++RDLK NI++
Sbjct: 61 VPGRTLREVL----AADGALPAGETGRLM---LQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 197 --DNDFNPKLSDFGLAKLGP-VGDNTHV----STRVMGTYGYCAPEYAMSGKLTLKSDIY 249
+ K+ DFG+ L P V D +T V+GT YCAPE +T SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 250 SFGVVLLELITGRKAM 265
++G++ LE +TG++ +
Sbjct: 174 AWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-17
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 29/273 (10%)
Query: 62 FREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 119
F + IG+G FG+V+KG + Q+VAIK ++ E + E I E+ +LS +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
G G + ++ EY+ GS D L D+ ++ T +K + +GL+YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLHSE 120
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
I+RD+K+AN+LL + KL+DFG+A G + D +GT + APE
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 240 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299
K+DI+S G+ A++L+KG+ + + R K P L
Sbjct: 176 SAYDSKADIWSLGIT---------AIELAKGEPPNSDMHPMRVLFLIPK----NNPPTLT 222
Query: 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
G + + + CLN++ +FRP +++
Sbjct: 223 GEFSKPFKEF----IDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 75/221 (33%), Positives = 109/221 (49%), Gaps = 29/221 (13%)
Query: 67 LIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDNLVT 120
++G+G FGKV R + +L AIK L + + Q+ VE M L+L +T
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVII--QDDDVECTMVEKRVLALPGKPPFLT 64
Query: 121 LIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
+ C RL V EY+ G L H+ + +EP + +IA+G L +LH K
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLHSK 120
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE--- 235
+IYRDLK N++LD + + K++DFG+ K G T TR GT Y APE
Sbjct: 121 G---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIA 174
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276
Y GK D ++FGV+L E++ G+ D G+ E L
Sbjct: 175 YQPYGK---SVDWWAFGVLLYEMLAGQPPFD---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 68 IGEGGFGKVY--------KGRLESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLL-HHDN 117
+GEG FG+V K + + VA+K L + + + + E+ M+ ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHL-----------YDLE--PDQEPLSWNTRMK 164
++ L+G CT ++ EY G+L ++L YD+ PD E +++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD-EQMTFKDLVS 141
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 224
ARG+EYL A+ I+RDL + N+L+ + K++DFGLA+ D +T
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 225 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ APE T +SD++SFGV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFI---VEVLMLSLLHHD--NLVT 120
IG G G+VYK R + +G ++A+KQ+ G + + I ++V++ S HD +V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVK 78
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
GY + + E M + D L L+ Q P+ + K+ V + L YL K
Sbjct: 79 CYGYFITDSDVFICMELM--STCLDKL--LKRIQGPIPEDILGKMTVAIVKALHYL--KE 132
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---- 236
VI+RD+K +NILLD N KL DFG++ G + D + TR G Y APE
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPP 189
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGR 262
+ K +++D++S G+ L+EL TG+
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 40/218 (18%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQ----LNHEGLQGHQEFIVEVLMLSLL--- 113
+ E IGEG +G VYK R L +G+ VA+K+ L+ EG+ + E+ +L L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLESF 58
Query: 114 HHDNLVTLIGYC-TSGDQR----LLVYEYMPMGSLED-HLYDLEPDQEP-LSWNTRMKIA 166
H N+V L+ C R LV+E++ +D Y L +P L T +
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVD----QDLATY-LSKCPKPGLPPETIKDLM 113
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 226
RG+++LH +++RDLK NIL+ +D K++DFGLA+ + T V+
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVV 167
Query: 227 GTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLEL 258
T Y APE YA D++S G + EL
Sbjct: 168 VTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 69/203 (33%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 67 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDNLVT 120
++G+G FGKV RL ESG+L A+K L + + Q+ VE M LSL + +T
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLT 59
Query: 121 LIGYCTSGDQRLL-VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHC 178
+ C RL V E++ G L H+ E R + A L +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEITSALMFLHD 114
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
K +IYRDLK N+LLD++ + KL+DFG+ K G + + ST GT Y APE
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTST-FCGTPDYIAPEILQ 169
Query: 239 SGKLTLKSDIYSFGVVLLELITG 261
D ++ GV+L E++ G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDN 117
FR+ ++G+GGFG+V ++ +G++ A K+L + ++ G + E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+V+L + D LV M G L+ H+Y + + + A GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
++YRDLK NILLD+ + ++SD GLA P G + RV GT GY APE
Sbjct: 120 ---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 238 MSGKLTLKSDIYSFGVVLLELITGR 262
+ + T D ++ G +L E+I G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-17
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 67 LIGEGGFGKVYKGRLESGQL-VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
++G+G +G VY R S Q+ +AIK++ + Q E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA--RGLEYLHCKANPP 183
+ + E +P GSL L PL N + I GL+YLH +
Sbjct: 75 SENGFFKIFMEQVPGGSLSAL---LRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQ 128
Query: 184 VIYRDLKSANILLDNDFNP--KLSDFG----LAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+++RD+K N+L+ N ++ K+SDFG LA + P + GT Y APE
Sbjct: 129 IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPCTET------FTGTLQYMAPEVI 181
Query: 238 MSGK--LTLKSDIYSFGVVLLELITGR 262
G +DI+S G ++E+ TG+
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 60/223 (26%), Positives = 113/223 (50%), Gaps = 26/223 (11%)
Query: 55 LAIATRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQL-NHEGLQGHQEFIVEVL 108
+AI+ ++L+ EG FG+++ G L + V +K + +H + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 109 MLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYD--LEPDQEPLSWNTR--M 163
+L L H N++ ++ C G+ ++Y YM G+L+ L L P + +T+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 164 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGP-----VGD 217
+A+ A G+ YLH + VI++D+ + N ++D + K++D L++ L P +GD
Sbjct: 121 HMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
N + + M A E ++ + + SD++SFGV+L EL+T
Sbjct: 178 NENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 61 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQL--NHEGLQGHQE---FIVEVLMLSLLH 114
N+R L+G+G FG+VY ++G+ +A+KQ+ + E + +E E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 115 HDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
H+ +V G +R L E+MP GS++D L L+ N K G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEG 118
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 231
+ YLH +++RD+K ANIL D+ N KL DFG +K L + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+PE K+DI+S G ++E++T +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-17
Identities = 68/249 (27%), Positives = 112/249 (44%), Gaps = 23/249 (9%)
Query: 61 NFREANLIGEGGFGKVY----KGRLESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSL 112
NF ++G G +GKV+ G ++G+L A+K L + + + E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 113 LHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-A 170
+ + + Y D +L L+ +Y+ G L HLY E E + +++ +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVRVYIAEIV 115
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 230
L++LH +IYRD+K NILLD++ + L+DFGL+K + + + GT
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIE 171
Query: 231 YCAPEYAMSGKLTLKS--DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288
Y APE G D +S GV+ EL+TG + Q Q+ + SR LK +
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSKP 229
Query: 289 KFVHLVDPL 297
F +
Sbjct: 230 PFPKTMSAE 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-17
Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 14/229 (6%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIG 123
+G+GGFG+V +++ +G++ A K+L+ + L+ G + ++E +L ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
S LV M G L+ H+Y++ + L + + G+ +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 243
++YRD+K N+LLD+ N +LSD GLA G T+ GT GY APE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYS 172
Query: 244 LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292
D ++ G + E++ GR K + + + R L+D+ KF H
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLEDEVKFEH 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 31/281 (11%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQL---NHEGLQGHQEFIVEVLMLSLLH 114
NF+ IG+G F VYK L G++VA+K++ + Q+ + E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 115 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
H N++ + ++ +V E G L + + + + T K V LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
++H K +++RD+K AN+ + KL D GL + T + ++GT Y +P
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294
E KSDI+S G +L E + + PF D+ L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLYSLC 217
Query: 295 DPLLHGRYPRRCLNYAVA----VTAMCLNEEANFRPLINDI 331
+ YP ++ + + C+N + RP I+ +
Sbjct: 218 KKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 20/200 (10%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
+G+G FGKVYK + E+G L A K ++ + + ++++VE+ +L+ H N+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
+ ++ E+ G+++ + +LE PL T +I V + LE L+ +I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELE---RPL---TEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 187 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAM----- 238
RDLK+ NIL D + KL+DFG++ NT R +GT + APE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 239 SGKLTLKSDIYSFGVVLLEL 258
K+D++S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 8e-17
Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDN---LV 119
+IG GGFG+VY R ++G++ A+K L+ + + QG + E +MLSL+ + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHC 178
+ + D+ + + M G L HL Q + M+ A GLE++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHMH- 114
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCAP 234
N V+YRDLK ANILLD + ++SD GLA K P H S +GT+GY AP
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMAP 164
Query: 235 EYAMSGKLTLKS-DIYSFGVVLLELITG 261
E G S D +S G +L +L+ G
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 68 IGEGGFGKVYK------GRLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLL-HHDNLV 119
+G G FGKV + + ++ VA+K L +E ++ E+ ++S L +H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
L+G CT G L++ EY G L + L + L+ + + A+G+ +L K
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEY 236
I+RDL + N+LL + K+ DFGLA+ + D+ +V + R+ + APE
Sbjct: 161 N---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 237 AMSGKLTLKSDIYSFGVVLLELIT 260
+ T +SD++S+G++L E+ +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLN-HEGLQGHQEFIV--EVLMLSLLHHD 116
+ +G G FG+V+ R S A+K + E ++ QE V E +L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 117 NLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA--ARG 172
++ L + T DQR L + EY+P G L +L + ++ + +
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL------RNSGRFSNSTGLFYASEIVCA 113
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
LEYLH K ++YRDLK NILLD + + KL+DFG AK + D T + GT Y
Sbjct: 114 LEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYL 165
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITG 261
APE S D ++ G+++ E++ G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 61 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQLN-HEGLQGHQEF----IVEVLMLSLLH 114
++ + IGEG +G V +G VAIK+++ E HQ F + E+ +L
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFK 61
Query: 115 HDNLVTL------IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 168
H+N++ + + + D +V E M E LY L Q LS +
Sbjct: 62 HENIIGILDIIRPPSFESFNDV-YIVQELM-----ETDLYKLIKTQ-HLSNDHIQYFLYQ 114
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG-PVGDNTHVSTRVMG 227
RGL+Y+H AN V++RDLK +N+LL+ + + K+ DFGLA++ P D+T T +
Sbjct: 115 ILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 228 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGR 262
T Y APE ++ K K+ DI+S G +L E+++ R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 66 NLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLI 122
IG G +G V +G+ VAIK++++ + L + + E+ +L L H+N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 123 GYCTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK-IAVGAARGLEYL 176
+V E M D L+ + +PL+ + ++ RGL+YL
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLT-DDHIQYFLYQILRGLKYL 119
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY----GYC 232
H AN VI+RDLK +NIL++++ + K+ DFGLA+ D + Y Y
Sbjct: 120 H-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGFLTEYVVTRWYR 173
Query: 233 APEYAMSGK-LTLKSDIYSFGVVLLELITGR 262
APE +S T DI+S G + EL+T +
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 68 IGEGGFGKVYK-GRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH---DNLVTLIG 123
+G G G V K + +G ++A K ++ ++ I+ L ++H +V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR--ELQIMHECRSPYIVSFYG 70
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
+ + + E+M GSL D +Y P+ KIAV GL YL+
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHR-- 124
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAMSGK 241
+++RD+K +NIL+++ KL DFG++ G+ N+ T V GT Y +PE GK
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFV-GTSTYMSPERIQGGK 178
Query: 242 LTLKSDIYSFGVVLLELITGR 262
T+KSD++S G+ ++EL G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHD 116
+F IG G +G VYK R + +G+L AIK + L+ ++F V E++M+ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
N+V G D+ + E+ GSL+D +Y + PLS + ++ +GL YL
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHV---TGPLSESQIAYVSRETLQGLYYL 122
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H K ++RD+K ANILL ++ + KL+DFG++ + +GT + APE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEV 177
Query: 237 AM---SGKLTLKSDIYSFGVVLLEL 258
A G DI++ G+ +EL
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 61 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQL-----NHEGLQGHQEFIVEVLMLSLLH 114
N+R L+G G FG+VY ++G+ +A+KQ+ + E + E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 115 HDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
HD +V G +++ L EYMP GS++D L L+ N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQG 118
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 231
+ YLH +++RD+K ANIL D+ N KL DFG +K + + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+PE K+D++S ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLV 119
F L+G G +G+VYKGR +++GQL AIK ++ G + +E E+ ML HH N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 120 TLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
T G DQ LV E+ GS+ D + + + + W I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
+LH VI+RD+K N+LL + KL DFG++ + +GT + A
Sbjct: 125 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMA 179
Query: 234 PEYAM-----SGKLTLKSDIYSFGVVLLELITG 261
PE KSD++S G+ +E+ G
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 83/266 (31%), Positives = 122/266 (45%), Gaps = 35/266 (13%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLV 119
F ++G G +G+VYKGR +++GQL AIK ++ + +E +E+ ML HH N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 120 TLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
T G DQ LV E+ GS+ D + + + + W I RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYG 230
+LH VI+RD+K N+LL + KL DFG+ A+L D T V R +GT
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPY 186
Query: 231 YCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR---P 282
+ APE +SDI+S G+ +E+ G A L + L R P
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG--APPLCDMHPMRALFLIPRNPPP 244
Query: 283 FLKDQ---KKFVHLVDPLLHGRYPRR 305
LK + KKF+ ++ L Y R
Sbjct: 245 KLKSKKWSKKFIDFIEGCLVKNYLSR 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 48/247 (19%)
Query: 68 IGEGGFGKVYKGRLES---GQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTL 121
IG G +G+VYK + ++ G+ AIK+ + Q Q E+ +L L H+N+V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 122 IGYC-TSGDQRL-LVYEYMPMGSLEDHLYDL--------EPDQEPLSWNTRMKIAVGAAR 171
+ D+ + L+++Y +DL + + + + +
Sbjct: 68 VEVFLEHADKSVYLLFDYAE--------HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKL------GPVGDNTHV 221
G+ YLH +N V++RDLK ANIL+ + K+ D GLA+L +
Sbjct: 120 GVHYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD--- 173
Query: 222 STRVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280
V+ T Y APE + + K+ DI++ G + EL+T +G + + S
Sbjct: 174 --PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF-----KGREAKIKKS 226
Query: 281 RPFLKDQ 287
PF +DQ
Sbjct: 227 NPFQRDQ 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDN---LV 119
+IG GGFG+VY R ++G++ A+K L+ + + QG + E +MLSL+ + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHC 178
+ + D+ + + M G L HL Q + M+ A GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVFSEKEMRFYATEIILGLEHMH- 114
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCAP 234
N V+YRDLK ANILLD + ++SD GLA K P H S +GT+GY AP
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMAP 164
Query: 235 EYAMSGKLTLKS-DIYSFGVVLLELITG 261
E G S D +S G +L +L+ G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 124
+G G +G VYK R L +G+L A+K + E G ++ E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
S ++ + EY GSL+D +Y + PLS + +GL YLH K
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHV---TGPLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGK 241
++RD+K ANILL ++ + KL+DFG+A + +GT + APE A +G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 242 LTLKSDIYSFGVVLLEL 258
DI++ G+ +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-16
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDN 117
FR ++G+GGFG+V ++ +G++ A K+L + ++ G + E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLE 174
+V+L + D LV M G L+ H+Y++ D+E + A GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-----YAAEITCGLE 116
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
LH + ++YRDLK NILLD+ + ++SD GLA P G+ + RV GT GY AP
Sbjct: 117 DLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAP 170
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGR 262
E + + T D + G ++ E+I G+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 22/216 (10%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQ----LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHH 115
F++ ++G G FG VYKG + G+ VAIK+L + ++E + E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 116 DNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPD---QEPLSWNTRMKIAVGAAR 171
++ L+G C TS Q L+ + MP G L D++ + + + Q L+W V A+
Sbjct: 69 PHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
G+ YL + +++RDL + N+L+ + K++DFGLAKL + + + +
Sbjct: 121 GMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 266
A E + T +SD++S+GV + EL+T G K D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 71/215 (33%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 62 FREANLIGEGGFGKV----YKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLM-------- 109
FR ++G G FGKV YK +G+L AIK L + E VE LM
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDE--VESLMCEKRIFET 55
Query: 110 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 168
+ H LV L C + + V EY G L H++ + S + A
Sbjct: 56 ANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAAC 109
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVM 226
GL+YLH ++YRDLK N+LLD + K++DFGL K +G GD T ST
Sbjct: 110 VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FC 162
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
GT + APE T D + GV++ E++ G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-16
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 61 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQL--NHEGLQGHQEFIV---EVLMLSLLH 114
N+R L+G+G FG+VY +++G+ +A KQ+ + E + +E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 115 HDNLVTLIGYCTSGDQRLLV--YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
H+ +V G ++ L EYMP GS++D L E ++ +I G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EG 118
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 231
+ YLH +++RD+K ANIL D+ N KL DFG +K L + + V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+PE K+D++S G ++E++T +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 68/222 (30%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 116
+F ++G+G FGKV + + +L AIK L + + + +VE +L+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 117 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
+T + C RL V EY+ G L H+ + +EP + +I+VG L +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFF 116
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 234
LH + +IYRDLK N++LD++ + K++DFG+ K V V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIAP 170
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276
E D +++GV+L E++ G+ D G+ E L
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 9e-16
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 68 IGEGGFGKVYKGRLESGQLVA---IKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIG 123
IG G FGKV G G A +K+L Q F+ EV L+H N++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSW----NTRMKIAVGAARGLEYLHCK 179
C LLV E+ P+G L+++ L ++ ++ + ++A A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNY---LRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-Q 118
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-- 237
A+ I+ DL N L D + K+ D+GLA D + APE
Sbjct: 119 AD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 238 -----MSGKLTLKSDIYSFGVVLLELIT 260
+ T KS+I+S GV + EL T
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQE-------FIVEVLMLSLLHHDNLV 119
IGEG +G VYK R + + +A+K++ E QE I E+ +L + H N+V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLE-----QEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM--KIAVGAARGLEYLH 177
L S + LV+EY+ + L+ H+ D PD + N R+ RG+ Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRLIKTYLYQILRGIAYCH 119
Query: 178 CKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYCAP 234
V++RDLK N+L+D N KL+DFGLA+ G PV TH T Y AP
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAP 172
Query: 235 EYAMSGK-LTLKSDIYSFGVVLLELITGR 262
E + + + DI+S G + E++ +
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 77/286 (26%), Positives = 131/286 (45%), Gaps = 42/286 (14%)
Query: 67 LIGEGGFGKVYKGRLE-SGQ---LVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHHDN 117
+IG G FG+V GRL+ G+ VAIK L G+ E F+ E ++ H N
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
++ L G T ++V EYM GSL+ L + + ++ G A G++YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL- 122
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG---TYGYCAP 234
++ ++RDL + NIL++++ K+SDFGL+++ + D+ + G + AP
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAP 178
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHL 293
E K T SD++S+G+V+ E+++ GE RP+ + + +
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMS----------YGE-------RPYWEMSNQDVIKA 221
Query: 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339
++ P C + C ++ N RP IV LD L+
Sbjct: 222 IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIK----QLNHEGLQGHQEFIVEVLMLSLLH---HDNLV 119
IG G +G VYK R SG VA+K Q N +GL + EV +L L H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP--LSTVREVALLKRLEAFDHPNIV 65
Query: 120 TLIGYCTSG--DQRL---LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
L+ C + D+ LV+E++ L +L + P P T + RGL+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLD 122
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCA 233
+LH +++RDLK NIL+ + KL+DFGLA++ + ++ T V+ T Y A
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRA 175
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 274
PE + D++S G + E+ RK + + +Q
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 62 FREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHH 115
F ++G+G FG V + +L+ S Q VA+K L + +EF+ E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 116 DNLVTLIGYC--TSGDQRL----LVYEYMPMGSLEDHLYDLEPDQEP--LSWNTRMKIAV 167
N++ LIG + RL ++ +M G L L +EP L T ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 227
A G+EYL ++ I+RDL + N +L+ + ++DFGL+K GD
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 228 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ A E T SD+++FGV + E++T
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IGEG G V R + SG+ VA+K ++ Q + EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
G++ ++ E++ G+L D + ++E ++ + + L YLH + VI+
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TVCESVLQALCYLHSQG---VIH 140
Query: 187 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 246
RD+KS +ILL D KLSDFG + + ++GT + APE +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 247 DIYSFGVVLLELITG 261
DI+S G++++E++ G
Sbjct: 199 DIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 17/211 (8%)
Query: 68 IGEGGFGKVYKG--RLESGQL-VAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIG 123
+G G FG V KG ++ Q+ VAIK L +E + E + E ++ L + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
C + + +LV E G L L + D+ +S + V + G++YL K
Sbjct: 63 VCEA-EALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQV--SMGMKYLEGKN--- 115
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAMSG 240
++RDL + N+LL N K+SDFGL+K LG D+++ R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 241 KLTLKSDIYSFGVVLLELIT-GRKAMDLSKG 270
K + +SD++S+G+ + E + G+K KG
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQL-NHEGLQGHQ--EFIVEVLMLSLLHHD 116
+F +G G FG+V + + +G+ AIK L E L+ Q E +L L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLE 174
+V ++ ++ + E++ G L HL P+ ++ + +A E
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA------FE 132
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
YLH K +IYRDLK N+LLDN + K++DFG AK V D T + GT Y AP
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLAP 184
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITG 261
E S D ++ GV+L E I G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 22/216 (10%)
Query: 62 FREANLIGEGGFGKVYKG-RLESGQ----LVAIKQL-NHEGLQGHQEFIVEVLMLSLLHH 115
++ ++G G FG VYKG + G+ VAIK L + + ++E + E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 116 DNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLY---DLEPDQEPLSWNTRMKIAVGAAR 171
+ L+G C TS Q LV + MP G L D++ D Q+ L+W V A+
Sbjct: 69 PYVCRLLGICLTSTVQ--LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAK 120
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
G+ YL +++RDL + N+L+ + + K++DFGLA+L + + + + +
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 266
A E + + T +SD++S+GV + EL+T G K D
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 67/202 (33%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 122
L+G+G FGKV R + +G+ A+K L E + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA--ARGLEYLHCKA 180
+ D+ V EY G L HL +E + R + GA LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARF-YGAEIVSALEYLHSRD 115
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
V+YRD+K N++LD D + K++DFGL K G + D + T GT Y APE
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDN 170
Query: 241 KLTLKSDIYSFGVVLLELITGR 262
D + GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDN 117
FR ++G+GGFG+V ++ +G++ A K+L + ++ G + E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+V+L + D LV M G L+ H+Y++ + A GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
++YRDLK NILLD+ + ++SD GLA P G+ V RV GT GY APE
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 238 MSGKLTLKSDIYSFGVVLLELITGR 262
+ K T D + G ++ E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 68 IGEGGFGKVYKGRL---ESGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLI 122
+GEG FG V +G+L +S VA+K + ++F+ E + + H N++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 123 GYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM--KIAVGAARGLE 174
G C + +++ +M G L L P T+M K A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
YL K+ I+RDL + N +L+ + N ++DFGL+K GD + A
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELIT 260
E T KSD++SFGV + E+ T
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 46/230 (20%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGH-QEFIVEVLMLSLLHHDNLVTLI 122
+IG G FG+V+ R ++GQ+ A+K L + + E +L+ +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 123 GYCTSGDQRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
Y + D+ L V EYMP G L + L D+ P++ + + +A+ + L ++H
Sbjct: 67 -YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH- 124
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----------------LGPVGDNTHVS 222
RD+K NIL+D D + KL+DFGL K DN V
Sbjct: 125 --------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 223 TR-----------VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
R +GT Y APE L+ D +S GV+L E++ G
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 67 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFI---VEVLMLSLLHHDNLVTLI 122
IG G FG V K SG ++A+K++ + Q+ + ++V+M S +V
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVKFY 69
Query: 123 GYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM--KIAVGAARGLEYLHCK 179
G GD + E M + SL D Y + + KIAV + L YL K
Sbjct: 70 GALFREGDC-WICMELMDI-SL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL--K 124
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
+I+RD+K +NILLD + N KL DFG++ +L ++ TR G Y APE
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPERID 180
Query: 239 SG---KLTLKSDIYSFGVVLLELITGR 262
++SD++S G+ L E+ TG+
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 68 IGEGGFGK--VYKGRLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIG 123
IGEG FGK + K + E G+ IK++N + +E EV +LS + H N+V
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ--- 63
Query: 124 YCTSGDQR---LLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMKIAVGAARGLEYL 176
Y S ++ +V +Y G L + L P+ + L W ++ +A L+++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHV 117
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H + +++RD+KS NI L D KL DFG+A++ + ++ +GT Y +PE
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEI 172
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGRKAMD 266
+ KSDI++ G VL E+ T + A +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 67 LIGEGGFGKVYKGRLESG--QLVAIKQLN----------HEGLQGHQEFIVEVLML-SLL 113
+G G FG VYK R ++ L+A+K++N E + + + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 114 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
H N+V D+ +V + + L +H L+ ++ + I V L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
YLH + +++RDL NI+L D ++DFGLAK + + T V+GT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGTILYSC 181
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELIT 260
PE + K+D+++FG +L ++ T
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 69/215 (32%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQ--LNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIG 123
+GEG + VYKGR + +GQLVA+K+ L HE +G I E +L L H N+VTL
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 124 YCTSGDQRLLVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
+ LV+EY+ ++D L N R+ RGL Y H +
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRL-FLFQLLRGLAYCHQRR 123
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-S 239
V++RDLK N+L+ KL+DFGLA+ V T+ + V T Y P+ + S
Sbjct: 124 ---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGS 178
Query: 240 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 274
+ + D++ G + E+ TGR S +Q
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 65/277 (23%), Positives = 117/277 (42%), Gaps = 35/277 (12%)
Query: 67 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQ----EFIVEVLMLSLLHHDNLVTLI 122
LI E +YKG + + V I+ +GH+ E+ L + +N++ +
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIY 84
Query: 123 GY----CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
G+ + L+ EY G L + L D E D LS+ T++ +A+ +GL L+
Sbjct: 85 GFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKD---LSFKTKLDMAIDCCKGLYNLYK 140
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
N P Y++L S + L+ ++ K+ GL K+ +V+ V +Y ++
Sbjct: 141 YTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS- 197
Query: 239 SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298
+ T+K DIYS GVVL E+ TG+ + + +L+ +
Sbjct: 198 --EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNNSL-------- 241
Query: 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335
+ P C + C + ++ RP I +I+ L
Sbjct: 242 --KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 46/275 (16%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGY 124
+G G +G V K R +G ++A+K++ Q+ ++ L +S+ + VT G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 125 C-TSGDQRLLVYEYMP-MGSLEDHLYD--LEPDQ---EP-LSWNTRMKIAVGAARGLEYL 176
GD V+ M M + D Y + E L KIAV + LEYL
Sbjct: 69 LFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYL 119
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H K + VI+RD+K +N+L++ + KL DFG++ G + D+ T G Y APE
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKTIDAGCKPYMAPER 174
Query: 237 ---AMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292
++ K +KSD++S G+ ++EL TGR D SW PF + K+ V
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWKTPF-QQLKQVVE 222
Query: 293 LVDPLL-HGRYPRRCLNYAVAVTAMCLNEEANFRP 326
P L ++ ++ CL + RP
Sbjct: 223 EPSPQLPAEKFSPEFQDF----VNKCLKKNYKERP 253
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYC 125
+GEG + V+KGR + + LVA+K++ E +G I EV +L L H N+VTL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 126 TSGDQRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
+ LV+EY+ + D+ +L +S + RGL Y H +
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNL------MSMHNVKIFMFQLLRGLSYCHKRK--- 123
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKL 242
+++RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + S +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181
Query: 243 TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 277
+ D++ G +L E+ TGR S + E +L+
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 67/245 (27%), Positives = 111/245 (45%), Gaps = 49/245 (20%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHHD 116
+ + IG+G FG+V+K R ++ Q+VA+K++ E + F + E+ +L LL H+
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLKHE 71
Query: 117 NLVTLIGYCTSGDQR--------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 168
N+V LI C + LV+E+ +H D L N +K +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFC------EH------DLAGLLSNKNVKFTLS 119
Query: 169 AAR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK---LGPVGD 217
+ GL Y+H +++RD+K+ANIL+ D KL+DFGLA+ L
Sbjct: 120 EIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 218 NTHVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 273
+ RV+ T Y PE + G D++ G ++ E+ T M + Q +
Sbjct: 177 PNRYTNRVV-TLWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232
Query: 274 QNLVS 278
L+S
Sbjct: 233 LTLIS 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 68 IGEGGFGKVYKGR--LESGQLVAIK----QLNHEGLQGHQEFIVEVL-MLSLLHHDNLVT 120
IGEG +GKV+K R G+ VA+K Q EG+ V VL L H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 121 LIGYCT-SGDQR----LLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLE 174
L CT S R LV+E++ +D L+ EP + T + RGL+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
+LH V++RDLK NIL+ + KL+DFGLA++ T V+ T Y AP
Sbjct: 125 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAP 178
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGR 262
E + D++S G + E+ +
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYC 125
+GEG + V+KGR + + LVA+K++ E +G I EV +L L H N+VTL
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
+ LV+EY+ L+ ++ D +S + RGL Y H + V+
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VL 126
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTL 244
+RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + S + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 245 KSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 277
+ D++ G + E+ +GR S + E +L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 65/200 (32%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVE-VLMLSLLHHDNLVTLI 122
IG+G FGKV + G+ A+K L + + +E + E ++L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKAN 181
+ D+ V +Y+ G L HL EP R + A A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSLN- 116
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
+IYRDLK NILLD+ + L+DFGL K G T ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 242 LTLKSDIYSFGVVLLELITG 261
D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 74/256 (28%), Positives = 114/256 (44%), Gaps = 38/256 (14%)
Query: 61 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL------QGHQEFIVEVLML 110
NF ++G G +GKV+ R ++G+L A+K L L H E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR--TERNVL 58
Query: 111 SLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
+ + + Y + +L L+ +Y+ G + HLY + E ++ G
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGE 113
Query: 170 A-RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVM 226
LE+LH ++YRD+K NILLD++ + L+DFGL+K L + T+
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFC 167
Query: 227 GTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WSR 281
GT Y APE GK D +S G+++ EL+TG L +GE+N S SR
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTL---EGERNTQSEVSR 221
Query: 282 PFLKDQKKFVHLVDPL 297
LK F + P
Sbjct: 222 RILKCDPPFPSFIGPE 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 9e-14
Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 68 IGEGGFGKVYKGRLESG---QLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIG 123
IG G FGKV G + SG V +K+L +Q +F+ E L H NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLY------DLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
CT LLV E+ P+G L+ +L + PD P T ++A A GL +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD--PT---TLQRMACEIALGLLHLH 117
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
K N I+ DL N LL D K+ D+GL+ D ++ + APE
Sbjct: 118 -KNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 238 --MSGKL-----TLKSDIYSFGVVLLEL 258
+ G L T +S+++S GV + EL
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 49/215 (22%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF--IVEVL-------MLSLLHHDN 117
IGEG F +V K + ++G+ AIK + + F + +V + L H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 118 LVTLIGYC---TSGDQRL-LVYEYMPMGSLEDHLYDLEPDQ-EPLSWNTRMKIAVGAARG 172
++ LI +G RL LV+E M M +LY+L + PL +
Sbjct: 60 ILRLIEVLFDRKTG--RLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH------VSTRVM 226
L+++H + +RD+K NIL+ +D KL+DFG + G + +STR
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYISTR-- 162
Query: 227 GTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELIT 260
Y APE + G K DI++ G V E+++
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 67 LIGEGGFGKVYKGR----LESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVT 120
++G+G FGKV+ R ++GQL A+K L L+ +E +L+ ++H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 121 L-IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEYLHC 178
L + T G + L+ +++ G L L +E + +K + A L++LH
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
+ +IYRDLK NILLD + + KL+DFGL+K + S GT Y APE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVN 171
Query: 239 SGKLTLKSDIYSFGVVLLELITG 261
T +D +SFGV++ E++TG
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYC 125
+GEG + VYKGR + + LVA+K++ E +G I EV +L L H N+VTL
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
+ LV+EY+ L+ +L D ++ + RGL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VL 126
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTL 244
+RDLK N+L++ KL+DFGLA+ + T+ + V T Y P+ + S +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 245 KSDIYSFGVVLLELITGR 262
+ D++ G + E+ TGR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 45/281 (16%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHD 116
NFR IG G F +VY+ L G VA+K++ L + + I E+ +L L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
N++ ++ +V E G L + + + + T K V LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H + V++RD+K AN+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296
KSDI+S G +L E + + PF D+ L
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLYSLCKK 219
Query: 297 LLHGRYP-----------RRCLNYAVAVTAMCLNEEANFRP 326
+ YP R+ +N MC+N + RP
Sbjct: 220 IEQCDYPPLPSDHYSEELRQLVN-------MCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 122
L+G+G FGKV R + SG+ A+K L E + E + E +L H L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKAN 181
+ D+ V EY+ G L HL +E + R + L+YLH +
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLH---S 113
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
++YRDLK N++LD D + K++DFGL K G + D + T GT Y APE
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 242 LTLKSDIYSFGVVLLELITGR 262
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 124
++GEG FG+ + S Q A+K++ + ++ E ++L+ + H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
+ +V EY G L + L P+ L W +M + V +++H K
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV------QHIHEKR 120
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAM 238
V++RD+KS NI L + KL DFG A+L P + T V GT Y PE
Sbjct: 121 ---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTPYYVPPEIWE 173
Query: 239 SGKLTLKSDIYSFGVVLLELIT 260
+ KSDI+S G +L EL T
Sbjct: 174 NMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 67 LIGEGGFGKVYKGRLESG-QLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 122
+IG G + KV RL+ Q+ A+K + E + ++ E + + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 123 GYCTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCK 179
C RL LV EY+ G L H+ P++ + + IA L +LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLHER 115
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYA 237
+IYRDLK N+LLD D + KL+D+G+ K LGP GD T + GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPEIL 168
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 275
+ D ++ GV++ E++ GR D+ + N
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 70/249 (28%), Positives = 111/249 (44%), Gaps = 23/249 (9%)
Query: 61 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSL 112
NF ++G G +GKV+ R +SG+L A+K L + + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 113 LHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-A 170
+ + + Y D +L L+ +Y+ G L HL E +E ++I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIYSGEIV 115
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 230
LE+LH +IYRD+K NILLD++ + L+DFGL+K D + GT
Sbjct: 116 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIE 171
Query: 231 YCAPEYAMSGKLTLKS--DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288
Y AP+ G D +S GV++ EL+TG + + Q + SR LK +
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEP 229
Query: 289 KFVHLVDPL 297
+ + L
Sbjct: 230 PYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 67/202 (33%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 122
L+G+G FGKV R + +G+ A+K L E + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA--ARGLEYLHCKA 180
+ D+ V EY G L HL E R GA L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF---YGAEIVSALGYLHSCD 115
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
V+YRDLK N++LD D + K++DFGL K G + D + T GT Y APE
Sbjct: 116 ---VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDN 170
Query: 241 KLTLKSDIYSFGVVLLELITGR 262
D + GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 23/224 (10%)
Query: 61 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 116
+F ++G+G FGKV R + +L AIK L + + + +VE +L+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 117 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
+T + C RL V EY+ G L + + +EP + +IA+G L +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVM-GTYGYC 232
LH K +IYRDLK N++LD++ + K++DFG+ K +N V+T+ GT Y
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYI 168
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276
APE D ++FGV+L E++ G+ + G+ E L
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNL 118
++ + +GEG + VYKG+ + +G+LVA+K + + +G I E +L L H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 119 VTLIGYCTSGDQRLLVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
V L + + LV+EY+ ++ H L P+ L RGL Y
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------FLFQLLRGLSY 118
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
+H + +++RDLK N+L+ + KL+DFGLA+ V +T+ + V T Y P+
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPD 173
Query: 236 YAM-SGKLTLKSDIYSFGVVLLELITGRKAM 265
+ S + + D++ G + +E+I G A
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 62 FREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNL 118
++ + +G G +G+V ++G+ VAIK+L+ + + E+ +L + H+N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 119 VTLIGYCT---SGDQRLLVYEYMP-MGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARG 172
+ L+ T S + VY MG+ DL + LS + + RG
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGA------DLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
L+Y+H A +I+RDLK +NI ++ D K+ DFGLA+ +V+TR Y
Sbjct: 131 LKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 182
Query: 233 APEYAMS-GKLTLKSDIYSFGVVLLELITGR 262
APE ++ DI+S G ++ EL+TG+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 122
IGEG +G V+K + E+ ++VA+K++ + EG+ + E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
S + LV+EY L+ + D +P +GL + H
Sbjct: 66 DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDP---EIVKSFMFQLLKGLAFCHSHN-- 119
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYCAPEYAMSG 240
V++RDLK N+L++ + KL+DFGLA+ G PV S V+ T Y P+
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---RCYSAEVV-TLWYRPPDVLFGA 174
Query: 241 KLTLKS-DIYSFGVVLLEL 258
KL S D++S G + EL
Sbjct: 175 KLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 31/276 (11%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN---HEGLQGHQEFIVEVLMLSLLHHD 116
NF+ IG G F +VY+ L + VA+K++ + Q+ + E+ +L L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
N++ + ++ +V E G L + + + + T K V +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H + V++RD+K AN+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296
KSDI+S G +L E + + PF D+ L
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLFSLCQK 219
Query: 297 LLHGRYPRRCLNYAVA----VTAMCLNEEANFRPLI 328
+ YP + + +MC+ + + RP I
Sbjct: 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 24/202 (11%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVL----MLSLLHHDNLVTLI 122
+G+GG+G+V+ + ++G++VA+K++ L E + VL +L+ + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTKSEWLVKLL 67
Query: 123 GYCTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCK 179
Y D+ L L EY+P G L +L + + M AV A L Y+H
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH-- 124
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
RDLK N L+D + KL+DFGL+K N+ V+G+ Y APE
Sbjct: 125 -------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRG 172
Query: 240 GKLTLKSDIYSFGVVLLELITG 261
D +S G +L E + G
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 122
L+G+G FGKV + + +G+ A+K L E + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA--ARGLEYLHCKA 180
+ D+ V EY G L HL +E + R + GA L+YLH +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARF-YGAEIVSALDYLHSEK 115
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
N V+YRDLK N++LD D + K++DFGL K G + D + T GT Y APE
Sbjct: 116 N--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDN 171
Query: 241 KLTLKSDIYSFGVVLLELITGR 262
D + GVV+ E++ GR
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 42/228 (18%)
Query: 66 NLIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQE-----------FIV--EVLML 110
+GEG +GKV K +G++VAIK++ E + F E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 111 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAV 167
+ + H+N++ L+ GD LV + M DL+ + L+ + I +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA--------SDLKKVVDRKIRLTESQVKCILL 126
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-------LGPVGDNTH 220
GL LH ++RDL ANI +++ K++DFGLA+ + +
Sbjct: 127 QILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 221 VSTRVMGTYG-----YCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 262
+ R T Y APE M + K D++S G + EL+TG+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 67 LIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNL 118
++G+GG+GKV++ R ++G++ A+K L + +Q+ E +L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEYLH 177
V LI +G + L+ EY+ G L HL ++E + + + LE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALEHLH 117
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEY 236
+ +IYRDLK NILLD + KL+DFGL K TH GT Y APE
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEI 171
Query: 237 AMSGKLTLKSDIYSFGVVLLELITG 261
M D +S G ++ +++TG
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDNLVT 120
++G+G FGKV L+ + ++ AIK L + + Q+ V+ M L+L +T
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL--QDDDVDCTMTEKRILALAAKHPFLT 59
Query: 121 LIGYCTSGDQRLL-VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
+ C RL V EY+ G L + EP S R A L +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS---RF-YAAEVTLALMFLHRH 115
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
VIYRDLK NILLD + + KL+DFG+ K G + T +T GT Y APE
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQE 170
Query: 240 GKLTLKSDIYSFGVVLLELITGR 262
+ D ++ GV++ E++ G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNL 118
+F + +G G G V K + + L+ ++L H ++ + I E+ +L + +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
V G S + + E+M GSL+ L + + E + K+++ RGL YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
K +++RD+K +NIL+++ KL DFG++ G + D+ ++ +GT Y +PE
Sbjct: 122 KHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQ 175
Query: 239 SGKLTLKSDIYSFGVVLLELITGR 262
+++SDI+S G+ L+EL GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 67 LIGEGGFGKVYKG--RLESGQ--LVAIKQLNHEGLQGHQE--FIVEVLMLSLLHHDNLVT 120
++G G FG++ +G +L S + VAI L G Q F+ E L L H N+V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
L G T G+ ++V EYM G+L+ L E L M + G A G++YL +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYL---S 124
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAM 238
+++ L + +L+++D K+S F + + T + G + APE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 239 SGKLTLKSDIYSFGVVLLELIT 260
+ SD++SFG+V+ E+++
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 67 LIGEGGFGKVYKG---RLESGQL-VAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTL 121
IGEG FG VY+G E+ ++ VA+K + +E F+ E ++ H ++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
IG T + +V E P+G L +L + ++ L + + + + L YL K
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSG 240
++RD+ + N+L+ + KL DFGL++ + D ++ +++ + APE
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFR 183
Query: 241 KLTLKSDIYSFGVVLLELI 259
+ T SD++ FGV + E++
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 68 IGEGGFGKVYK-GRLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 124
IG G FG V+ G+ VA+K++ + + L + E+ ML HDN+++ +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
Y+ ++ L+ + +PLS + RGL+YLH A +
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH-SAG--I 124
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLT 243
++RD+K N+L++++ K+ DFGLA++ ++ H++ V+ Y Y APE M S T
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRHYT 183
Query: 244 LKSDIYSFGVVLLELITGR 262
DI+S G + EL+ R
Sbjct: 184 SAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 68 IGEGGFGKVYKG--RLESGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGY 124
+GEG + VYKG R+ +GQLVA+K ++ + +G I E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 125 CTSGDQRLLVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
+ + V+EYM + H L P +N R+ RGL Y+H +
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRL-FMFQLLRGLAYIHGQH- 123
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SG 240
+++RDLK N+L+ KL+DFGLA+ + T+ S V T Y P+ + +
Sbjct: 124 --ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGAT 179
Query: 241 KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280
+ DI+ G + +E++ G+ A EQ W+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIG 123
+IG+G +G V +G+ VAIK++N E + + E+ +L LL H ++V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 124 YCTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
+R +V+E M E L+ + + L+ R L+Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYA 237
AN V +RDLK NIL + D K+ DFGLA++ T + T + T Y APE
Sbjct: 121 TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 238 MS--GKLTLKSDIYSFGVVLLELITGR 262
S K T DI+S G + E++TG+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 67 LIGEGGFGKVYKGRLESG-QLVAIKQLNHEGLQGHQEF-IVEVLMLSLLHHDNLVTLIGY 124
+IG G + KV L+ ++ A+K + E + ++ V+ N L+G
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 125 --CTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCK 179
C + RL V E++ G L H+ P++ ++ + +A L +LH +
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNFLHER 115
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYA 237
+IYRDLK N+LLD + + KL+D+G+ K + P GD T ST GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT--ST-FCGTPNYIAPEIL 168
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDL--SKGQGEQN 275
D ++ GV++ E++ GR D+ +QN
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF-IVEVLMLSLLHHDNLVTLIGY 124
+IG G + KV RL+ + ++ A+K + E + ++ V+ N L+G
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 125 --CTSGDQRLL-VYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCK 179
C + RL V EY+ G L H+ P++ ++ + +A L YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHER 115
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG-PVGDNTHVSTRVMGTYGYCAPEYAM 238
+IYRDLK N+LLD++ + KL+D+G+ K G GD T + GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILR 169
Query: 239 SGKLTLKSDIYSFGVVLLELITGRKAMDL--SKGQGEQN 275
D ++ GV++ E++ GR D+ S +QN
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 124
IG G +G V + E+ + VAIK++ + + + + E+ +L L H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 125 CTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
+ +VYE M + L+ + + LS + RGL+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH-S 126
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
AN V++RDLK +N+LL+ + + K+ DFGLA+ + T + T Y APE ++
Sbjct: 127 AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 240 -GKLTLKSDIYSFGVVLLELITGRK 263
+ T D++S G + EL+ GRK
Sbjct: 183 CSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 68 IGEGGFGKVYKG-RLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIG- 123
IG G +G V SG+ VAIK++ H + + + E+ +L HDN++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
G VY M + +E L+ + +PL+ RGL+Y+H AN
Sbjct: 73 LRPPGADFKDVYVVMDL--MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH-SAN-- 127
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAMS- 239
VI+RDLK +N+L++ D ++ DFG+A+ P ++ + T + T Y APE +S
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVATRWYRAPELLLSL 186
Query: 240 GKLTLKSDIYSFGVVLLELITGRKAM 265
+ T D++S G + E++ GR+ +
Sbjct: 187 PEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLM-LSLLHHDNLV 119
+F + +G G G V K L+ ++L H L+ +++ L +LH N
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH--LEIKPAIRNQIIRELKVLHECNSP 59
Query: 120 TLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
++G+ + G+ + + E+M GSL+ L E + KI++ RGL Y
Sbjct: 60 YIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENI----LGKISIAVLRGLTY 114
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD---NTHVSTRVMGTYGYC 232
L + +++RD+K +NIL+++ KL DFG++ G + D N+ V TR Y
Sbjct: 115 L--REKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFVGTR-----SYM 165
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+PE T++SDI+S G+ L+E+ GR
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 61/226 (26%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQL-----NHEGLQGHQEFIVEVLMLS-LLHHDNLVT 120
+G+G +G V+K + ++VA+K++ N Q E++ L L H N+V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVK 71
Query: 121 LIG-YCTSGDQRL-LVYEYMPM--------GSLED-H----LYDLEPDQEPLSWNTRMKI 165
L+ D+ + LV+EYM LED H +Y L
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQL--------------- 116
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNT----- 219
+ L+Y+H N VI+RDLK +NILL++D KL+DFGLA+ L + +N
Sbjct: 117 ----LKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 220 --HVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 262
+V+TR Y APE + S + T D++S G +L E++ G+
Sbjct: 170 TDYVATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 66/240 (27%), Positives = 100/240 (41%), Gaps = 47/240 (19%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG----HQEFIVEVLMLSLLHHDNLVTL 121
LIG+GG G+VY + VA+K++ E L + F+ E + + L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 122 IGYCTSGDQRLLVYEYMPM--GSLEDHLYDLEPDQEPLSWNTRMKIAVGA--------AR 171
C+ GD VY MP G L +E LS K +VGA
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL----------------GPV 215
+EY+H K V++RDLK NILL + D+G A
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT---------GRKAMD 266
+ + +++GT Y APE + + +DIY+ GV+L +++T GRK
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241
|
Length = 932 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHH 115
+F LI G +G VY R E+ Q A+K++N + L Q Q F VE +L+ +
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAEN 60
Query: 116 DNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
+V++ +C+ +R L V EY+ G L ++ ++ RM A L
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA---RMYFA-ETVLAL 114
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-------STR-- 224
EYLH N +++RDLK N+L+ + + KL+DFGL+K+G + T++ TR
Sbjct: 115 EYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 225 ----VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
V GT Y APE + D ++ G++L E + G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 70/262 (26%), Positives = 115/262 (43%), Gaps = 48/262 (18%)
Query: 29 SSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLV 87
S SS + + + + + + EL N IG G G VYK +G+L
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSEL-------ERVNRIGSGAGGTVYKVIHRPTGRLY 102
Query: 88 AIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 145
A+K + NHE Q E+ +L ++H N+V + ++ E+M GSLE
Sbjct: 103 ALKVIYGNHEDTVRRQ-ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161
Query: 146 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 205
E L+ +A G+ YLH + +++RD+K +N+L+++ N K++
Sbjct: 162 THIADEQF---LA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIA 210
Query: 206 DFGLAK-LGPVGDNTHVSTRVMGTYGYCAPE-------------YAMSGKLTLKSDIYSF 251
DFG+++ L D + S +GT Y +PE YA DI+S
Sbjct: 211 DFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSL 259
Query: 252 GVVLLELITGRKAMDLSKGQGE 273
GV +LE GR + + QG+
Sbjct: 260 GVSILEFYLGRFPFGVGR-QGD 280
|
Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 71/251 (28%), Positives = 119/251 (47%), Gaps = 22/251 (8%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNL 118
F ++GEG +G V K R E+ ++VAIK+ + E + + + E+ ML L +N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH- 177
V L + LV+EY+ LE L + P+ P K+ + ++ +H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAIHW 115
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
C N +++RD+K N+L+ ++ KL DFG A+ G N + T + T Y +PE
Sbjct: 116 CHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELL 173
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-QNLVSWSR---PFLKDQKKFVHL 293
+ D++S G +L EL G+ L G+ E L + + P +Q K +
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQP---LFPGESEIDQLFTIQKVLGPLPAEQMKLFY- 229
Query: 294 VDPLLHG-RYP 303
+P HG R+P
Sbjct: 230 SNPRFHGLRFP 240
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 66/255 (25%), Positives = 116/255 (45%), Gaps = 31/255 (12%)
Query: 22 PRSKSRYSSE--SSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKG 79
+ + E S N G E+ + R ++++ N+IG G FG VY+
Sbjct: 29 EMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS---PNKSYKLGNIIGNGSFGVVYEA 85
Query: 80 R-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY----CTSGDQRLL- 133
+++ + VAIK++ LQ Q E+L++ L+H N++ L Y C +++ +
Sbjct: 86 ICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141
Query: 134 ---VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 190
V E++P ++ ++ + L + R L Y+H K + +RDLK
Sbjct: 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLK 197
Query: 191 SANILLD-NDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKS 246
N+L+D N KL DFG AK L +++ +R Y APE + + T
Sbjct: 198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHI 252
Query: 247 DIYSFGVVLLELITG 261
D++S G ++ E+I G
Sbjct: 253 DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 66/243 (27%), Positives = 99/243 (40%), Gaps = 54/243 (22%)
Query: 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVL----MLSLLH 114
++F++ L+G+G G+V+ RL +G+L A+K L+ + + + + VL +L+ L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLD 59
Query: 115 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--- 171
H L TL + LV +Y P G L L +P + + V AR
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGK-------CLSEEV--ARFYA 109
Query: 172 -----GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV----- 221
LEYLH ++YRDLK NILL + LSDF L+K V
Sbjct: 110 AEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 222 -------------------STRVM---GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 259
S R GT Y APE D ++ G++L E++
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
Query: 260 TGR 262
G
Sbjct: 227 YGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 5e-12
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 68 IGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFI-----VEVLMLSLLHHDNLVTL 121
IG+G FG+VY+ R ++ ++ A+K L+ + + +E +L+ +LL +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 122 IGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEYLHCK 179
+ + D L LV +YM G L HL +E R K + LE+LH K
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL-----QKEGRFSEDRAKFYIAELVLALEHLH-K 114
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
+ ++YRDLK NILLD + L DFGL+K + T + GT Y APE +
Sbjct: 115 YD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLD 170
Query: 240 GK-LTLKSDIYSFGVVLLELITG 261
K T D +S GV++ E+ G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIK----QLNHEGLQGHQEFIVEVLMLSLLHH 115
+ + IGEG +GKVYK R +G+LVA+K +++ EG+ + E+ +L +L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSE 59
Query: 116 DN-LVTLIGY----CTSGDQRL-LVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAV 167
+V L+ +G L LV+EY+ + D PL T
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG--RPLPAKTIKSFMY 117
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLG--PVGDNTHVSTR 224
+G+ + H V++RDLK N+L+D K++D GL + PV TH
Sbjct: 118 QLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---- 170
Query: 225 VMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITG 261
+ T Y APE + + DI+S G + E+
Sbjct: 171 EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 37/275 (13%)
Query: 68 IGEGGFGKVY---------KGRLESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDN 117
+G+G FG VY + RL+ + + + +LN +E +Q +QE +LS L H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHPA 63
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+V D ++ EY L+ L +L+ + LS N + + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+ +++RDLK+ NI L N+ K+ DFG+++L + + ++T GT Y +PE
Sbjct: 124 QRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297
KSDI+S G +L E+ A + FL + V P
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------------FLSVVLRIVEGPTPS 224
Query: 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
L Y R+ LN ++ LN++ + RP +I+
Sbjct: 225 LPETYSRQ-LN---SIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-12
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLM-LSLLHHDNLVTLIGYC 125
+G+G +G VYK +G +A+K++ L+ + +++M L +LH ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR---LELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 126 TSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
+ VY EYM GSL D LY E + + +I +GL++L K
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL--KEEH 122
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSG 240
+I+RD+K N+L++ + KL DFG V N ++ +G Y APE SG
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFG------VSGNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 241 KL------TLKSDIYSFGVVLLELITGR 262
T++SD++S G+ +LE+ GR
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 62 FREANLIGEGGFGKV-YKGRLESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDN 117
+R+ +G G +G V +G VAIK+L + Q + E+ +L + H+N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 118 LVTLIGYCT---SGDQRLLVYEYMP-----MGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
++ L+ T S D+ Y MP +G L H E LS + +
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLSEDRIQFLVYQM 127
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
+GL+Y+H +I+RDLK N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----- 179
Query: 230 GYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 262
Y APE ++ T DI+S G ++ E++TG+
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 67 LIGEGGFGKVY-KGRLESGQLVAIKQLNHEGLQGHQE---FIVEV-LMLSLLHHDNLVTL 121
+IG+G FGKV R G+ A+K L + + +E + E ++L + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
+ ++ V +++ G L HL EP R A A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAA-EIASALGYLH---S 114
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
++YRDLK NILLD+ + L+DFGL K G +T +T GT Y APE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQP 172
Query: 242 LTLKSDIYSFGVVLLELITG 261
D + G VL E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVL--------- 108
T + + +G G FG V R +GQ VAIK++ + F VL
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61
Query: 109 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKI 165
+L L H+N+++L S + + V E + DL PL
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGT--------DLHRLLTSRPLEKQFIQYF 113
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
RGL+Y+H V++RDLK +NIL++ + + K+ DFGLA++ +VSTR
Sbjct: 114 LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY 170
Query: 226 MGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 262
Y APE ++ K ++ DI+S G + E++ G+
Sbjct: 171 -----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 65/199 (32%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLV-AIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIG 123
IG+G FGKV + R Q + A+K + + E + E +L+ ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-GLEYLHCKANP 182
S ++ LV ++ G L HL +E +R + LE LH K N
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYTAELLCALENLH-KFN- 113
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 242
VIYRDLK NILLD + L DFGL KL D+ + GT Y APE +
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGY 170
Query: 243 TLKSDIYSFGVVLLELITG 261
T D ++ GV+L E++TG
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 67 LIGEGGFGKVYKGRLES-GQLVAIKQLNHEGL--QGHQEFIV--EVLMLSLLHHDNLVTL 121
+IG+G FGKV + +S G A+K L + + + Q I+ ++L L H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKA 180
+ ++ V +Y+ G L HL EP R + A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSLN 116
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
+IYRDLK NILLD+ + L+DFGL K G + T ++ GT Y APE
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 241 KLTLKSDIYSFGVVLLELITG 261
D + G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 68 IGEGGFGKVYKGRLE---SGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+G G FG V KG + S + VA+K L N L+ E + E ++ L + +V
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALK--DELLREANVMQQLDNPYIVR 60
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
+IG C + +LV E +G L L + ++ ++ + G++YL +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLE-ET 114
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYA 237
N ++RDL + N+LL K+SDFGL+K LG D + + G + + APE
Sbjct: 115 N--FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECM 170
Query: 238 MSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKG 270
K + KSD++SFGV++ E + G+K KG
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 61/240 (25%), Positives = 111/240 (46%), Gaps = 28/240 (11%)
Query: 68 IGEGGFGKVYKG-RLESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
+G G G VYK L + +++A+K + + ++ ++ + E+ +L ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
++ + E+M GSL+ +Y P+ +IAV +GL YL + ++
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEH------VLGRIAVAVVKGLTYLW---SLKIL 117
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 245
+RD+K +N+L++ KL DFG++ ++ +GT Y APE + +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 246 SDIYSFGVVLLELITGR-KAMDLSKGQGE-------QNLVSWSRPFLKD---QKKFVHLV 294
SD++S G+ +EL GR + K QG Q +V P L +KFVH +
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 55/217 (25%), Positives = 105/217 (48%), Gaps = 39/217 (17%)
Query: 68 IGEGGFGKV--YKGRLESGQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHHDNLVT--- 120
+G+G +G+V + R + Q V IK+LN + + + E +LS L H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 121 -----------LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
++G+C GD +Y L++ L P+ + + W ++ +A
Sbjct: 67 SWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA--- 114
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
L+YLH K +++RDLK+ N+ L K+ D G+A++ + + +++ ++GT
Sbjct: 115 ---LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTP 166
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 266
Y +PE + KSD+++ G + E+ T + A +
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNL 118
+F + + +G G G V+K + L+ ++L H ++ + I E+ +L + +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
V G S + + E+M GSL+ L E + K+++ +GL YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
K +++RD+K +NIL+++ KL DFG++ G + D+ ++ +GT Y +PE
Sbjct: 122 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQ 175
Query: 239 SGKLTLKSDIYSFGVVLLELITGR 262
+++SDI+S G+ L+E+ GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 67 LIGEGGFGKVYKGRLESGQ-LVAIKQLNHEGLQGHQE----FIVEVLMLSLLHHDNLVTL 121
+IG+G FGKV R ++ + A+K L + + +E ++L + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
+ D+ V +Y+ G L Y L+ ++ L R A A L YLH +
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASALGYLH---S 114
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
++YRDLK NILLD+ + L+DFGL K + N ST GT Y APE
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNGTTST-FCGTPEYLAPEVLHKQP 172
Query: 242 LTLKSDIYSFGVVLLELITG 261
D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 53 RELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVL 108
+L + +F +IG G FG+V R S Q+ A+K L+ + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 109 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMK 164
+++ + + +V L + D + L V EYMP G L + + YD+ P++ + +
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVV 152
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVST 223
+A+ A + ++H RD+K N+LLD + KL+DFG K+ G T
Sbjct: 153 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDT 202
Query: 224 RVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITG 261
V GT Y +PE S G + D +S GV L E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 68 IGEGGFGKVYKGRLESGQLVA---IKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIG 123
IG G FGKV + + VA +K+L + + EF+ + +L H N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLY---DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
C LLV+EY +G L+ +L + + L ++A A G+ ++H K
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-KH 118
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS- 239
N ++ DL N L +D K+ D+G+ D + APE
Sbjct: 119 N--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 240 -GKL-----TLKSDIYSFGVVLLEL 258
G L T S++++ GV L EL
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 70/263 (26%), Positives = 111/263 (42%), Gaps = 77/263 (29%)
Query: 68 IGEGGFGKVYK------GRLESGQLVAIKQLNHEGLQG--HQEFIVEV-LMLSLLHHDNL 118
+G G FGKV + + S + VA+K L EG ++ + E+ +++ + HH N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLK-EGATASEYKALMTELKILIHIGHHLNV 73
Query: 119 VTLIGYCTSGDQRLLV-YEYMPMGSLEDHL------------------------------ 147
V L+G CT L+V EY G+L ++L
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 148 --------------------YDLEPDQE-------PLSWNTRMKIAVGAARGLEYLHCKA 180
D+E D+E PL+ + + ARG+E+L A
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---A 190
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYA 237
+ I+RDL + NILL + K+ DFGLA+ D +V R+ + APE
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPESI 247
Query: 238 MSGKLTLKSDIYSFGVVLLELIT 260
T +SD++SFGV+L E+ +
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 60 RNFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHH 115
+ +G G +G V +G+ VAIK+L Q + E+ +L + H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 116 DNLVTLIGYCTS---GDQRLLVYEYMPMGSLEDHLYDLEPDQ-EPLSWNTRMKIAVGAAR 171
+N++ L+ TS GD+ Y MP DL+ PLS + +
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-----DLQKIMGHPLSEDKVQYLVYQMLC 128
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
GL+Y+H +I+RDLK N+ ++ D K+ DFGLA+ +V TR Y
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180
Query: 232 CAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 262
APE ++ DI+S G ++ E++TG+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 62 FREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+ + +G G G V+ + + VA+K++ Q + + E+ ++ L HDN+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 121 LIGYCTSGDQRL--------------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 166
+ L +V EYM E L ++ +Q PLS
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVL-EQGPLSEEHARLFM 120
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK-LGPVGDNTHVSTR 224
RGL+Y+H AN V++RDLK AN+ ++ D K+ DFGLA+ + P + +
Sbjct: 121 YQLLRGLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 225 VMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283
+ T Y +P +S T D+++ G + E++TG+ + + L+ S P
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 284 LKDQKKFVHL-VDPLL---HGRYPRRCL 307
++++ + L V P G PRR L
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPL 265
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 68 IGEGGFGKVYKGRLE-------SGQLVAIKQLNHEGLQGHQ---EFIVEVLMLSLLHHDN 117
+G+G F +YKG L G + + H+ F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
LV L G C D+ ++V EY+ G L+ L+ E + L W ++ +A A L YL
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 178 CKANPPVIYRDLKSANILL----DNDFNP---KLSDFGLAKLGPVGDNTHVSTRVMGTYG 230
K +++ ++ NIL+ N+ KLSD G+ V R+
Sbjct: 119 DKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 231 YCAPEY--AMSGKLTLKSDIYSFGVVLLEL 258
+ APE LT+ +D +SFG LLE+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 54/231 (23%), Positives = 100/231 (43%), Gaps = 21/231 (9%)
Query: 29 SSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVA 88
+SES ++ K AR +A+ + + G G+V+
Sbjct: 41 ASESDDDDDDGLIPTKQKARE------VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPV 94
Query: 89 IKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY 148
+ ++ +G ++E ++L ++H +++ + SG +V +P S + + Y
Sbjct: 95 VLKIGQKGTT-----LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY 146
Query: 149 DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208
L PL + + I GL YLH + +I+RD+K+ NI +++ + D G
Sbjct: 147 -LTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLG 202
Query: 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 259
A+ PV + + GT APE K K+DI+S G+VL E++
Sbjct: 203 AAQF-PVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 68/217 (31%), Positives = 96/217 (44%), Gaps = 14/217 (6%)
Query: 55 LAIATRNFREANLIGEGGFGKVYK-GRLESGQLVAIKQLNHEGLQGHQEFIVEVLML-SL 112
L T + IG+G +GKVYK + G L A+K L+ +E E +L SL
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSL 75
Query: 113 LHHDNLVTLIGYC-----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 167
+H N+V G G Q LV E GS+ + + L + L I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGP--VGDNTHVSTR 224
GA GL++LH N +I+RD+K NILL + KL DFG+ A+L + NT V T
Sbjct: 136 GALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 192
Query: 225 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
A E + D++S G+ +EL G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 61 NFREANLIGEGGFGKVYKGRLESG-QLVAIKQLNH-EGLQGHQEFIVEVLMLSLLHHDN- 117
+F +IG G FG+V +L++ ++ A+K LN E L+ + L++ DN
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 118 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGL 173
+T + Y + L LV +Y G L L E P+ + M IA+ + L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
Y+H RD+K NIL+D + + +L+DFG + L + D T S+ +GT Y +
Sbjct: 122 HYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 234 PEYAMS-----GKLTLKSDIYSFGVVLLELITG 261
PE + GK + D +S GV + E++ G
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 18/149 (12%)
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLE 174
N+V L Y S D LV ++ G L H+ + P++ W M +A L+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYCA 233
LH + ++ RDL NILLD+ + +L+ F +++ D V YCA
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELITGR 262
PE + T D +S G +L EL+TG+
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 33/83 (39%), Positives = 49/83 (59%)
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 243
+I+RD+KSANILL ++ KL DFG +K+ + V GT Y APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 244 LKSDIYSFGVVLLELITGRKAMD 266
K+D++S GV+L EL+T ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 68 IGEGGFGKVYKG-RLESGQL-------VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 119
+G+G F K++KG R E G V +K L+ + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
G C GD+ ++V EY+ GSL+ +L + +SW ++++A A L +L K
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYA 237
+ + ++ + N+LL + + K + KL G + V + + + PE
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 238 MSGK-LTLKSDIYSFGVVLLELITG 261
+ + L+L +D +SFG L E+ +G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 53 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLV-AIKQLNHEGLQGHQE---FIVEVL 108
R+L + ++ +IG G FG+V R +S Q V A+K L+ + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 109 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMK 164
+++ + +V L +C D + L V EYMP G L + + YD+ P++ + +
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVV 152
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVST 223
+A+ A + +H RD+K N+LLD + KL+DFG K+ G T
Sbjct: 153 LALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDT 202
Query: 224 RVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITG 261
V GT Y +PE S G + D +S GV L E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 35/234 (14%)
Query: 42 KEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQL--VAIKQLNHEGLQG 99
K+ S + R+ + +F +G G FG+V ++ VAIK+ +
Sbjct: 12 KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71
Query: 100 HQEF---IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP 156
++ E +L+ ++H V L G LV E++ G L
Sbjct: 72 QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR------- 124
Query: 157 LSWNTRMKIAVGAARG------LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210
N R VG EYL + ++YRDLK N+LLD D K++DFG A
Sbjct: 125 ---NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 211 KLGPVGDNTHVSTR---VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
K+ V TR + GT Y APE ++ +D ++ G+ + E++ G
Sbjct: 179 KV--------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 68 IGEGGFGKVYKGRLESG---QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG- 123
+G G +G VYK + + G + A+KQ+ G+ E+ +L L H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKV 66
Query: 124 YCTSGDQRL-LVYEYMPMGSLEDHLYDL-------EPDQEPLSWNTRM--KIAVGAARGL 173
+ + D+++ L+++Y E L+ + + +++P+ M + G+
Sbjct: 67 FLSHSDRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAK-----LGPVGDNTHVST 223
YLH V++RDLK ANIL+ + P K++D G A+ L P+ D
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLAD----LD 173
Query: 224 RVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282
V+ T+ Y APE + + K+ DI++ G + EL+T Q + S P
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNP 228
Query: 283 FLKDQ 287
F DQ
Sbjct: 229 FHHDQ 233
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 40/99 (40%), Positives = 59/99 (59%), Gaps = 9/99 (9%)
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK---LGPVGDNTHVSTRVMG 227
GL+Y+H AN V++RDLK N+L++ D K+ DFGLA+ P G+N T +
Sbjct: 116 CGLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVA 171
Query: 228 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAM 265
T Y APE +S + K+ D++S G +L EL+ GRK +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 68 IGEGGFGKVYK-GRLESGQLVAIKQLN--HEGLQGHQEFIVEVLML-SLLHHDNLVTLIG 123
IG+G +GKV+K ++G A+K L+ H+ +E E +L +L H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYG 82
Query: 124 Y-----CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
+GDQ LV E GS+ D + E + I A GL++LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH- 141
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY-- 236
I+RD+K NILL + KL DFG++ + +GT + APE
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 237 ---AMSGKLTLKSDIYSFGVVLLELITG 261
+ + D++S G+ +EL G
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 61 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNH-EGLQGHQEFIV--EVLMLSLL 113
+F +IG G FG+V RL ++G + A+K+L E L+ Q V E +L+
Sbjct: 2 DFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA 58
Query: 114 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGA 169
+ +V L Y + D+ L+ EY+P G + L D ++E TR IA
Sbjct: 59 DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIA-ET 110
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-----------------L 212
++ +H K I+RD+K N+LLD + KLSDFGL L
Sbjct: 111 ILAIDSIH-KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 213 GPVGDNTHVSTR-------------------VMGTYGYCAPEYAMSGKLTLKSDIYSFGV 253
+ +GT Y APE + + D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 254 VLLELITG 261
++ E++ G
Sbjct: 228 IMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 22/181 (12%)
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWN 160
E+++L ++H N+++L+ T + L ++ Y+ M ++ +L +E D E +S+
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 161 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220
+ G+++LH +I+RDLK +NI++ +D K+ DFGLA+ N
Sbjct: 129 LYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFM 178
Query: 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280
++ V+ Y Y APE + DI+S G ++ EL+ G QG ++ W+
Sbjct: 179 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF-----QGTDHIDQWN 232
Query: 281 R 281
+
Sbjct: 233 K 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 53 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLV-AIKQLNHEGL--QGHQEFIVEVLM 109
R+L + ++ +IG G FG+V R +S + V A+K L+ + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 110 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIA 166
+ + V + Y D+ L +V EYMP G L + + YD+ P++ + + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLA 154
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG----LAKLGPVGDNTHVS 222
+ A + ++H RD+K N+LLD + KL+DFG + K G V +T V
Sbjct: 155 LDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 223 TRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITG 261
GT Y +PE S G + D +S GV L E++ G
Sbjct: 205 ----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 3/155 (1%)
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
E+ L+ H +V S D+ LL+ EY G L + + P +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
L+ +H + +++RDLKSANI L KL DFG +K + V++
Sbjct: 175 FYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
GT Y APE + + K+D++S GV+L EL+T
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 42/233 (18%)
Query: 52 FRELAIATRNF----REANL--IGEGGFGKVYKG-RLESGQLVAIKQLNH------EGLQ 98
F + + F R NL IG G G V +GQ VAIK+L+ +
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61
Query: 99 GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL-----VYEYMPMGSLEDH----LYD 149
++E VLM L++H N++ L+ T Q+ L VY M L D +
Sbjct: 62 AYREL---VLM-KLVNHKNIIGLLNVFTP--QKSLEEFQDVYLVM---ELMDANLCQVIQ 112
Query: 150 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209
++ D E +S+ + G+++LH + +I+RDLK +NI++ +D K+ DFGL
Sbjct: 113 MDLDHERMSYLLYQMLC-----GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 164
Query: 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
A+ G + ++ V+ Y Y APE + DI+S G ++ E+I G
Sbjct: 165 ARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLV-AIKQLNH-EGLQGHQEFIVEVLMLSLLHHD-N 117
+F +IG G FG+V +++ + + A+K LN E L+ + L++ D
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 118 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGL 173
+T + Y + L LV +Y G L L E P+ + M +A+ + L
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
Y+H RD+K N+LLD + + +L+DFG + L D T S+ +GT Y +
Sbjct: 122 HYVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 234 PEY--AMS---GKLTLKSDIYSFGVVLLELITG 261
PE AM GK + D +S GV + E++ G
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 36/105 (34%), Positives = 48/105 (45%), Gaps = 5/105 (4%)
Query: 155 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLG 213
PL + I L YLH + +I+RD+K+ NI LD N L DFG A KL
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 258
+T GT +PE K+DI+S G+VL E+
Sbjct: 237 -AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIG 123
I G FGKVY GR + + +L A+K + + + E L+L +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
S + LV EY+ G ++ L+ E ++ +K A L+YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYLHRHG--- 124
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKL 212
+I+RDLK N+L+ N+ + KL+DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 45/245 (18%)
Query: 68 IGEGGFGKVYKGRLESGQL---VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG- 123
+G G +G VYK + + G+ A+KQ+ G+ E+ +L L H N+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 66
Query: 124 YCTSGDQRL-LVYEYMPMGSLEDHLYDL-------EPDQEPLSWNTRM--KIAVGAARGL 173
+ + D+++ L+++Y E L+ + + +++P+ M + G+
Sbjct: 67 FLSHADRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAK-----LGPVGDNTHVST 223
YLH V++RDLK ANIL+ + P K++D G A+ L P+ D
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLAD----LD 173
Query: 224 RVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282
V+ T+ Y APE + + K+ DI++ G + EL+T Q + S P
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNP 228
Query: 283 FLKDQ 287
+ DQ
Sbjct: 229 YHHDQ 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 230
RGL+Y+H + +I+RDLK +N+ ++ D K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 231 YCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 262
Y APE ++ DI+S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHD 116
+F +IG G FG+V ++ +GQ+ A+K LN + E F E +L ++ D
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL--VNGD 59
Query: 117 N-LVTLIGYCTSGDQRL-LVYEYMPMGSL-------EDHLYDLEPDQEPLSWNTRMKIAV 167
+T + Y + L LV +Y G L ED L P+ + M +A+
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL----PEDMARFYLAEMVLAI 115
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 227
+ L Y+H RD+K N+LLD + + +L+DFG + L + D T S +G
Sbjct: 116 DSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVG 165
Query: 228 TYGYCAPEY--AM---SGKLTLKSDIYSFGVVLLELITG 261
T Y +PE AM G+ + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 30/231 (12%)
Query: 48 RSFTFRELAIATRNF----REANL--IGEGGFGKV---YKGRLESGQLVAIKQLNHE-GL 97
R F + I F R NL IG G G V Y LE VAIK+L+
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQN 63
Query: 98 QGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLE 151
Q H + E++++ ++H N++ L+ T + L ++ Y+ M ++ +L +E
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 152 PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211
D E +S+ + G+++LH +I+RDLK +NI++ +D K+ DFGLA+
Sbjct: 123 LDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
G + ++ V+ Y Y APE + DI+S G ++ E+I G
Sbjct: 175 TA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLH 114
++F +L+G G FG+V R + +G + A+K + L QE + E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISN 59
Query: 115 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEPLS--WNTRMKIAVGAA 170
+ L D LV EY P G L L Y+ + E ++ + + +A+ +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSV 118
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG-LAKLGPVGDNTHVSTRVMGTY 229
+ Y+H RD+K N+L+D + KL+DFG A+L + S +GT
Sbjct: 119 HQMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTP 167
Query: 230 GYCAPEY--AMSGKLT----LKSDIYSFGVVLLELITGR 262
Y APE M+G ++ D +S GV+ E+I GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 46/176 (26%)
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE---YMPMGSLEDHLY------DLEPDQEP 156
E+L L L+H+N++ + + +L E YM + LY + P
Sbjct: 213 EILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRP 264
Query: 157 LSWNTR--MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA---- 210
L TR MK + A +EY+H K +I+RD+K NI L+ D L DFG A
Sbjct: 265 LLKQTRAIMKQLLCA---VEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 211 ------KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
G VG S ++ GYC +DI+S G++LL++++
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCE-----------ITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 39/218 (17%)
Query: 67 LIGE----GGFGKVYKGRLESGQLVAIKQLN-----HEGLQGHQEFIVEVLMLSLLHHDN 117
LIG+ + K + + LVA+K++N E L+ Q+ E++ L H N
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQ---EIITSRQLQHPN 60
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLE 174
++ + + +V M GS ED L P+ P + IA L+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALD 115
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA--------KLGPVGDNTHVSTRVM 226
Y+H K I+R +K+++ILL D LS + + V D S + +
Sbjct: 116 YIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 227 GTYGYCAPEY---AMSGKLTLKSDIYSFGVVLLELITG 261
+ +PE + G KSDIYS G+ EL G
Sbjct: 173 P---WLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 83 SGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137
+G LV ++ E L+ Q EV++ H N++T T+G ++ +
Sbjct: 24 TGTLVTVRITDLENCTEEHLKALQN---EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80
Query: 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 197
M GS L P E +S I GA RGL YLH I+R++K+++IL+
Sbjct: 81 MAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 198 NDFNPKLSD----FGLAKLGP----VGDNTHVSTRVMGTYGYCAPEYA---MSGKLTLKS 246
D LS + L + G V D ST V+ + +PE + G +KS
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYG-YNVKS 191
Query: 247 DIYSFGVVLLELITGRKA-MDLSKGQ 271
DIYS G+ EL TGR D+ + Q
Sbjct: 192 DIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 60 RNFREANLIGEGGFGKV---YKGRLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLH 114
+ ++ IG G G V Y L+ VAIK+L+ + + E++++ ++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 115 HDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWNTRMKIAVGA 169
H N+++L+ T + L ++ Y+ M ++ +L +E D E +S+ +
Sbjct: 75 HKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC--- 130
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
G+++LH +I+RDLK +NI++ +D K+ DFGLA+ G + ++ V+ Y
Sbjct: 131 --GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 183
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELI 259
Y APE + DI+S G ++ E++
Sbjct: 184 -YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 68 IGEGGFGKV---YKGRLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLI 122
+G G +G V Y RL Q VA+K+L+ + L + E+ +L + H+N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 123 GY---CTSGDQRLLVYEYMP-MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
TS + VY MG+ +++ + LS + RGL+Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----LSDEHVQFLIYQLLRGLKYIHS 136
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
+I+RDLK +N+ ++ D ++ DFGLA+ +V+TR Y APE +
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIML 188
Query: 239 SG-KLTLKSDIYSFGVVLLELITGR 262
+ DI+S G ++ EL+ G+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 41/120 (34%), Positives = 61/120 (50%), Gaps = 16/120 (13%)
Query: 151 EPDQE-------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203
P QE PL+ + + ARG+E+L A+ I+RDL + NILL + K
Sbjct: 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVK 214
Query: 204 LSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ DFGLA+ D +V S R+ + APE T +SD++SFGV+L E+ +
Sbjct: 215 ICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 9/162 (5%)
Query: 104 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 163
E +L ++H +++ L G T L+ + + LY + ++ +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYKTDLYCYLAAKRNIAICDIL 185
Query: 164 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223
I R ++YLH +I+RD+K+ NI +++ + L DFG A PV N +
Sbjct: 186 AIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYY 241
Query: 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 265
GT APE DI+S G+VL E+ T ++
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194
Y+ +++ L D E L+ + ARG+E+L A+ ++RDL + N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 253
LL K+ DFGLA+ + D+ +VS + APE T SD++S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 254 VLLELIT 260
+L E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 69/266 (25%), Positives = 109/266 (40%), Gaps = 57/266 (21%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH-EGLQGHQEFIVEVLMLSLLHHDN-- 117
F + IG G FG+V R +++ L A+K L + L +Q V+ L DN
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 118 LVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
+V L Y + D+ L V +Y+P G + L L +E L+ R IA +E
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIES 116
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-------------------------- 209
+H I+RD+K NIL+D D + KL+DFGL
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 210 ---------AKLGPVGD-NTHVSTRVM-----GTYGYCAPEYAMSGKLTLKSDIYSFGVV 254
+L P+ R + GT Y APE + T D +S GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 255 LLELITGRKA-MDLSKGQGEQNLVSW 279
L E++ G+ + + + + +++W
Sbjct: 234 LYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 66/279 (23%), Positives = 108/279 (38%), Gaps = 82/279 (29%)
Query: 61 NFREANLIGEGGFGKVYKG------RLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLL 113
+G G FGKV + + ++ VA+K L +E ++ E+ +LS L
Sbjct: 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 95
Query: 114 -HHDNLVTLIG-------------YCTSGD--------------------------QRLL 133
+H N+V L+G YC GD + LL
Sbjct: 96 GNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLL 155
Query: 134 ---------VYEYMPM--------------------GSLEDHLYDLE-PDQEPLSWNTR- 162
+ EYM M GS D E +++ L+ +T
Sbjct: 156 HQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTED 215
Query: 163 -MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 221
+ + A+G+ +L A+ I+RDL + NILL + K+ DFGLA+ N V
Sbjct: 216 LLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272
Query: 222 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ APE + T +SD++S+G++L E+ +
Sbjct: 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRVM 226
A+G+E+L A+ I+RDL + NILL + K+ DFGLA+ D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ APE T++SD++SFGV+L E+ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 61/252 (24%), Positives = 99/252 (39%), Gaps = 60/252 (23%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDN-- 117
F + +G G FG+V R +++ L A+K L + L +Q V+ L DN
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEY 175
+V L D V +Y+P G + L + E L+ + + AV + + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL---------AKLGPVGDNTH------ 220
+H RD+K NIL+D D + KL+DFGL +K GD+
Sbjct: 123 IH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 221 ------------------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 250
++ ++GT Y APE + T D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 251 FGVVLLELITGR 262
GV+L E++ G+
Sbjct: 234 VGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 56/240 (23%), Positives = 94/240 (39%), Gaps = 48/240 (20%)
Query: 61 NFREANLIGEGGFGKV-YKGRLESGQLVAIKQLNH-EGLQGHQEFIVEVLMLSLLHHDNL 118
+F +IG G FG+V + ++G + A+K L + L+ Q + L+ D
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 119 VTLIGYCTSGDQR--LLVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAARGLE 174
+ + + D+R L+ E++P G + L D ++ + +A+ A L
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA---------------KLGPVGD-- 217
++H RD+K N+LLD + KLSDFGL P D
Sbjct: 122 FIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 218 ----------------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
++ +GT Y APE M D +S GV++ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 33/113 (29%), Positives = 61/113 (53%), Gaps = 11/113 (9%)
Query: 152 PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211
D PL + ++ + A+G+++L K I+RD+ + N+LL + K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 212 LGPVGDNTHVSTRVMGT----YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ D+ +V V G + APE T++SD++S+G++L E+ +
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 68 IGEGGFGKVYKGRLESGQ-LVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIG- 123
IG G FG+V+ + + Q K +++ GL+ + + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 124 YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
+ +Q+L ++ E+ G L ++ + + + I L Y H +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 183 P----VIYRDLKSANILLD-------------NDFN----PKLSDFGLAKLGPVGDNTHV 221
P V++RDLK NI L N+ N K+ DFGL+K + H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 222 STRVMGTYGYCAPEYAMSGKLTL--KSDIYSFGVVLLELITGR 262
+GT Y +PE + + KSD+++ G ++ EL +G+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
++Y+H + +I+RD+K+ N+L++ + L DFG A +T + GT
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLE 257
APE T DI+S G+V+ E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 25/161 (15%)
Query: 61 NFREANLIGEGGFGKV-YKGRLESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLHHDN- 117
+F +IG+G FG+V + ++G++ A+K L E + Q V+ L D+
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 118 -LVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-----AVGA 169
+V+L Y + D + L + E++P G L L + E + TR + A+ A
Sbjct: 62 WVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAECVLAIEA 116
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210
L ++H RD+K NIL+D + KLSDFGL+
Sbjct: 117 VHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 60/252 (23%)
Query: 62 FREANLIGEGGFGKV-YKGRLESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDN-- 117
F + +G G FG+V ++++ L A+K L + L +Q V+ L DN
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEY 175
+V L D V +Y+P G + L +E E L+ + + +A+ + + +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL---------AKLGPVGD--------- 217
+H RD+K NIL+D D + KL+DFGL +K G
Sbjct: 123 IH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 218 --------NTHVSTRVM-------------------GTYGYCAPEYAMSGKLTLKSDIYS 250
N R+ GT Y APE + T D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 251 FGVVLLELITGR 262
GV+L E++ G+
Sbjct: 234 VGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-05
Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 16/150 (10%)
Query: 67 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT--LIGY 124
L+ G +VY + V +K +E EV +L LL L ++
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRER--EVAILQLLARKGLPVPKVLAS 61
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
S L+ E++ G D + + E + IA A L LH +
Sbjct: 62 GESDGWSYLLMEWIE-GETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVL 110
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGP 214
+ DL NIL+D+ + D+ A GP
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 48/240 (20%)
Query: 61 NFREANLIGEGGFGKV-YKGRLESGQLVAIKQLNH-EGLQGHQEFIVEVLMLSLLHHDNL 118
+F +IG G FG+V + ++G + A+K L + L+ Q + L+ D+L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 119 VTLIGYCTSGDQR--LLVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAARGLE 174
+ + + D+ L+ E++P G + L D ++E + +A+ + L
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--------------- 219
++H RD+K N+LLD+ + KLSDFGL T
Sbjct: 122 FIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 220 ------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
++ +GT Y APE M D +S GV++ E++ G
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 61 NFREANLIGEGGFGKVYK------GRLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLL 113
N + +G G FGKV + G+ ++ VA+K L +E ++ E+ +LS L
Sbjct: 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL 98
Query: 114 -HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL 147
H N+V L+G CT G L++ EY G L + L
Sbjct: 99 GQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 32/109 (29%), Positives = 57/109 (52%), Gaps = 5/109 (4%)
Query: 153 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212
+ LS+ + + A G+E+L A+ ++RDL + N+L+ K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR- 287
Query: 213 GPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ D+ ++S + APE + T SD++SFG++L E+ T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 42/236 (17%)
Query: 109 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 168
M+ + H ++V L G C + ++V E++ G L+ L+ + + L+ + K+A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LF-MHRKSDVLTTPWKFKVAKQ 113
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILL-----DNDFNP--KLSDFGLAKLGPVGDNTHV 221
A L YL K +++ ++ + NILL D + P KLSD G+ P+ V
Sbjct: 114 LASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PIT----V 162
Query: 222 STR--VMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLEL-ITGRKAM-DLSKGQGEQNL 276
+R + + APE K L++ +D +SFG L E+ G + D + + E+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY 222
Query: 277 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
K+ L+ C+NY N+ FR ++ DI
Sbjct: 223 EGQCMLVTPSCKELADLM---------THCMNYDP-------NQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 20/158 (12%)
Query: 109 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 168
++S + H +L + G C G + ++V E++ G L D E + P++W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--KITVAQQ 125
Query: 169 AARGLEYLHCKANPPVIYRDLKSANIL-----LDNDFNP--KLSDFGLAKLGPVGDNTHV 221
A L YL K +++ ++ + NIL L +P KLSD G++ + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 222 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLEL 258
R+ + APE G L+ +D +SFG LLE+
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.002
Identities = 70/263 (26%), Positives = 103/263 (39%), Gaps = 55/263 (20%)
Query: 70 EGGFGKVY--KGRLESGQLV--AIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
+G FGKV K + V IK N + E +V LM + N + L
Sbjct: 26 DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMK---DNPNFIKLYYSV 78
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
T+ +L+ +Y+ G L +DL + LS KI L LH K N +I
Sbjct: 79 TTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALNDLH-KHN--II 131
Query: 186 YRDLKSANILLDNDFNPK--LSDFGLAKLGPVGDNTHVSTRVM--GTYGYCAPE------ 235
+ D+K N+L D + L D+GL K + T GT Y +PE
Sbjct: 132 HNDIKLENVLYD-RAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYFSPEKIKGHN 182
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGR--------KAMDLSKGQGEQNLVSWSRPFLKDQ 287
Y +S D ++ GV+ EL+TG+ + +DL Q PF+K+
Sbjct: 183 YDVS------FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNV 233
Query: 288 KKFVH-LVDPLLHGRYPRRCLNY 309
K + V +L R NY
Sbjct: 234 SKNANDFVQSMLKYNINYRLTNY 256
|
Length = 267 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 30/122 (24%), Positives = 50/122 (40%), Gaps = 13/122 (10%)
Query: 156 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-----------FNPKL 204
P S +I L+Y H + + +++ DLK NIL++ P
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 264
+ LG D H T ++ T Y +PE + +D++S G ++ EL TG+
Sbjct: 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344
Query: 265 MD 266
D
Sbjct: 345 YD 346
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 375 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.6 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.39 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.33 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.98 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.96 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.77 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.67 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.66 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.62 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.47 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.39 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.36 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.31 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.28 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.28 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.17 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.14 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.11 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.06 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.0 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.99 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.96 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.94 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.9 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.69 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.62 | |
| PLN02236 | 344 | choline kinase | 97.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.44 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.41 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.3 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.28 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.25 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.08 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.97 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.91 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.86 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.79 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.71 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.63 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.56 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.09 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.0 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.0 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.91 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-54 Score=396.84 Aligned_cols=292 Identities=58% Similarity=0.968 Sum_probs=253.5
Q ss_pred CCccccHHHHHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEE
Q 017246 46 GARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125 (375)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 125 (375)
....|++.++..++++|.....||+|+||.||+|...+|..||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 55679999999999999999999999999999999998899999988765433145699999999999999999999999
Q ss_pred eeCC-eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEE
Q 017246 126 TSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 204 (375)
Q Consensus 126 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl 204 (375)
.+.+ +.+||+||++.|+|.++|...... .++|..+++|+.++|+||+|||....++|+||||||+|||+|++++.||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999763322 8999999999999999999999988788999999999999999999999
Q ss_pred eecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhh
Q 017246 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 284 (375)
Q Consensus 205 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 284 (375)
+|||+|+..+.. .........||.+|+|||++..+..+.++||||||++|+||+||+.|.+.........+..|..+.+
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999764331 1111111179999999999999999999999999999999999999998766566666888887777
Q ss_pred hhccccchhcccccC-CCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 285 KDQKKFVHLVDPLLH-GRYPR-RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.+. .+..++|+.+. ..++. .....+..+..+|++.+|.+||+|.+|+++|+.+...
T Consensus 298 ~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 755 88889999987 66664 5777899999999999999999999999999776544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=403.88 Aligned_cols=245 Identities=25% Similarity=0.430 Sum_probs=213.9
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEcccc---CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.+|..+++||+|||+.||.++. .+|..||+|++.+. .....+.+.+|+++.+.|.|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4799999999999999999987 78999999999764 3345678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|+|..++|..+++. ...++|.+++.++.||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|.....
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999963 678999999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. .....+.||||.|.|||++.....+..+||||+||+||.||.|++||+...-.+ ...
T Consensus 171 ~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--------------------ty~ 228 (592)
T KOG0575|consen 171 D--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--------------------TYN 228 (592)
T ss_pred c--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH--------------------HHH
Confidence 2 233456899999999999999999999999999999999999999998432111 111
Q ss_pred cccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLH--GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... -.+|..++.+..+||.++|+.+|.+||++++|+.
T Consensus 229 ~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 229 KIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 1236688889999999999999999999999996
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=382.67 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=211.4
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEcccc-CccchHHHHHHHHHHccCCCCCcceeEeEEeeCC-eeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 135 (375)
..+++....||+|..|+||+++++ +++.+|+|++... .....+++.+|+++++..+||+||++|+.|.... .+.|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 346777889999999999999887 6889999999543 3345678999999999999999999999999998 599999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||++|+|.+++.. .+++++.....++.+|++||.|||. ++ ||||||||+||||+..|.|||||||.+....
T Consensus 158 EYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 158 EYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 99999999999964 4779999999999999999999995 66 9999999999999999999999999998643
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||...... ...+..++
T Consensus 231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---------------~~~~~~Ll 291 (364)
T KOG0581|consen 231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---------------YLDIFELL 291 (364)
T ss_pred hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---------------CCCHHHHH
Confidence 32 556789999999999999999999999999999999999999999754111 01111222
Q ss_pred cccc---CCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLL---HGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~---~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... ...+|.. +++++.+++..||++||.+||++.|+++
T Consensus 292 ~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 292 CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2222 2244555 9999999999999999999999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-55 Score=386.30 Aligned_cols=259 Identities=27% Similarity=0.362 Sum_probs=211.3
Q ss_pred HhhcccccceeccccceEEEEEE-EcCCceEEEEEccccCccc-------hHHHHHHHHHHccCCCCCcceeEeEEeeCC
Q 017246 58 ATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG-------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 129 (375)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++++..... ...+.+|+++|++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678999999999999999995 5579999999997753322 223578999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC---CceEEee
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSD 206 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~---~~vkl~D 206 (375)
..||||||++||+|.+++.. ++.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ -.+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999964 677888888999999999999999999 9999999999999766 6799999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCC---CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL---TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
||+|+... ......++||||.|.|||++.+..+ ..++|+|||||+||.+|+|.+||.....+...
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl--------- 390 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL--------- 390 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH---------
Confidence 99999643 3445567999999999999987653 34789999999999999999999743332210
Q ss_pred hhhccccchhccccc--CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCCCC
Q 017246 284 LKDQKKFVHLVDPLL--HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAG 352 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~~~ 352 (375)
..++..... .+..-..++++..+||.+||..||++||++.|+| +|||-+.++
T Consensus 391 ------~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL-----------~hpW~~~~~ 444 (475)
T KOG0615|consen 391 ------KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEAL-----------NHPWFKDAP 444 (475)
T ss_pred ------HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh-----------cChhhhccc
Confidence 001110000 0011246788999999999999999999999999 677777554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=368.01 Aligned_cols=256 Identities=27% Similarity=0.371 Sum_probs=211.1
Q ss_pred hcccccceeccccceEEEEEE-EcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEe-EEeeCCe-eEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIG-YCTSGDQ-RLLV 134 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 134 (375)
.+|++.+.||.|.||+||++. ..+|..+|.|.++.... ...+.+..|+.+|++|+|||||++++ .|..++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468999999999999999996 55899999999985533 34566889999999999999999998 5555555 8899
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||+|.+|+|...++..+..+..+++..+++++.|++.||..+|++- +..|+||||||.||+++++|.|||+|||+++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999998888899999999999999999999999831 233999999999999999999999999999974
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.. ........+|||.||+||++.+.+|+.+|||||+||++|||+.-++||...+ +.+ -..++.+-
T Consensus 179 ~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~-------L~~KI~qg 243 (375)
T KOG0591|consen 179 SS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLS-------LCKKIEQG 243 (375)
T ss_pred cc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHH-------HHHHHHcC
Confidence 33 3334556899999999999999999999999999999999999999997431 111 11111111
Q ss_pred cccccCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 294 VDPLLHGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 294 ~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
-..++| ..++..+..||..|+..||+.||+...++..
T Consensus 244 ----d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 244 ----DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred ----CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 011234 6789999999999999999999985444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=373.28 Aligned_cols=249 Identities=28% Similarity=0.373 Sum_probs=207.8
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..++|++.++||+|+||.||.++.+ +++.||+|++++.... .......|..+|..++||+||+++..|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3568999999999999999999754 6999999999886443 34567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
|+||+.||.|..+|.+ ...+++..++.++..|+.||.|||+++ ||||||||+|||+|++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999954 678999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
-. .......+|||+.|||||++.+..|+.++|+||||+++|||++|.+||...... .+... +
T Consensus 176 ~~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~----------I 237 (357)
T KOG0598|consen 176 LK--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDK----------I 237 (357)
T ss_pred cc--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHH----------H
Confidence 22 223344589999999999999999999999999999999999999999733211 11111 1
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC----CHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP----LINDIV 332 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP----s~~eil 332 (375)
.... ...+|.-.+.+..+++...|+.||++|. ++.+|-
T Consensus 238 ~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 238 LKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred hcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 1111 1123344788899999999999999995 455544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-52 Score=382.09 Aligned_cols=263 Identities=35% Similarity=0.526 Sum_probs=218.7
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccc--hHHHHHHHHHHccCCCCCcceeEeEEeeCC-eeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 135 (375)
...+.+.+.||.|+||+||+|.++....||+|++....... .+.|.+|+.+|.+++|||||+++|++.... .++|||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 34455567799999999999999844449999997754333 458999999999999999999999998877 799999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCccCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGP 214 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~~~~ 214 (375)
||+++|+|.+++... .+..+++..++.++.||++||.|||+++. ||||||||+||||+.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999763 46789999999999999999999997653 89999999999999998 99999999998533
Q ss_pred CCCCceeeeccccccccccccccc--cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
... ...+...||+.|||||++. ...|+.++||||||++||||+||..||..... ......
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----------------~~~~~~ 257 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----------------VQVASA 257 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHH
Confidence 221 2233368999999999999 56899999999999999999999999974322 111122
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
+.....+..+|..++..+..|+.+||+.||+.||++.+|+..|+.+.....
T Consensus 258 v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 258 VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 333344455566799999999999999999999999999999999987544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=373.04 Aligned_cols=199 Identities=33% Similarity=0.476 Sum_probs=179.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.++|.+.+.||+|+||+||+|+++ ++..||||.+.+.. .+..+.+..|+.+|+.++|||||.+++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357999999999999999999876 58999999998763 334556788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC------CceEEeecCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND------FNPKLSDFGL 209 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~------~~vkl~Dfg~ 209 (375)
|||+||+|.+|+.. .+++++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999965 558999999999999999999999998 9999999999999765 4589999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccc
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 267 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 267 (375)
|+.... .....+.||+|.|||||+++.+.|+.|+|+||+|+++|++++|+.||+.
T Consensus 162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 997653 3345568999999999999999999999999999999999999999973
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=375.86 Aligned_cols=261 Identities=31% Similarity=0.486 Sum_probs=222.1
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+....+.+++.||+|-||.||.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||++++++..++.++||||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 344556778899999999999999997779999999765 3445778899999999999999999999999889999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
||+.|+|.+||.. ..+..+...+.+.++.|||+||+||++++ +|||||...||||++++.|||+|||+|+... .
T Consensus 282 ~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d 355 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG-D 355 (468)
T ss_pred ecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC-C
Confidence 9999999999976 35677899999999999999999999998 9999999999999999999999999999422 2
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
+.........-...|.|||.+....++.+||||||||+||||+| |+.||.... ..+..+.+.
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le 418 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLE 418 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHh
Confidence 22222222334568999999999999999999999999999999 899986322 122333445
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.-.+...|..||..+.+++..||+.+|++||||..+...|+.+...
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 5555567899999999999999999999999999999999988654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=367.02 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=212.8
Q ss_pred HHHhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCc---cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCe
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 130 (375)
.....+|.+++.||.|+|++|++|+. .+++.||||++.+... .....+..|-.+|.+| +||.|++|+..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34467899999999999999999974 4799999999976533 2334566788899998 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
+|+|+||+++|+|.++|.. .+.+++..++.++.+|+.||+|||++| ||||||||+|||||.++++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999965 578999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc---------ee--eeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc
Q 017246 211 KLGPVGDNT---------HV--STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 211 ~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 279 (375)
+........ .. ...++||..|.+||++.+...+..+|+|+||||||+|+.|.+||...+.-. -
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-----i- 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-----I- 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-----H-
Confidence 865432211 11 245899999999999999999999999999999999999999996432210 0
Q ss_pred hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
+..++. +.-.+|+.+++...+||.+.|-.||.+|++..+|-+.
T Consensus 296 ----------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 ----------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 011111 1124577788999999999999999999999998773
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=341.19 Aligned_cols=237 Identities=27% Similarity=0.375 Sum_probs=205.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
-++|++.+.||.|+||.|.+++.+ +|..||+|++.+..... .+...+|..+|+.+.||+++++++.|.+.+.+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357899999999999999999876 58899999998865543 44567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||++||.|..+++. -+++++..++.++.||+.||+|||+++ |++|||||+|||+|.+|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999964 668999999999999999999999998 9999999999999999999999999998632
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
. . .-+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||...... .....++
T Consensus 196 ~--r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~iY~KI~ 254 (355)
T KOG0616|consen 196 G--R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QIYEKIL 254 (355)
T ss_pred C--c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HHHHHHH
Confidence 2 1 34589999999999999999999999999999999999999999643321 1111222
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 325 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 325 (375)
...+ .+|.-++.++.+|+...|+.|-.+|
T Consensus 255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2222 4688889999999999999999988
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=367.32 Aligned_cols=268 Identities=30% Similarity=0.492 Sum_probs=218.0
Q ss_pred HHHHHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCC
Q 017246 52 FRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 129 (375)
Q Consensus 52 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 129 (375)
..+..+..+.+.+++.||+|.||+||+|++. | .||||+++..... ..+.|.+|+.++++.+|.||+-++|++....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3556677778889999999999999999886 2 4999999876443 4678999999999999999999999998876
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
. .||..+|+|-+|+.+|+.. ...+.....+.|+.||++||.|||.++ |||||||..|||+.++++|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 6 9999999999999999863 467888999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCceeeecccccccccccccccc---CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
+.....-..........|...|||||++.. .+|++.+||||||+++|||+||..||.. ...++.+....+.++..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi--~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI--QNRDQIIFMVGRGYLMP 612 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC--CChhheEEEecccccCc
Confidence 975333233333344568889999999874 4699999999999999999999999972 22222211111111110
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
. + ......|+.++.+|+..||..++++||.+.+|+..|+.++..
T Consensus 613 d----------~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 613 D----------L-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred c----------c-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0 0 012357889999999999999999999999999999998774
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=364.77 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=213.3
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEcccc----Cc-cchHHHHHHHHHHccCC-CCCcceeEeEEeeCC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE----GL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGD 129 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 129 (375)
...+.|.+++.||+|+||.|+.|... ++..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999654 6899999987664 11 23445668999999999 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEeecC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFG 208 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~Dfg 208 (375)
.+++||||+.||+|.+++.. ..++.+..+..++.||+.|++|||+++ |+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999964 678899999999999999999999998 9999999999999999 999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCC-CC-ccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
++.... .........|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ......
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k---- 234 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK---- 234 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH----
Confidence 998653 2333456689999999999999877 86 789999999999999999999974211 111111
Q ss_pred ccccchhcccccCCCCCHHH-HHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 287 QKKFVHLVDPLLHGRYPRRC-LNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
+.... -.+|..+ +.++.+|+.+||..+|.+|+++.+|+ .-..++.
T Consensus 235 ------i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 235 ------IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred ------HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 11111 1235555 88999999999999999999999999 7666665
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=371.13 Aligned_cols=245 Identities=27% Similarity=0.398 Sum_probs=213.8
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
+-|++++.||+|+.|.|-+|++ .+|+.+|||++.+... .....+.+|+.+|+.++||||+++|+++++..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3588999999999999999976 4799999999977521 22445788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||++||.|++++.. ++++++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|....
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 99999999999964 778999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCceeeeccccccccccccccccCCCC-ccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
......+.||+|.|.|||++.+.+|. .++||||+|||||.||||+.||+ ..++..++
T Consensus 164 --~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--------------------DdNir~LL 221 (786)
T KOG0588|consen 164 --PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--------------------DDNIRVLL 221 (786)
T ss_pred --CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--------------------CccHHHHH
Confidence 23344568999999999999999986 78999999999999999999998 23333444
Q ss_pred ccccCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 295 DPLLHG--RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 295 ~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
....++ .+|..++.+.++|+.+|+..||++|.|++||++.
T Consensus 222 lKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 222 LKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 444444 3478899999999999999999999999999964
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=341.12 Aligned_cols=264 Identities=25% Similarity=0.327 Sum_probs=204.8
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+.|+...++|+|+||.||+++++ +|+.||||++..... .-.+-..+|+.+|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35888899999999999999876 699999999855322 224457899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
||+. ++.+-|.. ....++...+.+++.|++.|+.|+|+++ ++||||||+||||+.+|.+||||||+|+....
T Consensus 82 ~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9987 44444433 4567899999999999999999999998 99999999999999999999999999997542
Q ss_pred CCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch--------hhhhhhc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS--------RPFLKDQ 287 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~ 287 (375)
.....+..+.|.+|+|||.+.+ .+|...+||||+||++.||++|.+.|...++-+-...+... ...+...
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 3334455778999999999987 68999999999999999999999998755443211111110 0011111
Q ss_pred cccchhccccc------CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.-+..+.-+.. ...+ +..+..+.+++..||+.||++|++-++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111 1112 345668999999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=351.63 Aligned_cols=255 Identities=29% Similarity=0.429 Sum_probs=205.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCC--eeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 136 (375)
.+|...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35777899999999999999765 48999999987764444667889999999999999999999754444 6889999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-CCceEEeecCCCccCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~ 215 (375)
|+++|+|.+++.... ..+++..++.+..||++||+|||+++ |+||||||+||||+. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999997632 27999999999999999999999998 999999999999999 79999999999875432
Q ss_pred -CCCceeeeccccccccccccccccCC-CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 216 -GDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 216 -~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
...........||+.|||||++..+. ...++|||||||++.||+||.+||.... .... .+..+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~----------~~~~i 235 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAE----------ALLLI 235 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHH----------HHHHH
Confidence 12222234578999999999999643 3359999999999999999999997420 0000 01111
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 335 (375)
......+.+|..++.+..+++.+|++.+|++|||+.++|+..
T Consensus 236 g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 236 GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 111122256778899999999999999999999999999753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=358.04 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=205.0
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..++|+++..||+|+||.||+|+.+ +|..||+|++++.... ....++.|-.+|....+|+||+++..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4568999999999999999999755 6999999999886443 34567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||++||++..+|. ....|++..++.++.+++.||+.||+.| +|||||||+|+|||..|++||+|||++.-.
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999995 4778999999999999999999999999 999999999999999999999999998521
Q ss_pred CC----------------------CCCce-----------------------eeeccccccccccccccccCCCCccchh
Q 017246 214 PV----------------------GDNTH-----------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDI 248 (375)
Q Consensus 214 ~~----------------------~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 248 (375)
.. .+... .....+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 00000 0112579999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCcccccccc-ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 017246 249 YSFGVVLLELITGRKAMDLSKGQG-EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 327 (375)
Q Consensus 249 wslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs 327 (375)
|||||||||||.|.+||....+.. -.++..|...... .-...++.+..+||.+|+. ||++|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------P~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------PEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------CCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999997544332 2333333321111 0112445889999999998 9999965
Q ss_pred ---HHHHH
Q 017246 328 ---INDIV 332 (375)
Q Consensus 328 ---~~eil 332 (375)
+.||-
T Consensus 436 ~~G~~EIK 443 (550)
T KOG0605|consen 436 SKGAEEIK 443 (550)
T ss_pred cccHHHHh
Confidence 55544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=355.25 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=207.1
Q ss_pred HHhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCcc-chHHHHHHHHHHccCC-CCCcceeEeEEeeCC-eeE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGD-QRL 132 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~ 132 (375)
...++|.+.+.||.|+||.||+|+. .+|..||||.++..-.. ....-++|+..|++++ ||||+++++++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4457899999999999999999964 57999999999765332 1223467999999998 999999999998887 999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+|||||+. +|++.++.+ +..+++..++.|+.||++||+|+|.+| ++|||+||+|||+..+..|||+|||+|+.
T Consensus 87 fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 99999965 999999763 678999999999999999999999998 99999999999999888999999999986
Q ss_pred CCCCCCceeeeccccccccccccccc-cCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchhhh----hhh
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPF----LKD 286 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~----~~~ 286 (375)
..... ..+..+.|.+|+|||++. ...|+.+.||||+|||++|+++-++.|.+.+..+.- .+.+..... +..
T Consensus 160 v~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 43322 234467899999999887 567999999999999999999999999754432211 001100000 000
Q ss_pred ccccchhc---ccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 287 QKKFVHLV---DPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 287 ~~~~~~~~---~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
...+...+ .+...+ .+-+.++.+..+||.+||++||++|||+.+.++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00111111 111111 1123488899999999999999999999999964
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=346.59 Aligned_cols=264 Identities=27% Similarity=0.364 Sum_probs=212.1
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc-hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
...+.|++.+.||.|.-++||+|+.. .+..||||++..+.... ...+.+|+..++.++||||++++..|..++.+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 34568999999999999999999754 68999999998765543 47889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc-C
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL-G 213 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~-~ 213 (375)
|.||.+|++.+.+.... ...+.+..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+-. .
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999998754 445999999999999999999999998 99999999999999999999999997642 2
Q ss_pred CCCCCceee-ecccccccccccccccc--CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 214 PVGDNTHVS-TRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 214 ~~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
..+...... ..++||+.|||||+++. ..|+.|+||||||++.+||.+|..||....+.... .+.-....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--------l~tLqn~p 249 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--------LLTLQNDP 249 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--------HHHhcCCC
Confidence 233333333 67899999999999653 56999999999999999999999999744332110 00001111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......+...-...+...+.+++..||+.||++|||+.++++
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111111122345668999999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=359.60 Aligned_cols=266 Identities=27% Similarity=0.397 Sum_probs=208.8
Q ss_pred HHhhcccccceeccccceEEEEEEE------cCCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEeeC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 128 (375)
+..++|++.+.||+|+||.||+|.+ .++..||+|++..... .....+.+|+.++..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4457899999999999999999964 2356899999875432 2345688899999999 899999999988754
Q ss_pred -CeeEEEEeecCCCCHHHHHhccCCC------------------------------------------------------
Q 017246 129 -DQRLLVYEYMPMGSLEDHLYDLEPD------------------------------------------------------ 153 (375)
Q Consensus 129 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 153 (375)
+.++++|||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4588999999999999999653210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccccc
Q 017246 154 ----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229 (375)
Q Consensus 154 ----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~ 229 (375)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...............+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 235788899999999999999999988 9999999999999999999999999997532222222223345678
Q ss_pred ccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHH
Q 017246 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLN 308 (375)
Q Consensus 230 ~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (375)
.|+|||++.+..++.++|||||||++|||++ |..||....... ... ..... ......+..++.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~----------~~~~~~~~~~~~ 304 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKD----------GTRMRAPENATP 304 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhc----------CCCCCCCCCCCH
Confidence 8999999999999999999999999999997 999996432111 000 00000 011123455677
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 309 YAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 309 ~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.+.+++.+||+.||++||++.+|++.|+.+..+
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-49 Score=359.72 Aligned_cols=244 Identities=31% Similarity=0.431 Sum_probs=212.9
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+... ++...+.+|+++++.++||||+.++++|++..++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46889999999999999999755 689999999977543 335568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+.| +|..++.. .+.++++.+..++.+++.||.|||+.+ |.|||+||.|||++.+|.+|++|||+|+. ..
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~--m~ 151 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARA--MS 151 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhh--cc
Confidence 9977 99999954 678999999999999999999999998 99999999999999999999999999986 44
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
.++.+.+...|||.|||||++.+++|+..+|+|||||++||+++|++||-.. .+.+++..
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------------------si~~Lv~~ 211 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------------------SITQLVKS 211 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------------------HHHHHHHH
Confidence 5667778889999999999999999999999999999999999999999521 11122222
Q ss_pred ccCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 297 LLHG--RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 297 ~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
++.. .+|...+..+..++...|.+||.+|.+..+++.
T Consensus 212 I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 212 ILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2111 245688899999999999999999999999886
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=352.08 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=206.2
Q ss_pred HhhcccccceeccccceEEEEEE-EcCCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeC--CeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 132 (375)
..+.|+.++.||+|+||.||+|+ ..+|+.||+|+++.+..+ -.....+|+.+|++|+||||+++.+..... ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34678899999999999999996 457999999999876533 345577899999999999999999988776 7899
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
||+|||+. +|..++.. ..-.|++.++..++.||+.||+|||+++ |+|||||.+|||||++|.+||+|||+|+.
T Consensus 195 lVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence 99999977 88887753 4567999999999999999999999999 99999999999999999999999999997
Q ss_pred CCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCcccccccccc----------chhhchh
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ----------NLVSWSR 281 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~----------~~~~~~~ 281 (375)
+....... .+..+-|.+|+|||++++. .|+.++|+||+||||.||++|++.|.......-. ....|..
T Consensus 268 y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 268 YTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred ccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 65443332 4456679999999999975 6999999999999999999999999754321100 0000110
Q ss_pred hhhhhccccchhccc------ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 PFLKDQKKFVHLVDP------LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..+. ....+.+ .+... -..++....+|+..+|..||++|.|+.++|+
T Consensus 347 ~kLP----~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLP----HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCC----cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000 0000000 00000 1345677889999999999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=362.76 Aligned_cols=243 Identities=28% Similarity=0.443 Sum_probs=207.3
Q ss_pred HHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCe
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 130 (375)
....++|++.++||+|.||.|+++..+ +++.||||++++... ++.+....|..++... +||.++.++..|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345678999999999999999999876 588999999988744 3455667788888777 59999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
+|+||||+.||++..+. ....+++..++.++..|+.||.|||+++ |||||||.+|||+|.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 99999999999955444 3567999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
+..... .....++||||.|||||++.+..|+.++|+|||||+|||||.|..||.....+
T Consensus 516 Ke~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------------- 574 (694)
T KOG0694|consen 516 KEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------------- 574 (694)
T ss_pred cccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------
Confidence 864322 23456799999999999999999999999999999999999999999743221
Q ss_pred chhcccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 017246 291 VHLVDPLLH--GRYPRRCLNYAVAVTAMCLNEEANFRPLI 328 (375)
Q Consensus 291 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 328 (375)
.+++.++. ..||..++.+...++.++|..+|++|.-.
T Consensus 575 -e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22222222 24688899999999999999999999765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=357.61 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=212.3
Q ss_pred hhcccccceeccccceEEEEEE-EcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
...|.....||+|+.|.||.++ ..+++.||||.+....-...+-+.+|+.+|+..+|+|||.+++.|..++.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3568888999999999999996 457899999999887767778899999999999999999999999989999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
++||+|.+.+. ...+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.|||+|||+|.......
T Consensus 352 m~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999984 455999999999999999999999998 9999999999999999999999999997643332
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
......+|||.|||||++....|.++.||||||++++||+-|.+||-...+ +.. ..-+... ..
T Consensus 424 --~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrA--------lyLIa~n--g~ 486 (550)
T KOG0578|consen 424 --SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRA--------LYLIATN--GT 486 (550)
T ss_pred --CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHH--------HHHHhhc--CC
Confidence 245568899999999999999999999999999999999999999842110 000 0001111 11
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+..++..+.+++.+||+.|+++||++.|+|+
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 122346788999999999999999999999999997
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=319.39 Aligned_cols=265 Identities=26% Similarity=0.362 Sum_probs=207.2
Q ss_pred hcccccceeccccceEEEEEE-EcCCceEEEEEccccCccc--hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.+|...+.||+|.||.||+|+ ..+|+.||||+++.....+ .....+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999997 4579999999998764432 3467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|++. +|+..++. +...++...+..++.++++||+|||.+. |+||||||+|+|++.+|.+||+|||+|+.....
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9965 89998865 5677999999999999999999999998 999999999999999999999999999976544
Q ss_pred CCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccc----------cchhhchh-hhh
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE----------QNLVSWSR-PFL 284 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~----------~~~~~~~~-~~~ 284 (375)
... ....+-|.+|+|||++.+ ..|+..+||||.|||+.||+.|.+-|...++-+- ....+|.. ..+
T Consensus 155 ~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Ccc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 333 223378999999998886 4699999999999999999999888764332110 00001100 000
Q ss_pred hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.+-..+.....+.... +-..++.+..+|+..|+..||.+|+++.|.+++
T Consensus 233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0011111111111111 234566777999999999999999999999954
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=318.65 Aligned_cols=268 Identities=28% Similarity=0.367 Sum_probs=217.2
Q ss_pred HHHhhcccccceeccccceEEEEEE-EcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeC-----C
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----D 129 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 129 (375)
.+..++|++.+.||.|||+-||+++ ..++..||+|++.....++.+...+|++..++++|||+++++++...+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3567899999999999999999997 557899999999877777888999999999999999999998876433 4
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..||+++|...|+|.+.+.....++..+++.+++.|+.+|++||++||.. .+++.||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 58999999999999999998888888999999999999999999999987 46799999999999999999999999999
Q ss_pred CccCCCCCCcee-------eeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc
Q 017246 210 AKLGPVGDNTHV-------STRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 210 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 279 (375)
++.....-.... .....-|..|+|||.+. +...++++|||||||++|+|+.|..||+..-..+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G------- 248 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG------- 248 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-------
Confidence 975432211100 11123578899999886 4457899999999999999999999997322211
Q ss_pred hhhhhhhccccc-hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 280 SRPFLKDQKKFV-HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 280 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
..+. .+......-.-...+++.+.++|++|++.||.+||++.+++..++.|+
T Consensus 249 --------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 --------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 011111111111238889999999999999999999999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=339.26 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=210.0
Q ss_pred hhcccccceeccccceEEEEEE-EcCCceEEEEEccccCccchH---HHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQ---EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
..+|++.+.||+|+||.|-++. +..|+.||||.++++..++.+ .+.+|+++|..|+||||+.+|++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 5689999999999999999996 468999999999987666554 577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||..+|.|++|+.. .+.|++.+++.++.||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999954 678999999999999999999999888 9999999999999999999999999997654
Q ss_pred CCCCceeeeccccccccccccccccCCCC-ccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.. ....++||+|.|.+||++.+.+|. +.+|-||||++||.|+.|..||+.... ..+
T Consensus 205 ~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------------------k~l 261 (668)
T KOG0611|consen 205 DK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------------------KRL 261 (668)
T ss_pred cc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------------------HHH
Confidence 33 344569999999999999999886 789999999999999999999984321 111
Q ss_pred cccccCCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+....++.| .+.-+....-||.+||..+|++|.|+.+|..
T Consensus 262 vrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 262 VRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 222222221 2334555677999999999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=369.45 Aligned_cols=268 Identities=31% Similarity=0.479 Sum_probs=225.1
Q ss_pred HHHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeC
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 128 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 128 (375)
.+...+.+..+.||+|+||.||+|+.. +.+.||||.++..... ..++|.+|++++..++|||||+++|+|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344566778899999999999999743 3567999999886655 677899999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPD----------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 198 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~ 198 (375)
+.+|+|+|||+.|+|.+||.....+ ...|+..+.+.|+.|||.||.||-++. +|||||...|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 9999999999999999999865421 223889999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchh
Q 017246 199 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLV 277 (375)
Q Consensus 199 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 277 (375)
+..|||+|||+++.....+..+......-..+|||||.++.++|+.+||||||||+|||+++ |+.||.....+.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 99999999999986555555554434445679999999999999999999999999999999 999986433221
Q ss_pred hchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 278 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.+..+-...+ -..|..||.+++.|+..||+.+|.+||+|+||-..|........
T Consensus 714 -----------VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 714 -----------VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -----------HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 1112222222 35689999999999999999999999999999999998866544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=344.46 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=211.3
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEccccCccc-hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..|+..+.||+|.||.||+|.. .+++.||+|++..+...+ .+.+.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3577779999999999999964 579999999998765543 56788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
|.||++.+.+.. +..+.+..+..++.+++.||.|||..+ .+|||||+.||||..+|.|||+|||++-+...
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~-- 163 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN-- 163 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec--
Confidence 999999999953 555688888999999999999999988 99999999999999999999999999876332
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
......+++|||.|||||+++...|+.++||||||++.+||++|.+|+....+ .....++...
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----------------mrvlflIpk~ 226 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----------------MRVLFLIPKS 226 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------------ceEEEeccCC
Confidence 23334679999999999999988999999999999999999999999963322 1122233333
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..+.+...++..+.+++..||..+|+.||++.++++
T Consensus 227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 334445578888999999999999999999999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=350.75 Aligned_cols=247 Identities=30% Similarity=0.439 Sum_probs=211.6
Q ss_pred cccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
....++-||.|+.|.||+|+++ +..||||+++.-. .-++.-|++|+||||+.+.|+|.....+|||||||..
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred HhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 3445677999999999999988 7889999885432 2377889999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|-|...|+. +..++......|..+||.||.|||.+. |||||||.-||||..+..|||+|||.++..... .
T Consensus 197 GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S 266 (904)
T KOG4721|consen 197 GQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S 266 (904)
T ss_pred ccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence 999999954 677888999999999999999999988 999999999999999999999999998754322 2
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
..-.++||..|||||++.+.+.++++|||||||+|||||||..||..... ...+.-+-...+..
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----------------sAIIwGVGsNsL~L 330 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----------------SAIIWGVGSNSLHL 330 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----------------heeEEeccCCcccc
Confidence 33458999999999999999999999999999999999999999952110 11222333455666
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
..|..|++.+.-|+++||+..|..||+|.+|+..|+...+.
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 77899999999999999999999999999999999877653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=340.89 Aligned_cols=265 Identities=26% Similarity=0.418 Sum_probs=205.5
Q ss_pred hhcccccceeccccceEEEEEEEcC-----------------CceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcce
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES-----------------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVT 120 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~ 120 (375)
.++|++.+.||+|+||.||+|.+.+ +..||+|.+..... .....+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999997532 34699999876432 23456889999999999999999
Q ss_pred eEeEEeeCCeeEEEEeecCCCCHHHHHhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcc
Q 017246 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185 (375)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~ 185 (375)
+++++...+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999864321 1234678899999999999999999988 99
Q ss_pred cCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhC--CC
Q 017246 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG--RK 263 (375)
Q Consensus 186 H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg--~~ 263 (375)
||||||+|||++.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999754333333333345568899999999988999999999999999999974 55
Q ss_pred CccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 264 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 264 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
||...... ............. ........++.++..+.+++.+||+.+|++||++.+|.+.|+
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 66532211 1111111111100 001111123466788999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=349.41 Aligned_cols=248 Identities=29% Similarity=0.364 Sum_probs=214.8
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc--hHHHHHHHHHHccCCCCCcceeEeEEeeCCe-eEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-RLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 135 (375)
++|..++++|+|+||.+++++++ +++.|++|.+....... .....+|+.+++++.|||||.+.+.|..++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 47899999999999999999866 58899999997764433 3457889999999999999999999999888 99999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
+||+||+|.+.+.... +..+++..+..|+.|++.|+.|||+++ |+|||||+.|||++.++.|+|+|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998743 677999999999999999999999888 99999999999999999999999999997543
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. ......+|||.||.||++.+.+|+.++|||||||++|||++-+++|...+ +..++.
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------------------m~~Li~ 216 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------------------MSELIL 216 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------------------hHHHHH
Confidence 33 24456889999999999999999999999999999999999999997322 122222
Q ss_pred ccc---CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 296 PLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 296 ~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
... ....|...+.++..||..|++.+|+.||++.++|.+
T Consensus 217 ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 217 KINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 221 234577889999999999999999999999999986
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=362.91 Aligned_cols=265 Identities=24% Similarity=0.300 Sum_probs=216.0
Q ss_pred HHHHhhcccccceeccccceEEEEEEEcCC-ceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEE-ee----
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLESG-QLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYC-TS---- 127 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~---- 127 (375)
+.+...++++.+.|.+|||+.||+|....+ ..||+|++-..+....+.+.+|+.+|+.|. |+|||.+++.. ..
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 345567899999999999999999987654 999999987777777888999999999996 99999999932 11
Q ss_pred --CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEe
Q 017246 128 --GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 205 (375)
Q Consensus 128 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~ 205 (375)
.-+++|+||||.||.|-|++..+. ..+|++.++++|+.|+++|+.+||.. .+||||||||-|||||..+|+.|||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 135678999999999999998754 44599999999999999999999988 5889999999999999999999999
Q ss_pred ecCCCccCCCCC-Ccee----e--eccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccc
Q 017246 206 DFGLAKLGPVGD-NTHV----S--TRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 275 (375)
Q Consensus 206 Dfg~a~~~~~~~-~~~~----~--~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 275 (375)
|||.+...-... .... . -...-|+.|+|||++. +.+.++|+|||+|||+||-|+....||+...
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------ 262 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------ 262 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------
Confidence 999986321111 1000 0 0123699999999764 7789999999999999999999999997332
Q ss_pred hhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 276 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
...+++....-...+.++..+.+||..||+.+|++||++-++++.+-+|....
T Consensus 263 --------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 --------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 22233333333334688999999999999999999999999999999998643
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=335.61 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=201.6
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEee----CCeeEEEEeec
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLVYEYM 138 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 138 (375)
..||+|++|.||+|.. +|+.||||.+....... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999988 48899999997654333 4567799999999999999999999876 35688999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
++|+|.+++.. ...+++...+.++.|++.||.|||+. + ++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999954 45688999999999999999999974 6 8999999999999999999999999987532211
Q ss_pred Cceeeecccccccccccccccc--CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||....... ... .+..
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~-------------~i~~ 236 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYD-------------LIIN 236 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHH-------------HHHh
Confidence 23468899999999876 679999999999999999999999997432110 000 0111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
.......+..++..+.+++.+||+.||++||++.+|++.|++++.
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111223345678899999999999999999999999999998863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=350.53 Aligned_cols=264 Identities=26% Similarity=0.391 Sum_probs=207.3
Q ss_pred HHHhhcccccceeccccceEEEEEEE------cCCceEEEEEccccC-ccchHHHHHHHHHHccC-CCCCcceeEeEEee
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS 127 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 127 (375)
.+..++|++.+.||+|+||.||+|.. .++..||+|+++... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34456899999999999999999963 246689999986543 23345678899999999 89999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCC-------------------------------------------------------
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEP------------------------------------------------------- 152 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 152 (375)
.+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999964221
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 153 ----------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 153 ----------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 1225788899999999999999999988 999999999999999999999999999754332
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
..........++..|+|||++.+..++.++|||||||++|||++ |..||....... .... .. .
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~----------~ 331 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MI----------K 331 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HH----------H
Confidence 22222222345678999999999999999999999999999998 888886322111 0110 01 1
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.......+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111112334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=349.88 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=208.5
Q ss_pred HHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEeeC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 128 (375)
...++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44568999999999999999998642 345799999976432 2345678899999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccCC--------------------------------------------------------
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEP-------------------------------------------------------- 152 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 152 (375)
+..++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999864210
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceee
Q 017246 153 ----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 222 (375)
Q Consensus 153 ----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 222 (375)
....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1234788899999999999999999988 999999999999999999999999998754332222222
Q ss_pred eccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccCCC
Q 017246 223 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 301 (375)
Q Consensus 223 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (375)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ............
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~--------------~~~~~~~~~~~~ 335 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K--------------FYKMVKRGYQMS 335 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H--------------HHHHHHcccCcc
Confidence 23345678999999998899999999999999999997 999996322111 0 001111111112
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 302 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 302 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
.+...+.++.+++.+||+.+|.+||++.+|++.|+++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 23345678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=343.21 Aligned_cols=241 Identities=29% Similarity=0.364 Sum_probs=198.4
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 141 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 141 (375)
+.||+|+||.||+++.. +|+.||+|++..... .....+..|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999875422 23346778999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCcee
Q 017246 142 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 221 (375)
Q Consensus 142 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 221 (375)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 99999854 457899999999999999999999998 999999999999999999999999998742211 112
Q ss_pred eeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCC
Q 017246 222 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 301 (375)
Q Consensus 222 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (375)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .+... ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~-------------~~~~~--~~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE-------------LILME--EIR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHH-------------HHHcC--CCC
Confidence 23467999999999999999999999999999999999999999632111 0000 00000 113
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 302 YPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 302 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
++..++..+.++|.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4556778899999999999999999 7999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=357.58 Aligned_cols=253 Identities=22% Similarity=0.241 Sum_probs=207.8
Q ss_pred cccccceeccccceEEEEEEEc-C-CceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-S-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.|.+.+.||+|+||.||++... + +..||+|.+..........+..|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4999999999999999999644 4 6788999876555455566788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++|+|.+++.........+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988764444567899999999999999999999988 99999999999999999999999999986433322
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. . ..+....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~---~----------~~~~~~~- 287 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EI---M----------QQVLYGK- 287 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HH---H----------HHHHhCC-
Confidence 23344567999999999999999999999999999999999999999632211 00 0 0011000
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...++..++..+.++|.+||+.+|++||++.+++.
T Consensus 288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01224456778999999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=333.33 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=202.8
Q ss_pred cccccceeccccceEEEEEEE-cCCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.|++.+.||+|+||.||++.. .+|+.||+|.+...... ....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999975 47999999998754322 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999888642 2346899999999999999999999988 999999999999999999999999999753222
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... . ...+ .
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~------~-------~~~~-~ 218 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE------V-------DRRV-K 218 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH------H-------HHHh-h
Confidence 1 12345789999999999999999999999999999999999999974332111000 0 0000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~ 333 (375)
.....++..++..+.+|+.+||+.||++||+ +.++++
T Consensus 219 ~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111234566788999999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=321.51 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=206.8
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc--hHHHHHHHHHHccCCCCCcceeEeEEee--CCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 133 (375)
.+.|+....|++|+||.||+|+.+ ++..||+|+++.+.... .-..++|+.+|.+.+|||||.+..+... -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 457889999999999999999754 78999999998764322 2346789999999999999999987653 467999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
|||||+. +|...+.. ..+++...++..++.|++.|++|||.+. |+||||||+|+|+++.|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 9999977 89988875 3478999999999999999999999888 999999999999999999999999999975
Q ss_pred CCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccc-hh---------hc---
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LV---------SW--- 279 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~---------~~--- 279 (375)
... ....+..+-|.+|+|||++.+. .|+.+.|+||+|||+.||+++++.|...+..+-.+ +. .|
T Consensus 228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 433 3334567789999999999875 59999999999999999999999997543321100 00 00
Q ss_pred hhhhhhhccccchhcccccCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..........+.......++..++.. ..+.-.+|+..+|..||.+|.|+.+.|+
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000001111122222333333333 5678899999999999999999999985
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=326.75 Aligned_cols=256 Identities=29% Similarity=0.344 Sum_probs=210.5
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
...+.|++.+.||.|.-|+||+++.. ++..+|+|++.+..... ..++..|.+||..+.||.++.+|..|+.++..|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 34467899999999999999999876 46899999998764443 345667999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
++||||+||+|...++. +.+..+++..++.++..++-||+|||..| ||+|||||+||||.++|+|.|+||.++..
T Consensus 154 l~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999998876 45788999999999999999999999999 99999999999999999999999998743
Q ss_pred CCC---------------------------------CCC---------------------ceeeeccccccccccccccc
Q 017246 213 GPV---------------------------------GDN---------------------THVSTRVMGTYGYCAPEYAM 238 (375)
Q Consensus 213 ~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~ 238 (375)
... ... ......++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 211 000 01123368999999999999
Q ss_pred cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhc
Q 017246 239 SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCL 318 (375)
Q Consensus 239 ~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 318 (375)
+...+.++|+|+|||++|||+.|..||...+.. ..+.+++...+.-.-.+..+..+.+||.+.|
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999999754322 1222233222221112367789999999999
Q ss_pred CCCCCCCCC----HHHHHH
Q 017246 319 NEEANFRPL----INDIVV 333 (375)
Q Consensus 319 ~~~p~~RPs----~~eil~ 333 (375)
.+||.+|.. +.||-+
T Consensus 373 vKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ccChhhhhccccchHHhhc
Confidence 999999998 777765
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=342.79 Aligned_cols=245 Identities=26% Similarity=0.342 Sum_probs=202.9
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.+|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57999999999999999999875 689999999865422 33456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999964 456889999999999999999999988 99999999999999999999999999975422
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ..+..
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~----------~~i~~ 229 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIY----------EKILA 229 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHH----------HHHhc
Confidence 1 12357999999999999999999999999999999999999999632210 000 01111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVVA 334 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~~ 334 (375)
.. ..++..++..+.+||.+||+.||.+||+ +.+++..
T Consensus 230 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 230 GR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 1234446678899999999999999997 6887753
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=329.36 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=206.4
Q ss_pred hhcccccceeccccceEEEEEEEc----CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..+|++.+.||+|+||.||+|.+. .+..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457999999999999999999653 366899999876532 234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999864 2357899999999999999999999888 999999999999999999999999987643
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccch
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.... ........++..|+|||++.+..++.++|||||||++|||++ |..||....... ... ..
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~----~~-------- 221 (266)
T cd05064 158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK----AV-------- 221 (266)
T ss_pred cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH----HH--------
Confidence 2211 111112345678999999999999999999999999999875 999996432111 000 00
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
........+..++..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 222 --~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 --EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00111123456788899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=341.36 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=205.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+..|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999875 589999999976422 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999954 456889999999999999999999998 99999999999999999999999999975322
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
......||+.|+|||++.+..++.++|||||||++|||++|..||........... .......+.
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~----------i~~~~~~~~ 218 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN----------LKYWKETLQ 218 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH----------HHhcccccc
Confidence 23346799999999999999999999999999999999999999974332111000 000000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
..........++.++.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000001113467789999999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=335.98 Aligned_cols=266 Identities=24% Similarity=0.420 Sum_probs=210.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCc----eEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..+|++.+.||+|+||.||+|.+. ++. .||+|++..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 457999999999999999999753 333 489999875432 3456788899999999999999999998764 577
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+++||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999965 2346888999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..............++..|+|||++.+..++.++|||||||++|||++ |..||+...... + .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~--------------~ 221 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I--------------S 221 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H--------------H
Confidence 443332222222345678999999999999999999999999999998 999986322110 0 0
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCcc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 348 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~ 348 (375)
.++........+..++..+.+++.+||+.+|++||++.+++..|..+..........
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 278 (316)
T cd05108 222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 278 (316)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchheEe
Confidence 111111111223456678999999999999999999999999999998766544333
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=368.32 Aligned_cols=265 Identities=29% Similarity=0.443 Sum_probs=218.8
Q ss_pred hhcccccceeccccceEEEEEEEc--CCc----eEEEEEcccc-CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE--SGQ----LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
..+....+.||+|+||.||.|... .|. .||||.+... +.....+|.+|+.+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 456778899999999999999764 243 4899998764 445677899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPD---QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
+|++|||+||+|..||++.+.. ...++..+.+.++.|||+|+.||++++ +|||||...|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999874221 446889999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
+|+.....+.........-...|||||.++++.++.++|||||||+|||++| |..||.......
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------------- 912 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------------- 912 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---------------
Confidence 9984333343333332223458999999999999999999999999999999 889996322211
Q ss_pred cccch-hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCC
Q 017246 288 KKFVH-LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344 (375)
Q Consensus 288 ~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~ 344 (375)
+.. .+..- +...|..|+..+++++.+||+.+|++||++..|++.+..+......
T Consensus 913 --v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 913 --VLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred --HHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 111 11111 3456889999999999999999999999999999999999876443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=337.67 Aligned_cols=244 Identities=27% Similarity=0.335 Sum_probs=202.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999765 689999999865422 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999954 456899999999999999999999988 99999999999999999999999999875322
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. . .+..
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~---~----------~i~~ 212 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IY---E----------KILA 212 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---H----------HHHh
Confidence 1 123579999999999999899999999999999999999999996422110 00 0 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~ 333 (375)
. ...++...+..+.+||.+||+.||.+||+ +.++++
T Consensus 213 ~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 213 G--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred C--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 0 11234556778999999999999999995 888873
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=330.68 Aligned_cols=259 Identities=33% Similarity=0.501 Sum_probs=209.1
Q ss_pred hcccccceeccccceEEEEEEEcC------CceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLES------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
.+|++.+.||+|+||.||+|.... ...||+|.+..... .....+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478899999999999999997542 25799999865432 23456888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC
Q 017246 133 LVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 200 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~ 200 (375)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975321 1146888999999999999999999988 99999999999999999
Q ss_pred ceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhc
Q 017246 201 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 201 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 279 (375)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~--- 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V--- 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---
Confidence 999999999875433332223334557889999999998899999999999999999998 999986432110 0
Q ss_pred hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
...+........+..++..+.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus 236 -----------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 -----------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -----------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 001111111223567789999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=344.60 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=209.8
Q ss_pred HHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccCC-CCCcceeEeEEeeC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSG 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 128 (375)
...++|+++++||+|+||.||+|... .+..||||++..... ...+.+.+|+.+++.+. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 44668999999999999999999742 234699999975432 23456889999999996 99999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccCC--------------------------------------------------------
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEP-------------------------------------------------------- 152 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 152 (375)
+..+|||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999999865311
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE
Q 017246 153 ------------------------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 196 (375)
Q Consensus 153 ------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill 196 (375)
....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 1134788889999999999999999988 9999999999999
Q ss_pred eCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccc
Q 017246 197 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQN 275 (375)
Q Consensus 197 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 275 (375)
+.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~ 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--T 348 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--H
Confidence 9999999999999875432222222233456788999999999899999999999999999997 889986321110 0
Q ss_pred hhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 276 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
.. ..+........+..++..+.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 349 ~~--------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FY--------------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HH--------------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00 0000011112345667889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=330.37 Aligned_cols=265 Identities=29% Similarity=0.441 Sum_probs=213.5
Q ss_pred hhcccccceeccccceEEEEEEEc------CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..+|.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+.+++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 356888999999999999999642 35568999987665555667889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC
Q 017246 133 LVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 200 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~ 200 (375)
+||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 99999999999999965321 2345889999999999999999999988 99999999999999999
Q ss_pred ceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhc
Q 017246 201 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 201 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 279 (375)
.++|+|||++................++..|+|||++.+..++.++|||||||++|||+| |..||....... ....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~ 237 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC 237 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence 999999999975433222222334557889999999999999999999999999999999 999985332111 0000
Q ss_pred hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
+ ........+..++..+.+++.+||+.+|++||++.+|+++|+.+....+
T Consensus 238 -------------~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 238 -------------I-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred -------------H-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 0 0000111234466789999999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=332.01 Aligned_cols=255 Identities=30% Similarity=0.396 Sum_probs=201.7
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--------------chHHHHHHHHHHccCCCCCccee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--------------GHQEFIVEVLMLSLLHHDNLVTL 121 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~~ 121 (375)
...++|++.+.||+|.||.|-+|+.. +++.||||++.+.... ..+.+.+|+.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44568999999999999999999754 6999999998654221 23578899999999999999999
Q ss_pred EeEEee--CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC
Q 017246 122 IGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 199 (375)
Q Consensus 122 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~ 199 (375)
+++..+ .+.+|||+|||..|.+...- .....+++.++++++.+++.||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 999865 47899999999998875432 23333999999999999999999999999 9999999999999999
Q ss_pred CceEEeecCCCccCCCC---CCceeeeccccccccccccccccCC----CCccchhHhHHHHHHHHHhCCCCcccccccc
Q 017246 200 FNPKLSDFGLAKLGPVG---DNTHVSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAMDLSKGQG 272 (375)
Q Consensus 200 ~~vkl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~ 272 (375)
|.|||+|||.+.....+ .........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||......
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~- 325 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL- 325 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-
Confidence 99999999998754222 2222233478999999999988632 357899999999999999999999522110
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.-...++...+.-.-.+++.+.+.+||+++|.+||++|.++.+|...
T Consensus 326 ---------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 326 ---------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred ---------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 01112222222222234678899999999999999999999999854
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=336.05 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=204.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||+++.. ++..+|+|.+..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999865 688999999876422 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++.. ...+++..+..++.|++.||.|||++++ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999954 4568899999999999999999997522 999999999999999999999999998753221
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh----------
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD---------- 286 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 286 (375)
......|++.|+|||++.+..++.++|||||||++|||++|+.||............. ......
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSISP 231 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccCc
Confidence 1233568999999999999899999999999999999999999996332111000000 000000
Q ss_pred ------------------ccccch----hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 287 ------------------QKKFVH----LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 287 ------------------~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
...... +............++.++.+||.+||+.||++||++.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 000001111122467789999999999999999999999953
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=308.33 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=211.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++++.||+|-||.||.|+.+ ++-.||+|++.+... ....++.+|+++-..|+||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357999999999999999999765 678899999977543 3456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
+||..+|+|...|.. ....++++.....+..|++.||.|+|.++ ++||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999975 23567888999999999999999999888 9999999999999999999999999997643
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
. ......|||..|.|||...+..++..+|+|++|++.||++.|.+||......+. ...+.
T Consensus 176 ~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et----------------YkrI~ 235 (281)
T KOG0580|consen 176 S----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET----------------YKRIR 235 (281)
T ss_pred C----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH----------------HHHHH
Confidence 2 224458999999999999999999999999999999999999999973221110 00111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..+-.+|..++....++|.+|+..+|.+|.+..|++.
T Consensus 236 --k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 236 --KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --HccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1112346778889999999999999999999999984
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.42 Aligned_cols=264 Identities=26% Similarity=0.356 Sum_probs=200.0
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
++|++.+.||.|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46999999999999999999765 689999999875432 2344677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++ +|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 89988854 2345788999999999999999999988 9999999999999999999999999987532221
Q ss_pred Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hch-------hhhhhhcc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS-------RPFLKDQK 288 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~-------~~~~~~~~ 288 (375)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+ ... .+......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 12233568999999998875 56899999999999999999999999643321110000 000 00000000
Q ss_pred ccchhcccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 289 KFVHLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 289 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
.+.....+.... ......+.+..+|+.+||+.||.+|||++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 111111111100 01123566789999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=328.86 Aligned_cols=259 Identities=30% Similarity=0.461 Sum_probs=208.5
Q ss_pred hhcccccceeccccceEEEEEEEc------CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888999999999999999753 2478999998765443 356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLE----------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 201 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~ 201 (375)
++||||+++++|.+++.... .....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997532 12345788999999999999999999988 999999999999999999
Q ss_pred eEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhch
Q 017246 202 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 202 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 280 (375)
++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~-- 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIE-- 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--
Confidence 99999999875322222222233456788999999999999999999999999999998 999985332111 000
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
.+. .......+..++..+.+++.+||+.+|++||++.||++.|++
T Consensus 236 -----------~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 -----------CIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----------HHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 000 111112234567889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=326.04 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=213.0
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
..+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45789999999999999999998778999999998776556778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 999999999753 3456899999999999999999999888 9999999999999999999999999997543221
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... .... .+...
T Consensus 159 -~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~--------------~~~~~ 220 (261)
T cd05148 159 -YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYD--------------QITAG 220 (261)
T ss_pred -ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH--------------HHHhC
Confidence 11223346778999999988889999999999999999998 89999633211 0000 00111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.....+..++..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 12233456778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=337.80 Aligned_cols=239 Identities=27% Similarity=0.322 Sum_probs=195.2
Q ss_pred eccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 68 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
||+|+||.||+++.. +++.||+|++.... ......+..|+.++..++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999765 58899999986532 23345677899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeee
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 223 (375)
.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence 999954 456899999999999999999999988 999999999999999999999999998753221 12233
Q ss_pred ccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC
Q 017246 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303 (375)
Q Consensus 224 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (375)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +... ...++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~----------~~~~--~~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRK----------ILQE--PLRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHH----------HHcC--CCCCC
Confidence 467999999999999999999999999999999999999999632111 00011 1111 11234
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 017246 304 RRCLNYAVAVTAMCLNEEANFRPL---INDIVV 333 (375)
Q Consensus 304 ~~~~~~l~~li~~cl~~~p~~RPs---~~eil~ 333 (375)
..++..+.+++.+||+.||.+||+ +.+++.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 567788999999999999999985 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=329.67 Aligned_cols=264 Identities=28% Similarity=0.446 Sum_probs=211.4
Q ss_pred hhcccccceeccccceEEEEEEEc------CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..+|.+.+.||.|+||.||++... ++..+|+|.+..........+.+|+.+++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467999999999999999999742 34568999987655455667889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCC---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 133 LVYEYMPMGSLEDHLYDLEP---------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||+++ ++||||||+|||+++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999965321 2235899999999999999999999888 99999999999999999999
Q ss_pred EeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhh
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 282 (375)
|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~---- 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE---- 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----
Confidence 999999875432222222233446788999999998889999999999999999999 889986332111 000
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.+.... ....+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 234 ---------~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 234 ---------CITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred ---------HHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 000000 00112345667999999999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=337.93 Aligned_cols=242 Identities=29% Similarity=0.369 Sum_probs=198.4
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 141 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 141 (375)
+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 689999999976422 23456778999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCcee
Q 017246 142 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 221 (375)
Q Consensus 142 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 221 (375)
+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99988853 456899999999999999999999988 999999999999999999999999998742211 112
Q ss_pred eeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCC
Q 017246 222 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 301 (375)
Q Consensus 222 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (375)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .+.. ....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~-------------~~~~--~~~~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE-------------LILM--EDIK 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHH-------------Hhcc--CCcc
Confidence 23467999999999999989999999999999999999999999632211 0000 0000 0113
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 017246 302 YPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 334 (375)
Q Consensus 302 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~~ 334 (375)
++..++..+.+++.+||+.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3556778899999999999999997 89998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=353.67 Aligned_cols=257 Identities=23% Similarity=0.284 Sum_probs=208.1
Q ss_pred HhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCC-----
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----- 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 129 (375)
..++|++.+.||+|+||.||+++. .+|+.||||++..... .....+.+|+.++..++|+||++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 356899999999999999999975 4699999999876533 33456778999999999999999988765432
Q ss_pred ---eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 130 ---QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 130 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 367999999999999999765555667999999999999999999999988 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~---- 256 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHK---- 256 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHH----
Confidence 99997643332223334567999999999999999999999999999999999999999632110 00000
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.... ....++..++..+.+++.+||+.+|.+||++.++++.
T Consensus 257 ------~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 ------TLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------HhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0100 1112355677889999999999999999999999863
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=338.87 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=201.7
Q ss_pred hhcccccceeccccceEEEEEEEcC--CceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES--GQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.++|.+.+.||+|+||.||+|.... +..||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4579999999999999999997543 3689999986532 2334567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999964 456899999999999999999999998 999999999999999999999999999753
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||....... . ...+
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~-------------~~~i 240 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---I-------------YQKI 240 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---H-------------HHHH
Confidence 221 223579999999999999889999999999999999999999996322110 0 0001
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
.... ..+|...+..+.++|.+||+.+|.+|+ +++++++
T Consensus 241 ~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 241 LEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred hcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1111 123455667789999999999999995 8888875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=337.19 Aligned_cols=241 Identities=28% Similarity=0.366 Sum_probs=197.2
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 141 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 141 (375)
+.||+|+||.||+++.. +|..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999876422 23345678999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCcee
Q 017246 142 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 221 (375)
Q Consensus 142 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 221 (375)
+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCc
Confidence 99988853 456899999999999999999999998 999999999999999999999999998742211 112
Q ss_pred eeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCC
Q 017246 222 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 301 (375)
Q Consensus 222 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (375)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+... ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~-------------~~~~~~--~~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF-------------ELILME--EIR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HH-------------HHHhcC--CCC
Confidence 234679999999999999999999999999999999999999996322110 00 000000 112
Q ss_pred CCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 302 YPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 302 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
++..++..+.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3556778899999999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=334.51 Aligned_cols=244 Identities=28% Similarity=0.400 Sum_probs=196.2
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHH---ccCCCCCcceeEeEEeeCCeeEEE
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLML---SLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
|++.+.||+|+||.||+|... +++.||||++.+.. ......+..|+.++ ..++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999765 68999999997542 12234555665554 567899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|..++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998874 356899999999999999999999988 9999999999999999999999999986422
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. .......+|++.|+|||++.+..++.++|||||||++|||++|+.||....... . .. .+.
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~---~~----------~i~ 214 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---V---FD----------SIV 214 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---H---HH----------HHH
Confidence 21 122234679999999999999999999999999999999999999996332110 0 00 011
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
.. ...++..++..+.++|.+||+.||.+|| ++.++++
T Consensus 215 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 215 ND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 10 1123456678899999999999999999 5777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=331.09 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=216.9
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccch--HHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.+-|.+.+.||+|.|+.|-++++ -+|..||||++.+....+. ..+.+|+..|+.++|||||++|++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45688899999999999999975 4899999999988766543 46889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE-eCCCceEEeecCCCccCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL-DNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill-~~~~~vkl~Dfg~a~~~~ 214 (375)
|.-++|+|++||-. ....+.+..+.+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-|||+|||++..+.
T Consensus 97 ELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999975 5677999999999999999999999999 9999999999766 556889999999997544
Q ss_pred CCCCceeeeccccccccccccccccCCCC-ccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.+. ..+..||+..|.|||++.+..|+ +++||||||||||.|++|++||+..++.+.. ..+
T Consensus 171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----------------TmI 231 (864)
T KOG4717|consen 171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----------------TMI 231 (864)
T ss_pred Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----------------hhh
Confidence 433 34568999999999999999987 6799999999999999999999855433221 111
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCCC
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNA 351 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 351 (375)
++-. -..|...+.+..+||..||..||.+|.+.++|. +++|.+..
T Consensus 232 mDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~-----------s~~Wlq~~ 276 (864)
T KOG4717|consen 232 MDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIV-----------STSWLQAG 276 (864)
T ss_pred hccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHh-----------ccccccCC
Confidence 1111 134788999999999999999999999999998 77777743
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=323.40 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=208.7
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 356899999999999999999988778889999886543 3356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999999653 3456888999999999999999999888 9999999999999999999999999997643222
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. .......++..|+|||++....++.++|||||||++|+|++ |..||...... ..... .. .
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~----------~ 219 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSA----LQ----------R 219 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHH----HH----------c
Confidence 1 11222345678999999988889999999999999999998 99998632211 00000 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.........++..+.+++.+||+.+|++||++++|++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 220 GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 001111234667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=329.23 Aligned_cols=266 Identities=23% Similarity=0.291 Sum_probs=202.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999875 588999999875422 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|++++.+..+.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999877765442 2456899999999999999999999888 999999999999999999999999999764322
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchhhh-------hhhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPF-------LKDQK 288 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~-------~~~~~ 288 (375)
.. .......|++.|+|||++.+..++.++|||||||++|||++|++||......... .......+. .....
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 21 1223356899999999999888999999999999999999999999643221110 000000000 00000
Q ss_pred ccchhccccc------CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KFVHLVDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......+.. ...+...++..+.+|+.+||+.||++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 01122346778999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=322.10 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=210.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47999999999999999999764 689999998765322 22346788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999998765445566899999999999999999999888 99999999999999999999999999875332
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. .......|++.|+|||.+.+..++.++|+||||+++|||++|+.||....... ..+... +..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~----------~~~ 222 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQK----------IEQ 222 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHH----------Hhc
Confidence 21 11223568889999999998889999999999999999999999985322110 000000 000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
.......+...+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00111123456678999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=320.72 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=203.0
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
.+|++.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688899999999999999988878889999886543 335678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+|+|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence 99999998642 245889999999999999999999988 99999999999999999999999999875322211
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||....... .... ... . .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~---i~~-~----------~ 218 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEM---ISR-G----------F 218 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---HHC-C----------C
Confidence 11122335668999999988889999999999999999999 899986322110 0000 000 0 0
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112334567899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=335.73 Aligned_cols=264 Identities=27% Similarity=0.394 Sum_probs=206.6
Q ss_pred HhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEee-C
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS-G 128 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~ 128 (375)
..++|++.+.||.|+||.||+|... +++.||+|++..... .....+..|+.++..+ +|+||+++++++.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4568999999999999999999532 357899999875432 2245677899999999 89999999998764 4
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCC-------------------------------------------------------
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPD------------------------------------------------------- 153 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 153 (375)
..++++|||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5688999999999999998643211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccccccc
Q 017246 154 --QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231 (375)
Q Consensus 154 --~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 231 (375)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++................++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 136889999999999999999999888 999999999999999999999999999754322221222234567789
Q ss_pred ccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHH
Q 017246 232 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 310 (375)
Q Consensus 232 ~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 310 (375)
+|||++.+..++.++|||||||++|||++ |..||....... .. .... ........+...+..+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~~----------~~~~~~~~~~~~~~~~ 305 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRRL----------KEGTRMRAPEYATPEI 305 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHHH----------hccCCCCCCccCCHHH
Confidence 99999999999999999999999999998 999986422111 00 0000 0111112234566789
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 311 VAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 311 ~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
.+++.+||+.+|++||++.+|++.|+++..
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.78 Aligned_cols=267 Identities=24% Similarity=0.330 Sum_probs=205.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCC-cceeEeEEeeCC-----
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGD----- 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~----- 129 (375)
...|...+.||+|+||.||+|+.. +|+.||+|+++.... .......+|+.+|+.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777888999999999999754 799999999977543 23456789999999999999 999999998877
Q ss_pred -eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 130 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 130 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
.+++||||++. +|..++.........++...++.++.||+.||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 88999999955 999999875543356777899999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh--
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-- 285 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-- 285 (375)
+|+....... ..+..++|.+|+|||++.+. .|+...||||+|||++||+++++.|...... +++... ...+.
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~I-f~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRI-FRLLGTP 240 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHH-HHHcCCC
Confidence 9986443332 24557789999999999976 7999999999999999999999999754431 111110 00000
Q ss_pred hccccchhc-----ccccCCCC-C-------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 286 DQKKFVHLV-----DPLLHGRY-P-------RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 286 ~~~~~~~~~-----~~~~~~~~-~-------~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
....|.... ...+.... + +.......+++.+||+.+|.+|.+++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 001111000 00000000 1 1122478899999999999999999999965
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=321.80 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=208.4
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..++|++.+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346799999999999999999987777889999987653 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999996522 456899999999999999999999988 9999999999999999999999999987643211
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. ........+..|+|||++.+..++.++||||||+++|||++ |+.||....... ... .+..
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~--------------~~~~ 219 (261)
T cd05068 158 Y-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ--------------QVDQ 219 (261)
T ss_pred c-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--------------HHHc
Confidence 1 11111223457999999998899999999999999999999 999986321110 000 0001
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
......+..++..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 220 GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111123445678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=340.04 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=217.4
Q ss_pred HHHHhhcccccceeccccceEEEEEEEcC--C--ce-EEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEe
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLES--G--QL-VAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 126 (375)
......+..+.++||+|+||.||+|++.. + .. ||+|..+... .....++.+|++++++++|||||++||+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445666778999999999999997542 2 23 8999887522 345678999999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
....++||||+|+||+|.++|.. ....++..+...++.+.+.||+|||+++ ++||||...|+|++.++.+||+|
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 99999999999999999999975 3336999999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeee-ccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhh
Q 017246 207 FGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 284 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 284 (375)
||+++... ...... ...-...|+|||.+....|+.++|||||||++||+++ |..||......
T Consensus 306 FGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------------- 369 (474)
T KOG0194|consen 306 FGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------------- 369 (474)
T ss_pred cccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------------
Confidence 99998543 111111 1224568999999999999999999999999999999 88898643221
Q ss_pred hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCC
Q 017246 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~ 344 (375)
.....++....+...+...+..+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 370 ---~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 370 ---EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111122233344455678889999999999999999999999999999999876553
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=315.04 Aligned_cols=258 Identities=23% Similarity=0.265 Sum_probs=209.6
Q ss_pred HHhhcccccceeccccceEEEEEEE-cCCceEEEEEcccc--CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
...+.|.+.+.||+|.|+.|+++.+ .+|+.+|+|+++.. .....+++.+|+.+.+.|+||||+++++.+......||
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3456799999999999999999954 47999999988653 33467889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---CCceEEeecCCC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLA 210 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~vkl~Dfg~a 210 (375)
|+|++.|++|..-+-+ ..-+++..+-.++.||+.||.|+|.++ |||||+||+|+|+-. .--|||+|||+|
T Consensus 88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999887754 356788999999999999999999998 999999999999943 335999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
..... ......++|||.|||||++...+|+..+|||+.||+||-|+.|++||...... .+ .
T Consensus 161 i~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rl-------------y 221 (355)
T KOG0033|consen 161 IEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL-------------Y 221 (355)
T ss_pred EEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HH-------------H
Confidence 86542 22334578999999999999999999999999999999999999999731110 00 0
Q ss_pred chhcccc--cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCCC
Q 017246 291 VHLVDPL--LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNA 351 (375)
Q Consensus 291 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 351 (375)
+++.... ..++.-+...++..+|+.+||..||.+|.|+.|.| +|||..++
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL-----------~HpWi~~r 273 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL-----------KHPWICNR 273 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh-----------CCchhcch
Confidence 0111100 11111245677889999999999999999999988 67776654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=332.84 Aligned_cols=256 Identities=26% Similarity=0.288 Sum_probs=215.9
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 132 (375)
....|++.+.||.|.||.||+++.+ +|+.+|+|.+.+..... ...+.+|+.+|+.+. |||||.++++|++.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3557999999999999999999876 59999999998765543 458899999999998 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC----CceEEeecC
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND----FNPKLSDFG 208 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~----~~vkl~Dfg 208 (375)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999764 3999999999999999999999988 9999999999999543 579999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..........
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------------- 248 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------------- 248 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------
Confidence 9987544 344566899999999999999999999999999999999999999997443222111
Q ss_pred ccchhccc--ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCCC
Q 017246 289 KFVHLVDP--LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNA 351 (375)
Q Consensus 289 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 351 (375)
.+... .+....-+..+..+.++|..|+..||..|+++.++++ |||..+.
T Consensus 249 ---~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~-----------HpWi~~~ 299 (382)
T KOG0032|consen 249 ---AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ-----------HPWIKSI 299 (382)
T ss_pred ---HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc-----------CccccCC
Confidence 11111 1112223566889999999999999999999999996 7887754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=321.05 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=207.1
Q ss_pred hhcccccceeccccceEEEEEEEc----CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.++|++.+.||+|+||.||+|.+. +...||+|.+..... .....+..|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357999999999999999999764 245799999875432 234567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
+|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+|+||||+|||+++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999965 2347899999999999999999999888 999999999999999999999999999865
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccch
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~------------- 220 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKA------------- 220 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHH-------------
Confidence 32222222223345678999999998889999999999999999998 99998532111 00000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
+ ........+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 221 ~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 221 V-EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred H-HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00011112345677899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=333.23 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=197.5
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+++.. +++.||+|++..... .....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999765 688999999976422 2334577899998888 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999988853 457999999999999999999999998 999999999999999999999999998642111 11
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccc--ccchhhchhhhhhhccccchhccccc
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG--EQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||+...... ......+.... +....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~- 221 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV---------ILEKQ- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH---------HHcCC-
Confidence 2334679999999999999999999999999999999999999997433221 11111111110 11111
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPL------INDIVV 333 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs------~~eil~ 333 (375)
..+|..++..+.+++.+||+.||.+||+ +.++++
T Consensus 222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1235566778999999999999999997 567763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=321.67 Aligned_cols=265 Identities=26% Similarity=0.358 Sum_probs=204.4
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEcc--ccCccchHHHHHHHHHHccCCCCCcceeEeEEee-----CC
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-----GD 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~ 129 (375)
....|...+.||+|+||.|+.+... +|..||||++. .......++..+|+.+|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999754 79999999997 3455567788999999999999999999998865 46
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
.+|+|+|+| +.+|...++ .+..++...+..++.||++||+|+|+.+ |+||||||.|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 789999999 558888884 3556999999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccc-cCCCCccchhHhHHHHHHHHHhCCCCcccccccc------------ccch
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG------------EQNL 276 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~------------~~~~ 276 (375)
|+...........+..+-|.+|.|||++. ...|+.+.||||+|||+.||++|++.|.+...-. ....
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 99754322222334466799999999876 4679999999999999999999999996433211 1110
Q ss_pred hhc-----hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 277 VSW-----SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 277 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
... .++++..- .......+...+ +...+...+|+.+||..||.+|+|++|.|+.
T Consensus 252 l~~i~s~~ar~yi~sl---p~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSL---PQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhC---CCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 11111100 000000001112 3667788899999999999999999999963
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=332.05 Aligned_cols=241 Identities=27% Similarity=0.373 Sum_probs=196.5
Q ss_pred ceeccccceEEEEEEE----cCCceEEEEEccccCc----cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 66 NLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+.||+|+||.||+++. .+++.||+|++..... .....+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999974 3578999999875322 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ...+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999854 456788899999999999999999988 9999999999999999999999999986422111
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+....
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~----------~~~~~~~~ 216 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KT----------IDKILKGK 216 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HH----------HHHHHcCC
Confidence 1223467999999999999888999999999999999999999999632211 00 00111111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
..++..++..+.++|.+||+.+|++|| ++.++++
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 123456677899999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=324.51 Aligned_cols=259 Identities=26% Similarity=0.455 Sum_probs=204.6
Q ss_pred HhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
..++|++.+.||+|+||.||+|... .+..||+|.+..... ....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568999999999999999998643 356799999865322 234568889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEE
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 204 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl 204 (375)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999999653221 234677889999999999999999888 999999999999999999999
Q ss_pred eecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhh
Q 017246 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 205 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~---- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRF---- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----
Confidence 99999875333222222223345788999999998899999999999999999999 68888632211 00000
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
.... .....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 234 ---------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 ---------VMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---------HHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0000 001223456778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=312.63 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=203.7
Q ss_pred HHhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCc----cc----hHHHHHHHHHHccC-CCCCcceeEeEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL----QG----HQEFIVEVLMLSLL-HHDNLVTLIGYCT 126 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~----~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~ 126 (375)
..-..|...+.||.|..+.|.++.+ .+|+.+|+|++..... .. .+.-.+|+.+|+++ .||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3345788899999999999998865 4788999998854211 11 23345799999997 7999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
.+..+++|+|.|+.|.|.|+|. ..-.+++...+.|+.|+..|++|||.++ ||||||||+|||++++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 9999999999999999999995 4678999999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeeecccccccccccccccc------CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 280 (375)
||+++....+.. ....||||+|+|||.+.. ..|+..+|+|++|||||.|+.|.+||........
T Consensus 167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM------- 236 (411)
T KOG0599|consen 167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM------- 236 (411)
T ss_pred cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-------
Confidence 999987655443 345899999999998863 3588999999999999999999999964322110
Q ss_pred hhhhhhccccchhcccccCCCC------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRY------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+.....+.+ =.+.+....+||.+||+.||.+|.|++|.|.
T Consensus 237 -------------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 -------------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -------------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 011111111 1467788999999999999999999999997
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=335.05 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=194.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.+|+..+.||+|+||.||++... +++.||||++..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 46778899999999999999765 689999999865432 2245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+.. ...+..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 3456788899999999999999988 9999999999999999999999999987532211
Q ss_pred Cceeeecccccccccccccccc-----CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||............. .
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~---------- 287 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---A---------- 287 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---H----------
Confidence 11234579999999998743 234568999999999999999999997322111000000 0
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+........+..++..+.+||.+||+.||++||++.||++
T Consensus 288 -~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 288 -ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000111234566778999999999999999999999995
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=320.31 Aligned_cols=275 Identities=27% Similarity=0.346 Sum_probs=209.0
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCC-----eeEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRLL 133 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 133 (375)
-.|...+++|.|+||.||.|... ++..||||++..+.. .--+|+.+|+.+.|||||++..+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35788899999999999999765 579999999876533 2235999999999999999998885432 2348
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEeecCCCcc
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKL 212 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~Dfg~a~~ 212 (375)
||||++. +|.++++.....+..++...++-+..||.+||.|||+.+ |+||||||.|+|||.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 999999876667888999999999999999999999988 9999999999999987 8999999999997
Q ss_pred CCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhh----hh-
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL----KD- 286 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~- 286 (375)
...++.. ....-|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|...+.. +++.....-+- .+
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 5544433 123357789999998864 6999999999999999999999999753321 11111111000 00
Q ss_pred --------ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhhhhhccCCCCc
Q 017246 287 --------QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVSQRDSHPV 347 (375)
Q Consensus 287 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~--~L~~l~~~~~~~~~ 347 (375)
.....++....+..-+....++++.+|+.++|+.+|.+|.++.|++. .+++|....-..++
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~ 321 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPN 321 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcC
Confidence 11111111111111245677889999999999999999999999997 47777665434443
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=320.27 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=208.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..+|.+.+.||+|+||.||+|... .++.||+|.+.... .....+.+|+.+++.++||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 346888999999999999999754 58899999986542 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 9999999998652 2456889999999999999999999888 9999999999999999999999999987543221
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
.. ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .. ...+..
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~--------------~~~~~~ 220 (263)
T cd05052 159 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QV--------------YELLEK 220 (263)
T ss_pred ee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH--------------HHHHHC
Confidence 11 1112234668999999998899999999999999999998 88998632211 00 000111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
......+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112233456778899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=328.34 Aligned_cols=265 Identities=29% Similarity=0.416 Sum_probs=209.8
Q ss_pred HhhcccccceeccccceEEEEEEEc--------CCceEEEEEccccC-ccchHHHHHHHHHHccC-CCCCcceeEeEEee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS 127 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 127 (375)
..++|.+.+.||+|+||.||+++.. ....+|+|.+.... ......+..|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467999999999999999999742 23569999997642 23345678899999999 79999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEE
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 195 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nil 195 (375)
.+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+++ ++||||||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 9999999999999999999975322 1235889999999999999999999888 999999999999
Q ss_pred EeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCcccccccccc
Q 017246 196 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQ 274 (375)
Q Consensus 196 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 274 (375)
++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 99999999999999875432221111122234568999999998889999999999999999998 88888532211
Q ss_pred chhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 275 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.... .+........+..++..+.+++.+||+.+|++||++.+|++.|+++.+..
T Consensus 250 ~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ELFK--------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHH--------------HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 0000 01111112234566789999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=324.55 Aligned_cols=258 Identities=29% Similarity=0.425 Sum_probs=206.0
Q ss_pred hcccccceeccccceEEEEEEEc------CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
.+|++.+.||+|+||.||+|... .++.||+|++...... ....+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45888999999999999999753 2578999999754332 2356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC
Q 017246 133 LVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 200 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~ 200 (375)
+++||+.+++|.+++.... ..+..+++..++.++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 12345888899999999999999999988 99999999999999999
Q ss_pred ceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhc
Q 017246 201 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 201 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 279 (375)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~-- 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVI-- 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence 999999999875433322222233456789999999988889999999999999999998 88888632211 000
Q ss_pred hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
..+.......++..++..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 237 ------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 ------------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0011111123356788889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.81 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=204.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCc----eEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
.++|++.+.||+|+||.||+|... ++. .+++|.+..... ....++..|+.++..++||||+++++++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 357889999999999999999764 344 477887754322 22356777888999999999999999875 45678
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+|||+++++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 89999999999999964 3456899999999999999999999888 99999999999999999999999999975
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..............++..|+|||++.+..++.++|||||||++|||++ |..||....... . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~--------------~ 221 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V--------------P 221 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H--------------H
Confidence 433322222334557788999999998899999999999999999998 999986322111 0 0
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.++........+..++..+.+++.+||..+|++||++.|+++.|..+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 222 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 111111111122345667889999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=317.23 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=198.2
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999764 689999998865432 2345688999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeee
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 223 (375)
.+++.. ....+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999854 2456889999999999999999999888 9999999999999999999999999987532211111111
Q ss_pred ccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccCCCC
Q 017246 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 302 (375)
Q Consensus 224 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (375)
....+..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+........
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----------------TREAIEQGVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----------------HHHHHHcCCCCCC
Confidence 1223457999999998889999999999999999998 888886322110 0001111112233
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 303 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 303 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
+..++..+.+++.+||+.+|++||++.+|+++|.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4556778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=323.02 Aligned_cols=258 Identities=31% Similarity=0.475 Sum_probs=205.4
Q ss_pred hcccccceeccccceEEEEEEE-----cCCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.+|++.+.||+|+||.||+|.. ..+..+++|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999974 2467899999875332 233568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC
Q 017246 134 VYEYMPMGSLEDHLYDLEP-------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 200 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~ 200 (375)
||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ |+|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 1235788999999999999999999988 99999999999999999
Q ss_pred ceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhc
Q 017246 201 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 201 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 279 (375)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence 999999999975433322222333456778999999988889999999999999999998 88898532211 0010
Q ss_pred hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
.+........+..++..+.+++.+||+.+|.+||++.+|+++|..
T Consensus 238 -------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 -------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 011111112344567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=326.45 Aligned_cols=263 Identities=29% Similarity=0.446 Sum_probs=209.6
Q ss_pred HHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEeeC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 128 (375)
+..++|++.+.||+|+||.||++... ....+|+|.+..... .....+.+|+.++..+ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 44568999999999999999999753 236799999875422 3345678899999999 799999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 196 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill 196 (375)
+..+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+++ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 99999999999999999996532 23456889999999999999999999888 9999999999999
Q ss_pred eCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccc
Q 017246 197 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQN 275 (375)
Q Consensus 197 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 275 (375)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 9999999999999976433222222222335678999999988899999999999999999998 888886322110
Q ss_pred hhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 276 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
.. ..+........+..++..+.+|+.+||..+|++||++.+|++.|+.+.
T Consensus 243 ~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LF--------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH--------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 00 001111111234456778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=324.07 Aligned_cols=251 Identities=34% Similarity=0.551 Sum_probs=197.6
Q ss_pred cccceeccccceEEEEEEEc-----CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 63 REANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 63 ~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.+.+.||.|.||.||+|.+. .+..|+||.++.... .....+.+|+..++.++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35688999999999999766 367799999965432 336789999999999999999999999998888999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++... ....+++..+..|+.||+.||.|||+++ ++|+||+++|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999763 3567899999999999999999999988 999999999999999999999999999765323
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
..............|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~~--------------~~~~ 219 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EII--------------EKLK 219 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HHH--------------HHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc--------------cccc
Confidence 33333334557789999999999889999999999999999999 67887532111 000 0111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 335 (375)
.......+..++..+.+++.+||+.+|++||++.+|++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111233556788899999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=325.93 Aligned_cols=264 Identities=24% Similarity=0.325 Sum_probs=198.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357999999999999999999865 689999999875432 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 588888754 3456888999999999999999999998 999999999999999999999999998743221
Q ss_pred CCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc--------
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ-------- 287 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 287 (375)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .+.. ........
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLER-IFLVLGTPNEDTWPGV 232 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHH-HHHHhCCCChhhccch
Confidence 1 12233568999999999875 4588999999999999999999999964321100 0000 00000000
Q ss_pred cccchhcccccCCCCC---------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLHGRYP---------RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...............+ ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000000 113456889999999999999999999983
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=331.62 Aligned_cols=264 Identities=24% Similarity=0.337 Sum_probs=202.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||.|+||.||++... ++..+|+|.+..... .....+.+|+.+++.++||||++++++|...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999876 688899998865422 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999954 44688899999999999999999974 5 99999999999999999999999999864322
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhh----ch----------h
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS----WS----------R 281 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~----~~----------~ 281 (375)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............. .. .
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 1 1233568999999999998889999999999999999999999996432211100000 00 0
Q ss_pred h-------hhhhc---cccchhcccccCC---CC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 P-------FLKDQ---KKFVHLVDPLLHG---RY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ~-------~~~~~---~~~~~~~~~~~~~---~~-~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. +.... .....+....... .. ....+.++.+|+.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0 00000 0000000000000 01 1124677999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=335.55 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=196.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||++... +++.||+|++..... .....+..|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36899999999999999999765 689999999975422 22346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999954 457899999999999999999999988 99999999999999999999999999874321
Q ss_pred CCCc---------------------------------eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCC
Q 017246 216 GDNT---------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262 (375)
Q Consensus 216 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 262 (375)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0112357999999999999999999999999999999999999
Q ss_pred CCccccccccccchhhchhhhhhhccccchhcccccCCCCC--HHHHHHHHHHHHhhcC--CCCCCCCCHHHHHHH
Q 017246 263 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLN--EEANFRPLINDIVVA 334 (375)
Q Consensus 263 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~--~~p~~RPs~~eil~~ 334 (375)
.||........ . .. +........+| ..++..+.++|.+++. .++..||++.||++.
T Consensus 234 ~Pf~~~~~~~~---~---~~----------i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQET---Y---KK----------VMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHH---H---HH----------HHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99963321110 0 00 00000000111 1245677888887554 233456899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=331.59 Aligned_cols=236 Identities=28% Similarity=0.407 Sum_probs=191.5
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|+.. +++.||+|++.+.. ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 58899999987542 23345566788888766 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999998854 456899999999999999999999988 999999999999999999999999998742211 12
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... . ... +... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~---~~~----------i~~~--~~ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---L---FEA----------ILND--EV 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---H---HHH----------HhcC--CC
Confidence 2334679999999999999999999999999999999999999996432110 0 000 1100 01
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLI 328 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~ 328 (375)
.++..++..+.+++.+||+.||.+||++
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2344567788999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=332.05 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=196.2
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEcccc--CccchHHHHHHHHHHccCCCCCcceeEeEEeeC-----CeeE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRL 132 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 132 (375)
+|++.+.||+|+||.||+|... ++..||||++... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999765 6899999998643 223345678899999999999999999987543 3579
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689988853 456899999999999999999999998 99999999999999999999999999975
Q ss_pred CCCCC-Cceeeecccccccccccccccc--CCCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hch-------h
Q 017246 213 GPVGD-NTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS-------R 281 (375)
Q Consensus 213 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~-------~ 281 (375)
..... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||...........+ ... .
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 32211 1112234579999999999875 67899999999999999999999999643221100000 000 0
Q ss_pred hhhhh--ccccchhcccccCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 PFLKD--QKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... .......+.......+ .+..+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 0000000000000000 1234567889999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=332.90 Aligned_cols=251 Identities=27% Similarity=0.353 Sum_probs=200.1
Q ss_pred cccccceeccccceEEEEEEE----cCCceEEEEEccccCc----cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCee
Q 017246 61 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 131 (375)
+|++.+.||+|+||.||+++. .+++.||+|++.+... ...+.+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999964 3588999999865321 2234577899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999964 456899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
........ .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.......... .....
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~-------- 222 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRR-------- 222 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHH--------
Confidence 53222211 12346799999999998865 47889999999999999999999996432211110 00000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
+. .....++..++..+.+++.+||+.||++|| ++.++++
T Consensus 223 --~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 223 --IL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --Hh--cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00 011223455677889999999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=335.28 Aligned_cols=242 Identities=29% Similarity=0.366 Sum_probs=196.7
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 141 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 141 (375)
+.||+|+||.||++... +|..||+|++..... .....+..|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 689999999976422 23445678999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 142 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 142 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
+|..++.. ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 99988853 4568999999999999999999997 67 9999999999999999999999999987422111 1
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~-------------~i~~~--~~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE-------------LILME--EI 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHH-------------HHhcC--CC
Confidence 2234579999999999999999999999999999999999999996322110 000 00000 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 334 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~~ 334 (375)
.++..++..+.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 23455677899999999999999996 89998853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=316.99 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=211.7
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.+++.++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47999999999999999999876 799999998864322 23457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998765445667899999999999999999999988 99999999999999999999999999875322
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. .......+++.|+|||.+.+..++.++|||||||++|+|++|..||...... ...... .+.
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-----------~~~ 221 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-----------KIE 221 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh-----------hhh
Confidence 21 1123356888999999999888999999999999999999999998532211 000000 000
Q ss_pred cccCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 296 PLLHGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 296 ~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
.......+ ..++..+.++|.+||..+|++||++.+|++.|..+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00111122 266778999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=323.22 Aligned_cols=247 Identities=28% Similarity=0.423 Sum_probs=198.5
Q ss_pred eccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 68 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
||+|+||.||++... +++.||+|.+...... ....+..|+.+++.++|+||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999765 6899999998754322 234567899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeee
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 223 (375)
.+++......+..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9888654445667999999999999999999999988 99999999999999999999999999875332221 223
Q ss_pred ccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC
Q 017246 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303 (375)
Q Consensus 224 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (375)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . . ...+... ...++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~----~------~~~~~~~--~~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E----L------KQRILND--SVTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--H----H------HHhhccc--CCCCc
Confidence 3578999999999999999999999999999999999999996432211100 0 0 0001111 11234
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 304 RRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 304 ~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
..++..+.+++.+||+.+|++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 56778899999999999999999 6677774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=331.41 Aligned_cols=246 Identities=28% Similarity=0.389 Sum_probs=198.5
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCC-CcceeEeEEeeCCeeEEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHD-NLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 135 (375)
+|++.+.||+|+||.||+|... +++.||+|++.+.. ......+..|..++..+.|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999765 57899999987642 23345677888999888765 5888999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998854 456889999999999999999999988 99999999999999999999999999864222
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .+..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~-------------~i~~ 215 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQ-------------SIME 215 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH-------------HHHc
Confidence 11 1233467999999999999999999999999999999999999999632211 0000 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~eil~ 333 (375)
....++..++..+.+++.+||+.+|.+|++. .++++
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 216 --HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1123345667789999999999999999986 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.58 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=207.8
Q ss_pred cccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999743 235688998865432 234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCc
Q 017246 134 VYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 193 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~N 193 (375)
+|||+.+++|.+++..... ....+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999864321 1235788999999999999999999888 9999999999
Q ss_pred EEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCcccccccc
Q 017246 194 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQG 272 (375)
Q Consensus 194 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 272 (375)
||+++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999875432222112223446778999999988889999999999999999999 99998632211
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.+.. ..........+..++..+.+++.+||+.+|++||++.+|++.|+++..+
T Consensus 237 --~~~~--------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 --RLFN--------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --HHHH--------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111 1111112223455677899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=338.25 Aligned_cols=253 Identities=25% Similarity=0.293 Sum_probs=197.6
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999754 688999999976432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999864 456889999999999999999999988 999999999999999999999999997532100
Q ss_pred CC---------------------------------------------ceeeeccccccccccccccccCCCCccchhHhH
Q 017246 217 DN---------------------------------------------THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSF 251 (375)
Q Consensus 217 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 251 (375)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 001123579999999999999899999999999
Q ss_pred HHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHh--hcCCCCCCCCCHH
Q 017246 252 GVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM--CLNEEANFRPLIN 329 (375)
Q Consensus 252 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPs~~ 329 (375)
||++|||++|..||......... . ... .. ...+.......++.++.+||.+ |+..+|..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~--~----~i~----~~----~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ--L----KVI----NW----ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH--H----HHH----cc----ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999999643221100 0 000 00 0001111112456778888888 4455666699999
Q ss_pred HHHHH
Q 017246 330 DIVVA 334 (375)
Q Consensus 330 eil~~ 334 (375)
+++..
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.08 Aligned_cols=253 Identities=26% Similarity=0.299 Sum_probs=203.9
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|... +++.||||++..... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36899999999999999999865 689999999976422 33456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999964 367899999999999999999999988 99999999999999999999999999875432
Q ss_pred CC---------------------------CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 017246 216 GD---------------------------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 268 (375)
Q Consensus 216 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 268 (375)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001223456999999999999999999999999999999999999999643
Q ss_pred ccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 017246 269 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVVA 334 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~eil~~ 334 (375)
..... ...... +. ..+.......++..+.++|.+|++ +|.+||+ +.++++.
T Consensus 234 ~~~~~------~~~i~~----~~----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQET------YNKIIN----WK----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHH------HHHHhc----cC----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 31110 000000 00 001111112257889999999997 9999999 9999963
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=338.49 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=199.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36899999999999999999865 68999999997542 223345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999854 456899999999999999999999998 99999999999999999999999999864321
Q ss_pred CCCc------------------------------------eeeeccccccccccccccccCCCCccchhHhHHHHHHHHH
Q 017246 216 GDNT------------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 259 (375)
Q Consensus 216 ~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 259 (375)
.... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 0111246999999999999999999999999999999999
Q ss_pred hCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 017246 260 TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL---INDIVV 333 (375)
Q Consensus 260 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~eil~ 333 (375)
+|..||........ ...... .. ..+.......++..+.++|.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~~~------~~~i~~----~~----~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQET------YRKIIN----WK----ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHH------HHHHHc----CC----CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999964321110 000000 00 000000111356788899999996 9999998 888886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=336.10 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=209.5
Q ss_pred HHHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCcc-chHHHHHHHHHHccCC-CCCcceeEeEEee
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLH-HDNLVTLIGYCTS 127 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 127 (375)
.+..++|.+.+.||+|+||.||+|++. .+..||+|++...... ....+..|+.++..+. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 345567889999999999999999753 3467999999764322 2346888999999997 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCC-------------------------------------------------------
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEP------------------------------------------------------- 152 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 152 (375)
.+..++||||+++|+|.+++.....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999965321
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCc
Q 017246 153 ---------------------------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 193 (375)
Q Consensus 153 ---------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~N 193 (375)
....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 1134677888999999999999999887 9999999999
Q ss_pred EEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCcccccccc
Q 017246 194 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQG 272 (375)
Q Consensus 194 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 272 (375)
||+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999975322222122223457789999999998889999999999999999998 888986322110
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
. . ...+........+..++..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 350 ~--~--------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q--F--------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--H--------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 0 0001111111234556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=324.91 Aligned_cols=267 Identities=26% Similarity=0.414 Sum_probs=211.5
Q ss_pred HHhhcccccceeccccceEEEEEEEc--------CCceEEEEEccccC-ccchHHHHHHHHHHccC-CCCCcceeEeEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCT 126 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 126 (375)
+...+|.+.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44568999999999999999999641 24579999886542 23346788899999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
.....+++|||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999976322 1245788899999999999999999988 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGE 273 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 273 (375)
|++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 999999999999999975433222222223445678999999998889999999999999999998 778875322110
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.. . .+........+..++..+.+++.+||+.+|++||++.+|++.|+++.....
T Consensus 248 --~~---~-----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 248 --LF---K-----------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred --HH---H-----------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 00 0 000011112244677889999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.79 Aligned_cols=260 Identities=20% Similarity=0.205 Sum_probs=196.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..+|.+.+.||+|+||.||++... +++.||+|.... ..+.+|+.+++.++||||++++++|......++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999764 689999997532 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 85 688888854 456889999999999999999999988 9999999999999999999999999986422111
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccc-----cchhhchhh-------hhh
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-----QNLVSWSRP-------FLK 285 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~-------~~~ 285 (375)
........||+.|+|||++.+..++.++|||||||++|||++|..||........ ..+...... +..
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1122346799999999999999999999999999999999999987643211100 000000000 000
Q ss_pred -hccccchhc---------ccccCCCC--CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 286 -DQKKFVHLV---------DPLLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 286 -~~~~~~~~~---------~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
......... .+...... ....+.++.+||.+||+.||.+|||+.|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 00000000 1235678999999999999999999999994
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=335.88 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=201.5
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
...+|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568999999999999999999765 68899999986532 1233456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999998843 35788999999999999999999988 999999999999999999999999998753
Q ss_pred CCCCCceeeeccccccccccccccccC----CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
.... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .
T Consensus 193 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------------~ 255 (370)
T cd05596 193 DANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----------------T 255 (370)
T ss_pred cCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----------------H
Confidence 2221 1122346799999999998753 47899999999999999999999996422110 0
Q ss_pred cchhcccccCCCCC--HHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 017246 290 FVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 334 (375)
Q Consensus 290 ~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--RPs~~eil~~ 334 (375)
...+........++ ..++..+.++|.+||+.+|.+ ||++.++++.
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01111111011122 246788999999999999988 9999999853
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=329.29 Aligned_cols=243 Identities=27% Similarity=0.388 Sum_probs=193.1
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+++.. +++.||+|++.+... .....+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 688999999976422 2334567788887766 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 999988853 457899999999999999999999998 9999999999999999999999999987422111 1
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccc--cchhhchhhhhhhccccchhccccc
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE--QNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+... .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~i~~~-- 220 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---------VILEK-- 220 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH---------HHhcC--
Confidence 22346799999999999999999999999999999999999999964322111 111111100 01111
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLI 328 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 328 (375)
...+|..++..+.+++.+||+.||++||++
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 113456677889999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=317.23 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=203.8
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.++|++.+.||+|+||.||+++..++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 35689999999999999999988767779999987543 33567889999999999999999999999889999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
.+++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999998652 236899999999999999999999988 99999999999999999999999999875322211
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ... .+.. .
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~-------------~~~~-~ 217 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE-------------KVSQ-G 217 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH-------------HHhc-C
Confidence 11112335678999999988889999999999999999999 999986332110 000 0000 0
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
.....+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112335678999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=322.05 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=207.4
Q ss_pred HhhcccccceeccccceEEEEEEEc------CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4568999999999999999999754 24689999986543 2334567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEE
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 204 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl 204 (375)
.++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 99999999999999999754321 234788899999999999999999888 999999999999999999999
Q ss_pred eecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhh
Q 017246 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 205 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~----- 232 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK----- 232 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH-----
Confidence 99999875333222222233456789999999988889999999999999999998 888985322111 110
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
.+........+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 233 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 ---------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00011111234556788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=318.75 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=199.7
Q ss_pred ccccceeccccceEEEEEEEcC-Cc--eEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeC------Ce
Q 017246 62 FREANLIGEGGFGKVYKGRLES-GQ--LVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQ 130 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 130 (375)
|.+.+.||+|+||.||+|.... +. .+|+|.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998653 33 58999886542 23356688899999999999999999976432 24
Q ss_pred eEEEEeecCCCCHHHHHhccC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
.+++|||+.+|+|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885322 23345899999999999999999999888 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
++................+++.|+|||++.+..++.++|||||||++|||++ |..||...... .... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYD----YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHcC
Confidence 9976433222112223346778999999998899999999999999999999 78888632211 1100 11100
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
. ....+..++..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 231 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 N----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0112345667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=330.92 Aligned_cols=242 Identities=27% Similarity=0.368 Sum_probs=195.2
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 58899999987642 22344566788888765 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 999998854 456889999999999999999999998 9999999999999999999999999987432211 2
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. . .+.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~---~----------~i~~~~--~ 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LF---E----------SILHDD--V 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HH---H----------HHHcCC--C
Confidence 2334679999999999999999999999999999999999999997432110 00 0 010000 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCC-------CHHHHHHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRP-------LINDIVVA 334 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RP-------s~~eil~~ 334 (375)
.++..++.++.+++.+||+.+|++|| ++.++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 22345677899999999999999999 77888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=335.24 Aligned_cols=253 Identities=23% Similarity=0.281 Sum_probs=200.0
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
...++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999875 58899999986532 123445778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999843 35788999999999999999999988 99999999999999999999999999975
Q ss_pred CCCCCCceeeeccccccccccccccccC----CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
..... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 192 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--------------- 255 (370)
T cd05621 192 MDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--------------- 255 (370)
T ss_pred cccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---------------
Confidence 42221 1122356799999999998754 378899999999999999999999964321100
Q ss_pred ccchhcccccCCCCC--HHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 017246 289 KFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 334 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--RPs~~eil~~ 334 (375)
...+........++ ...+..+.+++..|+..++.+ ||++.++++.
T Consensus 256 -~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 -YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 01111111111122 245778889999999865544 8899999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=338.00 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=197.3
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||++... +++.||||++.+.. ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36899999999999999999754 68999999986532 223456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999854 456889999999999999999999998 99999999999999999999999999863211
Q ss_pred CCCc---------------------------------------------eeeeccccccccccccccccCCCCccchhHh
Q 017246 216 GDNT---------------------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 250 (375)
Q Consensus 216 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 250 (375)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC--HHHHHHHHHHHHhhcCCCCCCC---
Q 017246 251 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANFR--- 325 (375)
Q Consensus 251 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~R--- 325 (375)
|||++|||++|..||........ ...... +.. ...++ ..++..+.++|.+|++ +|.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~------~~~i~~----~~~------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHET------YRKIIN----WRE------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHH------HHHHHc----cCC------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 99999999999999963321100 000000 000 00111 1356778999999997 66665
Q ss_pred CCHHHHHHH
Q 017246 326 PLINDIVVA 334 (375)
Q Consensus 326 Ps~~eil~~ 334 (375)
+++.++++.
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 599998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=325.60 Aligned_cols=240 Identities=29% Similarity=0.432 Sum_probs=192.0
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHcc-CCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 588999999875421 233445556666654 4899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999998854 456899999999999999999999988 9999999999999999999999999997532222 2
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ... .. +.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~---~~----------i~~--~~~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELF---DS----------ILN--DRP 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHH---HH----------HHc--CCC
Confidence 234467999999999999989999999999999999999999999643211 000 00 000 112
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIV 332 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~-eil 332 (375)
.++..++..+.+++.+||+.+|++||++. +++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23455677889999999999999999876 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=320.78 Aligned_cols=265 Identities=25% Similarity=0.388 Sum_probs=210.2
Q ss_pred HHhhcccccceeccccceEEEEEEEcC-----CceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEee-CC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLES-----GQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GD 129 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 129 (375)
+..++|.+.+.||+|+||.||+|.... +..|++|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 446789999999999999999998654 6889999886532 2335567889999999999999999998765 46
Q ss_pred eeEEEEeecCCCCHHHHHhccCCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEe
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPD----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 205 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~ 205 (375)
..+++++|+++++|.+++...... ...+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 788999999999999998654322 156899999999999999999999888 9999999999999999999999
Q ss_pred ecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhh
Q 017246 206 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 284 (375)
Q Consensus 206 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 284 (375)
|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||....... +.. ..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~ 232 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA----YL 232 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH----HH
Confidence 9999975433322222223446778999999998889999999999999999999 999996432111 111 01
Q ss_pred hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.. ......+..++..+.+++.+||+.+|++||++.++++.|+.+..+
T Consensus 233 ~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 233 KD----------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred Hc----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 10 011112334567889999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=316.74 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=202.9
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
.+|++.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4688899999999999999988777789999986543 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 99999999642 346899999999999999999999988 99999999999999999999999999875322111
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .+....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~--------------~~~~~~ 218 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE--------------SVSAGY 218 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH--------------HHHcCC
Confidence 11111223457999999998899999999999999999999 788986432110 000 000111
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 335 (375)
....+..++..+.+++.+||+.+|++||++.++++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1122345678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=327.60 Aligned_cols=269 Identities=27% Similarity=0.415 Sum_probs=210.5
Q ss_pred HHhhcccccceeccccceEEEEEEEc--------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCT 126 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 126 (375)
....+|++.+.||+|+||.||++... .+..||+|.+..... .....+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 33457999999999999999999642 123689998875422 2346788899999999 7999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
..+..+++|||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 99999999999999999999975321 2345788899999999999999999988 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGE 273 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 273 (375)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 244 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 244 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence 999999999999999875332221111222334568999999999999999999999999999998 888885322111
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCC
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 345 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~ 345 (375)
... .+........+..++..+.+++.+||+.+|++||++.+|++.|+.+.......
T Consensus 245 --~~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~~ 300 (334)
T cd05100 245 --LFK--------------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD 300 (334)
T ss_pred --HHH--------------HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCCC
Confidence 000 00011111234456778999999999999999999999999999998655443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=321.78 Aligned_cols=258 Identities=31% Similarity=0.463 Sum_probs=206.5
Q ss_pred hhcccccceeccccceEEEEEEEc------CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..+|+..+.||+|+||.||++... ++..+|+|.+..........+.+|+.+++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888999999999999999632 35679999887665555678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc
Q 017246 133 LVYEYMPMGSLEDHLYDLEP-----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 201 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~ 201 (375)
++|||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999975321 1135889999999999999999999888 999999999999999999
Q ss_pred eEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhch
Q 017246 202 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 202 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 280 (375)
+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |.+||........ .
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~--- 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I--- 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H---
Confidence 99999999875332222222223345788999999999999999999999999999998 8999853221110 0
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
.... .......+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 235 ----------~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ----------ECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----------HHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000 00111223456778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=329.80 Aligned_cols=246 Identities=27% Similarity=0.375 Sum_probs=198.0
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 135 (375)
+|++.+.||+|+||.||+|... +++.||+|++.+... .....+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4888999999999999999765 578999999876432 2234456677777776 5889999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998854 456889999999999999999999988 99999999999999999999999999874221
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~-------------~~i~~ 215 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF-------------QSIME 215 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHH-------------HHHHh
Confidence 11 1233467999999999999999999999999999999999999999643211 000 00111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~eil~ 333 (375)
. ...+|...+..+.+++.+|++.+|++|++. .++++
T Consensus 216 ~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 216 H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred C--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1 112355677889999999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=322.07 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=202.5
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.|++.++||+|+||.||++... +++.||+|++...... ....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999764 6899999998654322 23446789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888642 2456899999999999999999999988 999999999999999999999999998753222
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. ......|++.|+|||++.+..++.++|||||||++|||++|..||........ .. . +...+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~---~-------~~~~~~~ 219 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---RE---E-------VERRVKE 219 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HH---H-------HHHHhhh
Confidence 1 12235789999999999988899999999999999999999999974321110 00 0 0000000
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
....++..++..+.+|+.+||+.||.+|| ++.++++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11223456778899999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=315.70 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=204.9
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.++|++.+.||+|+||.||+|...+...||+|++..... ....+.+|+.+++.++||||+++++.+.. +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 467999999999999999999877667799999976432 34578889999999999999999998754 5689999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999652 2346789999999999999999999888 99999999999999999999999999975432221
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ... .+ ...
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~-------------~~-~~~ 219 (262)
T cd05071 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD-------------QV-ERG 219 (262)
T ss_pred c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHH-------------HH-hcC
Confidence 1 1122346678999999988889999999999999999999 788886322110 000 00 000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.....+..++..+.+++.+|++.+|++||++.++++.|+..
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11122446677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=323.45 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=195.1
Q ss_pred hcccccceeccccceEEEEEEEc--CCceEEEEEccccCcc--chHHHHHHHHHHccC---CCCCcceeEeEEe-----e
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL---HHDNLVTLIGYCT-----S 127 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~ 127 (375)
++|++.+.||+|+||.||+|+.. ++..||+|.+...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999763 4688999988654322 233455677766655 6999999999875 3
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
....++||||+. ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 5899988653 2345899999999999999999999988 999999999999999999999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchhhhhhh
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKD 286 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~ 286 (375)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|++||......... .+....... .
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~--~ 229 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP--G 229 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC--C
Confidence 999754322 2233456899999999999889999999999999999999999999743321110 000000000 0
Q ss_pred ccccc-------hhcccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 287 QKKFV-------HLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 287 ~~~~~-------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...+. ..+...... ...+.++..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000000 111345677899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=319.81 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=204.5
Q ss_pred hhcccccceeccccceEEEEEEEc------CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|.+.+.||+|+||.||+|.+. .+..||+|.+...... ....+..|+.+++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467999999999999999999764 3567999988654322 345688899999999999999999999998999
Q ss_pred EEEEeecCCCCHHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC---ceEEe
Q 017246 132 LLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLS 205 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~---~vkl~ 205 (375)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999976431 1235889999999999999999999988 99999999999998765 58999
Q ss_pred ecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhh
Q 017246 206 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 284 (375)
Q Consensus 206 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 284 (375)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~------ 232 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME------ 232 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH------
Confidence 9999975422221111122334568999999998899999999999999999997 99998632211 1110
Q ss_pred hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
.+........+..++..+.+++.+||+.+|++||++.+|++.|.+
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 233 --------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111111123345667889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=320.02 Aligned_cols=268 Identities=30% Similarity=0.458 Sum_probs=205.5
Q ss_pred ccccceeccccceEEEEEEE-----cCCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeC--CeeEE
Q 017246 62 FREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLL 133 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 133 (375)
|.+.+.||+|+||.||++.. .++..||+|.+..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38899999999999988642 3578899999876432 2345678899999999999999999987653 46789
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++...
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999953 35899999999999999999999988 999999999999999999999999998764
Q ss_pred CCCCCce-eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 214 PVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 214 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..||......... ........ .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQ-MTVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccc-cchhhhhh
Confidence 3322211 122234567799999998888999999999999999999999998643221110 00000000 00011111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
.+........+..++..+.+++.+||+.+|++||++++|++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222222345567789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.48 Aligned_cols=198 Identities=27% Similarity=0.377 Sum_probs=170.9
Q ss_pred hcccccceeccccceEEEEEE-EcCCceEEEEEccccCccchHHHHHHHHHHccCC-C-----CCcceeEeEEeeCCeeE
Q 017246 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-H-----DNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~ 132 (375)
.+|++.++||+|+||.|.+|. .++++.||||+++... ....+...|+.+|..|+ | -|+|+++++|...+++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 378999999999999999996 4579999999997653 44566778999999997 4 38999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC--ceEEeecCCC
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF--NPKLSDFGLA 210 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~--~vkl~Dfg~a 210 (375)
||+|.+ .-+|+++++.. +...++...++.++.||+.||.+||..+ |||+||||+||||.+.+ .|||+|||++
T Consensus 265 iVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 999998 45999999873 4566999999999999999999999888 99999999999997554 6999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 269 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 269 (375)
......-. ..+.+..|+|||++.+.+|+.+.||||||||++||++|.+.|...+
T Consensus 339 c~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 86432222 3456788999999999999999999999999999999988886433
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=317.75 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=202.9
Q ss_pred ccccceeccccceEEEEEEEc----CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCe-----
Q 017246 62 FREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ----- 130 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 130 (375)
|.+.+.||+|+||.||+|... .+..||+|.+..... .....+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999754 246799999875432 234568889999999999999999998765544
Q ss_pred -eEEEEeecCCCCHHHHHhccC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 131 -RLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 131 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
.+++|||+++++|..++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999985532 22356899999999999999999999988 999999999999999999999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhh
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~----~~~- 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYD----YLR- 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHH-
Confidence 99875433322222222345678999999988889999999999999999999 88888532211 1000 000
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.......+..++..+.+++.+||+.||++||++.+|++.|+++
T Consensus 230 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 ---------HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011123456778899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=315.26 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=205.5
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.+++.++|+|++++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3467999999999999999999888788899999876443 3467889999999999999999999875 4568899999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++... ....+++..++.++.|++.||.|||+++ |+|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999999652 2456899999999999999999999988 9999999999999999999999999997533222
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||...... .... .+..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~--------------~~~~ 218 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLE--------------QVER 218 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHH--------------HHHc
Confidence 11 1112335668999999988889999999999999999999 88898632111 0000 0011
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
......+...+..+.+++.+||..+|++||++.++++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122345667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=327.86 Aligned_cols=240 Identities=28% Similarity=0.428 Sum_probs=193.2
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHcc-CCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|+.. +|..||+|++.... .........|..++.. ++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 68899999997642 1234456667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999998854 456889999999999999999999988 9999999999999999999999999987422211 1
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .... .+.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~-------------~~~~--~~~ 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFE-------------SIRV--DTP 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH-------------HHHh--CCC
Confidence 233467999999999999999999999999999999999999999632211 1000 0000 011
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIV 332 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~-eil 332 (375)
.++..++..+.+++.+||+.||++||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23445677899999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=337.02 Aligned_cols=251 Identities=23% Similarity=0.267 Sum_probs=196.4
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999764 688999999875422 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999854 356889999999999999999999998 999999999999999999999999997532100
Q ss_pred C---------------------------------------------CceeeeccccccccccccccccCCCCccchhHhH
Q 017246 217 D---------------------------------------------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSF 251 (375)
Q Consensus 217 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 251 (375)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC---H
Q 017246 252 GVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL---I 328 (375)
Q Consensus 252 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~ 328 (375)
||++|||++|+.||......... . .... . ............+.+..++|.+|+ .+|.+|++ +
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~--~----~i~~----~----~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQ--M----KVIN----W----QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHH--H----HHHc----c----CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 99999999999999643211000 0 0000 0 000111112345677888888876 49999997 8
Q ss_pred HHHHH
Q 017246 329 NDIVV 333 (375)
Q Consensus 329 ~eil~ 333 (375)
.++++
T Consensus 300 ~ei~~ 304 (382)
T cd05625 300 DEIKA 304 (382)
T ss_pred HHHhc
Confidence 88775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=315.47 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=207.5
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+..++|++.+.||+|+||.||+|...+++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 3457899999999999999999998888999999987644 33567889999999999999999999874 467899999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+.+++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999998652 3456889999999999999999999888 999999999999999999999999998754322
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. .......++..|+|||++....++.++||||||+++|||++ |+.||....... ... .+.
T Consensus 156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~--------------~~~ 217 (260)
T cd05067 156 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQ--------------NLE 217 (260)
T ss_pred Cc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHH--------------HHH
Confidence 11 11222345678999999998889999999999999999999 999996332111 000 000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.......+..++.++.+++.+||+.+|++||+++++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 1111122345667899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=332.77 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=201.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|.+.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36899999999999999999765 689999999976432 23455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999652 357899999999999999999999988 99999999999999999999999999975432
Q ss_pred CCCceeeeccccccccccccccc------cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAM------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
... .......||+.|+|||++. ...++.++|||||||++|||++|..||........ ......
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~---- 223 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMN---- 223 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHc----
Confidence 222 1233457899999999987 45678999999999999999999999963221100 000000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. ...+.-.....++..+.+|+..|++ +|.+||++.+++.
T Consensus 224 ~----~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 224 F----QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C----CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0000001122467788999999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=321.80 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=207.5
Q ss_pred HHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEeeC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 128 (375)
...++|.+.+.||+|+||.||++... .+..+|+|.+..... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34567999999999999999999641 355799998875432 3345688899999999 799999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
+..+++|||+.+++|.+++... ....+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999642 2334899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
++................++..|+|||++.+..++.++|||||||++|||++ |..||........ ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~---------- 254 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FY---------- 254 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HH----------
Confidence 9875433222222223456788999999999899999999999999999998 9999863321110 00
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
..+........+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 255 ----~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 ----KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00111111112334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=337.33 Aligned_cols=251 Identities=24% Similarity=0.282 Sum_probs=198.6
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+|++.+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999765 689999999865322 234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999954 456889999999999999999999988 999999999999999999999999997522100
Q ss_pred C-----------------------------------------CceeeeccccccccccccccccCCCCccchhHhHHHHH
Q 017246 217 D-----------------------------------------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 255 (375)
Q Consensus 217 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 255 (375)
. ........+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001235799999999999999999999999999999
Q ss_pred HHHHhCCCCcccccccccc-chhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC---CHHHH
Q 017246 256 LELITGRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP---LINDI 331 (375)
Q Consensus 256 ~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---s~~ei 331 (375)
|||++|+.||......... .+..| . ..........++..+.++|.+|+ .+|.+|+ ++.++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~-----------~----~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINW-----------E----TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhcc-----------C----ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 9999999999643321100 00000 0 00001112245667888888876 5999999 89999
Q ss_pred HHH
Q 017246 332 VVA 334 (375)
Q Consensus 332 l~~ 334 (375)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=318.18 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=205.4
Q ss_pred hhcccccceeccccceEEEEEEEc-CCc----eEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..+|++.+.||+|+||.||+|.+. ++. .||+|++..... .....+.+|+.++..+.||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457899999999999999999753 444 489999875433 234567889999999999999999999875 4578
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999864 2356899999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..............+++.|+|||.+.+..++.++|||||||++|||++ |..||+...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-------------- 221 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP-------------- 221 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH--------------
Confidence 433222211222335678999999998899999999999999999998 889986322110 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
..+........+..++..+.+++.+||+.||++||++.++++.|..+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011111111223456778999999999999999999999999998885543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=321.08 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=205.0
Q ss_pred hcccccceeccccceEEEEEEEc-CCc--eEEEEEcccc-CccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQ--LVAIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 134 (375)
++|++.+.||+|+||.||+|... ++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 47889999999999999999765 343 4788887642 223345688899999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCce
Q 017246 135 YEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 202 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~v 202 (375)
|||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965321 1235889999999999999999999888 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchh
Q 017246 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 281 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 281 (375)
||+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||....... .. .
T Consensus 159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~---~ 229 (297)
T cd05089 159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LY---E 229 (297)
T ss_pred EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---H
Confidence 9999999863211 111111223557999999998889999999999999999998 999986322110 00 0
Q ss_pred hhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 282 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.+........+..++..+.+++.+||+.+|.+||++.+|++.|+.+.....
T Consensus 230 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 -----------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred -----------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 001111112344567789999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=316.06 Aligned_cols=261 Identities=25% Similarity=0.330 Sum_probs=210.6
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.+|++.+.||.|+||.||++.. .++..+|||.+..... .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3688899999999999999975 4789999998865322 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998764445567899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...... .....
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-------~~~~~-- 223 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-------KIEQC-- 223 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh-------hhhcC--
Confidence 22 1122356889999999999888999999999999999999999998532111 001000 00000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
......+..++..+.+++.+||+.+|++|||+.+|++.+.++.
T Consensus 224 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 -DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0111112357778999999999999999999999999998873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.19 Aligned_cols=237 Identities=27% Similarity=0.351 Sum_probs=189.8
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHH-HHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|... +|+.||+|++..... .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999865 689999999875422 12234444544 56789999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 999998854 457899999999999999999999988 999999999999999999999999998742211 12
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .... .+.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~----------~i~~~~--~ 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYD----------NILNKP--L 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHH----------HHHcCC--C
Confidence 233467999999999999999999999999999999999999999632210 0000 011111 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLIN 329 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~ 329 (375)
..++..+..+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 22345577899999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=327.19 Aligned_cols=243 Identities=28% Similarity=0.364 Sum_probs=194.2
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|... +++.||+|++..... .....+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 588999999976432 2334577888888887 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence 999988853 456999999999999999999999998 999999999999999999999999998742211 12
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.............+.... +... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~--~~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---------ILEK--PI 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH---------HHhC--CC
Confidence 233467999999999999999999999999999999999999999643322211111111110 1111 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLI 328 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~ 328 (375)
.+|...+..+.+++.+||+.||.+||++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2355667788999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=327.55 Aligned_cols=241 Identities=28% Similarity=0.420 Sum_probs=195.6
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|... +++.||+|++.+.. ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 58899999997642 22344567788888777 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999998854 457899999999999999999999988 9999999999999999999999999986421111 1
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... . .+... ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~---~----------~i~~~--~~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELF---Q----------SILED--EV 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHH---H----------HHHcC--CC
Confidence 223357899999999999999999999999999999999999999632211 000 0 00000 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 333 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~eil~ 333 (375)
.++..++..+.++|.+||+.||++||++ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2345567789999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=321.37 Aligned_cols=266 Identities=27% Similarity=0.428 Sum_probs=203.8
Q ss_pred hhcccccceeccccceEEEEEEEcC---------------CceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES---------------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLI 122 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~ 122 (375)
..+|++.+.||+|+||.||+++... ...||+|.+..... .....+.+|+.+++.++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999986532 23589999876432 2345688999999999999999999
Q ss_pred eEEeeCCeeEEEEeecCCCCHHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEP--------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999864221 1124688899999999999999999988 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh--CCCCcccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQG 272 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~ 272 (375)
|++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875433322222233445778999999998889999999999999999998 556775322111
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
.......+.... ........+..++..+.+++.+||+.+|++||++.+|++.|.+
T Consensus 241 ---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ---VIENTGEFFRNQ-------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHhhhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111000011000 0001111233466789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.15 Aligned_cols=263 Identities=26% Similarity=0.350 Sum_probs=196.9
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeC--------
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-------- 128 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 128 (375)
...+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3468999999999999999999764 68899999885432 2345699999999999999999877432
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeec
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDF 207 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Df 207 (375)
..+++||||+++ +|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 788877655445678999999999999999999999998 99999999999998665 6999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh---
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF--- 283 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--- 283 (375)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||....... .+.......
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence 99975432221 2235689999999998764 68999999999999999999999996432211 111000000
Q ss_pred ----hh-hcc-----ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 284 ----LK-DQK-----KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 284 ----~~-~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ... .+..+....+...+|...+.++.+||.+||+.+|.+||++.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 000 000001111111234456678999999999999999999999995
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=318.46 Aligned_cols=269 Identities=29% Similarity=0.442 Sum_probs=205.1
Q ss_pred hcccccceeccccceEEEEEEE-----cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEee--CCeeE
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRL 132 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 132 (375)
.+|++.+.||+|+||.||++.. .++..||+|.+..........+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788999999999999999974 2578999999876655556678899999999999999999998643 35688
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999964 2346889999999999999999999888 99999999999999999999999999986
Q ss_pred CCCCCCcee-eeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh---hcc
Q 017246 213 GPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK---DQK 288 (375)
Q Consensus 213 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~ 288 (375)
......... .....++..|+|||++.+..++.++|||||||++|||++|..|+...... .......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence 433222111 11223445699999999888999999999999999999988765322110 0000000000 000
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.+...+........+..++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00111111111123456678899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=323.88 Aligned_cols=266 Identities=27% Similarity=0.422 Sum_probs=209.4
Q ss_pred HHhhcccccceeccccceEEEEEEEc--------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCT 126 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 126 (375)
....+|.+.+.||+|+||.||+++.. ....+|+|.+..... .....+..|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34568999999999999999999642 245789998875422 3345678899999999 6999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
..+..+++|||+++|+|.+++..... ....+++..+..++.||+.||.|||+++ |+|+||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 98999999999999999999975321 2245889999999999999999999988 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGE 273 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 273 (375)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~- 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE- 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999975432221111122234567999999998899999999999999999999 888885322111
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
... ... .......+..++..+.+++.+||+.+|++||++.++++.|.++....
T Consensus 245 --~~~----~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 --LFK----LLR----------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred --HHH----HHH----------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 000 000 01111234566778999999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=331.57 Aligned_cols=238 Identities=26% Similarity=0.347 Sum_probs=194.2
Q ss_pred ceeccccceEEEEEEE----cCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 66 NLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|+.+++.++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 3588999999976432 233456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence 9999999853 456899999999999999999999998 9999999999999999999999999987532221
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccC
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (375)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+... .
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~-------------~~i~~~--~ 214 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TM-------------TMILKA--K 214 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HH-------------HHHHcC--C
Confidence 12234679999999999998889999999999999999999999996322110 00 001110 1
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 017246 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLIND 330 (375)
Q Consensus 300 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e 330 (375)
..++..++..+.+++.+||+.||++||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1234566788999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=315.47 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=202.3
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..+|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999986 46889999998765445556678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998853 456899999999999999999999888 9999999999999999999999999987532211
Q ss_pred Cceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.......|++.|+|||.+. ...++.++|||||||++|||++|..||......... ..+. . ....
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~------~---~~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMS------K---SNFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeee------c---CCCC
Confidence 1122356889999999874 345788999999999999999999998532211100 0000 0 0000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.+.. .....++..+.+++.+||+.+|++||++++|++.
T Consensus 228 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 228 PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0111 1123456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=313.67 Aligned_cols=250 Identities=23% Similarity=0.280 Sum_probs=203.6
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+|++.+.||.|+||.||++... +++.||+|.+.... ....+.+..|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999765 68999999986532 234567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 999999988642 3456889999999999999999999988 999999999999999999999999998753221
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ..... +. ...
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~----------~~-~~~ 216 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILK----------VC-QGS 216 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHH----------Hh-cCC
Confidence 11223456899999999999888999999999999999999999999632110 00000 00 001
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
....+..++..+.+++.+||+.+|++||++.+|+..
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112344566788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=319.84 Aligned_cols=266 Identities=26% Similarity=0.436 Sum_probs=204.1
Q ss_pred hhcccccceeccccceEEEEEEEc-----------------CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcce
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-----------------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVT 120 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~ 120 (375)
.++|++.+.||+|+||.||++... ++..+|+|++..... .....+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998532 234689999875432 23467889999999999999999
Q ss_pred eEeEEeeCCeeEEEEeecCCCCHHHHHhccCCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCc
Q 017246 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 193 (375)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~N 193 (375)
+++++...+..+++|||+++++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 999999999999999999999999999763321 234778899999999999999999988 9999999999
Q ss_pred EEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh--CCCCccccccc
Q 017246 194 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQ 271 (375)
Q Consensus 194 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~ 271 (375)
||++.++.++|+|||++................++..|+|||+.....++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875432222222223345678999999888889999999999999999998 66787532211
Q ss_pred cccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 272 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
........+..... .......+..++..+.+++.+||+.+|++||++.+|++.|++
T Consensus 241 ---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 ---QVIENTGEFFRDQG-------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHHhhcc-------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11110001111000 000111234566889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=325.26 Aligned_cols=240 Identities=31% Similarity=0.458 Sum_probs=192.5
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHcc-CCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|+.. +++.||+|++.... .........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 58899999987642 1233455667777765 5899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999854 456889999999999999999999988 9999999999999999999999999987432211 1
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .... . .. . ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~---~-i~-------~----~~~ 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQ---S-IR-------M----DNP 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HH-------h----CCC
Confidence 223467999999999999999999999999999999999999999642211 0000 0 00 0 011
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIV 332 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~-eil 332 (375)
.++..++..+.+++.+||+.+|++||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 23445667889999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=330.43 Aligned_cols=264 Identities=21% Similarity=0.238 Sum_probs=200.5
Q ss_pred HHhhcccccceeccccceEEEEEEEc---CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
....+|++.+.||+|+||.||++... .+..||+|.+... ....+|+.+++.++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34567999999999999999999643 3678999988643 234579999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
+||++. ++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999985 68888883 3567899999999999999999999988 999999999999999999999999999754
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh-hc-----
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQ----- 287 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~----- 287 (375)
.............||+.|+|||++....++.++|||||||++|||++|+.||..................+. ..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 333332233346799999999999999999999999999999999999999965433221110000000000 00
Q ss_pred ---cccc---hhcccccCCCC--C-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 ---KKFV---HLVDPLLHGRY--P-----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ---~~~~---~~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..+. .......+..+ + ...+.++.++|.+||..||++||++.+++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 00000011100 1 124567889999999999999999999994
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=319.20 Aligned_cols=266 Identities=27% Similarity=0.433 Sum_probs=206.8
Q ss_pred hhcccccceeccccceEEEEEEEcC-----------------CceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcce
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES-----------------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVT 120 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~ 120 (375)
.++|++.+.||+|+||.||++.... +..||+|.+..... .....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4579999999999999999986532 24589999876532 33567888999999999999999
Q ss_pred eEeEEeeCCeeEEEEeecCCCCHHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCc
Q 017246 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 193 (375)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~N 193 (375)
+++++..++..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+++ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999965331 1236899999999999999999999988 9999999999
Q ss_pred EEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh--CCCCccccccc
Q 017246 194 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQ 271 (375)
Q Consensus 194 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~ 271 (375)
||++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433332233334556789999999988889999999999999999998 66777532211
Q ss_pred cccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 272 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
............. ........+..++.++.+++.+||+.+|++||++.+|++.|++
T Consensus 241 ---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 ---QVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111110000 0011111234566789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=336.99 Aligned_cols=244 Identities=27% Similarity=0.372 Sum_probs=207.1
Q ss_pred eeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHHH
Q 017246 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 145 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 145 (375)
+||+|+||+||.|+.. +....|||.+........+.+.+|+.+.+.|+|.|||+++|.+..++.+-|+||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999866 456789999988777778889999999999999999999999999899999999999999999
Q ss_pred HHhccCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-CCceEEeecCCCccCCCCCCceee
Q 017246 146 HLYDLEPDQEPL--SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVS 222 (375)
Q Consensus 146 ~l~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~ 222 (375)
++.. +-+++ .+..+-.+.+||++||.|||.+. |||||||-+||||+. .|.+||.|||.++.... -....
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T 733 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT 733 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence 9975 45566 78889999999999999999888 999999999999964 68899999999876432 22344
Q ss_pred eccccccccccccccccC--CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 223 TRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 223 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.++.||..|||||++..+ .|..++|||||||++.||.||++||-..... ...+.+.-.-..++
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---------------qAAMFkVGmyKvHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---------------QAAMFKVGMYKVHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---------------hHhhhhhcceecCC
Confidence 568899999999999865 4889999999999999999999999532211 11122222233456
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+|..++.+...+|.+|+.++|.+||+++++|+
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 778999999999999999999999999999997
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=321.70 Aligned_cols=262 Identities=29% Similarity=0.445 Sum_probs=205.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCc--eEEEEEccccC-ccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQ--LVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 133 (375)
.++|++.+.||+|+||.||+|... ++. .+++|.+.... ......+.+|+.++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357899999999999999999764 454 45777765432 22345678899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc
Q 017246 134 VYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 201 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~ 201 (375)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999965321 1236889999999999999999999888 999999999999999999
Q ss_pred eEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhch
Q 017246 202 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 202 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 280 (375)
+||+|||++..... ........++..|+|||++.+..++.++|||||||++|||+| |..||....... ..
T Consensus 163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~--- 233 (303)
T cd05088 163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY--- 233 (303)
T ss_pred EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH---
Confidence 99999999863211 111112234668999999988889999999999999999998 999986322110 00
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.. +........+..++..+.+|+.+||+.+|++||++.++++.|+.+.....
T Consensus 234 ~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 234 EK-----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HH-----------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00 00001111233456788999999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=312.31 Aligned_cols=251 Identities=32% Similarity=0.490 Sum_probs=205.8
Q ss_pred ceeccccceEEEEEEEcC----CceEEEEEccccCccc-hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||++.... +..|++|.+....... ...+.+|+.++..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997653 7889999997754433 56788999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 141 GSLEDHLYDLEPD-----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 141 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
++|.+++...... ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999763211 477999999999999999999999988 99999999999999999999999999986544
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
...........+++.|+|||.+....++.++||||||+++|+|++ |..||...... .... .+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~-------------~~~ 221 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLE-------------YLR 221 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHH-------------HHH
Confidence 332233344567889999999988889999999999999999999 68999743211 0000 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
.......+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 222 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 -KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01122335566889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.26 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=205.4
Q ss_pred HhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
..++|++.+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999643 245799998865432 233457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEE
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 204 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl 204 (375)
.++||||+++|+|.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753211 234567788999999999999999988 999999999999999999999
Q ss_pred eecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhh
Q 017246 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 205 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~----~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK----F 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----H
Confidence 99999875332222222223345778999999998899999999999999999999 788885322110 000 0
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
. ... .....+..++..+.+++.+||+.+|++||++.++++.|....
T Consensus 234 ~---------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 V---------MDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H---------HcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 000 001123455678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=313.23 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=208.4
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+..++|++.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3456899999999999999999988778889999987643 345678899999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999652 2356899999999999999999999988 999999999999999999999999998754321
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... ... .+ .
T Consensus 157 ~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~-------------~~-~ 218 (261)
T cd05034 157 E-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE-------------QV-E 218 (261)
T ss_pred h-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-------------HH-H
Confidence 1 111112234568999999998889999999999999999999 999985322110 000 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
.......+..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011112234457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=329.04 Aligned_cols=240 Identities=26% Similarity=0.334 Sum_probs=190.3
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHH-HHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+++.. +++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 578899999865322 1222334443 457788999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence 999999854 456888999999999999999999998 999999999999999999999999998742211 12
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||....... . .. .+... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~---~~----------~i~~~--~~ 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---M---YD----------NILNK--PL 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---H---HH----------HHHhC--Cc
Confidence 2334679999999999999999999999999999999999999996322110 0 00 01110 01
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
.+++.++..+.+++.+||+.+|.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 22345677899999999999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=315.19 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=203.6
Q ss_pred hcccccceeccccceEEEEEEEc-CC---ceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SG---QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.+|++.+.||+|+||.||+|... ++ ..||+|.+.... ......+..|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45889999999999999999764 23 369999987642 23356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999864 2356889999999999999999999988 9999999999999999999999999987533
Q ss_pred CCCCceeee-ccc--cccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhcccc
Q 017246 215 VGDNTHVST-RVM--GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 215 ~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
......... ... .+..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i---------- 224 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI---------- 224 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----------
Confidence 222111111 111 2457999999998899999999999999999887 99998632211 010000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
........+..++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 225 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 ----EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111122345677889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=325.29 Aligned_cols=237 Identities=27% Similarity=0.347 Sum_probs=189.4
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHH-HHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
++||+|+||.||+|+.. +++.||+|++.+... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999865422 2223444454 467889999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999988853 456888999999999999999999988 999999999999999999999999998742211 12
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .... .+... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~----------~i~~~--~~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYD----------NILHK--PL 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHH----------HHhcC--CC
Confidence 233467999999999999989999999999999999999999999632210 0000 01111 11
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLIN 329 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~ 329 (375)
.++...+..+.+++.+||+.+|.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23455677899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.72 Aligned_cols=250 Identities=29% Similarity=0.441 Sum_probs=202.3
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEE-eeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 137 (375)
..+|.+.+.||+|+||.||++... |..+|+|.+... .....+.+|+.+++.++|+|++++++++ ...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 357899999999999999999765 788999998654 2345788999999999999999999975 455678999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999998652 2345889999999999999999999888 9999999999999999999999999987432211
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .... .+..
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~--------------~~~~ 214 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP--------------RVEK 214 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--------------HHhc
Confidence 12344668999999998889999999999999999998 99998532110 0000 0001
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
......+..++..+.+++.+||+.+|++||++.++++.|+.|
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111223456778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=311.18 Aligned_cols=251 Identities=31% Similarity=0.484 Sum_probs=206.7
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
..+|++.+.||.|+||.||++... |+.||+|.+..... ....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457899999999999999999876 78899999976543 4667889999999999999999999999899999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999652 2336899999999999999999999988 99999999999999999999999999975422111
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
...++..|+|||++....++.++||||||+++|+|++ |..||....... .. ..+...
T Consensus 158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~--------------~~~~~~ 215 (256)
T cd05039 158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV--------------PHVEKG 215 (256)
T ss_pred -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH--------------HHHhcC
Confidence 2334567999999988889999999999999999998 999986322110 00 000011
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.....+..++..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11123445678899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=311.72 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=203.7
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEccccCcc-----chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQ-----GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
++|.+.+.||+|++|.||.+.. .++..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999975 46899999998654221 23467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999864 346888999999999999999999988 999999999999999999999999998753
Q ss_pred CCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 214 PVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 214 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~--------------~~~ 218 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--A--------------IFK 218 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--H--------------HHH
Confidence 221111 11133567889999999999889999999999999999999999986321100 0 000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.........++..++..+.+++.+||..+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111223455677889999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.84 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=204.7
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|.+.+.||+|++|.||++... ++..|++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999765 68999999986542 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999753 2457889999999999999999999888 9999999999999999999999999987543222
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...... ... . .+.. .
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~----------~~~~-~ 216 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI---L----------KIIR-G 216 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH---H----------HHHc-C
Confidence 1223356889999999999988999999999999999999999999643211 000 0 0000 1
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.....+..++..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1112234567789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=331.67 Aligned_cols=250 Identities=23% Similarity=0.288 Sum_probs=197.0
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||++... +++.||+|++.... ......+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999765 68999999987532 223456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999854 456899999999999999999999998 99999999999999999999999999864321
Q ss_pred CCCc---------------------------------eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCC
Q 017246 216 GDNT---------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262 (375)
Q Consensus 216 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 262 (375)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0112357999999999999999999999999999999999999
Q ss_pred CCccccccccccchhhchhhhhhhccccchhcccccCCCCC--HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 017246 263 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPL---INDIVV 333 (375)
Q Consensus 263 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs---~~eil~ 333 (375)
.||........ . . .+........++ ..++..+.++|.+|+. +|.+|++ +.++++
T Consensus 234 ~Pf~~~~~~~~---~---~----------~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQET---Y---R----------KVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHH---H---H----------HHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99964322110 0 0 000000000111 1256678889988774 9999985 566664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.41 Aligned_cols=238 Identities=26% Similarity=0.320 Sum_probs=189.6
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHH-HHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+++.. +|+.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 689999999865422 22334445544 57789999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999988853 557899999999999999999999988 999999999999999999999999998742211 12
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... +.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~----------~~~~~--~ 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDN----------ILHKP--L 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHH----------HHcCC--c
Confidence 2334679999999999999999999999999999999999999996322110 0000 11110 1
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLIND 330 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~e 330 (375)
.+++..+..+.+++.+|++.+|.+||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 123346677889999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.50 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=204.8
Q ss_pred hhcccccceeccccceEEEEEEEc-CC---ceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SG---QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..+|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+..|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999764 33 379999986542 2335678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999864 3456899999999999999999999888 999999999999999999999999998754
Q ss_pred CCCCCcee-eeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 214 PVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 214 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
........ ......+..|+|||++....++.++|||||||++|||++ |..||...... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~---~---------- 221 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVM---K---------- 221 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---H----------
Confidence 32221111 111223457999999988889999999999999999998 99998532211 000 0
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.+........+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 222 -~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 222 -AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000111122335677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=326.26 Aligned_cols=264 Identities=26% Similarity=0.380 Sum_probs=203.7
Q ss_pred HhhcccccceeccccceEEEEEEE------cCCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEeeC-
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG- 128 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~- 128 (375)
..++|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346899999999999999999963 3478899999975432 2345678899999999 689999999987654
Q ss_pred CeeEEEEeecCCCCHHHHHhccCC--------------------------------------------------------
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEP-------------------------------------------------------- 152 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 152 (375)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 567899999999999999864221
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecc
Q 017246 153 -------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225 (375)
Q Consensus 153 -------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 225 (375)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 0124678889999999999999999988 999999999999999999999999998753222211112223
Q ss_pred ccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCH
Q 017246 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 304 (375)
Q Consensus 226 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (375)
.++..|+|||++.+..++.++||||||+++|+|++ |..||....... ... .... .......+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~----------~~~~~~~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLK----------EGTRMRAPD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHh----------ccCCCCCCC
Confidence 45678999999998899999999999999999997 888985322110 000 0000 001111223
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 305 RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 305 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
..+..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 345678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=324.91 Aligned_cols=241 Identities=27% Similarity=0.374 Sum_probs=194.8
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 135 (375)
+|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999765 68999999987542 223455677888888775 577888999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999854 456899999999999999999999988 99999999999999999999999999874322
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ..+..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~-------------~~i~~ 215 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELF-------------QSIME 215 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHH-------------HHHHh
Confidence 11 1223457999999999999989999999999999999999999999643211 000 00111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 328 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 328 (375)
. ...++..++..+.+++.+||+.+|.+|++.
T Consensus 216 ~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 H--NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C--CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1 112345667788999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=317.04 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=193.4
Q ss_pred eccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 68 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
||+|+||.||+++.. +|+.||+|.+...... ....+..|+.+++.++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999765 6899999998653222 233456699999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeee
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 223 (375)
.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence 9888642 2445888999999999999999999988 999999999999999999999999998753322 1223
Q ss_pred ccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC
Q 017246 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303 (375)
Q Consensus 224 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (375)
...|++.|+|||++.+..++.++|||||||++|||++|..||......... ..... ........ ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~----------~~~~~~~~-~~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKR----------RTLEDEVK-FEH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHH----------Hhhccccc-ccc
Confidence 456899999999999888999999999999999999999999633211110 00000 01110110 011
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 304 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 304 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..++.++.+|+.+||+.||++||++.|+++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 245778899999999999999999977663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=317.26 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=205.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..+|++.+.||.|+||.||+|... +++.|++|.+..........+.+|+.+++.+.||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 358999999999999999999754 6889999999876656667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999843 35788999999999999999999988 9999999999999999999999999987532221
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........ ... .. ....
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~----~~---------~~~~ 233 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL----IA---------TNGT 233 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH----Hh---------cCCC
Confidence 112335688999999999988899999999999999999999999963321110 000 00 0000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+...+..+.+++.+||..+|++||++.+|++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 111224456678999999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=311.12 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=196.9
Q ss_pred eeccccceEEEEEEE---cCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCC
Q 017246 67 LIGEGGFGKVYKGRL---ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 141 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 141 (375)
.||+|+||.||+|.+ .++..+|+|++..... ...+.+..|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 3578899999865432 23457888999999999999999999875 45678999999999
Q ss_pred CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCcee
Q 017246 142 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 221 (375)
Q Consensus 142 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 221 (375)
+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||.|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999853 346899999999999999999999988 99999999999999999999999999975433322111
Q ss_pred -eeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccC
Q 017246 222 -STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299 (375)
Q Consensus 222 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (375)
.....++..|+|||.+....++.++|||||||++|||++ |..||....... . ...+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~--------------~~~i~~~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V--------------TQMIESGER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H--------------HHHHHCCCC
Confidence 122234678999999988889999999999999999998 999996322110 0 011111112
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 300 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
...+..++..+.++|.+||+.+|++||++.+|.+.|++
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23455677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=323.15 Aligned_cols=268 Identities=28% Similarity=0.423 Sum_probs=223.2
Q ss_pred HHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccc-hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
..+.+...+.++||+|-||.|.++....+..||+|.++...... ...|..|+++|.+|+||||+.++++|..++.++++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34567788999999999999999999888999999998865544 47899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
+||++.|+|.+|+.+.... .+.......|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||+++-..
T Consensus 614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999775322 2444566789999999999999998 9999999999999999999999999999777
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh--CCCCccccccccccchhhchhhhhhhccccch
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.++......+.+-..+|||||.+..++++.++|||+||+++||+++ ...||..... ++.++-...++.+..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~---- 761 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQG---- 761 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCC----
Confidence 7777777777788889999999999999999999999999999887 5578853221 222222222222111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.......|.-|+..+.+++.+||..+-.+||+++++...|...
T Consensus 762 ---~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 ---RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1112234678999999999999999999999999999888765
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=330.68 Aligned_cols=256 Identities=22% Similarity=0.254 Sum_probs=200.9
Q ss_pred HHHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCC
Q 017246 54 ELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 129 (375)
Q Consensus 54 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 129 (375)
.+....++|++.+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.+++.++||||+++++.+...+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455679999999999999999999865 688999999865321 23345678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999853 35788999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccC----CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 285 (375)
+....... .......+||+.|+|||++... .++.++|||||||++|||++|..||....... ..
T Consensus 189 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~----- 256 (371)
T cd05622 189 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TY----- 256 (371)
T ss_pred eeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HH-----
Confidence 97543221 1122346799999999998754 37899999999999999999999997432110 00
Q ss_pred hccccchhcccc--cCCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 017246 286 DQKKFVHLVDPL--LHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 334 (375)
Q Consensus 286 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~eil~~ 334 (375)
..+.... +.......++..+.++|..|+..++.+ ||++.+|++.
T Consensus 257 -----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 257 -----SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -----HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0111100 001112356778899999999844443 7899988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=310.52 Aligned_cols=254 Identities=30% Similarity=0.450 Sum_probs=203.8
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.++|++.+.||+|++|.||++....+..+|+|.+.... .....+.+|+.+++.++|||++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 45799999999999999999988777789999886543 33467888999999999999999999875 46688999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999652 2345889999999999999999999888 99999999999999999999999999975432221
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... . + ...
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~----------~-~~~ 219 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLE---Q----------V-ERG 219 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H----------H-HcC
Confidence 1 1122345678999999988889999999999999999999 888986322110 000 0 0 001
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
.....+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112344667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=308.90 Aligned_cols=248 Identities=29% Similarity=0.426 Sum_probs=200.7
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHH
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 144 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 144 (375)
++||.|+||.||++....++.||+|.+...... ....+.+|+.+++.+.|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998766999999998765443 4567889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeec
Q 017246 145 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 224 (375)
Q Consensus 145 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 224 (375)
+++.. ....+++..++.++.+++.||.|||+++ ++||||||+|||++.++.++|+|||++..............
T Consensus 81 ~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99864 2346788999999999999999999888 99999999999999999999999999875432111111122
Q ss_pred cccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC
Q 017246 225 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303 (375)
Q Consensus 225 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (375)
..++..|+|||++.+..++.++|+|||||++|+|++ |..||......... ..+........+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-----------------~~~~~~~~~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-----------------ERIESGYRMPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-----------------HHHhcCCCCCCC
Confidence 234567999999988899999999999999999999 78888533211100 001111111234
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 304 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 304 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 566788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=312.54 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=204.4
Q ss_pred hhcccccceeccccceEEEEEEEc-C---CceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-S---GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..+|++.+.||+|+||.||+|... + +..+|+|.+..... .....+..|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357899999999999999999753 2 34799999865432 234578889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999964 2346899999999999999999999988 999999999999999999999999998754
Q ss_pred CCCCCcee-eeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 214 PVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 214 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
........ .....++..|+|||.+.+..++.++|+|||||++||+++ |..||....... .... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~----~~------ 223 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKA----IE------ 223 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHH----Hh------
Confidence 32221111 111233568999999998889999999999999999887 999986332111 0000 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
. ......+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 224 ---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 ---E-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---C-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 001112345677889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=309.91 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=197.0
Q ss_pred eeccccceEEEEEEEc---CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCC
Q 017246 67 LIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 142 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 142 (375)
.||+|+||.||+|.+. .+..||+|++...... ..+.+.+|+.+++.++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999653 3557999998765322 24568899999999999999999998764 57899999999999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCcee-
Q 017246 143 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV- 221 (375)
Q Consensus 143 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~- 221 (375)
|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999864 2456899999999999999999999988 99999999999999999999999999875332222111
Q ss_pred eeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 222 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 222 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....++..|+|||++....++.++|||||||++|+|++ |..||....... ....+......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----------------VMSFIEQGKRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----------------HHHHHHCCCCC
Confidence 111223578999999988889999999999999999996 999996332111 00011111122
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
..+..++.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34556788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=307.98 Aligned_cols=247 Identities=29% Similarity=0.436 Sum_probs=198.9
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHH
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 144 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 144 (375)
++||+|+||.||+|...++..+|+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 469999999999998878899999998765332 2346788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeec
Q 017246 145 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 224 (375)
Q Consensus 145 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 224 (375)
+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........ .....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 98854 2345789999999999999999999888 99999999999999999999999999865322111 11112
Q ss_pred cccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC
Q 017246 225 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303 (375)
Q Consensus 225 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (375)
..++..|+|||++.+..++.++||||||+++|++++ |..||....... ... .+........+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~--------------~~~~~~~~~~~ 216 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---ARE--------------QVEKGYRMSCP 216 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH--------------HHHcCCCCCCC
Confidence 334667999999998889999999999999999999 999986322110 000 00011111234
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 304 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 304 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=312.16 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=206.3
Q ss_pred HhhcccccceeccccceEEEEEEEcC----CceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
...+|.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.+++.+.||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34578899999999999999997542 3468999887654 3345678899999999999999999998875 5678
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 99999999999999964 2346899999999999999999999888 99999999999999999999999999875
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
.... .........++..|+|||.+....++.++||||||+++|||++ |..||........ ... ..
T Consensus 157 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~----~~------ 222 (270)
T cd05056 157 LEDE-SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGR----IE------ 222 (270)
T ss_pred cccc-cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HH------
Confidence 4322 1112222334568999999988889999999999999999996 9999964322110 000 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.......+..++..+.+++.+|+..+|++||++.++++.|+++...
T Consensus 223 ----~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 223 ----NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011123456678899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=346.04 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=207.0
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|... +|+.||+|++...... ...++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47999999999999999999765 5899999998754222 2456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 136 EYMPMGSLEDHLYDLEP-------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
||++|++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 1234567788999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCC----------------CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccc
Q 017246 209 LAKLGPVGD----------------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 272 (375)
Q Consensus 209 ~a~~~~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 272 (375)
++....... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 997541110 0011123579999999999999999999999999999999999999996422111
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhhhhhcc
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQR 342 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~eil~~L~~l~~~~ 342 (375)
. .+. . .+..+.. ......++..+.+++.+|++.||++|| +++++++.|+......
T Consensus 239 i----~~~-~---------~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 I----SYR-D---------VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred h----hhh-h---------hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0 000 0 0000000 001134567789999999999999995 6777888888876543
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.65 Aligned_cols=259 Identities=27% Similarity=0.456 Sum_probs=204.5
Q ss_pred hhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|++.+.||+|+||.||++... ++..||+|++..... .....+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999753 467899999875432 2345688899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEP------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 193 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~N 193 (375)
+++|||+++++|.+++..... ....+++..++.++.||+.||.|||.++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999974321 1234788899999999999999999888 9999999999
Q ss_pred EEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCcccccccc
Q 017246 194 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQG 272 (375)
Q Consensus 194 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 272 (375)
||++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999874322221111222334667999999988899999999999999999998 88888532111
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
.... ... .... ...+..++..+.+++.+||+.+|++||++.||++.|++
T Consensus 240 --~~~~----~~~---------~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EVIY----YVR---------DGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHH----HHh---------cCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0000 000 0000 11234567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=322.22 Aligned_cols=255 Identities=21% Similarity=0.216 Sum_probs=196.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36899999999999999999865 58999999986532 223455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999954 2456899999999999999999999998 99999999999999999999999999864322
Q ss_pred CCCceeeecccccccccccccccc-----CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
... .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||....... ....... ....
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~-~~~~ 226 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMN-HKEH 226 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHc-CCCc
Confidence 211 11223569999999999873 457889999999999999999999996322110 0000000 0000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCC--CCCCHHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN--FRPLINDIVVA 334 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPs~~eil~~ 334 (375)
. .+ ......++..+.+++.+|+..+++ .||++.++++.
T Consensus 227 ~-----~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 F-----QF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c-----cC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 00 011123677788899887765444 37899999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=318.54 Aligned_cols=265 Identities=25% Similarity=0.365 Sum_probs=199.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.+|.+.+.||+|+||.||+|+.. ++..||+|.+...... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46999999999999999999765 6888999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++ +|.+++.. .+..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 88888754 2445888999999999999999999988 9999999999999999999999999987532221
Q ss_pred Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hch-------hhhhhhcc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS-------RPFLKDQK 288 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~-------~~~~~~~~ 288 (375)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ... .+......
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 11223467899999998865 46889999999999999999999999643322110000 000 00000000
Q ss_pred ccchhcccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KFVHLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......+.... .....++.++.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 011245678899999999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=311.57 Aligned_cols=251 Identities=30% Similarity=0.454 Sum_probs=196.9
Q ss_pred ceeccccceEEEEEEEc-CCc--eEEEEEccccC-ccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQ--LVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
++||+|+||.||+|... ++. .+++|.+.... ....+.+.+|+.++..+ .||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36999999999999865 343 46888886532 23345788899999999 799999999999999999999999999
Q ss_pred CCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 141 GSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 141 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
++|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999965321 1235789999999999999999999888 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
++..... .........+..|+|||++....++.++|||||||++|||++ |..||....... .. .
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~---~------ 222 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---E------ 222 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HH---H------
Confidence 9853211 111111234567999999988889999999999999999997 999985322110 00 0
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
.+........+..++..+.+++.+||+.+|.+||++.+++..|+++.
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 -----KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00011111223345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=309.54 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=206.2
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+..++|++.+.||+|+||.||++....+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3456899999999999999999987777889999886542 335678889999999999999999999887 77899999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999652 3456788899999999999999999888 999999999999999999999999998754322
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. .......++..|+|||++....++.++|+|||||++|++++ |+.||....... .... ..
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~~---------- 217 (260)
T cd05073 156 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA----LE---------- 217 (260)
T ss_pred Cc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----Hh----------
Confidence 21 11122345678999999998889999999999999999999 899986322110 0000 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.......+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0011112345667899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=314.05 Aligned_cols=271 Identities=25% Similarity=0.408 Sum_probs=204.4
Q ss_pred hcccccceeccccceEEEEEEE-----cCCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeC--Cee
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQR 131 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 131 (375)
..|++.+.||+|+||.||+++. .++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478899999999999999974 357889999987543 23345788999999999999999999998775 568
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 899999999999999854 2345899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
........ .......++..|+|||++.+..++.++|||||||++|||++++.|+.................. . ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~ 235 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM-T-VTRL 235 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc-c-HHHH
Confidence 54332221 1222355777899999998888999999999999999999987764321100000000000000 0 0000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
...+........+..++..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001111111122345778899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=324.39 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=196.1
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCC-----
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----- 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 129 (375)
..++|++.+.||+|+||.||++... +|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999764 68999999986542 233456788999999999999999999986543
Q ss_pred -eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 130 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 130 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 47899999965 6666662 24788899999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc---------
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW--------- 279 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~--------- 279 (375)
++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .....
T Consensus 169 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~ 243 (359)
T cd07876 169 LARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--QWNKVIEQLGTPSA 243 (359)
T ss_pred Ccccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCcH
Confidence 9974321 112233568999999999999999999999999999999999999997432110 00000
Q ss_pred ---------hhhhhhhcccc-----chhcccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 280 ---------SRPFLKDQKKF-----VHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 280 ---------~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...+....... ......... .......+..+.+||.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000 000000000 0011234567899999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=311.94 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=207.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCc----eEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..+|++.+.||+|+||.||+|... +|. .+|+|.+..... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 457899999999999999999754 333 589998876543 234578889999999999999999999887 7889
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999865 2345899999999999999999999888 99999999999999999999999999976
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..............++..|+|||.+....++.++|+||||+++|||++ |..||....... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~ 221 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----------------IP 221 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HH
Confidence 443322222222234568999999988889999999999999999999 999986432111 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
..+........+..++..+.+++.+||..+|++||++.++++.|+.+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 011111111223446678899999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=309.98 Aligned_cols=248 Identities=29% Similarity=0.376 Sum_probs=208.0
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHH---HHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.-++|..+++||+|.||.|.+++.+ +++.||||+++++..-...+ -+-|-.+|+..+||.+..+...|...+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467889999999999999999755 79999999998876554444 3458889999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||..||.|.-+|.. ...+++...+.+-..|+.||.|||+++ ||+||||.+|+|+|.+|++||+|||+++..
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999998854 567899999999999999999999988 999999999999999999999999999853
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
- ........+||||.|+|||++.+..|..++|+|.+||+||||++|+.||.... ...+..+
T Consensus 319 I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----------------h~kLFeL 379 (516)
T KOG0690|consen 319 I--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----------------HEKLFEL 379 (516)
T ss_pred c--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----------------hhHHHHH
Confidence 2 22334566999999999999999999999999999999999999999995211 1111111
Q ss_pred -cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 294 -VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 294 -~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
+.. .-.+|..++++...|+...|.+||.+|. .+.||.+
T Consensus 380 Il~e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 380 ILME--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHhh--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 111 1256788889999999999999999995 4555554
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=349.11 Aligned_cols=262 Identities=22% Similarity=0.320 Sum_probs=202.4
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee--CCee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQR 131 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 131 (375)
....+|++.+.||+|+||.||++... ++..||+|++..... .....+..|+.++..++||||++++++|.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999765 578899999875432 234568889999999999999999998854 3568
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC----CCcccCCCCCCcEEEeC---------
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN----PPVIYRDLKSANILLDN--------- 198 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~----~~i~H~Dlkp~Nill~~--------- 198 (375)
||||||+++++|.++|.........+++..++.|+.||+.||.|||..+. .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997644445679999999999999999999997431 33999999999999964
Q ss_pred --------CCceEEeecCCCccCCCCCCceeeecccccccccccccccc--CCCCccchhHhHHHHHHHHHhCCCCcccc
Q 017246 199 --------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLS 268 (375)
Q Consensus 199 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~ 268 (375)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999997532221 2234579999999999864 45889999999999999999999999632
Q ss_pred ccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhhh
Q 017246 269 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYL 338 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~--~L~~l 338 (375)
... ..+... +... +.+ .....+..+.+||..||+.+|.+||++.+++. .|..+
T Consensus 247 ~~~-----~qli~~-lk~~--------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 247 NNF-----SQLISE-LKRG--------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcH-----HHHHHH-HhcC--------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 211 000000 0000 000 11234678999999999999999999999994 44444
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=320.37 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=193.4
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
....+|++.+.||+|+||.||+|... ++..||+|+.... ....|+.+++.++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 33567999999999999999999865 5788999975433 2346899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|++. ++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 588888854 3456899999999999999999999988 99999999999999999999999999874221
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCC-ccccccccccc-------hhhchhhhhhhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQGEQN-------LVSWSRPFLKDQ 287 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-f~~~~~~~~~~-------~~~~~~~~~~~~ 287 (375)
. .......||+.|+|||++.+..++.++|||||||++|||+++..| |.......... +...........
T Consensus 210 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 210 A---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred C---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 1 112235689999999999999999999999999999999996554 43221111000 000000000000
Q ss_pred ccc---------chhcc--cccCCCC-------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKF---------VHLVD--PLLHGRY-------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~---------~~~~~--~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..+ ...+. ......+ ...++..+.+||.+||+.||.+|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 000 00000 0000000 0134556778999999999999999999993
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=315.25 Aligned_cols=251 Identities=28% Similarity=0.429 Sum_probs=201.0
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.|++.+.||+|+||.||++... +++.||+|.+....... ...+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3777899999999999999765 68999999986543222 2456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+.+++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999988652 2346899999999999999999999888 999999999999999999999999998653221
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||............ .. ...
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~----------~~~- 218 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ER----------LVK- 218 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hh----------hhh-
Confidence 1 112346899999999999989999999999999999999999999743211100000 00 000
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~ 333 (375)
.....++..++..+.+|+.+||+.||++||+ +.++++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 219 EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011234456678899999999999999999 888885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=313.86 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=202.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.+.|++.+.||.|+||.||+|+.. ++..+++|.+..........+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999875 5899999999776555567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|..++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999888754 2346899999999999999999999888 999999999999999999999999998642211
Q ss_pred Cceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 218 NTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
........+++.|+|||++. ...++.++|||||||++|||++|..||...... ..... ...
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~------- 229 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK----IAK------- 229 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHH----Hhc-------
Confidence 11123356888999999885 345788999999999999999999998632211 00000 000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...+ ....+..++..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 230 SEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 01123456678899999999999999999999984
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=325.51 Aligned_cols=262 Identities=21% Similarity=0.229 Sum_probs=195.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
...|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|+.+++.++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 347999999999999999999865 588899996432 2356799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+. ++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 94 689888854 2346899999999999999999999988 9999999999999999999999999997543322
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCc-ccccccccc----chhhchhhhhhhccccc-
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM-DLSKGQGEQ----NLVSWSRPFLKDQKKFV- 291 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf-~~~~~~~~~----~~~~~~~~~~~~~~~~~- 291 (375)
.........||+.|+|||++.+..++.++|||||||++|||++|..|+ ......... .+.............+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 222233467999999999999999999999999999999999988654 322111110 11110000000000000
Q ss_pred --------hhc---ccccCCCCC-------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 --------HLV---DPLLHGRYP-------RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 --------~~~---~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... ......... ......+.+||.+||+.||.+||++.|+|+
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 000000000 123457889999999999999999999994
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=314.25 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=205.3
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..+|.+.+.||.|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46899999999999999999975 47999999999766555566788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999843 45788999999999999999999988 9999999999999999999999999986532221
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|..||........ ... . .....
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~-----------~--~~~~~ 232 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL-----------I--ATNGT 232 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee-----------e--ccCCC
Confidence 112335688999999999988899999999999999999999999964221110 000 0 00000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+...+..+.+++.+||+.+|++||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011124456778899999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=315.50 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=201.4
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 6899999999999999999765 688899998865422 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||||+|||++.++.++|+|||++......
T Consensus 82 ~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 82 DGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999964 3568899999999999999999997 46 999999999999999999999999998643211
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc----------
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ---------- 287 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 287 (375)
......|++.|+|||++.+..++.++|+|||||++|+|++|+.||......................
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1234578999999999988889999999999999999999999986332111110000000000000
Q ss_pred ------cccchhcccc---cCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 288 ------KKFVHLVDPL---LHGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 288 ------~~~~~~~~~~---~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.......+.. .....+ ..++.++.+++.+||+.+|++||++.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 001111 2356789999999999999999999999953
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=320.79 Aligned_cols=255 Identities=21% Similarity=0.215 Sum_probs=196.8
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36899999999999999999865 57889999986432 122344778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999964 2356899999999999999999999988 99999999999999999999999999864322
Q ss_pred CCCceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
. ........+||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...........
T Consensus 155 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~- 226 (332)
T cd05623 155 D-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKER- 226 (332)
T ss_pred C-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCcc-
Confidence 1 122223457999999999986 3468899999999999999999999996322110 00000000000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 334 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~eil~~ 334 (375)
.........++..+.+|+.+|+..++++ |+++.++++.
T Consensus 227 ------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 ------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000112345778899999988665444 6899999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=307.60 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=200.1
Q ss_pred ceeccccceEEEEEEEcC--C--ceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLES--G--QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|++|.||+|.+.. + ..||+|.+..... .....+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997642 3 3689999987765 456678899999999999999999999988 889999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976321 56899999999999999999999988 9999999999999999999999999997643322211
Q ss_pred -eeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 221 -VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 221 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ... .... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~----------~~~ 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---KIDK----------EGE 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHh----------cCC
Confidence 1223457789999999998899999999999999999999 999986322111 000 0000 001
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=312.10 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=200.3
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
-|++.+.||.|+||.||++... ++..+++|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 4788899999999999999865 578899999876555556678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|..++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..... ..
T Consensus 86 ~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~ 157 (282)
T cd06643 86 GGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TI 157 (282)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc--cc
Confidence 9999988754 2456899999999999999999999988 99999999999999999999999999865322 11
Q ss_pred eeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 220 HVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.......+++.|+|||++. +..++.++|||||||++|||++|.+||....... .... ... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~----~~~-------~~ 224 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLK----IAK-------SE 224 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHH----Hhh-------cC
Confidence 2223456899999999884 3457889999999999999999999986322110 0000 000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
.+ ....+..++..+.++|.+||+.+|++||++.+++
T Consensus 225 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 225 PP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 00 0112345677899999999999999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=306.65 Aligned_cols=254 Identities=28% Similarity=0.362 Sum_probs=206.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|++.+.||.|+||.||+|... +++.+++|++..........+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357999999999999999999764 5788999999876555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+.+++|.+++.. ....+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~- 154 (262)
T cd06613 82 CGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT- 154 (262)
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh-
Confidence 999999998864 2357899999999999999999999988 999999999999999999999999998753221
Q ss_pred CceeeeccccccccccccccccC---CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
........++..|+|||.+... .++.++|+||||+++|+|++|..||........ ... .. .. ...
T Consensus 155 -~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~----~~--~~---~~~ 222 (262)
T cd06613 155 -IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL----IS--KS---NFP 222 (262)
T ss_pred -hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HH--hc---cCC
Confidence 1122335688899999998776 789999999999999999999999863221110 000 00 00 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ....+...+..+.+++.+||+.+|.+||++.+|+.
T Consensus 223 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PP--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Cc--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 11123456778999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=312.63 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=200.6
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
|+..+.||+|+||.||++... +++.||+|.+...... ....+.+|+.+++.++|+||+++++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677899999999999999764 6899999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999988652 2446999999999999999999999988 9999999999999999999999999986532211
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||.......... .... .....
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~~~~----------~~~~~- 220 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--EVDR----------RVLET- 220 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHH----------hhhcc-
Confidence 1223568999999999998899999999999999999999999996432111000 0000 00000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVVA 334 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~~ 334 (375)
...++..++..+.+|+..||+.+|++||+ +.+++..
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 -EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11234456678899999999999999999 6777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=336.82 Aligned_cols=268 Identities=26% Similarity=0.408 Sum_probs=224.7
Q ss_pred hhcccccceeccccceEEEEEEEc----CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.....+.++||.|.||.|++|+++ ....||||.++.... +....|+.|+.||-++.||||+++.|+........|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 445678899999999999999875 245799999987543 345679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
|.|||+.|+|..||+. +.+.++..++..++..|+.||+||-+.+ +|||||...||||+.+..+|++|||+++..
T Consensus 708 iTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999986 3355888999999999999999999988 999999999999999999999999999875
Q ss_pred CCCCCceeeeccc--cccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhcccc
Q 017246 214 PVGDNTHVSTRVM--GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 214 ~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
.+.... ..+... -..+|.|||.+...+++.+|||||+|++|||.++ |..||..... ++.
T Consensus 782 edd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----------------QdV 843 (996)
T KOG0196|consen 782 EDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------------QDV 843 (996)
T ss_pred ccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----------------HHH
Confidence 433311 122222 2568999999999999999999999999999998 9999853221 222
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCC
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRN 350 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~ 350 (375)
.+-++.-.+...|.+|+..|.+|++.||++|..+||.|.+|+..|++|+...++.....+
T Consensus 844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~ 903 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAP 903 (996)
T ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCC
Confidence 233444445566889999999999999999999999999999999999988777554443
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=310.08 Aligned_cols=252 Identities=29% Similarity=0.400 Sum_probs=198.8
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeC------C
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG------D 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~ 129 (375)
+.+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++..+ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3567889999999999999999765 58899999986543 3456778899999888 799999999998653 4
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..+++|||+.+++|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 688999999999999998652 2456889999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhh
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 284 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 284 (375)
+...... ........|++.|+|||++. +..++.++|||||||++|||++|..||......... ..
T Consensus 158 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~--------~~ 227 (272)
T cd06637 158 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--------FL 227 (272)
T ss_pred ceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH--------HH
Confidence 8753221 11223467899999999986 345888999999999999999999999632211100 00
Q ss_pred hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..........+..++..+.+|+.+||+.+|.+||++.++++
T Consensus 228 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 --------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000011112345678899999999999999999999984
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.83 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=218.9
Q ss_pred HHHHHHhhcccccceeccccceEEEEEEEc---CC--ceEEEEEccc-cCccchHHHHHHHHHHccCCCCCcceeEeEEe
Q 017246 53 RELAIATRNFREANLIGEGGFGKVYKGRLE---SG--QLVAIKQLNH-EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126 (375)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~--~~vaiK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 126 (375)
++..+......+.+.||.|-||.||.|.+. .| -.||||..+. ....+.+.|..|+.+++.++||||++++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 344455556677889999999999999743 23 3589999877 45566788999999999999999999999987
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
+ ...|||||.++-|.|..||.. .+..++......++.||..||.|||+++ +|||||...||||...--|||+|
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred c-cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence 6 678999999999999999976 5677899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhh
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK 285 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 285 (375)
||+++........ ..+...-..-|||||-+.-..++.+||||.|||.|||++. |..||......+
T Consensus 535 FGLSR~~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------------- 600 (974)
T KOG4257|consen 535 FGLSRYLEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------------- 600 (974)
T ss_pred cchhhhccccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------------
Confidence 9999875443332 2223334568999999999999999999999999999998 999997433221
Q ss_pred hccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
.--.+...-+..+|+.|++.|+.|+.+||..+|.+||++.+|...|..+..
T Consensus 601 ----VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 601 ----VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111223333446789999999999999999999999999999999988876
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=310.81 Aligned_cols=252 Identities=33% Similarity=0.506 Sum_probs=200.6
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCccchH--HHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
|++.+.||+|+||.||+++.. +++.||+|++......... ....|+.+++.++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 778999999999999999876 4678999999876544332 2356999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
.+++|.+++. ....+++..++.++.||+.||.+||+++ |+|+||||+|||++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 9999999996 2567899999999999999999999998 999999999999999999999999998743 222
Q ss_pred ceeeeccccccccccccccc-cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 THVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
........++..|+|||++. +..++.++||||||+++|+|++|..||............. .... .......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~-----~~~~~~~ 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILK-----RPLPSSS 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHH-----THHHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccc-----ccccccc
Confidence 23344567899999999998 7889999999999999999999999997441111110000 0000 0000000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.........+.+++.+||+.+|++||++.++++
T Consensus 224 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 ---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001112378999999999999999999999983
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=307.07 Aligned_cols=249 Identities=29% Similarity=0.466 Sum_probs=197.6
Q ss_pred ceeccccceEEEEEEEc-C---CceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-S---GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|... . +..+|+|.+...... ....+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999643 2 368999998765432 3456888999999999999999999876 4568999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
++|.+++.. ...+++..++.++.|++.||.|||..+ ++|+||||+|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999964 347899999999999999999999888 9999999999999999999999999987543322211
Q ss_pred e-eeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 221 V-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 221 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ....+ +....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~--------------~~~~~ 215 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAM--------------LESGE 215 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH--------------HHcCC
Confidence 1 111223567999999998899999999999999999998 99999643211 11110 00011
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
....+..++..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11234556778999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=314.74 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=204.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCc----eEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..+|+..+.||+|+||.||+|... +|. .+|+|.+...... ....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457888999999999999999753 444 4788988654332 234678899999999999999999998654 567
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999864 2346888999999999999999999888 99999999999999999999999999975
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~----~~~------ 225 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPD----LLE------ 225 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHH------
Confidence 433222212222345778999999998899999999999999999998 889986322111 100 011
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.......+..++..+.+++.+||..+|++||++.++++.|..+.....
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 226 ----KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred ----CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 001111233456788999999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.74 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=198.1
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEcccc--CccchHHHHHHHHHHccCCCCCcceeEeEEeeCC-----eeE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRL 132 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 132 (375)
+|++.+.||+|+||.||++... +++.||||++... .......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999764 6899999998653 2233456888999999999999999999998776 789
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 578887743 567899999999999999999999988 99999999999999999999999999975
Q ss_pred CCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hchh-----hhhh
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSR-----PFLK 285 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~-----~~~~ 285 (375)
...... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||...........+ .... .+..
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 432221 122334678999999998864 4789999999999999999999999643321110000 0000 0000
Q ss_pred hccccchhc-ccccC-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 286 DQKKFVHLV-DPLLH-------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 286 ~~~~~~~~~-~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
........+ ..... .......+..+.+||.+||+.||++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 00000 01123346788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=313.71 Aligned_cols=262 Identities=24% Similarity=0.304 Sum_probs=193.8
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccC---CCCCcceeEeEEee-----CC
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL---HHDNLVTLIGYCTS-----GD 129 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 129 (375)
+|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999765 6899999998754222 223455677666655 79999999998764 34
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..+++|||+.+ +|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999975 898888652 2345899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchhhhhhhcc
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKDQK 288 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 288 (375)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||......... ......... ...
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~--~~~ 229 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP--PED 229 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC--Chh
Confidence 87543221 123356899999999999889999999999999999999999999643221100 000000000 000
Q ss_pred ccc-------hhcccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KFV-------HLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~~-------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+. ....+... ....+.++..+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000 0112345678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=331.89 Aligned_cols=263 Identities=20% Similarity=0.309 Sum_probs=190.1
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC------CCCcceeEeEEeeC-
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH------HDNLVTLIGYCTSG- 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~- 128 (375)
...++|++.+.||+|+||.||+|... +++.||||+++... ........|+.++..++ |.++++++++|...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 44678999999999999999999764 58899999986432 22334455666666664 45688888888764
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCC-------
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDF------- 200 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~------- 200 (375)
...|+|||++ +++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 5788999988 7789998854 4578999999999999999999997 47 99999999999998765
Q ss_pred ---------ceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccc
Q 017246 201 ---------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 271 (375)
Q Consensus 201 ---------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 271 (375)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||+.....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886321 1223467999999999999999999999999999999999999999754321
Q ss_pred cccchhh---------chh--------hhhhhccccchhccc-----ccCCC-C-CHHHHHHHHHHHHhhcCCCCCCCCC
Q 017246 272 GEQNLVS---------WSR--------PFLKDQKKFVHLVDP-----LLHGR-Y-PRRCLNYAVAVTAMCLNEEANFRPL 327 (375)
Q Consensus 272 ~~~~~~~---------~~~--------~~~~~~~~~~~~~~~-----~~~~~-~-~~~~~~~l~~li~~cl~~~p~~RPs 327 (375)
.....+. |.. .++...........+ ..... . .......+.+||.+||+.||++||+
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1100000 000 000000000000000 00000 0 0012356789999999999999999
Q ss_pred HHHHHH
Q 017246 328 INDIVV 333 (375)
Q Consensus 328 ~~eil~ 333 (375)
+.|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999995
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=309.04 Aligned_cols=255 Identities=26% Similarity=0.357 Sum_probs=193.0
Q ss_pred ceeccccceEEEEEEEc---CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCC
Q 017246 66 NLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 141 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 141 (375)
+.||+|+||.||+|... ++..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999754 346799998876432 23346788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 142 SLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 142 sL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
+|.+++..... .....++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 2234567788899999999999999988 9999999999999999999999999987532222222
Q ss_pred eeeccccccccccccccccC-------CCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccch
Q 017246 221 VSTRVMGTYGYCAPEYAMSG-------KLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
......++..|+|||++.+. .++.++||||||+++|||++ |..||....... ...+. . ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~--~---~~~~-- 227 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT--V---REQQ-- 227 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH--h---hccc--
Confidence 22335678899999988642 35789999999999999996 999996432211 00000 0 0000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
............+..+.+++..|| .+|++||++++|++.|.
T Consensus 228 --~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 --LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 011111122345667888999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=323.82 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=196.7
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeC------
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------ 128 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 128 (375)
..++|++.+.||+|+||.||++... .++.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999754 688999999875422 2345677899999999999999999988643
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 357899999965 6766663 24788899999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hh----------
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LV---------- 277 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~---------- 277 (375)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ..
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99753221 12234578999999999999999999999999999999999999996432111000 00
Q ss_pred -----hchhhhhhhccccchhc-----cccc---CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 278 -----SWSRPFLKDQKKFVHLV-----DPLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 278 -----~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+.........+. .... ....+......+.+||.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00000000000000000 0000 00112234567899999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=310.20 Aligned_cols=252 Identities=28% Similarity=0.439 Sum_probs=199.1
Q ss_pred ceeccccceEEEEEEEcC-------CceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 66 NLIGEGGFGKVYKGRLES-------GQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999997542 2579999886543 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-----ceEEeecCC
Q 017246 138 MPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-----NPKLSDFGL 209 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-----~vkl~Dfg~ 209 (375)
+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||||+|||++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 2245788999999999999999999888 99999999999999877 899999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhcc
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
+................++..|+|||++.+..++.++|||||||++|+|++ |..||....... ... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~----~~---- 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQ----HV---- 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHH----HH----
Confidence 875433222222223345778999999999999999999999999999998 999986322110 000 00
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
........+..++..+.+++.+||+.+|++||++.+|++.|.+
T Consensus 227 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 ------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0011112345567889999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=310.45 Aligned_cols=253 Identities=28% Similarity=0.373 Sum_probs=201.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357889999999999999999754 6899999998766545556678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~-- 158 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA-- 158 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC--
Confidence 999999999854 456899999999999999999999988 99999999999999999999999999865322
Q ss_pred Cceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.........|++.|+|||++. ...++.++|+|||||++|+|++|..||........ ... .. .. ...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~----~~--~~---~~~ 227 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL----MT--KS---NFQ 227 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHh----hh--cc---CCC
Confidence 112223457899999999874 45688999999999999999999999853221110 000 00 00 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+.... ...++..+.+++.+||+.+|++||++.+|++
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000100 1134567899999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=313.18 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=204.6
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.+|++.+.||.|+||.||++.. .+++.|++|.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999975 468999999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++++|..++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~- 169 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ- 169 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc-
Confidence 99999998843 45899999999999999999999998 9999999999999999999999999987532221
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ..... ....
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~---------~~~~ 233 (296)
T cd06655 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIAT---------NGTP 233 (296)
T ss_pred -ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh---------cCCc
Confidence 1123356889999999999888999999999999999999999999643211100 00000 0000
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+..++..+.++|.+||..+|++||++.+|+.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11123456778999999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=305.67 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=202.1
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
.+|++.+.||.|+||.||++...++..+|+|.+.... .....+..|+.+++.++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688899999999999999987778889999886543 334578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 155 (256)
T cd05112 83 HGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-Y 155 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-c
Confidence 9999999864 2345789999999999999999999888 9999999999999999999999999987532211 1
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......++..|+|||++.+..++.++||||||+++|||++ |..||....... .... +....
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----------~~~~-------~~~~~ 218 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE----------VVET-------INAGF 218 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----------HHHH-------HhCCC
Confidence 11122335678999999998889999999999999999998 999986322110 0000 00001
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 335 (375)
....+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1111233567899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=311.76 Aligned_cols=271 Identities=30% Similarity=0.452 Sum_probs=207.8
Q ss_pred hcccccceeccccceEEEEEEEc-----CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEee--CCee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQR 131 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 131 (375)
..|.+.+.||+|+||.||++... ++..+|+|++...... ....+.+|+.+++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999753 3688999999765443 45678899999999999999999999877 5678
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
+++|||+++++|.+++... ...+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999652 335899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCCce-eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+............. . ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~~~~ 235 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIVTRL 235 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccHHHH
Confidence 654222211 1112345667999999988889999999999999999999999885432211000000 0 000000001
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
...+........+..++..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111112223455678899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=307.52 Aligned_cols=249 Identities=28% Similarity=0.445 Sum_probs=201.7
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCccc---------hHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
+|.+...||.|++|.||+|... +++.||+|.+....... ...+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999764 58899999886543322 2457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999954 356888999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCC----CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 211 KLGPVGD----NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 211 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
+...... .........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...... . ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~-------~~~-- 222 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--Q-------AIF-- 222 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--H-------HHH--
Confidence 7543211 111122346888999999999888999999999999999999999999632210 0 000
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... ......+..++..+.+++.+||+.+|++||++.+|++
T Consensus 223 -----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 -----KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 1122334567788999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=310.32 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=197.2
Q ss_pred cccccceeccccceEEEEEEE-cCCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+|++.++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 678899999999999999975 468999999986542 233456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999986542 3678889999999999999999988 999999999999999999999999998753221
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
......|+..|+|||++.+..++.++|||||||++|+|++|..||............. .. ...+.....
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~------~~~~~~~~~ 217 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL---QL------LQCIVDEDP 217 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH---HH------HHHHhccCC
Confidence 1233578999999999999899999999999999999999999996422211100000 00 000000000
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........+..+.+++.+||+.+|++||+++++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11112335667899999999999999999999994
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=305.94 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=201.0
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee-CCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 136 (375)
+|++.+.||+|++|.||++... +++.||+|.+..... .....+.+|+.+++.++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999765 578999999865432 334567889999999999999999998764 446789999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++... ....+++..++.++.|++.||.+||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999652 2456899999999999999999999988 999999999999999999999999998754221
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. .......+++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....... ..
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~----------~~ 217 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRII----------EG 217 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH----------hc
Confidence 1 2223456899999999999999999999999999999999999998632210 0000000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. ....+...+..+.+++.+||+.+|++||++.++++
T Consensus 218 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 218 K-LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred C-CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 11234567788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=329.21 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=207.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.+-|+|+..||.|+||.||++..+ ++-..|.|+|........+.+.-|++||..+.||+||++++.|..++.++|+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 345788899999999999999765 4556678998777777788899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
|.||-+...+... +..|++.++..++.|++.||.|||+++ |||||||..|||++-+|.++|+|||.+-.. ..
T Consensus 111 C~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~ 182 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN--KS 182 (1187)
T ss_pred cCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc--hh
Confidence 9999999888763 567999999999999999999999998 999999999999999999999999987532 22
Q ss_pred Cceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 218 NTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.......+.|||.|||||+++ +.+|+.++||||||++|.||..+.+|-...+.. . ..++ +..
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------R---VllK----iaK 249 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------R---VLLK----IAK 249 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------H---HHHH----Hhh
Confidence 223345689999999999875 568999999999999999999999997532221 1 0111 000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
--.+.+ --|..++..+.+++.+||.+||+.||++.+|++
T Consensus 250 SePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 250 SEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 001111 125678889999999999999999999999985
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=305.41 Aligned_cols=249 Identities=27% Similarity=0.350 Sum_probs=204.8
Q ss_pred hcccccceeccccceEEEEEEEcC-CceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
++|++.+.||.|+||.||+|.... +..+++|.+..... ...+.+|+.+++.++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578999999999999999998764 88999999876532 678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
.+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999854 3457899999999999999999999888 9999999999999999999999999987543221
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||......... .. ... ....
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---------~~----~~~--~~~~ 217 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---------FM----IPN--KPPP 217 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---------hh----hcc--CCCC
Confidence 1223355888999999999889999999999999999999999999642211100 00 000 0000
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+..++..+.+++.+||+.+|++||++.+|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11123456678999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=307.13 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=201.8
Q ss_pred cccccceeccccceEEEEEEEcCCceEEEEEccccCcc------chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
+|++.+.||+|+||.||+|...+++.+|+|.+...... ....+.+|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47889999999999999998878999999988653221 224578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999954 346889999999999999999999888 9999999999999999999999999986432
Q ss_pred CC----CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 215 VG----DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 215 ~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
.. ..........|+..|+|||++.+..++.++|||||||++|+|++|..||........ .. ... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~-----~~~---~- 222 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MF-----YIG---A- 222 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HH-----Hhh---h-
Confidence 11 111122335689999999999988899999999999999999999999963211100 00 000 0
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........+..++..+.++|.+||+.+|++||++.++++
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 ----HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000111234556788999999999999999999999984
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=311.60 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=203.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|++.+.||.|+||.||++... ++..+|+|.+..........+..|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457999999999999999999764 6899999998766555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999864 2356899999999999999999999988 9999999999999999999999999886532211
Q ss_pred Cceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 218 NTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.......+++.|+|||++. ...++.++|+||||+++|+|++|+.||....... ... .. ..
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~----~~-------~~ 222 (280)
T cd06611 158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLL----KI-------LK 222 (280)
T ss_pred --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHH----HH-------hc
Confidence 1223356899999999875 3457789999999999999999999996332110 000 00 00
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...+. ...+..++..+.+++.+||+.+|++||++.++++
T Consensus 223 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 223 SEPPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCCCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00000 1123456778999999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.72 Aligned_cols=252 Identities=29% Similarity=0.451 Sum_probs=193.0
Q ss_pred ceeccccceEEEEEEEc----CCceEEEEEcccc-CccchHHHHHHHHHHccCCCCCcceeEeEEe-eCCeeEEEEeecC
Q 017246 66 NLIGEGGFGKVYKGRLE----SGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT-SGDQRLLVYEYMP 139 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 139 (375)
+.||+|+||.||+|... .+..+|+|.+... .......+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2457999988543 2234567788999999999999999999765 4556889999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999964 2334677888999999999999999888 999999999999999999999999998743221111
Q ss_pred --eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhC-CCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 220 --HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 220 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
.......++..|+|||.+.+..++.++|||||||++|||++| .+||...... ..... . ..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~----~----------~~ 217 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVY----L----------LQ 217 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----H----------hc
Confidence 111223467789999999888899999999999999999995 5566422110 00000 0 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
......+..++..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00111123456789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=304.70 Aligned_cols=251 Identities=27% Similarity=0.361 Sum_probs=212.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..-|.+.++||+|+||.||++.++ +|+.+|||.+..+ .+.+++..|+.++.++..|++|++|+.+.....+||||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 345788999999999999999655 7999999998654 5788999999999999999999999999888999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
|-.|++.+.++. .++++++.++..++...+.||+|||... -+|||||..|||++.+|..||+|||.|-... +
T Consensus 110 CGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--D 181 (502)
T KOG0574|consen 110 CGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--D 181 (502)
T ss_pred cCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--h
Confidence 999999999976 4678999999999999999999999888 8999999999999999999999999997632 3
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.....+.+.|||.|||||++..-.|+.++||||||++..||.-|++||...-+.. .-++ +..-..+.
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------AIFM-----IPT~PPPT 248 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------AIFM-----IPTKPPPT 248 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------eeEe-----ccCCCCCC
Confidence 3344566889999999999999999999999999999999999999996211110 0000 00001111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
+ +.|...+.++.+++++||-++|++|-|+-++++.
T Consensus 249 F--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 F--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred C--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1 2367889999999999999999999999998863
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=320.55 Aligned_cols=254 Identities=24% Similarity=0.291 Sum_probs=204.8
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEcccc--CccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 133 (375)
+....|++.++||+||.+.||++...+.+.||+|.+... +.....-+.+|+.+|.+| .|.+|+++++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 445679999999999999999999888888999877553 334456789999999999 58999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
|||+- .-+|..+|... ...+..-.++.+..|++.|+.++|..| |||.||||.|+|+- .|.+||+|||.|...
T Consensus 438 vmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99976 44899999652 223333388999999999999999998 99999999999995 458999999999876
Q ss_pred CCCCCceeeeccccccccccccccccCC-----------CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGK-----------LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
............+||+.||+||.+.... .+.++||||||||||+|+.|++||..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------------- 574 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------------- 574 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---------------
Confidence 6656666677789999999999886432 55789999999999999999999962
Q ss_pred hhhhccccchhcccccCCCCCHHHHH-HHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLN-YAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+..-..++..+.++...-.||..-.. ++.++++.||+.||.+||++.++|+
T Consensus 575 ~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 575 IINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11112334445555444444432222 2999999999999999999999995
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=307.04 Aligned_cols=240 Identities=23% Similarity=0.337 Sum_probs=189.3
Q ss_pred ceeccccceEEEEEEEcC-------------CceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 66 NLIGEGGFGKVYKGRLES-------------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
+.||+|+||.||+|.... ...+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997432 2358899887655455567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc-------eEEe
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-------PKLS 205 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~-------vkl~ 205 (375)
++|||+++++|..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988754 2456899999999999999999999988 999999999999987664 8999
Q ss_pred ecCCCccCCCCCCceeeeccccccccccccccc-cCCCCccchhHhHHHHHHHHH-hCCCCccccccccccchhhchhhh
Q 017246 206 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELI-TGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 206 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
|||++..... .....++..|+|||++. +..++.++|||||||++|||+ +|..||......... .+
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~ 221 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RF 221 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HH
Confidence 9999864321 12245788899999887 467899999999999999998 488887532211000 00
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
.. ... .........+.+|+.+||+.||++||++.+|++.|+
T Consensus 222 ~~----------~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YE----------GQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Hh----------cCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 000 011223467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.41 Aligned_cols=258 Identities=25% Similarity=0.399 Sum_probs=204.6
Q ss_pred hhcccccceeccccceEEEEEEEc------CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
..+|++.+.||.|+||.||+|+.+ +.+.+++|.+...... ....+.+|+.+++.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 357899999999999999999753 3467999988654333 346788999999999999999999999998999
Q ss_pred EEEEeecCCCCHHHHHhccCCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPD-----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999653311 126899999999999999999999888 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhh
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK 285 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 285 (375)
||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~------- 229 (275)
T cd05046 161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLN------- 229 (275)
T ss_pred cccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHH-------
Confidence 99986432111 112223456778999999988888999999999999999999 78888532211 0100
Q ss_pred hccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
...........+..++..+.+++.+||+.+|++||++.+++..|.
T Consensus 230 ------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 ------RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001111111223456778999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=319.96 Aligned_cols=252 Identities=21% Similarity=0.212 Sum_probs=196.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|..++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 68899999986532 122345778899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999964 2356899999999999999999999988 99999999999999999999999999875322
Q ss_pred CCCceeeecccccccccccccccc-----CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~--------- 218 (331)
T cd05624 155 DG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YG--------- 218 (331)
T ss_pred CC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HH---------
Confidence 21 122233579999999999875 4678999999999999999999999963221100 00
Q ss_pred chhcccccCCCC---CHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 017246 291 VHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 334 (375)
Q Consensus 291 ~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~--RPs~~eil~~ 334 (375)
.+........+ ...++..+.+++.+|+..++++ |++++++++.
T Consensus 219 -~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 219 -KIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -HHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00000000011 1235678899999999866544 4678888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.30 Aligned_cols=264 Identities=24% Similarity=0.317 Sum_probs=199.3
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|++.+.||.|++|.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788999999999999999865 689999999865432 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+. ++|.+++.... .+..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58988886533 2467899999999999999999999988 9999999999999999999999999987532221
Q ss_pred CceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh-------hh---h
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-------LK---D 286 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~---~ 286 (375)
.......+++.|+|||++.+. .++.++|||||||++|+|+||++||........ ........ +. .
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchh
Confidence 122234578899999988754 578999999999999999999999964322110 00000000 00 0
Q ss_pred ccccchhcccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 287 QKKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 287 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
............. ......++.++.++|.+||+.||++||++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 0112236778899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=312.15 Aligned_cols=261 Identities=26% Similarity=0.318 Sum_probs=202.3
Q ss_pred HHHHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEe----
Q 017246 53 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCT---- 126 (375)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~---- 126 (375)
..+....++|++.+.||+|+||.||++... +++.+|+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 334455678999999999999999999764 58899999876532 2235677899999998 6999999999873
Q ss_pred -eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEe
Q 017246 127 -SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 205 (375)
Q Consensus 127 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~ 205 (375)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 446789999999999999988654334567899999999999999999999888 9999999999999999999999
Q ss_pred ecCCCccCCCCCCceeeecccccccccccccccc-----CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch
Q 017246 206 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 206 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 280 (375)
|||++....... .......|++.|+|||++.. ..++.++|||||||++|||++|..||....... ....
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~-- 240 (286)
T cd06638 167 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK-- 240 (286)
T ss_pred cCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh--
Confidence 999987532221 12233568999999998753 457889999999999999999999986322110 0000
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
......+ ....+..++..+.+++.+||+.+|++||++.+|++.
T Consensus 241 ---------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 ---------IPRNPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---------ccccCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000000 001123345679999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.20 Aligned_cols=247 Identities=27% Similarity=0.343 Sum_probs=202.5
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888999999999999999765 68999999987653 33445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ..+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999853 27899999999999999999999888 9999999999999999999999999997643221
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||....... .. ..+...
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~--------------~~~~~~ 213 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VL--------------FLIPKN 213 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HH--------------HHhhhc
Confidence 22234568889999999998889999999999999999999999996432110 00 000000
Q ss_pred cCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+.. ++..+.+++.+||..+|++||+++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111222 6678999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=313.24 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=199.3
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
++|++.+.||.|+||.||+|+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999765 688999999875432 2344677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
++ ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 589888864 2446889999999999999999999988 9999999999999999999999999987532221
Q ss_pred Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh--ccccchhc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD--QKKFVHLV 294 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 294 (375)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||........ .......+.. ...+..+.
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhh
Confidence 11223457889999998875 4578899999999999999999999964322110 0000000000 00000000
Q ss_pred ---------ccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 ---------DPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ---------~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+.... .....++..+.+||.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 112345678899999999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.63 Aligned_cols=247 Identities=30% Similarity=0.486 Sum_probs=199.8
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
++|++.+.||+|+||.||++.. .++.||+|.+.... ....+.+|+.+++.++|||++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 5699999999999999999875 57889999986542 34578889999999999999999999865 45799999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999999652 2346889999999999999999999888 999999999999999999999999998753221
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||....... . . ..+....
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~---~-----------~~~~~~~ 214 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---V---K-----------ECVEKGY 214 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---H---H-----------HHHhCCC
Confidence 112234568999999988889999999999999999998 999986332111 0 0 0001111
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
....+..++..+.+++.+||+.+|++||++.+|++.|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.74 Aligned_cols=250 Identities=23% Similarity=0.354 Sum_probs=204.2
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|++.+.||.|+||.||.++.. ++..+++|.+.... ......+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999754 68899999886543 23455688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999999653 2456899999999999999999999988 9999999999999999999999999987543222
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||...... .... .+....
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~----------~~~~~~ 217 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVV----------KIVQGN 217 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHH----------HHHcCC
Confidence 1233456899999999998888899999999999999999999998632211 0000 000111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
. ...+..++..+.+++.+||+.+|++||++.++++.
T Consensus 218 ~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 Y-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred C-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1 11224567789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=306.23 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=203.8
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..|...+.||.|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778899999999999999765 58899999987543 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998843 45888999999999999999999888 9999999999999999999999999986533222
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......++..|+|||++.+..++.++|+|||||++|||++|..||........ .......
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------------~~~~~~~ 216 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----------------LFLIPKN 216 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----------------hhhhhcC
Confidence 122335678899999999888899999999999999999999999863221100 0000111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.....+..++..+.+++.+||+.+|++||++.+++..
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1123455678889999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.91 Aligned_cols=254 Identities=25% Similarity=0.316 Sum_probs=190.1
Q ss_pred eeccccceEEEEEEEcC---CceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCC
Q 017246 67 LIGEGGFGKVYKGRLES---GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 142 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 142 (375)
.||+|+||.||+|.... ...+++|.+..... .....+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996432 45688887764432 223467889999999999999999999999999999999999999
Q ss_pred HHHHHhccCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCcee
Q 017246 143 LEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 221 (375)
Q Consensus 143 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 221 (375)
|.+++...... .....+..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764322 234567888999999999999999988 99999999999999999999999999864322221112
Q ss_pred eecccccccccccccccc-------CCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchh
Q 017246 222 STRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 222 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....... ... .... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~---~~~~------~~ 226 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLK---QVVR------EQ 226 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH---HHhh------cc
Confidence 223446778999998743 356789999999999999999 778885322110 000 0000 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
.........+..++..+.+++..|| .||++||++++|++.|.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0011112233456677888888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.65 Aligned_cols=239 Identities=27% Similarity=0.334 Sum_probs=186.5
Q ss_pred eccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccC---CCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLL---HHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 68 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
||+|+||.||+|+.. +++.||+|++...... .......|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999765 6899999998653222 222344566665554 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999998853 567899999999999999999999998 9999999999999999999999999987432211 2
Q ss_pred eeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccC
Q 017246 221 VSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (375)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||....... . ... +.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~---~~~----------i~~~~~- 214 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---M---YRN----------IAFGKV- 214 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---H---HHH----------HHcCCC-
Confidence 23346799999999998764 48999999999999999999999996322110 0 000 000000
Q ss_pred CCCC-HHHHHHHHHHHHhhcCCCCCCCC----CHHHHHH
Q 017246 300 GRYP-RRCLNYAVAVTAMCLNEEANFRP----LINDIVV 333 (375)
Q Consensus 300 ~~~~-~~~~~~l~~li~~cl~~~p~~RP----s~~eil~ 333 (375)
.++ ..++..+.+++.+||+.+|.+|| ++.++++
T Consensus 215 -~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 -RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 111 23567889999999999999998 5677665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=309.35 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=201.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..|...+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35777889999999999999754 588999999875432 3345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999884 346889999999999999999999888 9999999999999999999999999987533221
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......|+..|+|||++.+..++.++|||||||++|||++|..||........ . ..+...
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~--------------~~~~~~ 216 (277)
T cd06642 156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L--------------FLIPKN 216 (277)
T ss_pred --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H--------------hhhhcC
Confidence 122234688899999999988899999999999999999999999863221100 0 000011
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.....+..++..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1112234567789999999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=306.08 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=199.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 34555678999999999999754 57889999987765556678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-CCceEEeecCCCccCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPL--SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~ 215 (375)
++++|.+++... ...+ ++..+..++.||+.||.|||+++ |+||||||+||+++. ++.++|+|||++.....
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 88 PGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred CCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999642 2334 77888999999999999999888 999999999999976 67899999999865322
Q ss_pred CCCceeeeccccccccccccccccCC--CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.. .......|++.|+|||++.... ++.++||||||+++|+|++|+.||........ ..+. .
T Consensus 162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~------------~ 224 (268)
T cd06624 162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFK------------V 224 (268)
T ss_pred CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhh------------h
Confidence 11 1122345889999999986543 78999999999999999999999863221100 0000 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........++..++..+.+++.+||+.+|++||++.+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 225 GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0001112345567788999999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=312.47 Aligned_cols=198 Identities=26% Similarity=0.355 Sum_probs=160.7
Q ss_pred cceeccccceEEEEEEEc---CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEee--CCeeEEEEeecC
Q 017246 65 ANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMP 139 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 139 (375)
++.||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 568999999999999754 46789999986543 23457789999999999999999998854 456889999985
Q ss_pred CCCHHHHHhccC-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE----eCCCceEEeecCCC
Q 017246 140 MGSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLA 210 (375)
Q Consensus 140 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill----~~~~~vkl~Dfg~a 210 (375)
++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888875321 12235899999999999999999999988 9999999999999 45678999999999
Q ss_pred ccCCCCCC-ceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCcccc
Q 017246 211 KLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 268 (375)
Q Consensus 211 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~ 268 (375)
........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 75432211 112234678999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=304.33 Aligned_cols=252 Identities=27% Similarity=0.354 Sum_probs=204.5
Q ss_pred cccccceeccccceEEEEEEE-cCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee--CCeeEEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVY 135 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 135 (375)
+|++.+.||.|+||.||++.. .++..+|+|.+..... .....+..|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478899999999999999975 4688999999865433 234567889999999999999999997754 45678999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
||+++++|.+++.........+++..++.++.||+.||.||| +.+ ++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765555678999999999999999999999 666 999999999999999999999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
....... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||...... ....
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~------------ 220 (265)
T cd08217 158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS------------ 220 (265)
T ss_pred ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH------------
Confidence 8643322 1123356899999999999888999999999999999999999999743211 1000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.+........+...+..+.+++.+|++.+|++||++.+|++.
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 --KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 001111123455677889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.30 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=190.4
Q ss_pred eeccccceEEEEEEEcCC---ceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCC
Q 017246 67 LIGEGGFGKVYKGRLESG---QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 142 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 142 (375)
.||+|+||.||++...++ ..+++|.+..... .....+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 3466776654432 345678899999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceee
Q 017246 143 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 222 (375)
Q Consensus 143 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 222 (375)
|.+++.........+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999764433445677788999999999999999988 999999999999999999999999998642222111222
Q ss_pred ecccccccccccccccc-------CCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 223 TRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 223 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
....++..|+|||++.. ..++.++|||||||++|||++ |..||....... . ...... .....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~--~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---V---LNHVIK--DQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHh--hcccccC
Confidence 34568889999998753 245789999999999999997 566775322110 0 000111 0111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
. ...+......+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~----~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 K----PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred C----CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2 2223345677888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.43 Aligned_cols=262 Identities=22% Similarity=0.294 Sum_probs=195.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeC------C
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------D 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 129 (375)
.++|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 568999999999999999999754 68899999987542 23345678899999999999999999987543 3
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..|+||||+++ +|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999965 7777773 24788899999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhh----------
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVS---------- 278 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~---------- 278 (375)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ....
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9753221 1223457899999999999999999999999999999999999999643221100 0000
Q ss_pred -----chhhhhhhcccc-----chhccccc---CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 279 -----WSRPFLKDQKKF-----VHLVDPLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 279 -----~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+..+.... ..+..... ...........+.+||.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 00000000 00111223467899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=308.13 Aligned_cols=239 Identities=24% Similarity=0.358 Sum_probs=187.7
Q ss_pred eeccccceEEEEEEEcC-------------------------CceEEEEEccccCccchHHHHHHHHHHccCCCCCccee
Q 017246 67 LIGEGGFGKVYKGRLES-------------------------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 121 (375)
.||+|+||.||+|.... ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999986421 13588998876544445678889999999999999999
Q ss_pred EeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-
Q 017246 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF- 200 (375)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~- 200 (375)
++++......++||||+++|+|..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998854 3456889999999999999999999888 99999999999997654
Q ss_pred ------ceEEeecCCCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHH-hCCCCcccccccc
Q 017246 201 ------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELI-TGRKAMDLSKGQG 272 (375)
Q Consensus 201 ------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~ 272 (375)
.++|+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999987542111 12346788999998875 56899999999999999995 6899986432211
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
.. . +... ....+......+.++|.+||+.+|++||++.+|++.|.
T Consensus 230 ~~---~----~~~~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KE---R----FYEK------------KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---H----HHHh------------ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 10 0 0000 00112223457899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.52 Aligned_cols=259 Identities=27% Similarity=0.360 Sum_probs=201.6
Q ss_pred cHHHHHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEee-
Q 017246 51 TFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS- 127 (375)
Q Consensus 51 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~- 127 (375)
++.++....+.|++.+.||.|+||.||+|... +++.+|+|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 33444456678999999999999999999764 68899999886543 3345677888888888 79999999999853
Q ss_pred -----CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCce
Q 017246 128 -----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 202 (375)
Q Consensus 128 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~v 202 (375)
.+..+++|||+.+|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 467899999999999999986532 455888889999999999999999988 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchh
Q 017246 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 277 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 277 (375)
+|+|||++....... .......|++.|+|||++. ...++.++|||||||++|||++|..||.........
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--- 235 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--- 235 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh---
Confidence 999999987432111 1123356899999999876 346788999999999999999999999632211000
Q ss_pred hchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 278 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...............++..+.++|.+||+.+|.+||++.+|++
T Consensus 236 -------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000111112346778999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=305.04 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=202.2
Q ss_pred cccccceeccccceEEEEEEEcC--CceEEEEEccccCc----------cchHHHHHHHHHHcc-CCCCCcceeEeEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLES--GQLVAIKQLNHEGL----------QGHQEFIVEVLMLSL-LHHDNLVTLIGYCTS 127 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 127 (375)
.|.+.+.||+|+||.||+|.... ++.+|+|.+..... .....+..|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998654 78899998754321 123456678887764 799999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986654456679999999999999999999995 56 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ...
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~----- 223 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LAT----- 223 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHH-----
Confidence 99997543222 2334568899999999998889999999999999999999999986322110 000
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
.+............++..+.+++.+||+.||++||++.|+.+++.
T Consensus 224 -----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 -----KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000111111111245678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=302.25 Aligned_cols=251 Identities=32% Similarity=0.485 Sum_probs=200.8
Q ss_pred ccccceeccccceEEEEEEEcC-----CceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 62 FREANLIGEGGFGKVYKGRLES-----GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
+++.+.||.|+||.||++.... +..||+|.+...... ....+..|+.++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999997653 388999999765433 4667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.... ...+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999996522 222899999999999999999999988 99999999999999999999999999976433
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...... .... . +
T Consensus 156 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~---~-----------~ 217 (258)
T smart00219 156 DDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLE---Y-----------L 217 (258)
T ss_pred ccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-----------H
Confidence 32211 112336789999999988889999999999999999998 78888632111 0000 0 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 335 (375)
........+..++..+.+++.+||..+|++||++.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00011122344677899999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.18 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=194.4
Q ss_pred HhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeC------
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------ 128 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 128 (375)
..++|.+.+.||.|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999975 4688999999865422 2345577899999999999999999887543
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
...+++++++ +++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 4568999987 789988773 346899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh-----
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP----- 282 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----- 282 (375)
++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+..+...
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPS 236 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 99753321 223568999999999876 568999999999999999999999996432110 00000000
Q ss_pred --hhhh--ccccchhcccc--cC-C---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 --FLKD--QKKFVHLVDPL--LH-G---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 --~~~~--~~~~~~~~~~~--~~-~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... ........... .. . .........+.+|+.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00000000000 00 0 000123456789999999999999999999995
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=320.71 Aligned_cols=267 Identities=26% Similarity=0.404 Sum_probs=222.7
Q ss_pred HHHHHHhhcccccceeccccceEEEEEEEcC-CceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 53 RELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
..+.....+.....+||.|.||.||.|.++. .-.||||.++.+ ....++|+.|+.+|+.+.|||+|+++++|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444555567778999999999999998764 567999998654 45688999999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
|||.|||..|+|.+||++ .++..++....++++.||..||+||..++ +|||||...|+||.++..||++|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999987 34566788888999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
... ++.........-..-|.|||-+....++.++|||+|||+|||+.| |..||..... ...
T Consensus 414 lMt-gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----------------SqV 475 (1157)
T KOG4278|consen 414 LMT-GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQV 475 (1157)
T ss_pred hhc-CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----------------HHH
Confidence 642 222221222223567999999999999999999999999999999 8888863211 112
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
..++..-.+..-|..|++.+++|+.+||+++|.+||++.||-+.++.+....+
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 23444445556688999999999999999999999999999999999887544
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=302.86 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=202.9
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|++.+.||+|+||.||++... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888999999999999999754 68999999986542 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+.+++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988642 2346788999999999999999999988 9999999999999999999999999987532221
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||...... .... ......
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~----------~~~~~~ 217 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVL----------KIIRGS 217 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHH----------HHhcCC
Confidence 1122356888999999999888999999999999999999999998632110 0000 000000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+..++..+.++|.+||+.+|++||++.+|++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11234566788999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=307.50 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=195.7
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHH-HccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLM-LSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|+||.||++... +|+.||+|++..... .....+..|+.+ ++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36889999999999999999765 699999999876432 223445556554 666799999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|++ ++|.+++......+..+++..++.++.||+.||.|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 688888866444456799999999999999999999986 7 99999999999999999999999999875322
Q ss_pred CCCceeeecccccccccccccccc----CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
. .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...... ... ..
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~--------------~~ 218 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQ--------------LK 218 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHH--------------HH
Confidence 1 11223568889999998864 45688999999999999999999998532110 000 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..............++..+.++|.+||+.+|++||++.+|++
T Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001000000111245678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=305.11 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=199.8
Q ss_pred ccccceeccccceEEEEEEEc----CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCC------
Q 017246 62 FREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------ 129 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 129 (375)
|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999643 46889999986542 233456788999999999999999999886532
Q ss_pred eeEEEEeecCCCCHHHHHhccC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
..+++++|+.+|+|.+++.... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2468899999999998875422 12235788999999999999999999988 999999999999999999999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhh
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
|+++...............+++.|++||.+....++.++|||||||++|+|++ |.+||...... ....+ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNY----LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHH----HHc
Confidence 99875433222222233445678999999998889999999999999999999 88888632211 11110 000
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.. ....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112235667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=307.68 Aligned_cols=240 Identities=26% Similarity=0.428 Sum_probs=190.5
Q ss_pred ceeccccceEEEEEEEc-C-------CceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 66 NLIGEGGFGKVYKGRLE-S-------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+.||.|+||.||+|... . ...+++|.+........+.+.+|+.+++.+.||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999753 2 234888887655444556788899999999999999999999998999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc--------eEEeecCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--------PKLSDFGL 209 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~--------vkl~Dfg~ 209 (375)
+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999964 2346889999999999999999999988 999999999999987765 69999998
Q ss_pred CccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCC-CCccccccccccchhhchhhhhhhc
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .||........ . ....
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~----~~~~-- 219 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L----QFYE-- 219 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H----HHHH--
Confidence 864321 123467889999999986 45789999999999999999985 55542211100 0 0000
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
. ...++......+.+++.+||+.+|++||++++|++.|+
T Consensus 220 --------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 --------D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 11234445577999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=313.82 Aligned_cols=249 Identities=28% Similarity=0.397 Sum_probs=207.4
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.+.|+.-++||+|+||.||.++.+ +|+.||.|.+.+...+ .....++|..+|.+++.+.||.+-..|++.+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456888999999999999999755 7999999998765443 344678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|..|+||+|.-+|++.. +..+++..++.++.+|+.||++||+.+ ||+|||||+|||+|+.|+|+|+|+|+|....
T Consensus 264 LtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999998754 467999999999999999999999888 9999999999999999999999999998654
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.+.. ....+||.+|||||++++..|+...|+|||||+||||+.|+.||...........+. +...
T Consensus 339 ~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~---------- 403 (591)
T KOG0986|consen 339 EGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTL---------- 403 (591)
T ss_pred CCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHh----------
Confidence 4332 223489999999999999999999999999999999999999996443332211000 0000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 329 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ 329 (375)
.-...++..++++..+|....|+.||++|.-..
T Consensus 404 --~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 --EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 111245778899999999999999999996543
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=303.62 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=203.0
Q ss_pred cccccceeccccceEEEEEEE-cCCceEEEEEccccCc------cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
+|+..+.||+|+||.||++.. .+++.||+|++..... .....+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999975 4689999999875432 124567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCcc
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKL 212 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~~ 212 (375)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999864 346889999999999999999999998 99999999999998776 599999999875
Q ss_pred CCCCC--CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 213 GPVGD--NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 213 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
..... .........|+..|+|||++.+..++.++||||||+++|+|++|..||.......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------------~~ 220 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-------------LI 220 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-------------HH
Confidence 43221 1111233568899999999988889999999999999999999999986322111000 00
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
............+...+..+.+++.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111111223445677889999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=312.91 Aligned_cols=265 Identities=20% Similarity=0.243 Sum_probs=194.0
Q ss_pred ccceeccc--cceEEEEEEE-cCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 64 EANLIGEG--GFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 64 ~~~~lg~G--~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+.++||+| +|++||++.. .+|+.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6789999975 4789999999876432 22345677999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC-CC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV-GD 217 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~-~~ 217 (375)
++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++||+.+..... ..
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986422 345899999999999999999999988 99999999999999999999999986542211 11
Q ss_pred Cc----eeeecccccccccccccccc--CCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchhhhhhh----
Q 017246 218 NT----HVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKD---- 286 (375)
Q Consensus 218 ~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~---- 286 (375)
.. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .......+...+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 00 01122356778999999876 46899999999999999999999999632211000 000000000000
Q ss_pred --------------------ccccc---hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 287 --------------------QKKFV---HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 287 --------------------~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... ..........+...++..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000 000000001122345678999999999999999999999995
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=320.74 Aligned_cols=245 Identities=31% Similarity=0.431 Sum_probs=202.4
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..|.-++.||.|+||.||.++. .+...||||++....... .+.++.|+..|.+++|||++.+.++|..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4577788999999999999975 578899999998765443 456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||- |+-.|.+.- .++++.+.++..|+.+.+.||.|||+++ .||||||..|||+++.|.|||+|||.|....
T Consensus 106 EYCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 106 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA- 177 (948)
T ss_pred HHHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC-
Confidence 9994 477787754 4678999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
..+.++|||.|||||++. .+.|+-++||||||++..||.-.++|+.-.+.. .... .+.+
T Consensus 178 -----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM------SALY-------HIAQ 239 (948)
T KOG0577|consen 178 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALY-------HIAQ 239 (948)
T ss_pred -----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH------HHHH-------HHHh
Confidence 245589999999999987 578999999999999999999999986421111 0000 1111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.-.|.+. ...++..+.+++..||++-|.+|||..+++.
T Consensus 240 NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 240 NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1122222 4688999999999999999999999988764
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=309.73 Aligned_cols=253 Identities=27% Similarity=0.349 Sum_probs=202.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+..|+.+++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999765 5899999999765433 3456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998642 3467899999999999999999999888 99999999999999999999999999864322
Q ss_pred CCCc---------------------------eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 017246 216 GDNT---------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 268 (375)
Q Consensus 216 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 268 (375)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1100 0112346889999999999888999999999999999999999999633
Q ss_pred ccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC----HHHHHH
Q 017246 269 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL----INDIVV 333 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~eil~ 333 (375)
.... . +..+.............+..+.+++.+||+.+|++||+ +.+++.
T Consensus 236 ~~~~--~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDE--T--------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHH--H--------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2110 0 00111111111111226788999999999999999999 776664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=301.99 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=197.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-----cchHHHHHHHHHHccCCCCCcceeEeEEee--CCee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQR 131 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 131 (375)
.+|++.+.||+|+||.||++... ++..|++|.+..... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999764 689999998865422 123457789999999999999999998865 3678
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999954 345888999999999999999999888 9999999999999999999999999986
Q ss_pred cCCCCCC-ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
....... ........++..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----------------~~ 218 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----------------AI 218 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----------------HH
Confidence 4322111 111223458889999999998889999999999999999999999996321100 00
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...........++..+...+.+++ +||..+|++||++++|++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011111112234556677788888 788899999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=307.27 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=200.9
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEcccc-CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 6888999999999999999875 6899999988654 2233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
++++|..++.... ....+++..+..++.||+.||.|||+ .+ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999998885421 23478999999999999999999996 46 999999999999999999999999998753221
Q ss_pred CceeeeccccccccccccccccC------CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
......+++.|+|||++.+. .++.++|+|||||++|+|++|..||....... ... ...
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~----------~~~ 220 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFA----------QLS 220 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHH----------HHH
Confidence 12234688899999988543 35789999999999999999999996321110 000 000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+.. ......+..++.++.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 221 AIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111 1112345568888999999999999999999999994
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=307.20 Aligned_cols=258 Identities=27% Similarity=0.325 Sum_probs=200.7
Q ss_pred HHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeC----
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG---- 128 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~---- 128 (375)
+....++|.+.+.||+|+||.||++... +++.+|+|++.... .....+..|+.++..+ +|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 3344678999999999999999999764 68899999986542 2345667889999888 899999999998653
Q ss_pred -CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 129 -DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 129 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeec
Confidence 3589999999999999988654444567899999999999999999999888 999999999999999999999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccC-----CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
|++....... .......|+..|+|||++... .++.++|||||||++|||++|+.||...... ......
T Consensus 173 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~~--- 245 (291)
T cd06639 173 GVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFKI--- 245 (291)
T ss_pred ccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHHH---
Confidence 9987532211 112335688999999987643 3688999999999999999999998632211 000000
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. .. ..+ ....+......+.++|.+||+.+|++||++.+|++
T Consensus 246 -~---~~----~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 246 -P---RN----PPP--TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -h---cC----CCC--CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 00 000 00113345567999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=303.14 Aligned_cols=255 Identities=29% Similarity=0.386 Sum_probs=201.7
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCC------
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD------ 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------ 129 (375)
..++|++.+.||.|++|.||+|... +++.+++|++..... ....+.+|+.+++.+ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3578999999999999999999875 578999999876533 346788999999998 7999999999987644
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..++||||+++++|.+++......+..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998764444577899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCceeeecccccccccccccccc-----CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhh
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 284 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 284 (375)
+...... ........|+..|+|||++.. ..++.++|||||||++|+|++|..||...... ..... ..
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh
Confidence 8653221 122233568999999998753 34678899999999999999999999632111 00000 00
Q ss_pred hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+ ....+..++..+.+++.+||..||++||++.++++
T Consensus 232 -------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -------RNPPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -------ccCCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000 11123346778999999999999999999999984
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=300.36 Aligned_cols=247 Identities=28% Similarity=0.405 Sum_probs=201.3
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc-----cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
+|+..+.||+|+||.||+|... ++..|++|.+..... .....+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999865 789999999865432 2345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999854 345889999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCCceeeeccccccccccccccccCC-CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||....... .. . ..
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~----~----------~~ 214 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AV----F----------KI 214 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HH----H----------HH
Confidence 222 223456889999999987766 8999999999999999999999996432100 00 0 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........++..++..+.+++.+||+.+|++||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 215 GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000111234556788899999999999999999999984
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=307.14 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=196.4
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|++.+.||+|+||.||+|... +|..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888999999999999999865 689999999865422 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+. ++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 488887754 2456899999999999999999999988 9999999999999999999999999987533221
Q ss_pred CceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh--ccc---cc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD--QKK---FV 291 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~---~~ 291 (375)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||....... .. .......... ... ..
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQ-LKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HH-HHHHHHHhCCCChHHhHHhh
Confidence 112234578899999988764 47899999999999999999998864222111 00 0000000000 000 00
Q ss_pred hhcc----cccC-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVD----PLLH-----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~----~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... +... ....+.++..+.+++.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 0000 1112346678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=300.06 Aligned_cols=238 Identities=27% Similarity=0.408 Sum_probs=188.6
Q ss_pred ceeccccceEEEEEEEcC-C----------ceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 66 NLIGEGGFGKVYKGRLES-G----------QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~-~----------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
+.||+|+||.||+|.... + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999998653 3 25788877654333 6778899999999999999999999888 778999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-------ceEEeec
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-------NPKLSDF 207 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-------~vkl~Df 207 (375)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999652 226889999999999999999999888 99999999999999887 7999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccC--CCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhh
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 284 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 284 (375)
|++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||........ .. .+
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~---~~- 219 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ER---FY- 219 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HH---HH-
Confidence 99875322 2224567789999998876 78999999999999999999 5677754321110 00 00
Q ss_pred hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
... ...+......+.+++.+||..+|++||++.+|++.|+
T Consensus 220 ~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQ------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcC------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0011111278899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=305.99 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=206.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
..+|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 457899999999999999999765 68899999886543 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|+++++|.+++.. ...+++..+..++.+++.||.|||+ ++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999998854 4568999999999999999999996 46 99999999999999999999999999864211
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ......|+..|+|||++.+..++.++|+|||||++|+|++|..||............. ..... ....+..
T Consensus 157 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~--~~~~~---~~~~~~~ 227 (284)
T cd06620 157 S----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP--MGILD---LLQQIVQ 227 (284)
T ss_pred h----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh--hHHHH---HHHHHhh
Confidence 1 1223578999999999988889999999999999999999999997443321100000 00000 0000111
Q ss_pred cccCCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 296 PLLHGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 296 ~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
.. ...++ ..++..+.+|+.+||+.+|++||++.|+++..--+.
T Consensus 228 ~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 228 EP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred cc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00 11112 236678999999999999999999999998644443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=299.14 Aligned_cols=248 Identities=27% Similarity=0.373 Sum_probs=201.2
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|++.+.||+|+||.||++... +++.+|+|.+..... .....+.+|+.+++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999754 688999999876432 3355788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCccCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVG 216 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~~~~~~ 216 (375)
+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999652 2445889999999999999999999988 99999999999998654 5799999999754322
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... . .. ....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~---~~----------~~~~- 215 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---L---VL----------KIMS- 215 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---H---HH----------HHHh-
Confidence 1 1223568889999999998889999999999999999999999986432110 0 00 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
......+..++..+.+++.+||+.+|++||++.++++
T Consensus 216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 216 GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0011234456778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.17 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=197.7
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-----cchHHHHHHHHHHccCCCCCcceeEeEEeeC--Cee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQR 131 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 131 (375)
.+|++.+.||+|+||.||++... ++..||+|.+..... .....+.+|+.+++.+.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999764 589999998864321 1234678899999999999999999988663 567
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999864 345788899999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCC-ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~-----------~~ 218 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----A-----------AI 218 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----H-----------HH
Confidence 5322111 11122356889999999998888999999999999999999999998632110 0 00
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
............+......+.+++.+|+. +|++||++++|++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01111111223456677788899999995 9999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.48 Aligned_cols=265 Identities=25% Similarity=0.308 Sum_probs=199.7
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36889999999999999999876 589999998865422 223557889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|..++.. ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888877642 446899999999999999999999988 999999999999999999999999999754322
Q ss_pred CCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhchhhhhhh------cc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKD------QK 288 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~------~~ 288 (375)
.. ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.......... ........... ..
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1223457889999999876 557899999999999999999999996433211100 00000000000 00
Q ss_pred cc-chhcccccCCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KF-VHLVDPLLHGR-----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~-~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. .....+..... .....+..+.+++.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 00000000000 01234678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=309.33 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=200.0
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
.|.....||+|+||.||++... ++..||||.+..........+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 4555677999999999999764 688999999876554556678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 103 ~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 103 GGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 999999884 345889999999999999999999988 9999999999999999999999999986432211
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccC
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (375)
.......|+..|+|||.+.+..++.++||||||+++|||++|..||....... .. . .+.......+.
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~---~-------~~~~~~~~~~~ 239 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AM---R-------RIRDNLPPRVK 239 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---H-------HHHhcCCCccc
Confidence 11233568899999999988889999999999999999999999986322110 00 0 00001111111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 300 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.....+..+.+++.+||..+|.+||+++++++.
T Consensus 240 --~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 --DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122456678899999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.32 Aligned_cols=257 Identities=28% Similarity=0.384 Sum_probs=205.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
++|++.+.||.|+||.||+|... ++..+++|++..... .....+.+|+.+++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36899999999999999999754 688999999875432 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999965321 246899999999999999999999888 9999999999999999999999999986543332
Q ss_pred Cc--eeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 218 NT--HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 218 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. .......|+..|+|||++... .++.++|+|||||++|+|++|..||....... ..... .. . .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~----~~---~----~ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT----LQ---N----D 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHH----hc---C----C
Confidence 22 123345689999999998876 78999999999999999999999996432211 00000 00 0 0
Q ss_pred ccccCCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGR-YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+..... ....++..+.+++.+||+.+|++||++.+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0111111 12356788999999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=305.69 Aligned_cols=266 Identities=24% Similarity=0.364 Sum_probs=202.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||.|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999865 588999999865422 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|++++.+..+.. ....+++..+..++.||+.||.|||..+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 998877665553 2455899999999999999999999888 999999999999999999999999998764332
Q ss_pred CCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hchhhh-------hhhc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSRPF-------LKDQ 287 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~-------~~~~ 287 (375)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|++||............ ...... ....
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 22 122335678899999999887 8899999999999999999999999643221100000 000000 0000
Q ss_pred cccc-----hhccc-ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFV-----HLVDP-LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~-----~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... ..... .....++..++..+.++|.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 00000 0011233445788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.67 Aligned_cols=198 Identities=26% Similarity=0.355 Sum_probs=159.9
Q ss_pred cceeccccceEEEEEEEc---CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEee--CCeeEEEEeecC
Q 017246 65 ANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMP 139 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 139 (375)
+..||+|+||.||+|+.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999864 45789999886543 23457789999999999999999998853 567889999986
Q ss_pred CCCHHHHHhccC-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE----eCCCceEEeecCCC
Q 017246 140 MGSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLA 210 (375)
Q Consensus 140 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill----~~~~~vkl~Dfg~a 210 (375)
+ +|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 7888775321 12235889999999999999999999988 9999999999999 45678999999999
Q ss_pred ccCCCCCC-ceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCcccc
Q 017246 211 KLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 268 (375)
Q Consensus 211 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~ 268 (375)
+....... ........||+.|+|||++.+ ..++.++|||||||++|||+||.+||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 75432211 112234568999999999876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=307.62 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=199.8
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+|++.+.||+|+||.||++... +++.|++|.+..... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999865 588999999876532 234467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|++|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 82 YVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999954 356899999999999999999999988 999999999999999999999999998642111
Q ss_pred CC-------------ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh
Q 017246 217 DN-------------THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 217 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
.. ........++..|+|||.+.+..++.++|+|||||++|||++|..||...... .. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~---~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---EL---FGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHH
Confidence 10 00112245788999999998888999999999999999999999998632110 00 0000
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
.. ..... ......++..+.+++.+||+.+|++||+..++.+.|+.
T Consensus 229 ~~-----~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 IS-----DDIEW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hh-----cccCC----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 00000 01112467788999999999999999997655555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.48 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=198.9
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCcc----------chHHHHHHHHHHccCCCCCcceeEeEEeeCC
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ----------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 129 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 129 (375)
+|.+.+.||.|+||.||+|... +|+.+|+|.+...... ..+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999754 6899999988542111 1235678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999864 356889999999999999999999888 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCC--CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
+................|+..|+|||++.... ++.++|+||||+++|+|++|..||....... .... .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~----~~--~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFK----LG--N 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHH----hh--c
Confidence 87533221112223356889999999987654 7899999999999999999999985221100 0000 00 0
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. .....+.......++..+.+++.+||+.+|++||++.+|++
T Consensus 227 ~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 K----RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred c----ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0 00111111222356788999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=301.30 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=202.7
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeC--CeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 135 (375)
++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|+.+++.++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36888999999999999999874 688999999875433 3355688999999999999999999988653 4789999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988654445667899999999999999999999888 99999999999999999999999999864322
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||......... ..... ..... ...
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~~~~~------~~~ 225 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELL-SYIVN------MPN 225 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHH-HHHhc------CCc
Confidence 11 12345788999999999889999999999999999999999999744221000 00000 00000 000
Q ss_pred cccCCCCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+.+..... ...+..+.+++.+||+.+|++||++.||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 01111111 235678999999999999999999999995
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=305.15 Aligned_cols=244 Identities=28% Similarity=0.394 Sum_probs=201.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||++... +++.+|+|++..... .....+.+|+.+++.+.||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999765 689999999865422 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|.|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999854 467899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... .. ...+..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~-------------~~~~~~ 212 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QI-------------YEKILE 212 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH-------------HHHHhc
Confidence 2 23356899999999998888899999999999999999999998632210 00 000010
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
. ...++...+..+.+++.+||+.+|.+|| +++++++
T Consensus 213 ~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 G--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred C--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 1123445678899999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=307.70 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=200.4
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
.|.....||+|+||.||++... +++.||+|.+..........+.+|+.+++.++|||++++++++..++..+++|||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445667999999999999764 689999999876555556678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|..++. ...+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++...... .
T Consensus 102 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~ 171 (297)
T cd06659 102 GGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--V 171 (297)
T ss_pred CCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc--c
Confidence 999998773 345889999999999999999999888 999999999999999999999999998643221 1
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccC
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (375)
.......|+..|+|||++.+..++.++|||||||++|||++|..||....... . .. . .. ..... .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~-~~---~-~~------~~~~~--~ 236 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--A-MK---R-LR------DSPPP--K 236 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H-HH---H-Hh------ccCCC--C
Confidence 12233568999999999998889999999999999999999999986322110 0 00 0 00 00000 0
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 300 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.......+..+.+++.+||+.+|++||++.+|++.
T Consensus 237 ~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 01123456678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.49 Aligned_cols=262 Identities=27% Similarity=0.362 Sum_probs=196.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
++|++.+.||.|++|.||+|... +++.||+|.+...... ....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57999999999999999999765 6899999998754322 234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+.+ +|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 999988642 346889999999999999999999988 9999999999999999999999999986432211
Q ss_pred Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh--cccc----
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD--QKKF---- 290 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~---- 290 (375)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... . ......... ...+
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-L-HKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-H-HHHHHhcCCCChhhhhhhh
Confidence 1 1122346889999998875 45889999999999999999999999643311100 0 000000000 0000
Q ss_pred -----chhcc-----cccCCCCCHHH--HHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 -----VHLVD-----PLLHGRYPRRC--LNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 -----~~~~~-----~~~~~~~~~~~--~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... ..+... .... ...+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINH-APRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHh-CcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000000 0112 267889999999999999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.45 Aligned_cols=246 Identities=29% Similarity=0.360 Sum_probs=211.5
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc--hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
....|.+...||+|.|+.|.++++. ++..||||.+.+..... .+.+.+|+.+++.++|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567999999999999999999765 69999999998764433 35578999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+.+|.+++|+.. ..++.+..+..++.|+.+|++|||+++ |+|||||++||||+.+-++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999964 667777899999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCceeeeccccccccccccccccCCCC-ccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
........||++.|.|||++.+..|. +++|+||+|+++|.|+.|..||+... +..+
T Consensus 207 ---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------------------lk~L 263 (596)
T KOG0586|consen 207 ---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------------------LKEL 263 (596)
T ss_pred ---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------------------cccc
Confidence 33345568999999999999988765 78999999999999999999998432 2222
Q ss_pred cccccCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHG--RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
-.+.+.+ ++|.-+..+..++|.++|-.+|.+|+++++|.+
T Consensus 264 r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 264 RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 2333333 235567778899999999999999999999985
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.49 Aligned_cols=251 Identities=26% Similarity=0.354 Sum_probs=204.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|.+.+.||.|+||.||++... ++..||+|.+..........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999754 6889999998765555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999853 35788999999999999999999988 9999999999999999999999999886432222
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......+++.|+|||.+....++.++|+|||||++|+|++|..||........ .... . ....
T Consensus 170 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~----~---------~~~~ 232 (293)
T cd06647 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI----A---------TNGT 232 (293)
T ss_pred --cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeeh----h---------cCCC
Confidence 122335688899999999888899999999999999999999999964322110 0000 0 0000
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.....+...+..+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111233456789999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=305.40 Aligned_cols=265 Identities=25% Similarity=0.378 Sum_probs=199.8
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36889999999999999999875 5899999988654322 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|..+... ...+++..++.++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999988887643 345899999999999999999999988 999999999999999999999999998753222
Q ss_pred CCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccc-cchhhchhhhhhhccc-----
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-QNLVSWSRPFLKDQKK----- 289 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~----- 289 (375)
. .......++..|+|||++.+ ..++.++||||||+++|||++|.+||........ ................
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 22233567889999998875 4578899999999999999999999863321110 0000000000000000
Q ss_pred --cchhcccccC-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 --FVHLVDPLLH-----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 --~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
......+... ....+.++..+.+++.+||+.+|++||++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 0112356788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=300.24 Aligned_cols=247 Identities=27% Similarity=0.372 Sum_probs=200.8
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
-|++.+.||.|+||.||+|... ++..||+|.+..... .....+.+|+.++..++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778899999999999999754 688999998865432 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++++|.+++. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 9999999884 346889999999999999999999988 9999999999999999999999999986532211
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||....... ... .+....
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~--------------~~~~~~ 217 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLF--------------LIPKNN 217 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHH--------------HHhcCC
Confidence 11233568889999999988888999999999999999999999986322110 000 000011
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
...++..++..+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112334567789999999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.16 Aligned_cols=265 Identities=24% Similarity=0.319 Sum_probs=200.7
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|++.+.||.|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4888999999999999999864 689999999876542 2345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+ +++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998642 356899999999999999999999988 9999999999999999999999999987543322
Q ss_pred CceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhc-------hhhhhhhcc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW-------SRPFLKDQK 288 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~-------~~~~~~~~~ 288 (375)
. .......|+..|+|||++.+. .++.++|||||||++|||++|.+||.......... .... ..+......
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 122335689999999988754 46899999999999999999988875332111000 0000 000000000
Q ss_pred ccchhcccccC----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KFVHLVDPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+..+..+... ....+..+..+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0011244688999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=297.08 Aligned_cols=250 Identities=29% Similarity=0.412 Sum_probs=201.3
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|.+.+.||+|+||.||++... +++.|++|.+...... ....+..|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999764 6899999998765443 566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999854 445788999999999999999999988 9999999999999999999999999987643322
Q ss_pred Ccee--eeccccccccccccccccCC---CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 218 NTHV--STRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 218 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.... .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... +...+.. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~~-~----- 220 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHV-G----- 220 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHHH-h-----
Confidence 2111 12356788999999998766 889999999999999999999999632210 0000000 0
Q ss_pred hcccccCCCCCH--HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPR--RCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......+. .++..+.+++.+||+.+|++||++.+++.
T Consensus 221 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 221 ---AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---cCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000111222 34778889999999999999999999883
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=296.84 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=205.5
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+|++.+.||+|++|.||++... +++.|++|++..... .....+..|+..+..++|+|++++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6888999999999999999876 599999999877544 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999964 3678999999999999999999998 88 9999999999999999999999999987543222
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ..+.. .
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~-------------~~~~~-~ 218 (264)
T cd06623 155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM-------------QAICD-G 218 (264)
T ss_pred C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH-------------HHHhc-C
Confidence 1 122356788999999999889999999999999999999999999644321100000 00011 1
Q ss_pred cCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+.. ++..+.++|.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11122334 7788999999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=300.38 Aligned_cols=251 Identities=27% Similarity=0.366 Sum_probs=202.4
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+|++.+.||.|+||.||++... +++.+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5788899999999999999865 689999999876532 33456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
++++|.+++... ...+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999998652 2678899999999999999999998 77 9999999999999999999999999986432111
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ......... ...
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~----------~~~- 219 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYI----------VNE- 219 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHH----------hcC-
Confidence 1116688899999999998999999999999999999999999964322111 111111100 000
Q ss_pred cCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+.. ++..+.++|.+||..+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 01112222 7778999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=301.84 Aligned_cols=264 Identities=24% Similarity=0.294 Sum_probs=198.3
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCcc-----chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-----GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
+|.+.+.||.|+||.||+|... +++.||+|.+...... ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999865 6899999999765432 234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+ +++|.+++... ...+++..++.++.||++||.|||+++ |+|+||||+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999999541 236899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchh-h---hhhhcc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSR-P---FLKDQK 288 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~-~---~~~~~~ 288 (375)
... .......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......... ....... + ......
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 322 11222356788999998864 46789999999999999999998877533221100 0000000 0 000000
Q ss_pred ccchhcccccC-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KFVHLVDPLLH-----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........... .......+..+.++|.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000 0112345778999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=304.68 Aligned_cols=269 Identities=23% Similarity=0.293 Sum_probs=198.5
Q ss_pred cccccceeccccceEEEEEEEc---CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeC--CeeE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRL 132 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 132 (375)
+|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788999999999999999764 47899999997743 33345678899999999999999999999888 8899
Q ss_pred EEEeecCCCCHHHHHhccCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC----CCceEEeec
Q 017246 133 LVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN----DFNPKLSDF 207 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~----~~~vkl~Df 207 (375)
+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 777777543322 337899999999999999999999988 999999999999999 899999999
Q ss_pred CCCccCCCCCC-ceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-------hhh
Q 017246 208 GLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-------LVS 278 (375)
Q Consensus 208 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-------~~~ 278 (375)
|++........ ........+++.|+|||++.+ ..++.++|||||||++|+|++|++||.......... +..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99875432222 112233567899999998876 457899999999999999999999997443322000 000
Q ss_pred chhhh----------hhhccccchhcccccCCCCC---------H--HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 279 WSRPF----------LKDQKKFVHLVDPLLHGRYP---------R--RCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 279 ~~~~~----------~~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... ..................++ . ..+..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000000000000001111 1 34567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=295.39 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=207.8
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|.+.+.||.|+||.||++... ++..|++|++..... .....+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999765 689999999876543 4456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.........+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999764434578999999999999999999999988 9999999999999999999999999987543322
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... . ... ... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~---~~~----------~~~-~ 218 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---L---ALK----------ILK-G 218 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---H---HHH----------Hhc-C
Confidence 23334578999999999988889999999999999999999999986332110 0 000 000 1
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....++..++..+.+++.+||..+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 112234467788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=299.93 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=203.6
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+|++.+.||.|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999865 689999999976432 335678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+.+++|.+++.. ...+++..+..++.||+.||.|||.++ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999954 357889999999999999999999888 999999999999999999999999998754322
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|..||............ .....
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------------~~~~~ 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR--------------AKQET 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH--------------HHhcc
Confidence 1 223356888999999999888999999999999999999999999744322111100 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH--HHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI--NDIV 332 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~--~eil 332 (375)
.....+...+..+.++|.+||+.+|.+||++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1223455667899999999999999999999 6655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=296.58 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=200.8
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|.+.+.||+|+||.||+|... +|..+|+|.+..... .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788999999999999999765 588999999866422 3345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc-eEEeecCCCccCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-PKLSDFGLAKLGPVG 216 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~-vkl~Dfg~a~~~~~~ 216 (375)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999652 2346789999999999999999999888 999999999999998864 699999998754322
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ..... ....
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~----------~~~~ 217 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLK----------ICQG 217 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH----------Hhcc
Confidence 11223346899999999998888999999999999999999999998632211 00000 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ...++..+..+.+++.+||+.+|++||++.++++
T Consensus 218 ~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 218 YF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred cC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11 1123455678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=298.23 Aligned_cols=246 Identities=28% Similarity=0.389 Sum_probs=198.0
Q ss_pred cccccceeccccceEEEEEEE-cCCceEEEEEccccC-ccchHHHHHHHHHHccCC---CCCcceeEeEEeeCCeeEEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 135 (375)
.|++.+.||.|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999986 468999999987643 234556788999998886 999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998843 36889999999999999999999988 99999999999999999999999999875433
Q ss_pred CCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||........ .. .....
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~----------~~~~~- 217 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MM----------LIPKS- 217 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hh----------ccccC-
Confidence 22 22233568899999998875 4578999999999999999999999963221100 00 00000
Q ss_pred ccccCCCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPR-RCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....++. ..+.++.+++.+||+.+|++||++.++++
T Consensus 218 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 ---KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0011112 25678999999999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=318.65 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=194.6
Q ss_pred cccceeccccceEEEEEEEc-CCceEEEEEcccc----CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe--eEEEE
Q 017246 63 REANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE----GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ--RLLVY 135 (375)
Q Consensus 63 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~ 135 (375)
+...+||+|+|-+||+|-+. +|..||--.++.. .....+++..|+.+|+.|+||||++++.+|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999654 5888875444322 22345789999999999999999999999987665 77899
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEeecCCCccCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGP 214 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~Dfg~a~~~~ 214 (375)
|.+..|+|..|+++ ...++...++.|+.||++||.|||++ +|||+|||||-+||||+.+ |.|||+|+|+|+...
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999975 55678889999999999999999998 6999999999999999866 889999999998633
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
... ...+.|||.|||||++. ..|++.+||||||+.|+||+|+..||...... .++.
T Consensus 198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------------------AQIY 253 (632)
T KOG0584|consen 198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------------------AQIY 253 (632)
T ss_pred ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------------------HHHH
Confidence 222 23378999999999876 78999999999999999999999999743221 1111
Q ss_pred ccccCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+..| .--.+++.++|.+||.. .++||++.|+|.
T Consensus 254 KKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 254 KKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111222222 22356789999999999 999999999997
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=296.01 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=205.6
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|++.+.||.|+||.||++... +++.+++|.+..... .....+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4888999999999999999754 688999999875432 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999999765444567899999999999999999999988 999999999999999999999999999764332
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... .. ......
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~--------------~~~~~~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LR--------------YKVQRG 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH--------------HHHhcC
Confidence 2223457889999999999889999999999999999999999996432110 00 000111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+..++.++.+++.+||+.+|++||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112234567788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=298.80 Aligned_cols=264 Identities=24% Similarity=0.312 Sum_probs=195.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc-hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
..+|++.+.||+|+||.||+|... ++..||+|.+....... ...+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 357999999999999999999754 68899999986543322 3456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+. ++|.+++.. ....+.+..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 678777643 2345788889999999999999999988 999999999999999999999999998753221
Q ss_pred CCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh--------hc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK--------DQ 287 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------~~ 287 (375)
. .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.......+ .+... ...+. ..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKI-WTVLGVPTEDTWPGV 232 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHH-HHHcCCCChhhhhhh
Confidence 1 112234578899999998754 578899999999999999999999974332111 00000 00000 00
Q ss_pred cccchhcccccCCCCC---------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLHGRYP---------RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...............+ ...+..+.+++.+|++.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 012567889999999999999999999883
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=299.98 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=199.7
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
.|...+.||+|++|.||++... +++.+++|++..........+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555689999999999999754 688999998865544455668899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.++|+|||++...... .
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~ 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--V 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC--C
Confidence 9999999853 45888999999999999999999988 999999999999999999999999988643221 1
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccC
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (375)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ....... ....+..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~-------~~~~~~~- 235 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR-------DNLPPKL- 235 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-------hcCCCCC-
Confidence 1223356899999999998888999999999999999999999998532110 0000000 0000011
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 300 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..+..++..+.+++.+||+.+|++||++.++++
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 112235678999999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=301.22 Aligned_cols=265 Identities=25% Similarity=0.352 Sum_probs=199.5
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeC--CeeEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLV 134 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 134 (375)
++|++.+.||.|+||.||+|... +++.+++|.++..... ....+.+|+.+++.++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47889999999999999999875 5889999998754322 223467899999999999999999998877 899999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+.+ +|.+++... ...+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 999888642 346899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhh---------chh--
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS---------WSR-- 281 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~---------~~~-- 281 (375)
... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.......... +.. |..
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 321 112234578899999988754 46899999999999999999999996433211100 000 000
Q ss_pred hhhh-hccccchhcccccCCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 PFLK-DQKKFVHLVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... ............+...++.. .+..+.++|.+||+.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 00000011111112223333 5778999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=321.86 Aligned_cols=272 Identities=20% Similarity=0.235 Sum_probs=190.0
Q ss_pred HHhhcccccceeccccceEEEEEEEc--CCceEEEEEc--------------cc---cCccchHHHHHHHHHHccCCCCC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQL--------------NH---EGLQGHQEFIVEVLMLSLLHHDN 117 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~n 117 (375)
....+|++.+.||+|+||.||++..+ .+..+++|.+ .+ ........+.+|+.+|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998653 2222222211 11 11122345778999999999999
Q ss_pred cceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE
Q 017246 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 196 (375)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill 196 (375)
|+++++++...+..++|++++. ++|.+++..... .........++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 578777754221 1223446678899999999999999988 9999999999999
Q ss_pred eCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCC-Cccccccccccc
Q 017246 197 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQN 275 (375)
Q Consensus 197 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-pf~~~~~~~~~~ 275 (375)
+.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||++|.. ||..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999975432221 12233679999999999999999999999999999999999875 444322221111
Q ss_pred hhhchhhh-------hhhccccchhcccc----cCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 276 LVSWSRPF-------LKDQKKFVHLVDPL----LHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 276 ~~~~~~~~-------~~~~~~~~~~~~~~----~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+....... ......+...+... ....++ ...+..+.++|.+||+.||.+||++.|++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111000 00000000111000 000000 123456788899999999999999999986
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=299.43 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=197.6
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|++.+.||.|++|.||+|... +++.||||.+..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999765 689999999865432 2235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+. ++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 5898888652 3456899999999999999999999888 9999999999999999999999999987532221
Q ss_pred CceeeeccccccccccccccccCC-CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh----------hhh
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF----------LKD 286 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------~~~ 286 (375)
.......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||....... ......... ...
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhH
Confidence 1122345688999999887644 6889999999999999999999996432111 010000000 000
Q ss_pred ccccchhcccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 287 QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 287 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......+...... ...+.++..+.++|.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 011235567889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=292.11 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=206.2
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeC--CeeEEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVY 135 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 135 (375)
+|...+.||+|++|.||+|... ++..|++|++..... .....+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 689999999876543 3456788999999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999964 337899999999999999999999988 99999999999999999999999999876433
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
...........++..|+|||.+.+..++.++||||||+++|+|++|..||...... .. ....+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~----------~~~~~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MA----------ALYKIGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HH----------HHHhccc
Confidence 32211133456889999999998888999999999999999999999999743310 00 0001111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
......++...+..+.+++.+|++.+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11222345566889999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=290.68 Aligned_cols=249 Identities=31% Similarity=0.440 Sum_probs=203.7
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
+|++.+.||.|++|.||++... ++..+++|++..........+.+|+.+++.++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999875 689999999977655566788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++... ...+++..+..++.|++.||.+||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998652 257899999999999999999999888 99999999999999999999999999875433221
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccC
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (375)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .... . ... .+..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~-~~~-----~~~~- 217 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFKI-A-TNG-----PPGL- 217 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHH-H-hcC-----CCCc-
Confidence 2345688999999999888899999999999999999999999863321100 0000 0 000 0000
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 300 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..+..++..+.++|.+||+.+|++||++.++++
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 -RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011223678999999999999999999999984
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=298.14 Aligned_cols=251 Identities=29% Similarity=0.376 Sum_probs=203.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
...|++.+.||.|++|.||+|... ++..+++|++..... ....+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 456888899999999999999876 688999999976543 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999997522 47899999999999999999999888 9999999999999999999999999886432221
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||........ .. ... .. ..
T Consensus 171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~----~~~--~~-------~~ 233 (286)
T cd06614 171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LF----LIT--TK-------GI 233 (286)
T ss_pred --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHH--hc-------CC
Confidence 122334578899999999888899999999999999999999999863221100 00 000 00 00
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+..++..+.++|.+||+.+|.+||++.+|++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001112336778999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=314.92 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=213.5
Q ss_pred HHhhcccccceeccccceEEEEEEEc--CCc--eEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE--SGQ--LVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
+..+...+.++||+|.||.|++|.+. +|+ .||||.++..... ....|++|+.+|.+|+|||++++||+..+ ..+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 44556777899999999999999765 344 5899999876554 56789999999999999999999999877 778
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
.+|||+++.|+|.+.|.+ ..+..|.......++.||+.||.||.+++ +|||||...|+||-....|||+|||+.+
T Consensus 186 mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence 899999999999999987 45677888999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCceeee-ccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccc
Q 017246 212 LGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 212 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
.....+..+... ...-...|+|||.+....++.++|||+|||+||||+| |..||-...+- .
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----------------q 323 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----------------Q 323 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------------H
Confidence 766555544433 2334668999999999999999999999999999999 77898643321 1
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
+.+.++..-+..-|..|+++++++++.||..+|.+||+|..|.+.+-
T Consensus 324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 11222222223447899999999999999999999999999975443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=294.02 Aligned_cols=242 Identities=26% Similarity=0.343 Sum_probs=197.7
Q ss_pred eccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 68 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
||.|++|.||++... +++.||+|++..... ...+.+.+|+.+++.++||||+++++.+.+++..+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999865 589999999876432 2345688899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeee
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 223 (375)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999954 345889999999999999999999988 9999999999999999999999999997643322 122
Q ss_pred ccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC
Q 017246 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303 (375)
Q Consensus 224 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (375)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....+.. . ....+........++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~----------~~~~~~~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----E----------IYNDILKGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----H----------HHHHHhccCCCCCCC
Confidence 35688999999999888899999999999999999999999974332110 0 001111111222345
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 017246 304 RRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 333 (375)
Q Consensus 304 ~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~ 333 (375)
...+..+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 556789999999999999999999 777774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=296.81 Aligned_cols=241 Identities=26% Similarity=0.350 Sum_probs=188.3
Q ss_pred eeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHHH---HccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLM---LSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
+||+|+||.||++... +++.+|+|.+....... ...+.+|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 68999999886543221 2223444433 334479999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++.. ...+++..+..++.|++.||.|||+++ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998854 456999999999999999999999998 9999999999999999999999999986432211
Q ss_pred eeeeccccccccccccccc-cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 220 HVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.....|++.|+|||.+. +..++.++|||||||++|+|++|..||............. . ....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--------------~-~~~~ 214 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------------M-TLTV 214 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH--------------H-hhcC
Confidence 12346899999999886 4568999999999999999999999996432211110000 0 0011
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
...++..++..+.++|.+||+.||.+|| +++++++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1234556778899999999999999999 5988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=330.22 Aligned_cols=252 Identities=27% Similarity=0.345 Sum_probs=190.5
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeC------
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------ 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 128 (375)
.-..+|+..++||+||||.||+++.+ +|+.||||+|.... ......+.+|+.+|.+|+|||||+++..|...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567999999999999999999876 89999999997653 23345688899999999999999997543110
Q ss_pred --------------------------------------------------------------------------------
Q 017246 129 -------------------------------------------------------------------------------- 128 (375)
Q Consensus 129 -------------------------------------------------------------------------------- 128 (375)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEeecCCCCHHHHHhccCCCCCCC-CHHHHHHHHHHHHHHHH
Q 017246 129 ---------------------------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPL-SWNTRMKIAVGAARGLE 174 (375)
Q Consensus 129 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~qi~~~l~ 174 (375)
..+||-||||+..+|.+++... ... .....++++.+|++||.
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHHH
Confidence 0147899999987777777542 222 45789999999999999
Q ss_pred HhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC----------------CCCCceeeeccccccccccccccc
Q 017246 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP----------------VGDNTHVSTRVMGTYGYCAPEYAM 238 (375)
Q Consensus 175 ~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~ 238 (375)
|+|++| ||||||||.|||+++++.|||+|||+|+... .+......+..+||..|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999988 9999999999999999999999999997511 011122345578999999999998
Q ss_pred cCC---CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC--CCCHHHHHHHHHH
Q 017246 239 SGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG--RYPRRCLNYAVAV 313 (375)
Q Consensus 239 ~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 313 (375)
+.. |+.|+|+||||++++||+. ||...... ...+..+....+.. .+.......-..+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER---------------a~iL~~LR~g~iP~~~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER---------------ASILTNLRKGSIPEPADFFDPEHPEEASL 850 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHHH---------------HHHHHhcccCCCCCCcccccccchHHHHH
Confidence 654 9999999999999999985 46532211 11111222222221 1223334455789
Q ss_pred HHhhcCCCCCCCCCHHHHHH
Q 017246 314 TAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 314 i~~cl~~~p~~RPs~~eil~ 333 (375)
|.+|++.||++|||+.|+|.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999984
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=299.22 Aligned_cols=246 Identities=30% Similarity=0.414 Sum_probs=196.4
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
...|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356889999999999999999765 6899999998654322 234678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99996 577777653 2346899999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
.. ....+++.|+|||++. ...++.++||||||+++|||++|..||........ ..
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~---------- 224 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY---------- 224 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HH----------
Confidence 21 2346788999999874 45688999999999999999999999853221100 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+.........+..++..+.+++.+||+.+|++||++.+|+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 225 HIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred HHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000001112346778999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.52 Aligned_cols=266 Identities=24% Similarity=0.364 Sum_probs=199.6
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+|++.+.||.|++|.||+|+.. +|..||+|++...... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999875 6899999998765332 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++ +|.+++.... ....+++..+..++.||+.||.|||+++ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 75 8888886533 2356899999999999999999999988 9999999999999999999999999987432211
Q ss_pred ceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhch-hhh---hhhccccch
Q 017246 219 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWS-RPF---LKDQKKFVH 292 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~-~~~---~~~~~~~~~ 292 (375)
.......++..|++||++.+. .++.++|||||||++|+|++|..||......... ...... .+. +........
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 112234578899999988654 5789999999999999999999999643221100 000000 000 000000000
Q ss_pred hccccc------CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...... ...+.+.++..+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 01112345678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.37 Aligned_cols=262 Identities=17% Similarity=0.185 Sum_probs=186.9
Q ss_pred HHhhcccccceeccccceEEEEEEEcC----CceEEEEEccccCccch-----------HHHHHHHHHHccCCCCCccee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGLQGH-----------QEFIVEVLMLSLLHHDNLVTL 121 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~ 121 (375)
+..++|.+.++||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345689999999999999999998653 45667775433322111 112233445667789999999
Q ss_pred EeEEeeCC----eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe
Q 017246 122 IGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 197 (375)
Q Consensus 122 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~ 197 (375)
++.+.... ..+++++++. .++.+.+.. ....++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence 98765543 3467788763 366666643 233567889999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCCccCCCCCC-----ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccc
Q 017246 198 NDFNPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 272 (375)
Q Consensus 198 ~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 272 (375)
.++.++|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999975422111 111223569999999999999999999999999999999999999997542221
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
...... ...+. ..+..... ....++..+.+++..|++.+|++||++.+|++.|+
T Consensus 241 ~~~~~~-~~~~~------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAA-KCDFI------KRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHh-HHHHH------HHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 110000 00000 01111111 12345788999999999999999999999998764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=299.06 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=195.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 136 (375)
.+|...+.||+|+||.||++... +++.||+|.+..... .....+..|+.++.++. |+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999765 589999999875432 33456788999998886 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcc-CCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 137 YMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 137 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|+.. +|.++.... ......+++..+..++.|++.||+|||+. + |+||||||+|||++.++.++|+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9854 665543221 12346789999999999999999999974 6 9999999999999999999999999986432
Q ss_pred CCCCceeeeccccccccccccccccC---CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... ...... ...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~-------~~~ 224 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLT-------QVV 224 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHh-------hhc
Confidence 211 11234588899999998765 689999999999999999999999963320 000000 000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+.+....+..++..+.+|+.+||+.+|++||++++|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111222223457788999999999999999999999995
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=332.01 Aligned_cols=256 Identities=25% Similarity=0.298 Sum_probs=207.6
Q ss_pred HHHHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEcccc---CccchHHHHHHHHHHccCCCCCcceeEeEEeeC
Q 017246 53 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 128 (375)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 128 (375)
..+....++|++.++||+|+||.|.+++.+ +++.||+|++++. ...+..-|..|-.+|..-+.+-|+.++..|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455666789999999999999999999875 6999999999873 223445688899999888899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
.++|+||||++||+|..++.. ...+++..++.++..|+.||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999954 347999999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccc----c-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAM----S-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
.|-... .+..-.....+|||.|.+||++. + +.|+...|+||+||++|||+.|..||...... ..
T Consensus 221 sClkm~-~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv---------eT- 289 (1317)
T KOG0612|consen 221 SCLKMD-ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV---------ET- 289 (1317)
T ss_pred hHHhcC-CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH---------HH-
Confidence 986543 23444456688999999999987 2 56899999999999999999999999522111 11
Q ss_pred hhhccccchhcccccCCCCC--HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 017246 284 LKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPL---INDIVV 333 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs---~~eil~ 333 (375)
...+++..-.-.+| ...+....+||.+.+ .+|+.|.. +.++-.
T Consensus 290 ------Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 290 ------YGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred ------HHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 11122211111233 457888999999855 67888877 777653
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.29 Aligned_cols=265 Identities=23% Similarity=0.280 Sum_probs=196.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCC-CCCcceeEeEEeeCCe-----
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQ----- 130 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----- 130 (375)
++|++.+.||.|+||.||+|... +++.||+|++..... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36889999999999999999865 689999998865422 22356788999999995 6999999999877665
Q ss_pred eEEEEeecCCCCHHHHHhccCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-CCceEEeecC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFG 208 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg 208 (375)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 898888654322 456899999999999999999999988 999999999999998 8899999999
Q ss_pred CCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........ ...... .+...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~-~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFK-LLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHH-HhCCC
Confidence 9875322211 1122356889999998865 4578999999999999999999999964221110 000000 00000
Q ss_pred --cccchh---c----ccccC----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 --KKFVHL---V----DPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 --~~~~~~---~----~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..+... . .+... ....+.++..+.++|.+||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0 00000 0011346778999999999999999999999983
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=306.18 Aligned_cols=263 Identities=24% Similarity=0.309 Sum_probs=197.8
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEcccc--CccchHHHHHHHHHHccCCCCCcceeEeEEeeC------
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------ 128 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 128 (375)
..++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999764 6899999998653 223345677899999999999999999988643
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
...++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 488887742 2888999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc------------ch
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ------------NL 276 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~------------~~ 276 (375)
++....... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||......... .+
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 997543221 123346789999999999999999999999999999999999999643211100 00
Q ss_pred hhc----hhhhhhhc-----cccchhcccc----cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 277 VSW----SRPFLKDQ-----KKFVHLVDPL----LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 277 ~~~----~~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... ...+.... ..+..+.... .....+...+..+.++|.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00000000 0000111110 011112345677899999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=291.30 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=199.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC-----ccchHHHHHHHHHHccCCCCCcceeEeEEeeC--Cee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQR 131 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 131 (375)
.+|++.+.||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36899999999999999999754 68999999875421 12345678899999999999999999998664 468
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++++||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999854 345788999999999999999999888 9999999999999999999999999997
Q ss_pred cCCCCCC-ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
....... ........++..|+|||++.+..++.++|+|||||++|+|++|+.||...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~ 218 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------------AAI 218 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------------HHH
Confidence 5322111 11112356889999999999888999999999999999999999999632110 001
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...........+|...+..+.+++.+||+ +|..||++.+++.
T Consensus 219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111112233466788899999999999 5799999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=285.75 Aligned_cols=255 Identities=24% Similarity=0.277 Sum_probs=199.0
Q ss_pred Hhhccccc-ceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEee----CCe
Q 017246 58 ATRNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS----GDQ 130 (375)
Q Consensus 58 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~ 130 (375)
.+++|.+. ++||-|-.|.|..+.++ +++.+|+|++.. ....++|+++.-.. .|||||.++++|++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35567664 57999999999999654 799999999843 35566788776554 69999999998764 356
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC---CceEEeec
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDF 207 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~---~~vkl~Df 207 (375)
+.+|||.++||.|++.+.+.. ...+++.++..|+.||..|+.|||+.+ |.||||||+|+|.... -.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 779999999999999997743 567999999999999999999999998 9999999999999654 35899999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
|+|+.... .....+.|-||.|.|||++-..+|+...|+||+||+||-|++|.+||-...+..... .+..
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp--gMk~------ 277 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKR------ 277 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh--hHHh------
Confidence 99985321 223345788999999999999999999999999999999999999995221111000 0000
Q ss_pred cccchhcccccCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCC
Q 017246 288 KKFVHLVDPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRN 350 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~ 350 (375)
.+.... -.+| ...++...++|+.+|..+|.+|.|+.+++ .|||.+-
T Consensus 278 ----rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m-----------~hpwi~~ 327 (400)
T KOG0604|consen 278 ----RIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVM-----------DHPWINQ 327 (400)
T ss_pred ----HhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhh-----------cCchhcc
Confidence 000000 0122 35678899999999999999999999998 7777764
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=294.37 Aligned_cols=244 Identities=28% Similarity=0.406 Sum_probs=193.4
Q ss_pred eccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 68 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
||+|+||.||++... +|+.||+|.+..... .....+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 689999999865322 2234567899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeee
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 223 (375)
.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+...... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 99996532 346899999999999999999999988 999999999999999999999999998753221 1122
Q ss_pred ccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC
Q 017246 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303 (375)
Q Consensus 224 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (375)
...++..|+|||++.+..++.++|||||||++|+|++|+.||............ . .... .....++
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~------~~~~-~~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-------K------RRTL-EMAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH-------H------hccc-cccccCC
Confidence 345788999999998888999999999999999999999999643321110000 0 0000 0111234
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 304 RRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 304 ~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
..++..+.++|.+||+.+|++|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 55678899999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=289.05 Aligned_cols=247 Identities=31% Similarity=0.445 Sum_probs=204.1
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|++.+.||+|++|.||++... +++.|++|.+..... .....+.+|+.++..++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999765 688999999977654 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999854 357899999999999999999999888 9999999999999999999999999997543322
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
. ......++..|+|||.+.+..++.++|||+||+++|+|++|..||...... .. ... .. ..
T Consensus 154 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~----~~~-------~~-~~ 214 (254)
T cd06627 154 K--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AA----LFR-------IV-QD 214 (254)
T ss_pred c--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HH----HHH-------Hh-cc
Confidence 2 123356888999999998888899999999999999999999998632210 00 000 00 01
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+...+..+.+++.+||..+|++||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112334566788999999999999999999999983
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=312.76 Aligned_cols=274 Identities=27% Similarity=0.350 Sum_probs=206.9
Q ss_pred cccccceeccccceEEEEEEE-cCCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCC------eeE
Q 017246 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QRL 132 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~ 132 (375)
.|...+.||+|+||.||+|++ .+|..||||.+++.. ....+....|+++|++++|+|||++++.-++.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 456678899999999999985 479999999998753 345667888999999999999999998754433 457
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe--CCC--ceEEeecC
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--NDF--NPKLSDFG 208 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~--~~~--~vkl~Dfg 208 (375)
+|||||.||+|...+..-+ +...|++.+.+.++.++..||.|||.++ |+||||||.||++- ++| ..||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 9999999999999997644 4567999999999999999999999888 99999999999983 334 36999999
Q ss_pred CCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh----
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF---- 283 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---- 283 (375)
.|+...... ....++||+.|++||++.. +.|+..+|.|||||++|+++||..||-...+......+.|...-
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999643332 5667899999999999984 88999999999999999999999999765544321111111110
Q ss_pred ---------hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC--CHHHHHHHHhhhhhccC
Q 017246 284 ---------LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP--LINDIVVALDYLVSQRD 343 (375)
Q Consensus 284 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP--s~~eil~~L~~l~~~~~ 343 (375)
.+.+..+...+.. ...........+...+..++..+|.+|- .+.+....+..|....-
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred ceeEeeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 0001111111110 1122234455566667778999999998 77777777777766543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=289.29 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=190.8
Q ss_pred HHhhccccccee--ccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHcc-CCCCCcceeEeEEeeCCeeE
Q 017246 57 IATRNFREANLI--GEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 57 ~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~ 132 (375)
...++|++.+.+ |.|+||.||++... ++..+|+|.+........ |+..... .+||||+++++.+...+..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 334567777776 99999999999754 688999999865432221 2222222 26999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAK 211 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~ 211 (375)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .++|+|||++.
T Consensus 86 iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999954 347899999999999999999999988 99999999999999998 99999999987
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..... ....++..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.
T Consensus 159 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~----------- 220 (267)
T PHA03390 159 IIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL----------- 220 (267)
T ss_pred ecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-----------
Confidence 53221 12458899999999998899999999999999999999999997332211 0000000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIV 332 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~eil 332 (375)
.... .....+...+..+.++|.+||+.+|.+||+ +++++
T Consensus 221 ~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 221 KRQQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred Hhhc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 0000 011223467788999999999999999995 69988
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=337.99 Aligned_cols=264 Identities=30% Similarity=0.537 Sum_probs=206.7
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
...|...+.||+|+||.||+|.. .++..||+|.+...... ...|+..+++++||||+++++++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577788999999999999986 47899999998654322 12468889999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++|+|.+++. .+++..+..++.||+.||+|||....++|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 99999999994 27889999999999999999995534449999999999999998887775 665432111
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.||+..... ......|.+.... .......+++.
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 908 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYS-DCHLDMWIDPS 908 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcC-ccchhheeCcc
Confidence 11236789999999999999999999999999999999999999643221 2233444433222 12233344444
Q ss_pred cCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 298 LHG--RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 298 ~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
+.. ..+.....++.+++.+||+.+|++||++.|++++|+.+.+..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 433 234566778899999999999999999999999999986543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=293.98 Aligned_cols=261 Identities=20% Similarity=0.228 Sum_probs=191.9
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCC-CCCcceeEeEEeeC--CeeEEEEe
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSG--DQRLLVYE 136 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 136 (375)
|++.+.||+|+||.||+|... +++.||+|.+..... ........|+.++..+. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677899999999999999754 689999999876422 22234456888888885 99999999999887 88999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 588888754 2356899999999999999999999988 999999999999999 99999999999754222
Q ss_pred CCceeeeccccccccccccccc-cCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhch-------hhhhhhc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWS-------RPFLKDQ 287 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~-------~~~~~~~ 287 (375)
.. .....++..|+|||++. +..++.++|||||||++|||++|..||......+.. ...... .......
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 11 12245788999999765 455789999999999999999999999643221100 000000 0000000
Q ss_pred cccchhcccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
............ ......++..+.++|.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 0012356789999999999999999999999984
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.56 Aligned_cols=262 Identities=24% Similarity=0.304 Sum_probs=197.3
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
|++.+.||.|++|.||+|... +|..||+|++..... .....+.+|+.+++.++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999764 699999999875432 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
. ++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68999886522 246899999999999999999999888 99999999999999999999999999875322211
Q ss_pred ceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc-------ccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ-------KKF 290 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~ 290 (375)
......+++.|+|||++.+. .++.++||||||+++|+|++|..||........ ............ ...
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhc
Confidence 12223568899999988764 578999999999999999999999964322110 000000000000 000
Q ss_pred chh---ccc---ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHL---VDP---LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~---~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... +.. ..........+..+.+++.+||+.+|.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000 0001112345678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=304.16 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=195.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeC-----Cee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 131 (375)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999754 68999999986532 22345677899999999999999999876543 357
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++++||+.+ +|.+++. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 999999964 8887773 346899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCC-ceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh--c
Q 017246 212 LGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD--Q 287 (375)
Q Consensus 212 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~ 287 (375)
....... ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .......+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCH
Confidence 5322211 111233568999999998764 5689999999999999999999999963221100 0000000000 0
Q ss_pred cccchhcc-----------cccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 288 KKFVHLVD-----------PLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 288 ~~~~~~~~-----------~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
..+..+.. ..... ...+..+..+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00000 0012346778999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.77 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=195.5
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC-ccchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 136 (375)
++.+.+..||.|+-|.|++++.+ +|...|||.+.... .+...+++..+.++...+ +|+||+.+|+|..+...+|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34566788999999999999876 58999999997753 344567777887766654 8999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
.|. .-+..++.. -.+++++..+-++...++.||.||..+.+ |+|||+||+|||+|+.|++||||||.+-....
T Consensus 172 lMs-~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd- 244 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD- 244 (391)
T ss_pred HHH-HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec-
Confidence 873 244455543 35669999999999999999999987654 99999999999999999999999999864322
Q ss_pred CCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
....+...|.+.|||||.+. ...|+.++||||||++++||.||+.||.....+= .... .+.+-
T Consensus 245 --SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~lt----------kvln~ 310 (391)
T KOG0983|consen 245 --SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLT----------KVLNE 310 (391)
T ss_pred --ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHH----------HHHhc
Confidence 22334567999999999886 3468999999999999999999999997543210 0000 00011
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
..+.+.. ...+++.+.+++..||++|+.+||.+.++++.
T Consensus 311 ePP~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 EPPLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1122221 12378889999999999999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=284.02 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=201.6
Q ss_pred cceeccccceEEEEEE-EcCCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeecCCCC
Q 017246 65 ANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGS 142 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 142 (375)
.+.||+|+|+.|-.+. ..+|..||||++.+.......++.+|++++.+. .|+||++++++|+++..+|||||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4679999999999884 678999999999887666778899999999998 59999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc---eEEeecCCCccCCCC---
Q 017246 143 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKLGPVG--- 216 (375)
Q Consensus 143 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~---vkl~Dfg~a~~~~~~--- 216 (375)
|..+|.+ +..+++.++..+.++|+.||.|||.+| |.||||||+|||...... |||+||.+.......
T Consensus 163 lLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999965 667999999999999999999999998 999999999999966544 799999887431111
Q ss_pred --CCceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 217 --DNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 217 --~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
..+....+.+|+..|||||++. ...|+.+.|.||||||+|-||+|.+||...-+.+ ..|.+... -...
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CGWdrGe~-Cr~C 310 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CGWDRGEV-CRVC 310 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CCccCCCc-cHHH
Confidence 1122234578999999999764 2458999999999999999999999997543321 11111000 0000
Q ss_pred cchhcccccCCC--CC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVHLVDPLLHGR--YP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~~~~~~~~~~--~~----~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...++..+..+. +| ..++.+..+||...+-.++.+|.++.+++.
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 112223333332 23 256788899999999999999999998883
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=298.03 Aligned_cols=266 Identities=25% Similarity=0.329 Sum_probs=195.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeC--CeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 133 (375)
.++|++.+.||.|+||.||+|... +|+.||+|.+...... ....+.+|+.+++.++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457999999999999999999865 6899999998654322 233456799999999999999999998754 56899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+.+ +|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999964 888888642 356899999999999999999999988 999999999999999999999999998754
Q ss_pred CCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhchh-------hhh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSR-------PFL 284 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~-------~~~ 284 (375)
..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.......... +..... +..
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 33221 1222345788999998875 557899999999999999999999996432211100 000000 000
Q ss_pred hhccccchh-cccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 285 KDQKKFVHL-VDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 285 ~~~~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
......... ........ .....+..+.++|.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 00000000 01124677889999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=296.64 Aligned_cols=251 Identities=29% Similarity=0.407 Sum_probs=198.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..|...+.||+|+||.||+++.. ++..+|+|++..... .....+.+|+.+++.++|||++++++++..++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34788899999999999999764 688999999865422 22346788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99975 78777753 2456899999999999999999999988 99999999999999999999999999864322
Q ss_pred CCCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.....|++.|+|||++. ...++.++|||||||++|+|++|..||....... .. ..
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~--------------~~ 235 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL--------------YH 235 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HH--------------HH
Confidence 12346888999999874 4568899999999999999999999985321100 00 00
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
+............++..+.+++.+||+.+|.+||++.+|++.+-.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00000111112346678999999999999999999999998654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=296.42 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=196.9
Q ss_pred ccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCC
Q 017246 64 EANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 142 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 142 (375)
....||+|+||.||++... ++..||+|++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3467999999999999764 689999999865544455678889999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceee
Q 017246 143 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 222 (375)
Q Consensus 143 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 222 (375)
|.+++. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 104 L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~ 173 (292)
T cd06657 104 LTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR 173 (292)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccc
Confidence 999773 345789999999999999999999988 9999999999999999999999999886432211 122
Q ss_pred eccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCC
Q 017246 223 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 302 (375)
Q Consensus 223 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (375)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... .... .. ......+. .
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~----~~------~~~~~~~~--~ 238 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IR------DNLPPKLK--N 238 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HH------hhCCcccC--C
Confidence 33568899999999988888999999999999999999999986321110 0000 00 00011110 1
Q ss_pred CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 303 PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 303 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...++..+.+++.+||+.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1345667889999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.57 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=197.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEee----CCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 131 (375)
..+|++.+.||.|+||.||+|... +|..||+|++.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999754 69999999987542 2334567789999999999999999988753 3568
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 589888853 455899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCC--ceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh-----
Q 017246 212 LGPVGDN--THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF----- 283 (375)
Q Consensus 212 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----- 283 (375)
....... ........|+..|+|||++.+ ..++.++|||||||++|||++|+.||........ .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~ 232 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPS 232 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCCh
Confidence 5322221 111223578999999998865 4688999999999999999999999964321100 0000000
Q ss_pred ---hhh--ccccchhcc---cccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 284 ---LKD--QKKFVHLVD---PLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 284 ---~~~--~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... ......... .... ..+.+..+..+.++|.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 000000000 0000 0111345788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=291.11 Aligned_cols=242 Identities=26% Similarity=0.396 Sum_probs=193.8
Q ss_pred eccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 68 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
||.|+||.||++... +|+.+++|.+..... .....+.+|+.+++.++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 599999999876543 3455688899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC-----
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN----- 218 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~----- 218 (375)
.+++.. ...+++..++.++.||+.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999964 237899999999999999999999888 99999999999999999999999999875332211
Q ss_pred -ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 -THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
........++..|+|||.+....++.++||||||+++|+|++|..||....... .. ..+....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~-------------~~~~~~~ 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IF-------------QNILNGK 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HH-------------HHHhcCC
Confidence 112234567889999999988889999999999999999999999996332110 00 0000000
Q ss_pred cCCCCCHH--HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 298 LHGRYPRR--CLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 298 ~~~~~~~~--~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
...+.. .+..+.+++.+||+.+|++||++..+.+.
T Consensus 218 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 218 --IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred --cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 011222 37889999999999999999999444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=299.81 Aligned_cols=268 Identities=25% Similarity=0.345 Sum_probs=197.5
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEcccc--CccchHHHHHHHHHHccC-CCCCcceeEeEEeeC--Cee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG--DQR 131 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~ 131 (375)
..++|++.+.||.|+||.||+|... ++..+|+|++... .......+..|+.+++.+ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567999999999999999999865 6889999988542 223345577899999999 999999999988643 468
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+. ++|..++.. ..+.+..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 599888843 26788899999999999999999888 9999999999999999999999999987
Q ss_pred cCCCCCCc---eeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhchhhhh-h
Q 017246 212 LGPVGDNT---HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFL-K 285 (375)
Q Consensus 212 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~-~ 285 (375)
........ .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.......... ......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 54332211 12233568999999998765 457899999999999999999999996432211000 000000000 0
Q ss_pred h-----ccccchhcccccC------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 286 D-----QKKFVHLVDPLLH------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 286 ~-----~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
. ......++..... ....+.++..+.++|.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 0000000100000 01112367889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.55 Aligned_cols=253 Identities=28% Similarity=0.350 Sum_probs=205.3
Q ss_pred hhcccccceeccccceEEEEEE-EcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.-++.-+..||.|.||.||.+. ..+|...|+|.+..... .....+.+|..+|..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3466678899999999999995 56799999998865433 33456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||++|+|.+.+.. +....+.....+..|++.|+.|||++| ||||||||+|||++.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999953 455667777889999999999999999 99999999999999999999999999975332
Q ss_pred CC--CceeeeccccccccccccccccC---CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 216 GD--NTHVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 216 ~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
.. .........||+.|||||++.+. ....++|||||||++.||+||+.||.... +...+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----------------ne~aI 1450 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----------------NEWAI 1450 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----------------chhHH
Confidence 21 11222346799999999999854 35678999999999999999999996221 11122
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.-.+...-.+.+|..++.+-.++|.+||+.||.+|.++.||++.
T Consensus 1451 My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22222333446678899999999999999999999999888763
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=298.99 Aligned_cols=270 Identities=22% Similarity=0.280 Sum_probs=195.6
Q ss_pred ceeccc--cceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEG--GFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
..||.| +||+||++.+. +|+.||+|++..... ...+.+.+|+.+++.++||||++++++|...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999864 799999999875432 2245678899999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC-CCc
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG-DNT 219 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~-~~~ 219 (375)
++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++++||+.+...... ...
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987632 345889999999999999999999888 999999999999999999999999854321110 000
Q ss_pred ----eeeeccccccccccccccccC--CCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhh------chhhhh--
Q 017246 220 ----HVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVS------WSRPFL-- 284 (375)
Q Consensus 220 ----~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~------~~~~~~-- 284 (375)
.......++..|+|||++.+. .++.++|||||||++|+|++|..||......... .... +.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 001112356679999998764 4789999999999999999999999643211000 0000 000000
Q ss_pred -----hhc---------------cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhhhhh
Q 017246 285 -----KDQ---------------KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVS 340 (375)
Q Consensus 285 -----~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~--~L~~l~~ 340 (375)
... ..........+....+..++..+.+|+.+||+.||++|||+.++++ .+..+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000 0000011111122223467889999999999999999999999986 3555544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.20 Aligned_cols=243 Identities=29% Similarity=0.417 Sum_probs=200.2
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCC-CCCcceeEeEEeeCCee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 131 (375)
+...+|.++.+||+|+||.|.++..+ +...||||+++++.. .+.+--..|-.+|.... -|.+++++..|.+-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34557889999999999999999655 578899999987643 23334456777777764 56889999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
|+||||+.||+|.-++++. +.+.+..+..++..|+-||-+||+++ |++||||.+|||+|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999999888663 45677889999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..-... ....++||||.|+|||++..++|+.++|+||+||+||||+.|.+||+....+ .+ +.
T Consensus 499 Eni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---el-------------F~ 560 (683)
T KOG0696|consen 499 ENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL-------------FQ 560 (683)
T ss_pred ccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HH-------------HH
Confidence 543332 2345699999999999999999999999999999999999999999843221 11 11
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 326 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 326 (375)
.+.+... .+|..++.+...+....+.++|.+|.
T Consensus 561 aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 561 AIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 1222211 46888999999999999999999995
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=296.44 Aligned_cols=268 Identities=25% Similarity=0.330 Sum_probs=193.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCC------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------ 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 129 (375)
.++|++.+.||+|+||.||++... +++.||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999765 6899999988654322 2334567999999999999999999886654
Q ss_pred --eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 130 --QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 130 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
..++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 4599999996 488887753 2346899999999999999999999988 999999999999999999999999
Q ss_pred CCCccCCCCCCc--eeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchh---
Q 017246 208 GLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR--- 281 (375)
Q Consensus 208 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--- 281 (375)
|++......... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||................
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998754322211 112234578899999988654 47889999999999999999999996433211100000000
Q ss_pred --hhhhhccccc---hhc-ccc----cCCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 --PFLKDQKKFV---HLV-DPL----LHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 --~~~~~~~~~~---~~~-~~~----~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......... ... ... ....+ +......+.++|.+||+.+|.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000000 000 000 00000 1112456789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=293.64 Aligned_cols=266 Identities=23% Similarity=0.287 Sum_probs=195.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|++|.||+|... +|+.||+|.+..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46899999999999999999765 689999999865432 223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-CCceEEeecCCCccCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~ 215 (375)
|++ ++|.+++... ....+++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 5888877542 2334678889999999999999999988 999999999999985 45799999999975322
Q ss_pred CCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhch-hh---hhhhccc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS-RP---FLKDQKK 289 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~-~~---~~~~~~~ 289 (375)
. ........+++.|+|||++.+ ..++.++|||||||++|+|+||.+||.......... ..... .+ .+.....
T Consensus 156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 1 111223457889999998865 457899999999999999999999996432211000 00000 00 0000000
Q ss_pred cchhc--ccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVHLV--DPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... .+.... ...+..+..+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 000000 012345677899999999999999999999995
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=289.10 Aligned_cols=241 Identities=24% Similarity=0.288 Sum_probs=187.8
Q ss_pred ceeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHHH-HccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLM-LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||.|+||.||+|... +++.||+|.+....... ...+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999764 68999999987543221 2223444443 4556899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999854 356889999999999999999999988 99999999999999999999999999875322
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .. ....... ......
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~~~--------~~~~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AV---FDNILSR--------RINWPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHhc--------ccCCCC
Confidence 22356888999999998888899999999999999999999999632211 00 0000000 000111
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....++..+.+++.+||+.+|++||++.++.+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 123356788999999999999999997754443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=290.73 Aligned_cols=241 Identities=27% Similarity=0.354 Sum_probs=188.4
Q ss_pred eeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHH---HHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 67 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVL---MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
+||+|+||.||++... +++.||+|.+.+..... ...+..|.. .+....||||+.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 68899999987643221 122333433 4444679999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
|++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 9999998853 457999999999999999999999988 999999999999999999999999998643221
Q ss_pred eeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 220 HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
......|+..|+|||++.+. .++.++||||+||++|+|++|+.||............. . ....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~--------------~-~~~~ 214 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------------M-TLTM 214 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH--------------H-hhcc
Confidence 12235689999999998754 68999999999999999999999996432211110000 0 0011
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
...++..++..+.+++.+|+..+|.+|| ++.++++
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1223445678899999999999999999 9999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=301.38 Aligned_cols=270 Identities=22% Similarity=0.340 Sum_probs=199.8
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEcccc--CccchHHHHHHHHHHccCCCCCcceeEeEEeeC-----Ce
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 130 (375)
..+|.+.+.||+|+||.||++... ++..||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357999999999999999999754 6899999998653 223345677899999999999999999987644 34
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 689888853 457999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhchh-------
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSR------- 281 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~------- 281 (375)
....... .......++..|+|||++.. ..++.++|||||||++|+|++|++||.......... ......
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7543221 12233467889999998865 468899999999999999999999996432110000 000000
Q ss_pred hhhhh--ccccchhcccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhhh
Q 017246 282 PFLKD--QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYL 338 (375)
Q Consensus 282 ~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~--L~~l 338 (375)
.+..+ .......+...... ...+.++..+.+++.+||+.+|++||+++++++. +..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 00000000000000 1123567889999999999999999999999975 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=292.40 Aligned_cols=261 Identities=26% Similarity=0.334 Sum_probs=196.7
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeC--CeeEEEEe
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYE 136 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 136 (375)
|++.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999866 58899999997653 23345678899999999999999999999887 88999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++ +|.+++.. ....+++..++.++.||+.||+|||+.+ ++|+||+|+|||+++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 88888854 2257899999999999999999999888 999999999999999999999999998754332
Q ss_pred CCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh--ccccc--
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD--QKKFV-- 291 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~-- 291 (375)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|..||........ .......... ...+.
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGV 229 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccc
Confidence 21 11223456788999998765 4578999999999999999999999964332110 0000000000 00000
Q ss_pred -h-----------hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 -H-----------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 -~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. .....+...+...++..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000000111123778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=289.66 Aligned_cols=250 Identities=25% Similarity=0.303 Sum_probs=197.3
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccC-----ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
+|.+.+.||+|+||.||++... .+..+++|+++... ......+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999764 34556666554321 12234566789999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998765445667999999999999999999999988 999999999999975 569999999987532
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. ........|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..... ...
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~----------~~~ 218 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVL----------RIV 218 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH----------HHH
Confidence 22 1223345688899999999888889999999999999999999999852211 00000 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. ......+..++..+.++|.+||+.+|++||++.++++
T Consensus 219 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 219 E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 1111234567788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=293.40 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=203.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 134 (375)
++|.+.+.||.|+||.||++... +++.||+|++..... .....+..|+.+++.+. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36889999999999999999765 699999999876322 22456778999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
||++++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999964 347999999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCC------------------ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccch
Q 017246 215 VGDN------------------THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276 (375)
Q Consensus 215 ~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 276 (375)
.... ........++..|+|||++....++.++|+||||+++++|++|..||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence 2221 122234567899999999988889999999999999999999999997432100
Q ss_pred hhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHH
Q 017246 277 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI----NDIVV 333 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~----~eil~ 333 (375)
. . .... .....++...+..+.+++.+||+.+|++||++ .+++.
T Consensus 230 -~-----~------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 -T-----F------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -H-----H------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 0 0000 11123345567889999999999999999999 77763
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=294.63 Aligned_cols=264 Identities=20% Similarity=0.221 Sum_probs=194.2
Q ss_pred ccccceeccccceEEEEEEEcCCceEEEEEcccc--CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 62 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
+.+++.+|.|+++.|+++.. +++.||+|++... .......+..|+.+++.++|+||+++++++...+..+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34455566665555555544 6899999998765 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC-
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN- 218 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~- 218 (375)
+++|.+++.... ...+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||.+........
T Consensus 83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 83 YGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999997532 345889999999999999999999988 99999999999999999999999998864322111
Q ss_pred ----ceeeecccccccccccccccc--CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchh----------h
Q 017246 219 ----THVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR----------P 282 (375)
Q Consensus 219 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----------~ 282 (375)
........++..|+|||++.. ..++.++|||||||++|||++|..||....... ....... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCc
Confidence 111223457788999999875 358899999999999999999999996432111 0000000 0
Q ss_pred hhhhccccch----h----cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 FLKDQKKFVH----L----VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 ~~~~~~~~~~----~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......... . ................+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000000000 0 0001111234456788999999999999999999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.49 Aligned_cols=266 Identities=26% Similarity=0.309 Sum_probs=197.0
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCC----
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD---- 129 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 129 (375)
...++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34568999999999999999999875 588999999876432 22345678999999999999999999887654
Q ss_pred ------eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 130 ------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 130 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
..++|+||+++ +|.+.+.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999976 77777753 2456899999999999999999999888 99999999999999999999
Q ss_pred EeecCCCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hchh
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSR 281 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~ 281 (375)
|+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+ ....
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999875433221 11122346778999998864 45789999999999999999999999643221110000 0000
Q ss_pred hhhhhccccchh--------------cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 PFLKDQKKFVHL--------------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ....+..+ ....... ....++..+.+++.+||+.+|++||++.++++
T Consensus 236 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SP--CPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CC--Chhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00000000 0000000 01234678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=290.94 Aligned_cols=251 Identities=27% Similarity=0.366 Sum_probs=197.2
Q ss_pred cccccceeccccceEEEEEEE----cCCceEEEEEccccCc----cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCee
Q 017246 61 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 131 (375)
+|++.+.||.|+||.||++.. .+|..||+|++..... .....+.+|+.++..+ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999975 3688999999865322 2235677899999999 589999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999964 456889999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCCceeeeccccccccccccccccC--CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
....... .......|+..|+|||.+... .++.++||||||+++|+|++|..||........ ........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~------ 224 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRI------ 224 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHh------
Confidence 5332221 112235688999999998753 467899999999999999999999963221110 00000000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
.. ....++..++..+.+++.+||+.+|++|| ++.+++.
T Consensus 225 ----~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 ----LK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----hc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 01123456778899999999999999997 6777763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=298.98 Aligned_cols=272 Identities=25% Similarity=0.323 Sum_probs=204.0
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCC-----eeE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRL 132 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 132 (375)
+|++.+.||.|++|.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999865 58999999987643 334567888999999999999999999987765 789
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
++|||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 488888853 447999999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCC-ceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhchhhh----hh
Q 017246 213 GPVGDN-THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPF----LK 285 (375)
Q Consensus 213 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~----~~ 285 (375)
...... ........+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.......... ........ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 433221 0112334678899999999887 78999999999999999999999996443211000 00000000 00
Q ss_pred --hccccchhccc------ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhhhhh
Q 017246 286 --DQKKFVHLVDP------LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYLVS 340 (375)
Q Consensus 286 --~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~--L~~l~~ 340 (375)
........+.. .......+..+..+.+++.+||+.+|++||++.+++.. ++.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000 00001123357789999999999999999999999974 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=289.97 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=198.7
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
|++.+.||.|++|.||++... +++.+++|.+...... ....+..|+.+++.++|+||+++++++...+..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999764 6899999998764333 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++ +|.+++.. ....+++..++.++.||+.||.|||.++ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 88888754 2357899999999999999999999988 9999999999999999999999999987543322
Q ss_pred ceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccch-hh-chhhhhhhccccch---
Q 017246 219 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VS-WSRPFLKDQKKFVH--- 292 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~-~~~~~~~~~~~~~~--- 292 (375)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........... .. ........-.....
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 122234578899999998876 789999999999999999999999964332110000 00 00000000000000
Q ss_pred -----hcc--cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 -----LVD--PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 -----~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... ........+.++..+.++|.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00001122456789999999999999999999999984
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=291.57 Aligned_cols=272 Identities=19% Similarity=0.254 Sum_probs=204.7
Q ss_pred ccHHHHHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC-C-C----CcceeE
Q 017246 50 FTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-H-D----NLVTLI 122 (375)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~ 122 (375)
..+........+|.+..+||+|+||.|..+... .+..||||+++.- ....+...-|+.+|.++. + | -+|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 334444555789999999999999999999644 5789999998653 234455667999999984 2 2 378888
Q ss_pred eEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC----
Q 017246 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---- 198 (375)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---- 198 (375)
+||...++.|||+|.+ |.++++++.. ++-.+++...++.++.|+++++++||+.+ ++|.||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceE
Confidence 9999999999999987 7799999976 34567889999999999999999999988 999999999999931
Q ss_pred ----------------CCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCC
Q 017246 199 ----------------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262 (375)
Q Consensus 199 ----------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 262 (375)
+..|+|+|||.|+...... ...+.|..|+|||++++-.++..+||||+||||+||.||.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 3358999999998633222 4467899999999999999999999999999999999999
Q ss_pred CCccccccccccchhhch--------------hhhhhhc-ccc---------chhcccccC----CCCCHHHHHHHHHHH
Q 017246 263 KAMDLSKGQGEQNLVSWS--------------RPFLKDQ-KKF---------VHLVDPLLH----GRYPRRCLNYAVAVT 314 (375)
Q Consensus 263 ~pf~~~~~~~~~~~~~~~--------------~~~~~~~-~~~---------~~~~~~~~~----~~~~~~~~~~l~~li 314 (375)
..|+.....+...+++.. ..++... -++ ....++... ..........|.+|+
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 999876643322111111 0011100 000 000000000 011234566799999
Q ss_pred HhhcCCCCCCCCCHHHHHH
Q 017246 315 AMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 315 ~~cl~~~p~~RPs~~eil~ 333 (375)
..||..||.+|+|+.|++.
T Consensus 387 ~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHccCccccccHHHHhc
Confidence 9999999999999999985
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=286.47 Aligned_cols=261 Identities=24% Similarity=0.322 Sum_probs=194.1
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCccc--hHHHHHHHHHHccC---CCCCcceeEeEEeeCCe-----
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLL---HHDNLVTLIGYCTSGDQ----- 130 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 130 (375)
|++.+.||.|+||.||+|... +++.||+|.+....... ...+.+|+.+++.+ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999876 48999999997543221 23455677766555 69999999999988776
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.+++|||+.+ +|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8988886522 346899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh-hccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKK 289 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 289 (375)
........ .....++..|+|||++.+..++.++|+|||||++|+|++|.+||....... ........... ....
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence 75432211 122457889999999998899999999999999999999999986432211 11100000000 0000
Q ss_pred c-------chhcccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 F-------VHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~-------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+ ......... ....+..+..+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 1112345678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=291.31 Aligned_cols=255 Identities=27% Similarity=0.353 Sum_probs=199.8
Q ss_pred cccccceeccccceEEEEEEE----cCCceEEEEEccccCc----cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCee
Q 017246 61 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 131 (375)
+|++.+.||+|++|.||++.. .++..||+|++.+... .....+.+|+.++..+ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999864 2578899999865322 2234577899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||.||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999853 456889999999999999999999888 9999999999999999999999999987
Q ss_pred cCCCCCCceeeeccccccccccccccccCC--CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
....... .......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||........ ........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~------ 224 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRI------ 224 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHH------
Confidence 5332221 1122356889999999987654 78899999999999999999999963221110 00000000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
.. .....+..++..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 ----~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 225 ----LK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----Hc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00 0112344567789999999999999999998888776544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=290.84 Aligned_cols=244 Identities=29% Similarity=0.390 Sum_probs=193.1
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.|...+.||+|+||.||+|... ++..|++|++...... ....+.+|+.+++.++|||++++++++.+.+..++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3666788999999999999764 6889999998654322 23467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+. ++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 995 578777754 2456899999999999999999999988 99999999999999999999999999864211
Q ss_pred CCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||......... .. .
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~----------~ 232 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YH----------I 232 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HH----------H
Confidence 22356888999999884 456888999999999999999999998532211100 00 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
............++..+.+++.+||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 233 AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000011112345567899999999999999999999994
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=298.57 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=194.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeC---------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--------- 128 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 128 (375)
..+|.+.+.||.|+||.||+|... +|..||+|.+..........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999764 6899999998776656667788999999999999999999776543
Q ss_pred -----CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-CCce
Q 017246 129 -----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNP 202 (375)
Q Consensus 129 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~v 202 (375)
...++||||+. ++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999996 58988874 346889999999999999999999988 999999999999974 5578
Q ss_pred EEeecCCCccCCCCCC-ceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch
Q 017246 203 KLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 280 (375)
+|+|||++........ ........++..|+|||++.. ..++.++|||||||++|+|++|+.||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999875322111 111122457889999998754 56888999999999999999999999643221110000000
Q ss_pred hhhhh--hccc----cchhcc-cccCC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 281 RPFLK--DQKK----FVHLVD-PLLHG-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 281 ~~~~~--~~~~----~~~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+... .... ...... ..... ......+.++.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0000 000000 00000 011245678899999999999999999999994
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=290.48 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=192.6
Q ss_pred hhcccccceeccccceEEEEEEEcC-CceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.++|++.+.||+|+||.||+|.... ++.||||.+..... .....+..|+.++..+ .||||+++++++......+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4578999999999999999998764 89999999876432 2334566677666555 5999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
||+. ++|.+++.. ....+++..+..++.||+.||.|||+ .+ |+||||+|+||++++++.+||+|||++....
T Consensus 94 e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9984 477777654 23478999999999999999999997 46 9999999999999999999999999986532
Q ss_pred CCCCceeeeccccccccccccccccCC----CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||....... .. ........
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~---~~~~~~~~--- 235 (296)
T cd06618 167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EV---LTKILQEE--- 235 (296)
T ss_pred CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HH---HHHHhcCC---
Confidence 2111 12245788999999987553 7889999999999999999999996321110 00 00000000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.+.. .....++..+.+++.+||+.+|++||++.++++.
T Consensus 236 ----~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 ----PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0112356789999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=282.54 Aligned_cols=272 Identities=23% Similarity=0.246 Sum_probs=199.3
Q ss_pred hhcccccceeccccceEEEEEEE-c--C--CceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee-CCe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-E--S--GQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~--~--~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 130 (375)
...|+....||+|+||.||++.. + + .+.+|||.++.... .-.....+|+.+++.++|||++.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 34699999999999999999943 2 2 33799999976522 224567889999999999999999998876 788
Q ss_pred eEEEEeecCCCCHHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC----CceEEe
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND----FNPKLS 205 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~----~~vkl~ 205 (375)
+++++||.+. +|...|+-.+. ....++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999977 88888865432 3456889999999999999999999988 9999999999999877 899999
Q ss_pred ecCCCccCCCCC-CceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccc----hhhc
Q 017246 206 DFGLAKLGPVGD-NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN----LVSW 279 (375)
Q Consensus 206 Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~----~~~~ 279 (375)
|||+++.+...- .......++-|.+|+|||++.+. .|+.+.|||++|||+.||+|-.+.|.......+.. ..+.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999998754332 22234456789999999999875 59999999999999999999998886433221111 0000
Q ss_pred h-------------hhhhhhccccchhccccc---CCCC--C------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 280 S-------------RPFLKDQKKFVHLVDPLL---HGRY--P------RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 280 ~-------------~~~~~~~~~~~~~~~~~~---~~~~--~------~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
. ++.+..--.....+.... .... . ..-++.-.+|+.++|+.||-+|.|+++.++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 0 000000000000000000 0000 0 0113336789999999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=290.99 Aligned_cols=246 Identities=30% Similarity=0.410 Sum_probs=194.3
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..|...+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+.+++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999865 588899999864322 22346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 588777753 2345889999999999999999999888 99999999999999999999999999865321
Q ss_pred CCCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.....+++.|+|||++. ...++.++|||||||++|+|++|..||....... ... .
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~--------------~ 225 (308)
T cd06634 168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY--------------H 225 (308)
T ss_pred ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHH--------------H
Confidence 12346888999999875 3467889999999999999999999985321110 000 0
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
..........+..++..+.++|.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 000000111123567789999999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=287.99 Aligned_cols=263 Identities=26% Similarity=0.309 Sum_probs=195.2
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEEEeec
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
|.+.+.||.|++|.||+|... +++.|+||.+..... .......+|+..++.++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999875 588899999865422 22234456889999998 999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
+++|.+++.... ...+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 789999886522 357899999999999999999999988 9999999999999999999999999987532221
Q ss_pred ceeeeccccccccccccccc-cCCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhchhhh----hhhccccch
Q 017246 219 THVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPF----LKDQKKFVH 292 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~----~~~~~~~~~ 292 (375)
......++..|+|||++. ...++.++|+||||+++++|++|.+||......+... ...+.... +........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 122345788999999875 4457899999999999999999999996443211100 00000000 000000000
Q ss_pred hcccccC-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLH-------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+. .......+..+.+++.+||+.+|++||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0011122577999999999999999999999984
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=293.53 Aligned_cols=265 Identities=21% Similarity=0.262 Sum_probs=191.6
Q ss_pred cccccceeccccceEEEEEEEc-C--CceEEEEEccccCc--cchHHHHHHHHHHccC-CCCCcceeEeEEeeC----Ce
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-S--GQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG----DQ 130 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~ 130 (375)
+|++.+.||+|+||.||++... . +..||+|.+..... .....+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999764 4 78899999865321 2245677899999998 599999999875432 45
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.+++++++. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899885 689888853 567899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCC--ceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hh--------h
Q 017246 211 KLGPVGDN--THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LV--------S 278 (375)
Q Consensus 211 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~--------~ 278 (375)
........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.......... .. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 75332211 111223568999999998765 468999999999999999999999996433110000 00 0
Q ss_pred chhhhhhh-ccccchhcccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 279 WSRPFLKD-QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 279 ~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........ .............. ...+..+..+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00000000000000 011224678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.63 Aligned_cols=243 Identities=26% Similarity=0.328 Sum_probs=205.0
Q ss_pred hhcccccceeccccceEEEEEEEcCCc-eEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQ-LVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
-.+++....||-|+||.|-+++..... .+|+|++++....+ .+.+..|-.+|...+.|.||++|-.|.+...+|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 356777889999999999999876433 48999998765543 44577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
||-|-||.|+..+.. ++.+....++.++..+++|++|||+++ ||+|||||+|++++.+|-+||.|||+|+...
T Consensus 499 mEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999954 678888999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.+.. .-++||||.|.|||++.+...+.++|.||||+++|||++|.+||....+....+++-
T Consensus 572 ~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL---------------- 632 (732)
T KOG0614|consen 572 SGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL---------------- 632 (732)
T ss_pred cCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH----------------
Confidence 4433 345899999999999999999999999999999999999999998655433322211
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 327 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs 327 (375)
...-.-.+|..+.....+||++.+..+|.+|.-
T Consensus 633 kGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 633 KGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 111112456778888999999999999999975
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=299.29 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=196.1
Q ss_pred cceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCC
Q 017246 65 ANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 141 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 141 (375)
.++||+|.||+||-|.++ +|+.||||++.+-.. +....+.+|+.+|..+.||.||.+...|++.+.+++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 578999999999999765 799999999977544 3345688999999999999999999999999999999999966
Q ss_pred CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC---CceEEeecCCCccCCCCCC
Q 017246 142 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 142 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~---~~vkl~Dfg~a~~~~~~~~ 218 (375)
+..+.|.. ...+++++..-..+..||+.||.|||.++ |+|+||||+|||+... .++||||||+|+.....
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 55454443 35788999999999999999999999998 9999999999999654 46999999999974332
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
......+|||.|+|||++.++.|+..-|+||.|||+|.-++|..||+...+-. +++.+.. -+..+..
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-dQIQNAa-----------FMyPp~P 787 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-DQIQNAA-----------FMYPPNP 787 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-HHhhccc-----------cccCCCc
Confidence 23445889999999999999999999999999999999999999997432211 1111100 0111111
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
=.+++....+||...|+..-.+|-+...-+
T Consensus 788 ----W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 ----WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ----hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 135667788999999999999998887655
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=291.68 Aligned_cols=268 Identities=24% Similarity=0.323 Sum_probs=193.5
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc--hHHHHHHHHHHccCCCCCcceeEeEEeeC-------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSG------- 128 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~------- 128 (375)
.++|++.+.||.|+||.||+|... +++.+|+|++....... ...+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999865 68999999886543222 34567899999999999999999887543
Q ss_pred -CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 129 -DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 129 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
..+++||||+.+ +|...+.. ....+++..+..++.||++||.|||+++ |+|+||||+|||+++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 346899999865 67776643 3457999999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCCc---------eeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-h
Q 017246 208 GLAKLGPVGDNT---------HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-L 276 (375)
Q Consensus 208 g~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~ 276 (375)
|++......... .......+++.|+|||++.+ ..++.++|||||||++|||++|++||.......... .
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 998753222111 11123457889999998765 458899999999999999999999996433211100 0
Q ss_pred hhchhhhhhhc----cccchhcccccCCCCC-------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 277 VSWSRPFLKDQ----KKFVHLVDPLLHGRYP-------RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 277 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........... ...............+ ......+.+++.+||+.+|++||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 0000000000000111 123467889999999999999999999983
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=294.86 Aligned_cols=263 Identities=23% Similarity=0.291 Sum_probs=194.9
Q ss_pred hccc-ccceeccccceEEEEEEEc-CCceEEEEEccccCccc--------------hHHHHHHHHHHccCCCCCcceeEe
Q 017246 60 RNFR-EANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--------------HQEFIVEVLMLSLLHHDNLVTLIG 123 (375)
Q Consensus 60 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~ 123 (375)
++|. +.+.||.|+||.||+|... +++.||+|++....... ...+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4578999999999999765 68999999986543221 124678999999999999999999
Q ss_pred EEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 124 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
++...+..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ |+|+||+|+|||++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999996 589998853 456899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCccCCCCC------------CceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCcccccc
Q 017246 204 LSDFGLAKLGPVGD------------NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKG 270 (375)
Q Consensus 204 l~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~ 270 (375)
|+|||++....... .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987533110 01111223468889999998764 468999999999999999999999964332
Q ss_pred ccccchhhchhhhhhhc--cccchh--------cccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 271 QGEQNLVSWSRPFLKDQ--KKFVHL--------VDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~--~~~~~~--------~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... ........... ..+... ....... .....++..+.+++.+||+.+|++||++.+++.
T Consensus 240 ~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 110 00000000000 000000 0000000 011234677899999999999999999999994
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=294.53 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=195.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeC------C
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------D 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 129 (375)
..+|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999764 689999999865322 2234578899999999999999999988654 3
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..++|+||+.. +|..++ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999854 776655 235889999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhc---hhh-h
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW---SRP-F 283 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~---~~~-~ 283 (375)
+...... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .... ..+ +
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8753221 123457889999999876 468899999999999999999999997432111000 0000 000 0
Q ss_pred hhh--ccccchh---cccccCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhhhh
Q 017246 284 LKD--QKKFVHL---VDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYLV 339 (375)
Q Consensus 284 ~~~--~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~--L~~l~ 339 (375)
... ....... ......... .+..+..+.++|.+||+.||++||++.+++.. ++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 0000000 000000000 12345678899999999999999999999964 65554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.38 Aligned_cols=269 Identities=30% Similarity=0.442 Sum_probs=202.7
Q ss_pred cccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHcc--CCCCCcceeEeEEeeCC----eeEEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTSGD----QRLLV 134 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv 134 (375)
...+.++||+|.||.||+|.+. ++.||||++.. ...+.+..|-.+.+. +.|+||++++++-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4556788999999999999987 59999999965 445677777777665 58999999999866555 88999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK------ANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
++|.+.|+|.+||. ...++|....+++..+++||+|||.- .+++|+|||||..||||.++++..|+|||
T Consensus 287 t~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999995 56799999999999999999999953 25779999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCC-CC-----ccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LT-----LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
+|.....+.........+||.+|||||++.+.- +. .+.||||+|.+||||++....+.... .++ ....|...
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~-vp~-Yqlpfe~e 439 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP-VPE-YQLPFEAE 439 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC-CCc-ccCchhHH
Confidence 998765544433334478999999999987532 22 46899999999999999766553211 111 00111000
Q ss_pred hhhhccc----cchhcccccCCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 283 FLKDQKK----FVHLVDPLLHGRYPR-----RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 283 ~~~~~~~----~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
. ...-. ....+....++.++. .....+.+.+..||..||+-|.|+.=+.+++.++...
T Consensus 440 v-G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 440 V-GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred h-cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 0 00000 011222233333332 3456788999999999999999999999999888643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=282.41 Aligned_cols=268 Identities=25% Similarity=0.341 Sum_probs=203.2
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHcc--CCCCCcceeEeEEeeC----Ce
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTSG----DQ 130 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~~ 130 (375)
...++..+.+.||+|.||.||+|+++ |..||||++... +...+.+|.++... |+|+||+.+++.-..+ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 34567899999999999999999998 889999999653 45567788888766 5999999999876443 36
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCcccCCCCCCcEEEeCCCceEEe
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLS 205 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~i~H~Dlkp~Nill~~~~~vkl~ 205 (375)
++||.+|.+.|||+|||. ...++....++++..+|.||++|| .+|.|.|.|||||..||||..+|.+.|+
T Consensus 284 LwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 789999999999999994 467899999999999999999999 3567889999999999999999999999
Q ss_pred ecCCCccCCCC--CCceeeeccccccccccccccccCC------CCccchhHhHHHHHHHHHhC----------CCCccc
Q 017246 206 DFGLAKLGPVG--DNTHVSTRVMGTYGYCAPEYAMSGK------LTLKSDIYSFGVVLLELITG----------RKAMDL 267 (375)
Q Consensus 206 Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg----------~~pf~~ 267 (375)
|+|+|...... .-....+..+||-+|||||++...- .-..+||||||+++||++.. +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999753322 1222345578999999999986432 12469999999999999853 234432
Q ss_pred cccccccchhhchhhhhhhccccchhcccccCC-CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 268 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG-RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
..+.+.. + ..+.+..-..+ +.|.+.. -....+...+.+|++.||..+|.-|-|+=.|-+.|.++..
T Consensus 439 ~Vp~DPs-~-----eeMrkVVCv~~-~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPS-F-----EEMRKVVCVQK-LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCC-H-----HHHhcceeecc-cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2111110 0 00010111111 1122221 1235678899999999999999999999999999999875
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=291.92 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=196.6
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee-CCeeE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRL 132 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~ 132 (375)
...++|.+.+.||.|+||.||++... ++..||+|++..... .....+..|+.+++.++||||++++++|.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45678999999999999999999755 789999998865322 234567789999999999999999998865 56788
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+++||+ +++|.+++. ...+++..+..++.||+.||.|||+++ |+|+||+|.|||++.++.++|+|||++..
T Consensus 87 lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 568988874 345788889999999999999999988 99999999999999999999999999874
Q ss_pred CCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhh--------chhh
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS--------WSRP 282 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~--------~~~~ 282 (375)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ... +...
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 122457889999998766 568999999999999999999999996432211000 000 0000
Q ss_pred hhhhccccchhcccc-cCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 283 FLKDQKKFVHLVDPL-LHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
... .. ........ .....+ +.++..+.++|.+||+.+|++||++.+++..
T Consensus 233 ~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICS-EN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccc-hh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00 00000000 000111 2356789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=294.20 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=195.5
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCC-----
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----- 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 129 (375)
..++|.+.+.||+|+||.||++... ++..||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4568999999999999999999754 689999999864322 22346778999999999999999999887653
Q ss_pred -eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 130 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 130 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
..++||||+ +++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 779988874 346899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhh--------
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVS-------- 278 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~-------- 278 (375)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......... ....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 98753221 123457889999998876 45889999999999999999999999643211000 0000
Q ss_pred chhhhhhh-ccccchhcccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 279 WSRPFLKD-QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 279 ~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+....... .......+...... .....++..+.++|.+|++.||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 00000000000000 112345667899999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=284.66 Aligned_cols=263 Identities=26% Similarity=0.343 Sum_probs=197.6
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
|++.+.||.|++|.||+|... +++.||+|++.... ......+..|+.+++.++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999765 58999999997653 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
. ++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 5899999652 246899999999999999999999988 99999999999999999999999999875432221
Q ss_pred ceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchh-------hhhhhccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSR-------PFLKDQKK 289 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~-------~~~~~~~~ 289 (375)
......++..|+|||.+.+. .++.++|||||||++|||++|.+||......... ....... ........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 12234567789999998766 7899999999999999999999999643211100 0000000 00000000
Q ss_pred cchhcccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........... ...+..+..+.+++.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 001233678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=305.30 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=216.8
Q ss_pred ccccceeccccceEEEEEEEc-C----CceEEEEEcccc-CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 62 FREANLIGEGGFGKVYKGRLE-S----GQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.+..++||+|+||+||+|.+- . .-+||||++... ..+...+++.|+.+|..++|||++++++++.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 445688999999999999642 2 357899998664 3345678999999999999999999999998755 78999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
+|+++|+|.+|++. ++..+.....+.|..||++||.|||.++ ++||||-..||||..-..|||.|||+++....
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987 4567888999999999999999999888 99999999999999999999999999998665
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
....+......-.+-|||=|.+....|+.++|||||||++|||+| |..|++.....+ +.+++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----------------I~dll 913 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----------------IPDLL 913 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------------hhHHH
Confidence 555544444445678999999999999999999999999999999 999987544322 22222
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCC
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~ 344 (375)
..--+...|+.|+.+++.++.+||..|++.||+++++...+.++.+....
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 22223345889999999999999999999999999999999998776553
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=292.74 Aligned_cols=268 Identities=21% Similarity=0.306 Sum_probs=197.5
Q ss_pred HHHHHHhhcccccceeccccceEEEEEEE-cCCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeC-
Q 017246 53 RELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG- 128 (375)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~- 128 (375)
.++....++|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44555678999999999999999999975 468999999987532 22345677899999999999999999987543
Q ss_pred -----CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 129 -----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 129 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
...+++++++ +++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888876 789988774 245899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhch-
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS- 280 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~- 280 (375)
|+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .....
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998753211 123467889999998876 568899999999999999999999995322211000 00000
Q ss_pred ------hhhhhhc--cccchhcccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 281 ------RPFLKDQ--KKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 281 ------~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
....... ......+....... .....+..+.++|.+|++.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 00000000000000 011246678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=278.61 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=202.6
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 132 (375)
.-++|.++++||+|+|+.|..+++. +.+.||+|+++++-. ++..-...|..+..+- +||.+|.++.+|.++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3468999999999999999999865 688999999987532 3334445566666554 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+|.||++||+|.-++.+ +..++++.++.+...|+.||.|||+.| |++||||.+|+|+|..|++||+|+|+++.
T Consensus 328 fvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999988854 667999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccc-cccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ-GEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 291 (375)
.- .......++||||.|.|||++.+..|...+|+|+|||+|+||+.|+.||+....+ .+.+.-.+....
T Consensus 401 ~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-------- 470 (593)
T KOG0695|consen 401 GL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-------- 470 (593)
T ss_pred CC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------
Confidence 32 2223456799999999999999999999999999999999999999999865422 222222222211
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 326 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 326 (375)
++...+ ++|..++.....+++..|++||.+|.
T Consensus 471 -ilekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 -ILEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -Hhhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 122222 45667777778888999999999985
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=296.49 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=196.2
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe----
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ---- 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 130 (375)
..++|++.+.||+|++|.||+|+.. +++.||+|++.... ......+.+|+.+++.++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999875 58899999986532 2234567789999999999999999988766554
Q ss_pred --eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 131 --RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 131 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6799998843 56899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchh-----
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSR----- 281 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~----- 281 (375)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .+.....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99754221 223467889999998865 46789999999999999999999999643221100 0000000
Q ss_pred ---hhhhh-ccccchhcccccCCCC---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 ---PFLKD-QKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ---~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+ ...+...+.......+ ...++..+.++|.+||+.+|++||++.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 0000000000001111 1234678999999999999999999999984
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=279.36 Aligned_cols=236 Identities=31% Similarity=0.396 Sum_probs=193.6
Q ss_pred eccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 68 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
||.|+||.||++... +++.+|+|++...... ....+..|+.+++.++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999765 5899999998765432 345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeee
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 223 (375)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999954 346899999999999999999999988 9999999999999999999999999987533221 1233
Q ss_pred ccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC
Q 017246 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303 (375)
Q Consensus 224 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (375)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .... ..+.. ....++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~-------------~~~~~--~~~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIY-------------EKILK--DPLRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH-------------HHHhc--CCCCCC
Confidence 45688899999999888889999999999999999999999963221 0000 00111 112344
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 017246 304 RRCLNYAVAVTAMCLNEEANFRPLIND 330 (375)
Q Consensus 304 ~~~~~~l~~li~~cl~~~p~~RPs~~e 330 (375)
...+..+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 555788999999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.97 Aligned_cols=145 Identities=32% Similarity=0.414 Sum_probs=130.3
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|.+.+.||+|+||.||+|... +++.||||++...... ....+..|+.++..++||||+++++++...+..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999876 6899999999764322 2356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
||+.+++|.+++.. ...+++..++.++.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999954 346888999999999999999999988 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=279.89 Aligned_cols=258 Identities=25% Similarity=0.322 Sum_probs=195.5
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHH-ccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLML-SLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.++++-+..||.|+||+|++-.++ .|+..|||.++.... ....+++.|.+.. +.-++||||+++|.+..++..||.|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 345666788999999999999765 699999999988655 4556788888754 4457999999999999999999999
Q ss_pred eecCCCCHHHHHhc-cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 136 EYMPMGSLEDHLYD-LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 136 e~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|.|+- +|..+... +...+..+++..+-.|...++.||.||...-+ |+|||+||+|||++..|.|||||||.+-...
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99843 65543322 23456779999999999999999999976433 9999999999999999999999999986432
Q ss_pred CCCCceeeeccccccccccccccc--cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.....+.-.|...|||||.+. +..|+.+|||||||++|||+.||..||...... .+.... +..
T Consensus 220 ---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~-------Vv~ 284 (361)
T KOG1006|consen 220 ---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQ-------VVI 284 (361)
T ss_pred ---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHH-------HHc
Confidence 122234456888999999886 345999999999999999999999998633210 000000 000
Q ss_pred hcccccCCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 293 LVDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 293 ~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
--.+.+.... ....+..+..+|.-|+.+|.+.||.+.+++++
T Consensus 285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 0011111111 13467789999999999999999999998864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=286.99 Aligned_cols=257 Identities=27% Similarity=0.378 Sum_probs=199.1
Q ss_pred HhhcccccceeccccceEEEEEE-EcCCceEEEEEccccC-cc------chHHHHHHHHHHccCCCCCcceeEeEEe-eC
Q 017246 58 ATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEG-LQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCT-SG 128 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~-~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~ 128 (375)
..++|-++.+||+|||+.||++- +...+.||+|+-.... +. ..+...+|..+.+.|.||.||++|++|. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34688899999999999999995 4557889999754321 11 1234668999999999999999999985 45
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe---CCCceEEe
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLS 205 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~---~~~~vkl~ 205 (375)
+.+|-|+|||+|.+|.-||+. ...+++.+++.|+.||+.||.||... .+||||-||||.|||+. ..|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 778899999999999999964 67799999999999999999999987 58899999999999994 45789999
Q ss_pred ecCCCccCCCCCC-----ceeeeccccccccccccccccC----CCCccchhHhHHHHHHHHHhCCCCccccccccccch
Q 017246 206 DFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276 (375)
Q Consensus 206 Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 276 (375)
|||+++....... -.......||.+|++||.|.-+ ..+.++||||+|||+|..+.|+.||...... ..+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHH
Confidence 9999986443322 2334567899999999988633 4788999999999999999999999632211 000
Q ss_pred hhchhhhhhhccccchhccc-ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 277 VSWSRPFLKDQKKFVHLVDP-LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
+... . ++.. .+.-..-+..+.+..++|.+||+..-++|.+..++.
T Consensus 694 -------LqeN-T---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 -------LQEN-T---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------Hhhh-c---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1100 0 1100 011112246778889999999999999999888776
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=250.82 Aligned_cols=262 Identities=23% Similarity=0.288 Sum_probs=198.9
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+|.-.++||+|+||+||+++.+ ++..||+|.++.+... -.....+|+-+|+.+.|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555788999999999999754 6889999999775332 345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
|+. +|..+... -++.+....++.++.|+++||.++|+++ +.||||||.|+||+.+|.+||+|||+++... -
T Consensus 83 cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg--i 153 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG--I 153 (292)
T ss_pred hhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC--C
Confidence 965 78877754 4677899999999999999999999998 9999999999999999999999999998643 3
Q ss_pred CceeeeccccccccccccccccCC-CCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhh-hccccc---
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFV--- 291 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~--- 291 (375)
........+-|.+|.+|.++.+.+ |+...|+||.|||+.||.. |++.|....- .+++....+..-. ....+.
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCccc
Confidence 333444566799999999998754 8899999999999999998 6666653221 1111111111000 000110
Q ss_pred hhcccccCC---------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVDPLLHG---------RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
++.+-...+ .+.+.....-.+|++..+.-+|.+|.+++..++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111111 112344455678889999999999999998874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=274.69 Aligned_cols=219 Identities=24% Similarity=0.216 Sum_probs=177.3
Q ss_pred ccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhc
Q 017246 71 GGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD 149 (375)
Q Consensus 71 G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 149 (375)
|.+|.||++... +++.||+|.+.... ....|...+....||||+++++++...+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999764 68999999997643 223344555556799999999999999999999999999999999864
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccccc
Q 017246 150 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229 (375)
Q Consensus 150 ~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~ 229 (375)
...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 345899999999999999999999888 999999999999999999999999987543221 12244677
Q ss_pred ccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHH
Q 017246 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 309 (375)
Q Consensus 230 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (375)
.|+|||.+....++.++|+||+|+++|||++|..|+....... ........+..++..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCcccCCHH
Confidence 8999999988889999999999999999999998875321100 000011234556778
Q ss_pred HHHHHHhhcCCCCCCCCCH
Q 017246 310 AVAVTAMCLNEEANFRPLI 328 (375)
Q Consensus 310 l~~li~~cl~~~p~~RPs~ 328 (375)
+.+++.+|++.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=297.03 Aligned_cols=239 Identities=23% Similarity=0.284 Sum_probs=196.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHcc-CCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
...|.+...+|.|+|+.|-.+... +++.+++|++...... ..+|+.++.. -+||||+++++.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888889999999999998654 6899999999776222 2235544444 479999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE-eCCCceEEeecCCCccCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL-DNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill-~~~~~vkl~Dfg~a~~~~~ 215 (375)
.+.|+-|.+.+.. ..... ..+..|+.+|+.|+.|||++| ++||||||+|||+ ++.++++|+|||.+.....
T Consensus 397 ~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998888854 22333 678889999999999999998 9999999999999 6889999999999986433
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ....+-|..|.|||++....|++++|+||||++||+||+|+.||...+.. .++..
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ei~~ 524 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------IEIHT 524 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------HHHHH
Confidence 3 33356788999999999999999999999999999999999999754432 11222
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+.+....+...++|+.+||+.||.+||++.++..
T Consensus 525 ~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 525 RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 22333444678889999999999999999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=291.09 Aligned_cols=202 Identities=27% Similarity=0.352 Sum_probs=172.7
Q ss_pred cccccceeccccceEEEEEE-EcCCceEEEEEccccCccch---HHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
-|..++.||-|+||.|.+++ .++...||+|.+++.+.-.. ..+..|-.||..-..+-||+||..|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 45677899999999999995 55678899999987644333 345679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC-
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV- 215 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~- 215 (375)
|++||++..+|.+ .+.+.+..++.++..+..|+++.|..| +|||||||+|||||.+|++||+|||+|+-+..
T Consensus 710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999965 567889999999999999999999998 99999999999999999999999999852111
Q ss_pred --------CCCc-------------------------------eeeeccccccccccccccccCCCCccchhHhHHHHHH
Q 017246 216 --------GDNT-------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 256 (375)
Q Consensus 216 --------~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ 256 (375)
++.. ......+||+.|+|||++....|+...|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0000 0012257999999999999999999999999999999
Q ss_pred HHHhCCCCccccc
Q 017246 257 ELITGRKAMDLSK 269 (375)
Q Consensus 257 elltg~~pf~~~~ 269 (375)
||+.|++||-...
T Consensus 863 em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 863 EMLVGQPPFLADT 875 (1034)
T ss_pred HHhhCCCCccCCC
Confidence 9999999996443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=299.41 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=206.8
Q ss_pred HHHhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEe-----eC
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCT-----SG 128 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~ 128 (375)
....+.|++.++||.|.+|.||+++. ++++..|+|+..... ...+++..|..+|+.+ .|||++.++++|. .+
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34456799999999999999999974 478999999886653 3445677788888887 6999999999885 35
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
+++|||||||.||++.|+++... +.++.|..+..|+..++.||.+||... ++|||||-.|||++.++.|||+|||
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 88999999999999999998754 888999999999999999999999888 9999999999999999999999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccC-----CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
++.+.. .......+.+|||.|||||++... .|+.++|+||||++..||.-|.+|+...-+.
T Consensus 169 vSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------------ 234 (953)
T KOG0587|consen 169 VSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------------ 234 (953)
T ss_pred eeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------------
Confidence 987633 233345568899999999999743 4778999999999999999999998421110
Q ss_pred hhhccccchh-cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 284 LKDQKKFVHL-VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 284 ~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+.+..+ ..+-....-|......+.++|..||.+|.++||++.++++
T Consensus 235 ----raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 ----RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 001111 1111111236778999999999999999999999999885
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=304.06 Aligned_cols=267 Identities=26% Similarity=0.399 Sum_probs=212.7
Q ss_pred HHHHhhcccccceeccccceEEEEEEEc----C----CceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeE
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLE----S----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGY 124 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~ 124 (375)
..+..++..+.+.||+|.||.|++|... . ...||||.++.... .....+..|+.+++.+ .|+||+.++++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3445556677789999999999999632 1 34699999876433 4466788999999998 59999999999
Q ss_pred EeeCCeeEEEEeecCCCCHHHHHhccC----------CCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCC
Q 017246 125 CTSGDQRLLVYEYMPMGSLEDHLYDLE----------PDQ--EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 192 (375)
Q Consensus 125 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~ 192 (375)
+...+..++|+||+..|+|.++++..+ ... ..++..+.+.++.||+.|++||+++. ++||||...
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999998754 011 23899999999999999999999888 999999999
Q ss_pred cEEEeCCCceEEeecCCCccCCCCCCceeeeccc--cccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccc
Q 017246 193 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM--GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSK 269 (375)
Q Consensus 193 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 269 (375)
|||+..+..+||+|||+++............ .. -...|||||.+....|+.++||||||++|||++| |..||....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999998543333332221 12 2346999999999999999999999999999999 888986311
Q ss_pred cccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 270 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
. ... +.+.+....+...|..|+.+++++++.||+.+|++||++.++.+.|+.+...
T Consensus 527 ~--~~~--------------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 527 P--TEE--------------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred c--HHH--------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 0 001 1112222223345788899999999999999999999999999999996543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=268.16 Aligned_cols=273 Identities=21% Similarity=0.288 Sum_probs=202.2
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCC-----C---CCcceeEeEEee--
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----H---DNLVTLIGYCTS-- 127 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~-- 127 (375)
..+|.+.++||.|.|++||++.. ...+.||+|+.+... ...+....|+.+|++++ | ..||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 37999999999999999999964 467889999986542 33456778999999883 3 369999999964
Q ss_pred --CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC------
Q 017246 128 --GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND------ 199 (375)
Q Consensus 128 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~------ 199 (375)
+.++|+|+|++ |.+|..+|.. ..-..++...+.+|+.||+.||.|||...+ |||.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhh
Confidence 57899999998 8799999876 346678999999999999999999998654 9999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 017246 200 -------------------------------------------------------------------------------- 199 (375)
Q Consensus 200 -------------------------------------------------------------------------------- 199 (375)
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 017246 200 -------------------------------------------------------------------------------- 199 (375)
Q Consensus 200 -------------------------------------------------------------------------------- 199 (375)
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence
Q ss_pred CceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccc---cch
Q 017246 200 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE---QNL 276 (375)
Q Consensus 200 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~---~~~ 276 (375)
-+|||+|||-|.... ...+.-..|..|+|||++.+..|+..+||||++|++|||+||-..|+...+... +..
T Consensus 391 i~vKIaDlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 391 IRVKIADLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred eeEEEeeccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 012333333332210 011123467789999999999999999999999999999999999987665431 111
Q ss_pred hh------------------chhhhhhhccccchhcccccCC---------CCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 017246 277 VS------------------WSRPFLKDQKKFVHLVDPLLHG---------RYPRRCLNYAVAVTAMCLNEEANFRPLIN 329 (375)
Q Consensus 277 ~~------------------~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPs~~ 329 (375)
+. +.+.|+.....+..+-.-..++ .++.+...++.+++.-||+.+|++|||+.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 11 2233333333333322111111 34677888999999999999999999999
Q ss_pred HHHHHHhhhhhccCCCCccCCCCC
Q 017246 330 DIVVALDYLVSQRDSHPVSRNAGA 353 (375)
Q Consensus 330 eil~~L~~l~~~~~~~~~~~~~~~ 353 (375)
+.+ .|||.++...
T Consensus 546 ~cl-----------~hPwLn~~~~ 558 (590)
T KOG1290|consen 546 QCL-----------KHPWLNPVAG 558 (590)
T ss_pred HHh-----------cCccccCCCC
Confidence 999 6777775443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=248.69 Aligned_cols=207 Identities=25% Similarity=0.356 Sum_probs=172.4
Q ss_pred HHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHcc-CCCCCcceeEeEEeeCCee
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~ 131 (375)
+.+..+++..+..||+|++|.|-+.++. +|+..|+|.+...-. +...+.++|+.+..+ ..+|.+|.+||.+..+...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4455667777889999999999988764 799999999976532 344567788876555 4799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
+|.||.|+ .+|..+..+....+..+++..+-+|+..++.||.|||++-+ ++|||+||+|||++.+|+||+||||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 48888777766788999999999999999999999998754 9999999999999999999999999986
Q ss_pred cCCCCCCceeeecccccccccccccccc----CCCCccchhHhHHHHHHHHHhCCCCccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDL 267 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~ 267 (375)
...+. ...+...|...|||||.+.. ..|+.++||||||++++||.+++.||+.
T Consensus 198 ~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 43221 11222468889999998763 4689999999999999999999999973
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=290.07 Aligned_cols=261 Identities=20% Similarity=0.233 Sum_probs=168.8
Q ss_pred HhhcccccceeccccceEEEEEEEc-C----CceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeE------Ee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-S----GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY------CT 126 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~ 126 (375)
..++|.+.+.||+|+||.||+|.+. + +..||+|++..... .+....+ .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999865 4 68999998764322 1111111 1112222222222211 24
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCC----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCC
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEP----------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 190 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlk 190 (375)
.....++||||+.+++|.+++..... .........+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56788999999999999999864210 0011223456789999999999999988 9999999
Q ss_pred CCcEEEeC-CCceEEeecCCCccCCCCCCceeeeccccccccccccccccC----------------------CCCccch
Q 017246 191 SANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG----------------------KLTLKSD 247 (375)
Q Consensus 191 p~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 247 (375)
|+|||++. ++.+||+|||+++...... ........+++.|+|||++... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5789999999997533222 2233456789999999966422 2345679
Q ss_pred hHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc---cccchhcccccCCC------CCHHHHHHHHHHHHhhc
Q 017246 248 IYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ---KKFVHLVDPLLHGR------YPRRCLNYAVAVTAMCL 318 (375)
Q Consensus 248 vwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl 318 (375)
||||||++|||+++..+++.. ...+........ ..+.....+..... ..........+||.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999977664311 111110000000 00111111110000 00112234568999999
Q ss_pred CCCCCCCCCHHHHHH
Q 017246 319 NEEANFRPLINDIVV 333 (375)
Q Consensus 319 ~~~p~~RPs~~eil~ 333 (375)
+.||++|||+.++++
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999993
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=260.19 Aligned_cols=237 Identities=33% Similarity=0.422 Sum_probs=192.1
Q ss_pred cceEEEEEEEc-CCceEEEEEccccCccc-hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhc
Q 017246 72 GFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD 149 (375)
Q Consensus 72 ~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 149 (375)
+||.||+|... +++.+++|++....... ...+.+|+..++.++|+|++++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 48999999997765544 67889999999999999999999999999999999999999999999864
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccccc
Q 017246 150 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229 (375)
Q Consensus 150 ~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~ 229 (375)
...+++..++.++.+++.++.+||..+ ++|+||+|.||+++.++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 223889999999999999999999988 9999999999999999999999999997643322 233456888
Q ss_pred ccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC-HHHHH
Q 017246 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP-RRCLN 308 (375)
Q Consensus 230 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 308 (375)
.|++||.+....++.++||||||+++++|++|..||...... ...... +.......... ..++.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~-------------~~~~~~~~~~~~~~~~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKK-------------IGKPKPPFPPPEWKISP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHH-------------HhccCCCCccccccCCH
Confidence 999999998888899999999999999999999998642110 000000 00000000001 11667
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 309 YAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 309 ~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 8999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=261.25 Aligned_cols=267 Identities=26% Similarity=0.375 Sum_probs=194.3
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEee--------C
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--------G 128 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 128 (375)
..|+-..+||+|.||.||+++.+ +|+.||+|++-.++ ..-.....+|+.+|..+.|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 35666788999999999999765 58889998765432 2234567889999999999999999887643 3
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
..+|+||.+|+. +|...+.. ...+++...+.+++.+++.||.|+|+.. |+|||+|++|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 458999999976 88888743 3578999999999999999999999888 9999999999999999999999999
Q ss_pred CCccCCCCCCcee--eecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch-----
Q 017246 209 LAKLGPVGDNTHV--STRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS----- 280 (375)
Q Consensus 209 ~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~----- 280 (375)
+++.....++... .+..+-|.+|++||.+.+ ..|+++.|||+.||+|.||+|+.+.++..........++..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9975433332211 233456999999998886 46999999999999999999999988643322111111100
Q ss_pred hhhhhhccc--cchhc--ccccCCCC--------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 281 RPFLKDQKK--FVHLV--DPLLHGRY--------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 281 ~~~~~~~~~--~~~~~--~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...+.+... +.+-+ .+...+.+ |..-.++..+|+.+++..||.+|+++.+++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 000000000 00000 11111111 1122346789999999999999999998874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=277.87 Aligned_cols=266 Identities=20% Similarity=0.242 Sum_probs=180.1
Q ss_pred HhhcccccceeccccceEEEEEEE-----------------cCCceEEEEEccccCccchHH--------------HHHH
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL-----------------ESGQLVAIKQLNHEGLQGHQE--------------FIVE 106 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~--------------~~~e 106 (375)
..++|++.++||+|+||.||+|.. ..++.||||.+........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999853 235679999986543222222 3346
Q ss_pred HHHHccCCCCCc-----ceeEeEEee--------CCeeEEEEeecCCCCHHHHHhccCC--------------------C
Q 017246 107 VLMLSLLHHDNL-----VTLIGYCTS--------GDQRLLVYEYMPMGSLEDHLYDLEP--------------------D 153 (375)
Q Consensus 107 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 153 (375)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777766543 667776643 3568999999999999999864211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccccccccc
Q 017246 154 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233 (375)
Q Consensus 154 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 233 (375)
...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123467788999999999999999888 99999999999999999999999999864322211 11112335889999
Q ss_pred ccccccCC--------------------CC--ccchhHhHHHHHHHHHhCCC-Cccccccccccchhhchhhhhhhcccc
Q 017246 234 PEYAMSGK--------------------LT--LKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 234 PE~~~~~~--------------------~~--~~~DvwslG~il~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
||++.... |. .+.||||+||++|+|++|.. ||......... .. .+..+...+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~----~~~~~~~~~ 453 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LR----QYDNDLNRW 453 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hh----hccchHHHH
Confidence 99876432 11 24799999999999999875 66422111000 00 000000001
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCC---CCCCCHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEA---NFRPLINDIV 332 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPs~~eil 332 (375)
.........-......+....+|+.+++..+| .+|+++.|++
T Consensus 454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 11111111111224567788999999999766 6899999999
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=258.62 Aligned_cols=271 Identities=24% Similarity=0.339 Sum_probs=214.9
Q ss_pred HHHHHHHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeE
Q 017246 52 FRELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGY 124 (375)
Q Consensus 52 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~ 124 (375)
..++.+...+++...++-+|.||.||.|.+. +.+.|-+|.++... .-....++.|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3566777888999999999999999999543 23456677775432 2234568889999999999999999998
Q ss_pred Ee-eCCeeEEEEeecCCCCHHHHHhccCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC
Q 017246 125 CT-SGDQRLLVYEYMPMGSLEDHLYDLEP----DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 199 (375)
Q Consensus 125 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~ 199 (375)
+. +....+.++.++.-|+|..++...+. ..+.++..+...++.|++.|++|||+++ +||.||...|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 75 44677888999999999999984332 2345777889999999999999999998 9999999999999999
Q ss_pred CceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhh
Q 017246 200 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVS 278 (375)
Q Consensus 200 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 278 (375)
.+|||+|=.+++..-..+........-....||+||.+.+..|+.++|||||||+||||+| |+.||....+.+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm----- 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM----- 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence 9999999988875434443333333334668999999999999999999999999999999 8899863322211
Q ss_pred chhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 279 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
..+++++..+. -|.+||++|+.++.-||+..|++||++++++.-|.+.-.+.
T Consensus 508 --~~ylkdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 508 --EHYLKDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred --HHHHhccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 22344443333 37799999999999999999999999999999888775443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.01 Aligned_cols=247 Identities=28% Similarity=0.361 Sum_probs=187.8
Q ss_pred ccccceeccccceE-EEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 62 FREANLIGEGGFGK-VYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 62 ~~~~~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
|...+.+|.|+-|+ ||+|... |+.||||.+-.+. ...+.+|+..|+.. +|||||++++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44457799999876 7899887 8899999986532 33566799999887 69999999999999999999999996
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---C--CceEEeecCCCccCC
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---D--FNPKLSDFGLAKLGP 214 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~--~~vkl~Dfg~a~~~~ 214 (375)
. +|.+++...........-...+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++...
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 999999763111111222456889999999999999988 999999999999965 3 468999999998765
Q ss_pred CCCCce-eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhC-CCCccccccccccchhhchhhhhhhccccch
Q 017246 215 VGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 215 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.+.... ......||.+|+|||++....-+.++|||||||++|+.++| .+||...-.... ..+.....+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceee
Confidence 544322 23456799999999999988888899999999999999995 899963221110 00111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
-....++ +..+||.+|++.+|..||++.+|+.
T Consensus 735 -------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 -------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0111222 7889999999999999999999983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=269.86 Aligned_cols=272 Identities=22% Similarity=0.255 Sum_probs=204.1
Q ss_pred HHHHHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCC------CCcceeEeE
Q 017246 52 FRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH------DNLVTLIGY 124 (375)
Q Consensus 52 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~ 124 (375)
+.-......+|.+....|+|-|++|..|... .|+.||||+|..... -...=+.|+++|++|+. -|+++++-.
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3444566789999999999999999999755 488999999977532 23445679999999963 489999999
Q ss_pred EeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceE
Q 017246 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPK 203 (375)
Q Consensus 125 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vk 203 (375)
|...+++|||+|-+ ..+|.+.|..+. .+..|....+..++.|+..||..|...+ |+|.||||+||||++.. .+|
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 99999999999987 559999998765 4667888999999999999999999888 99999999999999875 579
Q ss_pred EeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccch-hh----
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VS---- 278 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~---- 278 (375)
|||||.|......+. +...-+..|.|||++.+.+|+...|+||.||+||||+||+..|..........+ +.
T Consensus 578 LCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 578 LCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 999999975332221 112235579999999999999999999999999999999999975433211100 00
Q ss_pred ----------chhhhhhhc----------------cccchhccc-------ccC-CCCC---HHHHHHHHHHHHhhcCCC
Q 017246 279 ----------WSRPFLKDQ----------------KKFVHLVDP-------LLH-GRYP---RRCLNYAVAVTAMCLNEE 321 (375)
Q Consensus 279 ----------~~~~~~~~~----------------~~~~~~~~~-------~~~-~~~~---~~~~~~l~~li~~cl~~~ 321 (375)
|....+... ..+...+.| +.. ..++ ......|.+|+..||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 000000000 000000011 000 0122 356778999999999999
Q ss_pred CCCCCCHHHHHH
Q 017246 322 ANFRPLINDIVV 333 (375)
Q Consensus 322 p~~RPs~~eil~ 333 (375)
|++|.+..+.|.
T Consensus 734 P~KRit~nqAL~ 745 (752)
T KOG0670|consen 734 PEKRITVNQALK 745 (752)
T ss_pred hhhcCCHHHHhc
Confidence 999999999885
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=247.06 Aligned_cols=266 Identities=24% Similarity=0.332 Sum_probs=192.0
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEccc--cCccchHHHHHHHHHHccCCCCCcceeEeEEeeC-----Cee
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQR 131 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 131 (375)
.+.+..+.||-|+||.||.+.. ++|+.||+|++.. .+....+.+.+|+.+|..++|.|++..++...-. ..+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3567788999999999999975 4799999998854 2334456788999999999999999888765433 245
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
|++.|.+ ..+|...+ ...+.++.+.+.-++.||++||+|||+.+ |.||||||.|+||+.+-.+||||||+++
T Consensus 133 YV~TELm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccc
Confidence 6777877 44666665 35778899999999999999999999888 9999999999999999999999999998
Q ss_pred cCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hchhhh-hhh--
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSRPF-LKD-- 286 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~-~~~-- 286 (375)
.....+.. ..+..+-|..|+|||++++. .|+.+.||||.|||+.||+..+..|..-++..-.+++ +..... ...
T Consensus 205 vee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 205 TWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred ccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 75443332 23345678999999999975 5999999999999999999988888643321111100 000000 000
Q ss_pred ---ccccchhcccccC-CC--------CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 287 ---QKKFVHLVDPLLH-GR--------YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 287 ---~~~~~~~~~~~~~-~~--------~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
......++..-.+ .. -+...-.+-..++..++..||++|.+..+.+..
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 0000011111110 00 122344466778889999999999999888764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=231.94 Aligned_cols=210 Identities=38% Similarity=0.562 Sum_probs=182.0
Q ss_pred eccccceEEEEEEEc-CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHHH
Q 017246 68 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 145 (375)
Q Consensus 68 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 145 (375)
||+|.+|.||++... +++.+++|++...... ....+.+|+..++.+.|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999876 4899999998765432 34678899999999999999999999999899999999999999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-CCceEEeecCCCccCCCCCCceeeec
Q 017246 146 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTR 224 (375)
Q Consensus 146 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~ 224 (375)
++... ...+++..++.++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 98642 146889999999999999999999988 999999999999999 89999999999875433221 1233
Q ss_pred cccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCC
Q 017246 225 VMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303 (375)
Q Consensus 225 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (375)
..+...|++||.+... .++.++|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5578899999998877 788999999999999998
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 304 RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 304 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 467899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=232.40 Aligned_cols=259 Identities=16% Similarity=0.289 Sum_probs=193.2
Q ss_pred hhcccccceeccccceEEEEEE-EcCCceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEEeeC--CeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSG--DQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 134 (375)
.++|++.+.+|+|.|+.||.|. ..++..++||++++ .....+.+|+.+|..|. ||||+++++...+. ....++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5689999999999999999996 45688999999865 34567888999999996 99999999987654 456799
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEeecCCCccC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLG 213 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~Dfg~a~~~ 213 (375)
+||++..+..... +.++...++.++.+++.||.|+|+.| |+|||+||.|++||.. ..++|+|+|+|..+
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999887766544 45777899999999999999999999 9999999999999865 46999999999876
Q ss_pred CCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccc-----------cchhhchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-----------QNLVSWSR 281 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-----------~~~~~~~~ 281 (375)
..+... +..+.+..|-.||++.+ ..|+.+-|+|||||++..|+..+.||-....... ..+..+..
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 544432 22345667889998875 5588999999999999999999999854332211 11111111
Q ss_pred hh-hhhccccchhcccccCCCC--------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 PF-LKDQKKFVHLVDPLLHGRY--------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ~~-~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+ +.-...+..++....+... ..-..++..+|+.+.|..|-.+|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11 0001111111111111110 1123577889999999999999999999885
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=258.89 Aligned_cols=196 Identities=24% Similarity=0.338 Sum_probs=168.8
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--------chHHHHHHHHHHccCC---CCCcceeEeEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLH---HDNLVTLIGYCTS 127 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 127 (375)
.+|...+.||.|+||.|+++.++ +...|+||.+.++..- +.-.+..|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999876 4677999998765331 1123556999999997 9999999999999
Q ss_pred CCeeEEEEeec-CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 128 GDQRLLVYEYM-PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 128 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
++.+||+||-- +|-+|++++. .+..+++.++..|+.|++-|+++||+++ |||||||-+|+.|+.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999974 6789999995 4778999999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCCC-ccchhHhHHHHHHHHHhCCCCcc
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMD 266 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~ 266 (375)
||.+.....+. ...++||..|.|||++.+.+|- ..-|||+||++||.++....||-
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987543322 3347899999999999988764 66899999999999999888873
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=266.87 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=204.6
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
..++|+....+|.|+||.||+++.. +++..|+|+++.....+..-+.+|+.+++..+||||+.+++.+...+.++|+||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3568999999999999999999754 799999999998877778888899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
||.||+|.+... ....+++.++..+++..++||+|||+++ =+|||||-.|||+++.|.|||+|||.+-...
T Consensus 93 ycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit-- 163 (829)
T KOG0576|consen 93 YCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT-- 163 (829)
T ss_pred ecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh--
Confidence 999999998664 3678999999999999999999999998 8999999999999999999999999875422
Q ss_pred CCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCc-cccccccccchhhchhhhhhhccccch
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAM-DLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
........+.||+.|||||+.. .+.|...+|||++|++..||---++|. +.... ..-++....
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---------r~l~LmTkS---- 230 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---------RALFLMTKS---- 230 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---------HHHHHhhcc----
Confidence 2223345688999999999764 567999999999999999998877663 32111 000111000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..++.. ..-.....+.+.++++.|+.++|.+||+++.++.
T Consensus 231 ~~qpp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 000000 0113456778999999999999999999988764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=229.94 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=185.8
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEe-EEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIG-YCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-~~~~~~~~~lv~ 135 (375)
.+.|.+.+.||+|.||.+-+++++ +.+.+++|.+..+. .....|.+|..---.| .|.||+..|+ .|+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467999999999999999999877 57889999886653 4567788887754445 5899998876 467778888999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe-CC-CceEEeecCCCccC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-ND-FNPKLSDFGLAKLG 213 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~-~~-~~vkl~Dfg~a~~~ 213 (375)
||++.|+|.+.+. ...+.+.....++.|++.||.|||+++ +||||||.+||||- .+ -+|||||||+.+..
T Consensus 102 E~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999884 356788899999999999999999999 99999999999993 33 47999999998742
Q ss_pred CCCCCceeeeccccccccccccccccC-----CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
+. ......-+..|.+||+.... ...+.+|+|.||+++|.++||..||+... .....+.+|..-.
T Consensus 174 g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~----- 242 (378)
T KOG1345|consen 174 GT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWL----- 242 (378)
T ss_pred Cc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHh-----
Confidence 21 11123345679999976532 24678999999999999999999998322 2222333322111
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.-..+.+... -..+++.+..+.++-+..+|++|=.+.+..++
T Consensus 243 ---~rk~~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 243 ---KRKNPALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ---cccCccCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 0011111111 12455667788899999999999555555444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=229.01 Aligned_cols=199 Identities=37% Similarity=0.465 Sum_probs=171.3
Q ss_pred ccccceeccccceEEEEEEEcC-CceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 62 FREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
|.+.+.||.|++|.||++.... ++.+++|.+...... ....+.+|+..++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999998764 899999999876554 56788899999999999999999999999899999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++.... ..+++..+..++.+++.++.+||..+ ++|+||+|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 999999996522 11788999999999999999999888 99999999999999999999999999876433220
Q ss_pred eeeecccccccccccccc-ccCCCCccchhHhHHHHHHHHHhCCCCccc
Q 017246 220 HVSTRVMGTYGYCAPEYA-MSGKLTLKSDIYSFGVVLLELITGRKAMDL 267 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~~ 267 (375)
.......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122335678899999998 666788899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=233.76 Aligned_cols=260 Identities=25% Similarity=0.303 Sum_probs=190.6
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEcccc--CccchHHHHHHHHHHccCCCCCcceeEeEEeeC------C
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------D 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 129 (375)
..+|.-...+|.|+- .|..+-. -.+++||+|++..+ ......+..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888889999998 6666643 35889999987554 223345677899999999999999999998543 3
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..|+|||+|. .+|...+. ..+.-..+..++.|++.|++|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 5689999995 48888875 23555778999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccc------------ccc---
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ------------GEQ--- 274 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~------------~~~--- 274 (375)
++.... .-..+..+.|..|.|||++.+..|.+.+||||+||++.||++|...|.....- ...
T Consensus 165 ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 165 ARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 985322 23345567899999999999999999999999999999999999888621110 000
Q ss_pred -chhhchhhhhhhc-----cccchhc-ccccCCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 275 -NLVSWSRPFLKDQ-----KKFVHLV-DPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 275 -~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
++..-.+.+.... ..+..++ +..+... .++.-.....+++.+||-.+|++|-+++++|
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 0111111111100 0011111 1111111 1123455688899999999999999999999
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=239.59 Aligned_cols=266 Identities=25% Similarity=0.358 Sum_probs=197.2
Q ss_pred HHHHhhcccccceeccccceEEEEEEEc----CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCC
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD 129 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 129 (375)
+......|...++||.|+|++||++.+. ....||+|.+... ....++.+|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445678999999999999999999643 4678999998765 3456788999999998 5899999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEeecC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFG 208 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~Dfg 208 (375)
..++||||++..+..++... ++...+..++..++.||.++|.+| ||||||||.|+|.+.. +.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999888888743 567899999999999999999999 9999999999999754 568999999
Q ss_pred CCccCCC-------------------C--------------CC---------ceeeeccccccccccccccccC-CCCcc
Q 017246 209 LAKLGPV-------------------G--------------DN---------THVSTRVMGTYGYCAPEYAMSG-KLTLK 245 (375)
Q Consensus 209 ~a~~~~~-------------------~--------------~~---------~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 245 (375)
+|..... + .. ........||++|+|||++... ..+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 9861000 0 00 0001124699999999998854 47889
Q ss_pred chhHhHHHHHHHHHhCCCCccccccccccchhh----------------------chhh----hhhhccccchh-ccccc
Q 017246 246 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS----------------------WSRP----FLKDQKKFVHL-VDPLL 298 (375)
Q Consensus 246 ~DvwslG~il~elltg~~pf~~~~~~~~~~~~~----------------------~~~~----~~~~~~~~~~~-~~~~~ 298 (375)
+||||.|+|++-+++++.||-....+-.. +.+ |... .......+..+ .....
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~a-l~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADA-LAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred cceeeccceeehhhccccccccCccccch-HHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 99999999999999999999544332110 000 0000 00000011111 01111
Q ss_pred C--------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 299 H--------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 299 ~--------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. .......+..+.+|+.+|++.||.+|.++++.|.
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 1 1112334668999999999999999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=267.08 Aligned_cols=196 Identities=16% Similarity=0.212 Sum_probs=136.9
Q ss_pred cCCC-CCcceeEeEE-------eeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 017246 112 LLHH-DNLVTLIGYC-------TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183 (375)
Q Consensus 112 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 183 (375)
.++| +||+.++++| .....++++||++ +++|.+++.. ....+++..++.++.||+.||.|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3445 5777788876 2334567788887 6699999963 2456899999999999999999999988
Q ss_pred cccCCCCCCcEEEeCCCc-------------------eEEeecCCCccCCCCCC--------------ceeeeccccccc
Q 017246 184 VIYRDLKSANILLDNDFN-------------------PKLSDFGLAKLGPVGDN--------------THVSTRVMGTYG 230 (375)
Q Consensus 184 i~H~Dlkp~Nill~~~~~-------------------vkl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~ 230 (375)
|+||||||+||||+..+. +||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965444 55555555542110000 000112458899
Q ss_pred cccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHH
Q 017246 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 310 (375)
Q Consensus 231 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 310 (375)
|||||++.+..|+.++|||||||+||||++|.+|+..... ....... ..+.+ .. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----------~~~~~----~~-~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----------RVLPP----QI-LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----------hhcCh----hh-hhcCHHH
Confidence 9999999999999999999999999999999888642110 0000000 00000 00 1112345
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHH
Q 017246 311 VAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 311 ~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+++.+||+.+|.+||++.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 68888999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=208.78 Aligned_cols=169 Identities=24% Similarity=0.201 Sum_probs=126.5
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|+|.+++.. .+..+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 689999964 2456999999999999999999999765 999999999999999 9998753221
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ...... .. .+. ..
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~----~~~~~~---~~-~~~-~~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEI----LLNGMP---AD-DPR-DR 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHH----HHHHhc---cC-Ccc-cc
Confidence 1258999999999999999999999999999999999999986322111 00000 000000 00 000 00
Q ss_pred CCCHHHHH--HHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 301 RYPRRCLN--YAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 301 ~~~~~~~~--~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
..+..... .+.+++.+||+.+|++||++.++++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11233343 69999999999999999999999999877754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-27 Score=219.16 Aligned_cols=263 Identities=22% Similarity=0.233 Sum_probs=200.2
Q ss_pred cccccceeccccceEEEEEEEcC--CceEEEEEccccCccchHHHHHHHHHHccCCC----CCcceeEeEE-eeCCeeEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLES--GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH----DNLVTLIGYC-TSGDQRLL 133 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 133 (375)
+|.+.+.||+|+||.||.|.... ...+|+|+...........+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999998654 35789998766533333367778888888863 6899999988 47778899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-----CceEEeecC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-----FNPKLSDFG 208 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-----~~vkl~Dfg 208 (375)
||+.+ |.+|.++..... ...++...+..++.|++.+|++||+.| ++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 889999775533 678999999999999999999999998 9999999999999755 469999999
Q ss_pred CCc--cCCCCCCc----e-e-eeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch
Q 017246 209 LAK--LGPVGDNT----H-V-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 209 ~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 280 (375)
+++ ........ . . ...+.||..|.++.+..+...+.+.|+||++.++.+|+.|..||.......... .+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--KFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH--HHH
Confidence 998 32222211 1 1 233569999999999999999999999999999999999999996433222110 000
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
. .........+....+..+.++...+-..+...+|....+...|..+....
T Consensus 251 ~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 K-----------DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred H-----------HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 0 00000000022344566777777777799999999999999988887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=204.94 Aligned_cols=262 Identities=20% Similarity=0.225 Sum_probs=206.5
Q ss_pred hcccccceeccccceEEEEEE-EcCCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
-.|+++++||+|.||..+.|+ +-++++||||.-... ....++..|....+.| ..++|..++.+...+-+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999996 457999999964332 3455677888888888 478999999888887788899998
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-----ceEEeecCCCcc
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-----NPKLSDFGLAKL 212 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-----~vkl~Dfg~a~~ 212 (375)
+ |.+|+|+..- .+.+++...+..++.|++.-++|+|++. +|+|||||+|+||...+ .|.|+|||+|+.
T Consensus 106 L-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 8899998864 5778999999999999999999999998 99999999999996433 489999999987
Q ss_pred CCCCCC-----ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 213 GPVGDN-----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 213 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
+.+... ........||.+||+-....+...+.+.|+=|||-++++.|-|..||+...........+
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe--------- 249 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE--------- 249 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH---------
Confidence 554332 223445789999999999999999999999999999999999999998766543321111
Q ss_pred cccchhcccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 288 KKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 288 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.+-+..... .+-..+|.++..-+...-..+-.+-|+.+-+...+..++.+..
T Consensus 250 ----KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 250 ----KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred ----HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 111111110 1123467777777778888888999999998888777776533
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=216.89 Aligned_cols=167 Identities=19% Similarity=0.127 Sum_probs=128.6
Q ss_pred HHHhhcccccceeccccceEEEEEEEc--CCceEEEEEccccC-----ccchHHHHHHHHHHccCCCCCcceeEeEEeeC
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 128 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 128 (375)
.....+|.+.+.||+|+||.||+|.+. +++.+|||++.... ......+.+|+.+|+.++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999764 57888999875331 1124568899999999999999853332 2
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCC-CCCcEEEeCCCceEEeec
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL-KSANILLDNDFNPKLSDF 207 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dl-kp~Nill~~~~~vkl~Df 207 (375)
+..++||||++|++|.. +. ... ...++.|++.||.|||+++ |+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 46799999999999963 21 111 1467899999999999988 999999 999999999999999999
Q ss_pred CCCccCCCCCCcee------eecccccccccccccccc
Q 017246 208 GLAKLGPVGDNTHV------STRVMGTYGYCAPEYAMS 239 (375)
Q Consensus 208 g~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 239 (375)
|+++.......... .....+++.|+|||.+..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99986433221111 134678889999998864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=195.01 Aligned_cols=266 Identities=22% Similarity=0.237 Sum_probs=205.6
Q ss_pred HHhhcccccceeccccceEEEEEE-EcCCceEEEEEccccCccchHHHHHHHHHHccCCC-CCcceeEeEEeeCCeeEEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv 134 (375)
+..+.|++.+.||.|+||.+|.|. ..+|..||||+-+.. .....+..|..+...|++ ..|..+..++.+.+.-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 445689999999999999999996 567999999986554 334567779999988865 6788888888888888999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---CCceEEeecCCCc
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAK 211 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~vkl~Dfg~a~ 211 (375)
|+.+ |.+|+++..- ....++...++-++.|++.-++|+|.++ ++||||||+|+|+.- ...+.|+|||+++
T Consensus 90 MdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence 9988 8899998864 4567899999999999999999999998 999999999999954 4568999999998
Q ss_pred cCCCCCC-----ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 212 LGPVGDN-----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 212 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
.+.+... ........||..|.+--...+...+.+.|+=|+|.+|.++.-|..||+........+..+...+.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek--- 239 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK--- 239 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh---
Confidence 6433221 12234467999999988888888899999999999999999999999876655443332222111
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
++...+. .+-..+|.++.-.+..|-...-++-|+..-+-+.+.-|...
T Consensus 240 --K~s~~ie-----~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 240 --KMSTPIE-----VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred --hcCCCHH-----HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 1110010 11234567778888889999999999998888777766643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-28 Score=235.50 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=187.8
Q ss_pred cccceeccccceEEEEEEEc-CCceEEEEEccc----c-Cccch-HHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 63 REANLIGEGGFGKVYKGRLE-SGQLVAIKQLNH----E-GLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 63 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~----~-~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
....++|.|++|.|+.+... ....++.|.+.. . ..... ..+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45788999999988877533 344455554431 1 11111 12556777788889999988877766655555569
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||++ +|..++.. ...+...++-.++.|++.|++|||..| |.|||||++|++++.+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999954 357888999999999999999999999 99999999999999999999999999875433
Q ss_pred CCC--ceeeeccccccccccccccccCCCCc-cchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 216 GDN--THVSTRVMGTYGYCAPEYAMSGKLTL-KSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 216 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
... .......+|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||............. . ......
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~---~----~~~~~~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN---N----YSDQRN 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh---c----cccccc
Confidence 332 35566688999999999999999886 5899999999999999999997654443321000 0 000000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... ...+-..++.....+|.+||+.+|.+|.|+++|++
T Consensus 546 ~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 00122456778889999999999999999999994
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-25 Score=201.12 Aligned_cols=261 Identities=33% Similarity=0.437 Sum_probs=197.4
Q ss_pred ccccceeccccceEEEEEEEcCCceEEEEEccccCccc---hHHHHHHHHHHccCCCC-CcceeEeEEeeCCeeEEEEee
Q 017246 62 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHD-NLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 137 (375)
|.+.+.||.|+||.||++... ..+++|.+....... ...+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999876 788999987754433 56788899999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCccCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVG 216 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~~~~~~ 216 (375)
+.++++.+++...... ..+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777542111 36889999999999999999999998 99999999999999998 6999999998743332
Q ss_pred CCce----eeecccccccccccccccc---CCCCccchhHhHHHHHHHHHhCCCCccccccc-cccchhhchhhhhhhcc
Q 017246 217 DNTH----VSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ-GEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 217 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 288 (375)
.... ......|+..|+|||.+.+ ..++...|+|++|++++++++|..||...... .......... ....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL---ELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH---hcCC
Confidence 2221 3456789999999999987 57889999999999999999999997543321 0000000000 0000
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
. .................+.+++..|+..+|..|.+..+....
T Consensus 233 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000002234678899999999999999999887764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=196.53 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=194.8
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++.+..+|.+...|..|+|+++ |..+++|++..... .....|..|.-.|+.+.||||+++++.|....++.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 34455677899999999999998 44566777654322 2234677888899999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEE--eecCCCccCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL--SDFGLAKLGPV 215 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl--~Dfg~a~~~~~ 215 (375)
|+.|+|+..+.. ...--+...++.+++.++++|++|||+.. +-|.---|....++||++.+.+| +|--++.+
T Consensus 269 mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred ccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee---
Confidence 999999999975 23334566789999999999999999874 43555578999999999987765 33222211
Q ss_pred CCCceeeeccccccccccccccccCCCC---ccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLT---LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.......|.||+||.++..+-+ .++|+|||++++|||.|...||...++.+- -.+
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----------------gmk 400 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----------------GMK 400 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----------------hhh
Confidence 1112347899999999876533 579999999999999999999974443221 112
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
+-..-++..+|+..+..+..|+.-|.+.||.+||.+..|+-.|++++
T Consensus 401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 23334555678899999999999999999999999999999998874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=192.52 Aligned_cols=174 Identities=13% Similarity=0.128 Sum_probs=136.0
Q ss_pred HHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHH---------HHHHHHHHccCCCCCcceeEeEEe
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQE---------FIVEVLMLSLLHHDNLVTLIGYCT 126 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~ 126 (375)
.+..++|++.++||.|+||.||++.. ++..+|+|++.......... +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45678999999999999999999766 47789999997654433322 578999999999999999988865
Q ss_pred eC--------CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC
Q 017246 127 SG--------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 198 (375)
Q Consensus 127 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~ 198 (375)
.. ...+|+|||++|.+|.++.. +++ ....+++.+|..||..| ++||||||.||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 43 35789999999999988641 222 34669999999999988 999999999999999
Q ss_pred CCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh
Q 017246 199 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260 (375)
Q Consensus 199 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 260 (375)
+| ++|+|||........... ..+++...|..++|+|+||+++..+..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 88 999999988643211110 114455567789999999999876643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-26 Score=224.30 Aligned_cols=247 Identities=22% Similarity=0.212 Sum_probs=183.5
Q ss_pred cccccceeccccceEEEEEEEcCCceEEEEEccccCc-cchH---HHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL-QGHQ---EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+|...+.||.+.|=.|.+++++.|. |+||++-+... -... +.+.|+. ...+++||++++..+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777899999999999999988777 88999866432 2233 3334444 556689999999988888888889999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC-
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV- 215 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~- 215 (375)
|+.. +|+|.+ ..+.-+...+.+.|+.||+.||..+|..| |+|+|||.+||||+.-.-+.|+||..-+....
T Consensus 102 yvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9855 888888 34667888899999999999999999998 99999999999999999999999987764221
Q ss_pred ----CCCceeeeccccccccccccccccC----------C-CCccchhHhHHHHHHHHHh-CCCCccccccccccchhhc
Q 017246 216 ----GDNTHVSTRVMGTYGYCAPEYAMSG----------K-LTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 216 ----~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 279 (375)
.+......+...-..|.|||.|... . .+++.||||+||+++||++ |++||..+.- ..|
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------LAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------HhH
Confidence 1222222223334479999987642 1 5788999999999999999 8999974321 111
Q ss_pred hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.... ......++... ....++.||..|++.||++|.++++.|+.
T Consensus 248 r~~~---~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGN---ADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccC---ccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1100 00111111111 11257899999999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-26 Score=212.79 Aligned_cols=225 Identities=27% Similarity=0.338 Sum_probs=184.0
Q ss_pred eeccccceEEEEEE----EcCCceEEEEEccccCccc--hHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEEEeecC
Q 017246 67 LIGEGGFGKVYKGR----LESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 67 ~lg~G~~g~V~~~~----~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
++|.|+||.|++++ ...|..||+|+.++..... ......|..++..++ ||.+++++..++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999884 3358889999987753322 224456778888886 9999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
||.|...+. +...+.+.....+...++-+++++|..+ |+|||+|++||+++.+|++++.|||+.+..-....
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999998884 3566778888999999999999999998 99999999999999999999999999875322111
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccC
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (375)
.|||..|||||++. ....++|.||||++++||+||..||.. ..+..++. ..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~--~~ 203 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILK--AE 203 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhh--hc
Confidence 28999999999998 568899999999999999999999973 00011111 11
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 017246 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLI 328 (375)
Q Consensus 300 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 328 (375)
..+|........+++..++..+|.+|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 24578899999999999999999999755
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=181.89 Aligned_cols=138 Identities=18% Similarity=0.127 Sum_probs=107.9
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCcc--c-------h-----------------HHHHHHHHHHccCCCCCc
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--G-------H-----------------QEFIVEVLMLSLLHHDNL 118 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni 118 (375)
...||+|+||.||+|...+|+.||||+++..... . . .....|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998778999999999764221 1 0 112348899999988776
Q ss_pred ceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCcccCCCCCCcEEEe
Q 017246 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL-HCKANPPVIYRDLKSANILLD 197 (375)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~i~H~Dlkp~Nill~ 197 (375)
.....+.. ...+|||||++|+++..... ....+++..+..++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 43333222 22389999999887765432 235688899999999999999999 6888 99999999999998
Q ss_pred CCCceEEeecCCCcc
Q 017246 198 NDFNPKLSDFGLAKL 212 (375)
Q Consensus 198 ~~~~vkl~Dfg~a~~ 212 (375)
++.++|+|||++..
T Consensus 153 -~~~v~LiDFG~a~~ 166 (190)
T cd05147 153 -DGKLYIIDVSQSVE 166 (190)
T ss_pred -CCcEEEEEcccccc
Confidence 47899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=187.34 Aligned_cols=235 Identities=22% Similarity=0.303 Sum_probs=149.7
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCC----------CCcceeEeE-
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHH----------DNLVTLIGY- 124 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~niv~~~~~- 124 (375)
..+..++.||.|+++.||.+++. +|+.+|+|++..... ...+.+.+|......+.+ -.++.-++.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 35677889999999999999875 699999999855432 234455555544444322 122222221
Q ss_pred --------EeeC---C-----eeEEEEeecCCCCHHHHHhccC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcc
Q 017246 125 --------CTSG---D-----QRLLVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185 (375)
Q Consensus 125 --------~~~~---~-----~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~ 185 (375)
+... . ..+++|+-+ .++|.+++.... .....+.....+.+..|+++.+++||..| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1111 1 235677776 558888765322 12223444555777899999999999999 99
Q ss_pred cCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccccccccccccccc--------CCCCccchhHhHHHHHHH
Q 017246 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--------GKLTLKSDIYSFGVVLLE 257 (375)
Q Consensus 186 H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 257 (375)
|+||+|+|+|++.+|.++|+||+.....+ . .... ...+..|.|||.... -.++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g--~--~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAG--T--RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETT--E--EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecC--c--eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999999999999999876422 1 1111 344578999997643 247889999999999999
Q ss_pred HHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 017246 258 LITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 325 (375)
Q Consensus 258 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 325 (375)
|.+|..||+.......... ....+. +.++.+..||..+|+.+|.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999985432221110 122455 889999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=187.89 Aligned_cols=200 Identities=22% Similarity=0.188 Sum_probs=144.2
Q ss_pred CCCCcceeEeEEee---------------------------CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHH
Q 017246 114 HHDNLVTLIGYCTS---------------------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 166 (375)
Q Consensus 114 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 166 (375)
+|||||+++.+|.+ ...+|+||...+. +|..++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 59999999887743 2356899998855 99999953 345666778899
Q ss_pred HHHHHHHHHhhcCCCCCcccCCCCCCcEEE--eCC--CceEEeecCCCccCCCC----CCceeeeccccccccccccccc
Q 017246 167 VGAARGLEYLHCKANPPVIYRDLKSANILL--DND--FNPKLSDFGLAKLGPVG----DNTHVSTRVMGTYGYCAPEYAM 238 (375)
Q Consensus 167 ~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill--~~~--~~vkl~Dfg~a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~ 238 (375)
.|+++|+.|||+++ |.|||+|.+|||| |++ ..+.|+|||++-..+.- ....-.-...|....||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999998 9999999999999 333 35799999988532220 0111122345788899999887
Q ss_pred cCC------CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHH
Q 017246 239 SGK------LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVA 312 (375)
Q Consensus 239 ~~~------~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 312 (375)
..+ ...++|.|+.|.+.||+++...||-...... ... +.|. ...-..+|..++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~----r~Yq-----------e~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDT----RTYQ-----------ESQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ech----hhhh-----------hhhCCCCcccCChHHHH
Confidence 432 2368999999999999999999996321110 000 0010 01112346788899999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 313 VTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 313 li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
++...|+.||++||+..-....|+-.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHHHH
Confidence 99999999999999987666555443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=174.70 Aligned_cols=139 Identities=19% Similarity=0.139 Sum_probs=109.6
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccc--------------------------hHHHHHHHHHHccCCCCCc
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--------------------------HQEFIVEVLMLSLLHHDNL 118 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni 118 (375)
...||+|+||.||+|...+|+.||||+++...... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999987789999999987652210 1123568889999999987
Q ss_pred ceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEe
Q 017246 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLD 197 (375)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~ 197 (375)
.....+... ..+|||||++|+++..... ....++...+..++.|++.+|.+||. .| |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 544433332 2489999999886544322 13457788999999999999999998 88 99999999999999
Q ss_pred CCCceEEeecCCCccC
Q 017246 198 NDFNPKLSDFGLAKLG 213 (375)
Q Consensus 198 ~~~~vkl~Dfg~a~~~ 213 (375)
++.++|+|||++...
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 789999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=208.10 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=186.7
Q ss_pred HHHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCC---CCCcceeEeEEeeCCe
Q 017246 54 ELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 54 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~ 130 (375)
+..+....|.|.+.||+|+||.||+|...+|+.||+|+-++...... .--.+++.+|+ -+.|+.+...+...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 34455678999999999999999999888899999998776644321 11122333333 3556666666677788
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-------CCceE
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-------DFNPK 203 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-------~~~vk 203 (375)
.++|+||.+.|+|.+++. ..+.+++..++.++.|++..|+.||..+ |||+||||+|+||.. .-.++
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 899999999999999995 5677899999999999999999999998 999999999999942 23589
Q ss_pred EeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
|+|||.+-....-.........++|..+-.+|...+.+++.++|.|.|+.+++.||.|+..- .
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~---------------- 904 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-V---------------- 904 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-h----------------
Confidence 99999885322222223344578899999999999999999999999999999999998532 0
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.++..+ .+...++. ..-.+.+.+++..+|+.|-..=|.+.+|...|+......
T Consensus 905 -~~g~~~--~~~~~~~R---y~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 905 -KNGSSW--MVKTNFPR---YWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred -cCCcce--eccccchh---hhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 000000 00100110 112233556666777766666688888888887776543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=170.65 Aligned_cols=185 Identities=20% Similarity=0.145 Sum_probs=138.8
Q ss_pred cccceeccccceEEEEEEEcCCceEEEEEccccCccc----hHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEEEee
Q 017246 63 REANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG----HQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 63 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.+...|++|+||+||.+.. .+.+++.+.+.....-. ...+.+|+.+|++|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998766 57888877775543311 125788999999995 5789999886 457999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCC-CCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL-KSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dl-kp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
+.|.+|...+.. ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998654311 11357889999999999998 999999 799999999999999999999854322
Q ss_pred CCc----e-------eeeccccccccccccccccC-CCC-ccchhHhHHHHHHHHHhCCCCcc
Q 017246 217 DNT----H-------VSTRVMGTYGYCAPEYAMSG-KLT-LKSDIYSFGVVLLELITGRKAMD 266 (375)
Q Consensus 217 ~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~elltg~~pf~ 266 (375)
... . .......++.|+.|+...-. ..+ .+.++++.|+.+|.++|++.++.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 210 0 01112367788888854322 223 67899999999999999988764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=168.13 Aligned_cols=136 Identities=19% Similarity=0.222 Sum_probs=106.3
Q ss_pred cccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccC-----CCCCcceeEeEEeeCC---eeE-E
Q 017246 63 REANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-----HHDNLVTLIGYCTSGD---QRL-L 133 (375)
Q Consensus 63 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-l 133 (375)
.-.++||+|+||.||. +......+||++..........+.+|+.+++.+ .||||++++++++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 433233479988765445567789999999999 5799999999998874 333 7
Q ss_pred EEee--cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCcccCCCCCCcEEEeC----CCceEEee
Q 017246 134 VYEY--MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL-EYLHCKANPPVIYRDLKSANILLDN----DFNPKLSD 206 (375)
Q Consensus 134 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~i~H~Dlkp~Nill~~----~~~vkl~D 206 (375)
|+|| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 567999999953 235554 35678888887 9999998 999999999999974 34799999
Q ss_pred cCCC
Q 017246 207 FGLA 210 (375)
Q Consensus 207 fg~a 210 (375)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=184.03 Aligned_cols=219 Identities=27% Similarity=0.384 Sum_probs=165.2
Q ss_pred HccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc-ccCC
Q 017246 110 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV-IYRD 188 (375)
Q Consensus 110 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i-~H~D 188 (375)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ....+++.....+.++|+.||.|||... | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4678899999999999999999999999999999999975 4567888899999999999999999654 5 9999
Q ss_pred CCCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCC-------CCccchhHhHHHHHHHHHhC
Q 017246 189 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-------LTLKSDIYSFGVVLLELITG 261 (375)
Q Consensus 189 lkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~elltg 261 (375)
+++.|.++|....+||+|||+.................-...|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987543211111111222455799999887631 46679999999999999999
Q ss_pred CCCcccccccccc-chhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 262 RKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 262 ~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
..||+........ .++.+ +.. .....+.+.+... ....+++..++.+||..+|.+||++++|-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~----~~~--~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR----VKK--GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHH----HHh--cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999754332221 12111 111 1111222222211 1455589999999999999999999999999888866
Q ss_pred cc
Q 017246 341 QR 342 (375)
Q Consensus 341 ~~ 342 (375)
..
T Consensus 227 ~~ 228 (484)
T KOG1023|consen 227 GG 228 (484)
T ss_pred cc
Confidence 44
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-22 Score=196.56 Aligned_cols=210 Identities=26% Similarity=0.372 Sum_probs=145.2
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
...+|..+++|..|+||.||.++++ +.+.+|+| +++.+.-.++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn-------ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN-------ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc-------cccccCCccee-----------------
Confidence 3467999999999999999999876 47889994 5544322111 33333444443
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+-...++. -+.++... +.+++|||+.+ |+|||+||+|+||+.-|++|++|||+.+..-..
T Consensus 136 ----gDc~tllk~----~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhccc----CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 333444422 23333322 78899999888 999999999999999999999999998642211
Q ss_pred CC-------------ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh
Q 017246 217 DN-------------THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 217 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
.. .-....++|||.|.|||++..+.|...+|+|++|+|+||.+-|..||....+. .+. ..+
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elf---g~v 270 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELF---GQV 270 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHH---hhh
Confidence 11 11123468999999999999999999999999999999999999999743221 111 111
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 326 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 326 (375)
+.+...+.+ -....+.+.+++|.+.|+.+|..|-
T Consensus 271 isd~i~wpE---------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 271 ISDDIEWPE---------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhccccc---------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 111111111 1234566788999999999999995
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-20 Score=161.00 Aligned_cols=134 Identities=22% Similarity=0.299 Sum_probs=112.1
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCccc--------hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
+.||+|++|.||+|.. .|..+++|+........ ...+.+|+.++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57789999865432211 23467899999999999988777777777888999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
++|++|.+++... . . ....++.+++.+|.+||..+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988531 1 1 77899999999999999988 99999999999999 78899999999863
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=179.68 Aligned_cols=172 Identities=26% Similarity=0.339 Sum_probs=128.5
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 208 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg 208 (375)
..+||.|++|.-.+|.+||.... .....++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 35789999999999999996533 35566788999999999999999 77 9999999999999999999999999
Q ss_pred CCccCCCCC----CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhC-CCCccccccccccchhhchhhh
Q 017246 209 LAKLGPVGD----NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 209 ~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
+........ .....+...||.+||+||.+.+..|+.++||||||++|+||+.- ..+|+-
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------------- 465 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------------- 465 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------------
Confidence 987533222 12234457899999999999999999999999999999999982 222210
Q ss_pred hhhccccchhcccccCCCCCHHH---HHHHHHHHHhhcCCCCCCCCCHHH
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRC---LNYAVAVTAMCLNEEANFRPLIND 330 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~~p~~RPs~~e 330 (375)
...+..+.+ +.+|+.. -+.-..|+.+++...|.+||++.+
T Consensus 466 ---~~t~~d~r~----g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 466 ---IATLTDIRD----GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---HHhhhhhhc----CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 111111111 1222211 112347889999999999994443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=162.74 Aligned_cols=142 Identities=18% Similarity=0.104 Sum_probs=110.0
Q ss_pred hcccccceeccccceEEEEEE--EcCCceEEEEEccccCcc------------------------chHHHHHHHHHHccC
Q 017246 60 RNFREANLIGEGGFGKVYKGR--LESGQLVAIKQLNHEGLQ------------------------GHQEFIVEVLMLSLL 113 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~--~~~~~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l 113 (375)
.-|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+.++..+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 457999999998754211 012245799999999
Q ss_pred CCCC--cceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCC
Q 017246 114 HHDN--LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 191 (375)
Q Consensus 114 ~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp 191 (375)
.+.+ +.+++++ ...++||||++|.+|...... ...+....+..++.||+.+|.+||..+. |+||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCCh
Confidence 7533 3444443 235899999999888765422 3345566778999999999999996653 99999999
Q ss_pred CcEEEeCCCceEEeecCCCcc
Q 017246 192 ANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 192 ~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||+++ ++.++|+|||.+..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=154.42 Aligned_cols=138 Identities=20% Similarity=0.113 Sum_probs=108.6
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCcc----------------------chHHHHHHHHHHccCCCC
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ----------------------GHQEFIVEVLMLSLLHHD 116 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~ 116 (375)
...|.+.+.||+|+||.||++...+|+.||||++...... .......|..++..+.|+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 3348889999999999999998878999999987653210 011255688888888777
Q ss_pred C--cceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 117 N--LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 117 n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
+ ++..++. ...++||||++|++|...... .....++.+++.++.++|..+ |+|+||||+||
T Consensus 94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Ni 156 (198)
T cd05144 94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNI 156 (198)
T ss_pred CCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccE
Confidence 4 4444432 456899999999998765420 245678899999999999988 99999999999
Q ss_pred EEeCCCceEEeecCCCccC
Q 017246 195 LLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~ 213 (375)
++++++.++|+|||++...
T Consensus 157 ll~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EEcCCCcEEEEECCccccC
Confidence 9999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=154.84 Aligned_cols=130 Identities=25% Similarity=0.333 Sum_probs=105.2
Q ss_pred eeccccceEEEEEEEcCCceEEEEEccccCcc--------chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 67 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+||+|+||.||+|.. +|..+++|........ ...++.+|+.++..+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 4788999986543211 1245678999999998887655555555667788999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+|++|.+++.. .. ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~----~~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEE----GN-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhh----cH-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743 11 078999999999999988 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=7e-19 Score=173.42 Aligned_cols=137 Identities=23% Similarity=0.267 Sum_probs=110.8
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEcccc--Cc------cchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHE--GL------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
...|...+.||+|+||.||++.+... .+++|+.... .. ...+.+.+|+.++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556789999999999999987643 3444432211 11 112457889999999999999888777777778
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999884 34678999999999999988 9999999999999 5778999999999
Q ss_pred cc
Q 017246 211 KL 212 (375)
Q Consensus 211 ~~ 212 (375)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 74
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-19 Score=178.98 Aligned_cols=256 Identities=24% Similarity=0.282 Sum_probs=192.8
Q ss_pred hcccccceeccccceEEEEEEEc--CCceEEEEEccccC--ccchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 134 (375)
..|.+.+.||+|+|+.|-..... ....+|.|.+.... .........|..+-..+. |.|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45778888999999999888543 34556777765543 122233444777777776 99999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCcc
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKL 212 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~~ 212 (375)
+++..|+++.+.+.. ......+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988731 22225666788899999999999999 888 99999999999999999 999999999987
Q ss_pred CCC-CCCceeeecccc-ccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 213 GPV-GDNTHVSTRVMG-TYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 213 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
... ..........+| ++.|+|||...+. ...+..|+||+|+++.-+++|..|++........ ...|.. ...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~----~~~- 248 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS----NKG- 248 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc----ccc-
Confidence 655 444555556788 9999999998884 5567899999999999999999998754433211 111110 000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...............+++.+++..+|+.|.+.+++-.
T Consensus 249 -------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 -------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0011122345556778888999999999999988764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=142.71 Aligned_cols=134 Identities=22% Similarity=0.173 Sum_probs=96.5
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccc--hHH----------------------HHHHHHHHccCCCCC--c
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--HQE----------------------FIVEVLMLSLLHHDN--L 118 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i 118 (375)
.+.||+|+||.||+|...+++.||||++....... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 56799999999999987789999999987542211 111 123555555554332 4
Q ss_pred ceeEeEEeeCCeeEEEEeecCCCCHHHH-HhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEE
Q 017246 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDH-LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILL 196 (375)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill 196 (375)
.+.++. ...++||||++++++... +... ... ..+..++.+++.++.++|. .+ |+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 444443 346899999998554321 1110 001 5678999999999999998 77 9999999999999
Q ss_pred eCCCceEEeecCCCcc
Q 017246 197 DNDFNPKLSDFGLAKL 212 (375)
Q Consensus 197 ~~~~~vkl~Dfg~a~~ 212 (375)
+ ++.++|+|||.+..
T Consensus 149 ~-~~~~~liDfg~a~~ 163 (187)
T cd05119 149 D-DGKVYIIDVPQAVE 163 (187)
T ss_pred E-CCcEEEEECccccc
Confidence 9 88999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-17 Score=145.58 Aligned_cols=135 Identities=24% Similarity=0.236 Sum_probs=104.4
Q ss_pred cceec-cccceEEEEEEEcCCceEEEEEccccCc-------------cchHHHHHHHHHHccCCCCCc--ceeEeEEeeC
Q 017246 65 ANLIG-EGGFGKVYKGRLESGQLVAIKQLNHEGL-------------QGHQEFIVEVLMLSLLHHDNL--VTLIGYCTSG 128 (375)
Q Consensus 65 ~~~lg-~G~~g~V~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 128 (375)
...|| .|+.|+||.+... +..++||.+..... .....+.+|+.++..+.|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999876 67789998754211 123457789999999998875 6667664432
Q ss_pred C----eeEEEEeecCC-CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 129 D----QRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 129 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
. ..++|||+++| .+|.+++.. ..+++. .+.+|+.+|.+||+.| |+|+||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 689888743 234443 3678999999999998 99999999999999999999
Q ss_pred EeecCCCcc
Q 017246 204 LSDFGLAKL 212 (375)
Q Consensus 204 l~Dfg~a~~ 212 (375)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-17 Score=134.23 Aligned_cols=135 Identities=21% Similarity=0.164 Sum_probs=113.0
Q ss_pred ccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCC--CCcceeEeEEeeCCeeEEEEeecCCC
Q 017246 64 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMG 141 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 141 (375)
+.+.||.|.++.||++...+ ..+++|.+..... ...+..|+.+++.+.| .++++++.++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999998764 7899999866533 4568889999999976 58999999888888899999999887
Q ss_pred CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 142 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 142 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
.+..+ +......++.+++.+|.+||.....+++|+||+|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 4456678899999999999985334499999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=144.32 Aligned_cols=250 Identities=26% Similarity=0.260 Sum_probs=183.7
Q ss_pred hhcccccceecc--ccceEEEEEEE---cCCceEEEEEcccc--CccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCe
Q 017246 59 TRNFREANLIGE--GGFGKVYKGRL---ESGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 130 (375)
...+.+...+|. |.+|.||.++. .++..+|+|.-... .......-.+|+...+.+ .|+|.++.+..++..+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 446777888999 99999999975 36888999874332 223333445576666666 48999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEe
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIYRDLKSANILLDND-FNPKLS 205 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~ 205 (375)
.++-+|++ +.+|..+... ....++...++..+.+... ||..+|..+ ++|-|+||+||+...+ ...+++
T Consensus 193 lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence 99999998 4688887754 3344677888888888888 999999888 9999999999999999 789999
Q ss_pred ecCCCccCCCCCC---ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 206 DFGLAKLGPVGDN---THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 206 Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
|||+......... ........|...|++||.. ..-++..+|+|+||.++.+..+|-++.......
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----------- 333 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS----------- 333 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-----------
Confidence 9999875444332 2222334678899999966 456689999999999999999988765422111
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.|.++....+...+-......+...+.+|+..+|-.|++.+.+..
T Consensus 334 ------~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 ------SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111222222334456666899999999999999887663
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.1e-16 Score=137.43 Aligned_cols=203 Identities=26% Similarity=0.319 Sum_probs=143.5
Q ss_pred HHccCCCCCcceeEeEEeeC-----CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 017246 109 MLSLLHHDNLVTLIGYCTSG-----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183 (375)
Q Consensus 109 ~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 183 (375)
-|-++-|-|+|+++.|+.+. ....++.||+..|+|..+|++....+..+......+|+-||+.||.|||+. .++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 44456799999999988654 456789999999999999999888888999999999999999999999988 688
Q ss_pred cccCCCCCCcEEEeCCCceEEeecCCCc--cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhC
Q 017246 184 VIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261 (375)
Q Consensus 184 i~H~Dlkp~Nill~~~~~vkl~Dfg~a~--~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 261 (375)
|+|+++..+-|++..+|-+|++----.. ..-............+.++|.+||.=.....+.++|||+||....+|..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999888874311110 00001111122234567899999976666677899999999999999887
Q ss_pred CCC-ccc-cccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 262 RKA-MDL-SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 262 ~~p-f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
..- -+. +....+.+..+ .-..+..-+ -..++..|++..|..||++.+++..
T Consensus 279 Eiq~tnseS~~~~ee~ia~-----------~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN-----------VIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhhhh-----------heeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 642 110 00000111100 000001011 1356788999999999999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.9e-15 Score=141.71 Aligned_cols=140 Identities=24% Similarity=0.176 Sum_probs=96.8
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccchH----------------------------------------HHH
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQ----------------------------------------EFI 104 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~----------------------------------------~~~ 104 (375)
.+.||.|++|.||+|++.+|+.||||+.++....... .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999998654211100 133
Q ss_pred HHHHHHccCC----CCCcceeEeEE-eeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHH-HHHHhhc
Q 017246 105 VEVLMLSLLH----HDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-GLEYLHC 178 (375)
Q Consensus 105 ~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~l~~LH~ 178 (375)
+|+..+.++. +.+-+.+-..+ ......+|||||++|++|.++..... ... ....++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 4555444442 22222222222 22455789999999999988764311 112 22345555555 4678898
Q ss_pred CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 179 ~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
.| ++|+|+||.||+++.++.++|+|||++...
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 88 999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-14 Score=118.13 Aligned_cols=131 Identities=18% Similarity=0.090 Sum_probs=96.7
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcc-eeEeEEeeCCeeEEEEeecCCCCH
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV-TLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
.+.|+.|.++.||+++.. +..|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999876 77899998765432 223456788888888665554 455443 2345799999999877
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
.+.. .....++.+++.+|..||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 011345788999999999876 12249999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.7e-15 Score=142.02 Aligned_cols=143 Identities=17% Similarity=0.148 Sum_probs=94.7
Q ss_pred hcccccceeccccceEEEEEEEcC-CceEEEEEccccCccc----------------------------------hH---
Q 017246 60 RNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQG----------------------------------HQ--- 101 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~----------------------------------~~--- 101 (375)
..|.. +.||+|++|.||+|++++ |+.||||+.++.-... ..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 789999999999999886 9999999997542110 00
Q ss_pred ---HHHHHHHHHccCC----CCCcceeEeEEe-eCCeeEEEEeecCCCCHHHHHh--ccCCCCCCCCHHHHHHHHHHHHH
Q 017246 102 ---EFIVEVLMLSLLH----HDNLVTLIGYCT-SGDQRLLVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAAR 171 (375)
Q Consensus 102 ---~~~~e~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~--~~~~~~~~l~~~~~~~i~~qi~~ 171 (375)
.+.+|+..+.++. +.+.+.+-.++. -....+|||||++|+.+.+... ........+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 1233444333332 333333333322 2456779999999999987432 1111112344555555666654
Q ss_pred HHHHhhcCCCCCcccCCCCCCcEEEeCCC----ceEEeecCCCccC
Q 017246 172 GLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDFGLAKLG 213 (375)
Q Consensus 172 ~l~~LH~~~~~~i~H~Dlkp~Nill~~~~----~vkl~Dfg~a~~~ 213 (375)
..| ++|+|+||.||+++.++ .++++|||++...
T Consensus 278 ------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 ------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 356 99999999999999888 9999999998654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-12 Score=125.52 Aligned_cols=167 Identities=17% Similarity=0.168 Sum_probs=125.7
Q ss_pred EEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCH
Q 017246 80 RLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSW 159 (375)
Q Consensus 80 ~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 159 (375)
+..++.+|.|+.+............+-+..|+.++||||++++..++.+...|||+|.+. .|..++.+. ..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GK 103 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HH
Confidence 344688899988866544334556778889999999999999999999999999999873 567777542 25
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccccccccccccccc
Q 017246 160 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239 (375)
Q Consensus 160 ~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 239 (375)
..+...+.||+.||.|||..++ ++|++|.-..|+|+..|..||++|.++........ ......--..|..|+.+..
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 6778889999999999985443 99999999999999999999999988753211111 0111112224666665432
Q ss_pred CCCCccchhHhHHHHHHHHHhC
Q 017246 240 GKLTLKSDIYSFGVVLLELITG 261 (375)
Q Consensus 240 ~~~~~~~DvwslG~il~elltg 261 (375)
.. -..|.|.|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 346999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.1e-12 Score=114.97 Aligned_cols=264 Identities=17% Similarity=0.175 Sum_probs=167.6
Q ss_pred cccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHcc-CCCCCcceeEeE------EeeC-CeeEEE
Q 017246 63 REANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL-LHHDNLVTLIGY------CTSG-DQRLLV 134 (375)
Q Consensus 63 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~------~~~~-~~~~lv 134 (375)
..++.||+|+-+.+|..-.-.+ .+.|++.........+. +..|.. -.||-+-.-+.| .-+. ..+-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhhc--hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3467899999999996532111 35677766544333322 222323 345543321111 1122 236688
Q ss_pred EeecCCCCHHHHHhc---cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 135 YEYMPMGSLEDHLYD---LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
|..+.|..--..++. .+..-....|..+++.+..++.+.+-||..| .+-+|++++|+||.+++.|.|+|=....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 888876532222222 1223345779999999999999999999988 9999999999999999999999966554
Q ss_pred cCCCCCCceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhC-CCCccccccc------cccchhhc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQ------GEQNLVSW 279 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~------~~~~~~~~ 279 (375)
.. .+.......+|.+.|.+||... +..-+...|.|.||+++|+|+.| ++||...... .+..+...
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 43 2223334467999999999654 34456789999999999999996 9999743221 11122222
Q ss_pred hhhhhhhccccchhcccccCCCCC-HHHHHHHHHHHHhhcCCC--CCCCCCHHHHHHHHhhhhhc
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYP-RRCLNYAVAVTAMCLNEE--ANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~--p~~RPs~~eil~~L~~l~~~ 341 (375)
...+..+... -..+.. ...| .-+++.+..|+.+|+... +.-||+++-|+..|..+..+
T Consensus 243 ~f~ya~~~~~---g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 243 RFAYASDQRR---GLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeeechhccC---CCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 2222221100 000000 1112 345677888888888764 56899999999999888764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.1e-14 Score=131.96 Aligned_cols=247 Identities=20% Similarity=0.199 Sum_probs=176.9
Q ss_pred HhhcccccceeccccceEEEEEEE--cCCceEEEEEccccCccchHH--HHHHHHHHccC-CCCCcceeEeEEeeCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL--ESGQLVAIKQLNHEGLQGHQE--FIVEVLMLSLL-HHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 132 (375)
...+|..+..||.|.|+.|+.+.. .++..|++|.+.+.-.....+ -..|+.+...+ .|.++++++..|....+.|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 345788899999999999999854 468889999886654433332 24566666665 4888888887777778888
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEeecCCCc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAK 211 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~Dfg~a~ 211 (375)
+-.|||+++++...+. ....+.+...+.+..|++.++.++|++. ++|+|+||+||++..+ +..+++|||.++
T Consensus 343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 9999999999887662 2445677888999999999999999988 9999999999999886 778999999986
Q ss_pred cCCCCCCceeeeccccccccc--cccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYC--APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
....... ......+++ +|+......+..+.|+||||..+.+.++|..--.- ...
T Consensus 416 ~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------------------~~~ 471 (524)
T KOG0601|consen 416 RLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------------------GVQ 471 (524)
T ss_pred ccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcc-------------------ccc
Confidence 4222111 122344455 44444466788999999999999999998752210 111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhh
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 337 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 337 (375)
+..+..... ... +.....+..+...+...++..||.+.++....+-
T Consensus 472 ~~~i~~~~~-p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 472 SLTIRSGDT-PNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ceeeecccc-cCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111111111 111 2233778888889999999999999887765443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=5e-12 Score=106.85 Aligned_cols=136 Identities=14% Similarity=0.036 Sum_probs=97.0
Q ss_pred cceeccccceEEEEEEEcC-------CceEEEEEccccCc----------------------cchHH----HHHHHHHHc
Q 017246 65 ANLIGEGGFGKVYKGRLES-------GQLVAIKQLNHEGL----------------------QGHQE----FIVEVLMLS 111 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~----------------------~~~~~----~~~e~~~l~ 111 (375)
...||.|--+.||.|...+ +..+|||+.+.... ..... ...|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999997542 47899998742110 00112 236888888
Q ss_pred cCCC--CCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCcccCC
Q 017246 112 LLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL-HCKANPPVIYRD 188 (375)
Q Consensus 112 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~i~H~D 188 (375)
++.. -++...+++ ...+|||||+.+..+..... ....++......+..+++.+|..| |..+ |+|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 8854 355666654 56779999997644322111 122345566778889999999999 8777 99999
Q ss_pred CCCCcEEEeCCCceEEeecCCCcc
Q 017246 189 LKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 189 lkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
|++.|||++ ++.+.|+|||-+..
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCcee
Confidence 999999997 46899999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.5e-12 Score=102.69 Aligned_cols=143 Identities=20% Similarity=0.239 Sum_probs=106.2
Q ss_pred ccceeccccceEEEEEEEcCCceEEEEEccccCcc--------chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 64 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
...+|-+|+-+.|+++... |+.+.||.-...... ...+..+|+.+|.++.--.|.--.-+|.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999876 777777753222211 1345678999998887656654445566667778999
Q ss_pred eecCC-CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC---ceEEeecCCCc
Q 017246 136 EYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAK 211 (375)
Q Consensus 136 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~---~vkl~Dfg~a~ 211 (375)
||++| .++.+++...- ...........++..|-+.+.-||..+ |+|+||..+||++..++ .+.|+|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 57888886532 222222333788999999999999888 99999999999997655 35899999986
Q ss_pred c
Q 017246 212 L 212 (375)
Q Consensus 212 ~ 212 (375)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.6e-12 Score=110.63 Aligned_cols=142 Identities=20% Similarity=0.252 Sum_probs=109.2
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCc-cchHHHHHHHHHHccCCCC--CcceeEeEEeeC---CeeEEEEeecC
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHD--NLVTLIGYCTSG---DQRLLVYEYMP 139 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~ 139 (375)
+.|+.|..+.||++...+|..+++|....... .....+..|+.+++.+.+. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999877678999998765432 1345678899999998753 457777776553 26689999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--------------------------------------- 180 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------- 180 (375)
|.++.+.+. ...++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 988876552 134677777888888888888888531
Q ss_pred --------------CCCcccCCCCCCcEEEeC--CCceEEeecCCCcc
Q 017246 181 --------------NPPVIYRDLKSANILLDN--DFNPKLSDFGLAKL 212 (375)
Q Consensus 181 --------------~~~i~H~Dlkp~Nill~~--~~~vkl~Dfg~a~~ 212 (375)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.8e-12 Score=102.26 Aligned_cols=131 Identities=24% Similarity=0.305 Sum_probs=98.5
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCccc--------hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..+++|+-+.+|.+.+. |..+++|.-.+..... ..+..+|+.++..+.--.|.--.-++.+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45889999999999765 4446666432222211 23456799999888665554444455666778899999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
++|..|.+++... ...++..+-.-+.-||..+ |+|+||.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888542 2567778888889999888 99999999999998765 99999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-13 Score=136.73 Aligned_cols=250 Identities=21% Similarity=0.192 Sum_probs=173.4
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEcccc---CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
...+.+.+.+.+-.|.++.++.+.-. .|...++|+.... ...+.+....+-.++-...+|-++.....+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34556778889999999999988533 3544455544321 1111222233333333344566666555556677889
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
++++|..+++|...++. -...+...++.....+..++++||... +.|+|++|.|+|+..+|..++.|||....
T Consensus 881 L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 99999999999998865 234566667778888899999999887 99999999999999999999999984321
Q ss_pred CCCC-----------------------------CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCC
Q 017246 213 GPVG-----------------------------DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 263 (375)
Q Consensus 213 ~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 263 (375)
.... +.........||+.|.+||...+......+|+|++|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 0000 00011233679999999999999999999999999999999999999
Q ss_pred Cccccccccccchhhchhhhhhhccccchhcccc-cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 017246 264 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL-LHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 329 (375)
Q Consensus 264 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ 329 (375)
||+...... .+..++... .+..-+...+....+++...+..+|.+|-.+.
T Consensus 1034 p~na~tpq~----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQ----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhh----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 997332211 111111111 11122455677788889999999999997766
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.9e-11 Score=111.89 Aligned_cols=168 Identities=21% Similarity=0.253 Sum_probs=128.2
Q ss_pred eEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEe----eCCeeEEEEeecCC-CCHHHHH
Q 017246 74 GKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT----SGDQRLLVYEYMPM-GSLEDHL 147 (375)
Q Consensus 74 g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~~l 147 (375)
.+.|++.. .+|..|++|+++............-++.++++.|+|||++.++|. .+..+++|++|.++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56788854 479999999995544444444455678899999999999998876 34678899999864 6787766
Q ss_pred hccCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 148 YDLEP-----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 148 ~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
..... .+..+++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+-+++|..+|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 54322 2335778999999999999999999998 999999999999999999999988887643221
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCC
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 263 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 263 (375)
. . |.+.. -.+-|.=.||.+++.|.||..
T Consensus 447 ~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 P--------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred C--------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 1 0 11211 235689999999999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.6e-11 Score=100.11 Aligned_cols=124 Identities=23% Similarity=0.187 Sum_probs=81.2
Q ss_pred EEEEEEEcCCceEEEEEccccCcc--------------------------chHHHHHHHHHHccCCCC--CcceeEeEEe
Q 017246 75 KVYKGRLESGQLVAIKQLNHEGLQ--------------------------GHQEFIVEVLMLSLLHHD--NLVTLIGYCT 126 (375)
Q Consensus 75 ~V~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 126 (375)
.||.|...+|..+|+|+.+..... ......+|...|..+..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489998888999999987432110 012356799999999766 45666654
Q ss_pred eCCeeEEEEeecC--CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 127 SGDQRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY-LHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 127 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
...+|||||+. |..+..+... .++......++.+++..+.. +|+.| |+|+||.+.|||++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 24469999998 6555443322 11123456777888885555 57887 9999999999999988 999
Q ss_pred EeecCCCcc
Q 017246 204 LSDFGLAKL 212 (375)
Q Consensus 204 l~Dfg~a~~ 212 (375)
|+|||.+..
T Consensus 147 iIDf~qav~ 155 (188)
T PF01163_consen 147 IIDFGQAVD 155 (188)
T ss_dssp E--GTTEEE
T ss_pred EEecCccee
Confidence 999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.8e-10 Score=99.57 Aligned_cols=141 Identities=18% Similarity=0.137 Sum_probs=99.0
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCcc-----------chHHHHHHHHHHccCCCCCc--ceeEeEEee-----
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-----------GHQEFIVEVLMLSLLHHDNL--VTLIGYCTS----- 127 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~----- 127 (375)
+.+-.-....|+++... |+.|.||........ ....+.+|...+..+..-+| +..+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44444444556676654 778999977443311 11136788888877743333 344445443
Q ss_pred CCeeEEEEeecCCC-CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-------C
Q 017246 128 GDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-------D 199 (375)
Q Consensus 128 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-------~ 199 (375)
....+||+|++++. +|.+++.... ...........++.+++..+.-||..| |+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23578999999876 8998885321 234456777899999999999999998 999999999999975 4
Q ss_pred CceEEeecCCCcc
Q 017246 200 FNPKLSDFGLAKL 212 (375)
Q Consensus 200 ~~vkl~Dfg~a~~ 212 (375)
+.+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999998853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.2e-10 Score=97.63 Aligned_cols=143 Identities=20% Similarity=0.120 Sum_probs=102.5
Q ss_pred HHHHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCcc----------------------chHHHHHHHHHH
Q 017246 53 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ----------------------GHQEFIVEVLML 110 (375)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l 110 (375)
..+.....-..++..||-|--+.||.|....|.++|||.-+..... ......+|.++|
T Consensus 84 ~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L 163 (304)
T COG0478 84 HALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL 163 (304)
T ss_pred HHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence 3333333346778999999999999999988999999964322110 112356799999
Q ss_pred ccCCCC--CcceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCC
Q 017246 111 SLLHHD--NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 188 (375)
Q Consensus 111 ~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~D 188 (375)
..|... .+.+.+++ +...+|||+++|-.|...- +.....-.++..|+.-+..+-..| |||+|
T Consensus 164 ~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGD 227 (304)
T COG0478 164 QRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGD 227 (304)
T ss_pred HHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccC
Confidence 998654 67777766 7778999999996664322 122333445555555555555667 99999
Q ss_pred CCCCcEEEeCCCceEEeecCCCc
Q 017246 189 LKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 189 lkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
+.+-||||+++|.+.++||-=+.
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred CchheEEEecCCCEEEEeCcccc
Confidence 99999999999999999997654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.7e-10 Score=111.32 Aligned_cols=151 Identities=19% Similarity=0.259 Sum_probs=104.4
Q ss_pred HHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc-------eeeecccccccccccccccc
Q 017246 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-------HVSTRVMGTYGYCAPEYAMS 239 (375)
Q Consensus 167 ~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 239 (375)
.+++.|+.|+|.. +.+||++|.|++|.++.++..||+.|+++......... .......-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3445899999964 45999999999999999999999999987643221111 01111224557999999999
Q ss_pred CCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhc
Q 017246 240 GKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCL 318 (375)
Q Consensus 240 ~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 318 (375)
...+.++|+||+||++|.+.. |+.-+...+..... ......+..-...++..++.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------------SFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh--------------hhhhcccccccccccccCcHHHHHHHHHHh
Confidence 888999999999999999995 44444322211110 011111111122334677888899999999
Q ss_pred CCCCCCCCCHHHHHH
Q 017246 319 NEEANFRPLINDIVV 333 (375)
Q Consensus 319 ~~~p~~RPs~~eil~ 333 (375)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.6e-09 Score=104.68 Aligned_cols=139 Identities=18% Similarity=0.121 Sum_probs=90.9
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCccch------------------------------H----------HHHH
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH------------------------------Q----------EFIV 105 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~------------------------------~----------~~~~ 105 (375)
+.|+.++-|.||+|++++|+.||||+.++.-.... . .+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999865422110 0 1234
Q ss_pred HHHHHccCC-----CCCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhcc--CCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 017246 106 EVLMLSLLH-----HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAARGLEYLHC 178 (375)
Q Consensus 106 e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 178 (375)
|+..+.+++ .+++.--.=+++-...-.|+|||++|-.+.+..... ..+...+....+..++.|+. .
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~-------~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL-------R 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------h
Confidence 554444442 233321122334456778999999999988874321 11111233333333334432 2
Q ss_pred CCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 179 ~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
.| ++|.|.+|.||+++.+|.+.+.|||+....+
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 45 9999999999999999999999999986543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.1e-08 Score=88.23 Aligned_cols=106 Identities=25% Similarity=0.230 Sum_probs=81.9
Q ss_pred hHHHHHHHHHHccCCCC--CcceeEeEEeeC----CeeEEEEeecCCC-CHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 017246 100 HQEFIVEVLMLSLLHHD--NLVTLIGYCTSG----DQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172 (375)
Q Consensus 100 ~~~~~~e~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~ 172 (375)
.....+|...+..+... .+.+.+++.+.. ...+||+|++++. +|.+++.... ..+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 34567788877776433 345556655543 2457999999874 7999886422 25566788999999999
Q ss_pred HHHhhcCCCCCcccCCCCCCcEEEeCCC---ceEEeecCCCcc
Q 017246 173 LEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAKL 212 (375)
Q Consensus 173 l~~LH~~~~~~i~H~Dlkp~Nill~~~~---~vkl~Dfg~a~~ 212 (375)
+.-||..| |+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999998 99999999999999887 899999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.5e-08 Score=82.90 Aligned_cols=139 Identities=14% Similarity=0.110 Sum_probs=93.2
Q ss_pred HHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHH---------HHHHHHHccC---CCCCcceeEe
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEF---------IVEVLMLSLL---HHDNLVTLIG 123 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~~e~~~l~~l---~h~niv~~~~ 123 (375)
.+...+|.+.+++-......|.+...+ |..+++|..+.........+ .+.+..+..+ .-.....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 355678999899988888888877766 78899998876543322221 1222222222 2223333332
Q ss_pred EE-----eeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC
Q 017246 124 YC-----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 198 (375)
Q Consensus 124 ~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~ 198 (375)
+. .-....+++|||++|..|.+... +++ .+...+.+++.-||..| ++|+|++|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 22 22345568999999988866542 222 24456778899999998 999999999999986
Q ss_pred CCceEEeecCCCc
Q 017246 199 DFNPKLSDFGLAK 211 (375)
Q Consensus 199 ~~~vkl~Dfg~a~ 211 (375)
++ ++++||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 54 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.2e-08 Score=81.55 Aligned_cols=140 Identities=16% Similarity=0.156 Sum_probs=102.3
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEcccc---C---ccchHHHHHHHHHHccCCCCC--cceeEeEEe-e----CCeeE
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHE---G---LQGHQEFIVEVLMLSLLHHDN--LVTLIGYCT-S----GDQRL 132 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~---~---~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~-~----~~~~~ 132 (375)
---|.||-+-|+..... |+.+-+|.-..- . +-....|.+|...|..+..-+ +.+.. ++. . ....+
T Consensus 24 pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 24 PNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred CCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 33567899999998776 446888876421 1 234667899999998885433 44444 322 1 13457
Q ss_pred EEEeecCC-CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc--eEEeecCC
Q 017246 133 LVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSDFGL 209 (375)
Q Consensus 133 lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~--vkl~Dfg~ 209 (375)
||+|-+.+ -+|.+++... .-.+.+......++.+++..+.-||..| +.|+|+.+.|||++.++. |+++||.-
T Consensus 102 LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 99997753 5888887442 2234567778899999999999999998 999999999999987777 99999987
Q ss_pred Ccc
Q 017246 210 AKL 212 (375)
Q Consensus 210 a~~ 212 (375)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.77 E-value=2e-07 Score=81.58 Aligned_cols=140 Identities=14% Similarity=0.105 Sum_probs=85.5
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCC--cceeEeEEeeCCeeEEEEeecCCCC-
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIGYCTSGDQRLLVYEYMPMGS- 142 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs- 142 (375)
..||+|..+.||+. .+..+++|...... ......+|..+++.+..-+ +.+.+.+....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25567889876532 3455788999998886433 4677888777778889999999964
Q ss_pred HHHHH---------------------hccCCCCCCCCHHHHHHHHHH----------HHH-HHHHhhc-CCCCCcccCCC
Q 017246 143 LEDHL---------------------YDLEPDQEPLSWNTRMKIAVG----------AAR-GLEYLHC-KANPPVIYRDL 189 (375)
Q Consensus 143 L~~~l---------------------~~~~~~~~~l~~~~~~~i~~q----------i~~-~l~~LH~-~~~~~i~H~Dl 189 (375)
+...+ +........+.. ....+..+ +.. ...+|.. .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11111 000000111110 00000000 000 1111211 12334789999
Q ss_pred CCCcEEEeCCCceEEeecCCCcc
Q 017246 190 KSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 190 kp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.5e-09 Score=100.11 Aligned_cols=188 Identities=18% Similarity=0.107 Sum_probs=136.6
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCC-cceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~ 138 (375)
..+....-+++|+++.+++.+-...+....+.+... ....-++++|.+++||| .+..++.+..++..++.++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 344555668999999999876433333335555332 44566889999999999 777777777788889999999
Q ss_pred CCC-CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 139 PMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 139 ~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
.++ +...... .....+...+...+...-++++++||+.. =+|+| ||+..+ +.+++.||+.........
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 776 2221111 11223334455566677778999999765 58998 777765 678999999987544332
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 266 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 266 (375)
......+++.++|||+.....+....|+|++|+-..++.-|.+|-.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4456789999999999999999999999999998888887877754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.7e-07 Score=75.36 Aligned_cols=130 Identities=19% Similarity=0.208 Sum_probs=91.8
Q ss_pred ccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcce-eEeEEeeCCeeEEEEeecCC
Q 017246 62 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT-LIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~ 140 (375)
.++.+.|++|++|.||++.+. |..+|+|+-+.+ .....+..|+++|..+.--++.+ ++.| +..++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcC
Confidence 455778999999999999987 568999987665 34567788999999987766644 4444 333466999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCC-CCcEEEeCCCceEEeecCCCcc
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK-SANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlk-p~Nill~~~~~vkl~Dfg~a~~ 212 (375)
-.|.++-... . .+-...++++---|-..| |-|+.|. |...+|.+++.+.|+||..|+.
T Consensus 97 ~~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG-------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc-------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8888766320 1 222334444444455556 9999987 4555555555999999999974
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.3e-07 Score=79.51 Aligned_cols=141 Identities=18% Similarity=0.124 Sum_probs=84.3
Q ss_pred eccccc-eEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEEEeecCCCCHHH
Q 017246 68 IGEGGF-GKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 145 (375)
Q Consensus 68 lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 145 (375)
|-.|.. +.||+.... +..+.+|...... ...+..|+.+++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 889998765 4678888875543 335667888887773 3446677877776667899999999987764
Q ss_pred HHh-------------------ccCCCCCCCCHH--HHHHH-----------------------HHHHHHHHHHhh-cCC
Q 017246 146 HLY-------------------DLEPDQEPLSWN--TRMKI-----------------------AVGAARGLEYLH-CKA 180 (375)
Q Consensus 146 ~l~-------------------~~~~~~~~l~~~--~~~~i-----------------------~~qi~~~l~~LH-~~~ 180 (375)
... ........+... ..... ..++...|.... ...
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 000000011100 00000 111111111110 011
Q ss_pred CCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 181 ~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
.+.++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23499999999999999987788999998853
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.6e-07 Score=79.48 Aligned_cols=144 Identities=22% Similarity=0.245 Sum_probs=83.2
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCC--CcceeEeEEe---eCCeeEEEEeecC
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD--NLVTLIGYCT---SGDQRLLVYEYMP 139 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~ 139 (375)
.+.|+.|..+.||++...+ ..+++|..... .....+..|..+++.+... .+.+++.+.. .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999886 68999987554 4456677888888877533 3556665432 2345689999999
Q ss_pred CCCHHH----------------HHhccC---CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhc
Q 017246 140 MGSLED----------------HLYDLE---PDQEPLSWNT---------RMKI------------AVGAAR-GLEYLHC 178 (375)
Q Consensus 140 ~gsL~~----------------~l~~~~---~~~~~l~~~~---------~~~i------------~~qi~~-~l~~LH~ 178 (375)
|.++.. .+.... .....+.... .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111110 0111111000 0000 011112 2333331
Q ss_pred ----CCCCCcccCCCCCCcEEEe-CCCceEEeecCCCc
Q 017246 179 ----KANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK 211 (375)
Q Consensus 179 ----~~~~~i~H~Dlkp~Nill~-~~~~vkl~Dfg~a~ 211 (375)
.....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1233499999999999999 66666899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.7e-07 Score=89.04 Aligned_cols=138 Identities=20% Similarity=0.160 Sum_probs=89.5
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccch---------------------------H----------HHHHHH
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH---------------------------Q----------EFIVEV 107 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~---------------------------~----------~~~~e~ 107 (375)
.+.||.-+.|.||+|++++|+.||||+-++.-.... . .|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 367999999999999999999999998654321100 0 123344
Q ss_pred HHHc----cCCCCC------cceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 017246 108 LMLS----LLHHDN------LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177 (375)
Q Consensus 108 ~~l~----~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 177 (375)
+... .+.|-+ |.+++- .-.....|+||||+|..+.|.-.- ....++...+..-+.+...-+-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf-- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIF-- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHH--
Confidence 3322 223444 333332 223567899999999988775432 23445555544444443322222
Q ss_pred cCCCCCcccCCCCCCcEEEeC----CCceEEeecCCCcc
Q 017246 178 CKANPPVIYRDLKSANILLDN----DFNPKLSDFGLAKL 212 (375)
Q Consensus 178 ~~~~~~i~H~Dlkp~Nill~~----~~~vkl~Dfg~a~~ 212 (375)
..| ++|+|-+|.||+++. ++.+.+-|||+...
T Consensus 319 ~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 319 KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred hcC---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 235 999999999999983 56799999999875
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.56 E-value=2e-06 Score=73.22 Aligned_cols=132 Identities=21% Similarity=0.233 Sum_probs=92.6
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccC----------------ccchHHHHHHHHHHccCC------CCCcceeE
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEG----------------LQGHQEFIVEVLMLSLLH------HDNLVTLI 122 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~ 122 (375)
...||+|+.-.||. +.......||+..+.. .....+..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999999996 4556678899987765 112344555665444444 78899999
Q ss_pred eEEeeCCeeEEEEeecC------CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE
Q 017246 123 GYCTSGDQRLLVYEYMP------MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 196 (375)
Q Consensus 123 ~~~~~~~~~~lv~e~~~------~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill 196 (375)
|+.+++-...+|+|.+. ..+|.+++. ...++. .....+.++ ..||-..+ |+.+||+|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence 99999999999999863 246888883 334555 445555554 45555556 9999999999999
Q ss_pred eCCC----ceEEee-cCCC
Q 017246 197 DNDF----NPKLSD-FGLA 210 (375)
Q Consensus 197 ~~~~----~vkl~D-fg~a 210 (375)
.... .+.|+| ||..
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 5332 577888 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.3e-06 Score=75.52 Aligned_cols=149 Identities=19% Similarity=0.148 Sum_probs=96.8
Q ss_pred cHHHHHHHhhcccccc---eeccccceEEEEEEEcCCceEEEEEccccCccch-------------------H-----HH
Q 017246 51 TFRELAIATRNFREAN---LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH-------------------Q-----EF 103 (375)
Q Consensus 51 ~~~~~~~~~~~~~~~~---~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~-------------------~-----~~ 103 (375)
++..+.....+..+.. .|..|--+.||+|...++..+|+|++......-. . -.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3344444444554444 4556777789999888899999999854322110 0 12
Q ss_pred HHHHHHHccCCC--CCcceeEeEEeeCCeeEEEEeecCCC-CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-C
Q 017246 104 IVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-K 179 (375)
Q Consensus 104 ~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~ 179 (375)
..|...|+++.. -.+.+-+.+. .-.|||||+... .-.-.| +...+...++..+..++++.+.-|-+ .
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 346677766643 2344445442 335999998432 111111 12223334678888999999999887 5
Q ss_pred CCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 180 ~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+ +||+||..-|||+. ++.+.++|||-+..
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECccccc
Confidence 5 99999999999999 88999999998764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.8e-06 Score=88.36 Aligned_cols=79 Identities=16% Similarity=0.270 Sum_probs=57.5
Q ss_pred cceeccccceEEEEEEEcCC---ceEEEEEccccC-ccchHHHHHHHHHHccCC-CCCc--ceeEeEEeeC---CeeEEE
Q 017246 65 ANLIGEGGFGKVYKGRLESG---QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLH-HDNL--VTLIGYCTSG---DQRLLV 134 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 134 (375)
.+.|+.|.++.+|+....++ ..+++|+..... ......+.+|+.+++.+. |.++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999876643 467888764432 223456788999999985 6654 7778777654 467899
Q ss_pred EeecCCCCH
Q 017246 135 YEYMPMGSL 143 (375)
Q Consensus 135 ~e~~~~gsL 143 (375)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.3e-05 Score=67.84 Aligned_cols=103 Identities=29% Similarity=0.332 Sum_probs=79.2
Q ss_pred HHHHHHccCCC-CCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 017246 105 VEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183 (375)
Q Consensus 105 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 183 (375)
.|..++..+.+ +++++++|+|. .++|.||...+++....... ..--.-+|..+.+|+.++++.+.+|+......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888876 69999999983 35789999876654210000 01123589999999999999999999754344
Q ss_pred cccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 184 VIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 184 i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+.-.|++|+|+-++++|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.5e-06 Score=69.98 Aligned_cols=125 Identities=26% Similarity=0.397 Sum_probs=87.9
Q ss_pred hcccccceeccccc-eEEEEEEEcCCceEEEEEccc---cCcc------------------chHHHHHHHHHHccC---C
Q 017246 60 RNFREANLIGEGGF-GKVYKGRLESGQLVAIKQLNH---EGLQ------------------GHQEFIVEVLMLSLL---H 114 (375)
Q Consensus 60 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vaiK~~~~---~~~~------------------~~~~~~~e~~~l~~l---~ 114 (375)
.+++..+.||.|.- |.||+++.. |..||+|++.. .... ....|..|.....+| .
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67899999999999 999999987 77999999321 1110 112356677766666 4
Q ss_pred CCCc--ceeEeEEeeC------------------CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHH
Q 017246 115 HDNL--VTLIGYCTSG------------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174 (375)
Q Consensus 115 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~ 174 (375)
+.++ |+++||..-. ....||.||++... .++ ..-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 5566 8999987322 12347777765432 122 334556777788
Q ss_pred HhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 175 ~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.+|..| |+-+|+++.|.. + -+|+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc---C--CEEEecccC
Confidence 899888 999999999987 2 389999975
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.6e-06 Score=72.57 Aligned_cols=73 Identities=14% Similarity=0.160 Sum_probs=45.8
Q ss_pred ceeccccce-EEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCC---CcceeEeEEeeC---CeeEEEEeec
Q 017246 66 NLIGEGGFG-KVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD---NLVTLIGYCTSG---DQRLLVYEYM 138 (375)
Q Consensus 66 ~~lg~G~~g-~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~ 138 (375)
+.|+.|+.. .||+. +..+++|..... .....+..|+.++..+... .+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 48875 235778865442 2345678899988877532 344445443322 2347899999
Q ss_pred CCCCHH
Q 017246 139 PMGSLE 144 (375)
Q Consensus 139 ~~gsL~ 144 (375)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.6e-05 Score=72.64 Aligned_cols=79 Identities=16% Similarity=0.101 Sum_probs=57.6
Q ss_pred ccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCC---CCcceeEeEEee---CCeeEEEE
Q 017246 62 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH---DNLVTLIGYCTS---GDQRLLVY 135 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~ 135 (375)
..-.+.||.|..+.||.....++ .+.+|..+. ......+..|+..|+.+.- -.+.++++++.. .+..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34456799999999999876655 467776432 1234578889999988853 357788887754 36689999
Q ss_pred eecCCCCH
Q 017246 136 EYMPMGSL 143 (375)
Q Consensus 136 e~~~~gsL 143 (375)
|+++|.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-05 Score=70.83 Aligned_cols=74 Identities=19% Similarity=0.182 Sum_probs=48.6
Q ss_pred cceeccccceEEEEEEEcC--CceEEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEEeecCCC
Q 017246 65 ANLIGEGGFGKVYKGRLES--GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMG 141 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 141 (375)
.+.|..|-...+|++...+ +..|++|+....... .....+|+.++..+...++ ++++..+. + .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence 3567888889999997664 678999977543221 1223468888888754333 44544432 2 3799999987
Q ss_pred CH
Q 017246 142 SL 143 (375)
Q Consensus 142 sL 143 (375)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-05 Score=82.02 Aligned_cols=195 Identities=21% Similarity=0.186 Sum_probs=134.3
Q ss_pred HHHHHHHHccCCCCCcceeEeEEeeCCeeE----EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 017246 103 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRL----LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178 (375)
Q Consensus 103 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 178 (375)
...|...+....|+|++.++.|....-... +..++|..-++...+.. -..++....+.+..+++.||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 345677788889999999998875443222 44577888888887753 5567888999999999999999998
Q ss_pred CCCCCcccCCCCCC---cEEEeCCCceEEe--ecCCCccCCCCCCceeeeccccccccccccccccCCCCcc--chhHhH
Q 017246 179 KANPPVIYRDLKSA---NILLDNDFNPKLS--DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK--SDIYSF 251 (375)
Q Consensus 179 ~~~~~i~H~Dlkp~---Nill~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Dvwsl 251 (375)
.. ..|.-|... +.-++..+.+.++ ||+............ ...-+..+.+||......+..+ .|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 75 666555544 4445666677776 888887544333221 1233556788887776655544 799999
Q ss_pred HHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 017246 252 GVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331 (375)
Q Consensus 252 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ei 331 (375)
|.....+..|..+-... .....++ +..+...+.++..+|+-.++++|+++.++
T Consensus 379 gll~~~~~~~~~i~~~~-------------------~~~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKS-------------------AVPVSLL--------DVLSTSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCcccccc-------------------cchhhhh--------ccccchhhhhhhhhhcchhhhhccchhhh
Confidence 99999999876543210 0011111 11111257788889999999999999999
Q ss_pred HHH
Q 017246 332 VVA 334 (375)
Q Consensus 332 l~~ 334 (375)
+..
T Consensus 432 l~~ 434 (1351)
T KOG1035|consen 432 LTH 434 (1351)
T ss_pred hhc
Confidence 975
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.3e-05 Score=68.26 Aligned_cols=140 Identities=14% Similarity=0.029 Sum_probs=78.6
Q ss_pred eeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEEeecCCCCHHH
Q 017246 67 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMGSLED 145 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~ 145 (375)
.+..|-.+.+|+... ++..+++|...............|..+++.+...++ .+++.... -++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677889998874 467788997654322211134668888888864434 33444322 368999999876542
Q ss_pred H-----------------HhccCCCCCCCCHH-HHHHHHHHH---------HHHHHHhhcC-----CCCCcccCCCCCCc
Q 017246 146 H-----------------LYDLEPDQEPLSWN-TRMKIAVGA---------ARGLEYLHCK-----ANPPVIYRDLKSAN 193 (375)
Q Consensus 146 ~-----------------l~~~~~~~~~l~~~-~~~~i~~qi---------~~~l~~LH~~-----~~~~i~H~Dlkp~N 193 (375)
. ++........++.. .+..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111111122211 111211111 1111112111 02238999999999
Q ss_pred EEEeCCCceEEeecCCCcc
Q 017246 194 ILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 194 ill~~~~~vkl~Dfg~a~~ 212 (375)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 89999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.6e-05 Score=70.81 Aligned_cols=76 Identities=20% Similarity=0.193 Sum_probs=53.8
Q ss_pred cceeccccceEEEEEEEcCC-ceEEEEEcccc------C-ccchHHHHHHHHHHccCC---CCCcceeEeEEeeCCeeEE
Q 017246 65 ANLIGEGGFGKVYKGRLESG-QLVAIKQLNHE------G-LQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 133 (375)
.+.||.|.+..||++...+| +.++||.-.+. . .-...+...|...|..+. -.++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36799999999999988776 48999985421 1 123456677888887763 2356677766 3456789
Q ss_pred EEeecCCCC
Q 017246 134 VYEYMPMGS 142 (375)
Q Consensus 134 v~e~~~~gs 142 (375)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.1e-05 Score=69.93 Aligned_cols=144 Identities=18% Similarity=0.109 Sum_probs=83.2
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCC--cceeEe------EEeeCCeeEEEEe
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIG------YCTSGDQRLLVYE 136 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~------~~~~~~~~~lv~e 136 (375)
.+.|..|....+|+....+ ..+++|+... .....+..|+.++..+.+.+ +.+++. +....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567788888999987654 4688998764 23345666777777774322 344433 1233456789999
Q ss_pred ecCCCCHHH----HHh----------ccC-CCC------CCCCHHHH----------HHHHHHHHHHHHHhhcC----CC
Q 017246 137 YMPMGSLED----HLY----------DLE-PDQ------EPLSWNTR----------MKIAVGAARGLEYLHCK----AN 181 (375)
Q Consensus 137 ~~~~gsL~~----~l~----------~~~-~~~------~~l~~~~~----------~~i~~qi~~~l~~LH~~----~~ 181 (375)
|++|..+.. ... ... ... ....+... ......+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876532 000 000 000 00011110 00111123334444321 12
Q ss_pred CCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 182 ~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999887778999998863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00025 Score=65.58 Aligned_cols=144 Identities=15% Similarity=0.135 Sum_probs=76.3
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCC--CcceeEe------EEeeCCeeEEEEe
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD--NLVTLIG------YCTSGDQRLLVYE 136 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e 136 (375)
.+.|+.|....+|+....+| .+++|++.. .....+..|..++..|... .+.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35567788789999987655 688998752 2233344455555444211 1233332 1233566789999
Q ss_pred ecCCCCHH-----------HHHhcc---CCC-------CCCCCH-HHHH------------HHHHH-HHHHHHHhhcC--
Q 017246 137 YMPMGSLE-----------DHLYDL---EPD-------QEPLSW-NTRM------------KIAVG-AARGLEYLHCK-- 179 (375)
Q Consensus 137 ~~~~gsL~-----------~~l~~~---~~~-------~~~l~~-~~~~------------~i~~q-i~~~l~~LH~~-- 179 (375)
|++|..+. ..+.+. ... ...+.+ .... ..+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99887431 111110 000 001111 1110 01111 11122222211
Q ss_pred --CCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 180 --ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 180 --~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
-..+++|+|+.|.|||++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 122499999999999999665568999998864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.7e-06 Score=74.61 Aligned_cols=133 Identities=17% Similarity=0.067 Sum_probs=93.8
Q ss_pred cccccceeccccceEEEEEEEcCCceEEEEEccccCccc----------------------hHHHHHHHHHHccCCC-C-
Q 017246 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG----------------------HQEFIVEVLMLSLLHH-D- 116 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----------------------~~~~~~e~~~l~~l~h-~- 116 (375)
-+.+++.||-|--+.+|.+-...|++.++|.-+.....- .-....|...|+.|.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467889999999999999998889999999643221100 0123457777777743 2
Q ss_pred CcceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE
Q 017246 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 196 (375)
Q Consensus 117 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill 196 (375)
-+.+.+++ +..++|||++.|..|...-.- . ....+...+..-+.-|-.+| +||+|..-=||+|
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~---d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------E---DPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec-------C---ChHHHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 34445544 677899999999877653311 1 12234444444556666677 9999999999999
Q ss_pred eCCCceEEeecCCC
Q 017246 197 DNDFNPKLSDFGLA 210 (375)
Q Consensus 197 ~~~~~vkl~Dfg~a 210 (375)
++++.++++||--+
T Consensus 236 ~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQM 249 (465)
T ss_pred ecCCCEEEeechHh
Confidence 99999999999744
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.7e-05 Score=68.38 Aligned_cols=74 Identities=22% Similarity=0.240 Sum_probs=48.6
Q ss_pred ceeccccceEEEEEEEcC-------CceEEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEEee
Q 017246 66 NLIGEGGFGKVYKGRLES-------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 137 (375)
+.|..|-...+|++...+ +..+++|+..... .......+|..++..+...++ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456677778999987654 5789999875542 223345678888777754333 355555432 368999
Q ss_pred cCCCCHH
Q 017246 138 MPMGSLE 144 (375)
Q Consensus 138 ~~~gsL~ 144 (375)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00041 Score=63.73 Aligned_cols=145 Identities=19% Similarity=0.184 Sum_probs=80.8
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCC--cceeEeE------EeeCCeeEEEEe
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIGY------CTSGDQRLLVYE 136 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 136 (375)
.+.++.|....+|++...+| .+++|+..... ....+..|..++..|...+ +.+++.. ....+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876545 57889775421 2334455666666663222 3343331 122456789999
Q ss_pred ecCCCCHH-----------HHH---hccCC----CC-C--CC-CHHHHH------------HHHHHHHHHHHHhhc----
Q 017246 137 YMPMGSLE-----------DHL---YDLEP----DQ-E--PL-SWNTRM------------KIAVGAARGLEYLHC---- 178 (375)
Q Consensus 137 ~~~~gsL~-----------~~l---~~~~~----~~-~--~l-~~~~~~------------~i~~qi~~~l~~LH~---- 178 (375)
|++|..+. ..+ +.... .. . .+ .|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885432 111 10000 00 0 00 010000 011123334555532
Q ss_pred CCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 179 ~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
.-...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1123499999999999999987778999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=1.2e-06 Score=91.88 Aligned_cols=160 Identities=14% Similarity=0.020 Sum_probs=118.5
Q ss_pred HHHHHHHccCCCCCcceeEeEEe--eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-
Q 017246 104 IVEVLMLSLLHHDNLVTLIGYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA- 180 (375)
Q Consensus 104 ~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~- 180 (375)
..|...++...|+++.....-.. .....+..++++.+|.+.+.+..-..+...+...-+.....+.+.+..-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 33444555567888876655443 234567899999999999999765444555555555555555466666666553
Q ss_pred -CCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHH
Q 017246 181 -NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 259 (375)
Q Consensus 181 -~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 259 (375)
+.-.+|++||+-|.+|..+.+|+++++|+.+... ..........+++.|+.|++...-.++.++|+|..|+.+|++-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 3347999999999999999999999999998321 1222334456788999999999889999999999999999999
Q ss_pred hCCCCc
Q 017246 260 TGRKAM 265 (375)
Q Consensus 260 tg~~pf 265 (375)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 998877
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00042 Score=62.67 Aligned_cols=76 Identities=20% Similarity=0.299 Sum_probs=48.4
Q ss_pred ccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCC---CCCcceeEeEEeeCCeeEEEEeec
Q 017246 62 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.+-.+.++.|....+|+.. .+++.+.||+-.. .....+..|+.-|+.|. .-.+.+++++....+..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678999999999988 5578899997652 33456777888777773 345778899888888889999999
Q ss_pred CCC
Q 017246 139 PMG 141 (375)
Q Consensus 139 ~~g 141 (375)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00058 Score=61.64 Aligned_cols=30 Identities=33% Similarity=0.483 Sum_probs=25.7
Q ss_pred CcccCCCCCCcEEEeCCCc-eEEeecCCCcc
Q 017246 183 PVIYRDLKSANILLDNDFN-PKLSDFGLAKL 212 (375)
Q Consensus 183 ~i~H~Dlkp~Nill~~~~~-vkl~Dfg~a~~ 212 (375)
.++|+|++|.|||+++++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0011 Score=61.96 Aligned_cols=143 Identities=15% Similarity=0.168 Sum_probs=81.6
Q ss_pred cceeccccceEEEEEEEcC-----CceEEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEEeec
Q 017246 65 ANLIGEGGFGKVYKGRLES-----GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~ 138 (375)
...|-.|-...+|++...+ ++.|++|+.......... ..+|..+++.+..-++ .++++.+... .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3455568888999987532 367899988654322222 2568888888765444 3556665332 579999
Q ss_pred CCCCHHHH-----------------HhccCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHh----hc
Q 017246 139 PMGSLEDH-----------------LYDLEPDQE--PLSWNTRMKIAVGA-----------------ARGLEYL----HC 178 (375)
Q Consensus 139 ~~gsL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~qi-----------------~~~l~~L----H~ 178 (375)
++.+|... ++....... ...+..+..+..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87665421 111110111 11123333333221 1111111 11
Q ss_pred -CCCCCcccCCCCCCcEEEeC-CCceEEeecCCCcc
Q 017246 179 -KANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKL 212 (375)
Q Consensus 179 -~~~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg~a~~ 212 (375)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11234899999999999986 46799999998863
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00067 Score=62.15 Aligned_cols=139 Identities=19% Similarity=0.136 Sum_probs=91.2
Q ss_pred ccceeccccceEEEEEEEcCCceEEEEEccccCc--c--------------------chH----HHHHHHHHHccCCCCC
Q 017246 64 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--Q--------------------GHQ----EFIVEVLMLSLLHHDN 117 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~--------------------~~~----~~~~e~~~l~~l~h~n 117 (375)
+-..|..|--+.||.+...+|..+|||+++-.-. . ... -...|+..|++++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3455777888889999988899999998732100 0 011 1345777888876554
Q ss_pred cceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe
Q 017246 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 197 (375)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~ 197 (375)
|.----... ....|||+|+-. += |-.- .-+...++...+..+-.|++.-|.-|..... +||.||.--|+|+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGr-dg--w~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGR-DG--WAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccC-CC--CcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE
Confidence 321111111 344689999832 21 1111 1134557777888888888888888876543 99999999999995
Q ss_pred CCCceEEeecCCCc
Q 017246 198 NDFNPKLSDFGLAK 211 (375)
Q Consensus 198 ~~~~vkl~Dfg~a~ 211 (375)
+|.+.++|-+=+.
T Consensus 300 -dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSV 312 (520)
T ss_pred -CCEEEEEEccccc
Confidence 5689999987654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0021 Score=58.62 Aligned_cols=139 Identities=19% Similarity=0.226 Sum_probs=81.6
Q ss_pred ccceeccccceEEEEEEEcCCceEEEEEccc--cCccchHHHHHHHHHHccCCC--CCcceeEeEEeeCC--eeEEEEee
Q 017246 64 EANLIGEGGFGKVYKGRLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGD--QRLLVYEY 137 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~ 137 (375)
+.+.+..|.--.+|..... ++.+++. ... ..........+|..+++.+.- --+...++.|..+. ..+.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3344433433444544433 7778887 321 122334445667777777632 23445566776665 67899999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHH-HHHHHHHHHhhcC-------------------------------------
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCK------------------------------------- 179 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~qi~~~l~~LH~~------------------------------------- 179 (375)
++|..+.+.+... ... .+++ ..++..|.-||+-
T Consensus 107 veGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 107 VEGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred ecceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 9885433322110 000 1111 2444444444421
Q ss_pred ------------------CCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 180 ------------------ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 180 ------------------~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
+.+.++|+|+++.||+++.++-+=|.||+++...
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1245999999999999999988999999999864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0034 Score=59.24 Aligned_cols=73 Identities=16% Similarity=0.109 Sum_probs=50.3
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCc-------cchHHHHHHHHHHccCC---CCCcceeEeEEeeCCeeEEE
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL-------QGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 134 (375)
.+.||.|....||++... +..++||.-..... ....+...|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998865 55688997642111 13344455677766653 247778888776 456789
Q ss_pred EeecCC
Q 017246 135 YEYMPM 140 (375)
Q Consensus 135 ~e~~~~ 140 (375)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0034 Score=57.71 Aligned_cols=29 Identities=24% Similarity=0.257 Sum_probs=25.4
Q ss_pred CCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 182 ~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999988 678999999775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0034 Score=57.72 Aligned_cols=30 Identities=17% Similarity=0.222 Sum_probs=27.7
Q ss_pred CcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 183 ~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
.++|+|+.+.|||+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0046 Score=57.36 Aligned_cols=79 Identities=14% Similarity=0.102 Sum_probs=49.6
Q ss_pred eeccccceEEEEEEEcCC-ceEEEEEcccc-------CccchHHHHHHHHHHccCC--CCC-cceeEeEEeeCCeeEEEE
Q 017246 67 LIGEGGFGKVYKGRLESG-QLVAIKQLNHE-------GLQGHQEFIVEVLMLSLLH--HDN-LVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~ 135 (375)
.||.|....||++...+| +.++||.-.+. -.-...+..-|...|+... .|. +.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478999999999987654 57999974321 1223455566777776653 353 4445443 445667999
Q ss_pred eecCC-CCHHHHH
Q 017246 136 EYMPM-GSLEDHL 147 (375)
Q Consensus 136 e~~~~-gsL~~~l 147 (375)
|+++. ..|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99854 3343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0054 Score=56.95 Aligned_cols=142 Identities=17% Similarity=0.197 Sum_probs=78.7
Q ss_pred ceeccccceEEEEEEEcC----CceEEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.|..|-...+|++...+ +..|++|+....... .-.-.+|..+++.+..-++ .++++++. +. +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence 445557788899886543 237889987654322 2223568888888865555 35565553 22 58899877
Q ss_pred CCHHH--------------HHh---ccCCC--CCCCCHHHHHHHHHHH----------------------HHHHHH----
Q 017246 141 GSLED--------------HLY---DLEPD--QEPLSWNTRMKIAVGA----------------------ARGLEY---- 175 (375)
Q Consensus 141 gsL~~--------------~l~---~~~~~--~~~l~~~~~~~i~~qi----------------------~~~l~~---- 175 (375)
.+|.. .+. ..... ...-.+..+..+..++ ..-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 011 10000 0011122222222221 111111
Q ss_pred hhcCC-CCCcccCCCCCCcEEEeC-CCceEEeecCCCcc
Q 017246 176 LHCKA-NPPVIYRDLKSANILLDN-DFNPKLSDFGLAKL 212 (375)
Q Consensus 176 LH~~~-~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg~a~~ 212 (375)
+...+ ..-++|.|+.+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111 123799999999999975 46899999998854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0046 Score=52.86 Aligned_cols=116 Identities=17% Similarity=0.142 Sum_probs=70.6
Q ss_pred cceEEEEEEEcCCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhcc
Q 017246 72 GFGKVYKGRLESGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL 150 (375)
Q Consensus 72 ~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 150 (375)
+-++.-.++.+-|.. .+|++..-... ...-+.++..+++++. .|+++..- +.....++.|+|.....
T Consensus 74 gNsTl~~~kt~iG~L-~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIGPL-FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CceEEEEeccccchh-hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 334444444333433 34444332222 3345677888888874 67777743 44556689999843111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 151 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 151 ~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.. .-.+... +.+|...|+. ++..+|+|-.|+||+-|..|.+||.|-+..
T Consensus 142 ------~~---~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 ------NF---SNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------ch---hHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 00 0111111 4667788854 344999999999999999999999997754
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0067 Score=56.97 Aligned_cols=74 Identities=18% Similarity=0.166 Sum_probs=49.3
Q ss_pred cceeccccceEEEEEEEcC-CceEEEEEcccc-----C-ccchHHHHHHHHHHccCC--CCC-cceeEeEEeeCCeeEEE
Q 017246 65 ANLIGEGGFGKVYKGRLES-GQLVAIKQLNHE-----G-LQGHQEFIVEVLMLSLLH--HDN-LVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~-----~-~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv 134 (375)
.+.||.|.-.-||++...+ ++.++||.-.+. . .-...+..-|...|+... .|. +.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999998743 567999974321 1 223556667888877663 454 4445544 44566789
Q ss_pred EeecCC
Q 017246 135 YEYMPM 140 (375)
Q Consensus 135 ~e~~~~ 140 (375)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.012 Score=54.25 Aligned_cols=141 Identities=21% Similarity=0.314 Sum_probs=80.7
Q ss_pred eeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCC---cce---eEe----EEeeCCeeEEEEe
Q 017246 67 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN---LVT---LIG----YCTSGDQRLLVYE 136 (375)
Q Consensus 67 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n---iv~---~~~----~~~~~~~~~lv~e 136 (375)
.|.+ .-..||+....+|+. ++|+.+.. ....++..|...+..|.-.+ .++ +=| ........+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 557799998876665 89988776 44566667777777663221 122 111 1111136778899
Q ss_pred ecCCCCHHH-----HHh--------------ccC----CCCCCCCHH-------------HHHHHHHHHHHHHHHhhcC-
Q 017246 137 YMPMGSLED-----HLY--------------DLE----PDQEPLSWN-------------TRMKIAVGAARGLEYLHCK- 179 (375)
Q Consensus 137 ~~~~gsL~~-----~l~--------------~~~----~~~~~l~~~-------------~~~~i~~qi~~~l~~LH~~- 179 (375)
|++|..+.. .+. ... .......|. .-.....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887762 000 000 000011221 0011233334444444321
Q ss_pred ---C-CCC--cccCCCCCCcEEEeCCCc-eEEeecCCCc
Q 017246 180 ---A-NPP--VIYRDLKSANILLDNDFN-PKLSDFGLAK 211 (375)
Q Consensus 180 ---~-~~~--i~H~Dlkp~Nill~~~~~-vkl~Dfg~a~ 211 (375)
- ..+ +||+|+.|.|||++.+.. +-++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 112 899999999999999885 8899999886
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.041 Score=50.96 Aligned_cols=71 Identities=17% Similarity=0.124 Sum_probs=44.7
Q ss_pred ccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCC--cceeE---e--EEeeCCeeEEEEeecCCCC
Q 017246 71 GGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLI---G--YCTSGDQRLLVYEYMPMGS 142 (375)
Q Consensus 71 G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~e~~~~gs 142 (375)
+.-..||+....++..+++|+.+... .....+..|...+..|.... ++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 44578999988778889999886432 34556667777776663211 22211 1 2233466778999998764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.018 Score=49.58 Aligned_cols=79 Identities=24% Similarity=0.336 Sum_probs=54.0
Q ss_pred ccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccC---CCCCcceeEeEEeeCCeeEEEEeec
Q 017246 62 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL---HHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.+..+.+..|..-..|..... ..++.+|+-.. .....|..|+.-|..+ +.-++.+++.+....++.|+||||+
T Consensus 18 i~er~~v~gG~inea~~v~dg-~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 18 IKEREEVSGGDINEAWRLRDG-TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred hhcccccCCccccceeEeecC-CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 333455666666666665543 56788886432 3345667777766665 4456888899989999999999999
Q ss_pred CCCCHH
Q 017246 139 PMGSLE 144 (375)
Q Consensus 139 ~~gsL~ 144 (375)
+-+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876655
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0053 Score=58.77 Aligned_cols=49 Identities=27% Similarity=0.362 Sum_probs=38.0
Q ss_pred hHHHHHHHHHHccCCCCCcceeEeEEeeC-CeeEEEEeecCCCCHHHHHhc
Q 017246 100 HQEFIVEVLMLSLLHHDNLVTLIGYCTSG-DQRLLVYEYMPMGSLEDHLYD 149 (375)
Q Consensus 100 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~ 149 (375)
...+.....+++.+.|+|...++.+-... ....+|||++ +.+|++.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 34566678889999999999999887544 3466889998 5699998854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.037 Score=59.17 Aligned_cols=143 Identities=20% Similarity=0.206 Sum_probs=78.1
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccC-------CCCCcceeE-----eEEee-CC--e
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-------HHDNLVTLI-----GYCTS-GD--Q 130 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~-----~~~~~-~~--~ 130 (375)
+.|+ |..-.+|+....+|..+++|+.+... .......|..+|..| ..|.+++.. ..... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 45688899988888899999997642 223333444455433 233333322 11111 12 4
Q ss_pred eEEEEeecCCCCHHHHH-------h--------------ccCC--CCCCCCHH-----------------HHHHHHHHHH
Q 017246 131 RLLVYEYMPMGSLEDHL-------Y--------------DLEP--DQEPLSWN-----------------TRMKIAVGAA 170 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l-------~--------------~~~~--~~~~l~~~-----------------~~~~i~~qi~ 170 (375)
.+.+++|++|..|.+.. . .... ....+.|. ..+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999997775411 0 0000 00111111 1122222333
Q ss_pred HHHH-----HhhcCCCCCcccCCCCCCcEEEeCCC--ceE-EeecCCCcc
Q 017246 171 RGLE-----YLHCKANPPVIYRDLKSANILLDNDF--NPK-LSDFGLAKL 212 (375)
Q Consensus 171 ~~l~-----~LH~~~~~~i~H~Dlkp~Nill~~~~--~vk-l~Dfg~a~~ 212 (375)
.... .+... ...+||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3222 12111 23399999999999999875 565 999998864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.059 Score=50.98 Aligned_cols=75 Identities=19% Similarity=0.253 Sum_probs=44.5
Q ss_pred cceeccccceEEEEEEEcCC--ce-----EEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEEe
Q 017246 65 ANLIGEGGFGKVYKGRLESG--QL-----VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~--~~-----vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 136 (375)
.+.|..|-...+|++...++ .. |.+....... ...-.-.+|..+++.+...++ .++++.+.. +++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 34565688899999975432 22 3444322111 111122458888888866555 455666542 58999
Q ss_pred ecCCCCHH
Q 017246 137 YMPMGSLE 144 (375)
Q Consensus 137 ~~~~gsL~ 144 (375)
|++|-+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99887664
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.074 Score=51.31 Aligned_cols=75 Identities=13% Similarity=0.093 Sum_probs=46.4
Q ss_pred ccceeccccceEEEEEEEcC---------CceEEEEEccccCccchHHHHHHHHHHccCCCCCcc-eeEeEEeeCCeeEE
Q 017246 64 EANLIGEGGFGKVYKGRLES---------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV-TLIGYCTSGDQRLL 133 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~l 133 (375)
-.+.|..|-.-.+|++...+ ++.|.+++.......-. .-..|..+++.+...+|. ++++.+. -+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence 34567777788899987542 45788888755432222 234577777777555553 4555543 235
Q ss_pred EEeecCCCCH
Q 017246 134 VYEYMPMGSL 143 (375)
Q Consensus 134 v~e~~~~gsL 143 (375)
|.+|++|-+|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 7899987644
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.022 Score=49.12 Aligned_cols=28 Identities=39% Similarity=0.493 Sum_probs=20.6
Q ss_pred cccCCCCCCcEEE-eCCCceEEeecCCCc
Q 017246 184 VIYRDLKSANILL-DNDFNPKLSDFGLAK 211 (375)
Q Consensus 184 i~H~Dlkp~Nill-~~~~~vkl~Dfg~a~ 211 (375)
++|+||.|.|||+ +.++.++|+||..|.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 8999999999999 888999999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.028 Score=51.79 Aligned_cols=53 Identities=30% Similarity=0.325 Sum_probs=45.0
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 157 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 157 l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
..+.++..++.+.+..+.-+..+- +.-|||+...||||+ +|+|-|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 346788889998888777776543 489999999999999 99999999999984
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 375 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-63 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-44 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-26 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-26 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-26 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-26 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-26 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-26 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-26 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-26 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-26 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-26 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-26 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-26 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-26 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-26 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-25 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-25 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-24 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-24 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-24 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-24 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-21 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-21 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-18 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 519 bits (1338), Expect = 0.0
Identities = 125/322 (38%), Positives = 178/322 (55%), Gaps = 4/322 (1%)
Query: 24 SKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES 83
SK ++ S + + + +L AT NF LIG G FGKVYKG L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 84 GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143
G VA+K+ E QG +EF E+ LS H +LV+LIG+C ++ +L+Y+YM G+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203
+ HLY + +SW R++I +GAARGL YLH +I+RD+KS NILLD +F PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179
Query: 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 263
++DFG++K G D TH+ST V GT GY PEY + G+LT KSD+YSFGVVL E++ R
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 264 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN 323
A+ S + NL W+ + +VDP L + L CL +
Sbjct: 240 AIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 324 FRPLINDIVVALDYLVSQRDSH 345
RP + D++ L+Y + ++S
Sbjct: 299 DRPSMGDVLWKLEYALRLQESV 320
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 509 bits (1313), Expect = 0.0
Identities = 121/306 (39%), Positives = 170/306 (55%), Gaps = 19/306 (6%)
Query: 45 SGARSFTFRELAIATRNFRE------ANLIGEGGFGKVYKGRLESGQLVAIKQL----NH 94
+ SF+F EL T NF E N +GEGGFG VYKG + VA+K+L +
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI 68
Query: 95 EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 154
+ Q+F E+ +++ H+NLV L+G+ + GD LVY YMP GSL D L L+
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GT 127
Query: 155 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214
PLSW+ R KIA GAA G+ +LH I+RD+KSANILLD F K+SDFGLA+
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 274
T +++R++GT Y APE + G++T KSDIYSFGVVLLE+ITG A+D + Q
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQ 241
Query: 275 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334
L+ ++K +D + + +V + CL+E+ N RP I +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 335 LDYLVS 340
L + +
Sbjct: 301 LQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 496 bits (1280), Expect = e-178
Identities = 131/293 (44%), Positives = 184/293 (62%), Gaps = 5/293 (1%)
Query: 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQ-EFIV 105
+ F+ REL +A+ NF N++G GGFGKVYKGRL G LVA+K+L E QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
EV M+S+ H NL+ L G+C + +RLLVY YM GS+ L + Q PL W R +I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
A+G+ARGL YLH +P +I+RD+K+ANILLD +F + DFGLAKL D THV+T V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAV 195
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ--NLVSWSRPF 283
GT G+ APEY +GK + K+D++ +GV+LLELITG++A DL++ + L+ W +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336
LK+ KK LVD L G Y + + V +C RP ++++V L+
Sbjct: 256 LKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 1e-95
Identities = 80/327 (24%), Positives = 126/327 (38%), Gaps = 28/327 (8%)
Query: 38 GNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL 97
G+ S L + + + G FG V+K +L + VA+K +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK 60
Query: 98 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPD 153
Q + EV L + H+N++ IG G L+ + GSL D L
Sbjct: 61 QS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----- 114
Query: 154 QEPLSWNTRMKIAVGAARGLEYLH-------CKANPPVIYRDLKSANILLDNDFNPKLSD 206
+SWN IA ARGL YLH P + +RD+KS N+LL N+ ++D
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITG 261
FGLA G + + +GT Y APE L+ D+Y+ G+VL EL +
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 262 RKAMDLSKGQGEQNLVS--WSRPFLKDQKKFV--HLVDPLLHGRYPRRCLNYAVAVTAM- 316
A D + P L+D ++ V P+L + + + T
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 317 CLNEEANFRPLINDIVVALDYLVSQRD 343
C + +A R + + + +
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQRLTN 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 3e-77
Identities = 78/333 (23%), Positives = 130/333 (39%), Gaps = 47/333 (14%)
Query: 50 FTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI--VEV 107
E ++ N + LIG G +G VYKG L+ + VA+K + Q FI +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFS---FANRQNFINEKNI 58
Query: 108 LMLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 162
+ L+ HDN+ I + LLV EY P GSL +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 163 MKIAVGAARGLEYLH------CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----- 211
++A RGL YLH P + +RDL S N+L+ ND +SDFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 212 -LGPVGDNTHVSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELITGRK 263
L G+ + + +GT Y APE + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 264 AMDLSKGQGEQNL----VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM--- 316
+ + E + + P +D + V ++P ++AV ++
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV--SREKQRPKFPEAWKENSLAVRSLKET 291
Query: 317 ---CLNEEANFRPLINDIVVALDYLVSQRDSHP 346
C +++A R + L+ + +
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-74
Identities = 86/330 (26%), Positives = 131/330 (39%), Gaps = 35/330 (10%)
Query: 25 KSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESG 84
K + + + + ++ I + IG G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-G 60
Query: 85 QLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 142
VA+K L + EF+ EV ++ L H N+V +G T +V EY+ GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 143 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 202
L L+ +E L R+ +A A+G+ YLH + NPP+++R+LKS N+L+D +
Sbjct: 121 LYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTV 178
Query: 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
K+ DFGL++L S GT + APE KSD+YSFGV+L EL T +
Sbjct: 179 KVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
Query: 263 ------KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM 316
+ G + R + PR A+
Sbjct: 237 QPWGNLNPAQVVAAVGFKCK----RLEI------------------PRNLNPQVAAIIEG 274
Query: 317 CLNEEANFRPLINDIVVALDYLVSQRDSHP 346
C E RP I+ L L+ P
Sbjct: 275 CWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-70
Identities = 68/197 (34%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG V K + + VAIKQ+ E + + FIVE+ LS ++H N+V L G C
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ LV EY GSL + L+ EP + M + ++G+ YLH +I+R
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 188 DLKSANILLDNDFN-PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 246
DLK N+LL K+ DFG A D T G+ + APE + K
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 247 DIYSFGVVLLELITGRK 263
D++S+G++L E+IT RK
Sbjct: 185 DVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 3e-70
Identities = 88/309 (28%), Positives = 138/309 (44%), Gaps = 56/309 (18%)
Query: 53 RELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGH-------QEFI 104
R +A IG+GGFG V+KGRL +VAIK L +G QEF
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 105 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 164
EV ++S L+H N+V L G + +V E++P G L L D P+ W+ +++
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLR 126
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-----DFNPKLSDFGLAKLGPVGDNT 219
+ + A G+EY+ + NPP+++RDL+S NI L + K++DFGL++ +
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSV 180
Query: 220 HVSTRVMGTYGYCAPE--YAMSGKLTLKSDIYSFGVVLLELITGRK--------AMDLSK 269
H + ++G + + APE A T K+D YSF ++L ++TG +
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240
Query: 270 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 329
E+ L RP + P C V +C + + RP +
Sbjct: 241 MIREEGL----RPTI------------------PEDCPPRLRNVIELCWSGDPKKRPHFS 278
Query: 330 DIVVALDYL 338
IV L L
Sbjct: 279 YIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-68
Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 55/299 (18%)
Query: 52 FRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH--QEFIVEVLM 109
F++L T+ + E G+++KGR G + +K L ++F E
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 110 LSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 167
L + H N++ ++G C S + +MP GSL + L++ + + +K A+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFAL 118
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 227
ARG+ +LH P + L S ++++D D ++S + + S M
Sbjct: 119 DMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMY 170
Query: 228 TYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGR------KAMDLSKGQGEQNLV 277
+ APE A+ K +D++SF V+L EL+T M++ + L
Sbjct: 171 APAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL- 228
Query: 278 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336
RP + P + + +C+NE+ RP + IV L+
Sbjct: 229 ---RPTI------------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 6e-68
Identities = 81/303 (26%), Positives = 124/303 (40%), Gaps = 57/303 (18%)
Query: 52 FRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH----QEFIVEV 107
F EL + IG GGFGKVY+ G VA+K H+ + + E
Sbjct: 6 FAELTLEEI-------IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 108 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 167
+ ++L H N++ L G C LV E+ G L L + + + + AV
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAV 112
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--------KLSDFGLAKLGPVGDNT 219
ARG+ YLH +A P+I+RDLKS+NIL+ K++DFGLA+ T
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRT 169
Query: 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR------KAMDLSKGQGE 273
+ G Y + APE + + SD++S+GV+L EL+TG + ++ G
Sbjct: 170 TKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333
L + P C + C N + + RP +I+
Sbjct: 229 NKL----ALPI------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266
Query: 334 ALD 336
L
Sbjct: 267 QLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-64
Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 34/291 (11%)
Query: 68 IGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
+G+G FG+ K E+G+++ +K+L + + F+ EV ++ L H N++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
+ + EY+ G+L + ++ W+ R+ A A G+ YLH +I+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 187 RDLKSANILLDNDFNPKLSDFGLAKL------------GPVGDNTHVSTRVMGTYGYCAP 234
RDL S N L+ + N ++DFGLA+L + V+G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294
E K D++SFG+VL E+I A + + + F + + F+
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADP--------DYLPRTMDFGLNVRGFLDR- 242
Query: 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 345
P C +T C + + RP + L+ L H
Sbjct: 243 -YC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-64
Identities = 76/230 (33%), Positives = 105/230 (45%), Gaps = 14/230 (6%)
Query: 38 GNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL 97
G + I IG G FG VYKG+ G VA+K LN
Sbjct: 2 KKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAP 59
Query: 98 QGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE 155
Q F EV +L H N++ +GY T Q +V ++ SL HL+ E
Sbjct: 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASET--- 115
Query: 156 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215
+ IA ARG++YLH K +I+RDLKS NI L D K+ DFGLA
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172
Query: 216 GDNTHVSTRVMGTYGYCAPE---YAMSGKLTLKSDIYSFGVVLLELITGR 262
+H ++ G+ + APE S + +SD+Y+FG+VL EL+TG+
Sbjct: 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 7e-63
Identities = 60/248 (24%), Positives = 96/248 (38%), Gaps = 23/248 (9%)
Query: 29 SSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVA 88
+ K+ S +E I LIG+G FG+VY GR G+ VA
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE-VA 59
Query: 89 IKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 146
I+ ++ E + F EV+ H+N+V +G C S ++ +L
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 147 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206
+ D + L N +IA +G+ YLH K ++++DLKS N+ DN ++D
Sbjct: 120 VRDAKI---VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNG-KVVITD 172
Query: 207 FGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL---------TLKSDIYSFGVV 254
FGL + G G + APE + SD+++ G +
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 255 LLELITGR 262
EL
Sbjct: 233 WYELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-62
Identities = 68/310 (21%), Positives = 120/310 (38%), Gaps = 32/310 (10%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLH 114
+ + IG+G +G+V+ G+ G+ VA+K + E+ L+
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMR 89
Query: 115 HDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 170
H+N++ I G Q L+ +Y GSL D+L L + +K+A +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSV 144
Query: 171 RGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--VST 223
GL +LH + P + +RDLKS NIL+ + ++D GLA N
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 224 RVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG-QGEQNL 276
+GT Y PE + + +D+YSFG++L E+ + + + Q +
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 277 VSWSRPFLKDQKKFVHLVD---PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333
+ S P +D ++ V + + CL + C R +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 334 ALDYLVSQRD 343
L + +D
Sbjct: 325 TLAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-61
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLHHD 116
R+ +G+G +G+V++G + G+ VA+K + + + + E+ +L H+
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHE 62
Query: 117 NLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
N++ I + Q L+ Y MGSL D+L L + ++I + A G
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASG 117
Query: 173 LEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV--STRV 225
L +LH + P + +RDLKS NIL+ + ++D GLA + N +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 226 MGTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLELITG 261
+GT Y APE + DI++FG+VL E+
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-58
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLHHDNLVTLIG 123
IG+G FG+V++G+ G+ VA+K + + + + E+ +L H+N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 124 YCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-- 177
+ Q LV +Y GSL D+L ++ ++ +K+A+ A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 178 ---CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYC 232
+ P + +RDLKS NIL+ + ++D GLA +T +GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 233 APEYAMSGKL-------TLKSDIYSFGVVLLELITG 261
APE + + ++DIY+ G+V E+
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 66/320 (20%), Positives = 121/320 (37%), Gaps = 42/320 (13%)
Query: 30 SESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVA 88
S + + G+E + + I +++ +GEGGF V L G A
Sbjct: 2 GSSHHHHHHSSGRENLYFQG---HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYA 58
Query: 89 IKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC----TSGDQRLLVYEYMPMGSLE 144
+K++ Q +E E M L +H N++ L+ YC + + L+ + G+L
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 145 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 204
+ + L+ L+ + + + +G RGLE +H +RDLK NILL ++ P L
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVL 175
Query: 205 SDFGLAKLGPVGDNTHVSTRVM-------GTYGYCAPE------YAMSGKLTLKSDIYSF 251
D G + + T Y APE + + + ++D++S
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSL 232
Query: 252 GVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAV 311
G VL ++ G D+ +G+ L Q + R+
Sbjct: 233 GCVLYAMMFGEGPYDMVFQKGDSVA-------LAVQNQL----SIPQSPRHSSALWQ--- 278
Query: 312 AVTAMCLNEEANFRPLINDI 331
+ + + + RP I +
Sbjct: 279 -LLNSMMTVDPHQRPHIPLL 297
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-44
Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 37/293 (12%)
Query: 68 IGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 122
+G+G FG V R + +G++VA+K+L H + ++F E+ +L L HDN+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 123 GYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
G C S +R L+ EY+P GSL D+L +E + ++ +G+EYL K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPE 235
I+RDL + NIL++N+ K+ DFGL K+ P + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295
K ++ SD++SFGVVL EL T + + + + + Q HL++
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI--GNDKQ--GQMIVFHLIE 274
Query: 296 PLLHGR---YPRRCLN--YAVAVTAM--CLNEEANFRPLINDIVVALDYLVSQ 341
L + P C + Y + M C N N RP D+ + +D + Q
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMI----MTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-44
Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 22/205 (10%)
Query: 68 IGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 122
+G+G FG V R + +G++VA+K+L H + ++F E+ +L L HDN+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 123 GYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
G C S +R L+ EY+P GSL D+L +E + ++ +G+EYL K
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPE 235
I+RDL + NIL++N+ K+ DFGL K+ P G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 236 YAMSGKLTLKSDIYSFGVVLLELIT 260
K ++ SD++SFGVVL EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-44
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 68 IGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 122
+G+G FG V R +G LVA+KQL H G ++F E+ +L LH D +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 123 GYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
G ++ LV EY+P G L D L L + + + +G+EYL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRR 147
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPE 235
++RDL + NIL++++ + K++DFGLAKL P+ + +V G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 236 YAMSGKLTLKSDIYSFGVVLLELIT 260
+ +SD++SFGVVL EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-44
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 116
R + IG G F VYKG E+ VA +L L Q F E ML L H
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85
Query: 117 NLVTLIGYCTS---GDQRLLVY-EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
N+V S G + +++ E M G+L+ +L + + +G
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKG 141
Query: 173 LEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
L++LH + PP+I+RDLK NI + + K+ D GLA L + V+GT +
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEF 196
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
APE K D+Y+FG+ +LE+ T
Sbjct: 197 MAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-42
Identities = 76/301 (25%), Positives = 130/301 (43%), Gaps = 41/301 (13%)
Query: 60 RNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLL 113
R + +GEG FGKV R + +G+ VA+K L G + E+ +L L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 114 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
+H+N+V G CT L+ E++P GSL+++L ++ ++ ++K AV +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICK 137
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG- 230
G++YL + ++RDL + N+L++++ K+ DFGL K +
Sbjct: 138 GMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRD 190
Query: 231 ----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK 285
+ APE M K + SD++SFGV L EL+T L
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS----DSSPMALFLKMIGPTH-- 244
Query: 286 DQKKFVHLVDPLLHGR---YPRRCLN--YAVAVTAM--CLNEEANFRPLINDIVVALDYL 338
Q LV+ L G+ P C + Y + M C + + R +++ + L
Sbjct: 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQL----MRKCWEFQPSNRTSFQNLIEGFEAL 300
Query: 339 V 339
+
Sbjct: 301 L 301
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG V G+ + VA+K + EG EF E + L H LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+V EY+ G L ++L + L + +++ G+ +L I+R
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHR 128
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 244
DL + N L+D D K+SDFG+ + V D+ + +GT + APE K +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 245 KSDIYSFGVVLLELIT-GRK 263
KSD+++FG+++ E+ + G+
Sbjct: 185 KSDVWAFGILMWEVFSLGKM 204
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 68 IGEGGFGKVYKGRLESGQL-VAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
IG G FG+V+ GRL + VA+K +F+ E +L H N+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
T +V E + G L + L T +++ AA G+EYL K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY--CAPEYAMSGKLT 243
+RDL + N L+ K+SDFG+++ D + ++ + APE G+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 244 LKSDIYSFGVVLLELIT 260
+SD++SFG++L E +
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
IG G FG V+ G + VAIK + EG ++FI E ++ L H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
LV E+M G L D+L + + T + + + G+ YL VI+R
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 244
DL + N L+ + K+SDFG+ + V D+ + T GT + +PE + +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 245 KSDIYSFGVVLLELIT-GRK 263
KSD++SFGV++ E+ + G+
Sbjct: 185 KSDVWSFGVLMWEVFSEGKI 204
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 83/294 (28%), Positives = 127/294 (43%), Gaps = 35/294 (11%)
Query: 68 IGEGGFGKVYKGRLE-----SGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FGKV + +G++VA+K L G Q + E+ +L L+H++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 122 IGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
G C LV EY+P+GSL D+L + + + A G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAP 234
I+RDL + N+LLDND K+ DFGLAK P G + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAP 206
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293
E K SD++SFGV L EL+T + E + Q + L
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI----AQ--GQMTVLRL 260
Query: 294 VDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344
+ L G P +C + C EA+FRP +++ L + +
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 67/279 (24%), Positives = 111/279 (39%), Gaps = 31/279 (11%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHD 116
NFR IG G F +VY+ L G VA+K++ L + I E+ +L L+H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
N++ ++ +V E G L + + + + T K V LE++
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H + V++RD+K AN+ + KL D GL + T + ++GT Y +PE
Sbjct: 153 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 207
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296
KSDI+S G +L E+ + PF D+ L
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNLYSLCKK 249
Query: 297 LLHGRYPRRCLNY----AVAVTAMCLNEEANFRPLINDI 331
+ YP ++ + MC+N + RP + +
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 7e-42
Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG V G+ VAIK + EG EFI E ++ L H+ LV L G CT
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
++ EYM G L ++L ++ +++ +EYL K ++R
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHR 144
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 244
DL + N L+++ K+SDFGL++ V D+ + T +G+ + PE M K +
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 245 KSDIYSFGVVLLELIT 260
KSDI++FGV++ E+ +
Sbjct: 201 KSDIWAFGVLMWEIYS 216
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 14/196 (7%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
+G G FG+V+ G VA+K L +G F+ E ++ L H LV L T
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ ++ EYM GSL D L P L+ N + +A A G+ ++ + I+R
Sbjct: 79 QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 244
DL++ANIL+ + + K++DFGLA+L + DN + T G + APE G T+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 245 KSDIYSFGVVLLELIT 260
KSD++SFG++L E++T
Sbjct: 190 KSDVWSFGILLTEIVT 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-41
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 66 NLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 124
+ +G G +G+VY+G + VA+K L E +EF+ E ++ + H NLV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
CT ++ E+M G+L D+L + + +S + +A + +EYL K
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---F 339
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG-TYGYCAPEYAMSGKLT 243
I+R+L + N L+ + K++DFGL++L + +T+ + + APE K +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 244 LKSDIYSFGVVLLELIT 260
+KSD+++FGV+L E+ T
Sbjct: 398 IKSDVWAFGVLLWEIAT 414
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
+G+G FG+V+ G VAIK L G + F+ E ++ L H+ LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
+ + +V EYM GSL D L + L + +A A G+ Y+ +
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 245
+RDL++ANIL+ + K++DFGLA+L + T + APE A+ G+ T+K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 246 SDIYSFGVVLLELIT 260
SD++SFG++L EL T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-41
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 68 IGEGGFGKVYKGRLESG-----QLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 121
+G G FG VYKG VAIK+L + ++E + E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HC 178
+G C L+ + MP G L D++ + ++ + + V A+G+ YL
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
++RDL + N+L+ + K++DFGLAKL + + + + A E +
Sbjct: 139 ------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 239 SGKLTLKSDIYSFGVVLLELIT-GRK 263
T +SD++S+GV + EL+T G K
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 62/197 (31%), Positives = 106/197 (53%), Gaps = 14/197 (7%)
Query: 68 IGEGGFGKVYKGRLESGQL-VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
+G G +G+VY+G + L VA+K L E +EF+ E ++ + H NLV L+G CT
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
++ E+M G+L D+L + + +S + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 187 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLT 243
RDL + N L+ + K++DFGL++L + +T+ + G + APE K +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFS 190
Query: 244 LKSDIYSFGVVLLELIT 260
+KSD+++FGV+L E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 32/282 (11%)
Query: 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 116
++ IG G +G+ K R G+++ K+L++ + Q + EV +L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 117 NLVTLIG-YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
N+V + L +V EY G L + +++ L +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 175 YLHCKANPP--VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
H +++ V++RDLK AN+ LD N KL DFGLA++ + +T + +GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYM 183
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292
+PE KSDI+S G +L EL PF
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM------------------PPF--TAFSQKE 223
Query: 293 LVDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDI 331
L + G++ R Y + LN + RP + +I
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
+G G FG+V+ VA+K + G + F+ E ++ L HD LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
T + ++ E+M GSL D L + + + A G+ ++ + I
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKL 242
+RDL++ANIL+ K++DFGLA++ + DN + T G + APE G
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFGSF 362
Query: 243 TLKSDIYSFGVVLLELIT 260
T+KSD++SFG++L+E++T
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 60/245 (24%), Positives = 100/245 (40%), Gaps = 17/245 (6%)
Query: 23 RSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGR-L 81
S S + N G + E +G G FG+V++ +
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 82 ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 141
++G A+K++ E + E E++ + L +V L G G + E + G
Sbjct: 81 QTGFQCAVKKVRLEVFR--VE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135
Query: 142 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 201
SL + + E + + A GLEYLH + +++ D+K+ N+LL +D +
Sbjct: 136 SLGQLIKQMGCLPEDRA----LYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGS 188
Query: 202 P-KLSDFGLAK-LGPVGDNTHVSTR--VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 257
L DFG A L P G + T + GT + APE M K DI+S ++L
Sbjct: 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
Query: 258 LITGR 262
++ G
Sbjct: 249 MLNGC 253
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 66/220 (30%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FGKV+ + LVA+K L L ++F E +L+ L H+++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------PLSWNTRMKIAVGA 169
G C GD ++V+EYM G L L PD L + + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 170 ARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV- 225
A G+ YL H ++RDL + N L+ + K+ DFG+++ D V
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 226 -----MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
M PE M K T +SD++SFGV+L E+ T
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
+G+G FG+V+ G VAIK L G + F+ E ++ L H+ LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
+ + +V EYM GSL D L + L + +A A G+ Y+ +
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 385
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 245
+RDL++ANIL+ + K++DFGLA+L + T + APE A+ G+ T+K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 246 SDIYSFGVVLLELIT 260
SD++SFG++L EL T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-40
Identities = 69/328 (21%), Positives = 112/328 (34%), Gaps = 43/328 (13%)
Query: 10 QTKDTKVDIDDAPRSKSRYSSESSENGK--GNGGKEKSGARSFTFRELAIATRNFREANL 67
+ + + R S E + + G + S SF ++F+ +
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFF-------QQSFQRLSR 64
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLN--HEGLQGHQEFIVEV-LMLSLLHHDNLVTLIG 123
+G G +G+V+K R E G+L A+K+ G + + EV + H V L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
G L E SL+ H L L +LH +
Sbjct: 125 AWEEGGILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG--- 177
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 243
+++ D+K ANI L KL DFGL +G + G Y APE + G
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE-LLQGSYG 233
Query: 244 LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 303
+D++S G+ +LE+ + G+G Q L Q L +
Sbjct: 234 TAADVFSLGLTILEVACNMELP--HGGEGWQQLR---------QGY--------LPPEFT 274
Query: 304 RRCLNYAVAVTAMCLNEEANFRPLINDI 331
+ +V M L + R +
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-40
Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FGKV+ + LVA+K L Q+F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE-----------PLSWNTRMKIAVGAA 170
G CT G L+V+EYM G L L PD + PL + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 171 RGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV-- 225
G+ YL H ++RDL + N L+ K+ DFG+++ D V R
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 226 ----MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
M PE + K T +SD++SFGVVL E+ T
Sbjct: 223 PIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 53/290 (18%)
Query: 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL 118
+F+E LIG GGFG+V+K + G+ IK++ + + +E V L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66
Query: 119 VTLIGY---------------CTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 162
V G S + L + E+ G+LE + E L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLA 124
Query: 163 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 222
+++ +G++Y+H K +I RDLK +NI L + K+ DFGL N
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178
Query: 223 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 281
TR GT Y +PE S + D+Y+ G++L EL+ A + SK
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------------ 226
Query: 282 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
L G + L+++ RP ++I
Sbjct: 227 -----------FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 66/245 (26%), Positives = 106/245 (43%), Gaps = 24/245 (9%)
Query: 40 GGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQ 98
GG F + + + R ++ EGGF VY+ + + SG+ A+K+L +
Sbjct: 8 GGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE 67
Query: 99 GHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQR-------LLVYEYMPMGSLEDHLYDL 150
++ I EV M L H N+V + G + L+ + G L + L +
Sbjct: 68 KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 151 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210
E + PLS +T +KI R ++++H + PP+I+RDLK N+LL N KL DFG A
Sbjct: 128 E-SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
Query: 211 ---KLGPVGDNTHVSTRVM-------GTYGYCAPE--YAMSGK-LTLKSDIYSFGVVLLE 257
P + ++ T Y PE S + K DI++ G +L
Sbjct: 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 258 LITGR 262
L +
Sbjct: 246 LCFRQ 250
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 68 IGEGGFGKVYKGRLESGQL-----VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 121
+G G FG V+KG V IK + + G Q Q +L + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
+G C G LV +Y+P+GSL DH+ + L + V A+G+ YL
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
+++R+L + N+LL + +++DFG+A L P D + + + A E GK
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 242 LTLKSDIYSFGVVLLELIT-GRK 263
T +SD++S+GV + EL+T G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 24/239 (10%)
Query: 39 NGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ 98
+ G + F+ +++ R + IG GG KV++ E Q+ AIK +N E
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 66
Query: 99 GH--QEFIVEVLMLSLL--HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 154
+ E+ L+ L H D ++ L Y + +V E L L +
Sbjct: 67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK----KK 121
Query: 155 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214
+ + R + +H +++ DLK AN L+ + KL DFG+A
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 177
Query: 215 VGDNTHVSTRVMGTYGYCAPE-----------YAMSGKLTLKSDIYSFGVVLLELITGR 262
+ V +GT Y PE K++ KSD++S G +L + G+
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 68 IGEGGFGKVYKGRLESGQL----VAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVT 120
+G+G FG V +G ++ VA+K L + L + +FI EV + L H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
L G +V E P+GSL D L Q T + AV A G+ YL K
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYA 237
I+RDL + N+LL K+ DFGL + P D+ +V + +CAPE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 238 MSGKLTLKSDIYSFGVVLLELIT-GRK 263
+ + SD + FGV L E+ T G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 20/207 (9%)
Query: 68 IGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVT 120
IG G FG+VYKG L + VAIK L G Q +F+ E ++ H N++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
L G + +++ EYM G+L+ L + + + S + + G A G++YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLANMN 167
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYA 237
++RDL + NIL++++ K+SDFGL+++ + D+ + G + APE
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 238 MSGKLTLKSDIYSFGVVLLELIT-GRK 263
K T SD++SFG+V+ E++T G +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 68 IGEGGFGKVYKGRLESG----QLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTL 121
IG G G+V GRL VAIK L G Q +F+ E ++ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
G T G ++V EYM GSL+ L + + + G G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAM 238
++RDL + N+L+D++ K+SDFGL+++ + D+ + G + APE
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 239 SGKLTLKSDIYSFGVVLLELIT-GRK 263
+ SD++SFGVV+ E++ G +
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVT 120
+G+G FG VY+G E VAIK +N ++ EF+ E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHL------YDLEPDQEPLSWNTRMKIAVGAARGLE 174
L+G + G L++ E M G L+ +L P P S + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV------MGT 228
YL+ ++RDL + N ++ DF K+ DFG+ + D + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 229 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+PE G T SD++SFGVVL E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-39
Identities = 65/277 (23%), Positives = 113/277 (40%), Gaps = 33/277 (11%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDN 117
+ IGEG FGK + E G+ IK++N + +E EV +L+ + H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+V +V +Y G L + + + + V L+++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVH 142
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+ +++RD+KS NI L D +L DFG+A++ + ++ +GT Y +PE
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEIC 197
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297
+ KSDI++ G VL EL T + F + +LV +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK------------------HAF--EAGSMKNLVLKI 237
Query: 298 LHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDI 331
+ G +P L+Y ++ + RP +N I
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-38
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
++G+G +G VY GR L + +AIK++ + Q E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 126 TSGDQRLLVYEYMPMGSLED---HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
+ + E +P GSL + D E +I GL+YLH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI----LEGLKYLHDNQ-- 142
Query: 183 PVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
+++RD+K N+L++ K+SDFG +K + + GT Y APE G
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 242 L--TLKSDIYSFGVVLLELITGR 262
+DI+S G ++E+ TG+
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 48/277 (17%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 117
+F E ++G+G FG+V K R + AIK++ H + + EV++L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 118 LVTLIG-YCTSGDQRL------------LVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRM 163
+V + + + EY G+L D ++ Q W
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 164 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL----------- 212
+I L Y+H + +I+RDLK NI +D N K+ DFGLAK
Sbjct: 124 QIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 213 --GPVGDNTHVSTRVMGTYGYCAPE-YAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLS 268
G + ++++ + GT Y A E +G K D+YS G++ E+I M+
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 269 K-----GQGEQNLVSW-SRPFLKDQKKFVHL---VDP 296
+K +KK + L DP
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDP 272
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
IG+G FG V G G VA+K + Q F+ E +++ L H NLV L+G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIK-NDAT-AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 126 TSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
L +V EYM GSL D+L + L + +K ++ +EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 138
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAMSG 240
++RDL + N+L+ D K+SDFGL K +T + ++ APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 189
Query: 241 KLTLKSDIYSFGVVLLELIT-GRK 263
K + KSD++SFG++L E+ + GR
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRV 213
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 68 IGEGGFGKVYKGRLESGQ---LVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLI 122
+G G FG V +G + VAIK L +G + E + E ++ L + +V LI
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCK 179
G C + +LV E G L L +E + + ++ + G++YL +
Sbjct: 77 GVCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 233
++RDL + N+LL N K+SDFGL+K D+ + + + A
Sbjct: 132 -----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 263
PE K + +SD++S+GV + E ++ G+K
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 68 IGEGGFGKVYKGRLESG-----QLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 121
+G G FG VYKG VAIK+L + ++E + E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
+G C L+ + MP G L D++ + ++ + + V A+G+ YL +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
+++RDL + N+L+ + K++DFGLAKL + + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 242 LTLKSDIYSFGVVLLELIT-GRK 263
T +SD++S+GV + EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 22/198 (11%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
IG+G FG V G G VA+K + ++ Q F+ E +++ L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 128 GDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
L +V EYM GSL D+L + L + +K ++ +EYL ++
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 187 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAMSGKL 242
RDL + N+L+ D K+SDFGL K +T + ++ APE K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKKF 363
Query: 243 TLKSDIYSFGVVLLELIT 260
+ KSD++SFG++L E+ +
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 68 IGEGGFGKVYKGRL----ESGQLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTL 121
+G G FG+V GRL + VAIK L G Q +F+ E ++ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
G T ++V EYM GSL+ L + + + + G A G++YL
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAM 238
++RDL + NIL++++ K+SDFGL ++ + D+ + G + +PE
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 239 SGKLTLKSDIYSFGVVLLELIT-GRK 263
K T SD++S+G+VL E+++ G +
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 59/295 (20%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNL 118
++ +IG G V + VAIK++N E Q + ++ E+ +S HH N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN-TRMKIAV---GAARGLE 174
V+ D+ LV + + GS+ D + + E S IA GLE
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGY 231
YLH I+RD+K+ NILL D + +++DFG+ A L GD T R +GT +
Sbjct: 136 YLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 232 CAPEYAMSGKL-TLKSDIYSFGVVLLELITGR---------KAMDL----------SKGQ 271
APE + K+DI+SFG+ +EL TG K + L + Q
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 272 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 326
++ L + + F +K + ++CL ++ RP
Sbjct: 253 DKEMLKKYGKSF----RKMI-----------------------SLCLQKDPEKRP 280
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 68 IGEGGFGKVYKGRLESGQL---VAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLI 122
+G G FG V KG + ++ VA+K L +E E + E ++ L + +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCK 179
G C + +LV E +G L +L + +++ + G++YL +
Sbjct: 85 GICE-AESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNF- 138
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 233
++RDL + N+LL K+SDFGL+K +N + + + A
Sbjct: 139 -----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYA 188
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 263
PE K + KSD++SFGV++ E + G+K
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 67/222 (30%), Positives = 99/222 (44%), Gaps = 42/222 (18%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLV 119
+GE FGKVYKG L E Q VAIK L + +EF E ++ + L H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------PLSWNTRMKIAV 167
L+G T +++ Y G L + L P + L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 168 GAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 223
A G+EYL H +++DL + N+L+ + N K+SD GL + D +
Sbjct: 136 QIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 224 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
R M APE M GK ++ SDI+S+GVVL E+ +
Sbjct: 190 SLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 55/280 (19%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLV 119
F + IG+G FG+V+KG + ++VAIK ++ E + ++ E+ +LS +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYL 176
G + ++ EY+ GS D L + P E +IA +GL+YL
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDET-------QIATILREILKGLDYL 135
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H + I+RD+K+AN+LL KL+DFG+A G + D +GT + APE
Sbjct: 136 HSEK---KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGEQNLVS-WSRPFLKD 286
K+DI+S G+ +EL G K + L L +S+P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL--- 247
Query: 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 326
K+FV CLN+E +FRP
Sbjct: 248 -KEFV-----------------------EACLNKEPSFRP 263
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+G G FG+VY+G++ S VA+K L Q +F++E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE---PLSWNTRMKIAVGAARGLEYL- 176
IG R ++ E M G L+ L + P L+ + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 177 --HCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
H I+RD+ + N LL K+ DFG+A+ M +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
PE M G T K+D +SFGV+L E+ +
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-38
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 34/215 (15%)
Query: 68 IGEGGFGKVYKGRL----ESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTL 121
+GEG FG V +G L + VA+K + + + +EF+ E + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 122 IGYCTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEP--LSWNTRMKIAVGAARGLE 174
+G C + +++ +M G L +L + P + T +K V A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 175 YL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV------ 225
YL + ++RDL + N +L +D ++DFGL+K GD
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ A E T KSD+++FGV + E+ T
Sbjct: 216 I------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-38
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 66 NLIGEGGFGKVYKGRLESG---QLVAIKQLNHE-GLQGHQEFIVEV-LMLSLLHHDNLVT 120
++IGEG FG+V K R++ AIK++ H++F E+ ++ L HH N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMKIAVG 168
L+G C L EY P G+L D L LS + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST----- 223
ARG++YL K I+RDL + NIL+ ++ K++DFGL++ + T
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 224 -RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
R M A E T SD++S+GV+L E+++
Sbjct: 205 VRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-38
Identities = 45/219 (20%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIV-----------------EVLML 110
+ +G F K+ + + A+K+ L+ ++F E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 111 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 170
+ + ++ +T G T+ D+ ++YEYM S+ + + +++
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 171 R----GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 226
+ Y+H + N + +RD+K +NIL+D + KLSDFG ++ + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG-SR 211
Query: 227 GTYGYCAPEYAMSGKLT---LKSDIYSFGVVLLELITGR 262
GTY + PE S + + K DI+S G+ L +
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-38
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 68 IGEGGFGKVYKGRLESGQL----VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLI 122
+GEG FG+VY+G + + VA+K + L ++F+ E +++ L H ++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
G + ++ E P G L +L + L T + ++ + + YL
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEY 236
++RD+ NIL+ + KL DFGL++ + D + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 237 AMSGKLTLKSDIYSFGVVLLELIT-GRK 263
+ T SD++ F V + E+++ G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 63 REANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDN 117
+IG+G FG VY G ++ AIK L+ +Q + F+ E L++ L+H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 118 LVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
++ LIG + ++ YM G L + + + + + + ARG+EYL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYL 140
Query: 177 ---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG------ 227
++RDL + N +LD F K++DFGLA+ + D + S +
Sbjct: 141 AEQKF------VHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPV 192
Query: 228 --TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
T A E + + T KSD++SFGV+L EL+T
Sbjct: 193 KWT----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 24/218 (11%)
Query: 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLL--HH 115
R + IG GG KV++ E Q+ AIK +N E + E+ L+ L H
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
D ++ L Y + +V E L L ++ + R +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 123
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
+H +++ DLK AN L+ + KL DFG+A + V +GT Y PE
Sbjct: 124 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 236 -----------YAMSGKLTLKSDIYSFGVVLLELITGR 262
K++ KSD++S G +L + G+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 56/256 (21%), Positives = 96/256 (37%), Gaps = 25/256 (9%)
Query: 23 RSKSRYSSESSENGKGNGGKEKSGARSFTFRE-LAIATRNFREANLIGEGGFGKVYKGRL 81
+ + E + G + S + E +++ R + IG GG KV++
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77
Query: 82 ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEY 137
E Q+ AIK +N E Q + E+ L+ L D ++ L Y + +V E
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 197
L L ++ + R + +H +++ DLK AN L+
Sbjct: 138 GN-IDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV 189
Query: 198 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----------YAMSGKLTLKS 246
+ KL DFG+A + V +G Y PE K++ KS
Sbjct: 190 DG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 247 DIYSFGVVLLELITGR 262
D++S G +L + G+
Sbjct: 249 DVWSLGCILYYMTYGK 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 68 IGEGGFGKVYKGRL--------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 119
+G+G F K++KG V +K L+ + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL--- 176
G C GD+ +LV E++ GSL+ +L ++ ++ ++++A A + +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 177 HCKANPPVIYRDLKSANILLDNDFNP--------KLSDFGLAKLGPVGDNTHVSTRVMGT 228
I+ ++ + NILL + + KLSD G++ V + R+
Sbjct: 133 TL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIPWV 184
Query: 229 YGYCAPEYAMSGKL-TLKSDIYSFGVVLLELIT-GRK 263
PE + K L +D +SFG L E+ + G K
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 35/216 (16%)
Query: 68 IGEGGFGKVYKGRL----ESGQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121
+G+G FG V + +L S VA+K L + +EF+ E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 122 IGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEP--LSWNTRMKIAVGAARGL 173
+G + +++ +M G L L + P L T ++ V A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 174 EYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV----- 225
EYL + I+RDL + N +L D ++DFGL++ GD
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 226 -MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ A E T+ SD+++FGV + E++T
Sbjct: 205 WL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 68 IGEGGFGKVYKGRLESG----QLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTL 121
IGEG FG V++G S VAIK +F+ E L + H ++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
IG T + ++ E +G L L + L + + A + L YL K
Sbjct: 82 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR- 136
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPE 235
++RD+ + N+L+ ++ KL DFGL++ + D+T+ + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 236 YAMSGKLTLKSDIYSFGVVLLELIT-GRK 263
+ T SD++ FGV + E++ G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+G G FG+VY+G++ S VA+K L Q +F++E L++S +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE---PLSWNTRMKIAVGAARGLEYL- 176
IG R ++ E M G L+ L + P L+ + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 177 --HCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
H I+RD+ + N LL K+ DFG+A+ M +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
PE M G T K+D +SFGV+L E+ +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 66 NLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHD 116
+G G FGKV + ++ VA+K L + + E+ +M L H+
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMSHLGQHE 110
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL----------YDLEPDQEPLSWNTRMKIA 166
N+V L+G CT G L++ EY G L + L S + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST--- 223
A+G+ +L K I+RD+ + N+LL N K+ DFGLA+ N V
Sbjct: 171 SQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 224 ---RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ M APE T++SD++S+G++L E+ +
Sbjct: 228 LPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-37
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 68 IGEGGFGKVYKGRL--------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHD 116
+GEG FG+V + VA+K L + + + + E+ +M + H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMK 164
N++ L+G CT ++ EY G+L ++L +E +++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 223
ARG+EYL + I+RDL + N+L+ + K++DFGLA+ D +T
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 224 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ M APE T +SD++SFGV++ E+ T
Sbjct: 219 GRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 76/260 (29%), Positives = 117/260 (45%), Gaps = 42/260 (16%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 117
+ + IG+G G VY + +GQ VAI+Q+N + + I E+L++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLE 174
+V + GD+ +V EY+ GSL D + E +IA + LE
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEG-------QIAAVCRECLQALE 130
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGY 231
+LH VI+RD+KS NILL D + KL+DFG A++ P +T V GT +
Sbjct: 131 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYW 182
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGE---QNLVSW 279
APE K DI+S G++ +E+I G +A+ L G QN
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 280 SRPFLKDQKKFVHL---VDP 296
S F + F++ +D
Sbjct: 243 SAIF----RDFLNRCLEMDV 258
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-37
Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 42/260 (16%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 117
IGEG G V R SG+ VA+K ++ Q + EV+++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLE 174
+V + G++ ++ E++ G+L D + E +IA + L
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEE-------QIATVCEAVLQALA 155
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGY 231
YLH + VI+RD+KS +ILL D KLSDFG A++ + V R ++GT +
Sbjct: 156 YLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI-----SKDVPKRKSLVGTPYW 207
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGE---QNLVSW 279
APE + DI+S G++++E++ G +AM + +N
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267
Query: 280 SRPFLKDQKKFVHL---VDP 296
S + F+ DP
Sbjct: 268 SPVL----RDFLERMLVRDP 283
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-37
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 66 NLIGEGGFGKVYKGRL----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVT 120
+IG G FG VY G L A+K LN + +F+ E +++ H N+++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 121 LIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL--- 176
L+G C + L+V YM G L + + + + + + + A+G++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLASK 147
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG------TYG 230
++RDL + N +LD F K++DFGLA+ + V +
Sbjct: 148 KF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-- 199
Query: 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
A E + K T KSD++SFGV+L EL+T
Sbjct: 200 --ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNL 118
+G G FGKV + ++ VA+K L L + + E+ ++ L +H N+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHL--------------YDLEPDQEPLSWNTRMK 164
V L+G CT G L++ EY G L + L +E D+ L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 223
+ A+G+ +L K I+RDL + NILL + K+ DFGLA+ N V
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 224 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ M APE + T +SD++S+G+ L EL +
Sbjct: 207 ARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 44/227 (19%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLV 119
+GEG FGKV K VA+K L E ++ + E +L ++H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHL--------------------YDLEPDQEPLSW 159
L G C+ LL+ EY GSL L PD+ L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 160 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219
+ A ++G++YL +++RDL + NIL+ K+SDFGL++ D+
Sbjct: 150 GDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 220 HVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ + M A E T +SD++SFGV+L E++T
Sbjct: 207 VKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTL 121
+G GG VY VAIK + + +E + EV S L H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
I D LV EY+ +L +++ PLS +T + G+++ H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH-DMR 131
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSG 240
+++RD+K NIL+D++ K+ DFG+AK + + + T V+GT Y +PE A
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 241 KLTLKSDIYSFGVVLLELITGR 262
+DIYS G+VL E++ G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 68 IGEGGFGKVYKGRL--------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHD 116
+GEG FG+V + VA+K L + + + + E+ +M + H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMK 164
N++ L+G CT ++ EY G+L ++L +E +++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 223
ARG+EYL + I+RDL + N+L+ + K++DFGLA+ D +T
Sbjct: 208 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 224 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ M APE T +SD++SFGV++ E+ T
Sbjct: 265 GRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+ +G+G FGKVYK + E+G L A K + + + +++IVE+ +L+ H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLH 177
L+G + ++ E+ P G+++ + L T +I V L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAI---MLELDRGL---TEPQIQVVCRQMLEALNFLH 134
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAP 234
K +I+RDLK+ N+L+ + + +L+DFG++ N + +GT + AP
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAP 186
Query: 235 EYAMSGKLT-----LKSDIYSFGVVLLELITG 261
E M + K+DI+S G+ L+E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 62/298 (20%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNL 118
+F +G GGFG V++ + AIK++ + +E ++ EV L+ L H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 119 VTLIGY---------CTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 166
V ++ +Y + +L+D + +E + + I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIF 124
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL----------GPVG 216
+ A +E+LH K +++RDLK +NI D K+ DFGL
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276
T +GT Y +PE + K DI+S G++L EL+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------------- 225
Query: 277 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDI 331
PF ++ L D + + ++P + L+ RP +I
Sbjct: 226 -----PFSTQMERVRTLTD-VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-36
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 68 IGEGGFGKVYKGRLESGQ---LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIG 123
+G G FG V +G + VAIK L +E + E ++ L + +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
C + +LV E G L L + +E + + ++ + G++YL K
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFL--VGKREE-IPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSG 240
++R+L + N+LL N K+SDFGL+K D+ + + + APE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFR 514
Query: 241 KLTLKSDIYSFGVVLLELIT-GRK 263
K + +SD++S+GV + E ++ G+K
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 66 NLIGEGGFGKVYKGRL----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVT 120
+IG G FG VY G L A+K LN + +F+ E +++ H N+++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 121 LIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL--- 176
L+G C + L+V YM G L + + + + + + + A+G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLASK 211
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG------TYG 230
++RDL + N +LD F K++DFGLA+ + V +
Sbjct: 212 KF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-- 263
Query: 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
A E + K T KSD++SFGV+L EL+T
Sbjct: 264 --ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 15/206 (7%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHD 116
+F +G+G FG VY R +S ++A+K L L+ + EV + S L H
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
N++ L GY + L+ EY P+G++ L L E + A L Y
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----ATYITELANALSYC 125
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H K VI+RD+K N+LL + K++DFG + P + GT Y PE
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLPPEM 178
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGR 262
K D++S GV+ E + G+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 68 IGEGGFGKVYKGRL--------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHD 116
+GEG FG+V VA+K L + + I E+ +M + H
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHK 135
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMK 164
N++ L+G CT ++ EY G+L ++L +E LS +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 223
A ARG+EYL K I+RDL + N+L+ D K++DFGLA+ D +T
Sbjct: 196 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 224 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ M APE T +SD++SFGV+L E+ T
Sbjct: 253 GRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNL 118
+G G FG+V + + + VA+K L EG H+ + E+ +++ + HH N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNV 93
Query: 119 VTLIGYCTSGDQ-RLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMKI 165
V L+G CT +++ E+ G+L +L + ++ L+ +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-- 223
+ A+G+E+L + I+RDL + NILL K+ DFGLA+ +
Sbjct: 154 SFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 224 ----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
+ M APE T++SD++SFGV+L E+ +
Sbjct: 211 RLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 117
F +GEG +G VYK E+GQ+VAIKQ+ E QE I E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLE 174
+V G +V EY GS+ D + L L T +IA +GLE
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNK--TL---TEDEIATILQSTLKGLE 139
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGY 231
YLH I+RD+K+ NILL+ + + KL+DFG+ +L NT + GT +
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFW 191
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
APE +DI+S G+ +E+ G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 23/212 (10%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY 124
++G+G V++GR ++G L AIK N+ + + E +L L+H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 125 CTSGDQRL--LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
R L+ E+ P GSL L + L + + + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 183 PVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--- 235
+++R++K NI+ D KL+DFG A+ + D+ + GT Y P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYE 188
Query: 236 -----YAMSGKLTLKSDIYSFGVVLLELITGR 262
K D++S GV TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 68 IGEGGFGKVYKGRLESG----QLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLI 122
IGEG FG V++G S VAIK + ++F+ E L + H ++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
G T + ++ E +G L L + L + + A + L YL K
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESKR-- 511
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYA 237
++RD+ + N+L+ ++ KL DFGL++ + D+T+ G + APE
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKLPIKWMAPESI 564
Query: 238 MSGKLTLKSDIYSFGVVLLELIT 260
+ T SD++ FGV + E++
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILM 587
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 48/229 (20%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVT 120
IGEG FG+V++ R E +VA+K L E +F E +++ + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE--------------------PLSWN 160
L+G C G L++EYM G L + L + P PLS
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 161 TRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
++ IA A G+ YL ++RDL + N L+ + K++DFGL++ D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 218 NTHVSTRV------MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
M PE + T +SD++++GVVL E+ +
Sbjct: 229 YYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 44/227 (19%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNL 118
+G G FGKV VA+K L E + + E+ +M L H+N+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENI 111
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHL-------------------YDLEPDQEPLSW 159
V L+G CT L++EY G L ++L + E D L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 160 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219
+ A A+G+E+L K+ ++RDL + N+L+ + K+ DFGLA+ N
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 220 HVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
V + M APE G T+KSD++S+G++L E+ +
Sbjct: 229 VVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY 124
++G+G V++GR ++G L AIK N+ + + E +L L+H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 125 --CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
T+ ++L+ E+ P GSL L + + L + + + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 183 PVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--- 235
+++R++K NI+ D KL+DFG A+ + D+ + GT Y P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYE 188
Query: 236 -----YAMSGKLTLKSDIYSFGVVLLELITGR 262
K D++S GV TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 27/218 (12%)
Query: 62 FREANLIGEG--GFGKVYKGR-LESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHD 116
+ +IG+G V R +G+ V ++++N E E+ + L +H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD--QEPLSWNTRMKIAV---GAAR 171
N+V + ++ +V +M GS +D + D E IA G +
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IAYILQGVLK 139
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG-LAKLGPVGD--NTHVSTRVM-- 226
L+Y+H ++R +K+++IL+ D LS + G
Sbjct: 140 ALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 227 GTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 262
+ +PE KSDIYS G+ EL G
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-34
Identities = 49/228 (21%), Positives = 77/228 (33%), Gaps = 33/228 (14%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHE--GLQGHQEFIVEV-LMLSLLH 114
T F E IG G FG V+K G + AIK+ G Q + EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 115 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
H ++V D L+ EY GSL D + + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNP-------------------KLSDFGLAKLGPV 215
Y+H + +++ D+K +NI + P K+ D G
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---R 183
Query: 216 GDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
+ V G + A E K+DI++ + ++
Sbjct: 184 ISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 81/295 (27%), Positives = 117/295 (39%), Gaps = 71/295 (24%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLS-LLHHDNLV 119
F L+G G +G+VYKGR +++GQL AIK ++ G +E E+ ML HH N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 120 TLIG-----YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAA 170
T G D +L LV E+ GS+ D L L IA
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGN-TL---KEEWIAYICREIL 139
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMG 227
RGL +LH VI+RD+K N+LL + KL DFG++ R +G
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIG 191
Query: 228 TYGYCAPEYAMSGKLT-----LKSDIYSFGVVLLELITGR---------KAMDLSKGQGE 273
T + APE + KSD++S G+ +E+ G +A+ L
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251
Query: 274 QNLVS--WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 326
L S WS+ F + F+ CL + + RP
Sbjct: 252 PRLKSKKWSKKF----QSFI-----------------------ESCLVKNHSQRP 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 35/228 (15%), Positives = 73/228 (32%), Gaps = 21/228 (9%)
Query: 53 RELAIATRNFREANLIGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQGHQEFIVE 106
E + ++ +L+GEG F +VY+ ++ Q +K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 107 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKI 165
+ L + + +LV E G+L + + ++ + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-----------KLSDFGLAKLGP 214
A+ +E +H +I+ D+K N +L N F L D G +
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+ + T T G+ E + + D + + ++ G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 82/290 (28%), Positives = 119/290 (41%), Gaps = 66/290 (22%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLH 114
+ F + IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 115 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAAR 171
H N + G LV EY GS D LE ++PL ++IA GA +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD---LLEVHKKPL---QEVEIAAVTHGALQ 165
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYG 230
GL YLH +I+RD+K+ NILL KL DFG + + P N+ +GT
Sbjct: 166 GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS-----FVGTPY 215
Query: 231 YCAPEYAMSGKLT---LKSDIYSFGVVLLELITGR---------KAMDLSKGQGEQNLVS 278
+ APE ++ K D++S G+ +EL + A+ L S
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 275
Query: 279 --WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 326
WS F + FV CL + RP
Sbjct: 276 GHWSEYF----RNFV-----------------------DSCLQKIPQDRP 298
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 67 LIGEGGFGKVYKG---RLESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLV 119
++G GG +V+ R + VA+K L L F + E + L+H +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 120 TL--IGYCTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
+ G L Y EY+ +L D ++ + P++ +++ A + L
Sbjct: 76 AVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALN 130
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGY 231
+ H + +I+RD+K ANI++ K+ DFG+A+ + D+ + T+ V+GT Y
Sbjct: 131 FSH-QNG--IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQY 185
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+PE A + +SD+YS G VL E++TG
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 63/206 (30%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLI--- 122
+G GGFG V + ++G+ VAIKQ E ++E E+ ++ L+H N+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 123 ---GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
D LL EY G L +L E + L + + L YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 180 ANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
+I+RDLK NI+L K+ D G AK + + V GT Y APE
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GTLQYLAPEL 194
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGR 262
K T+ D +SFG + E ITG
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 2e-33
Identities = 30/248 (12%), Positives = 67/248 (27%), Gaps = 53/248 (21%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL-------------------- 97
R ++G+ + E+G+ +
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 98 --------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM----GSLED 145
+ H FI ++ ++ + + Y M + +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 146 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 205
L + L + R+++ + R L LH +++ L+ +I+LD L+
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLT 248
Query: 206 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVV 254
F G + G+ PE +T D ++ G+V
Sbjct: 249 GFEHLV--RDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 255 LLELITGR 262
+ +
Sbjct: 303 IYWIWCAD 310
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 54/202 (26%), Positives = 78/202 (38%), Gaps = 16/202 (7%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTL 121
L+G GG G VY+ ++VA+K + E L F E L ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
+ Q + + L L Q PL+ + I L+ H A
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH-AAG 154
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSG 240
+RD+K NIL+ D L DFG+A D +GT Y APE
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 241 KLTLKSDIYSFGVVLLELITGR 262
T ++DIY+ VL E +TG
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 30/277 (10%), Positives = 62/277 (22%), Gaps = 43/277 (15%)
Query: 21 APRSKSRYSSESSENGKGNGGKEKSGARSFTFR-ELAIATRNFREANLIGEGGFGKVYKG 79
+ E + + T L+ R + + G V+
Sbjct: 22 IGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLV 81
Query: 80 R-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYC---------- 125
R +E + A+K E + L ++
Sbjct: 82 RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141
Query: 126 ----------------TSGDQRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAV 167
+ LL+ + L L + + +
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 227
R L K +++ N+ + D L D VG S+
Sbjct: 202 QLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS---V 253
Query: 228 TYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 262
Y E+ + T + + G+ + +
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 51/204 (25%), Positives = 80/204 (39%), Gaps = 25/204 (12%)
Query: 67 LIGEGGFGKVYKGR--LESGQLVAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTLIG 123
I GG G +Y +G+ V +K L H G Q + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 124 YCTSGDQRL-----LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
+ D+ +V EY+ SL+ + L + + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLH- 199
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
+ ++Y DLK NI+L + KL D G + + GT G+ APE
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINS----FGYLYGTPGFQAPEIVR 250
Query: 239 SGKLTLKSDIYSFGVVLLELITGR 262
T+ +DIY+ G L L
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDL 273
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 62 FREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 119
F + + +G G G V+K SG ++A K ++ E + I+ E+ +L + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLEYLHC 178
G S + + E+M GSL+ L E L K+++ +GL YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 149
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYA 237
K +++RD+K +NIL+++ KL DFG++ +L ++ ++ V GT Y +PE
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV-GTRSYMSPERL 202
Query: 238 MSGKLTLKSDIYSFGVVLLELITGR 262
+++SDI+S G+ L+E+ GR
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-33
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 17/217 (7%)
Query: 55 LAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLML 110
+ + + +G G +G V K R + SGQ++A+K++ Q+ ++ ++ M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM- 60
Query: 111 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 170
+ VT G + E M SL+ + + + + KIAV
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTY 229
+ LE+LH K + VI+RD+K +N+L++ K+ DFG+ L + G
Sbjct: 120 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCK 173
Query: 230 GYCAPE----YAMSGKLTLKSDIYSFGVVLLELITGR 262
Y APE ++KSDI+S G+ ++EL R
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 46/368 (12%), Positives = 95/368 (25%), Gaps = 78/368 (21%)
Query: 53 RELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQL------------------- 92
EL R ++G+ + E+G+ +
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 93 ---------NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLVYEYM--P 139
N + + H FI ++ ++ + R +Y M
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 199
+ + + L + L + R+++ + R L LH +++ L+ +I+LD
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 247
Query: 200 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY----------AMSGKLTLKSDIY 249
L+ F G S G+ PE +T D +
Sbjct: 248 GGVFLTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 250 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG--RYPRRCL 307
+ G+ + + P D + + + P+
Sbjct: 302 TLGLAIYWIWCAD------------------LPNTDDAA--LGGSEWIFRSCKNIPQ--- 338
Query: 308 NYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGS 367
A+ L R L + +Y + + G PT
Sbjct: 339 -PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSG 397
Query: 368 NSRRSSSA 375
S+ +
Sbjct: 398 TSQPDEAG 405
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-33
Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLH 114
+F +G+G FG VY R ++ ++A+K QL EG++ E+ + S L
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHLR 72
Query: 115 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
H N++ + Y + L+ E+ P G L L E S A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS----ATFMEELADALH 128
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
Y H + VI+RD+K N+L+ K++DFG + P GT Y P
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPP 181
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGR 262
E K D++ GV+ E + G
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 57 IATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLMLSL 112
+ ++ IG G +G V K SGQ++A+K++ + Q+ ++ +V+M
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM-RS 77
Query: 113 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
+V G + E M + + Y + + KI + +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGY 231
L +L +I+RD+K +NILLD N KL DFG+ +L ++ TR G Y
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPY 191
Query: 232 CAPE----YAMSGKLTLKSDIYSFGVVLLELITGR 262
APE A ++SD++S G+ L EL TGR
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHH 115
R + +G+GGF K ++ ++ ++ A K + L ++ +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
++V G+ D +V E SL + + EP + G +Y
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQY 130
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 234
LH VI+RDLK N+ L+ D K+ DFGLA +V+ GT Y AP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 184
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGR 262
E + + D++S G ++ L+ G+
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHH 115
R + +G+GGF K ++ ++ ++ A K + L ++ +E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
++V G+ D +V E SL + + EP + G +Y
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQY 156
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 234
LH VI+RDLK N+ L+ D K+ DFGLA +V+ GT Y AP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 210
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGR 262
E + + D++S G ++ L+ G+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 36 GKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH 94
G +++G + + + +G G G+V+K R ++G ++A+KQ+
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 95 EGLQGHQEFIV---EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE 151
G + + I+ +V++ +V G + + E M + +
Sbjct: 61 SGNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 152 PDQEP-LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL- 209
P E L K+ V + L YL K VI+RD+K +NILLD KL DFG+
Sbjct: 120 PIPERILG-----KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 210 AKLGPVGDNTHVSTRVMGTYGYCAPE-----YAMSGKLTLKSDIYSFGVVLLELITGR 262
+L + R G Y APE +++D++S G+ L+EL TG+
Sbjct: 173 GRL----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHD 116
+F+ NL+G+G F VY+ + +G VAIK ++ + + Q EV + L H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE-PDQEPLSWNTRMKIAVGAARGLEY 175
+++ L Y + LV E G + +L + P E + + +I G+ Y
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLY 127
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
LH +++RDL +N+LL + N K++DFGLA + H T + GT Y +PE
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPE 182
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGR 262
A L+SD++S G + L+ GR
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 116
F + ++G GGFG+V+ ++ +G+L A K+LN + L+ + + +VE +L+ +H
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 117 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLE 174
+V+L Y L LV M G + H+Y+++ D R GLE
Sbjct: 246 FIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLE 303
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
+LH + +IYRDLK N+LLD+D N ++SD GLA G GT G+ AP
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAP 358
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELITGR 262
E + + D ++ GV L E+I R
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 20/211 (9%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLV 119
+F +++G G G + + + VA+K++ E +E V++L H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE--VQLLR-ESDEHPNVI 81
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
+ + E +L++++ + L + + GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL 137
Query: 180 ANPPVIYRDLKSANILLDN-----DFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCA 233
+++RDLK NIL+ +SDFGL K L + + V GT G+ A
Sbjct: 138 N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 234 PEY---AMSGKLTLKSDIYSFGVVLLELITG 261
PE T DI+S G V +I+
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 72/267 (26%), Positives = 118/267 (44%), Gaps = 21/267 (7%)
Query: 5 SCLTRQTKDTKVDI-DDAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFR 63
+C R + D+ + R Y S + + + + FR
Sbjct: 128 NCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFR 187
Query: 64 EANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLV 119
+ ++G+GGFG+V ++ +G++ A K+L + ++ + + E +L ++ +V
Sbjct: 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 120 TLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQ--EPLSWNTRMKI-AVGAARGLEY 175
+L Y L LV M G L+ H+Y + E R A GLE
Sbjct: 248 SLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-----RAVFYAAEICCGLED 301
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
LH + ++YRDLK NILLD+ + ++SD GLA P G RV GT GY APE
Sbjct: 302 LHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPE 355
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGR 262
+ + T D ++ G +L E+I G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY 124
+GEG +G+V + + VA+K ++ + E I E+ + +L+H+N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYL 176
G+ + L EY G L D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H + +RD+K N+LLD N K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 237 AMSGKL--TLKSDIYSFGVVLLELITGR 262
+ + D++S G+VL ++ G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 25/248 (10%)
Query: 20 DAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKG 79
D ++ R + S ++ + K F F ++ +GEG F V
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKI------------LGEGSFSTVVLA 49
Query: 80 RL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135
R + + AIK L + + E ++S L H V L ++
Sbjct: 50 RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 109
Query: 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKANPPVIYRDLKSANI 194
Y G L ++ + E TR A + +A LEYLH K +I+RDLK NI
Sbjct: 110 SYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA--LEYLHGKG---IIHRDLKPENI 161
Query: 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 254
LL+ D + +++DFG AK+ + +GT Y +PE SD+++ G +
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 221
Query: 255 LLELITGR 262
+ +L+ G
Sbjct: 222 IYQLVAGL 229
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 116
+F +IG GGFG+VY R ++G++ A+K L+ + ++ Q + E +MLSL+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 117 N---LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAAR 171
+ +V + Y +L + + M G L HL E M+ A
Sbjct: 250 DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIIL 303
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
GLE++H + V+YRDLK ANILLD + ++SD GLA H V GT+GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHGY 356
Query: 232 CAPEYAMSGKLTLKS-DIYSFGVVLLELITGR 262
APE G S D +S G +L +L+ G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY 124
+GEG +G+V + + VA+K ++ + E I E+ + +L+H+N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYL 176
G+ + L EY G L D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H + +RD+K N+LLD N K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 237 AMSGKL--TLKSDIYSFGVVLLELITGR 262
+ + D++S G+VL ++ G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 43/244 (17%)
Query: 68 IGEGGFGKVYKGR---LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 124
+G G +G VYK + + + A+KQ+ G+ E+ +L L H N+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 125 CTS-GDQRL-LVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAA---------- 170
S D+++ L+++Y +H DL S + + +
Sbjct: 87 FLSHADRKVWLLFDYA------EH--DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKL--GPVGDNTHVSTR 224
G+ YLH V++RDLK ANIL+ + K++D G A+L P+ +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 225 VMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283
V+ T+ Y APE + + T DI++ G + EL+T Q + S P+
Sbjct: 196 VV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNPY 249
Query: 284 LKDQ 287
DQ
Sbjct: 250 HHDQ 253
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 49/271 (18%), Positives = 89/271 (32%), Gaps = 73/271 (26%)
Query: 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIK----------------------QLNHEG 96
+F +G GGFG V++ + AIK +L H G
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 97 -LQGHQEFIVEVLM--------------------------------LSLLHHDNLVTLIG 123
++ ++ + + + +G
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 124 YCTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
++ +Y + +L+D + ++ + I + A +E+LH K
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-EHGVCLHIFIQIAEAVEFLHSKG 184
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAK----------LGPVGDNTHVSTRVMGTYG 230
+++RDLK +NI D K+ DFGL + T +GT
Sbjct: 185 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
Y +PE + K DI+S G++L EL+
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTL 121
L+GEG +GKV + E+ A+K L + L+ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 122 --IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-------- 171
+ Y + +V EY G E + D P++ R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQ--AHGYFCQLID 120
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
GLEYLH + ++++D+K N+LL K+S G+A+ G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 232 CAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 262
PE A K DI+S GV L + TG
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 124
IG+G F KV R + +G+ VAIK ++ L + EV ++ +L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYL 176
+ L+ EY G + D+L + RMK AR ++Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVA----------HGRMKEKE--ARSKFRQIVSAVQYC 130
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H K +++RDLK+ N+LLD D N K++DFG + + G Y APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAPE- 183
Query: 237 AMSGKL--TLKSDIYSFGVVLLELITGR 262
GK + D++S GV+L L++G
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 51/223 (22%), Positives = 85/223 (38%), Gaps = 35/223 (15%)
Query: 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGY 124
++G G G V G+ VA+K++ + ++E+ L+ H N++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKAN 181
T+ + E +L+D + E L A G+ +LH
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135
Query: 182 PPVIYRDLKSANILLDN-------------DFNPKLSDFGLAKL---GPVGDNTHVSTRV 225
+I+RDLK NIL+ + +SDFGL K G T+++
Sbjct: 136 --IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 226 MGTYGYCAPE-------YAMSGKLTLKSDIYSFGVVLLELITG 261
GT G+ APE +LT DI+S G V +++
Sbjct: 194 -GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHH 115
F++ +G G + VYKG +G VA+K++ + +G I E+ ++ L H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKH 62
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPM---GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
+N+V L + ++ LV+E+M ++ P L N +G
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP--RGLELNLVKYFQWQLLQG 120
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYG 230
L + H +++RDLK N+L++ KL DFGLA+ PV + V+ T
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173
Query: 231 YCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
Y AP+ M + + DI+S G +L E+ITG+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHD 116
++ + +IG G FG VY+ +L +SG+LVAIK++ LQ + F E+ ++ L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQ-DKRFKNRELQIMRKLDHC 107
Query: 117 NLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 170
N+V L + S ++ LV +Y+P ++ ++ L
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LGPVGDNTH-VSTRVMG 227
R L Y+H + +RD+K N+LLD D KL DFG AK L N + +R
Sbjct: 167 RSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 220
Query: 228 TYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
Y Y APE T D++S G VL EL+ G+
Sbjct: 221 -Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 124
IGEG +G V+K R ++GQ+VAIK+ + I E+ ML L H NLV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
+ LV+EY L++L+ Q + + I + + + H
Sbjct: 71 FRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 185 IYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAMSGK 241
I+RD+K NIL+ KL DFG A+L GP V+TR Y +PE
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE------ 172
Query: 242 LTLKS-------DIYSFGVVLLELITGR 262
L + D+++ G V EL++G
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHH 115
+ IGEG +G VYK + G+ A+K++ L+ E I E+ +L L H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELKH 59
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
N+V L + + +LV+E++ L+ L + L T + G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAY 115
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCA 233
H + V++RDLK N+L++ + K++DFGLA+ PV TH ++ T Y A
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRA 168
Query: 234 PEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
P+ M K + DI+S G + E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+G G FGKV G +G VA+K ++ + G + E+ L L H +++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIK 75
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------G 172
L ++ +V EY+ G L D++ + R++ AR
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYI----------CKHGRVEEME--ARRLFQQILSA 123
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
++Y H V++RDLK N+LLD N K++DFGL+ + G+ S G+ Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 177
Query: 233 APEYAMSGKL--TLKSDIYSFGVVLLELITGR 262
APE +SG+L + DI+S GV+L L+ G
Sbjct: 178 APE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 56/255 (21%), Positives = 101/255 (39%), Gaps = 25/255 (9%)
Query: 21 APRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGR 80
+ S + + +E ++ L+G GGFG VY G
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 81 -LESGQLVAIK-----QLNHEGLQGHQEFI-VEVLMLSLLHHD--NLVTLIGYCTSGDQR 131
+ VAIK +++ G + + +EV++L + ++ L+ + D
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 132 LLVYEY-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 190
+L+ E P+ L D + + QE L+ R + + H V++RD+K
Sbjct: 124 VLILERPEPVQDLFDFITERGALQEELA---R-SFFWQVLEAVRHCHNCG---VLHRDIK 176
Query: 191 SANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSD 247
NIL+D N KL DFG L +T + GT Y PE+ + +
Sbjct: 177 DENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYSPPEW-IRYHRYHGRSAA 231
Query: 248 IYSFGVVLLELITGR 262
++S G++L +++ G
Sbjct: 232 VWSLGILLYDMVCGD 246
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHH 115
+ + IGEG +G V+K + E+ ++VA+K++ + EG+ + E+ +L L H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKH 60
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
N+V L S + LV+E+ L+ + L +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGF 116
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCA 233
H + V++RDLK N+L++ + KL++FGLA+ PV + V+ T Y
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169
Query: 234 PEYAMSGKL-TLKSDIYSFGVVLLELITGRKAM 265
P+ KL + D++S G + EL + +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 37/214 (17%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--------EVLMLSLLHHDNL 118
+G G FG V+ E + V +K + E + E+ +LS + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR------- 171
+ ++ + LV E G L+ L+ + + R+ + A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAF------IDRHPRLDEPL--ASYIFRQLV 140
Query: 172 -GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 230
+ YL K +I+RD+K NI++ DF KL DFG A G + GT
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIE 194
Query: 231 YCAPEYAMSGKLTL--KSDIYSFGVVLLELITGR 262
YCAPE + G + +++S GV L L+
Sbjct: 195 YCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 124
+G G +G+V R + AIK + + + EV +L LL H N++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184
LV E G L D + + + I G+ YLH +
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKHN---I 157
Query: 185 IYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
++RDLK N+LL++ D K+ DFGL+ + + + R+ GT Y APE + K
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERL-GTAYYIAPE-VLRKK 213
Query: 242 LTLKSDIYSFGVVLLELITGR 262
K D++S GV+L L+ G
Sbjct: 214 YDEKCDVWSIGVILFILLAGY 234
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDN 117
+ L+GEG +G V K R ++G++VAIK+ + I E+ +L L H+N
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
LV L+ C + LV+E++ L DLE L + K G+ + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAP 234
+I+RD+K NIL+ KL DFG A+ P V+TR Y AP
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAP 193
Query: 235 E-------YAMSGKLTLKSDIYSFGVVLLELITGR 262
E Y + D+++ G ++ E+ G
Sbjct: 194 ELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEF-------IVEVLMLSLL 113
+++ +GEG +G VYK + G++VA+K++ + E I E+ +L L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLD-----AEDEGIPSTAIREISLLKEL 76
Query: 114 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
HH N+V+LI S LV+E+M L+ L + + L + RG+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGV 132
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGY 231
+ H +++RDLK N+L+++D KL+DFGLA+ PV TH V+ T Y
Sbjct: 133 AHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWY 185
Query: 232 CAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
AP+ M K + DI+S G + E+ITG+
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 59 TRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG---HQEFIVEVLML 110
T F + ++G+G FG+V + +GQ A+K ++ ++ + + EV +L
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 111 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 170
L H N++ L + LV E G L D + + E + ++ +
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSG- 138
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMG 227
+ Y+H +++RDLK N+LL++ D N ++ DFGL+ + + +G
Sbjct: 139 --ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIG 190
Query: 228 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
T Y APE + G K D++S GV+L L++G
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLL 113
+ + + + +GEG F VYK R + Q+VAIK++ ++ + E+ +L L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 114 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGA 169
H N++ L+ LV+++M DL + + L+ + +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMET--------DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVM 226
+GLEYLH +++RDLK N+LLD + KL+DFGLAK P TH V TR
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-- 176
Query: 227 GTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
Y APE ++ + D+++ G +L EL+
Sbjct: 177 ---WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 28/214 (13%)
Query: 66 NLIGEGGFGKVYKGR-LESGQLVAIKQLN-------------HEGLQGHQEFIVEVLMLS 111
+G G +G+V + AIK + + H+E E+ +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 112 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
L H N++ L LV E+ G L + + + E + N MK +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-MKQILSG-- 158
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 228
+ YLH +++RD+K NILL+N N K+ DFGL+ + +GT
Sbjct: 159 -ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGT 211
Query: 229 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
Y APE + K K D++S GV++ L+ G
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 74/259 (28%), Positives = 105/259 (40%), Gaps = 17/259 (6%)
Query: 10 QTKDTKVDIDDAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIG 69
T + D + + S + N G E+ + + F L+G
Sbjct: 99 WTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKH-RVTMNEFEYLKLLG 157
Query: 70 EGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYC 125
+G FGKV + +G+ A+K L E + E + E +L H L L Y
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YS 216
Query: 126 TSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPP 183
RL V EY G L HL E R + L+YLH + N
Sbjct: 217 FQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALDYLHSEKN-- 269
Query: 184 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 243
V+YRDLK N++LD D + K++DFGL K G + D + T GT Y APE
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDNDYG 327
Query: 244 LKSDIYSFGVVLLELITGR 262
D + GVV+ E++ GR
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 31/269 (11%)
Query: 8 TRQTKDTKVDIDDAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFRE--- 64
+R + ++ R +S A F R +
Sbjct: 32 SRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPA-PFDHRIVTAKQGAVNSFYT 90
Query: 65 ---ANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 120
++G G FG+V+K +G +A K + G++ +E E+ +++ L H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 121 LIGYCTSGDQRLLVYEYMPMGSL------EDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
L S + +LV EY+ G L E + E D MK G+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-ELDTILF-----MKQICE---GIR 201
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
++H +++ DLK NIL N K+ DFGLA+ + GT +
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFL 255
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITG 261
APE ++ +D++S GV+ L++G
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 51/260 (19%), Positives = 101/260 (38%), Gaps = 40/260 (15%)
Query: 27 RYSSESSENGKGNGGKEKSGA------------RSFTFRELAIATRNFRE----ANLIGE 70
R S +G GK + + + + + + + +G
Sbjct: 2 RGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGS 61
Query: 71 GGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 129
G FG V++ +G++ K +N E+ +++ LHH L+ L
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 130 QRLLVYEYMPMGSL------EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 183
+ +L+ E++ G L ED+ E + M+ A GL+++H +
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMS-EAEVINY-----MRQACE---GLKHMHEHS--- 169
Query: 184 VIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 241
+++ D+K NI+ + K+ DFGLA + + V T + APE
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEIVDREP 226
Query: 242 LTLKSDIYSFGVVLLELITG 261
+ +D+++ GV+ L++G
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG 246
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCT 126
IG G FG V++ +L VAIK++ LQ + F E+ ++ ++ H N+V L +
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKV----LQ-DKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 127 SGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
S + LV EY+P ++ ++ + R L Y+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SI 160
Query: 181 NPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYA 237
+ +RD+K N+LLD KL DFG AK L N + +R Y Y APE
Sbjct: 161 G--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELI 213
Query: 238 MSGKL-TLKSDIYSFGVVLLELITGR 262
T DI+S G V+ EL+ G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHH 115
+ + + +GEG + VYKG+ + LVA+K++ E +G I EV +L L H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKH 59
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAAR 171
N+VTL + LV+EY+ DL + ++ + R
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK--------DLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTY 229
GL Y H + V++RDLK N+L++ KL+DFGLA+ P + V+ T
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TL 164
Query: 230 GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
Y P+ + + + D++ G + E+ TGR
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 53 RELAIATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIV 105
RE F E ++G+G FG+V K + + Q A+K +N + +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
EV +L L H N++ L +V E G L D + + E + +K
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQ 129
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVS 222
+ Y+H +++RDLK NILL++ D + K+ DFGL+ NT +
Sbjct: 130 VFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK 181
Query: 223 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
R+ GT Y APE + G K D++S GV+L L++G
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 56/244 (22%), Positives = 86/244 (35%), Gaps = 53/244 (21%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 121
IG+G +G V ++ + AIK ++ + + EV ++ LHH N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 122 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG------------- 168
LV E G L D L D +K +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 169 ----------------AAR-------GLEYLHCKANPPVIYRDLKSANILL--DNDFNPK 203
+ L YLH + + +RD+K N L + F K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 204 LSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPE--YAMSGKLTLKSDIYSFGVVLLEL 258
L DFGL+K G+ ++T+ GT + APE + K D +S GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 259 ITGR 262
+ G
Sbjct: 270 LMGA 273
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 38 GNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEG 96
G G A + F+ + G+G FG V G+ +G VAIK++
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---- 56
Query: 97 LQGHQEF----IVEVLMLSLLHHDNLVTLIGYCTSGDQR-------LLVYEYMPMGSLED 145
+Q F + + L++LHH N+V L Y + +R +V EY+P +L
Sbjct: 57 IQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114
Query: 146 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLD-NDFNPK 203
+ Q R + LH N V +RD+K N+L++ D K
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK 172
Query: 204 LSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELIT 260
L DFG AK L P N + +R Y Y APE + T DI+S G + E++
Sbjct: 173 LCDFGSAKKLSPSEPNVAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 261 GR 262
G
Sbjct: 228 GE 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-25
Identities = 69/248 (27%), Positives = 105/248 (42%), Gaps = 45/248 (18%)
Query: 30 SESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVY----KGRLESGQ 85
E + G EK+ F L ++G+G FGKV+ ++ Q
Sbjct: 6 KEIAITHHVKEGHEKADPSQFEL--LK----------VLGQGSFGKVFLVKKISGSDARQ 53
Query: 86 LVAIKQLNHEGLQGHQEFIVEVLM----LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPM 140
L A+K L L+ V M L ++H +V L Y + +L L+ +++
Sbjct: 54 LYAMKVLKKATLKVRDR--VRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRG 110
Query: 141 GSLEDHLYDLEPDQEPLSWNTRMK-----IAVGAARGLEYLHCKANPPVIYRDLKSANIL 195
G L L E +K +A+ L++LH +IYRDLK NIL
Sbjct: 111 GDLFTRLSKEVMFTEE-----DVKFYLAELALA----LDHLHSLG---IIYRDLKPENIL 158
Query: 196 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVV 254
LD + + KL+DFGL+K + GT Y APE T +D +SFGV+
Sbjct: 159 LDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVL 215
Query: 255 LLELITGR 262
+ E++TG
Sbjct: 216 MFEMLTGT 223
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 62/202 (30%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYC 125
+G G FG V+ SG IK +N + Q E I E+ +L L H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN---TRMKIAVGAARGLEYLHCKANP 182
+V E G L + + + + LS MK + A L Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQH-- 144
Query: 183 PVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
V+++DLK NIL + K+ DFGLA+L + H + GT Y APE
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAA-GTALYMAPE-VFK 199
Query: 240 GKLTLKSDIYSFGVVLLELITG 261
+T K DI+S GVV+ L+TG
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 59/255 (23%), Positives = 97/255 (38%), Gaps = 42/255 (16%)
Query: 29 SSESSENGKGNGGKEKSGARSFTFRELAIATR--NFREANLIGEGGFGKVYKGR-LESGQ 85
+ + G + G S + AT +R +GEG +G+VYK + +
Sbjct: 2 AHHHHHH-MGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 86 LVAIKQLNHEGLQGHQEF-------IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138
VAIK++ E E I EV +L L H N++ L + L++EY
Sbjct: 61 TVAIKRIRLE-----HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115
Query: 139 PMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 195
DL+ +S G+ + H + ++RDLK N+L
Sbjct: 116 EN--------DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLL 164
Query: 196 LDNDFNP-----KLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSD 247
L K+ DFGLA+ P+ TH ++ T Y PE + + + D
Sbjct: 165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPEILLGSRHYSTSVD 220
Query: 248 IYSFGVVLLELITGR 262
I+S + E++
Sbjct: 221 IWSIACIWAEMLMKT 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 116
+F IG+G FGKV + ++ ++ A+K +N + E E+ ++ L H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 117 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLE 174
LV L Y ++ + +V + + G L HL +E ++ I + A L+
Sbjct: 76 FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET---VKLFICELVMA--LD 129
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
YL + +I+RD+K NILLD + ++DF +A + P T + GT Y AP
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 235 EYAMSGKLTLKS---DIYSFGVVLLELITGR 262
E S K S D +S GV EL+ GR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 33/210 (15%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLI 122
+G G FGKV G+ +G VA+K LN + ++ E+ L L H +++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLE 174
++ +V EY+ G L D++ N R+ +R G++
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI----------CKNGRLDEKE--SRRLFQQILSGVD 130
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
Y H V++RDLK N+LLD N K++DFGL+ + G+ S G+ Y AP
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAP 184
Query: 235 EYAMSGKL--TLKSDIYSFGVVLLELITGR 262
E +SG+L + DI+S GV+L L+ G
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 38/212 (17%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+GEG FGKV ++ Q VA+K L + E E+ L LL H +++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIK 73
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------G 172
L T+ ++V EY G L D++ RM R
Sbjct: 74 LYDVITTPTDIVMVIEYAG-GELFDYI----------VEKKRMTEDE--GRRFFQQIICA 120
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
+EY H +++RDLK N+LLD++ N K++DFGL+ + G+ S G+ Y
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 174
Query: 233 APEYAMSGKL--TLKSDIYSFGVVLLELITGR 262
APE ++GKL + D++S G+VL ++ GR
Sbjct: 175 APE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 44/229 (19%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-------------------- 105
IG+G +G V A+K L+ + L F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 106 ------EVLMLSLLHHDNLVTLIG-YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPL 157
E+ +L L H N+V L+ + L +V+E + G + + P +PL
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPL 134
Query: 158 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
S + +G+EYLH + +I+RD+K +N+L+ D + K++DFG++ G
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGS 190
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKLTL----KSDIYSFGVVLLELITGR 262
+ +S V GT + APE ++S + D+++ GV L + G+
Sbjct: 191 DALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-24
Identities = 50/192 (26%), Positives = 78/192 (40%), Gaps = 15/192 (7%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
IG G +G+V + A K++ ++ F E+ ++ L H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 186
LV E G L + + +E + MK + A + Y H V +
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSA---VAYCHKLN---VAH 129
Query: 187 RDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 243
RDLK N L D KL DFGLA + T+V GT Y +P+ + G
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQ-VLEGLYG 185
Query: 244 LKSDIYSFGVVL 255
+ D +S GV++
Sbjct: 186 PECDEWSAGVMM 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-24
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
++G G F +V+ + +G+L A+K + E+ +L + H+N+VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
S LV + + G L D + + E D + ++ + A ++YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA---VKYLHENG- 126
Query: 182 PPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
+++RDLK N+L + + ++DFGL+K + N +ST GT GY APE
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTAC-GTPGYVAPEVLA 180
Query: 239 SGKLTLKSDIYSFGVVL 255
+ D +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVIT 197
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-24
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQ--LNHEGLQGHQEF----IVEV---LML 110
+ IG G +G VYK R SG VA+K + + G G + EV L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG-GGGGGLPISTVREVALLRRL 68
Query: 111 SLLHHDNLVTLI----GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 165
H N+V L+ T + ++ LV+E++ L +L L T +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAP--PPGLPAETIKDL 125
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 225
RGL++LH +++RDLK NIL+ + KL+DFGLA+ ++ V
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTPVV 180
Query: 226 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+ T Y APE + D++S G + E+ +
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLH----H 115
L+G+GGFG V+ G L VAIK + L +EV +L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 116 DNLVTLIGYCTSGDQRLLVYEY-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
++ L+ + + + +LV E +P L D++ + P E S R ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---R-CFFGQVVAAIQ 153
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
+ H + V++RD+K NIL+D KL DFG L + + GT Y
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFD-GTRVYSP 206
Query: 234 PEYAMSGKL--TLKSDIYSFGVVLLELITGR 262
PE+ +S L + ++S G++L +++ G
Sbjct: 207 PEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 24/234 (10%)
Query: 43 EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQ 101
+ + +E+ + +F +IG G F +V ++ ++GQ+ A+K +N +
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG 103
Query: 102 E---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPL 157
E F E +L + L + + L LV EY G L L ++ P
Sbjct: 104 EVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPA 161
Query: 158 SWNTRMKIA--VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215
R +A V A ++ +H ++RD+K NILLD + +L+DFG
Sbjct: 162 EM-ARFYLAEIVMA---IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214
Query: 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY-------SFGVVLLELITGR 262
V GT Y +PE + + Y + GV E+ G+
Sbjct: 215 DGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 65/244 (26%), Positives = 99/244 (40%), Gaps = 18/244 (7%)
Query: 24 SKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-E 82
+ + S + S KE + T + F +G G FG+V + E
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 83 SGQLVAIKQLNHEGL--QGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139
SG A+K L+ + + E + E +L ++ LV L +V EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 140 MGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKANPPVIYRDLKSANILLDN 198
G + HL + EP R A + EYLH +IYRDLK N+L+D
Sbjct: 125 GGEMFSHLRRIGRFSEPH---ARFYAAQIVLT--FEYLHSLD---LIYRDLKPENLLIDQ 176
Query: 199 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 258
+++DFG AK V T T + GT APE +S D ++ GV++ E+
Sbjct: 177 QGYIQVTDFGFAKR--VKGRTW--T-LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 259 ITGR 262
G
Sbjct: 232 AAGY 235
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 55/242 (22%), Positives = 101/242 (41%), Gaps = 35/242 (14%)
Query: 44 KSGARSFTFRELAIATRNFREANL---------IGEGGFGKVYKGR-LESGQLVAIKQLN 93
S + F F +L + ++ L +G G G+V ++ + VAI+ ++
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169
Query: 94 HEGLQGHQEFIV--------EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 145
E+ +L L+H ++ + + + D +V E M G L D
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFD 228
Query: 146 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNP 202
+ + +E ++ ++YLH +I+RDLK N+LL + D
Sbjct: 229 KVVGNKRLKEATCKLYFYQM----LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281
Query: 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAMSGKLTLKSDIYSFGVVLLELI 259
K++DFG +K+ +G+ + + T GT Y APE + D +S GV+L +
Sbjct: 282 KITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 260 TG 261
+G
Sbjct: 339 SG 340
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 41/226 (18%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEF----IVEVLMLS 111
+ + IG+G FG+V+K R ++GQ VA+K++ EG F + E+ +L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG------FPITALREIKILQ 71
Query: 112 LLHHDNLVTLIGYCTSGDQRL--------LVYEYMPMGSLEDHLYDL----EPDQEPLSW 159
LL H+N+V LI C + LV+++ +H DL +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EH--DLAGLLSNVLVKFTL 123
Query: 160 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGD 217
+ ++ GL Y+H +++RD+K+AN+L+ D KL+DFGLA+
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
+ T + T Y PE + + D++ G ++ E+ T
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 53/211 (25%), Positives = 80/211 (37%), Gaps = 37/211 (17%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIG 123
IG G FG R + +LVA+K + V E++ L H N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKE 83
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEY 175
+ ++ EY G L + + + R AR G+ Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICN----------AGRFSEDE--ARFFFQQLLSGVSY 131
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
H + +RDLK N LLD P K+ DFG +K + + V GT Y A
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIA 185
Query: 234 PEYAMSGKL--TLKSDIYSFGVVLLELITGR 262
PE + + +D++S GV L ++ G
Sbjct: 186 PE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 66/248 (26%), Positives = 97/248 (39%), Gaps = 49/248 (19%)
Query: 33 SENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL----ESGQLVA 88
S N G EK F L ++G+GG+GKV++ R +G++ A
Sbjct: 2 SSETSVNRGPEKIRPECFEL--LR----------VLGKGGYGKVFQVRKVTGANTGKIFA 49
Query: 89 IKQLNHEGLQGHQEFIVEVLM----LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSL 143
+K L + + + L + H +V LI Y +L L+ EY+ G L
Sbjct: 50 MKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL 108
Query: 144 EDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSANIL 195
L E A L +LH K +IYRDLK NI+
Sbjct: 109 FMQLEREGIFMEDT------------ACFYLAEISMALGHLHQKG---IIYRDLKPENIM 153
Query: 196 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVV 254
L++ + KL+DFGL K T GT Y APE M D +S G +
Sbjct: 154 LNHQGHVKLTDFGLCKESIHDGTV---THTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210
Query: 255 LLELITGR 262
+ +++TG
Sbjct: 211 MYDMLTGA 218
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/268 (20%), Positives = 99/268 (36%), Gaps = 24/268 (8%)
Query: 5 SCLTRQTKDTKVDIDDAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFRE 64
+ + + K + + + + + + I + +
Sbjct: 98 APVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLD 157
Query: 65 ----ANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 119
+G G FG V++ +G A K + + E+ +S+L H LV
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEY 175
L ++ +++YE+M G L + + D + +S AV R GL +
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMS----EDEAVEYMRQVCKGLCH 270
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
+H ++ DLK NI+ + KL DFGL + V GT + A
Sbjct: 271 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTT-GTAEFAA 324
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELITG 261
PE A + +D++S GV+ L++G
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 124
+G+G FG+V K + + Q A+K +N + + EV +L L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
+V E G L D + E D + +K + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHKHN 141
Query: 181 NPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+++RDLK NILL + D + K+ DFGL+ NT + R+ GT Y APE
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAYYIAPE-V 194
Query: 238 MSGKLTLKSDIYSFGVVL 255
+ G K D++S GV+L
Sbjct: 195 LRGTYDEKCDVWSAGVIL 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 59/278 (21%), Positives = 105/278 (37%), Gaps = 46/278 (16%)
Query: 8 TRQTKDTKVDIDDAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAI----ATRNFR 63
Q + + D P + +E+ + ++ E + A + F
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93
Query: 64 EA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVL---------M 109
+ ++IG G V + +G A+K + + E + EV +
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 110 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPLSWNTRM 163
+ H +++TLI S LV++ M G L D L E + + M
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS--EKETRSI-----M 206
Query: 164 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223
+ + A + +LH +++RDLK NILLD++ +LSDFG + + +
Sbjct: 207 RSLLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRE 258
Query: 224 RVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVL 255
GT GY APE + D+++ GV+L
Sbjct: 259 LC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 65/254 (25%), Positives = 103/254 (40%), Gaps = 30/254 (11%)
Query: 29 SSESSENGKGNGGKEKSGARSFTFRELAIATR-------NFREANLIGEGGFGKVY---- 77
+ + G G E+ R + NF ++G G +GKV+
Sbjct: 16 GGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRK 75
Query: 78 KGRLESGQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDNLVTLIGYCTSGDQRL 132
++G+L A+K L + + + LVTL Y + +L
Sbjct: 76 ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKL 134
Query: 133 -LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKANPPVIYRDLK 190
L+ +Y+ G L HL E E ++ + + A LE+LH +IYRD+K
Sbjct: 135 HLILDYINGGELFTHLSQRERFTEHE---VQIYVGEIVLA--LEHLHKLG---IIYRDIK 186
Query: 191 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDI 248
NILLD++ + L+DFGL+K + GT Y AP+ G D
Sbjct: 187 LENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDW 245
Query: 249 YSFGVVLLELITGR 262
+S GV++ EL+TG
Sbjct: 246 WSLGVLMYELLTGA 259
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 19/209 (9%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 116
+F L+G+G FGKV R +G+ A+K L E + E + E +L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 117 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLE 174
L L Y RL V EY G L HL E R + LE
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGAEIVSALE 119
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCA 233
YLH + V+YRD+K N++LD D + K++DFGL K G T + GT Y A
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELITGR 262
PE D + GVV+ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-23
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 22/232 (9%)
Query: 43 EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQ 101
E + + +++ + +F +IG G FG+V +L + ++ A+K LN +
Sbjct: 57 EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA 116
Query: 102 E---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPL 157
E F E +L + TL Y D L LV +Y G L L E D+ P
Sbjct: 117 ETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPE 174
Query: 158 SWNTRMKIA--VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215
R +A V A ++ +H ++RD+K NIL+D + + +L+DFG
Sbjct: 175 EM-ARFYLAEMVIA---IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227
Query: 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS-----DIYSFGVVLLELITGR 262
S V GT Y +PE + + D +S GV + E++ G
Sbjct: 228 DGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-23
Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 24/231 (10%)
Query: 41 GKEKSGARSFTFRELAIATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIK----- 90
G ++A F + +IG+G F V + E+GQ A+K
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 91 QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL 150
+ ++ E + +L H ++V L+ +S +V+E+M L +
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 151 EPDQEPLSWN---TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKL 204
S M+ + A L Y H +I+RD+K +LL +N KL
Sbjct: 121 ADAGFVYSEAVASHYMRQILEA---LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKL 174
Query: 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 255
FG+A +G++ V+ +GT + APE D++ GV+L
Sbjct: 175 GGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 8e-23
Identities = 52/211 (24%), Positives = 82/211 (38%), Gaps = 28/211 (13%)
Query: 59 TRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIVEVLMLS 111
+ F + +G+G F V + +G A K +N + L Q+ E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 112 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
L H N+V L LV++ + G L + + E E A +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQ 112
Query: 172 ----GLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTR 224
+ Y H +++R+LK N+LL KL+DFGLA V D+
Sbjct: 113 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGF 167
Query: 225 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 255
GT GY +PE + DI++ GV+L
Sbjct: 168 A-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 68/243 (27%), Positives = 105/243 (43%), Gaps = 34/243 (13%)
Query: 29 SSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLV 87
++ + NG +++ F F L ++G+G FGKV + +L
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNF--LM----------VLGKGSFGKVMLSERKGTDELY 48
Query: 88 AIKQLNHEGLQGHQEF---IVE--VLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMG 141
A+K L + + + +VE VL L L L C RL V EY+ G
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGG 106
Query: 142 SLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 200
L H+ + +EP A A GL +L K +IYRDLK N++LD++
Sbjct: 107 DLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 158
Query: 201 NPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 259
+ K++DFG+ K T T+ GT Y APE D ++FGV+L E++
Sbjct: 159 HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
Query: 260 TGR 262
G+
Sbjct: 216 AGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 72/242 (29%), Positives = 105/242 (43%), Gaps = 34/242 (14%)
Query: 30 SESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVA 88
S NG G + G +F F + ++G+G FGKV R+ E+G L A
Sbjct: 5 SSKEGNGIGVNSSNRLGIDNFEF--IR----------VLGKGSFGKVMLARVKETGDLYA 52
Query: 89 IKQLNHEGLQGHQEF---IVE--VLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGS 142
+K L + + + + E +L L+ +H L L C RL V E++ G
Sbjct: 53 VKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLF-CCFQTPDRLFFVMEFVNGGD 110
Query: 143 LEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 201
L H+ E R + A L +LH K +IYRDLK N+LLD++ +
Sbjct: 111 LMFHIQKSRRFDEA-----RARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGH 162
Query: 202 PKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 260
KL+DFG+ K G T T GT Y APE D ++ GV+L E++
Sbjct: 163 CKLADFGMCKEGICNGVT---TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
Query: 261 GR 262
G
Sbjct: 220 GH 221
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-22
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 45/226 (19%)
Query: 58 ATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLN--------HEGLQGHQEFI 104
+T F E ++G G V + + + A+K ++ E +Q +E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 105 ---VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQE 155
V++L + H N++ L + LV++ M G L D L E +
Sbjct: 71 LKEVDILR-KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS--EKETR 127
Query: 156 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215
+ M+ + + LH +++RDLK NILLD+D N KL+DFG + +
Sbjct: 128 KI-----MRALLEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--L 174
Query: 216 GDNTHVSTRVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVL 255
+ GT Y APE + D++S GV++
Sbjct: 175 DPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 68/262 (25%), Positives = 108/262 (41%), Gaps = 34/262 (12%)
Query: 10 QTKDTKVDIDDAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIG 69
+ K + I ++ ++ + NG +++ F F L ++G
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNF--LM----------VLG 350
Query: 70 EGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLM------LSLLHHDNLVTLI 122
+G FGKV + +L A+K L + + + VE M L L
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPGKPPFLTQLH 408
Query: 123 GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
C RL V EY+ G L H+ + +EP A A GL +L K
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH---AVFYAA-EIAIGLFFLQSKG- 462
Query: 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSG 240
+IYRDLK N++LD++ + K++DFG+ K T T+ GT Y APE
Sbjct: 463 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQ 517
Query: 241 KLTLKSDIYSFGVVLLELITGR 262
D ++FGV+L E++ G+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 29/217 (13%)
Query: 52 FRELAIATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVE 106
++L + F + IG G + + + A+K ++ +E +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IE 67
Query: 107 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTR 162
+ +L H N++TL G +V E M G L D + E + +
Sbjct: 68 I-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV----- 121
Query: 163 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDN 218
+ +EYLH + V++RDLK +NIL N + ++ DFG AK +N
Sbjct: 122 LFTITKT---VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AEN 174
Query: 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 255
+ T T + APE DI+S GV+L
Sbjct: 175 GLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 51/198 (25%), Positives = 79/198 (39%), Gaps = 24/198 (12%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGY 124
+G+G F V + +G A K +N + L Q+ E + L H N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKA 180
LV++ + G L + + E E A + + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 148
Query: 181 NPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+++R+LK N+LL KL+DFGLA V D+ GT GY +PE
Sbjct: 149 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVL 202
Query: 238 MSGKLTLKSDIYSFGVVL 255
+ DI++ GV+L
Sbjct: 203 KKDPYSKPVDIWACGVIL 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 43/225 (19%)
Query: 61 NFREANLIGEGGFGKVYKGR--LESGQLVAIKQL----NHEGLQGHQEF----IVEV--- 107
+ IGEG +GKV+K R G+ VA+K++ EG I EV
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVL 65
Query: 108 LMLSLLHHDNLVTLI----GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEP--DQEPLSWN 160
L H N+V L T + +L LV+E++ D DL D+ P
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQ--DLTTYLDKVPEPGV 117
Query: 161 TRMKIAVGAA---RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
I RGL++LH V++RDLK NIL+ + KL+DFGLA+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSF 172
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+++ V+ T Y APE + D++S G + E+ +
Sbjct: 173 QMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVE--VLMLSLLH 114
+F ++G+G FGKV+ ++ Q AIK L + + + +VE VL L+
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-E 76
Query: 115 HDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARG 172
H L + + L V EY+ G L H+ R A G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILG 130
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 231
L++LH K ++YRDLK NILLD D + K++DFG+ K +GD T GT Y
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDY 184
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
APE + K D +SFGV+L E++ G+
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 55/248 (22%), Positives = 96/248 (38%), Gaps = 58/248 (23%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHD 116
++ + +G G FG V + +ESG+ A+K++ LQ + E+ ++ +L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQ-DPRYKNRELDIMKVLDHV 60
Query: 117 NLVTLIGYCTSGDQRL--------------------------------------LVYEYM 138
N++ L+ Y + ++ EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD- 197
P +L L + N R + ++H + +RD+K N+L++
Sbjct: 121 PD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LG--ICHRDIKPQNLLVNS 176
Query: 198 NDFNPKLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVV 254
D KL DFG AK L P + + +R + Y APE + T D++S G V
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDLWSIGCV 231
Query: 255 LLELITGR 262
ELI G+
Sbjct: 232 FGELILGK 239
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 6e-22
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 67 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 122
+G G FG+V+ R +G+ A+K L E + ++ E LMLS++ H ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 123 GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKA 180
Q++ ++ +Y+ G L L + P+ + A V A LEYLH K
Sbjct: 73 -GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---AKFYAAEVCLA--LEYLHSKD 126
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
+IYRDLK NILLD + + K++DFG AK V D T+ T + GT Y APE +
Sbjct: 127 ---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCGTPDYIAPEVVSTK 178
Query: 241 KLTLKSDIYSFGVVLLELITGR 262
D +SFG+++ E++ G
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGY 200
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 6e-22
Identities = 54/266 (20%), Positives = 97/266 (36%), Gaps = 78/266 (29%)
Query: 68 IGEGGFGKVYKGRL------ESGQLVAIKQLNHE-GLQGHQEFIVEV-LMLSLLHHDNLV 119
+G G FG+V + + + VA+K L H+ + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 120 TLIG--------------YCTSGDQRLLVY------------------------------ 135
L+G +C G+ L Y
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 136 ---------------------EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
E + +E+ + ++ L+ + + A+G+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
+L + I+RDL + NILL K+ DFGLA+ + + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 235 EYAMSGKLTLKSDIYSFGVVLLELIT 260
E T++SD++SFGV+L E+ +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-22
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 53 RELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQE---FIVEVL 108
R+L + ++ +IG G FG+V R + ++ A+K L+ + + F E
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 109 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKI 165
+++ + +V L Y D+ L +V EYMP G L + + YD+ R
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW------ARFYT 174
Query: 166 A-VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 224
A V A L+ +H I+RD+K N+LLD + KL+DFG T
Sbjct: 175 AEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 225 VMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGR 262
V GT Y +PE S G + D +S GV L E++ G
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-22
Identities = 70/253 (27%), Positives = 101/253 (39%), Gaps = 34/253 (13%)
Query: 19 DDAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYK 78
+ + + + S + G + F F L +IG+G FGKV
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHF--LK----------VIGKGSFGKVLL 56
Query: 79 GRL-ESGQLVAIKQLNHEGLQGHQEF---IVE--VLMLSLLHHDNLVTLIGYCTSGDQRL 132
R A+K L + + +E + E VL+ ++ H LV L + +L
Sbjct: 57 ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLH-FSFQTADKL 114
Query: 133 -LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLK 190
V +Y+ G L HL EP R + A A L YLH ++YRDLK
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSLN---IVYRDLK 166
Query: 191 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIY 249
NILLD+ + L+DFGL K ++T T GT Y APE D +
Sbjct: 167 PENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPYDRTVDWW 223
Query: 250 SFGVVLLELITGR 262
G VL E++ G
Sbjct: 224 CLGAVLYEMLYGL 236
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 23/205 (11%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLN--HEGLQGHQEFIVEV-LMLSLLHHDNLVTLIG 123
+G G F V + +GQ A K L G E + E+ ++ ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCK 179
+ + +L+ EY G + L E +S + + G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC--LPELAEMVS----ENDVIRLIKQILEGVYYLHQN 150
Query: 180 ANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
+++ DLK NILL + + K+ DFG+++ +G + + GT Y APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEI 204
Query: 237 AMSGKLTLKSDIYSFGVVLLELITG 261
+T +D+++ G++ L+T
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTH 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 67/256 (26%), Positives = 105/256 (41%), Gaps = 32/256 (12%)
Query: 15 KVDIDDAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFG 74
+ A S E+ + G + F L +IG G +
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDL--LR----------VIGRGSYA 66
Query: 75 KVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVE--VLMLSLLHHDNLVTLIGYCTSG 128
KV RL ++ ++ A++ + E + ++ E V + +H LV L C
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLH-SCFQT 124
Query: 129 DQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187
+ RL V EY+ G L H+ E R A + L YLH + +IYR
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEH---ARFYSAE-ISLALNYLHERG---IIYR 177
Query: 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKS 246
DLK N+LLD++ + KL+D+G+ K G +T T GT Y APE
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSV 234
Query: 247 DIYSFGVVLLELITGR 262
D ++ GV++ E++ GR
Sbjct: 235 DWWALGVLMFEMMAGR 250
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 38/209 (18%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--------EVLMLSLLHHDNL 118
+G G G+V ++ + VAIK ++ E+ +L L+H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPLSWNTRMKIAVGAARG 172
+ + + + D +V E M G L D L E + + A
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK--EATCKLY-----FYQMLLA--- 126
Query: 173 LEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
++YLH +I+RDLK N+LL + D K++DFG +K+ +G+ + + T GT
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTP 180
Query: 230 GYCAPE---YAMSGKLTLKSDIYSFGVVL 255
Y APE + D +S GV+L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+G G F V K R +G A K + +E EV +L + H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYL 176
L + +L+ E + G L D L E E + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 177 HCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
H K + + DLK NI+L + P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITG 261
APE L L++D++S GV+ L++G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+G G F V K R +G A K + +E EV +L + H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYL 176
L + +L+ E + G L D L E E + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 177 HCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
H K + + DLK NI+L + P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITG 261
APE L L++D++S GV+ L++G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGY 124
++GEG +V L + Q A+K + + EV ++ H N++ LI +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR-----MKIAVGAARGLEYLHCK 179
D+ LV+E M GS+ H+ + +N ++ A L++LH K
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHI------HKRRHFNELEASVVVQDVASA---LDFLHNK 130
Query: 180 ANPPVIYRDLKSANILL---DNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM----GTYGY 231
+ +RDLK NIL + K+ DF L + GD + +ST + G+ Y
Sbjct: 131 G---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 232 CAPE-----YAMSGKLTLKSDIYSFGVVL 255
APE + + D++S GV+L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+G G F V K R +G+ A K + +E EV +L + H N++T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYL 176
L + +L+ E + G L D L + E E A + G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 177 HCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
H K + + DLK NI+L + P KL DFG+A + GT +
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPEFV 178
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITG 261
APE L L++D++S GV+ L++G
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 48/239 (20%)
Query: 40 GGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQ 98
G + G + F L +IG G + KV RL ++ ++ A+K + E +
Sbjct: 1 GAMDPLGLQDFDL--LR----------VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN 48
Query: 99 GHQEF---IVE--VLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEP 152
++ E V + +H LV L C + RL V EY+ G L H+
Sbjct: 49 DDEDIDWVQTEKHVFEQAS-NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK 106
Query: 153 DQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 204
E AR L YLH + +IYRDLK N+LLD++ + KL
Sbjct: 107 LPEE------------HARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKL 151
Query: 205 SDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+D+G+ K G +T T GT Y APE D ++ GV++ E++ GR
Sbjct: 152 TDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 27/213 (12%)
Query: 57 IATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIVEVLM 109
I F E +G+G F V + + +GQ A +N + L HQ+ E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 110 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKI 165
LL H N+V L + L+++ + G L + + E D ++
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQ 118
Query: 166 AVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVS 222
+ A + + H V++R+LK N+LL KL+DFGLA V
Sbjct: 119 ILEA---VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAW 170
Query: 223 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 255
GT GY +PE D+++ GV+L
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 25/197 (12%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYC 125
+GEG F K +S Q A+K ++ Q+ E+ + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 181
LV E + G L + + E + + M+ V A + ++H
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHMHDVG- 126
Query: 182 PPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
V++RDLK N+L +++ K+ DFG A+L P DN + T T Y APE
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHYAAPELLN 182
Query: 239 SGKLTLKSDIYSFGVVL 255
D++S GV+L
Sbjct: 183 QNGYDESCDLWSLGVIL 199
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-21
Identities = 56/248 (22%), Positives = 93/248 (37%), Gaps = 31/248 (12%)
Query: 20 DAPRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREA----NLIGEGGFGK 75
D + S SS G + + + +G G
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWI---DGSNRDALSDFFEVESELGRGATSI 68
Query: 76 VYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134
VY+ + + + A+K L + E+ +L L H N++ L + + LV
Sbjct: 69 VYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126
Query: 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIYRDLK 190
E + G L D + + E + A A + + YLH +++RDLK
Sbjct: 127 LELVTGGELFDRIVEKGYYSE--------RDAADAVKQILEAVAYLHENG---IVHRDLK 175
Query: 191 SANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 247
N+L D K++DFGL+K+ V + T GT GYCAPE + D
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRGCAYGPEVD 232
Query: 248 IYSFGVVL 255
++S G++
Sbjct: 233 MWSVGIIT 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 36/206 (17%), Positives = 82/206 (39%), Gaps = 31/206 (15%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126
+G G FG V++ S + K + +G E+ +L++ H N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 127 SGDQRLLVYEYMPMGSLEDHLYDL-----EPDQEPLSWNTRMKIAVGAAR----GLEYLH 177
S ++ ++++E++ + + + E + V L++LH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNERE------------IVSYVHQVCEALQFLH 119
Query: 178 CKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
+ + D++ NI+ + K+ +FG A+ + + Y APE
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPE 173
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITG 261
++ +D++S G ++ L++G
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 29/209 (13%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVT 120
+G G F V K R +G A K + ++ EV +L + H N++T
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYL 176
L + +L+ E + G L D L + E E + A + G+ YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 177 HCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
H + + DLK NI+L + P K+ DFGLA + GT +
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF-GTPEFV 184
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITG 261
APE L L++D++S GV+ L++G
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 41/228 (17%)
Query: 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIV-----------EV 107
+ I G +G V G G VAIK++ + G I+ E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 108 LMLSLLHHDNLVTLIGYCTSGDQRL-----LVYEYMPMGSLEDHLYDLE----PDQEPLS 158
+L+ HH N++ L ++ LV E M DL + +S
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR--------TDLAQVIHDQRIVIS 132
Query: 159 WNTRMK-IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
++ GL LH +A V++RDL NILL ++ + + DF LA+
Sbjct: 133 -PQHIQYFMYHILLGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 218 NT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 262
N +V+ R Y APE M T D++S G V+ E+ +
Sbjct: 189 NKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 49/230 (21%), Positives = 83/230 (36%), Gaps = 38/230 (16%)
Query: 45 SGARSFTFRELAIATRNFRE-----ANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQ 98
S F+ + ++G G GKV + +GQ A+K L
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68
Query: 99 GHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQR----LLVYEYMPMGSLEDHLYDLEPD 153
EV ++V ++ + L++ E M G L + +
Sbjct: 69 RQ-----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE---- 119
Query: 154 QEPLSWNTR-----MKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLS 205
+ ++ R M+ A +++LH + +RD+K N+L + D KL+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTA---IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 206 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 255
DFG AK + T T Y APE K D++S GV++
Sbjct: 174 DFGFAK---ETTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 115
+ ++ IG G G V + VAIK+L+ + + E++++ ++H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 116 DNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVG 168
N+++L+ T LV E M +L + Q L +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA--------NLCQVIQMELDHERMSYLLYQ 172
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVM 226
G+++LH A +I+RDLK +NI++ +D K+ DFGLA+ +V TR
Sbjct: 173 MLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 228
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
Y APE + DI+S G ++ E++ +
Sbjct: 229 ----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 115
+ ++ IG G G V + VAIK+L+ + + E++++ ++H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 116 DNLVTLIGYCTSGDQRL------LVYEYMP--------MGSLEDH----LYDLEPDQEPL 157
N++ L+ T +V E M M + LY +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM------- 136
Query: 158 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
G+++LH A +I+RDLK +NI++ +D K+ DFGLA
Sbjct: 137 ------------LCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAG 178
Query: 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+ + T + T Y APE + DI+S G ++ E+I G
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 28/200 (14%), Positives = 56/200 (28%), Gaps = 42/200 (21%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLI 122
G + ++ + VA+ ++ +G+ QE + L LS + + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 182
+ L+V E++ GSL++ S ++ A + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 242
V + + + D G L
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVLA--------------YPATMPDA------- 179
Query: 243 TLKSDIYSFGVVLLELITGR 262
+ DI G L L+ R
Sbjct: 180 NPQDDIRGIGASLYALLVNR 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 53/249 (21%), Positives = 90/249 (36%), Gaps = 32/249 (12%)
Query: 21 APRSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGR 80
P + + ++ AI + ++G G GKV +
Sbjct: 23 PPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIF 82
Query: 81 -LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIG-YCTSGDQR---LLV 134
+ + A+K L + EV L ++V ++ Y R L+V
Sbjct: 83 NKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137
Query: 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTR-----MKIAVGAARGLEYLHCKANPPVIYRDL 189
E + G L + D+ ++ R MK A ++YLH + +RD+
Sbjct: 138 MECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEA---IQYLHSIN---IAHRDV 187
Query: 190 KSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 246
K N+L + KL+DFG AK + ++T T Y APE K
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPYYVAPEVLGPEKYDKSC 244
Query: 247 DIYSFGVVL 255
D++S GV++
Sbjct: 245 DMWSLGVIM 253
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 44/212 (20%), Positives = 90/212 (42%), Gaps = 38/212 (17%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLML-SLLHHDNLVTLIGYC 125
+G G + +V++ + + + V +K L ++ E+ +L +L N++TL
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIV 100
Query: 126 TSGDQR--LLVYEYMPMGSLEDHLYDLEPDQ------EPLSWNTRMKIAVGAARGLEYLH 177
R LV+E++ + L E L + L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 178 CKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAP 234
+++RD+K N+++D++ +L D+GLA+ G N V++R + P
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 235 EYAMSGKLTLKS-DIYSFGVVLLELITGRKAM 265
E + ++ S D++S G +L +I ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 48/228 (21%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN---HEGLQGHQEFIVEVLMLSLLH 114
+ + IGEG +G V + VAIK+++ H+ Q + E+ +L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRFR 83
Query: 115 HDNLVTLIGYCTSGDQRL-----LVYEYMP--------MGSL-EDH----LYDLEPDQEP 156
H+N++ + + +V + M L DH LY +
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------ 137
Query: 157 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPV 215
RGL+Y+H AN V++RDLK +N+LL+ + K+ DFGLA+ P
Sbjct: 138 -------------LRGLKYIH-SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 216 GDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
D+T T + T Y APE ++ K T DI+S G +L E+++ R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 49/226 (21%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 115
+ + +G G +G V SG+ VAIK+L+ + + E+L+L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 116 DNLVTLIGYCTSGDQRL------LVYEYMP--------MGSLEDH----LYDLEPDQEPL 157
+N++ L+ T LV +M + E+ +Y +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML------ 136
Query: 158 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217
+GL+Y+H A V++RDLK N+ ++ D K+ DFGLA+
Sbjct: 137 -------------KGLKYIH-SAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 218 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 262
+V TR + Y APE +S DI+S G ++ E++TG+
Sbjct: 181 TGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 115
+R+ +G G +G V +G VAIK+L + + E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 116 DNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
+N++ L+ T + LV +M L L + L + +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHE-KLGEDRIQFLVYQM 137
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
+GL Y+H A +I+RDLK N+ ++ D K+ DFGLA+ +V TR
Sbjct: 138 LKGLRYIH-AAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW---- 190
Query: 230 GYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 262
Y APE ++ + T DI+S G ++ E+ITG+
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 53/235 (22%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 117
+ + +G GG G V+ + + VAIK++ Q + + E+ ++ L HDN
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 118 LVTLIGYCTSGDQRL--------------LVYEYMP--------MGSL-EDH----LYDL 150
+V + +L +V EYM G L E+H +Y L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 151 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGL 209
RGL+Y+H AN V++RDLK AN+ ++ D K+ DFGL
Sbjct: 130 -------------------LRGLKYIH-SAN--VLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 210 AK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
A+ + P + + + T Y +P +S T D+++ G + E++TG+
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 51/233 (21%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHD 116
+ +F+ +L+GEG +G V +G++VAIK++ + + E+ +L H+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 117 NLVTLIGYCTSGDQRL-----LVYEYMP--------MGSL-EDH----LYDLEPDQEPLS 158
N++T+ ++ E M L +DH +Y L
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT------L- 122
Query: 159 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA----KLGP 214
R ++ LH +N VI+RDLK +N+L++++ + K+ DFGLA +
Sbjct: 123 ------------RAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 215 VGDNTHVSTRVMGTY----GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
M + Y APE ++ + D++S G +L EL R
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 115
++ + +G G +G V ++G VA+K+L+ + + + E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 116 DNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
+N++ L+ T LV M L ++ Q L+ + +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQ-KLTDDHVQFLIYQI 141
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
RGL+Y+H A+ +I+RDLK +N+ ++ D K+ DFGLA+ +V+TR
Sbjct: 142 LRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW---- 194
Query: 230 GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
Y APE ++ DI+S G ++ EL+TGR
Sbjct: 195 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 58/303 (19%), Positives = 106/303 (34%), Gaps = 77/303 (25%)
Query: 23 RSKSRYSSESSENGKGNGGKEKSGARSFTFRELAIA---TRNFREANLIGEGGFGKVYKG 79
S ++++ S+ + S + + + +LIG G +G V +
Sbjct: 13 NSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEA 72
Query: 80 R-LESGQLVAIKQLN----HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-- 132
++VAIK++ + + E+ +L+ L+HD++V ++ D
Sbjct: 73 YDKLEKRVVAIKKILRVFEDLIDC--KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130
Query: 133 ---LVYEYMPM---------GSL-EDH----LYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
+V E L E H LY+L G++Y
Sbjct: 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNL-------------------LVGVKY 171
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG----- 230
+H A +++RDLK AN L++ D + K+ DFGLA+ +N + +
Sbjct: 172 VH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 231 --------------------YCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSK 269
Y APE + + T D++S G + EL+ K
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 270 GQG 272
Sbjct: 289 ADR 291
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 70/309 (22%), Positives = 110/309 (35%), Gaps = 85/309 (27%)
Query: 42 KEKSGARSFTFRELA--IATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EG 96
SG + F+ + N+ +LIG G +G VY + + VAIK++N E
Sbjct: 6 HHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED 65
Query: 97 LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-----LVYEYM----------PMG 141
L + + E+ +L+ L D ++ L D +V E P+
Sbjct: 66 LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF 125
Query: 142 SLEDH----LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 197
E+H LY+L L G ++H ++ +I+RDLK AN LL+
Sbjct: 126 LTEEHIKTILYNL------L-------------LGENFIH-ESG--IIHRDLKPANCLLN 163
Query: 198 NDFNPKLSDFGLAKLGPVGDNT-------------------------HVSTRVMGTYGYC 232
D + K+ DFGLA+ +T HV TR Y
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYR 218
Query: 233 APEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLS--------KGQGEQNLVSWSRPF 283
APE + + T DI+S G + EL+ ++ G L
Sbjct: 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSK 278
Query: 284 LKDQKKFVH 292
+K
Sbjct: 279 KVHEKSNRD 287
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 23/215 (10%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNL 118
+++ IGEG FG +++G L + Q VAIK + E LL +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGI 68
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
+ + G +LV + + SLED L DL + S T A ++ +H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGP-SLED-LLDLCGRK--FSVKTVAMAAKQMLARVQSIHE 124
Query: 179 KANPPVIYRDLKSANILLDNDFNPK-----LSDFGLAKL-GPVGDNTHVSTR----VMGT 228
K+ ++YRD+K N L+ + + DFG+ K H+ R + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 229 YGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 262
Y G+ + + D+ + G V + + G
Sbjct: 182 ARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 54 ELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL 112
EL + R +R IG G FG +Y G + +G+ VAIK + H + +E + +
Sbjct: 4 ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKM 60
Query: 113 LHH-DNLVTLIGYCTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAA 170
+ + T+ GD ++V E +G SLED L++ + S T + +A
Sbjct: 61 MQGGVGIPTIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRK--FSLKTVLLLADQMI 115
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPK---LSDFGLAKL-GPVGDNTHVSTR-- 224
+EY+H K I+RD+K N L+ + DFGLAK + H+ R
Sbjct: 116 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 225 --VMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 262
+ GT Y A G + + D+ S G VL+ G
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNL 118
NFR IG G FG++ G+ L + + VAIK + + +E L D +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGI 67
Query: 119 VTLIGYCTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+ + G +V E +G SLED L+DL S T + IA+ +EY+H
Sbjct: 68 PQVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRT--FSLKTVLMIAIQLISRMEYVH 122
Query: 178 CKANPPVIYRDLKSANILLDNDFNPK-----LSDFGLAKL-GPVGDNTHVSTR----VMG 227
K +IYRD+K N L+ N + DF LAK H+ R + G
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 228 TYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 262
T Y GK + + D+ + G + + + G
Sbjct: 180 TARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 44/221 (19%), Positives = 92/221 (41%), Gaps = 39/221 (17%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLH---------- 114
+G G F V+ + + + VA+K + + + E+ +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 115 -HDNLVTLIGY----CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAV 167
++++ L+ + +G ++V+E +G +L L + + + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE--VLGE---NLLALIKKYEHRGIPLIYVKQISK 138
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLD------NDFNPKLSDFGLAKLGPVGDNTHV 221
GL+Y+H + +I+ D+K N+L++ N K++D G A +
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 222 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
TR Y +PE + +DI+S ++ ELITG
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 21/213 (9%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNL 118
FR IG G FG++Y G +++ + VAIK N + H + + E + +L +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGI 65
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
+ + GD +LV + + SLED LS T + +A +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS 121
Query: 179 KANPPVIYRDLKSANILLDNDFNPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTYG 230
K+ ++RD+K N L+ + DFGLAK + H+ R + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 231 YCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 262
Y A G + + D+ S G VL+ + G
Sbjct: 179 Y-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 61/243 (25%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLH- 114
R + +G+G +G V+K +G++VA+K++ + Q E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 115 HDNLVTLIGYCTSGDQR--LLVYEYMP--------MGSLED-H----LYDLEPDQEPLSW 159
H+N+V L+ + + R LV++YM LE H +Y L
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL--------- 118
Query: 160 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA--------- 210
+ ++YLH +++RD+K +NILL+ + + K++DFGL+
Sbjct: 119 ----------IKVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 211 ------KLGPVGDNTHVSTRVMGTY----GYCAPEYAMSGKL-TLKSDIYSFGVVLLELI 259
+ +N ++ Y Y APE + T D++S G +L E++
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 260 TGR 262
G+
Sbjct: 226 CGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 3e-13
Identities = 53/308 (17%), Positives = 88/308 (28%), Gaps = 62/308 (20%)
Query: 48 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQ------ 101
F + T + IGEG FG+V++ + VAIK + EG
Sbjct: 9 GPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 102 --EFIVEVLMLSLLH---------HDNLVTLIGY--CTSGDQRLLVYEYMPMGS------ 142
E + E+++ L + + L LL+ + S
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 143 ----------------LEDHLYDLE-PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
E DLE + S T I L
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FE 184
Query: 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP--EYAMSGKLT 243
+RDL N+LL KL K + + + G +Y +S
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLER 233
Query: 244 LKSDIYSFGVVLLELITGRKAM--DLSKGQGEQNLVSWSRPFLKDQKKFVH-LVDPLLHG 300
++ + +L TG D+ + ++N W ++H L D +L
Sbjct: 234 DGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ 293
Query: 301 RYPRRCLN 308
+ N
Sbjct: 294 MTFKTKCN 301
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLH-HD-----NL 118
+IG+G FG+V K + Q VA+K + N + H++ E+ +L L D N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 119 VTLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGA 169
+ ++ C + +E L +LY+L + + S K A
Sbjct: 162 IHMLENFTFRNHIC-------MTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMG 227
+ L+ LH +I+ DLK NILL K+ DFG + T++ +R
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-- 264
Query: 228 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
Y APE + + + D++S G +L EL+TG
Sbjct: 265 ---YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 39/216 (18%)
Query: 66 NLIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLL-HHD-----N 117
+LIG+G FG+V K + VAIK + N + + +EV +L L+ HD
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY 117
Query: 118 LVTLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVG 168
+V L + C LV+E L +LYDL + +S N K A
Sbjct: 118 IVHLKRHFMFRNHLC-------LVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVM 226
L +L +I+ DLK NILL N K+ DFG + ++ +R
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
Y +PE + L D++S G +L+E+ TG
Sbjct: 224 ----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 36/159 (22%), Positives = 58/159 (36%), Gaps = 31/159 (19%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIG-Y 124
+G G GKV + + + A+K L + EV L ++V ++ Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 80
Query: 125 CTSGDQRLLVY---EYMPMGSLED------HLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
R + E + G L E + + MK A ++Y
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSIGEA---IQY 132
Query: 176 LHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAK 211
LH + +RD+K N+L + KL+DFG AK
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 31/175 (17%), Positives = 63/175 (36%), Gaps = 30/175 (17%)
Query: 60 RNFREANLIGEGGFGKVYKGR---------LESGQLVAIK------QLNHEGL----QGH 100
R ++ + G +Y+ Q ++K +L +E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 101 QEFIVEVLMLSLLHHDNLVTLIGY-CTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLS 158
+ + L + T +G+ R LV +G SL+ D+ P LS
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQS-ALDVSPKH-VLS 157
Query: 159 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK--LSDFGLAK 211
+ +++A LE+LH ++ ++ + NI +D + + L+ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 46/236 (19%), Positives = 86/236 (36%), Gaps = 45/236 (19%)
Query: 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIK-------------QLNHEG----LQGHQE 102
++ IG+GGFG +Y + S + V L E E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 103 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM---G-SLEDHLYDLEPDQEPLS 158
I + + L + + G Y +M M G L+ +Y+ + S
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQK-IYEANAKR--FS 150
Query: 159 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK--LSDFGLAKL-GPV 215
T +++++ LEY+H ++ D+K++N+LL+ + L D+GLA P
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 216 GDNTHVSTR----VMGTYGYCAPEYA-----MSGKLTLKSDIYSFGVVLLELITGR 262
G + + GT E+ + + D+ G +++ +TG
Sbjct: 208 GVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 33/170 (19%), Positives = 62/170 (36%), Gaps = 23/170 (13%)
Query: 60 RNFREANLIGEGGFGKVYKG-RLESGQLVAIK----------QLNHEG-----LQGHQEF 103
+ IG GGFG +Y + A L E + ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDC 95
Query: 104 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 163
I + + L + + G + + Y +M M L L + +T +
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRS-YRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 164 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK--LSDFGLAK 211
++ + LEY+H ++ D+K+AN+LL + L+D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 48/258 (18%), Positives = 81/258 (31%), Gaps = 75/258 (29%)
Query: 68 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH--------HDNL 118
+G G F V+ ++ + VA+K + + + E+ +L + + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 119 VTLIGYCT----SGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
V L+ +G +V+E +G L + PL KI +GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQQVLQGL 159
Query: 174 EYLHCKANPPVIYRDLKSANILL------------------------------------- 196
+YLH K +I+ D+K NILL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 197 ------------DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 244
K++D G A + TR Y + E +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272
Query: 245 KSDIYSFGVVLLELITGR 262
+DI+S + EL TG
Sbjct: 273 PADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 1e-08
Identities = 52/307 (16%), Positives = 91/307 (29%), Gaps = 80/307 (26%)
Query: 48 RSFTFRELAIATRNFREANLI---GEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI 104
R + +L A R A + G G GK VA+ +Q +F
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGSGK---------TWVALDVCLSYKVQCKMDF- 182
Query: 105 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL---SWNT 161
++ L+L C S + L + L+ LY ++P+ S N
Sbjct: 183 -KIFWLNL----------KNCNSPETVLEM--------LQKLLYQIDPNWTSRSDHSSNI 223
Query: 162 RMKIAVGAARGLEYLHCKANPP--VIYRDLKSANILLDNDFNPK---L---SDFGLAKLG 213
+++I A L K ++ ++++A N FN L +
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAFNLSCKILLTTRFKQVTDFL 281
Query: 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 273
TH+S + E LL + DL + E
Sbjct: 282 SAATTTHISL-DHHSMTLTPDE-------VKS---------LLLKYLDCRPQDLPR---E 321
Query: 274 QNLVSWSRPFL-----KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLN--EEANFRP 326
+ P + + + D H + L + LN E A +R
Sbjct: 322 VLTTN---PRRLSIIAESIRDGLATWDNWKHVNCDK--LTTII---ESSLNVLEPAEYRK 373
Query: 327 LINDIVV 333
+ + + V
Sbjct: 374 MFDRLSV 380
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 67/238 (28%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLHHD-----NLV 119
+G+G FG+V + +++ + A+K + N + + +E +L + +D N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY--TRSAKIEADILKKIQNDDINNNNIV 99
Query: 120 TLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAA 170
G C L++E L LY++ + +
Sbjct: 100 KYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNP-------------------------KLS 205
+ L YL K + + + DLK NILLD+ + KL
Sbjct: 148 KALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 206 DFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
DFG A D + ++TR Y APE ++ + SD++SFG VL EL TG
Sbjct: 205 DFGCA--TFKSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 48/235 (20%), Positives = 79/235 (33%), Gaps = 65/235 (27%)
Query: 67 LIGEGGFGKVYKG--RLESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLL-HHD-----N 117
+GEG FGKV + VA+K + N + +E+ +L + D
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY--REAARLEINVLKKIKEKDKENKFL 83
Query: 118 LVTLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVG 168
V + + C + +E L + ++ E + +P +A
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-------------------KLSDFGL 209
L +LH + + + DLK NIL N +++DFG
Sbjct: 132 LCHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 210 AKLGPVGDNTH---VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
A H V+TR Y PE + D++S G +L E G
Sbjct: 189 ATFD---HEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 55/234 (23%), Positives = 86/234 (36%), Gaps = 63/234 (26%)
Query: 67 LIGEGGFGKVYKG--RLESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLL-HHD-----N 117
+GEG FGKV + G+ VA+K + N + + E+ +L L D
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY--CEAARSEIQVLEHLNTTDPNSTFR 78
Query: 118 LVTLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVG 168
V ++ + C +V+E L YD E P + K+A
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-------------------KLSDFGL 209
+ + +LH + + DLK NIL K+ DFG
Sbjct: 127 ICKSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 210 AKLGPVGDN--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261
A ++ T VSTR Y APE ++ + D++S G +L+E G
Sbjct: 184 ATY--DDEHHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 375 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.24 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.0 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.82 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.82 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.68 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.67 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.65 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.46 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.46 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.95 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.92 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.83 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.64 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.52 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.5 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.52 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.15 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.64 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.62 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.32 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-62 Score=445.40 Aligned_cols=264 Identities=28% Similarity=0.432 Sum_probs=219.8
Q ss_pred hhcccccceeccccceEEEEEEEc------CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
.++|.+.+.||+|+||.||+|++. ++..||||+++.......++|.+|+.+|++++|||||++++++.+.+.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467999999999999999999763 47789999998766566778999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccC---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 133 LVYEYMPMGSLEDHLYDLE---------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
||||||++|+|.++|.... .....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 23457999999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhh
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 282 (375)
|+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~---- 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE---- 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH----
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----
Confidence 999999975433333333444679999999999999999999999999999999999 89999643211 1110
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.+........|..++.++.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 242 ----------~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 242 ----------CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp ----------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ----------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 00011112346678889999999999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=446.26 Aligned_cols=263 Identities=30% Similarity=0.463 Sum_probs=213.5
Q ss_pred hhcccccceeccccceEEEEEEEc------CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..+|.+.+.||+|+||.||+|++. +++.||||+++.......+.|.+|+.+|++++|||||+++++|.+.+.++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 457888999999999999999864 47889999998766666778999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc
Q 017246 133 LVYEYMPMGSLEDHLYDLEP-----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 201 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~ 201 (375)
||||||++|+|.+++..... ....+++..++.|+.||+.||.|||+++ |+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999976432 2346999999999999999999999988 999999999999999999
Q ss_pred eEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhch
Q 017246 202 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 202 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 280 (375)
+||+|||+++..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||...... ....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~-- 271 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAID-- 271 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHH--
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHH--
Confidence 99999999986544444444456789999999999999999999999999999999999 89999643211 1110
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.+....+...|..+++++.+|+.+||+.||++|||+.||++.|+.|.+.
T Consensus 272 ------------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 ------------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ------------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 0011112234667888999999999999999999999999999999764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-62 Score=440.68 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=218.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999865 69999999997642 234567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999965 457999999999999999999999998 99999999999999999999999999987544
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
..........+||+.|||||++.+..|+.++|||||||++|||++|++||...... .+ .. .+..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~---~~----------~i~~ 248 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LI---FA----------KIIK 248 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HH----------HHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HH---HH----------HHHc
Confidence 44444455689999999999999999999999999999999999999999632211 00 00 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCCCCC
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGA 353 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 353 (375)
. ...+|..++.++.+||.+||+.||++||++.|++..-.-+ +|||-.+.++
T Consensus 249 ~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~-----~Hp~F~~idw 299 (311)
T 4aw0_A 249 L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK-----AHPFFESVTW 299 (311)
T ss_dssp T--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHH-----TSGGGTTCCC
T ss_pred C--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHH-----CCCCcCCCCH
Confidence 1 1134556778899999999999999999999875332211 4666554443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-61 Score=439.29 Aligned_cols=265 Identities=21% Similarity=0.245 Sum_probs=216.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
...|++.+.||+|+||.||+|++. +|+.||||+++..... .+|+.+++.++|||||++++++.+.+.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356889999999999999999875 6999999999765332 3699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCccCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVG 216 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~~~~~~ 216 (375)
|+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+| .+||+|||+|+.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999965 457999999999999999999999998 99999999999999988 5999999999864332
Q ss_pred CC---ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 217 DN---THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 217 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.. .......+||+.|||||++.+..|+.++|||||||++|||+||++||........ . .......
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~---~~i~~~~------ 272 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---C---LKIASEP------ 272 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---H---HHHHHSC------
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---H---HHHHcCC------
Confidence 21 1223346899999999999999999999999999999999999999964322111 0 0011100
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC--CCCccCC
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD--SHPVSRN 350 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~--~~~~~~~ 350 (375)
.....+++.++..+.+||.+||+.||++|||+.||++.|........ .|||...
T Consensus 273 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 273 ---PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp ---CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred ---CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 00112456778899999999999999999999999999998887654 5888653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-61 Score=438.34 Aligned_cols=259 Identities=31% Similarity=0.444 Sum_probs=215.4
Q ss_pred hcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
.++++.+.||+|+||.||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||++++++.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46788999999999999999862 467899999976432 34578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC
Q 017246 133 LVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 200 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~ 200 (375)
||||||++|+|.++|..... ....+++..++.++.||+.||.|||+++ |+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 1346899999999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhc
Q 017246 201 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 201 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 279 (375)
.+||+|||+++.....+........+||+.|||||++.+..|+.++|||||||+||||+| |..||...... .+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~- 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVE- 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHH-
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHH-
Confidence 999999999986433333334455789999999999999999999999999999999999 89999643211 1111
Q ss_pred hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.+........|..++..+.+|+.+||+.||++||++.||++.|+.+
T Consensus 259 -------------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 -------------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -------------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111112235678889999999999999999999999999999865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-61 Score=442.35 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=215.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
..|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999875 69999999998766666777899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
+||+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+.....
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--
Confidence 99999999853 46999999999999999999999998 999999999999999999999999999864322
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||...... .... ... ....+
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~---~i~-------~~~~~-- 288 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK---MIR-------DNLPP-- 288 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHH-------HSSCC--
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH---HHH-------cCCCC--
Confidence 22344578999999999999999999999999999999999999999632211 0000 000 00001
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCCC
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNA 351 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 351 (375)
....+..++.++.+||.+||+.||++|||+.|++ .|||-.+.
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l-----------~Hp~~~~~ 330 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL-----------KHPFLAKA 330 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------TCGGGGGC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------cCHhhcCC
Confidence 1122356788999999999999999999999998 57776643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=433.50 Aligned_cols=263 Identities=29% Similarity=0.466 Sum_probs=207.9
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..++|++.+.||+|+||+||+|++.. .||||+++.... ...+.|.+|+.++++++|||||++++++.. +.++|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 35678899999999999999998653 599999875432 335678999999999999999999998764 6789999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||++|+|.++|.. ....+++..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999964 3457999999999999999999999988 99999999999999999999999999986543
Q ss_pred CCCceeeecccccccccccccccc---CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
..........+||+.|||||++.+ ..|+.++|||||||+||||+||+.||....... .+. ..... .
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~----~~~~~-----~ 253 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QII----FMVGR-----G 253 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH----HHHHT-----T
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHH----HHHhc-----C
Confidence 333344456789999999999864 458999999999999999999999996432111 000 00000 0
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
...+.+ ...+..++..+.+|+.+||+.||++|||+.||++.|+.|+..
T Consensus 254 ~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 254 YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 011111 134567888999999999999999999999999999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-61 Score=443.68 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=204.5
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999865 699999999976533 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
||+||+|.++|... ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~- 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS- 177 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH-
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC-
Confidence 99999999999752 3456899999999999999999999998 99999999999999999999999999985321
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
........+||+.|||||++.+..|+.++|||||||++|||+||++||...... ..... +...
T Consensus 178 -~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~----------i~~~ 240 (350)
T 4b9d_A 178 -TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLK----------IISG 240 (350)
T ss_dssp -HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH----------HHHT
T ss_pred -CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHH----------HHcC
Confidence 122234578999999999999999999999999999999999999999643211 00000 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ...+..++.++.+||.+||+.||++|||+.|+++
T Consensus 241 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 241 SF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1234567788999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=443.22 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=215.3
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
..|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999875 69999999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
+||+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+.....
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-- 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--
Confidence 99999999853 45999999999999999999999998 999999999999999999999999999864322
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||...... .... .. .....+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~---~i-------~~~~~~-- 365 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK---MI-------RDNLPP-- 365 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HH-------HHSCCC--
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH---HH-------HcCCCC--
Confidence 22334578999999999999999999999999999999999999999632211 0000 00 000011
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCCC
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNA 351 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 351 (375)
....+..++.++.+||.+||+.||++|||+.|++ .|+|-.++
T Consensus 366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell-----------~Hp~~~~~ 407 (423)
T 4fie_A 366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL-----------KHPFLAKA 407 (423)
T ss_dssp CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------TCGGGGGC
T ss_pred CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------cCHHhcCC
Confidence 1122346778899999999999999999999998 56776644
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=418.34 Aligned_cols=245 Identities=27% Similarity=0.358 Sum_probs=193.8
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|+.. +|+.||||++.+... .....+.+|+.+++.++|||||++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999864 699999999976432 33567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+ +|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999965 467999999999999999999999998 99999999999999999999999999985432
Q ss_pred CCCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
. ......+||+.|||||++.+..| +.++|||||||++|+|+||+.||...... ..... +.
T Consensus 165 ~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~----------i~ 225 (275)
T 3hyh_A 165 G---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKN----------IS 225 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH----------HH
T ss_pred C---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHH----------HH
Confidence 2 22345789999999999998876 57999999999999999999999632211 10000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ...+|..+++++.+||.+||+.||++|||+.|+++
T Consensus 226 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 226 NG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 11235567788999999999999999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-59 Score=418.92 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=198.1
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee----CCeeEEE
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLV 134 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 134 (375)
|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.+++.++|||||+++++|.+ .+.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 477788999999999999865 689999999975432 234678899999999999999999999865 3568999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-CCceEEeecCCCccC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLG 213 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg~a~~~ 213 (375)
||||+||+|.+++.. ...+++..++.|+.||+.||.|||+++ ++|+||||||+||||+. +|.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999965 457899999999999999999999764 45999999999999984 799999999999853
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ..+. . .+
T Consensus 183 ~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~---~----------~i 242 (290)
T 3fpq_A 183 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIY---R----------RV 242 (290)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHH---H----------HH
T ss_pred CC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHH---H----------HH
Confidence 22 12345789999999998865 6999999999999999999999999632211 0000 0 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
........++..+++++.+||.+||+.||++|||+.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 011111112334566799999999999999999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=434.16 Aligned_cols=272 Identities=24% Similarity=0.351 Sum_probs=223.0
Q ss_pred HHHHHHHhhcccccceeccccceEEEEEEEcC------CceEEEEEccccCc-cchHHHHHHHHHHccCCC-CCcceeEe
Q 017246 52 FRELAIATRNFREANLIGEGGFGKVYKGRLES------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHH-DNLVTLIG 123 (375)
Q Consensus 52 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~~ 123 (375)
.....+..++|++.+.||+|+||.||+|.+.. ++.||||.+..... .....+.+|+.+|..+.| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34455677899999999999999999997542 35799999976533 335678899999999965 89999999
Q ss_pred EEeeC-CeeEEEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCC
Q 017246 124 YCTSG-DQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 190 (375)
Q Consensus 124 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlk 190 (375)
+|... +.++||||||++|+|.++|..... ....+++..++.++.||+.||.|||+++ |||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 98664 578999999999999999975321 2356899999999999999999999998 9999999
Q ss_pred CCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccc
Q 017246 191 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSK 269 (375)
Q Consensus 191 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 269 (375)
|+|||+++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986544444444556789999999999999999999999999999999998 999996432
Q ss_pred cccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 270 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
... . +...+....+...|..+++++.+++.+||+.||++|||+.+|++.|+.+++..
T Consensus 293 ~~~--~--------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 293 IDE--E--------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CSH--H--------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH--H--------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 111 0 01111112223456778889999999999999999999999999999987643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=426.82 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=199.8
Q ss_pred hcccccceeccccceEEEEEEEc----CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
++|++.+.||+|+||.||+|+.. +++.||||++.+... .....+.+|+.+|+.++|||||++++++.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 478899999976432 234467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
|||||+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999965 457999999999999999999999998 999999999999999999999999999753
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||...... ... . .+
T Consensus 177 ~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~---~----------~i 238 (304)
T 3ubd_A 177 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETM---T----------MI 238 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---H----------HH
T ss_pred cCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHH---H----------HH
Confidence 222 22234578999999999999999999999999999999999999999642211 000 0 01
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIV 332 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~eil 332 (375)
... ...+|..+++++.+||.+||+.||++||++ +|++
T Consensus 239 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil 280 (304)
T 3ubd_A 239 LKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK 280 (304)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHH
T ss_pred HcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHH
Confidence 111 113456678889999999999999999984 6666
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-58 Score=417.56 Aligned_cols=275 Identities=25% Similarity=0.310 Sum_probs=203.7
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCC----eeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 135 (375)
++|.+.+.||+|+||.||+|++. |+.||||++..... .......|+..+..++|||||++++++...+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 57889999999999999999885 89999999965422 1222344666677889999999999997654 579999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-----NPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
|||++|+|.+++.. ..+++..++.++.|++.||+|||++. .++|+||||||+||||+.++.+||+|||++
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999964 46899999999999999999999761 224999999999999999999999999999
Q ss_pred ccCCCCCCce--eeeccccccccccccccccC------CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 211 KLGPVGDNTH--VSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 211 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
+......... .....+||+.|||||++.+. .|+.++|||||||++|||+||.+||......... ...+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~~~~~~~ 234 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLVPS 234 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTSCS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-chhcccc
Confidence 7643322221 22346899999999999764 3678999999999999999999888543321110 0000000
Q ss_pred hhhhccccchhcccccCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 283 FLKDQKKFVHLVDPLLHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
..........+....++..+| ..++..+.+|+.+||+.||++|||+.||++.|++|..+.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 000000001112222223332 356788999999999999999999999999999997654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=406.81 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=188.9
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCC--------
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-------- 129 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 129 (375)
.+|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999865 6999999999765432 3467889999999999999999999987654
Q ss_pred ----eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEe
Q 017246 130 ----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 205 (375)
Q Consensus 130 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~ 205 (375)
.+|||||||++|+|.+++.... ......+..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999996532 1233556778999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCCc----------eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccc
Q 017246 206 DFGLAKLGPVGDNT----------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 275 (375)
Q Consensus 206 Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 275 (375)
|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||.....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----- 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----- 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----
Confidence 99999864332211 11234689999999999999999999999999999999996 6642110
Q ss_pred hhhchhhhhhhccccchhcccccCCCCC---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 276 LVSWSRPFLKDQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... .+..+ ....+| ...++.+.+||.+||+.||++|||+.|+++
T Consensus 233 ~~~----------~~~~~----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVR----------TLTDV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH----------HHHHH----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH----------HHHHH----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 00000 011222 334456788999999999999999999984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-55 Score=410.94 Aligned_cols=266 Identities=22% Similarity=0.292 Sum_probs=201.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee------CCe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQ 130 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 130 (375)
++|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999875 799999999976432 234568899999999999999999998754 367
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
+|||||||+ |+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 689999953 568999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCC--CceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hchhhh---
Q 017246 211 KLGPVGD--NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSRPF--- 283 (375)
Q Consensus 211 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~--- 283 (375)
+...... ........+||+.|||||++.+. .|+.++||||+||++|||++|++||...........+ ......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8543221 22234457899999999998875 5689999999999999999999999643321110000 000000
Q ss_pred -hhh--ccccchhcc---cccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 284 -LKD--QKKFVHLVD---PLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 284 -~~~--~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... .......+. ..... ...+.++.++.+||.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000000000 00000 011235678899999999999999999999984
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=399.86 Aligned_cols=198 Identities=25% Similarity=0.351 Sum_probs=169.8
Q ss_pred HhhcccccceeccccceEEEEEEEc----CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 132 (375)
..++|++.+.||+|+||+||+|+.+ +++.||+|++... .....+.+|+.+|+.+ +||||++++++|.+.+.+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999753 4678999998654 3345678899999988 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEeecCCCc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAK 211 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~Dfg~a~ 211 (375)
|||||++||+|.+++. .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999982 4899999999999999999999999 9999999999999877 799999999997
Q ss_pred cCCCCCC--------------------------ceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCC
Q 017246 212 LGPVGDN--------------------------THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKA 264 (375)
Q Consensus 212 ~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p 264 (375)
....... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 5332211 0112345799999999999875 589999999999999999999999
Q ss_pred ccc
Q 017246 265 MDL 267 (375)
Q Consensus 265 f~~ 267 (375)
|..
T Consensus 247 f~~ 249 (361)
T 4f9c_A 247 FYK 249 (361)
T ss_dssp SSC
T ss_pred CCC
Confidence 953
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=417.68 Aligned_cols=249 Identities=26% Similarity=0.352 Sum_probs=203.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHH---HHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFI---VEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
-++|++.++||+|+||.||+|+.. +|+.||||++.+... .....+. .++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999875 699999999975422 2222333 346677888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
|||||||+||+|.++|.. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999965 457999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
...... ....+||+.|||||++.+ ..|+.++|||||||++|||++|++||..........+.. .
T Consensus 341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~-------- 405 (689)
T 3v5w_A 341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---M-------- 405 (689)
T ss_dssp ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---H--------
T ss_pred ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---h--------
Confidence 643222 234789999999999974 579999999999999999999999996433221111100 0
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~ 333 (375)
+.. ....+|..++.++.+||.+||+.||.+|++ +.||++
T Consensus 406 --i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 406 --TLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --HHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --hcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 000 112345677889999999999999999998 688775
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=389.65 Aligned_cols=283 Identities=43% Similarity=0.714 Sum_probs=239.4
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
...++|++.+.||+|+||.||+|...+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 34578999999999999999999988899999999987766667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999764444457999999999999999999999998 999999999999999999999999999764333
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.............|..... ....+...+++
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDP 271 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTTCCCSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccccHHHhcCh
Confidence 33333445678999999999999999999999999999999999999997655444333443332221 12334455566
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
......+..++..+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 66666788999999999999999999999999999999999986543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=417.11 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=210.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 58999999999999999999875 69999999998776666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC--CceEEeecCCCccCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND--FNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~--~~vkl~Dfg~a~~~~~~ 216 (375)
+||+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 237 ~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999954 3457999999999999999999999998 9999999999999854 89999999999865332
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. .....+||+.|||||++.+..|+.++|||||||++|||++|++||....... .. ....... .
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~---~~i~~~~--------~ 373 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TL---RNVKSCD--------W 373 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHTTC--------C
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH---HHHHhCC--------C
Confidence 2 2344689999999999999999999999999999999999999996432211 00 0000000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+.......++.++.+||.+||+.||.+||++.|+++
T Consensus 374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111112356778999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=379.75 Aligned_cols=294 Identities=45% Similarity=0.752 Sum_probs=242.1
Q ss_pred CccccHHHHHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEE
Q 017246 47 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYC 125 (375)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~ 125 (375)
...+++.++....++|++.+.||+|+||.||+|+..+|+.||||++...... ....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3467788899999999999999999999999998878999999999765332 334688999999999999999999999
Q ss_pred eeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEe
Q 017246 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 205 (375)
Q Consensus 126 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~ 205 (375)
...+..++||||+++|+|.+++.........+++..++.++.||+.||.|||++..++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998766566679999999999999999999999811129999999999999999999999
Q ss_pred ecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccc--cccchhhchhhh
Q 017246 206 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ--GEQNLVSWSRPF 283 (375)
Q Consensus 206 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~ 283 (375)
|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||+..... .......|....
T Consensus 177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999998643322 22334466999999999999999999999999999999999999999643211 122223333332
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.. ......+.+......++...+..+.+++.+||+.||.+||++.+|++.|+......
T Consensus 256 ~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 256 LK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred hh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 22 33445556666667778899999999999999999999999999999998764443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=371.20 Aligned_cols=263 Identities=25% Similarity=0.376 Sum_probs=217.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|++.+.||+|+||.||+|... ++..||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468999999999999999999875 6899999998766666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999975 3456899999999999999999999998 9999999999999999999999999997543222
Q ss_pred Cce------------eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh
Q 017246 218 NTH------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285 (375)
Q Consensus 218 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 285 (375)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~------- 235 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN------- 235 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-------
Confidence 111 1114679999999999999999999999999999999999999986433221111000
Q ss_pred hccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
...... ...+..++..+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 236 ----~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 236 ----VRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ----HHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----hhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000111 1124556678999999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=379.13 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=218.3
Q ss_pred HhhcccccceeccccceEEEEEEEc--------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS 127 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 127 (375)
..++|++.+.||+|+||.||+|+.. ++..||||++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3568999999999999999999752 355799999976532 3346788999999999 89999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEE
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 195 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nil 195 (375)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999976432 1346899999999999999999999998 999999999999
Q ss_pred EeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCcccccccccc
Q 017246 196 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQ 274 (375)
Q Consensus 196 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 274 (375)
|+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999985443333223334567889999999999999999999999999999999 999996432111
Q ss_pred chhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 275 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.. ..+........+..++..+.++|.+||+.+|++||++.+|++.|+.+.....
T Consensus 314 -~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 314 -LF--------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp -HH--------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -HH--------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 00 1111111223456778899999999999999999999999999999986543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=372.31 Aligned_cols=274 Identities=26% Similarity=0.319 Sum_probs=211.1
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCC----eeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l 133 (375)
..++|++.+.||+|+||.||+|+.. ++.||||++.... ........|+.+++.++||||+++++++.... .+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3568999999999999999999876 7999999996543 23345566889999999999999999998754 4699
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------CCCCcccCCCCCCcEEEeCCCceE
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK----------ANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999954 3589999999999999999999988 7 99999999999999999999
Q ss_pred EeecCCCccCCCCCCceeeeccccccccccccccccC-----CCCccchhHhHHHHHHHHHhCCCCccccccccccchhh
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 278 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 278 (375)
|+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999764433333333446799999999999863 46678999999999999999999997543322111111
Q ss_pred chhhhhhhccccchhcccccCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 279 WSRPFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.......................+ ...++..+.+||.+||+.||++|||+.+|++.|++|...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000000000000001111111111 235677899999999999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=365.42 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=210.4
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999985 46899999999876666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999964 35899999999999999999999998 9999999999999999999999999987543222
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ...
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~---------~~~ 233 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIAT---------NGT 233 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH---------HCS
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh---------CCC
Confidence 223446799999999999999999999999999999999999999963221100 000000 001
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....+..++..+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111235567788999999999999999999999983
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=369.48 Aligned_cols=265 Identities=26% Similarity=0.398 Sum_probs=214.9
Q ss_pred HhhcccccceeccccceEEEEEEEc----CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..++|++.+.||+|+||.||+|... .+..||||++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3568999999999999999999874 34569999997642 234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 127 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999964 3457999999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCC-CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhcccc
Q 017246 213 GPVGD-NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 213 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
..... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~-------------- 263 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---V-------------- 263 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---H--------------
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---H--------------
Confidence 43322 1222233456889999999999999999999999999999999 999996322111 0
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCC
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 345 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~ 345 (375)
...+........+..++..+.+|+.+||+.||++||++.+|++.|+.+.....+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 0011111222345677889999999999999999999999999999998765543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=368.35 Aligned_cols=247 Identities=27% Similarity=0.363 Sum_probs=207.3
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.++|++.+.||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999987 4799999999976432 33556889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999965 356899999999999999999999998 99999999999999999999999999975432
Q ss_pred CCCceeeeccccccccccccccccCCCC-ccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... ..... .
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i----------~ 227 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERV----------L 227 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH----------H
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHH----------H
Confidence 22 23456899999999999988765 79999999999999999999997432110 00000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ....|..++..+.+|+.+||+.||.+|||+.|+++
T Consensus 228 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 228 RG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred hC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01 11234556788999999999999999999999984
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=366.02 Aligned_cols=270 Identities=31% Similarity=0.433 Sum_probs=208.6
Q ss_pred HHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.+...+|++.+.||+|+||.||+|+. .|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34567899999999999999999987 488999999876543 234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999996421 1224899999999999999999999764 34999999999999999999999999999753
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ..+
T Consensus 190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~-------------~~~ 251 (309)
T 3p86_A 190 AS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VV-------------AAV 251 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HH-------------HHH
T ss_pred cc--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-------------HHH
Confidence 22 1122334679999999999999999999999999999999999999996432111 00 001
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCC
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~ 346 (375)
........++..++..+.+||.+||+.+|.+||++.+|++.|+.+.......+
T Consensus 252 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 252 GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 11112223456778889999999999999999999999999999987654433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=366.27 Aligned_cols=249 Identities=28% Similarity=0.358 Sum_probs=209.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEcccc---CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999875 6999999999764 223456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999965 456899999999999999999999998 9999999999999999999999999997532
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .. ... +.
T Consensus 157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~---~~~----------i~ 218 (337)
T 1o6l_A 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL---FEL----------IL 218 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHH----------HH
T ss_pred cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HH---HHH----------HH
Confidence 21 12234578999999999999999999999999999999999999999632211 00 000 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 334 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~~ 334 (375)
.. ...+|..++..+.+||.+||+.||++|| ++.+|++.
T Consensus 219 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 219 ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11 1134566788899999999999999999 89999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=355.86 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=215.6
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 356899999999999999999998888899999997653 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999964 3456899999999999999999999998 9999999999999999999999999997532211
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... .. ..+..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~--------------~~~~~ 222 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV--------------EDIST 222 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH--------------HHHHT
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HH--------------HHHhc
Confidence 112233456788999999999999999999999999999999 999996432110 00 00011
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
......+..++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 223 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 112223455677899999999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=363.65 Aligned_cols=278 Identities=29% Similarity=0.431 Sum_probs=214.2
Q ss_pred HhhcccccceeccccceEEEEEEE-----cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEee--CCe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQ 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~ 130 (375)
..++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 457899999999999999999984 2688999999987665566788999999999999999999999854 356
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 89999999999999999752 345899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCC-ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 211 KLGPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 211 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
........ ........++..|+|||++.+..++.++||||||+++|||++|..||................... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH-HHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch-hHHH
Confidence 86433221 122333557888999999999999999999999999999999999986432110000000000000 0001
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
....+........+..++..+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11112222233446678889999999999999999999999999999997653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=354.44 Aligned_cols=285 Identities=42% Similarity=0.633 Sum_probs=228.6
Q ss_pred CccccHHHHHHHhhccccc------ceeccccceEEEEEEEcCCceEEEEEccccC----ccchHHHHHHHHHHccCCCC
Q 017246 47 ARSFTFRELAIATRNFREA------NLIGEGGFGKVYKGRLESGQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHHD 116 (375)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~ 116 (375)
...+++.++.....+|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3567778888887777666 8999999999999986 48899999986532 22356788999999999999
Q ss_pred CcceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE
Q 017246 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 196 (375)
Q Consensus 117 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill 196 (375)
||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999997533 2456899999999999999999999998 9999999999999
Q ss_pred eCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccch
Q 017246 197 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276 (375)
Q Consensus 197 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 276 (375)
+.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ..
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence 9999999999999976544333333445679999999998765 58899999999999999999999997543221 11
Q ss_pred hhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 277 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
..+..........+...++..+ ...+..++..+.+++.+||+.+|.+||++.+|++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111111122222333333333 23567889999999999999999999999999999999853
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=378.23 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=214.6
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
+..++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34568999999999999999999876 689999999875422 2234678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++|+|.+++.. .+..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999975 2346899999999999999999999998 9999999999999999999999999997532
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchh
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
............+++.|+|||++.+..++.++|||||||++|||++ |..||....... . ...
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~--------------~~~ 327 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---T--------------REF 327 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---H--------------HHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H--------------HHH
Confidence 2211111122335778999999999999999999999999999998 999996432111 0 011
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
+........+..++..+.+|+.+||+.||++||++.+|++.|+.+..+
T Consensus 328 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 111112234566788999999999999999999999999999999754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=364.56 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=205.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 789999999865433 224567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999998843 556999999999999999999999998 999999999999999999999999999754333
Q ss_pred CCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+ ..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~--------------~~ 223 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW--------------KE 223 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH--------------HT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH--------------hc
Confidence 33333445789999999999987775 7889999999999999999999974332111 00000 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..........++..+.+|+.+||+.||++||++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 01111112456778899999999999999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=362.65 Aligned_cols=264 Identities=27% Similarity=0.399 Sum_probs=217.4
Q ss_pred HhhcccccceeccccceEEEEEEE------cCCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
..++|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 457899999999999999999975 235789999997643 2334678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 190 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlk 190 (375)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976432 1234899999999999999999999998 9999999
Q ss_pred CCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccc
Q 017246 191 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSK 269 (375)
Q Consensus 191 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 269 (375)
|+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999976544333333344567889999999999999999999999999999999 999996432
Q ss_pred cccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 270 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
... .. ..+........+..++..+.+++.+||+.||++||++.+|++.|+.+..+
T Consensus 258 ~~~---~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PER---LF--------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGG---HH--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH---HH--------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 211 00 11111112233556778899999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=371.10 Aligned_cols=270 Identities=28% Similarity=0.408 Sum_probs=221.0
Q ss_pred HHhhcccccceeccccceEEEEEEEc--------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCT 126 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 126 (375)
+..++|++.+.||+|+||.||+|+.. .+..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999752 235799999976532 3346788999999999 9999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
..+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999976432 1346999999999999999999999998 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGE 273 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 273 (375)
||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~- 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999986544333333444567899999999999999999999999999999999 999996332110
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCC
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~ 346 (375)
+...+........+..++..+.+|+.+||+.+|++||++.+|++.|+.+........
T Consensus 302 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 302 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp ----------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred ----------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 011111111223345677889999999999999999999999999999987655433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=365.05 Aligned_cols=251 Identities=25% Similarity=0.295 Sum_probs=206.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc------chHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999876 6899999999765332 346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC----ceEEeec
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDF 207 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~----~vkl~Df 207 (375)
++||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999953 567999999999999999999999998 99999999999998877 7999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
|++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. .......
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~---~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANITAVS 234 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHTTC
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhcC
Confidence 9997643322 2234679999999999999999999999999999999999999996432111 00 0000000
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. +...+...++..+.+||.+||..||++||++.|+++
T Consensus 235 ~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YD--------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000011345678999999999999999999999984
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=354.02 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=215.0
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..++|++.+.||+|+||.||+|+..++..||+|++.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 356899999999999999999998888899999997653 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999653 345899999999999999999999998 9999999999999999999999999997543322
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... . .+..
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~-----------~~~~ 220 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------L-----------KVSQ 220 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------H-----------HHHT
T ss_pred -hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------H-----------HHHc
Confidence 222233456788999999999899999999999999999999 99999643221100 0 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
......+..++..+.+++.+||+.+|++||++.++++.|+.+..+.
T Consensus 221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 221 GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1111223445678999999999999999999999999999997653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=372.98 Aligned_cols=273 Identities=24% Similarity=0.371 Sum_probs=219.8
Q ss_pred ccHHHHHHHhhcccccceeccccceEEEEEEE------cCCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCccee
Q 017246 50 FTFRELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTL 121 (375)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~ 121 (375)
+......+..++|++.+.||+|+||.||+|++ .+++.||||++..... .....+.+|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455566788999999999999999999973 2467899999976433 3345688999999999 78999999
Q ss_pred EeEEeeCCe-eEEEEeecCCCCHHHHHhccCCC-----------------------------------------------
Q 017246 122 IGYCTSGDQ-RLLVYEYMPMGSLEDHLYDLEPD----------------------------------------------- 153 (375)
Q Consensus 122 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------- 153 (375)
++++...+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999887554 89999999999999999764321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 154 ---------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 154 ---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999998 99999999999999999999999999986544444
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
........||+.|+|||++.+..++.++|||||||++|||++ |..||....... .. ...+...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~--------------~~~~~~~ 312 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF--------------CRRLKEG 312 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HH--------------HHHHHHT
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HH--------------HHHHHcC
Confidence 444455678999999999999999999999999999999998 999996432211 00 0011111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.....+..++..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 12233456778899999999999999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=370.29 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=202.8
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 131 (375)
...++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+..|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44578999999999999999999875 68999999997642 23455677899999887 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999965 356999999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ..
T Consensus 173 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~---~~---------- 234 (353)
T 3txo_A 173 EGIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---L---FE---------- 234 (353)
T ss_dssp CSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HH----------
T ss_pred eccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---H---HH----------
Confidence 5322 2223445789999999999999999999999999999999999999996432110 0 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~eil~ 333 (375)
.+... ...+|..++..+.+||.+||+.||.+||++ .+|++
T Consensus 235 ~i~~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 235 AILND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11111 113455677889999999999999999998 77775
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=371.54 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=204.2
Q ss_pred hhcccccceeccccceEEEEEEEc----CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..+|.+.+.||+|+||.||+|+.. ++..||||++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 458999999999999999999764 57789999997643 2335678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999964 3456999999999999999999999998 999999999999999999999999999764
Q ss_pred CCCCC-ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 214 PVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 214 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||....... . .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~--------------~ 260 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---V--------------I 260 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---H--------------H
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H--------------H
Confidence 32221 111222345778999999999999999999999999999998 999996332110 0 0
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
..+........+..++..+.+++.+||+.+|++||++.+|++.|+.+.....
T Consensus 261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 1111111222345677889999999999999999999999999999987544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=360.36 Aligned_cols=273 Identities=20% Similarity=0.216 Sum_probs=215.6
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 478999999986543 234578899999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc-----eEEeecCCCc
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-----PKLSDFGLAK 211 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~-----vkl~Dfg~a~ 211 (375)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999752 457999999999999999999999998 999999999999999887 9999999997
Q ss_pred cCCCCCCce-----eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 212 LGPVGDNTH-----VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 212 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--- 235 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT--- 235 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH---
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh---
Confidence 543322111 124568999999999999999999999999999999999999999754322211111100000
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC---CCCccCCC
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD---SHPVSRNA 351 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~---~~~~~~~~ 351 (375)
... .....+ ...++ .+.+++..||+.+|.+||++.+|++.|+.+..+.. ...++|..
T Consensus 236 ~~~---~~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 236 KRA---TPIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHH---SCHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred hcc---CCHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 000 000000 11244 89999999999999999999999999999987643 23445543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=357.17 Aligned_cols=264 Identities=24% Similarity=0.322 Sum_probs=210.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+++.. ++..||+|++...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 568999999999999999999865 6899999998654332 245688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999965 346899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...... ..
T Consensus 163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~------~~- 228 (294)
T 4eqm_A 163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQ------DS- 228 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHS------SC-
T ss_pred ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhh------cc-
Confidence 221 1223346799999999999999999999999999999999999999964321110 000000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhhhhhccC
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQRD 343 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~eil~~L~~l~~~~~ 343 (375)
.+......+..++..+.++|.+||+.||.+|| ++.++.+.|..+.....
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 00001112345678899999999999999998 99999999999876544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=369.29 Aligned_cols=256 Identities=22% Similarity=0.245 Sum_probs=207.2
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC-----ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
..++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3568999999999999999999865 68999999986432 12456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc---eEEeecC
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFG 208 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~---vkl~Dfg 208 (375)
++||||+++++|.+++......+..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999988765444567899999999999999999999998 999999999999987655 9999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
++...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ... ........
T Consensus 179 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~---~~i~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF---EGIIKGKY 249 (351)
T ss_dssp TCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH---HHHHHTCC
T ss_pred ceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH---HHHHcCCC
Confidence 99764322 2223446799999999999999999999999999999999999999964211 000 00000000
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. .+ .....++..+.+||.+||+.||++||++.++++
T Consensus 250 ~~----~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KM----NP----RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC----CH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC----Cc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00 001235678999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=355.79 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=213.5
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+..++|++.+.||+|+||.||++...++..||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3456899999999999999999998888899999997653 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999652 356899999999999999999999998 999999999999999999999999999753221
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ ...+.
T Consensus 174 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-----------------~~~~~ 235 (283)
T 3gen_A 174 E-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----------------AEHIA 235 (283)
T ss_dssp H-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----------------HHHHH
T ss_pred c-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-----------------HHHHh
Confidence 1 111223456788999999999999999999999999999998 9999964322110 00011
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.......+..++..+.+++.+||+.+|++||++.++++.|..+..+.
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 236 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 11122234455678999999999999999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=366.84 Aligned_cols=269 Identities=26% Similarity=0.431 Sum_probs=216.2
Q ss_pred HHHHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEee
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 127 (375)
+....++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445689999999999999999999864 347899999976533 234678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccC
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEPD--------------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 187 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~ 187 (375)
.+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 99999999999999999999764321 257899999999999999999999998 9999
Q ss_pred CCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCcc
Q 017246 188 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 266 (375)
Q Consensus 188 Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~ 266 (375)
||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999875332222222334568999999999999999999999999999999999 999996
Q ss_pred ccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 267 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
...... ... . +.. ......+..++..+.+++.+||+.||++||++.+|++.|+++..+..
T Consensus 279 ~~~~~~---~~~----~---------~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEE---VIY----Y---------VRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHH---HHH----H---------HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHH---HHH----H---------HhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 322110 000 0 000 01112355677889999999999999999999999999999976543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=373.34 Aligned_cols=266 Identities=27% Similarity=0.402 Sum_probs=215.1
Q ss_pred HhhcccccceeccccceEEEEEEEc------CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
..++|++.+.||+|+||.||+|... ++..||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3568999999999999999999843 46789999996542 2334568889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC---ceEE
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKL 204 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~---~vkl 204 (375)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999976542 2356899999999999999999999998 99999999999999655 4999
Q ss_pred eecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhh
Q 017246 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 205 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~------- 295 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---V------- 295 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H-------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-------
Confidence 99999864221122222334568999999999999999999999999999999998 999996432110 0
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
...+........+..++..+.+|+.+||+.+|++||++.+|++.|+.+.....
T Consensus 296 -------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 296 -------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp -------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 01111111223355677889999999999999999999999999999987543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=359.11 Aligned_cols=269 Identities=26% Similarity=0.397 Sum_probs=220.2
Q ss_pred HHhhcccccceeccccceEEEEEEE------cCCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEeeC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 128 (375)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 4457899999999999999999974 2467899999976533 3356788999999999 999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEP--------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999976431 1235899999999999999999999998 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGE 273 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 273 (375)
|++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999986544443334445667889999999999999999999999999999999 9999964322110
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCC
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~ 344 (375)
. ...+........+..++..+.+++.+||+.||.+||++.+|++.|+++.....+
T Consensus 257 --~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 257 --F--------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp --H--------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred --H--------------HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 0 001111112223456678899999999999999999999999999999876544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=362.84 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=205.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCce----EEEEEcccc-CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQL----VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999864 4554 477776543 3345678899999999999999999999998754 78
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+|++++.+|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999975 3456899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..............+|+.|+|||++.+..++.++|||||||++|||++ |..||....... +.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~~ 229 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------IS 229 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HH
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------HH
Confidence 443333333344567889999999999999999999999999999999 999997432211 11
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
..+........+..++..+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 111112222335567788999999999999999999999999999998653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=363.13 Aligned_cols=259 Identities=25% Similarity=0.431 Sum_probs=206.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCc----eEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
.++|++.+.||+|+||.||+|++. +++ .||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 468999999999999999999864 344 35888876532 24457789999999999999999999999875 478
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999975 3456899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------------~~ 229 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------IS 229 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HH
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----------------HH
Confidence 443333333344567889999999999999999999999999999999 999997432211 11
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
..+........+..++..+.+++.+||+.+|++||++.+|++.|+.+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11111222234566778899999999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=367.61 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=206.7
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 132 (375)
..++|++.++||+|+||.||+|+.. +++.||+|++.+... .....+..|..++..+ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3568999999999999999999876 588999999976532 2334577899998876 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999965 356999999999999999999999998 99999999999999999999999999975
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc--chhhchhhhhhhcccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ--NLVSWSRPFLKDQKKF 290 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 290 (375)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......
T Consensus 203 ~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~--------- 271 (396)
T 4dc2_A 203 GLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------- 271 (396)
T ss_dssp CCC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH---------
T ss_pred ccc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH---------
Confidence 222 122344578999999999999999999999999999999999999999643221110 0000000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~eil~ 333 (375)
..+... ...+|..++..+.+||.+||+.||.+||++ .||++
T Consensus 272 ~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 272 QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred HHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 001111 123456778889999999999999999985 56665
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=361.09 Aligned_cols=267 Identities=22% Similarity=0.366 Sum_probs=200.2
Q ss_pred HHhhcccccceeccccceEEEEEEEcC-C---ceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLES-G---QLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
+..++|++.+.||+|+||.||+|.... + ..||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999997653 3 279999997652 3345678899999999999999999999987765
Q ss_pred e------EEEEeecCCCCHHHHHhccCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCce
Q 017246 131 R------LLVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 202 (375)
Q Consensus 131 ~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~v 202 (375)
. ++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 899999999999999965332 2336899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchh
Q 017246 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 281 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 281 (375)
||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~--- 250 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---YN--- 250 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---HH---
Confidence 9999999976443333333334567889999999999999999999999999999999 8999974322110 00
Q ss_pred hhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 282 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.+........+..++..+.+++.+||+.||++||++.++++.|+++.....
T Consensus 251 -----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 251 -----------YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp -----------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -----------HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 000011123345677889999999999999999999999999999987543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=353.60 Aligned_cols=276 Identities=21% Similarity=0.278 Sum_probs=214.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCC--eeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 134 (375)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 468999999999999999999876 58999999997643 244567889999999999999999999987765 78999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE----eCCCceEEeecCCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLA 210 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill----~~~~~vkl~Dfg~a 210 (375)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997643 2334899999999999999999999998 9999999999999 77888999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccc--------cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAM--------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
....... ......||+.|+|||++. +..++.++|||||||++|||++|..||.......... .....
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~ 238 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYK 238 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH--HHHHH
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH--HHHHH
Confidence 7643322 223457999999999886 5778999999999999999999999996433221110 00000
Q ss_pred hhh-hcc-c---cchhc--------ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 283 FLK-DQK-K---FVHLV--------DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 283 ~~~-~~~-~---~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
... ... . ..... .......++..++..+.+++.+||+.||++||++.|+++....-.....
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~ 312 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC---
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCC
Confidence 000 000 0 00000 0011124567899999999999999999999999999999887765443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=363.94 Aligned_cols=268 Identities=25% Similarity=0.403 Sum_probs=214.7
Q ss_pred HHhhcccccceeccccceEEEEEEE------cCCceEEEEEccccC-ccchHHHHHHHHHHccC-CCCCcceeEeEEeeC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 128 (375)
+..++|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++..+ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 4467899999999999999999985 245689999997542 23456788999999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPD-------------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 189 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dl 189 (375)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999763311 134899999999999999999999998 999999
Q ss_pred CCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCcccc
Q 017246 190 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 268 (375)
Q Consensus 190 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 268 (375)
||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999975433333333445668889999999999999999999999999999998 99999643
Q ss_pred ccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 269 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.... . ....+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+.....
T Consensus 279 ~~~~--~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDA--N--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSH--H--------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHH--H--------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 2211 0 011111112223355677889999999999999999999999999999976543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=354.37 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=207.1
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
.|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 3778889999999999999876 699999999987766667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+++|.+++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 126 ~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~ 195 (321)
T 2c30_A 126 GGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--V 195 (321)
T ss_dssp SCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--S
T ss_pred CCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccC--c
Confidence 999999984 346899999999999999999999998 999999999999999999999999998754322 1
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccC
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 299 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (375)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ... .....+.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~---~~~-------~~~~~~~~- 261 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM---KRL-------RDSPPPKL- 261 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHH-------HHSSCCCC-
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHH-------hcCCCCCc-
Confidence 22344679999999999999999999999999999999999999996322110 00 000 00000111
Q ss_pred CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 300 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 300 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..+..++..+.+++.+||+.||++||++.++++
T Consensus 262 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 262 -KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 123456778999999999999999999999994
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=355.61 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=202.1
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||+|+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4689999999999999999999888999999999754322 24568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++ +|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9975 88888764 3456999999999999999999999998 999999999999999999999999999764322
Q ss_pred CCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccch-hhchhh----hhhhcccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWSRP----FLKDQKKF 290 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~----~~~~~~~~ 290 (375)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ...... ........
T Consensus 173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp --CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred --cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 222334578999999999876 5689999999999999999999999974433221100 000000 00000000
Q ss_pred c-------hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 291 V-------HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 291 ~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
. ............+.++.++.+||.+||+.||++|||+.|++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 0 00000000011234567889999999999999999999999
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=363.18 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=208.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCce----EEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQL----VAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ......+.+|+.+++.++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 457999999999999999999864 4554 7788775432 233456778999999999999999999986 46789
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999965 2456888999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..............||+.|+|||++.+..++.++|||||||++|+|++ |..||........ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----------------~ 227 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-----------------P 227 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-----------------H
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-----------------H
Confidence 554444444455678889999999999999999999999999999999 9999974322111 0
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
..+........+..++..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 228 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp HHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred HHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 111111122234456667889999999999999999999999999997653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=360.26 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=205.0
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35899999999999999999986 478999999986532 22345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+ +|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 7899999865 456999999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..+
T Consensus 160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i 220 (336)
T 3h4j_B 160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKV 220 (336)
T ss_dssp TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCC
T ss_pred CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHH
Confidence 22 22344679999999999988776 68999999999999999999999642211100 000
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ....+|..++..+.+||.+||+.||.+|||+.|+++
T Consensus 221 ~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred Hc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 011235567788999999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=356.71 Aligned_cols=245 Identities=28% Similarity=0.391 Sum_probs=207.5
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999875 69999999997642 23456778899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999965 456899999999999999999999988 9999999999999999999999999997532
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
. .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ... ..++
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~----------~~i~ 216 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTY----------EKIL 216 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH----------HHHH
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHH----------HHHH
Confidence 2 123468999999999999999999999999999999999999999632211 000 0111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
... ..++..++..+.++|.+||+.||.+|| ++.+|++
T Consensus 217 ~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 217 NAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred hCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111 134556778899999999999999999 8999885
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=364.57 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=207.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||++... +++.||+|++.+.. ......+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999865 58899999986542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+.||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999964 557999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCCceeeecccccccccccccccc---CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
.. ......+||+.|+|||++.. ..|+.++|||||||++|||++|+.||............. ...
T Consensus 167 ~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~------- 233 (384)
T 4fr4_A 167 RE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFE------- 233 (384)
T ss_dssp TT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHH-------
T ss_pred CC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHh-------
Confidence 22 22345789999999999874 458999999999999999999999997443322111111 000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~eil~ 333 (375)
.....++..++..+.+||.+||+.||.+||+ +.+|++
T Consensus 234 -----~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 -----TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0112345667889999999999999999998 676664
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=350.86 Aligned_cols=273 Identities=18% Similarity=0.184 Sum_probs=216.6
Q ss_pred HhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+.+++.+ +|+|++++++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356899999999999999999986 479999999986542 334577899999998 7999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc-----eEEeecCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-----PKLSDFGLA 210 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~-----vkl~Dfg~a 210 (375)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 9999999975 2446999999999999999999999988 999999999999987776 999999999
Q ss_pred ccCCCCCCc-----eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh
Q 017246 211 KLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285 (375)
Q Consensus 211 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 285 (375)
......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 754332211 123456799999999999999999999999999999999999999975432221111110000000
Q ss_pred hccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC---CCCccC
Q 017246 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD---SHPVSR 349 (375)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~---~~~~~~ 349 (375)
.... ......++..+.+++.+||+.+|++||++.+|++.|+++..+.. ..+++|
T Consensus 239 -~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 239 -STPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp -HSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred -CccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 0000 00123456789999999999999999999999999999987643 344444
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=357.92 Aligned_cols=251 Identities=18% Similarity=0.241 Sum_probs=205.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999875 68899999986543 3455688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC--CCceEEeecCCCccCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~--~~~vkl~Dfg~a~~~~~ 215 (375)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999954 3456999999999999999999999998 999999999999987 78999999999986433
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... . ...........
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~---~~~i~~~~~~~----- 222 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---I---IENIMNAEYTF----- 222 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHHTCCCC-----
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---H---HHHHHcCCCCC-----
Confidence 22 2334679999999999999889999999999999999999999996432110 0 00000000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......++..+.+|+.+||+.||.+||++.|+++
T Consensus 223 ---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00001245678999999999999999999999997
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=348.61 Aligned_cols=254 Identities=31% Similarity=0.448 Sum_probs=200.3
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCc----cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|.+. ++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999876 88999999876432 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC--------CCceEEee
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--------DFNPKLSD 206 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~--------~~~vkl~D 206 (375)
|||+++++|.+++. ...+++..++.++.|++.||.|||+++..+|+||||||+|||++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999983 457899999999999999999999887445889999999999986 67899999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------- 222 (271)
T 3dtc_A 160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------------- 222 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------------
T ss_pred CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------
Confidence 99997532221 2235789999999999999999999999999999999999999964221100
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
.............+..++..+.+++.+||+.+|++||++.++++.|+.|
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 ---AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0011111222234566778899999999999999999999999999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=363.51 Aligned_cols=253 Identities=22% Similarity=0.245 Sum_probs=206.0
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
...++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999875 689999999976533 234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC---ceEEeecCCC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLA 210 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~---~vkl~Dfg~a 210 (375)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999953 567899999999999999999999998 99999999999998654 5999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ... ........
T Consensus 179 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~---~~i~~~~~-- 247 (362)
T 2bdw_A 179 IEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY---AQIKAGAY-- 247 (362)
T ss_dssp BCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTCC--
T ss_pred eEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHhCCC--
Confidence 7643222 223467999999999999999999999999999999999999999632211 000 00000000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.........++..+.+||.+||+.||++||++.++++
T Consensus 248 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 248 ------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000111356778999999999999999999999885
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=358.03 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=206.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 133 (375)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+.... ....+.+|..++..+ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999876 5899999999765332 244577899999887 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999965 356899999999999999999999998 999999999999999999999999999753
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc--chhhchhhhhhhccccc
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ--NLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~ 291 (375)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... .
T Consensus 161 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------~ 229 (345)
T 3a8x_A 161 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---------Q 229 (345)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH---------H
T ss_pred cCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH---------H
Confidence 221 12234578999999999999999999999999999999999999999643221110 0000000 0
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~eil~ 333 (375)
.+... ...+|..++..+.+||.+||+.||.+||++ .++++
T Consensus 230 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 230 VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred HHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 01111 113456678889999999999999999995 56664
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=358.97 Aligned_cols=267 Identities=26% Similarity=0.413 Sum_probs=216.5
Q ss_pred HhhcccccceeccccceEEEEEEEc--------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS 127 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 127 (375)
..++|++.+.||+|+||.||+|+.. ++..||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 467899999976532 3356688999999999 89999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEE
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 195 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nil 195 (375)
.+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 99999999999999999999764321 235899999999999999999999998 999999999999
Q ss_pred EeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCcccccccccc
Q 017246 196 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQ 274 (375)
Q Consensus 196 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 274 (375)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 99999999999999976443333333344567889999999999899999999999999999999 99999643211
Q ss_pred chhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCC
Q 017246 275 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~ 344 (375)
.... .+........+..++..+.+++.+||+.+|.+||++.+|++.|+.+......
T Consensus 267 ~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 ELFK--------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHH--------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHH--------------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 0000 0011111233456778899999999999999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=363.45 Aligned_cols=251 Identities=29% Similarity=0.432 Sum_probs=206.4
Q ss_pred HHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCe
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 130 (375)
....++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999875 68999999997642 23455677888888876 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999965 356899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..
T Consensus 166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~---~~-------- 229 (345)
T 1xjd_A 166 KENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF---HS-------- 229 (345)
T ss_dssp BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH--------
T ss_pred hhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHH---HH--------
Confidence 7532222 2234578999999999999999999999999999999999999999632211 000 00
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-eil~ 333 (375)
+... ...++..++..+.+||.+||+.||++||++. +|++
T Consensus 230 --i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 230 --IRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp --HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --HHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 0000 1134556778899999999999999999997 6653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=349.86 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=202.0
Q ss_pred HHhhcccccceeccccceEEEEEEEc----CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
+..++|++.+.||+|+||.||+|... .+..||+|++..... ...+.+.+|+.+++.++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34568999999999999999999764 245799999876432 33557889999999999999999999984 5678
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999999965 2456899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 165 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~------------ 228 (281)
T 1mp8_A 165 YMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG------------ 228 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH------------
T ss_pred ccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHH------------
Confidence 543222 112233457889999999999999999999999999999997 999996432211 000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.+ ........+..++..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 229 -~i-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 229 -RI-ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -HH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HH-HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 00111234566788899999999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=369.36 Aligned_cols=254 Identities=22% Similarity=0.221 Sum_probs=205.7
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
...++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34678999999999999999999764 689999999976543 234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe---CCCceEEeecCCC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLA 210 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~---~~~~vkl~Dfg~a 210 (375)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999965 456999999999999999999999998 99999999999998 4678999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
....... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||....... .. ........
T Consensus 161 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~---~~i~~~~~-- 230 (444)
T 3soa_A 161 IEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LY---QQIKAGAY-- 230 (444)
T ss_dssp BCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHHHTCC--
T ss_pred EEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HH---HHHHhCCC--
Confidence 7543222 22334679999999999999999999999999999999999999996322110 00 00000000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.........++..+.+||.+||+.||++||++.|+++
T Consensus 231 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 ------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0001112356778999999999999999999999996
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=376.13 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=215.9
Q ss_pred HHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.+..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+.+++.++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 35567899999999999999999999888899999997653 45778999999999999999999999986 57789999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 262 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999996421 235788999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. ........++..|+|||++....++.++|||||||++|||++ |+.||...... .... .+
T Consensus 337 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~--------------~i 398 (454)
T 1qcf_A 337 NE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR--------------AL 398 (454)
T ss_dssp HH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH--------------HH
T ss_pred Cc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH--------------HH
Confidence 11 111223446788999999999999999999999999999999 99999632211 0000 01
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
........+..++..+.+||.+||+.||++||++.+|++.|+.+....
T Consensus 399 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 399 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 111122335677889999999999999999999999999999987543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=371.07 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=211.8
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCC-eeEEEEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVYE 136 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 136 (375)
..++|++.+.||+|+||.||+|... |+.||||+++... ..+.+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3578999999999999999999886 7899999997653 4578899999999999999999999987665 7899999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999997632 344789999999999999999999998 999999999999999999999999999743211
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+.
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~--------------~~i~ 400 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV--------------PRVE 400 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH--------------HHHH
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH--------------HHHH
Confidence 122357889999999999999999999999999999999 999996432211 00 0111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.......+..++..+.+||.+||+.||++||++.+|++.|+.+...
T Consensus 401 ~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1122334667888999999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=355.40 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=205.8
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc------chHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457999999999999999999875 6899999998764322 356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC----ceEEeec
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDF 207 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~----~vkl~Df 207 (375)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999953 567999999999999999999999998 99999999999998887 7999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. .......
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~~~~~~ 233 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANVSAVN 233 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHHTC
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHHhcC
Confidence 9997643222 1234679999999999999999999999999999999999999996322110 00 0000000
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. .........++..+.+||.+||+.||++||++.++++
T Consensus 234 ~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 Y--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C--------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C--------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000011245678899999999999999999999995
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=353.79 Aligned_cols=273 Identities=26% Similarity=0.391 Sum_probs=213.2
Q ss_pred hhcccccceeccccceEEEEEEE-----cCCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeC--Ce
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 130 (375)
...|++.+.||+|+||.||+|++ .+++.||+|++.... ......+.+|+.+++.++||||+++++++... +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45799999999999999999983 368899999997543 23457788999999999999999999999876 67
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 89999999999999999652 356899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 211 KLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 211 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+................ ......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~ 251 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG--QMTVTR 251 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG--GGHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc--ccCHHH
Confidence 764433221 23344668889999999999999999999999999999999999875221100000000000 000011
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
....+........+..++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11112222233446677889999999999999999999999999999885
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=347.12 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=214.4
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46899999999999999999998888899999997654 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++++|.+++.. ....+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++...... .
T Consensus 86 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~ 158 (267)
T 3t9t_A 86 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-Q 158 (267)
T ss_dssp TTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-H
T ss_pred CCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-c
Confidence 99999999965 2456899999999999999999999998 999999999999999999999999998753221 1
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .. .. +...
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~-----------i~~~ 221 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV---ED-----------ISTG 221 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HH-----------HHTT
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HH---HH-----------HhcC
Confidence 111223457889999999998999999999999999999999 899996422110 00 00 0001
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.....+..++..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 222 FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11223445677899999999999999999999999999999753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=377.39 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=218.1
Q ss_pred HHhhcccccceeccccceEEEEEEEcC-CceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
+...+|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++...+..+|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345689999999999999999998764 8899999997653 45678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 999999999999753 3456899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
. .........++..|+|||++....++.++|||||||++|||++ |..||....... +...+
T Consensus 371 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-----------------~~~~~ 432 (495)
T 1opk_A 371 D-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYELL 432 (495)
T ss_dssp C-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------HHHHH
T ss_pred C-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHH
Confidence 2 1222233456789999999999999999999999999999999 999996432111 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
........+..++..+.+||.+||+.||++||++.+|++.|+.+...
T Consensus 433 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 12222344567888999999999999999999999999999998643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=356.47 Aligned_cols=268 Identities=24% Similarity=0.334 Sum_probs=213.2
Q ss_pred HhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEe----eCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT----SGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~ 132 (375)
..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999987 479999999987765566778899999999999999999999986 345788
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999876556678999999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCce-------eeeccccccccccccccccCC---CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 213 GPVGDNTH-------VSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 213 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------- 255 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-------- 255 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--------
Confidence 32111000 012245799999999987654 689999999999999999999999632111110
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.............+..++..+.++|.+||+.||.+||++.+|++.|+.+.....
T Consensus 256 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 256 -------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp -------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred -------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 000001111112234567789999999999999999999999999999965443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=360.17 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=206.6
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 131 (375)
...++|++.+.||+|+||.||+|+.. +++.||||++.+.. ......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34568999999999999999999876 48899999997642 23456678899999887 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999965 346899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ..
T Consensus 170 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~---~~---------- 231 (353)
T 2i0e_A 170 ENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL---FQ---------- 231 (353)
T ss_dssp CCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HH----------
T ss_pred ccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HH---HH----------
Confidence 53221 12234578999999999999999999999999999999999999999632211 00 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~ 333 (375)
.+... ...+|..++..+.+||.+||+.||.+||+ +.+|++
T Consensus 232 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 232 SIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111 11345667889999999999999999995 577765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=351.22 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=200.2
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHcc--CCCCCcceeEeEEee----CCee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTS----GDQR 131 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~ 131 (375)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356899999999999999999987 5899999998653 33445556666555 799999999998654 3568
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--------CKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
++||||+++|+|.+++. ...+++..++.++.||+.||.||| +++ |+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 89999999999999994 356999999999999999999999 888 99999999999999999999
Q ss_pred EeecCCCccCCCCCCce--eeeccccccccccccccccC------CCCccchhHhHHHHHHHHHhC----------CCCc
Q 017246 204 LSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITG----------RKAM 265 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~pf 265 (375)
|+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997532222211 12335799999999999876 456799999999999999999 6666
Q ss_pred cccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 266 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
......... ... ........ ..........++..++..+.+|+.+||+.||++||++.+|++.|++|
T Consensus 234 ~~~~~~~~~-~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPS-FED-MRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCC-HHH-HHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcc-hhh-hhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 432211110 000 00000000 00000011112346788999999999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=360.09 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=201.7
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCCC--CCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l 133 (375)
..++|++.+.||+|+||.||++...+++.||||++..... .....+.+|+.++..++| |||+++++++...+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3567999999999999999999888899999999876433 234668899999999976 999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||| +.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++...
T Consensus 87 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 568899999965 457899999999999999999999998 99999999999997 578999999999865
Q ss_pred CCCCCceeeecccccccccccccccc-----------CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------- 226 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------- 226 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----------
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----------
Confidence 43333333445689999999999865 67899999999999999999999999632110
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.......+.+.....++...+..+.+|+.+||+.||.+||++.++++.
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 ----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 011122223333334455666789999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=371.51 Aligned_cols=259 Identities=20% Similarity=0.226 Sum_probs=207.2
Q ss_pred HHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
+....++|++.++||+|+||.||+|+.. +++.||+|++.+... .....+.+|..++..++||||++++++|.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3344578999999999999999999876 588999999965321 223347889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence 9999999999999999964 2467999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 285 (375)
+..... ........+||+.|+|||++. ...|+.++|||||||++|||++|+.||........ . .....
T Consensus 223 ~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~---~~i~~ 295 (437)
T 4aw2_A 223 LKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---Y---GKIMN 295 (437)
T ss_dssp EECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHHHT
T ss_pred hhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---H---Hhhhh
Confidence 754322 223334578999999999987 56789999999999999999999999964321110 0 00000
Q ss_pred hccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 017246 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVV 333 (375)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~eil~ 333 (375)
... .. ........++..+.+||.+||..+|++ ||+++|+++
T Consensus 296 ~~~---~~----~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 296 HKE---RF----QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHH---HC----CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccc---cc----cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000 00 001112346778999999999988888 999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=353.00 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=219.2
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
....+|++.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 44678999999999999999999876 48899999997543 44677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999999763 3456899999999999999999999998 99999999999999999999999999976432
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+
T Consensus 164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----------------~~~~~ 225 (288)
T 3kfa_A 164 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYELL 225 (288)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------HHHHH
T ss_pred Cc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHH
Confidence 22 223334567889999999999999999999999999999999 999996432111 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
........+..++..+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 112222345667788999999999999999999999999999988653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=359.80 Aligned_cols=277 Identities=28% Similarity=0.409 Sum_probs=217.5
Q ss_pred hhcccccceeccccceEEEEEEE-----cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEe--eCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT--SGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 131 (375)
.++|++.+.||+|+||.||++++ .+++.||+|++........+.+.+|+.+++.++||||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 368899999998776666677899999999999999999999886 45678
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999753 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ... .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~-~~~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCE-RDVPALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-----CCHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccc-cccccHHHH
Confidence 64433222 223345688899999999999999999999999999999999999863221100000 000 000000111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
...+........+..++..+.+|+.+||+.||++||++.+|++.|+.+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 12222233334566788899999999999999999999999999999976543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=360.01 Aligned_cols=252 Identities=19% Similarity=0.247 Sum_probs=207.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457999999999999999999875 6899999999776555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC--CCceEEeecCCCccCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~--~~~vkl~Dfg~a~~~~~ 215 (375)
+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999854 3456999999999999999999999998 999999999999974 46799999999986433
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ...... .
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~---~~i~~~--------~ 266 (387)
T 1kob_A 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL---QNVKRC--------D 266 (387)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHHC--------C
T ss_pred Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HH---HHHHhC--------C
Confidence 22 2234579999999999999999999999999999999999999996432110 00 000000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..........++..+.+||.+||+.||++||++.++++
T Consensus 267 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 267 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 01111223456778999999999999999999999995
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=351.20 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=197.4
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--------------------------chHHHHHHHHHHc
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--------------------------GHQEFIVEVLMLS 111 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~ 111 (375)
.++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999865 6899999998654321 1356789999999
Q ss_pred cCCCCCcceeEeEEee--CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCC
Q 017246 112 LLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 189 (375)
Q Consensus 112 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dl 189 (375)
.++||||+++++++.. .+..++||||+++++|.+++ ....+++..++.++.||+.||.|||+++ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999986 57889999999999998765 3457999999999999999999999998 999999
Q ss_pred CCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCC---CCccchhHhHHHHHHHHHhCCCCcc
Q 017246 190 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMD 266 (375)
Q Consensus 190 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~ 266 (375)
||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999997643222 2234467999999999998665 4788999999999999999999996
Q ss_pred ccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 267 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... ...... ............++..+.++|.+||+.||++||++.|+++
T Consensus 242 ~~~~~------~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIM------CLHSKI----------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHH------HHHHHH----------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHH------HHHHHH----------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 32110 000000 0001111112356678999999999999999999999984
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=358.95 Aligned_cols=245 Identities=25% Similarity=0.303 Sum_probs=207.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999875 69999999986542 23456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999965 346899999999999999999999998 9999999999999999999999999998542
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .+.
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~----------~i~ 251 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYE----------KIV 251 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH----------HHH
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHH----------HHH
Confidence 21 23467999999999999999999999999999999999999999632211 0000 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~ 333 (375)
.. ...+|..++..+.++|.+||+.||.+||+ +.+|++
T Consensus 252 ~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 252 SG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11 11345567888999999999999999998 888875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=369.17 Aligned_cols=253 Identities=22% Similarity=0.263 Sum_probs=205.8
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
...++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.++..++||||++++++|.+.+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34578999999999999999999876 58999999986532 123345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.
T Consensus 146 lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 99999999999999854 35899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCCceeeeccccccccccccccccCC----CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
..... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ..
T Consensus 218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~------- 283 (410)
T 3v8s_A 218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YS------- 283 (410)
T ss_dssp CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH-------
T ss_pred eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HH-------
Confidence 43222 22334578999999999998765 88999999999999999999999963321110 00
Q ss_pred ccchhcccccCCCCC--HHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 017246 289 KFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 334 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--RPs~~eil~~ 334 (375)
.++.......+| ..++..+.+||.+||+.+|.+ ||++.||++.
T Consensus 284 ---~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 284 ---KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 011100001111 246788999999999999988 9999999963
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=355.48 Aligned_cols=266 Identities=24% Similarity=0.383 Sum_probs=204.4
Q ss_pred HHhhcccccceeccccceEEEEEEEc----CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCC-
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD- 129 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 129 (375)
+..++|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 45678999999999999999999754 345899999976532 23456889999999999999999999987655
Q ss_pred ----eeEEEEeecCCCCHHHHHhccC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 130 ----QRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 130 ----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 3489999999999999985422 34567999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhh
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 282 (375)
|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---- 260 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD---- 260 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH----
Confidence 999999976433332233344567889999999999999999999999999999999 888986432211 000
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.+........+..++..+.+++.+||+.+|++||++.+|++.|+.+....
T Consensus 261 ----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 261 ----------YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ----------HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00011112335567788999999999999999999999999999997653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=353.14 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=206.4
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457999999999999999999864 689999999875332 3345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.........+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999765445677999999999999999999999998 9999999999999999999999999987532
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. ........|++.|+|||++.+..++.++||||||+++|+|++|..||....... ...... +.
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~----------~~ 251 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK----------IE 251 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHHH----------HH
T ss_pred CC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHHH----------hh
Confidence 21 122234578999999999999999999999999999999999999996322110 000000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCC
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~ 346 (375)
...........++..+.+++.+||+.||++||++.+|++.|++|.+....++
T Consensus 252 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 252 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp TTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred cccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0011111124567789999999999999999999999999999988665544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=355.73 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=198.2
Q ss_pred hhcccccceeccccceEEEEEEE----cCCceEEEEEccccCc----cchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
.++|++.+.||+|+||.||+++. .+++.||+|++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999986 4689999999976432 234557789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999965 346889999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
...... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... . ..
T Consensus 169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~---~~--------- 231 (327)
T 3a62_A 169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---T---ID--------- 231 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HH---------
T ss_pred cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---H---HH---------
Confidence 742211 122345679999999999999999999999999999999999999996432110 0 00
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
.+... ...++..++..+.+||.+||+.||.+|| ++.++++
T Consensus 232 -~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 232 -KILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -HHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -HHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 01111 1134556778899999999999999999 7888876
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=349.15 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=200.9
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
++|++.+.||+|+||.||+|+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47999999999999999999888899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++ +|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc-
Confidence 975 99998864 3456899999999999999999999998 999999999999999999999999998753221
Q ss_pred Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh-------hhhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-------LKDQKK 289 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~ 289 (375)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ........ ......
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGG
T ss_pred -ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhc
Confidence 112234578999999999876 4589999999999999999999999964322110 00000000 000000
Q ss_pred cch------hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVH------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... ...+.....+...++..+.+||.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00000011122356778999999999999999999999983
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=355.23 Aligned_cols=273 Identities=24% Similarity=0.364 Sum_probs=218.9
Q ss_pred cHHHHHHHhhcccccceeccccceEEEEEEE------cCCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeE
Q 017246 51 TFRELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLI 122 (375)
Q Consensus 51 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~ 122 (375)
.........++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++..+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444556678999999999999999999974 2468899999976533 2345688999999999 799999999
Q ss_pred eEEeeCC-eeEEEEeecCCCCHHHHHhccCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCC
Q 017246 123 GYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 189 (375)
Q Consensus 123 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dl 189 (375)
+++...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987754 589999999999999999763321 223889999999999999999999998 999999
Q ss_pred CCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCcccc
Q 017246 190 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 268 (375)
Q Consensus 190 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 268 (375)
||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986544333334445678999999999999999999999999999999998 99999643
Q ss_pred ccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 269 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.... ... . .+........+..++..+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 255 ~~~~--~~~----~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDE--EFC----R----------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSH--HHH----H----------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhH--HHH----H----------HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 2211 000 0 00011112234556778999999999999999999999999999998643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=360.10 Aligned_cols=278 Identities=16% Similarity=0.166 Sum_probs=211.4
Q ss_pred hhcccccceeccccceEEEEEEEcC------CceEEEEEccccCccc-----------hHHHHHHHHHHccCCCCCccee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES------GQLVAIKQLNHEGLQG-----------HQEFIVEVLMLSLLHHDNLVTL 121 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~ 121 (375)
.++|++.+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999998754 4789999986653211 1223456667788899999999
Q ss_pred EeEEeeC----CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe
Q 017246 122 IGYCTSG----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 197 (375)
Q Consensus 122 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~ 197 (375)
++++... ...+|||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998764 4589999999 9999999975 3467999999999999999999999998 99999999999999
Q ss_pred --CCCceEEeecCCCccCCCCCC-----ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 017246 198 --NDFNPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 270 (375)
Q Consensus 198 --~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~ 270 (375)
.++.+||+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999975332111 1112335699999999999999999999999999999999999999974322
Q ss_pred ccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC---CCCc
Q 017246 271 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD---SHPV 347 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~---~~~~ 347 (375)
.. .......... ...+..+++..+. ...++..+.+++..||+.+|++||++.+|++.|+.+..... ..++
T Consensus 267 ~~--~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 339 (364)
T 3op5_A 267 DP--KYVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL 339 (364)
T ss_dssp CH--HHHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred CH--HHHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence 11 1111111000 1112222222221 23456789999999999999999999999999999987543 3455
Q ss_pred cCC
Q 017246 348 SRN 350 (375)
Q Consensus 348 ~~~ 350 (375)
+|+
T Consensus 340 dw~ 342 (364)
T 3op5_A 340 DLS 342 (364)
T ss_dssp CC-
T ss_pred ceE
Confidence 554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=370.96 Aligned_cols=262 Identities=28% Similarity=0.428 Sum_probs=212.0
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+..++|++.+.||+|+||.||+|.+..+..||||++.... ...+.+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4567899999999999999999998877889999997654 345788999999999999999999999876 77899999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999642 2345899999999999999999999998 999999999999999999999999999754322
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+.
T Consensus 334 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~--------------~~i~ 395 (452)
T 1fmk_A 334 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL--------------DQVE 395 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH--------------HHHH
T ss_pred c-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HH--------------HHHH
Confidence 1 112223456789999999999999999999999999999999 999996322110 00 0111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.......+..++..+.+||.+||+.||++||++.+|++.|+.+.....
T Consensus 396 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 112223456788899999999999999999999999999999875543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=349.08 Aligned_cols=263 Identities=31% Similarity=0.483 Sum_probs=199.0
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
+..++|++.+.||+|+||.||+|+.. ..||+|++..... ...+.+.+|+.+++.++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 44678999999999999999999864 3599999876433 3346788999999999999999999965 55678999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999954 3466899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
............||+.|+|||++. +..++.++||||||+++|+|++|+.||....... .... .....
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~~~---- 241 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----MVGRG---- 241 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----HHHHT----
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----Hhccc----
Confidence 323333334567999999999987 5678899999999999999999999996432211 0110 00000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
...+ ........++..+.+|+.+||+.+|++||++.+|++.|+.+..
T Consensus 242 -~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 -SLSP-DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -SCCC-CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -ccCc-chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0000 0112234677889999999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=347.38 Aligned_cols=263 Identities=20% Similarity=0.273 Sum_probs=201.9
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47999999999999999999875 6899999999764332 24678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++ +|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 66666643 3567999999999999999999999998 999999999999999999999999999764322
Q ss_pred CCceeeeccccccccccccccccCC-CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh-hcccc---c
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKF---V 291 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~---~ 291 (375)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ............ ....+ .
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhhhhhc
Confidence 22234467899999999998765 8999999999999999999888863222111 000000000000 00000 0
Q ss_pred h---------hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 292 H---------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 292 ~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
. ...........+.++..+.+||.+||+.||++|||+.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 0 0000111122345778899999999999999999999999
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=358.66 Aligned_cols=253 Identities=21% Similarity=0.262 Sum_probs=196.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|++.+.||+|+||.||+++.. +++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 458999999999999999999876 78999999997643 3346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc--eEEeecCCCccCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSDFGLAKLGPV 215 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~--vkl~Dfg~a~~~~~ 215 (375)
+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999965 346899999999999999999999998 999999999999987765 99999999974221
Q ss_pred CCCceeeeccccccccccccccccCCCCcc-chhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLK-SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ...... .+.
T Consensus 171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~----------~~~ 235 (361)
T 3uc3_A 171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQ----------RIL 235 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHH----------HHH
T ss_pred ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHH----------HHh
Confidence 122334679999999999988887655 8999999999999999999974332111 001000 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
...........++..+.+||.+||+.||.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1111111122456788999999999999999999999963
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=343.40 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=209.4
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeC--CeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 134 (375)
.++|++.+.||+|+||.||+|+.. ++.||+|++..... .....+.+|+.+++.++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 468999999999999999999986 88999999976532 3345788999999999999999999999877 788999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999752 2346899999999999999999999763 449999999999999999999999998875321
Q ss_pred CCCCceeeeccccccccccccccccCCCCc---cchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTL---KSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
.....||+.|+|||++.+..++. ++|||||||++|||++|+.||....... ...
T Consensus 165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~ 221 (271)
T 3kmu_A 165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----------------IGM 221 (271)
T ss_dssp -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----------------HHH
T ss_pred -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----------------HHH
Confidence 12246899999999998765554 7999999999999999999996322110 001
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
...........+..++..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 222 KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111222234456778889999999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=348.61 Aligned_cols=259 Identities=29% Similarity=0.398 Sum_probs=203.4
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.++|++.+.||+|+||.||+++.. ++.||+|++... ...+.+.+|+.+++.++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 467999999999999999999876 788999998654 34567889999999999999999999876 4589999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc-eEEeecCCCccCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-PKLSDFGLAKLGPVGD 217 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~-vkl~Dfg~a~~~~~~~ 217 (375)
++++|.+++.... ....+++..++.++.||+.||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 9999999996532 2235788999999999999999999822122999999999999998887 799999999743211
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .. . .....
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~--~-----------~~~~~ 220 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IM--W-----------AVHNG 220 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HH--H-----------HHHTT
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HH--H-----------HHhcC
Confidence 22346899999999999999999999999999999999999999643221100 00 0 00001
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.....+..++..+.+++.+||+.||++||++.++++.|+.+.....
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1122345667789999999999999999999999999999987544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.85 Aligned_cols=274 Identities=29% Similarity=0.435 Sum_probs=215.7
Q ss_pred cccccceeccccceEEEEEEEc-----CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEee--CCeeE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRL 132 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 132 (375)
.|++.+.||+|+||.||++.+. +++.||||++..... .....+.+|+.+++.++||||+++++++.+ ....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3499999999999999988642 688999999976532 335668899999999999999999999987 46789
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999954 34899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....+..... ....+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQM-TVLRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHH-HHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccch-hHHHHH
Confidence 5433222 223445688899999999999999999999999999999999999864321100 0000000000 011112
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCC
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~ 344 (375)
..+........+..++..+.+||.+||+.||++||++.+|++.|+.+.....+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 22233333345667888999999999999999999999999999999876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=362.20 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=201.1
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCC--CCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv 134 (375)
..+|++.+.||+|+||.||++....++.||||++..... .....+.+|+.++..+. ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 456999999999999999999887899999999876432 33467889999999996 59999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|| +.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 568899999965 347889999999999999999999988 99999999999995 5899999999998654
Q ss_pred CCCCceeeecccccccccccccccc-----------CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
...........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~------ 274 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I------ 274 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H------
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H------
Confidence 3333333445689999999999875 36889999999999999999999999632111 0
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
..+..++.+.....++...+..+.+||.+||+.||++||++.++++.
T Consensus 275 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 ----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 01112222222333444556789999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=343.83 Aligned_cols=255 Identities=32% Similarity=0.542 Sum_probs=207.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc-------hHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
.++|++.+.||+|+||.||+|+.. +++.||+|++....... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999874 78999999986543322 157889999999999999999999987655
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc-----eEEe
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-----PKLS 205 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~-----vkl~ 205 (375)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998865 3457999999999999999999999764 34999999999999988776 9999
Q ss_pred ecCCCccCCCCCCceeeeccccccccccccccc--cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh
Q 017246 206 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 206 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... .
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~---- 238 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----F---- 238 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----H----
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----H----
Confidence 9999974221 234467999999999984 556789999999999999999999999643221110 0
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
............++..++..+.+++.+||+.||++||++.+|++.|++|
T Consensus 239 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 239 ------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0011112222344567788999999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=350.97 Aligned_cols=269 Identities=22% Similarity=0.324 Sum_probs=191.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357999999999999999999865 689999999976432 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 137 YMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|++ ++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 59999986532 22346899999999999999999999998 9999999999999999999999999997643
Q ss_pred CCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccch-hhchh----hhhhhcc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWSR----PFLKDQK 288 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~----~~~~~~~ 288 (375)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ..... ..+....
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 221 12234578999999999876 4689999999999999999999999964332111000 00000 0000000
Q ss_pred ccchh---cc--------cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KFVHL---VD--------PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~~~~---~~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... +. ..+....+..++..+.+||.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 00 00000112245678999999999999999999999983
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=353.23 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=199.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCC-------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------- 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 129 (375)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999876 799999999975433 34567899999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEeecCCCCHHHHHhccCCCCCCCCH
Q 017246 130 --------------------------------------------------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSW 159 (375)
Q Consensus 130 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 159 (375)
..++||||+++++|.+++.... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3799999999999999997633 2344567
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC----------ceeeecccccc
Q 017246 160 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN----------THVSTRVMGTY 229 (375)
Q Consensus 160 ~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~----------~~~~~~~~gt~ 229 (375)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ ........||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 789999999999999999998 99999999999999999999999999976433221 11223457999
Q ss_pred ccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHH
Q 017246 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 309 (375)
Q Consensus 230 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (375)
.|+|||++.+..++.++|||||||++|||++|..|+.... . .. ..... ..........+..
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~----~~------~~~~~-~~~~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------R----II------TDVRN-LKFPLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------H----HH------HHHHT-TCCCHHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------H----HH------HHhhc-cCCCcccccCChh
Confidence 9999999999999999999999999999999987653110 0 00 00000 0000112345677
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 310 AVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 310 l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+.++|.+||+.||++||++.++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 899999999999999999999994
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=345.44 Aligned_cols=264 Identities=26% Similarity=0.355 Sum_probs=214.5
Q ss_pred hhcccccc-eeccccceEEEEEEEc---CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREAN-LIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.++|.+.+ .||+|+||.||+|... ++..||+|++..... ...+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45677776 9999999999999753 578899999976432 3456788999999999999999999999 4567899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999964 3456999999999999999999999998 999999999999999999999999999764
Q ss_pred CCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 214 PVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 214 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~------------- 224 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA------------- 224 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH-------------
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHH-------------
Confidence 332221 11233457899999999998899999999999999999999 999996432211 100
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCC
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~ 346 (375)
.+.......++..++..+.++|.+||+.+|++||++.++++.|+.+........
T Consensus 225 -~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 225 -FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp -HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred -HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 011111223456778899999999999999999999999999999987654433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=362.16 Aligned_cols=244 Identities=26% Similarity=0.313 Sum_probs=195.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHH-HccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLM-LSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.++|++.+.||+|+||.||+|+.. +++.||||++.+.... ....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999876 5889999999765432 23345566666 577899999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999965 356889999999999999999999998 999999999999999999999999999752
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .... .+
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~----------~i 251 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYD----------NI 251 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHH----------HH
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH----------HH
Confidence 211 12234578999999999999999999999999999999999999999632211 0000 11
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 329 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ 329 (375)
+... ..++..++..+.+||.+||+.||.+||++.
T Consensus 252 ~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 252 LNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred Hhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1111 123456778899999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=352.61 Aligned_cols=263 Identities=29% Similarity=0.443 Sum_probs=211.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceE--EEEEcccc-CccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLV--AIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~v--aiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 133 (375)
.++|++.+.||+|+||.||+|+.. ++..+ |+|.+... .......+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368999999999999999999764 56644 99988653 223456788999999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhccC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc
Q 017246 134 VYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 201 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~ 201 (375)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999997532 22357999999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhch
Q 017246 202 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 202 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 280 (375)
+||+|||++.... .........+++.|+|||++.+..++.++|||||||++|+|++ |+.||....... ..
T Consensus 181 ~kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~--- 251 (327)
T 1fvr_A 181 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY--- 251 (327)
T ss_dssp EEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---
T ss_pred EEEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---HH---
Confidence 9999999987422 1112233457889999999999899999999999999999998 999996432110 00
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCC
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~ 344 (375)
..+........+..++..+.+||.+||+.+|++||++.++++.|+.+......
T Consensus 252 -----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 252 -----------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp -----------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -----------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 00111112233456778899999999999999999999999999999887553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=370.21 Aligned_cols=249 Identities=28% Similarity=0.359 Sum_probs=198.6
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEcccc---CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3468999999999999999999865 6899999999754 22334567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ ++ |+||||||+||||+.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999965 4568999999999999999999997 88 99999999999999999999999999975
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..
T Consensus 299 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~---------- 360 (446)
T 4ejn_A 299 GIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF---EL---------- 360 (446)
T ss_dssp TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HH----------
T ss_pred ccC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HH---HH----------
Confidence 322 2222345789999999999999999999999999999999999999996322110 00 00
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
+... ...++..++..+.+||.+||+.||.+|| ++.++++
T Consensus 361 i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 361 ILME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0001 1124556778899999999999999999 9999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=354.63 Aligned_cols=265 Identities=26% Similarity=0.433 Sum_probs=214.7
Q ss_pred HHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 129 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 129 (375)
+..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 45678999999999999999999654 367899999976432 33456889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLE------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999997532 11245789999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhh
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 282 (375)
|+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---- 251 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLR---- 251 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHH----
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---HHH----
Confidence 999999975332222222334567889999999999999999999999999999999 889986432110 000
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
. +... .....+..++..+.+++.+||+.||++||++.++++.|+++...
T Consensus 252 ~---------~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 252 F---------VMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp H---------HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred H---------HHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 0 0000 01123456778899999999999999999999999999988653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=346.72 Aligned_cols=264 Identities=27% Similarity=0.393 Sum_probs=208.2
Q ss_pred hhcccccceeccccceEEEEEEEcC----CceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEE-eeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~ 132 (375)
..+|++.+.||+|+||.||+|.... ...+|+|.+..... .....+.+|+.+++.++||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578999999999999999997542 33589998876332 3456788999999999999999999985 4556889
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999964 3456899999999999999999999998 99999999999999999999999999975
Q ss_pred CCCCCC--ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccc
Q 017246 213 GPVGDN--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 213 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |.+||........ ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~----------- 243 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV----------- 243 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HH-----------
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HH-----------
Confidence 432221 122333567889999999999999999999999999999999 5566653221110 00
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCC
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 345 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~ 345 (375)
..........+..++..+.+++.+||+.+|++||++.++++.|+.+.......
T Consensus 244 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 244 ---YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp ---HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred ---HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 00001111224456778999999999999999999999999999998765543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=351.97 Aligned_cols=263 Identities=28% Similarity=0.425 Sum_probs=207.7
Q ss_pred hhcccccceeccccceEEEEEEEcC-----CceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES-----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..+|.+.+.||+|+||.||+|.... +..||+|++..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678899999999999999997542 23599999876432 23456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999965 3457899999999999999999999998 99999999999999999999999999975
Q ss_pred CCCCCC-ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhcccc
Q 017246 213 GPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 213 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~------------- 260 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVM------------- 260 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH-------------
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHH-------------
Confidence 432211 111223456889999999999999999999999999999999 99999632211 000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCC
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~ 344 (375)
..+........+..++..+.+++.+||+.+|++||++.+|++.|+.+......
T Consensus 261 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 261 -KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp -HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 00011111223456778899999999999999999999999999999875443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=364.74 Aligned_cols=258 Identities=21% Similarity=0.205 Sum_probs=205.0
Q ss_pred HHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
.....++|++.+.||+|+||.||+++.. +|+.||||++.+... .....+.+|..++..++||||+++++++.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3344678999999999999999999875 699999999975321 223457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.|+||||++||+|.+++... +..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999753 347899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccc-------cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAM-------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
+...... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||........ . ...
T Consensus 210 ~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~---~~i 282 (412)
T 2vd5_A 210 LKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---Y---GKI 282 (412)
T ss_dssp EECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHH
T ss_pred eeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---H---HHH
Confidence 7643222 22233468999999999987 35689999999999999999999999964321110 0 000
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHH
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR---PLINDIVV 333 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~eil~ 333 (375)
.... ........+..++.++.+||.+||. +|.+| |++.||++
T Consensus 283 ~~~~-------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 VHYK-------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTHH-------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred Hhcc-------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0000 0000011224567889999999999 99998 68999885
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=350.51 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=206.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CC-------ceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SG-------QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
.++|++.+.||+|+||.||+|... ++ ..||+|++........+.+.+|+.+++.++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 568999999999999999999754 34 4699999977666667889999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc--------e
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--------P 202 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~--------v 202 (375)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999975 2344899999999999999999999998 999999999999998887 9
Q ss_pred EEeecCCCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCC-Cccccccccccchhhch
Q 017246 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~-pf~~~~~~~~~~~~~~~ 280 (375)
||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|.. ||........ .
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~--- 228 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---L--- 228 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---H---
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH---H---
Confidence 9999999864321 123568899999999987 678999999999999999999654 4432111100 0
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCC
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 345 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~ 345 (375)
..... ...++...+..+.+++.+||+.||++||++.++++.|+.+.......
T Consensus 229 -~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 229 -QFYED------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp -HHHHT------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred -HHhhc------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 00000 11123334567889999999999999999999999999998755443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=347.52 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=204.4
Q ss_pred HHHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHcc--CCCCCcceeEeEEeeC---
Q 017246 54 ELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTSG--- 128 (375)
Q Consensus 54 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~--- 128 (375)
......++|++.+.||+|+||.||+|+.. ++.||||++... .......|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33455678999999999999999999876 899999998543 23344455555554 4899999999999887
Q ss_pred -CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCCCcccCCCCCCcEEEeCC
Q 017246 129 -DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK--------ANPPVIYRDLKSANILLDND 199 (375)
Q Consensus 129 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~~~~i~H~Dlkp~Nill~~~ 199 (375)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ + |+||||||+|||++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN 178 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred CCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence 789999999999999999954 3689999999999999999999987 6 9999999999999999
Q ss_pred CceEEeecCCCccCCCCCCc--eeeeccccccccccccccccCCCCcc------chhHhHHHHHHHHHhCCCCc------
Q 017246 200 FNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSGKLTLK------SDIYSFGVVLLELITGRKAM------ 265 (375)
Q Consensus 200 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg~~pf------ 265 (375)
+.+||+|||++......... .......||+.|+|||++.+..++.. +|||||||++|||++|..|+
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 99999999999753322211 11234579999999999987766655 99999999999999995544
Q ss_pred ----cccccccccchhhchhhhhhhccccchhcccccCCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 266 ----DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 266 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
......... .. ... ...........++ ..++..+.+++.+||+.||++||++.+|++.|+
T Consensus 259 ~~p~~~~~~~~~~--~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 259 QLPYHDLVPSDPS--YE----DMR-----EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp CCTTTTTSCSSCC--HH----HHH-----HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cccHhhhcCCCCc--hh----hhH-----HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 321111100 00 000 0011111122222 378899999999999999999999999999999
Q ss_pred hhhhccC
Q 017246 337 YLVSQRD 343 (375)
Q Consensus 337 ~l~~~~~ 343 (375)
.+.....
T Consensus 328 ~l~~~~~ 334 (337)
T 3mdy_A 328 KMSESQD 334 (337)
T ss_dssp HHHHTTT
T ss_pred HHHhhcc
Confidence 9987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=345.38 Aligned_cols=252 Identities=26% Similarity=0.307 Sum_probs=200.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||++... ++..+|+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 457999999999999999999865 689999999876533 346778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE---eCCCceEEeecCCCccC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill---~~~~~vkl~Dfg~a~~~ 213 (375)
|+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999764444577999999999999999999999998 9999999999999 45678999999999753
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||............. .
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~--------------~ 239 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT--------------Y 239 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------------H
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc--------------c
Confidence 322 2233467999999999875 568999999999999999999999996432111000000 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
...... .....++..+.+|+.+||+.||++||++.|++
T Consensus 240 ~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 277 (285)
T 3is5_A 240 KEPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277 (285)
T ss_dssp CCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred CCcccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 000000 00112456788999999999999999999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=350.89 Aligned_cols=259 Identities=21% Similarity=0.262 Sum_probs=187.1
Q ss_pred hccccc---ceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEE
Q 017246 60 RNFREA---NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 60 ~~~~~~---~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 134 (375)
++|++. +.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 356554 78999999999999875 6899999998653 3456778999999997 99999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC---ceEEeecCCCc
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAK 211 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~---~vkl~Dfg~a~ 211 (375)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 85 MELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp ECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999999999965 467999999999999999999999998 99999999999998766 79999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchhhhhhhcccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~ 290 (375)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 158 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 226 (325)
T 3kn6_A 158 LKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK--------- 226 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH---------
T ss_pred ecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH---------
Confidence 53322 22234467899999999999999999999999999999999999999743321110 0000000
Q ss_pred chhcccccC--CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCCC
Q 017246 291 VHLVDPLLH--GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNA 351 (375)
Q Consensus 291 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~~ 351 (375)
.+...... ......++..+.+||.+||+.||.+||++.+++ .|+|-.+.
T Consensus 227 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell-----------~h~w~~~~ 277 (325)
T 3kn6_A 227 -KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR-----------YNEWLQDG 277 (325)
T ss_dssp -HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST-----------TCGGGCTT
T ss_pred -HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh-----------cChhhccC
Confidence 01111110 001134678899999999999999999999987 57777654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=359.59 Aligned_cols=269 Identities=19% Similarity=0.229 Sum_probs=204.8
Q ss_pred hhcccccceeccc--cceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEG--GFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.++|++.+.||+| +||.||+|+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999876 699999999976532 234567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999763 2456999999999999999999999998 999999999999999999999999987532
Q ss_pred CCCC-----Cceeeecccccccccccccccc--CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh-
Q 017246 214 PVGD-----NTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK- 285 (375)
Q Consensus 214 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~- 285 (375)
.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCc
Confidence 1111 1111223478999999999987 6799999999999999999999999964322211 0000000000
Q ss_pred --hc------------------cccchhc---------ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 286 --DQ------------------KKFVHLV---------DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 286 --~~------------------~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
+. ....... .......++..++..+.+||.+||+.||++||++.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0000000 0000112345567889999999999999999999999963
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=343.82 Aligned_cols=273 Identities=21% Similarity=0.259 Sum_probs=210.9
Q ss_pred HhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEE-eeCCeeEEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVY 135 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 135 (375)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 356899999999999999999986 4689999998765432 23577899999999988877666554 6778889999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE---eCCCceEEeecCCCcc
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKL 212 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill---~~~~~vkl~Dfg~a~~ 212 (375)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999964 2456999999999999999999999998 9999999999999 7889999999999975
Q ss_pred CCCCCCc-----eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch-hhhhhh
Q 017246 213 GPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS-RPFLKD 286 (375)
Q Consensus 213 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~ 286 (375)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 4332221 1223467999999999999999999999999999999999999999754433222211110 000000
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC---CCCccCC
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD---SHPVSRN 350 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~---~~~~~~~ 350 (375)
. .. .....++..+.+++.+||+.+|++||++.+|++.|+.+..... ..+++|+
T Consensus 238 ~-------~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 238 P-------IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp C-------HH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred h-------hh----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 0 00 0113346789999999999999999999999999999998654 3556664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=367.76 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=206.8
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|.+.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457999999999999999999876 799999999965422 3356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999953 567999999999999999999999988 9999999999999999999999999998643
Q ss_pred CCCCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .. .. .+
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~---~~----------~i 228 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TL---FK----------KI 228 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HH---HH----------HH
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HH---HH----------HH
Confidence 322 2334679999999999988765 68999999999999999999999732211 00 00 01
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... ...+..++..+.+||.+||+.||.+||++.+|++
T Consensus 229 ~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 229 CDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1111 1224456778999999999999999999999997
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=358.46 Aligned_cols=264 Identities=28% Similarity=0.413 Sum_probs=202.0
Q ss_pred hcccccceeccccceEEEEEEEc--CC--ceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEe-eCCeeEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE--SG--QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCT-SGDQRLL 133 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~l 133 (375)
..|++.+.||+|+||.||+|... ++ ..||+|.+.... ......+.+|+.+++.++||||+++++++. ..+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999753 22 468999986532 234567889999999999999999999864 4568899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999964 3456889999999999999999999998 999999999999999999999999999753
Q ss_pred CCCCCc--eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhcccc
Q 017246 214 PVGDNT--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 214 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||........ .. ...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~----~~~----- 310 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV----YLL----- 310 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HH----HHH-----
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HH----HHH-----
Confidence 322211 12233457889999999999999999999999999999999 6777764322111 00 000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCC
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~ 346 (375)
.......+..++..+.+++.+||+.+|++||++.+|++.|+.+........
T Consensus 311 -----~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 311 -----QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 001112245677889999999999999999999999999999987665443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=350.29 Aligned_cols=262 Identities=22% Similarity=0.293 Sum_probs=199.0
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEeeCCe----
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ---- 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 130 (375)
.++|++.+.||+|+||.||+++. .+++.||||++....... ...+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999986 468999999997653332 3467889999999999999999999876543
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999965 346899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCC-ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 211 KLGPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 211 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
........ ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCC
Confidence 75432221 1223346799999999999999999999999999999999999999964321110 0000000000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH-HHHhhhhhc
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV-VALDYLVSQ 341 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil-~~L~~l~~~ 341 (375)
........++..+.++|.+||+.||++||+..+++ ..|..+...
T Consensus 238 --------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 238 --------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp --------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred --------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00001234677899999999999999999666555 456665443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=357.24 Aligned_cols=266 Identities=26% Similarity=0.385 Sum_probs=215.2
Q ss_pred HHhhcccccceeccccceEEEEEEEcC-C-----ceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEeeC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLES-G-----QLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 128 (375)
...++|++.+.||+|+||.||+|.... + ..||+|.+..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 445789999999999999999998642 3 4799999876432 3456788999999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccCC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEP----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 198 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~ 198 (375)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 999999999999999999975321 1346899999999999999999999998 999999999999999
Q ss_pred CCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchh
Q 017246 199 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLV 277 (375)
Q Consensus 199 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 277 (375)
++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||........ .
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~- 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F- 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H-
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H-
Confidence 99999999999975433333333444567889999999999999999999999999999999 9999964321110 0
Q ss_pred hchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 278 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
...+........+..++..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 277 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 277 -------------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 011111112223445677899999999999999999999999999988653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=353.10 Aligned_cols=276 Identities=29% Similarity=0.444 Sum_probs=215.5
Q ss_pred hhcccccceeccccceEEEEEEE-----cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCC--ee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 131 (375)
.++|++.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 56799999999999999999984 368899999998766566678899999999999999999999986644 78
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 999999999999999975 2356899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 212 LGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 212 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
........ .......++..|+|||++.+..++.++|||||||++|+|++|..||......-............ ....+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 272 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFHL 272 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH-HHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh-hHHHH
Confidence 64333221 12233457888999999999899999999999999999999999986321100000000000000 00001
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
...+........+..++..+.++|.+||+.||++||++.+|++.|+.+..+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111122222234567788999999999999999999999999999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=349.63 Aligned_cols=246 Identities=22% Similarity=0.254 Sum_probs=194.6
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 133 (375)
..++|++.+.||+|+||+||+|+.. +|+.||||++...... .......|+..+..+ +||||+++++++...+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4568999999999999999999876 7999999988654322 233444555555444 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+ +++|.+++... +..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 77999988763 456999999999999999999999998 999999999999999999999999998754
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... .......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... +..+
T Consensus 208 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------------------~~~~ 264 (311)
T 3p1a_A 208 GTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------------------WQQL 264 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------------HHHH
T ss_pred ccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------------HHHH
Confidence 322 22334569999999998876 789999999999999999999766542110 0001
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........++..++..+.++|.+||+.||++||++.++++
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 265 RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111111122345678999999999999999999999993
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=344.07 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=213.6
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+..++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3457899999999999999999998888899999987643 346778999999999999999999999864 56899999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999542 1236899999999999999999999998 999999999999999999999999999764322
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ... .+.
T Consensus 163 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~--------------~~~ 224 (279)
T 1qpc_A 163 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ--------------NLE 224 (279)
T ss_dssp C-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH--------------HHH
T ss_pred c-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHH--------------HHh
Confidence 2 122233457889999999998899999999999999999999 899996432110 000 000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.......+..++..+.+++.+||+.+|++||++.+|++.|+.+.....
T Consensus 225 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 111122345667889999999999999999999999999999986543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=344.16 Aligned_cols=263 Identities=27% Similarity=0.366 Sum_probs=209.7
Q ss_pred cccccceeccccceEEEEEEEc-CC---ceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCee-EEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SG---QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR-LLV 134 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv 134 (375)
.|.+.+.||+|+||.||+|.+. ++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5677799999999999999753 22 3799999876433 3356788999999999999999999999876665 999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999965 3567899999999999999999999998 9999999999999999999999999997533
Q ss_pred CCC--CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCC-ccccccccccchhhchhhhhhhccccc
Q 017246 215 VGD--NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 215 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
... .........+|+.|+|||++.+..++.++|||||||++|+|++|..| |....... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-----------------~~ 238 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----------------LT 238 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-----------------HH
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-----------------HH
Confidence 221 11222345688999999999999999999999999999999996555 43221110 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCC
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~ 346 (375)
..+........+..++..+.+++.+||+.||.+||++.++++.|+++........
T Consensus 239 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 1111111122345667889999999999999999999999999999988765443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=343.31 Aligned_cols=258 Identities=22% Similarity=0.372 Sum_probs=207.3
Q ss_pred HhhcccccceeccccceEEEEEEEcC----CceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..++|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35689999999999999999997542 3469999997653 2345678899999999999999999999865 5678
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999965 2456899999999999999999999998 99999999999999999999999999975
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ ..
T Consensus 163 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~------------- 225 (281)
T 3cc6_A 163 IEDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IG------------- 225 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HH-------------
T ss_pred ccccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HH-------------
Confidence 43222 112233557889999999999999999999999999999998 9999963322110 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
.+........+..++..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 226 -~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 226 -VLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 000011112345567889999999999999999999999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=353.91 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=191.1
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567999999999999999999876 58899999997643 34567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---CCceEEeecCCCccC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLG 213 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~vkl~Dfg~a~~~ 213 (375)
|+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999954 456899999999999999999999998 999999999999975 889999999999753
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....... .. ........
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~---~~~i~~~~------ 267 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM---FRRILNCE------ 267 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH---HHHHHTTC------
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH---HHHHHhCC------
Confidence 221 22334679999999999999999999999999999999999999996322110 00 00000000
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..........++..+.+||.+||+.||++||++.++++
T Consensus 268 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 268 --YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111122456778999999999999999999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=341.27 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=210.1
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEE-eeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999986 579999999986653 234688899999999998876666554 66778899999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE---eCCCceEEeecCCCccC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill---~~~~~vkl~Dfg~a~~~ 213 (375)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 9999999964 2456999999999999999999999998 9999999999999 48889999999999754
Q ss_pred CCCCCc-----eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchh-hhhhhc
Q 017246 214 PVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR-PFLKDQ 287 (375)
Q Consensus 214 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~ 287 (375)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 236 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-- 236 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC--
Confidence 332221 11244679999999999999999999999999999999999999997543322221111110 0000
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
...+ .....++..+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus 237 -----~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 237 -----TPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----SCHH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -----CchH----HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0000 0123456789999999999999999999999999999987644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=368.93 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=211.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.++||+|+||.||+|+.. +|+.||+|++.+... .....+..|+.+++.++||||+++++++.+.+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999875 699999999975432 3356788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||++||+|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999775545667999999999999999999999998 9999999999999999999999999997643
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ...... +.
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~----------i~ 406 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR----------VL 406 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHH----------HH
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHH----------Hh
Confidence 222 1233468999999999999999999999999999999999999999743221110 000000 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~eil~ 333 (375)
.. ...++..++..+.+||.+||+.||++||++ .+|++
T Consensus 407 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 407 EQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11 113456778899999999999999999975 66664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=353.74 Aligned_cols=259 Identities=17% Similarity=0.200 Sum_probs=210.3
Q ss_pred HHhhcccccceeccccceEEEEEE------EcCCceEEEEEccccCccchHHHHHHHHHHccCC---CCCcceeEeEEee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTS 127 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 127 (375)
...++|++.+.||+|+||.||+|. ..+++.||+|++... ...++..|+.++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999993 446899999999754 3456667777777776 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC--------
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-------- 198 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-------- 198 (375)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999975432 3567999999999999999999999988 999999999999988
Q ss_pred ---CCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccc
Q 017246 199 ---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 275 (375)
Q Consensus 199 ---~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 275 (375)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999965333333344556789999999999999999999999999999999999999985322110
Q ss_pred hhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCC-CCHHHHHHHHhhhhhccC
Q 017246 276 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR-PLINDIVVALDYLVSQRD 343 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Ps~~eil~~L~~l~~~~~ 343 (375)
.. +...+. .+ .....+.+++..|++.+|.+| |++.++.+.|+.+.....
T Consensus 293 ------------~~----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 293 ------------CK----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ------------EE----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ------------ee----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 00 001111 11 235678899999999999999 688999999998876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=339.91 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=185.8
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999986 479999999986542 22346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999964 3457899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ....
T Consensus 164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~~~ 225 (278)
T 3cok_A 164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------------NKVV 225 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CC
T ss_pred CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------------HHHh
Confidence 221 1223357899999999999989999999999999999999999999643221100 0000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
.. ....+..++..+.++|.+||+.||++||++.+++
T Consensus 226 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 226 LA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp SS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 00 1123455677899999999999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=347.02 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=203.9
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeC-CeeEEEEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-DQRLLVYE 136 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 136 (375)
..++|++.+.||+|+||.||+++.. |+.||+|++... ...+.+.+|+.+++.++||||+++++++... +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 3568999999999999999999875 889999999754 3456788999999999999999999987544 57899999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999996521 223788999999999999999999998 999999999999999999999999998753221
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... .. ..+.
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~--------------~~~~ 228 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV--------------PRVE 228 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH--------------HHHT
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH--------------HHHh
Confidence 123457889999999999999999999999999999998 999996432111 00 0011
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.......+..++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1112234566788899999999999999999999999999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=358.36 Aligned_cols=275 Identities=20% Similarity=0.266 Sum_probs=215.5
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCC--eeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 134 (375)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 468999999999999999999876 589999999976432 34567789999999999999999999998765 77999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE----eCCCceEEeecCCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLA 210 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill----~~~~~vkl~Dfg~a 210 (375)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999996533 2234899999999999999999999998 9999999999999 77788999999999
Q ss_pred ccCCCCCCceeeecccccccccccccccc--------CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMS--------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ....
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~--~~~~ 238 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE--VMYK 238 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH--HHHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH--HHHH
Confidence 754322 12234679999999999875 5678899999999999999999999974332211100 0000
Q ss_pred hhh-hccc----cchhc--------ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 283 FLK-DQKK----FVHLV--------DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 283 ~~~-~~~~----~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
... .... ..... .......++..++..+.+++.+||+.||++||++.++++.++.++.+.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 000 0000 00000 001112345788999999999999999999999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=343.25 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=208.8
Q ss_pred Hhhcccccc-eeccccceEEEEEEEc---CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 58 ATRNFREAN-LIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 58 ~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
...+|.+.+ .||+|+||.||+|... +++.||||++...... ..+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 356798888 9999999999999542 4688999999765322 256788999999999999999999998 56788
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999965 456899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCce-eeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccc
Q 017246 212 LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 212 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~------------ 230 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT------------ 230 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH------------
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH------------
Confidence 643332221 1223456789999999998889999999999999999999 999996432211 00
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
..+........+..++..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 231 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 231 --AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 01111112234567788999999999999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=357.80 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=198.0
Q ss_pred ccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCC
Q 017246 64 EANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 142 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 142 (375)
..+.||+|+||.||+|... +|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3678999999999999864 689999999987665667789999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE--eCCCceEEeecCCCccCCCCCCce
Q 017246 143 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL--DNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 143 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill--~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 173 L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 9998865 2356899999999999999999999998 9999999999999 5667899999999986433221
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (375)
....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ........... +..
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~~--------~~~ 309 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACRWD--------LED 309 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCC--------SCS
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccCC--------CCh
Confidence 233579999999999999999999999999999999999999996432211 00001100000 000
Q ss_pred CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 301 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 301 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....++..+.+||.+||+.||.+||++.++++
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112345778999999999999999999999997
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=346.15 Aligned_cols=251 Identities=25% Similarity=0.292 Sum_probs=205.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc------chHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999875 6899999998764332 356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC----ceEEeec
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDF 207 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~----~vkl~Df 207 (375)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999964 457899999999999999999999998 99999999999999887 7999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. .......
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANITSVS 234 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHTTC
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHhcc
Confidence 9997543322 1234579999999999999999999999999999999999999996422110 00 0000000
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. .....++..++..+.++|.+||+.||++||++.++++
T Consensus 235 ~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y--------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C--------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c--------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0000011245678999999999999999999999995
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=346.16 Aligned_cols=263 Identities=22% Similarity=0.233 Sum_probs=203.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999875 68899999997653332 36688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999965 346899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ........ .
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~------~ 251 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQA------I 251 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSC------C
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccC------C
Confidence 2221 12234578999999999999999999999999999999999999996422110 00000000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhhhhhccCC
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQRDS 344 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~eil~~L~~l~~~~~~ 344 (375)
. .....+..++..+.++|.+||+.||++|| ++.++++.|+.+......
T Consensus 252 ~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 252 P--RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp C--CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred C--CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0 00122455677899999999999999999 999999999998765543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=339.02 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=206.9
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3568999999999999999999875 689999999875433 33567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999998843 456899999999999999999999998 99999999999999999999999999975432
Q ss_pred CCCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
...........||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-------------- 222 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-------------- 222 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH--------------
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh--------------
Confidence 222223345679999999999987765 7889999999999999999999974332110 000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...........++..+.+++.+||+.||++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000001112456778999999999999999999999984
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=339.75 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=206.1
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
..++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3568999999999999999999876 578899999987766777889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE---eCCCceEEeecCCCccC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill---~~~~~vkl~Dfg~a~~~ 213 (375)
|+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999865 456899999999999999999999998 9999999999999 78889999999999754
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||........ . .. +
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~---~~----------~ 219 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV---M---LK----------I 219 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HH----------H
T ss_pred cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH---H---HH----------H
Confidence 3222 23345799999999988654 89999999999999999999999964321110 0 00 0
Q ss_pred cccccCCCCCH----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPR----RCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... ..++. .++..+.+++.+||+.||++||++.++++
T Consensus 220 ~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 220 REGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHCC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhCC--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01121 45678999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=352.88 Aligned_cols=273 Identities=16% Similarity=0.147 Sum_probs=204.0
Q ss_pred hhcccccceeccccceEEEEEEEc----CCceEEEEEccccCcc-----------chHHHHHHHHHHccCCCCCcceeEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQ-----------GHQEFIVEVLMLSLLHHDNLVTLIG 123 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~ 123 (375)
.++|++.+.||+|+||.||+|... ++..+|+|++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999875 5788999998765322 1223567888999999999999999
Q ss_pred EEee----CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC
Q 017246 124 YCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 199 (375)
Q Consensus 124 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~ 199 (375)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9987 78899999999 9999999964 337899999999999999999999998 9999999999999988
Q ss_pred C--ceEEeecCCCccCCCCCC-----ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccc
Q 017246 200 F--NPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 272 (375)
Q Consensus 200 ~--~vkl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 272 (375)
+ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999975322111 111234579999999999999999999999999999999999999996322111
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCC
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~ 346 (375)
. ........... .....+.... ....++..+.+++.+||+.||++||++.+|++.|+.+....+...
T Consensus 268 ~-~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d 334 (345)
T 2v62_A 268 V-AVQTAKTNLLD---ELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLD 334 (345)
T ss_dssp H-HHHHHHHHHHH---TTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCC
T ss_pred H-HHHHHHHhhcc---cccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCC
Confidence 1 00000000000 0000000000 012566789999999999999999999999999999866444433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=355.38 Aligned_cols=264 Identities=26% Similarity=0.325 Sum_probs=194.7
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEEe--------
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCT-------- 126 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-------- 126 (375)
....+|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++..+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34568999999999999999999865 68999999987665556677889999999995 999999999984
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
.....++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+++ ++|+||||||+||||+.++.+||+|
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 3445789999995 69999886543 2456999999999999999999999763 3499999999999999999999999
Q ss_pred cCCCccCCCCCCce----------eeecccccccccccccc---ccCCCCccchhHhHHHHHHHHHhCCCCccccccccc
Q 017246 207 FGLAKLGPVGDNTH----------VSTRVMGTYGYCAPEYA---MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 273 (375)
Q Consensus 207 fg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 273 (375)
||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 99997643322111 11235689999999998 5667899999999999999999999999632111
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.+.........+...+..+.+|+.+||+.||++||++.++++.|..+.....
T Consensus 260 ------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 ------------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ------------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0111111111123344568899999999999999999999999999987544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=369.04 Aligned_cols=254 Identities=28% Similarity=0.430 Sum_probs=209.8
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..++|++.++||+|+||.||+|+.. +|+.||+|++.+.. ......+.+|+.+|+.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999875 69999999996542 2345567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||++||+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||++...
T Consensus 262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999999753 2345999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .... .
T Consensus 337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~-----------~ 400 (576)
T 2acx_A 337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVER-----------L 400 (576)
T ss_dssp CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHH-----------H
T ss_pred ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHH-----------H
Confidence 3322 2234689999999999999999999999999999999999999997433211100 0000 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
+. .....++..++..+.+||.+||+.||.+|| ++.||++
T Consensus 401 i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 401 VK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00 011234566778999999999999999999 7888885
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=341.37 Aligned_cols=246 Identities=21% Similarity=0.252 Sum_probs=201.6
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 133 (375)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3568999999999999999999876 799999999876432 3355678899999888 99999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC--------------
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-------------- 199 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-------------- 199 (375)
||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999764433467899999999999999999999998 9999999999999844
Q ss_pred -----CceEEeecCCCccCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccc
Q 017246 200 -----FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 273 (375)
Q Consensus 200 -----~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 273 (375)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 47999999999764322 124589999999999866 567899999999999999999887642110
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
. ..+.. .....++..++..+.+++.+||+.||++||++.+++
T Consensus 237 --~--------------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 237 --W--------------HEIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp --H--------------HHHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --H--------------HHHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 0 00000 111233456778899999999999999999999999
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=351.38 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=202.0
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..++|++.+.||+|+||.||++... +|+.||+|++...... ..+|+.++..+ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3568999999999999999999875 6899999999765432 34577777777 7999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC----CceEEeecCCCc
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND----FNPKLSDFGLAK 211 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~----~~vkl~Dfg~a~ 211 (375)
||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+..+ +.+||+|||++.
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999964 456999999999999999999999998 9999999999998443 359999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+... ... .
T Consensus 169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~~-~---- 238 (342)
T 2qr7_A 169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---IGS-G---- 238 (342)
T ss_dssp ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH---HHH-C----
T ss_pred cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH---Hcc-C----
Confidence 543222 223446899999999999988899999999999999999999999974322221111110 000 0
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...+...+...++..+.+||.+||+.||++||++.++++
T Consensus 239 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 239 ---KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111223567788999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=353.42 Aligned_cols=270 Identities=26% Similarity=0.376 Sum_probs=198.1
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHH--HccCCCCCcceeEeEEee-----CCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLM--LSLLHHDNLVTLIGYCTS-----GDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~-----~~~~ 131 (375)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|..+ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999976 58999999986542 3334444444 555899999999985532 2367
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------CCCCcccCCCCCCcEEEeCCCce
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK---------ANPPVIYRDLKSANILLDNDFNP 202 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~~~~i~H~Dlkp~Nill~~~~~v 202 (375)
++||||+++|+|.+++.. ...++..++.++.||+.||.|||++ + |+||||||+||||+.++.+
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 899999999999999954 3458899999999999999999988 7 9999999999999999999
Q ss_pred EEeecCCCccCCCCC------Cceeeecccccccccccccccc-------CCCCccchhHhHHHHHHHHHhCCCCccccc
Q 017246 203 KLSDFGLAKLGPVGD------NTHVSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELITGRKAMDLSK 269 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~pf~~~~ 269 (375)
||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999997543221 1122234579999999999986 456788999999999999999987764332
Q ss_pred cccccchhhchhhhhh--hccccch-hcccccCCCC------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 270 GQGEQNLVSWSRPFLK--DQKKFVH-LVDPLLHGRY------PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
........ +...... ....+.. .........+ ...++..+.+||.+||+.||++||++.|+++.|++|..
T Consensus 240 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 240 SVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCCT-THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhHHHHh-hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 21111000 0000000 0000000 0111111111 23577899999999999999999999999999999975
Q ss_pred c
Q 017246 341 Q 341 (375)
Q Consensus 341 ~ 341 (375)
.
T Consensus 319 ~ 319 (336)
T 3g2f_A 319 I 319 (336)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=352.08 Aligned_cols=259 Identities=23% Similarity=0.208 Sum_probs=201.8
Q ss_pred HHHhhcccccceeccccceEEEEEEEc-CCceEEEEEcccc-----CccchHHHHHHHHHHccCCCCCcceeEeEEeeCC
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE-----GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 129 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 129 (375)
....++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 355678999999999999999999865 6889999998654 2344567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPD------------------------------------QEPLSWNTRMKIAVGAARGL 173 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~~l 173 (375)
..++||||+++|+|.+++...... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998532111 12246778899999999999
Q ss_pred HHhhcCCCCCcccCCCCCCcEEEeCCC--ceEEeecCCCccCCCC--CCceeeecccccccccccccccc--CCCCccch
Q 017246 174 EYLHCKANPPVIYRDLKSANILLDNDF--NPKLSDFGLAKLGPVG--DNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSD 247 (375)
Q Consensus 174 ~~LH~~~~~~i~H~Dlkp~Nill~~~~--~vkl~Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 247 (375)
.|||+++ |+||||||+|||++.++ .+||+|||++...... ..........||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999998 99999999999998776 8999999999753221 11122345679999999999875 67899999
Q ss_pred hHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccC--CCCCHHHHHHHHHHHHhhcCCCCCCC
Q 017246 248 IYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH--GRYPRRCLNYAVAVTAMCLNEEANFR 325 (375)
Q Consensus 248 vwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~R 325 (375)
||||||++|||++|+.||........ ... +...... ......++..+.+||.+||+.+|.+|
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~------~~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADT------ISQ----------VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHH------HHH----------HHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHH------HHH----------HHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 99999999999999999964322110 000 1111110 01113467789999999999999999
Q ss_pred CCHHHHHH
Q 017246 326 PLINDIVV 333 (375)
Q Consensus 326 Ps~~eil~ 333 (375)
|++.++++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=374.26 Aligned_cols=262 Identities=28% Similarity=0.430 Sum_probs=215.5
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
+..++|++.+.||+|+||.||+|.+..+..||||++.... ...+.+.+|+.+|+.++||||+++++++.. +..+||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 4567899999999999999999998878889999997654 345789999999999999999999999876 77899999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999999642 1345899999999999999999999998 999999999999999999999999999754321
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ........++..|+|||++....++.++|||||||+||||++ |+.||...... ... ..+.
T Consensus 417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~--------------~~i~ 478 (535)
T 2h8h_A 417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL--------------DQVE 478 (535)
T ss_dssp H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHH--------------HHHH
T ss_pred c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH--------------HHHH
Confidence 1 111223456789999999999999999999999999999999 99999632211 000 0111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
...+...+..++..+.+||.+||+.||++||++.+|++.|+.+.....
T Consensus 479 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 111223456778899999999999999999999999999999875443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=342.69 Aligned_cols=265 Identities=25% Similarity=0.301 Sum_probs=198.8
Q ss_pred HHhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCc-----cchHHHHHHHHHHccC---CCCCcceeEeEEee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLL---HHDNLVTLIGYCTS 127 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~ 127 (375)
...++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467899999999999999999986 4689999999865322 1234566777777666 49999999999987
Q ss_pred CC-----eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCce
Q 017246 128 GD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 202 (375)
Q Consensus 128 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~v 202 (375)
.. ..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 65 5789999996 5999999752 2345999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|++||........ .......
T Consensus 160 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~ 234 (308)
T 3g33_A 160 KLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDL 234 (308)
T ss_dssp EECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--HHHHHHH
T ss_pred EEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHH
Confidence 99999999754322 223446799999999999999999999999999999999999999964332111 0000000
Q ss_pred hh-hhccccch---hcccccCC-------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 283 FL-KDQKKFVH---LVDPLLHG-------RYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 283 ~~-~~~~~~~~---~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
.. .....+.. .....+.. ...+.++..+.+||.+||+.||++|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 00 00000000 00000000 01234677899999999999999999999999
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=350.84 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=203.6
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--------chHHHHHHHHHHccCCCCCcceeEeEEeeC
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 128 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 128 (375)
..++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999864 6899999999765321 233567799999999999999999999999
Q ss_pred CeeEEEEeecCCC-CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 129 DQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 129 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
+..++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999998766 99999954 456999999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 9997643322 2234679999999999988776 78999999999999999999999631110
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.... ...+..++..+.+||.+||+.||++||++.++++.
T Consensus 237 -------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01233466789999999999999999999999963
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=351.13 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=209.5
Q ss_pred HhhcccccceeccccceEEEEEEE------cCCceEEEEEccccC-ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
..++|++.+.||+|+||.||+|+. .++..||||++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 356899999999999999999973 257789999996542 2345578889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC---CceEE
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKL 204 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~---~~vkl 204 (375)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ ..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976432 1245899999999999999999999998 9999999999999844 46999
Q ss_pred eecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhh
Q 017246 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 283 (375)
Q Consensus 205 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 283 (375)
+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----- 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE----- 256 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH-----
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHH-----
Confidence 99999864322222222334568999999999999999999999999999999998 99998633211 0000
Q ss_pred hhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.+........+..++..+.++|.+||+.||.+||++.+|++.|..+....
T Consensus 257 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 257 ---------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 00111112234567788999999999999999999999999999997654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=349.53 Aligned_cols=264 Identities=20% Similarity=0.265 Sum_probs=194.0
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
...++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44678999999999999999999765 6899999999765332 24457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe-----CCCceEEeecC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-----NDFNPKLSDFG 208 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~-----~~~~vkl~Dfg 208 (375)
||||+++ +|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 111 v~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999975 99999965 456899999999999999999999998 99999999999994 44559999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh----
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF---- 283 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---- 283 (375)
++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ........
T Consensus 183 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~ 258 (329)
T 3gbz_A 183 LARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPD 258 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCC
T ss_pred CccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCc
Confidence 99753221 1223345789999999999874 589999999999999999999999964322110 00000000
Q ss_pred ------hhhccccchhc----ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 284 ------LKDQKKFVHLV----DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 284 ------~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
......+.... ...+...++..++..+.+||.+||+.||++||++.|++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 00000000000 00000001223567889999999999999999999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=343.64 Aligned_cols=265 Identities=23% Similarity=0.286 Sum_probs=199.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999875 5899999998664332 24567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999988753 456899999999999999999999998 999999999999999999999999999764322
Q ss_pred CCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc-h-------hhhhhhc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW-S-------RPFLKDQ 287 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~-------~~~~~~~ 287 (375)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............. . .......
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 --SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred --ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 122334578999999999876 6689999999999999999999999965432211100000 0 0000000
Q ss_pred cccchhcccccCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........+...... .+.++..+.+|+.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000000 1346677999999999999999999999993
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=341.85 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=208.0
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEee--------
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-------- 127 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 127 (375)
....+|++.+.||+|+||.||+|... +++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34568999999999999999999876 79999999997543 346689999999999999999998854
Q ss_pred --------CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC
Q 017246 128 --------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 199 (375)
Q Consensus 128 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~ 199 (375)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 455789999999999999997532 457899999999999999999999998 9999999999999999
Q ss_pred CceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc
Q 017246 200 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 200 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 279 (375)
+.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~- 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------K- 226 (284)
T ss_dssp TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------H-
T ss_pred CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------H-
Confidence 999999999987643322 1233569999999999999999999999999999999999998874210 0
Q ss_pred hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.. ..+.. ..++..++..+.++|.+||+.||.+||++.++++.|..+....
T Consensus 227 ---~~------~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 227 ---FF------TDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ---HH------HHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ---HH------HHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 00 00111 1223445677899999999999999999999999999987543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=373.48 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=207.8
Q ss_pred hcccccc-eeccccceEEEEEEEc---CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 60 RNFREAN-LIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 60 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++.+.+ .||+|+||.||+|.+. ++..||||+++.... ...+.+.+|+.+++.++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3445555 7999999999999764 466799999976532 356789999999999999999999999876 568999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999964 3566999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccch
Q 017246 215 VGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 215 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .. .
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~--------------~ 550 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM--------------A 550 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH--------------H
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH--------------H
Confidence 32211 11222345789999999999999999999999999999998 999997432211 11 1
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.+........+..++..+.+||.+||+.+|++||++.+|++.|+.+.....
T Consensus 551 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 551 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 111111234466788999999999999999999999999999999876543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=345.67 Aligned_cols=269 Identities=25% Similarity=0.322 Sum_probs=210.9
Q ss_pred cHHHHHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHcc--CCCCCcceeEeEEeeC
Q 017246 51 TFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTSG 128 (375)
Q Consensus 51 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~ 128 (375)
.+.......++|++.+.||+|+||.||+|+.. |+.||||++... ....+..|+.++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 33444566789999999999999999999875 899999998653 34566778888776 7999999999999887
Q ss_pred C----eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCcccCCCCCCcEEE
Q 017246 129 D----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--------CKANPPVIYRDLKSANILL 196 (375)
Q Consensus 129 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~Dlkp~Nill 196 (375)
. ..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +++ |+||||||+||||
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 6 78999999999999999954 35899999999999999999999 777 9999999999999
Q ss_pred eCCCceEEeecCCCccCCCCCCce--eeeccccccccccccccccC------CCCccchhHhHHHHHHHHHhC-------
Q 017246 197 DNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITG------- 261 (375)
Q Consensus 197 ~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg------- 261 (375)
+.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 999999999999997543322211 23345799999999998865 234789999999999999999
Q ss_pred ---CCCccccccccccchhhchhhhhhhccccchhcccccCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 262 ---RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 262 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..||......... ...+. ..+........+ ...++..+.+|+.+||+.||++||++.+|++
T Consensus 261 ~~~~~p~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPS-VEEMR----------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CCCCCTTTTTSCSSCC-HHHHH----------HHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCccccCcCccc-HHHHH----------HHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 5566432211100 00000 001111122222 2467889999999999999999999999999
Q ss_pred HHhhhhhcc
Q 017246 334 ALDYLVSQR 342 (375)
Q Consensus 334 ~L~~l~~~~ 342 (375)
.|+.+..+.
T Consensus 330 ~L~~i~~~~ 338 (342)
T 1b6c_B 330 TLSQLSQQE 338 (342)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHHh
Confidence 999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=362.81 Aligned_cols=262 Identities=22% Similarity=0.284 Sum_probs=195.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEcccc--CccchHHHHHHHHHHccCCCCCcceeEeEEeeC------C
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------D 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 129 (375)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999765 6899999999754 223356788999999999999999999999654 4
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999976 5666663 24899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhh----------
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS---------- 278 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~---------- 278 (375)
++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... +..
T Consensus 211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9854322 22344689999999999999999999999999999999999999996432111000 000
Q ss_pred -----chhhhhhhcc-----ccchhcccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 279 -----WSRPFLKDQK-----KFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 279 -----~~~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+..... .+.......+... .....+..+.+||.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0000000000000 01123678999999999999999999999996
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=347.28 Aligned_cols=259 Identities=21% Similarity=0.233 Sum_probs=205.7
Q ss_pred HHHHHHhhccccc-ceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccC-CCCCcceeEeEEee
Q 017246 53 RELAIATRNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS 127 (375)
Q Consensus 53 ~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 127 (375)
.......++|.+. +.||+|+||.||+|... +++.||+|++..... .....+.+|+.++..+ .||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3345667788887 89999999999999876 689999999876432 3356788999999998 56999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---CCceEE
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKL 204 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~vkl 204 (375)
.+..++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred CCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 9999999999999999999854 23467999999999999999999999998 999999999999988 789999
Q ss_pred eecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhh
Q 017246 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 284 (375)
Q Consensus 205 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 284 (375)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ . ....
T Consensus 176 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~----~~i~ 246 (327)
T 3lm5_A 176 VDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--Y----LNIS 246 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHHH
T ss_pred eeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--H----HHHH
Confidence 9999997543221 22346799999999999999999999999999999999999999964321110 0 0000
Q ss_pred hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. ............++..+.++|.+||+.||++||++.++++
T Consensus 247 -------~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 -------Q-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -------H-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -------h-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 0011111223456778999999999999999999999983
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=355.03 Aligned_cols=253 Identities=21% Similarity=0.222 Sum_probs=192.1
Q ss_pred hhccccc-ceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHH-ccCCCCCcceeEeEEee----CCee
Q 017246 59 TRNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLML-SLLHHDNLVTLIGYCTS----GDQR 131 (375)
Q Consensus 59 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~ 131 (375)
.++|.+. ++||+|+||.||++... +++.||||++.. ...+.+|+.++ +..+||||+++++++.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3467665 78999999999999875 689999999853 24566788876 44589999999999876 5678
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---CCceEEeecC
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFG 208 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~vkl~Dfg 208 (375)
||||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999752 2356999999999999999999999998 999999999999987 7889999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ .........
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~i~~~~~ 284 (400)
T 1nxk_A 210 FAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KTRIRMGQY 284 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH--HHHHHHTCC
T ss_pred cccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH--HHHHHcCcc
Confidence 99853321 1233567999999999999999999999999999999999999999643322110000 000000000
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.........++..+.+||.+||+.||++||++.+|++.
T Consensus 285 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 --------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00001113567789999999999999999999999973
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=344.09 Aligned_cols=265 Identities=23% Similarity=0.270 Sum_probs=200.2
Q ss_pred hhccccc-ceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.+.|++. +.||+|+||.||+|... +++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3578884 78999999999999854 6899999999876656677889999999884 7999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc---eEEeecCCCcc
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKL 212 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~---vkl~Dfg~a~~ 212 (375)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999965 346899999999999999999999998 999999999999988776 99999999875
Q ss_pred CCCCCC-----ceeeecccccccccccccccc-----CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 213 GPVGDN-----THVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 213 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 322111 111223569999999999875 5588999999999999999999999975432211000000000
Q ss_pred hhhhccccchhcccccCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 FLKDQKKFVHLVDPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... ......+..... .++ ..++..+.+||.+||+.||++||++.|+++
T Consensus 244 ~~~-~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQ-NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHH-HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHH-HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000 000000111100 112 235678999999999999999999999994
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=344.28 Aligned_cols=259 Identities=25% Similarity=0.343 Sum_probs=206.4
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee--CCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 133 (375)
.++|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 689999999976432 334568899999999999999999998753 678999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
||||+++++|.+++.........+++..++.++.||+.||.|||+++ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999775545567999999999999999999999765 2349999999999999999999999999987
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ... .. ..
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~-i~------ 229 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA---GK-IR------ 229 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH-HH------
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHH---HH-Hh------
Confidence 532221 1223357899999999999999999999999999999999999999743211 000 00 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
. .....++..++..+.++|.+||+.||++||++.+|++.+.
T Consensus 230 ---~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 230 ---E-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---H-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---h-cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0 0111234567788999999999999999999999996543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=349.62 Aligned_cols=246 Identities=29% Similarity=0.389 Sum_probs=201.1
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
...|++.+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999986 47899999998754322 235688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+. |+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 588888754 2457899999999999999999999998 9999999999999999999999999997532
Q ss_pred CCCCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
. .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... .......
T Consensus 206 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~------ 267 (348)
T 1u5q_A 206 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ------ 267 (348)
T ss_dssp S------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH------
T ss_pred C------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHh------
Confidence 2 22357999999999985 5678999999999999999999999986322110 0000000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......+..++..+.++|.+||+.||++||++.++++
T Consensus 268 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 268 ----NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ----SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00111123456778999999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=355.04 Aligned_cols=207 Identities=25% Similarity=0.336 Sum_probs=178.1
Q ss_pred ccHHHHHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC-----CCCcceeEe
Q 017246 50 FTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----HDNLVTLIG 123 (375)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~ 123 (375)
+++.......++|++.+.||+|+||.||+|+.. +++.||||++... ......+..|+.+++.+. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344444456789999999999999999999874 6899999998643 233456677999998886 999999999
Q ss_pred EEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-----
Q 017246 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN----- 198 (375)
Q Consensus 124 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~----- 198 (375)
++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 999999999999999 99999999763 2346899999999999999999999998 999999999999975
Q ss_pred --------------------CCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHH
Q 017246 199 --------------------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 258 (375)
Q Consensus 199 --------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 258 (375)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 788999999999753221 2346799999999999999999999999999999999
Q ss_pred HhCCCCcccc
Q 017246 259 ITGRKAMDLS 268 (375)
Q Consensus 259 ltg~~pf~~~ 268 (375)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999999643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=361.70 Aligned_cols=195 Identities=26% Similarity=0.372 Sum_probs=154.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEee-----CCe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-----GDQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~ 130 (375)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999765 68999999986532 2345678899999999999999999999843 357
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 5699998853 567999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCc-------------------------eeeeccccccccccccccc-cCCCCccchhHhHHHHHHHHHhC
Q 017246 211 KLGPVGDNT-------------------------HVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITG 261 (375)
Q Consensus 211 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg 261 (375)
+........ ......+||+.|+|||++. ...|+.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 864322110 1233467899999999864 66799999999999999999994
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=338.75 Aligned_cols=246 Identities=26% Similarity=0.406 Sum_probs=203.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999765 57899999986532 22345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999965 346899999999999999999999888 9999999999999999999999999886432
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .....
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~---------- 220 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRIS---------- 220 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH----------
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------HHHHH----------
Confidence 21 22345789999999999999999999999999999999999999963221110 00000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.....++..++..+.+||.+||+.||.+||++.++++
T Consensus 221 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 221 --RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0112334556788999999999999999999999996
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=340.63 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=207.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.+.|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 457999999999999999999764 689999999976533 345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999984 356899999999999999999999998 999999999999999999999999999753222
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
........||+.|+|||++.+..++.++||||||+++|+|++|..||....... .. . .. ..
T Consensus 173 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---~-~~----------~~ 233 (303)
T 3a7i_A 173 --QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VL---F-LI----------PK 233 (303)
T ss_dssp --BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---H-HH----------HH
T ss_pred --ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HH---H-Hh----------hc
Confidence 122334679999999999999999999999999999999999999996332110 00 0 00 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
.....++..++..+.+|+.+||+.||++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 234 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11112344567789999999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=336.42 Aligned_cols=251 Identities=22% Similarity=0.251 Sum_probs=204.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 568999999999999999999865 589999999866432 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc---eEEeecCCCcc
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKL 212 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~---vkl~Dfg~a~~ 212 (375)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998865 356899999999999999999999998 999999999999987665 99999999975
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... . .........
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~---~~~~~~~~~---- 224 (284)
T 3kk8_A 158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L---YAQIKAGAY---- 224 (284)
T ss_dssp CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHHTCC----
T ss_pred cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---H---HHHHHhccc----
Confidence 43222 2234679999999999999999999999999999999999999996322110 0 000000000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.........++..+.+++.+||+.||++||++.++++
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 ----DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001112356678999999999999999999999995
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=356.48 Aligned_cols=268 Identities=24% Similarity=0.370 Sum_probs=191.7
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEcccc--CccchHHHHHHHHHHccCC-CCCcceeEeEEeeCC--e
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGD--Q 130 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~ 130 (375)
...++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999865 6899999998653 2234556788999999997 999999999997544 7
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 589998854 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCC-------------------CCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 017246 211 KLGPVG-------------------DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKG 270 (375)
Q Consensus 211 ~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~ 270 (375)
+..... .........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 753221 01112334689999999999986 6789999999999999999999999964332
Q ss_pred ccccch-hh----------------chhhhhhhccccchhcccccCC------------CCCHHHHHHHHHHHHhhcCCC
Q 017246 271 QGEQNL-VS----------------WSRPFLKDQKKFVHLVDPLLHG------------RYPRRCLNYAVAVTAMCLNEE 321 (375)
Q Consensus 271 ~~~~~~-~~----------------~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~~ 321 (375)
...... .. +...+................. ..+..++..+.+|+.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 110000 00 0000000000000000000000 011245678999999999999
Q ss_pred CCCCCCHHHHHH
Q 017246 322 ANFRPLINDIVV 333 (375)
Q Consensus 322 p~~RPs~~eil~ 333 (375)
|++|||+.|+++
T Consensus 317 P~~R~t~~e~l~ 328 (388)
T 3oz6_A 317 PNKRISANDALK 328 (388)
T ss_dssp GGGSCCHHHHTT
T ss_pred cccCCCHHHHhC
Confidence 999999999994
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=341.46 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=204.5
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
..++|++.+.||+|+||.||+++.. +|+.||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3568999999999999999999875 689999999987655555678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE---eCCCceEEeecCCCccC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill---~~~~~vkl~Dfg~a~~~ 213 (375)
|+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999865 346899999999999999999999998 9999999999999 78889999999998753
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ..... ..
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~---~~i~~-~~----- 223 (304)
T 2jam_A 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF---EKIKE-GY----- 223 (304)
T ss_dssp CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHH-CC-----
T ss_pred CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHc-CC-----
Confidence 221 123356899999999999999999999999999999999999999642211 000 00000 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..........++..+.++|.+||+.||++||++.++++
T Consensus 224 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 224 --YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred --CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111223456788999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=350.44 Aligned_cols=267 Identities=16% Similarity=0.168 Sum_probs=208.3
Q ss_pred hhcccccceeccccceEEEEEEEcC---------CceEEEEEccccCccchHHHHHHHHHHccCCCCCcce---------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES---------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT--------- 120 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 120 (375)
.++|++.+.||+|+||.||+|+... ++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999998653 789999998654 45778999999999999887
Q ss_pred ------eEeEEee-CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCc
Q 017246 121 ------LIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 193 (375)
Q Consensus 121 ------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~N 193 (375)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 5677765 68889999999 99999999752 2367999999999999999999999998 9999999999
Q ss_pred EEEeCCC--ceEEeecCCCccCCCCCC-----ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcc
Q 017246 194 ILLDNDF--NPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 266 (375)
Q Consensus 194 ill~~~~--~vkl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 266 (375)
||++.++ .+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 899999999975332111 111234579999999999999999999999999999999999999997
Q ss_pred ccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 267 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
...... .........+..... .+.... .....++..+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDKPG---PFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHSCC---CEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCH-HHHHHHHHhccCChh---hhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 543211 111111111111110 000000 0112456789999999999999999999999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=347.06 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=195.3
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc-hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47999999999999999999876 68999999987543221 12345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
++ |+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 97 599998865 3456899999999999999999999998 999999999999999999999999998753222
Q ss_pred Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh--ccccc---
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD--QKKFV--- 291 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~--- 291 (375)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .......... ...+.
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGG
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhh
Confidence 222334578999999999876 5689999999999999999999999974332111 0000000000 00000
Q ss_pred ------hhcccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 ------HLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ------~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+.... .....++..+.+||.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 012345678899999999999999999999995
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=376.30 Aligned_cols=250 Identities=27% Similarity=0.372 Sum_probs=207.8
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEcccc---CccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 131 (375)
...++|++.+.||+|+||.||+|+.. +++.||||++.+. .......+..|..++..+ +||+|+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999865 6889999999754 223456678899999887 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
||||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999975 356999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .. ..
T Consensus 491 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~-------------~~ 552 (674)
T 3pfq_A 491 ENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL-------------FQ 552 (674)
T ss_dssp ECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------------HH
T ss_pred ccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HH-------------HH
Confidence 532222 2244578999999999999999999999999999999999999999642211 00 01
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~eil~ 333 (375)
.++.. ...+|..++.++.+||.+||+.||++||++ .+|++
T Consensus 553 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 553 SIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11111 123466788899999999999999999998 77765
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=360.79 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=202.9
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3568999999999999999999875 68999999986532 24467788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe---CCCceEEeecCCCc
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAK 211 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~---~~~~vkl~Dfg~a~ 211 (375)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999999865 356899999999999999999999998 99999999999995 45679999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||....... .. ........
T Consensus 173 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~~~~--- 239 (486)
T 3mwu_A 173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---IL---KRVETGKY--- 239 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHTCC---
T ss_pred ECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCC---
Confidence 54322 12334679999999999875 58999999999999999999999996432111 00 00000000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.........++..+.+||.+||+.||.+|||+.++++
T Consensus 240 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 240 -----AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -----CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000112356778999999999999999999999996
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=336.68 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=200.9
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
|....+||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 444559999999999999864 6889999999876656677889999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-CCceEEeecCCCccCCCCCCc
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
++|.+++.... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.+||+|||++.......
T Consensus 104 ~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 104 GSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 99999997632 2345678999999999999999999998 999999999999998 8999999999997543221
Q ss_pred eeeeccccccccccccccccCC--CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ . .. ......
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~----~~-------~~~~~~ 242 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----A----MF-------KVGMFK 242 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----H----HH-------HHHHHC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----H----HH-------hhcccc
Confidence 2233467899999999987654 88999999999999999999999963221110 0 00 000001
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....++..++..+.+++.+||+.||++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122345667788999999999999999999999983
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=340.92 Aligned_cols=254 Identities=24% Similarity=0.282 Sum_probs=191.9
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc--hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
..++|++.+.||+|+||.||+|... +|+.||+|++....... ...+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4578999999999999999999874 68999999997643222 22344455568889999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
|||+++ +|.+++.........+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999974 88888866544567899999999999999999999997 8 999999999999999999999999999753
Q ss_pred CCCCCceeeecccccccccccccc----ccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYA----MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
... .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ .
T Consensus 161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~----------- 222 (290)
T 3fme_A 161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ----Q----------- 222 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH----H-----------
T ss_pred ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH----H-----------
Confidence 222 122335799999999996 466789999999999999999999999963221100 0
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.............+..++..+.+++.+||+.||++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00111111111123456778999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=350.30 Aligned_cols=264 Identities=22% Similarity=0.278 Sum_probs=205.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||++... ++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999876 689999999876532 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999965 34689999999999999999999985 7 99999999999999999999999999864211
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc----------------
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW---------------- 279 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~---------------- 279 (375)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 122345799999999999999999999999999999999999999964332111000000
Q ss_pred ------hhhhhhhccccch----hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 280 ------SRPFLKDQKKFVH----LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 280 ------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
............. +............++..+.+||.+||+.||++|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000000 11111111122346778999999999999999999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=355.26 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=192.5
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--------cchHHHHHHHHHHccCCCCCcceeEeEEee
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 127 (375)
...++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 44678999999999999999999765 689999999865421 112347789999999999999999999754
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC---ceEE
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKL 204 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~---~vkl 204 (375)
+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 568999999999999998853 567999999999999999999999998 99999999999997554 5999
Q ss_pred eecCCCccCCCCCCceeeecccccccccccccccc---CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchh
Q 017246 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 281 (375)
Q Consensus 205 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 281 (375)
+|||+++.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...
T Consensus 284 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~--- 355 (419)
T 3i6u_A 284 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD--- 355 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH---
T ss_pred eecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH---
Confidence 99999986432 222344679999999999863 6688999999999999999999999964322111 000
Q ss_pred hhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... .. . ........++..+.+||.+||+.||++||++.++++
T Consensus 356 -~i~~~-~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 -QITSG-KY-N-----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHHTT-CC-C-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHhcC-CC-C-----CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 00 0 000001235678999999999999999999999995
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=346.49 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=207.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|.+.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999875 588999999876432 3345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998864 356899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .....
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~---------- 254 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIK---------- 254 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH----------
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHh----------
Confidence 221 223346799999999999999999999999999999999999999964321100 00000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ...++..++..+.+||.+||+.||++||++.++++
T Consensus 255 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 255 KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 11234556778999999999999999999999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=335.92 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=207.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc------chHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|++.+.||+|+||.||++... +++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999876 6899999998664322 356789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC----ceEEeec
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDF 207 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~----~vkl~Df 207 (375)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999964 456899999999999999999999998 99999999999998877 7999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .. .......
T Consensus 157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---~~~~~~~ 227 (283)
T 3bhy_A 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TL---TNISAVN 227 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHTTC
T ss_pred ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HH---HHhHhcc
Confidence 9997543221 1234568999999999999999999999999999999999999996432110 00 0000000
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhhhhhc
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVSQ 341 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~--~L~~l~~~ 341 (375)
..........++..+.+++.+||+.||++||++.++++ .+..+..+
T Consensus 228 --------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 228 --------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp --------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred --------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 00000011345677999999999999999999999997 46665443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=338.69 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=206.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|.+.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999876 588999999866432 2345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998864 356899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .. .+.
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~----------~~~ 228 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YL----------RIK 228 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH----------HHH
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH----------HHh
Confidence 221 223346799999999999998899999999999999999999999964321110 00 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ...++..++..+.+++.+||+.||++||++.++++
T Consensus 229 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 229 KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 11234566778999999999999999999999996
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=340.11 Aligned_cols=261 Identities=29% Similarity=0.405 Sum_probs=200.3
Q ss_pred hhcccccceeccccceEEEEEEEc--CCc--eEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE--SGQ--LVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|++.+.||+|+||.||+|++. +++ .||+|++.... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 568999999999999999999753 233 68999987643 233567889999999999999999999998754 8
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999752 356899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccc
Q 017246 212 LGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 212 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... . ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~-------- 235 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---I---LH-------- 235 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HH--------
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---H---HH--------
Confidence 64333222 22234567889999999999889999999999999999999 999996432110 0 00
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.+.........+..++..+.+++.+||+.||++||++.++++.|+++.+..
T Consensus 236 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 236 --KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp --HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred --HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 011111111234567788999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=346.92 Aligned_cols=266 Identities=23% Similarity=0.387 Sum_probs=201.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 458999999999999999999876 5899999998654332 2345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999887643 456999999999999999999999998 99999999999999999999999999975322
Q ss_pred CCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhh-------chhhhhhh
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS-------WSRPFLKD 286 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~-------~~~~~~~~ 286 (375)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... ... .....+..
T Consensus 177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 2 1223346789999999999875 78999999999999999999999996443211100 000 00000000
Q ss_pred ccccchhcccccCCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 287 QKKFVHLVDPLLHGR-----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.........+..... ..+.++..+.+||.+||+.||++||++.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001111111111111 12346788999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=349.55 Aligned_cols=254 Identities=28% Similarity=0.370 Sum_probs=204.4
Q ss_pred hhcccccceeccccceEEEEEEE----cCCceEEEEEccccCc----cchHHHHHHHHHHccC-CCCCcceeEeEEeeCC
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 129 (375)
.++|++.+.||+|+||.||+++. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999986 3689999999875422 2345567799999999 6999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999965 346899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeecccccccccccccccc--CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
++...... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 206 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~-- 280 (355)
T 1vzo_A 206 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK-- 280 (355)
T ss_dssp EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHH--
T ss_pred CeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhc--
Confidence 97532211 222334679999999999985 34789999999999999999999999743322111 111111100
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 334 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~~ 334 (375)
....++..++..+.+||.+||+.||++|| ++.++++.
T Consensus 281 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 281 ----------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11234566778899999999999999999 99999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=361.45 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=198.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999876 68899999997643 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC---CceEEeecCCCcc
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLAKL 212 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~---~~vkl~Dfg~a~~ 212 (375)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998865 356899999999999999999999998 9999999999999764 4599999999975
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.... ......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||....... .. .........
T Consensus 189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~~~~~--- 255 (494)
T 3lij_A 189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---IL---RKVEKGKYT--- 255 (494)
T ss_dssp CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHTCCC---
T ss_pred CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCCC---
Confidence 4322 2233467999999999876 568999999999999999999999996432211 00 000000000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........++..+.+||.+||+.||.+|||+.++++
T Consensus 256 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 -----FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -----CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000001345678999999999999999999999996
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=358.29 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=209.1
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCC-CCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+..|+.+++.+.| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999986 4689999998765432 3457789999999987 456666667778889999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE---eCCCceEEeecCCCccC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill---~~~~~vkl~Dfg~a~~~ 213 (375)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999964 2456999999999999999999999998 9999999999999 68899999999999764
Q ss_pred CCCCCc-----eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 214 PVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 214 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----- 231 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----- 231 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-----
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-----
Confidence 332221 1223567999999999999999999999999999999999999999754432221111111000
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.....+. .+...++.++.+|+..||+.+|++||++.+|++.|+.+....
T Consensus 232 ~~~~~~~-----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 232 KVATSIE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHSCHH-----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccccHH-----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0000000 011245678999999999999999999999999999997643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=340.54 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=201.1
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
..++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3568999999999999999999876 589999999987766677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~-- 168 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-- 168 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHH--
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccc--
Confidence 99999999998652 456899999999999999999999998 9999999999999999999999999874211
Q ss_pred CCceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||....... ........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~----- 237 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS----- 237 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-----
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhcc-----
Confidence 0111123356899999999884 6678999999999999999999999996432110 00000000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......+..++..+.++|.+||+.||++||++.++++
T Consensus 238 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 238 ----DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00011224566788999999999999999999999983
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=342.59 Aligned_cols=265 Identities=24% Similarity=0.294 Sum_probs=197.3
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc-----hHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-----HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
..++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+|+.+++.++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3568999999999999999999865 68999999997543221 24678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++ +|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999976 88888854 3456888999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh-hccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKK 289 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 289 (375)
..... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||....... .+......... ....
T Consensus 161 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTT
T ss_pred eccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCCCChhh
Confidence 64322 2223446789999999998764 58999999999999999999999986432211 00000000000 0000
Q ss_pred cc---hhccccc---CCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FV---HLVDPLL---HGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~---~~~~~~~---~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+. ...+... .... ...++..+.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 0000000 0001 1345688999999999999999999999995
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=371.55 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=202.6
Q ss_pred ceeccccceEEEEEEEc---CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|.+. .++.||||+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999976433 235789999999999999999999999865 568899999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC-c
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN-T 219 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~ 219 (375)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999964 457899999999999999999999998 99999999999999999999999999976433222 1
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +...+....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGE 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCC
Confidence 22233457889999999999999999999999999999998 999996432211 111111122
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
....+..++..+.+||.+||+.||++||++.+|++.|+.+...
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2344667888999999999999999999999999999988643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=344.24 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=204.9
Q ss_pred HHHHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--------chHHHHHHHHHHccC-CCCCcceeE
Q 017246 53 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLL-HHDNLVTLI 122 (375)
Q Consensus 53 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~ 122 (375)
.......++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.+++.+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999875 6999999998764321 134577899999998 799999999
Q ss_pred eEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCce
Q 017246 123 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 202 (375)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~v 202 (375)
+++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999964 356899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCceeeecccccccccccccccc------CCCCccchhHhHHHHHHHHHhCCCCccccccccccch
Q 017246 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 276 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 276 (375)
||+|||++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .
T Consensus 240 kl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~ 313 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---M 313 (365)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H
T ss_pred EEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---H
Confidence 999999987543322 2234679999999999863 358899999999999999999999996322110 0
Q ss_pred hhchhhhhhhccccchhcccccCCCC--CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 277 VSWSRPFLKDQKKFVHLVDPLLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. ..... ....... ...++..+.++|.+||+.||++||++.++++
T Consensus 314 ~---~~i~~----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 L---RMIME----------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H---HHHHH----------TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H---HHHHh----------CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00000 0000000 0134567999999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=335.35 Aligned_cols=246 Identities=23% Similarity=0.343 Sum_probs=206.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999875 58899999986532 22346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999965 346899999999999999999999988 9999999999999999999999999986532
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .. .+.
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~----------~~~ 225 (284)
T 2vgo_A 166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HR----------RIV 225 (284)
T ss_dssp SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH----------HHH
T ss_pred cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HH----------HHh
Confidence 21 12346799999999999999999999999999999999999999964321110 00 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. ....++..++..+.++|.+||+.||.+||++.++++
T Consensus 226 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 226 N--VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp T--TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 011234567788999999999999999999999995
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=333.62 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=197.9
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999876 69999999986542 2345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999965 346899999999999999999999998 999999999999999999999999999754
Q ss_pred CCCCCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ... .. ..
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~-~~------- 224 (276)
T 2h6d_A 162 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF---KK-IR------- 224 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HH-HH-------
T ss_pred CCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH---HH-hh-------
Confidence 3221 2234578999999999987765 68999999999999999999999632211 000 00 00
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ....+..++..+.++|.+||+.||++||++.++++
T Consensus 225 --~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 225 --GG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp --HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00 01234556778999999999999999999999997
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=362.84 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=205.5
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
..++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3568999999999999999999876 79999999986543 2346778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE---eCCCceEEeecCCC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLA 210 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill---~~~~~vkl~Dfg~a 210 (375)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999964 457999999999999999999999998 9999999999999 56789999999998
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||....... ... .
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~-------- 238 (484)
T 3nyv_A 177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILK---K-------- 238 (484)
T ss_dssp HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H--------
T ss_pred EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHH---H--------
Confidence 7543322 2234579999999998866 68999999999999999999999997432111 000 0
Q ss_pred chhcccccCC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHG--RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+....... .....++..+.+||.+||+.+|.+|||+.++++
T Consensus 239 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 239 --VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --HHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00000000 112356788999999999999999999999995
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=338.12 Aligned_cols=252 Identities=27% Similarity=0.355 Sum_probs=202.1
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
...++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999876 5899999999764 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999864 2457899999999999999999999998 99999999999999999999999999975322
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ........||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...... .
T Consensus 178 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~---------~ 240 (314)
T 3com_A 178 T--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPT---------N 240 (314)
T ss_dssp T--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH---------S
T ss_pred h--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhc---------C
Confidence 1 1223345789999999999999999999999999999999999999963221100 000000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......+..++..+.++|.+||+.||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 241 PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00011224556788999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=360.69 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=200.3
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-------------cchHHHHHHHHHHccCCCCCcceeEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-------------QGHQEFIVEVLMLSLLHHDNLVTLIG 123 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~ 123 (375)
..++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3568999999999999999999875 588999999876432 23467889999999999999999999
Q ss_pred EEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC---
Q 017246 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF--- 200 (375)
Q Consensus 124 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~--- 200 (375)
++.+....++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999965 356899999999999999999999998 99999999999998776
Q ss_pred ceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch
Q 017246 201 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 201 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 280 (375)
.+||+|||++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|.+||....... ...
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~-- 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIK-- 257 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH--
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH--
Confidence 69999999997643221 233467999999999886 468999999999999999999999997432211 000
Q ss_pred hhhhhhccccchhcccccCCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 281 RPFLKDQKKFVHLVDPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... ....... ....++..+.+||.+||+.||.+|||+.++++
T Consensus 258 -~i~----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 -KVE----------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -HHH----------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHH----------cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 0000000 01245678999999999999999999999984
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=339.97 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=200.9
Q ss_pred HHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCC--CCCcceeEeEEeeCCe
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 130 (375)
+....++|++.+.||+|+||.||++...+++.||+|++..... .....+.+|+.++..++ ||||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3345678999999999999999999988899999999875432 33467889999999997 5999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+++ +.+||+|||++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999 568899999965 457899999999999999999999998 999999999999975 89999999999
Q ss_pred ccCCCCCCceeeecccccccccccccccc-----------CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 279 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 279 (375)
................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------- 246 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------- 246 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-------
Confidence 76433332223344679999999999875 468889999999999999999999996322110
Q ss_pred hhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..............++...+..+.++|.+||+.||++||++.++++
T Consensus 247 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 0111122222233344555778999999999999999999999995
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=340.54 Aligned_cols=268 Identities=24% Similarity=0.330 Sum_probs=199.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEee--------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTS-------- 127 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 127 (375)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 358999999999999999999874 7899999998664332 34567899999999999999999999877
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
.+..++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 4568999999975 77777754 3456999999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCC--Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc-hh--
Q 017246 208 GLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW-SR-- 281 (375)
Q Consensus 208 g~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~-- 281 (375)
|++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.. ..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9997543221 1222344678999999999876 4589999999999999999999999974332111000000 00
Q ss_pred --hhhhhcc--ccchhcccccC--CCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 --PFLKDQK--KFVHLVDPLLH--GRYPR-----RCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 --~~~~~~~--~~~~~~~~~~~--~~~~~-----~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....... .....+..... ..... ..+..+.+||.+||+.||++||++.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000 00000000000 00001 12456889999999999999999999993
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=355.35 Aligned_cols=200 Identities=29% Similarity=0.368 Sum_probs=167.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEcccc--CccchHHHHHHHHHHccCCCCCcceeEeEEeeC-----Ce
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 130 (375)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999865 6889999999753 223456788999999999999999999998776 57
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 599999954 567999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCc--------------------eeeecccccccccccccc-ccCCCCccchhHhHHHHHHHHHhCCCCcc
Q 017246 211 KLGPVGDNT--------------------HVSTRVMGTYGYCAPEYA-MSGKLTLKSDIYSFGVVLLELITGRKAMD 266 (375)
Q Consensus 211 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~ 266 (375)
+........ ......+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 864322211 123457899999999986 45679999999999999999998766553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=349.81 Aligned_cols=270 Identities=23% Similarity=0.305 Sum_probs=202.3
Q ss_pred HHhhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeC-------
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------- 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------- 128 (375)
...++|++.+.||+|+||.||+|.. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999986 47999999998654322 23699999999999999999998443
Q ss_pred -------------------------------CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 017246 129 -------------------------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177 (375)
Q Consensus 129 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 177 (375)
...++||||++ ++|.+.+......+..+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34889999997 5888888765445678999999999999999999999
Q ss_pred cCCCCCcccCCCCCCcEEEe-CCCceEEeecCCCccCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHH
Q 017246 178 CKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVL 255 (375)
Q Consensus 178 ~~~~~~i~H~Dlkp~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il 255 (375)
+++ |+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 988 99999999999998 68899999999998543222 22345689999999998865 489999999999999
Q ss_pred HHHHhCCCCccccccccccchhhchhh--------hhhhccc-----cchhcccccCCCCCHHHHHHHHHHHHhhcCCCC
Q 017246 256 LELITGRKAMDLSKGQGEQNLVSWSRP--------FLKDQKK-----FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEA 322 (375)
Q Consensus 256 ~elltg~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 322 (375)
|||++|+.||....... .+...... ....... +.......+...++..++..+.+||.+||+.||
T Consensus 233 ~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999997432211 11110000 0000000 000001111112345577889999999999999
Q ss_pred CCCCCHHHHHH--HHhhhh
Q 017246 323 NFRPLINDIVV--ALDYLV 339 (375)
Q Consensus 323 ~~RPs~~eil~--~L~~l~ 339 (375)
++|||+.|+++ .++.+.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHH
T ss_pred hhCCCHHHHhcCHHHHHHH
Confidence 99999999996 244443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=335.84 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=201.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC----ccchHHHHHHHHHHccCCCCCcceeEeEE--eeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHHDNLVTLIGYC--TSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~ 131 (375)
.++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++ ......
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999864 68899999997642 23356788999999999999999999998 445688
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||++++ |.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 77777653 3567899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccCC--CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
...............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i------ 225 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENI------ 225 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHH------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHH------
Confidence 644333333344567999999999987644 478999999999999999999999742211 000000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
... ...++..++..+.++|.+||+.||++||++.++++.
T Consensus 226 ----~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 ----GKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----HHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----hcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 012345667789999999999999999999999963
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=356.65 Aligned_cols=248 Identities=15% Similarity=0.162 Sum_probs=193.2
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEcccc---CccchHHHHHHH---HHHccCCCCCcceeE-------eE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHE---GLQGHQEFIVEV---LMLSLLHHDNLVTLI-------GY 124 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 124 (375)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36799999999999999999985 46999999999743 223456788999 455556899999998 66
Q ss_pred EeeCC-----------------eeEEEEeecCCCCHHHHHhccCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 017246 125 CTSGD-----------------QRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184 (375)
Q Consensus 125 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 184 (375)
+...+ ..++||||+ +|+|.+++..... ....+++..++.++.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 278999999 6799999975321 1123445888899999999999999998 9
Q ss_pred ccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccC-----------CCCccchhHhHHH
Q 017246 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----------KLTLKSDIYSFGV 253 (375)
Q Consensus 185 ~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~ 253 (375)
+||||||+||||+.++.+||+|||+++... ......+| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998522 12344677 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 254 VLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 254 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
++|||++|+.||........ ...+.. ....++..+.+||.+||+.||++||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~----------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG----------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC----------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc----------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999963321110 000000 01345678999999999999999999999996
Q ss_pred --HHhhh
Q 017246 334 --ALDYL 338 (375)
Q Consensus 334 --~L~~l 338 (375)
.+..+
T Consensus 360 hp~f~~~ 366 (377)
T 3byv_A 360 TPEYEQL 366 (377)
T ss_dssp SHHHHHH
T ss_pred ChHHHHH
Confidence 34444
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=342.00 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=189.0
Q ss_pred HHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.+..++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 355678999999999999999999754 689999999876432 335567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccC----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 134 VYEYMPMGSLEDHLYDLE----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999986421 12456899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCC---Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhh
Q 017246 210 AKLGPVGD---NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 285 (375)
Q Consensus 210 a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 285 (375)
+....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... . ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--M----LTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--H----HHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--H----HHhc
Confidence 86533221 1112234579999999999875 56899999999999999999999999743321110 0 0000
Q ss_pred hccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..................++..+.+++.+||+.||.+||++.++++
T Consensus 242 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 --NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp --SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000111111223455678999999999999999999999994
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=345.56 Aligned_cols=273 Identities=23% Similarity=0.246 Sum_probs=200.7
Q ss_pred cHHHHHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccc-----------hHHHHHHHHHHccCCCCCcc
Q 017246 51 TFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG-----------HQEFIVEVLMLSLLHHDNLV 119 (375)
Q Consensus 51 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv 119 (375)
...++....++|++.+.||+|+||.||+|...+|..||||++....... .+.+.+|+.+++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3456677789999999999999999999988889999999986542221 26788999999999999999
Q ss_pred eeEeEEee-----CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 120 TLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 120 ~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
++++++.. ....++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 99999854 346899999997 588888864 3457999999999999999999999998 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 273 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 273 (375)
|++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999743221 22334678999999999887 6789999999999999999999999974332111
Q ss_pred cc-hhhchhh-hhh-----hccccchhcccccC-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 274 QN-LVSWSRP-FLK-----DQKKFVHLVDPLLH-------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 274 ~~-~~~~~~~-~~~-----~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. +...... ... ........+..... ...++.++..+.+||.+||+.||++||++.++++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00 0000000 000 00000000000000 0112345678999999999999999999999994
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=338.69 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=196.9
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--------cchHHHHHHHHHHccCCCCCcceeEeEEeeC
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 128 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 128 (375)
..++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999865 588999999865422 1223477899999999999999999998765
Q ss_pred CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc---eEEe
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLS 205 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~---vkl~ 205 (375)
+ .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 8999999999999999853 567999999999999999999999998 999999999999987665 9999
Q ss_pred ecCCCccCCCCCCceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 206 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 206 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...
T Consensus 160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---- 230 (322)
T 2ycf_A 160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD---- 230 (322)
T ss_dssp CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----
T ss_pred cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----
Confidence 99999754221 1223457899999999874 46789999999999999999999999964322111 000
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...... . . ........++..+.++|.+||+.||++||++.++++
T Consensus 231 ~~~~~~-~-~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITSGK-Y-N-----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTC-C-C-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCc-c-c-----cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000000 0 0 000001235678999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=338.74 Aligned_cols=252 Identities=28% Similarity=0.376 Sum_probs=197.7
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEee------CC
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS------GD 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~ 129 (375)
..++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.+++.+ +||||+++++++.. .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 4568999999999999999999874 68999999986543 3456788999999998 79999999999977 56
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 889999999999999999753 2457899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhh
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 284 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 284 (375)
+...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||........ .....
T Consensus 176 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~ 247 (326)
T 2x7f_A 176 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIP 247 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH
T ss_pred ceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHhh
Confidence 8753221 11233457999999999987 56789999999999999999999999963221100 00000
Q ss_pred hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 285 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........+..++..+.++|.+||+.||.+||++.++++
T Consensus 248 ----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 ----------RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ----------HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----------cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000011113445678999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.06 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=204.3
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccch-----------------HHHHHHHHHHccCCCCCccee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH-----------------QEFIVEVLMLSLLHHDNLVTL 121 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~-----------------~~~~~e~~~l~~l~h~niv~~ 121 (375)
.++|++.+.||+|+||.||+|.. +++.||+|++........ ..+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 899999999865432211 788999999999999999999
Q ss_pred EeEEeeCCeeEEEEeecCCCCHHHH------HhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcE
Q 017246 122 IGYCTSGDQRLLVYEYMPMGSLEDH------LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANI 194 (375)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Ni 194 (375)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ ++ |+|+||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 9999999999999999999999998 432 225679999999999999999999998 88 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccC-CCCc-cchhHhHHHHHHHHHhCCCCcccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTL-KSDIYSFGVVLLELITGRKAMDLSKGQG 272 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~pf~~~~~~~ 272 (375)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence 9999999999999999753222 33446799999999999877 6666 999999999999999999999743321
Q ss_pred ccchhhchh----hhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 273 EQNLVSWSR----PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 273 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........ .+......................++..+.+|+.+||+.||.+||++.++++
T Consensus 259 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 -VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00100000 0000000000000000001112456788999999999999999999999994
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=343.32 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=192.8
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCC------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------ 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 129 (375)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999765 68999999987542 233456788999999999999999999997665
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 7888874 34889999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhh--------c-
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVS--------W- 279 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~--------~- 279 (375)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+.. +
T Consensus 174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9753221 1233467999999999999999999999999999999999999999643321100 0000 0
Q ss_pred ------hhhhhhhcc-----ccchhcccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 280 ------SRPFLKDQK-----KFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 280 ------~~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...+..... .+........... .+...+..+.+||.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000 0000011110000 11234788999999999999999999999997
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=344.57 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=195.4
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCC------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------ 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 129 (375)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 457999999999999999999874 699999999865322 23456789999999999999999999997653
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999854 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhch----hhh
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWS----RPF 283 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~----~~~ 283 (375)
++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.... ..+
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9864321 234578999999999887 67999999999999999999999999743321100 000000 000
Q ss_pred hhh-----ccccchhcccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 284 LKD-----QKKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 284 ~~~-----~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... .......+..... ......++..+.+|+.+||+.||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 0000000000000 1122456778999999999999999999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=349.78 Aligned_cols=198 Identities=25% Similarity=0.325 Sum_probs=171.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccC------CCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL------HHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~ 131 (375)
..+|++.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999765 58999999997542 3345566788777776 578999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc--eEEeecCC
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSDFGL 209 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~--vkl~Dfg~ 209 (375)
++||||+. ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999995 6999998763 2455899999999999999999999998 999999999999999887 99999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 268 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 268 (375)
+...... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9753221 22357899999999999999999999999999999999999999643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=346.27 Aligned_cols=263 Identities=19% Similarity=0.217 Sum_probs=202.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC--------CCCcceeEeEEe---
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH--------HDNLVTLIGYCT--- 126 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~--- 126 (375)
.++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999764 6889999999654 233566788999998885 788999999987
Q ss_pred -eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCC----
Q 017246 127 -SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDF---- 200 (375)
Q Consensus 127 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~---- 200 (375)
.....++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 556889999999 66777777542 345699999999999999999999998 8 99999999999998775
Q ss_pred ---------------------------------------------ceEEeecCCCccCCCCCCceeeecccccccccccc
Q 017246 201 ---------------------------------------------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235 (375)
Q Consensus 201 ---------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 235 (375)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999754321 23357899999999
Q ss_pred ccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchh---------------------hhhhhccccchhc
Q 017246 236 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR---------------------PFLKDQKKFVHLV 294 (375)
Q Consensus 236 ~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~ 294 (375)
++.+..++.++|||||||++|||++|+.||................ .++........+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999997544322111000000 0000000000000
Q ss_pred ccc---------cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 295 DPL---------LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 295 ~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... -....+...+..+.+||.+||+.||++||++.|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 001245778889999999999999999999999993
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=336.87 Aligned_cols=258 Identities=17% Similarity=0.273 Sum_probs=201.2
Q ss_pred hhcccccceeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEEee--CCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTS--GDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+|+.+++.++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46899999999999999999976 46899999998643 3567889999999997 9999999999987 6778999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCccC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLG 213 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~~~ 213 (375)
|||+++++|.+++. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999883 3788999999999999999999998 99999999999999777 8999999999754
Q ss_pred CCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh--------hh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP--------FL 284 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------~~ 284 (375)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+...... ..
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHH
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHH
Confidence 3322 2234578999999999887 6789999999999999999999999953222110 00000000 00
Q ss_pred hh-c----ccc--------chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 285 KD-Q----KKF--------VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 285 ~~-~----~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. . ... ............+..++..+.+||.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0 000 0000111122223446889999999999999999999999993
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=334.81 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=200.6
Q ss_pred hhcccccceeccccceEEEEEEE--cCCceEEEEEccccCc--cchHHHHHHHHHHccC---CCCCcceeEeEEe-----
Q 017246 59 TRNFREANLIGEGGFGKVYKGRL--ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL---HHDNLVTLIGYCT----- 126 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----- 126 (375)
.++|++.+.||+|+||.||+|+. .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46899999999999999999987 3588999999865432 2233556677777666 8999999999987
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
.....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5577899999997 5999999763 2445899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhh-h
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-K 285 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~ 285 (375)
||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ......... .
T Consensus 164 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCC
T ss_pred CcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCC
Confidence 999975322 1223346789999999999999999999999999999999999999974332110 000000000 0
Q ss_pred hccccc-------hhcc---cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 286 DQKKFV-------HLVD---PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 286 ~~~~~~-------~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+. .... ......+...++..+.+||.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000 00001223456788999999999999999999999983
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=343.08 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=202.0
Q ss_pred HHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.+..++|++.+.||+|+||.||+|.... .+|+|++..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3446789999999999999999998753 499999875432 234557789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp ECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 9999999999999954 3456899999999999999999999998 99999999999998 679999999998653
Q ss_pred CCCC---Cceeeecccccccccccccccc---------CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchh
Q 017246 214 PVGD---NTHVSTRVMGTYGYCAPEYAMS---------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 281 (375)
Q Consensus 214 ~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 281 (375)
.... .........||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .. .
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~---~ 253 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---II---W 253 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---HH---H
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---H
Confidence 2111 1122233568999999999874 457899999999999999999999996432110 00 0
Q ss_pred hhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 282 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
. +.........+..++..+.+++.+||+.+|++||++.+|++.|+.+..+..
T Consensus 254 ~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 254 Q----------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp H----------HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred H----------hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 000000011122456678999999999999999999999999999987643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=329.68 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=197.8
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee----CCeeE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRL 132 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 132 (375)
..|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45889999999999999999765 688999999875432 335668899999999999999999998865 35689
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe-CCCceEEeecCCCc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK 211 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~-~~~~vkl~Dfg~a~ 211 (375)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ .+|+|+||||+|||++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999965 356899999999999999999999764 3499999999999997 78999999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||........ . ..
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~---~~---------- 240 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---YR---------- 240 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---HH----------
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--H---HH----------
Confidence 53222 223457999999999876 4589999999999999999999999963221110 0 00
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
.+........++...+..+.++|.+||+.||++||++.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 00000011112334456799999999999999999999999
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=339.49 Aligned_cols=270 Identities=22% Similarity=0.251 Sum_probs=192.6
Q ss_pred HHHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe--
Q 017246 54 ELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-- 130 (375)
Q Consensus 54 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-- 130 (375)
......++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+++..+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34456789999999999999999999875 68999999886543 334456778888888999999999999866443
Q ss_pred -----eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCCcccCCCCCCcEEEeC-CCce
Q 017246 131 -----RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--CKANPPVIYRDLKSANILLDN-DFNP 202 (375)
Q Consensus 131 -----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~~i~H~Dlkp~Nill~~-~~~v 202 (375)
.++||||+++ +|.+.+.........+++..++.++.||+.||.||| +++ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999976 666555544345677899999999999999999999 888 999999999999997 8999
Q ss_pred EEeecCCCccCCCCCCceeeeccccccccccccccccCC-CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchh
Q 017246 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 281 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 281 (375)
||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ ......
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHH
Confidence 999999998543222 223467899999999987654 89999999999999999999999974332111 111000
Q ss_pred hhhhhccccc----------h------hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 PFLKDQKKFV----------H------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ~~~~~~~~~~----------~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.......... . ..........+...+..+.+||.+||+.||.+||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000 0 00000111122346789999999999999999999999994
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=349.45 Aligned_cols=267 Identities=27% Similarity=0.341 Sum_probs=199.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeC------Cee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 131 (375)
..+|++.+.||+|+||.||+|++. +|+.||||++..... ...+|+.+++.++||||++++++|... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 347999999999999999999875 699999999865422 233699999999999999999988542 236
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEeecCCC
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLA 210 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~Dfg~a 210 (375)
++||||+++ +|.+.+.........+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999975 677776554445678999999999999999999999988 9999999999999965 56899999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh------
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF------ 283 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------ 283 (375)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+.......
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHH
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 85432221 2335789999999998765 7999999999999999999999999743221 1111111000
Q ss_pred -hh-hccccchhcccccC-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhhh
Q 017246 284 -LK-DQKKFVHLVDPLLH-----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYL 338 (375)
Q Consensus 284 -~~-~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~--L~~l 338 (375)
+. ..........+.+. ..++...+.++.+||.+||+.||.+||++.|+++. ++.+
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 00 00000000000000 01234567889999999999999999999999863 4444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=365.33 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=209.0
Q ss_pred HHHhhcccccceeccccceEEEEEEEc----CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCe
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 130 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 130 (375)
.+..++|++.+.||+|+||.||+|.+. .+..||+|.+..... ...+.+.+|+.+++.++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 345678999999999999999999864 245799999875432 33467889999999999999999999985 467
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 8999999999999999965 2446899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ... .
T Consensus 539 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~---~------- 604 (656)
T 2j0j_A 539 RYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---R------- 604 (656)
T ss_dssp CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---H-------
T ss_pred eecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---H-------
Confidence 8643222 122233557889999999999999999999999999999997 999996432111 000 0
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
+........+..++..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 605 ----i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 605 ----IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ----HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 000111234567788999999999999999999999999999998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=332.16 Aligned_cols=252 Identities=24% Similarity=0.267 Sum_probs=203.7
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---------cchHHHHHHHHHHccCC-CCCcceeEeEEe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---------QGHQEFIVEVLMLSLLH-HDNLVTLIGYCT 126 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 126 (375)
..++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3568999999999999999999875 689999999865431 12345778999999995 999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
..+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999965 356899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccc------cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 280 (375)
||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||....... . .
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~ 238 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---M---L 238 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---H---H
Confidence 99997543222 223467899999999885 4568899999999999999999999996332110 0 0
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....... ..........++..+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCC--------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0000000 00011112456788999999999999999999999984
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=346.60 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=195.8
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCe------eE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ------RL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~ 132 (375)
..+|++.+.||+|+||.||+|+...+..+|+|++...... ..+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999877667999988654222 2359999999999999999999865433 78
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe-CCCceEEeecCCCc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK 211 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~-~~~~vkl~Dfg~a~ 211 (375)
+||||+++ ++...+.........+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999976 444444433334667999999999999999999999998 99999999999999 78999999999997
Q ss_pred cCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh-------
Q 017246 212 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF------- 283 (375)
Q Consensus 212 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------- 283 (375)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......
T Consensus 191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQ 265 (394)
T ss_dssp ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHH
T ss_pred cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence 6432221 2345789999999998765 58999999999999999999999997433211 111100000
Q ss_pred hh-hcccc-----chhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 284 LK-DQKKF-----VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 284 ~~-~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+. ..... .......+...++..++.++.+||.+||+.||.+||++.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 00000 0000000011123446778999999999999999999999996
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=342.50 Aligned_cols=266 Identities=24% Similarity=0.282 Sum_probs=200.4
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeC-----Cee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 131 (375)
..+|++.+.||+|+||.||+|... ++..||||++..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 358999999999999999999865 688999999975432 2346788999999999999999999998665 468
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 599998853 45899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCC-ceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hchhh----hh
Q 017246 212 LGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSRP----FL 284 (375)
Q Consensus 212 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~----~~ 284 (375)
....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+ ..... ..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 5432211 111234679999999998764 55899999999999999999999999644322111000 00000 00
Q ss_pred hhcc--ccchhccccc-CC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 285 KDQK--KFVHLVDPLL-HG-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 285 ~~~~--~~~~~~~~~~-~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.... .......... .. .....++..+.+||.+||+.||++||++.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0000000000 00 112345678999999999999999999999994
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=338.83 Aligned_cols=263 Identities=18% Similarity=0.252 Sum_probs=199.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC-----------CCCcceeEeEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----------HDNLVTLIGYCT 126 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 126 (375)
.++|++.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.+. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999864 68999999997532 33456778999888876 899999999987
Q ss_pred eCC----eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEe----
Q 017246 127 SGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLD---- 197 (375)
Q Consensus 127 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~---- 197 (375)
..+ ..++|||++ +++|.+++.... ...+++..++.++.||+.||.|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 654 789999999 899999997632 45689999999999999999999997 8 99999999999995
Q ss_pred --CCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-
Q 017246 198 --NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ- 274 (375)
Q Consensus 198 --~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~- 274 (375)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 3447999999999754321 23357899999999999999999999999999999999999999754322110
Q ss_pred ---chhhch-----------------hhhhhhccccchhccc---------ccCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 017246 275 ---NLVSWS-----------------RPFLKDQKKFVHLVDP---------LLHGRYPRRCLNYAVAVTAMCLNEEANFR 325 (375)
Q Consensus 275 ---~~~~~~-----------------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~R 325 (375)
.+.... ..++.....+..+... .....++..++..+.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 000000 0000000000000000 00113567889999999999999999999
Q ss_pred CCHHHHHH
Q 017246 326 PLINDIVV 333 (375)
Q Consensus 326 Ps~~eil~ 333 (375)
|++.|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=344.67 Aligned_cols=252 Identities=12% Similarity=0.001 Sum_probs=181.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHH---HHccCCCCCcceeE-------eEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVL---MLSLLHHDNLVTLI-------GYC 125 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~~~-------~~~ 125 (375)
.+|++.+.||+|+||.||+|.+. +|+.||||++..... .....+.+|+. +|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45999999999999999999865 789999999987543 23445667754 5555 799988755 444
Q ss_pred eeC-----------------CeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCC
Q 017246 126 TSG-----------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR------MKIAVGAARGLEYLHCKANP 182 (375)
Q Consensus 126 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~~~~ 182 (375)
... ...+|||||++ |+|.+++.... ..+.+..+ ..++.||+.||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 333 34799999998 89999997632 22333444 677799999999999998
Q ss_pred CcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccccccccccccccc--CCCCccchhHhHHHHHHHHHh
Q 017246 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELIT 260 (375)
Q Consensus 183 ~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt 260 (375)
|+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999985321 1113557799999999987 679999999999999999999
Q ss_pred CCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 261 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 261 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
|+.||.............. .................++..+.+||.+||+.||++||++.++++
T Consensus 289 g~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999975432211100000 000000111111122466788999999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.90 Aligned_cols=268 Identities=22% Similarity=0.247 Sum_probs=184.1
Q ss_pred hhcccc-cceeccccceEEEEEEEc---CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEee--CCeeE
Q 017246 59 TRNFRE-ANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRL 132 (375)
Q Consensus 59 ~~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 132 (375)
.+.|++ +++||+|+||.||+|+.. +++.||||++.... ....+.+|+.+|+.++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345776 568999999999999865 57899999997543 23567889999999999999999999954 67899
Q ss_pred EEEeecCCCCHHHHHhccC-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE----eCCCceE
Q 017246 133 LVYEYMPMGSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPK 203 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill----~~~~~vk 203 (375)
+||||+.+ +|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999964 8888775322 12235899999999999999999999998 9999999999999 6778999
Q ss_pred EeecCCCccCCCCC-Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccc-------c
Q 017246 204 LSDFGLAKLGPVGD-NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-------Q 274 (375)
Q Consensus 204 l~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-------~ 274 (375)
|+|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||........ .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999997643221 1122344679999999999987 4589999999999999999999999964332110 0
Q ss_pred chhhchhhhhh--hccccch---------h---cccccCCC---------CCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 017246 275 NLVSWSRPFLK--DQKKFVH---------L---VDPLLHGR---------YPRRCLNYAVAVTAMCLNEEANFRPLINDI 331 (375)
Q Consensus 275 ~~~~~~~~~~~--~~~~~~~---------~---~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~RPs~~ei 331 (375)
.+.... ..+. ....+.. . +....... .....+..+.+||.+||+.||.+|||+.|+
T Consensus 253 ~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 253 QLDRIF-NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHH-HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHH-HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 000000 0000 0000000 0 00000000 001125678899999999999999999999
Q ss_pred HH
Q 017246 332 VV 333 (375)
Q Consensus 332 l~ 333 (375)
++
T Consensus 332 L~ 333 (405)
T 3rgf_A 332 MQ 333 (405)
T ss_dssp HT
T ss_pred hc
Confidence 95
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=327.42 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=194.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEee----------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS---------- 127 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 127 (375)
.++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 568999999999999999999865 6899999998653 2345678899999999999999999998865
Q ss_pred ---CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEE
Q 017246 128 ---GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 204 (375)
Q Consensus 128 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl 204 (375)
.+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 4567899999999999999975 3456788999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCC------------CceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccc
Q 017246 205 SDFGLAKLGPVGD------------NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 271 (375)
Q Consensus 205 ~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~ 271 (375)
+|||++....... .........||+.|+|||++.+. .++.++|||||||++|+|++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999997543211 01122345789999999999864 68999999999999999998 44311100
Q ss_pred cccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 272 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....... . .....+...++...+..+.+++.+||+.||++||++.++++
T Consensus 235 -----~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 -----VNILKKL-------R-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -----HHHHHHH-------H-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----HHHHHhc-------c-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0000000 0 01111223345667778999999999999999999999994
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=344.13 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=183.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeC------C
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------D 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 129 (375)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999764 68999999986542 23356778999999999999999999998654 5
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
..++|+|++ +++|.+++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999998 789988884 356999999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccc-hhhchh----hh
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSR----PF 283 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~----~~ 283 (375)
++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... +..... ..
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 975322 1234679999999999887 678999999999999999999999996433211000 000000 00
Q ss_pred hhh--ccccchhcccc---cCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 284 LKD--QKKFVHLVDPL---LHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 284 ~~~--~~~~~~~~~~~---~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... .......+... .... .....+..+.+||.+||+.||++||++.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000 00000000000 0000 01234678899999999999999999999995
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=327.23 Aligned_cols=250 Identities=23% Similarity=0.297 Sum_probs=202.7
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 44678999999999999999999875 68999999986543 2346778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC---CceEEeecCCC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLA 210 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~---~~vkl~Dfg~a 210 (375)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998865 346899999999999999999999998 9999999999999764 46999999998
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcccc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 290 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (375)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... . ......
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~~~----- 236 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---I---LKRVET----- 236 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHH-----
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHc-----
Confidence 7543221 1223468999999998865 48999999999999999999999996432110 0 000000
Q ss_pred chhcccccCCCC--CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 291 VHLVDPLLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 291 ~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....... ...++..+.++|.+||+.||++||++.++++
T Consensus 237 -----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 237 -----GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000011 1345678999999999999999999999997
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=332.90 Aligned_cols=264 Identities=19% Similarity=0.270 Sum_probs=203.1
Q ss_pred HhhcccccceeccccceEEEEEEE-c-CCceEEEEEccccCccchHHHHHHHHHHccCCCC------CcceeEeEEeeCC
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRL-E-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD------NLVTLIGYCTSGD 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~ 129 (375)
..++|++.+.||+|+||.||+|.. . +++.||+|++.... .....+.+|+.+++.++|+ +++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 356899999999999999999976 3 68899999986532 3346678899998888665 4999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-----------
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN----------- 198 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~----------- 198 (375)
..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 88999999762 2346899999999999999999999998 999999999999987
Q ss_pred --------CCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccc
Q 017246 199 --------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 270 (375)
Q Consensus 199 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~ 270 (375)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999753221 2346789999999999999999999999999999999999999974332
Q ss_pred ccccchhhch-----hhhhhhcc----------c----------cchhcccc-cCCCCCHHHHHHHHHHHHhhcCCCCCC
Q 017246 271 QGEQNLVSWS-----RPFLKDQK----------K----------FVHLVDPL-LHGRYPRRCLNYAVAVTAMCLNEEANF 324 (375)
Q Consensus 271 ~~~~~~~~~~-----~~~~~~~~----------~----------~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~ 324 (375)
.......... ........ . ......+. .....+...+..+.+||.+||+.||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 2110000000 00000000 0 00000000 001224567889999999999999999
Q ss_pred CCCHHHHHH
Q 017246 325 RPLINDIVV 333 (375)
Q Consensus 325 RPs~~eil~ 333 (375)
||++.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=337.51 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=196.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCee----
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR---- 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---- 131 (375)
.++|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999865 6899999999764322 246788999999999999999999999877665
Q ss_pred --EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 132 --LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 132 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
++||||+. ++|.+++ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 5888877 334899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhch----hhh
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWS----RPF 283 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~----~~~ 283 (375)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...... ..+
T Consensus 191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 975322 1234678999999999887 67899999999999999999999999743221100 000000 000
Q ss_pred hhh-----ccccchhcccccCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 284 LKD-----QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 284 ~~~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... .......+...... .....++..+.+||.+||+.||++||++.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000 00000000000000 012345788999999999999999999999994
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=331.56 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=195.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEe-----------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT----------- 126 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----------- 126 (375)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999876 58999999997766566678899999999999999999999873
Q ss_pred ---eCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe-CCCce
Q 017246 127 ---SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNP 202 (375)
Q Consensus 127 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~-~~~~v 202 (375)
.....++||||+. |+|.+++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 4467899999997 59999984 356899999999999999999999998 99999999999997 56789
Q ss_pred EEeecCCCccCCCCC-Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhch
Q 017246 203 KLSDFGLAKLGPVGD-NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 280 (375)
||+|||++....... .........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999997543211 1112234567999999998875 67899999999999999999999999743321100000000
Q ss_pred hhhh--hhccc----cchhcccccC-C-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 281 RPFL--KDQKK----FVHLVDPLLH-G-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 281 ~~~~--~~~~~----~~~~~~~~~~-~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+.. ..... ....+..... . .....++..+.++|.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000 00000 0000000000 0 012346788999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=332.92 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=181.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHH-HHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 468999999999999999999875 689999999976432 22334555555 778889999999999999999999999
Q ss_pred eecCCCCHHHHHhcc-CCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 136 EYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 136 e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||+++ +|.+++... ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 888777532 12356789999999999999999999998 8 999999999999999999999999999753
Q ss_pred CCCCCceeeecccccccccccccc----ccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYA----MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
... .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ .. ..
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~-----------~~ 241 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-QL-----------TQ 241 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------CC
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-HH-----------HH
Confidence 222 122334799999999998 456789999999999999999999999964321100 00 00
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
......+.+.......++..+.+|+.+||+.||++||++.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000111111222456778999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=335.83 Aligned_cols=263 Identities=21% Similarity=0.294 Sum_probs=198.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeC-----Cee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 131 (375)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999875 689999999965432 2345678899999999999999999987654 678
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 589998854 46899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCc--------eeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 212 LGPVGDNT--------HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 212 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .. ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~-~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL--LL-IFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HH-HHH
Confidence 54322111 01223578999999998764 67899999999999999999999999743321100 00 000
Q ss_pred hhhhc-----------cccchhcccc---cCC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 FLKDQ-----------KKFVHLVDPL---LHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 ~~~~~-----------~~~~~~~~~~---~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... ......+... ... ...+.++..+.+||.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 0000000000 000 012356778999999999999999999999994
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.23 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=196.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEeeCCe-----
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ----- 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 130 (375)
.++|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357999999999999999999865 6899999998764322 24567889999999999999999999987654
Q ss_pred -eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 131 -RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 131 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
.++||||+. ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58877762 34899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh------
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP------ 282 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------ 282 (375)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +......
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGT 245 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence 9753221 233578999999999887 6789999999999999999999999974332110 0000000
Q ss_pred -hhhh--c---cccchhcccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 -FLKD--Q---KKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 -~~~~--~---~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+... . ......+..... ......++..+.+||.+||+.||++||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0 000000000001 1223467889999999999999999999999994
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=331.42 Aligned_cols=253 Identities=21% Similarity=0.225 Sum_probs=175.1
Q ss_pred Hhhcccccc-eeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEee----CCee
Q 017246 58 ATRNFREAN-LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQR 131 (375)
Q Consensus 58 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 131 (375)
..++|.+.+ +||+|+||.||+|... +|+.||||++... .....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356899854 6999999999999876 6999999998643 1222223334566799999999999876 4558
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC---CceEEeecC
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFG 208 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~---~~vkl~Dfg 208 (375)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 9999999999999999752 2457999999999999999999999998 9999999999999764 459999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ...
T Consensus 177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~------ 244 (336)
T 3fhr_A 177 FAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRR------ 244 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHh------
Confidence 99753221 223457899999999998889999999999999999999999999643322110000 000
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. ..............++..+.+||.+||+.||++||++.++++
T Consensus 245 -~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 245 -I-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -h-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 000000111112456778999999999999999999999996
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=341.22 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=188.5
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+.|.+.+.||+|+||+||.+...+|+.||||++... ....+.+|+.++..+ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456778899999999998776677999999998653 235677899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCC---CCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-------------Cce
Q 017246 139 PMGSLEDHLYDLEPDQEP---LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-------------FNP 202 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-------------~~v 202 (375)
. |+|.+++......... ..+..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 5999999753322211 133356789999999999999998 9999999999999764 479
Q ss_pred EEeecCCCccCCCCCCc--eeeecccccccccccccccc-------CCCCccchhHhHHHHHHHHHh-CCCCcccccccc
Q 017246 203 KLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQG 272 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 272 (375)
||+|||++......... ......+||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999864332211 11234679999999999975 668999999999999999999 999996322111
Q ss_pred ccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 273 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ........ +.........++.++.+||.+||+.||.+||++.+|++
T Consensus 248 -~~-------i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -SN-------IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HH-------HHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HH-------HhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 00000000 11111224578899999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=328.26 Aligned_cols=243 Identities=25% Similarity=0.405 Sum_probs=192.5
Q ss_pred HHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc------chHHHHHHHHHHccC----CCCCcceeEeE
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLL----HHDNLVTLIGY 124 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~~~ 124 (375)
....++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 455678999999999999999999764 6889999999765332 223345688888888 89999999999
Q ss_pred EeeCCeeEEEEee-cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe-CCCce
Q 017246 125 CTSGDQRLLVYEY-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNP 202 (375)
Q Consensus 125 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~-~~~~v 202 (375)
+...+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999965 346899999999999999999999998 99999999999999 88999
Q ss_pred EEeecCCCccCCCCCCceeeeccccccccccccccccCCCC-ccchhHhHHHHHHHHHhCCCCccccccccccchhhchh
Q 017246 203 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 281 (375)
Q Consensus 203 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 281 (375)
||+|||++....... .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||.....
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------- 244 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------- 244 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence 999999997643222 2345689999999998876664 589999999999999999999963210
Q ss_pred hhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 282 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... . ...++..++..+.++|.+||+.+|++||++.++++
T Consensus 245 -~~~----------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -ILE----------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHH----------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -Hhh----------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 11234556778999999999999999999999995
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=331.61 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=200.5
Q ss_pred HHHHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc------chHHHHHHHHHHccCC--CCCcceeEeEE
Q 017246 55 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLH--HDNLVTLIGYC 125 (375)
Q Consensus 55 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~ 125 (375)
.....++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|+.+++.+. ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3445678999999999999999999764 6899999999765332 2244667999999986 59999999999
Q ss_pred eeCCeeEEEEeecCC-CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe-CCCceE
Q 017246 126 TSGDQRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPK 203 (375)
Q Consensus 126 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~-~~~~vk 203 (375)
...+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999976 899999965 456899999999999999999999998 99999999999999 789999
Q ss_pred EeecCCCccCCCCCCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 282 (375)
|+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 191 L~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------ 254 (320)
T 3a99_A 191 LIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------ 254 (320)
T ss_dssp ECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------
T ss_pred EeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------
Confidence 9999999764322 1234579999999999987665 6889999999999999999999963210
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... . ...++..++..+.+||.+||+.||++||++.+|++
T Consensus 255 ~~~-~-----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 IIR-G-----------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHH-C-----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhc-c-----------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 00123455678999999999999999999999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=337.29 Aligned_cols=250 Identities=22% Similarity=0.249 Sum_probs=187.8
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..+|.+.++||+|+||+||.....+++.||||++...... .+.+|+.+|+.+ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4579999999999999977665667999999999764332 345799999998 799999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---C--CceEEeecCCCcc
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---D--FNPKLSDFGLAKL 212 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~--~~vkl~Dfg~a~~ 212 (375)
+. |+|.+++... ...+.+..++.++.||+.||.|||+++ |+||||||+||||+. + ..+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 5999999753 233444567899999999999999998 999999999999953 2 3578999999976
Q ss_pred CCCCCC-ceeeeccccccccccccccc---cCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhc
Q 017246 213 GPVGDN-THVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 213 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
...... .......+||+.|+|||++. ...++.++|||||||++|||++ |..||........ . .....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~----~~~~~ 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----N----ILLGA 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----H----HHTTC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----H----HHhcc
Confidence 433221 12234467999999999997 4567889999999999999999 8999853211100 0 00000
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.. ..........+..+.+||.+||+.||.+||++.+|++
T Consensus 245 ~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CS-------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CC-------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC-------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 0001123456677899999999999999999999994
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=328.37 Aligned_cols=262 Identities=18% Similarity=0.234 Sum_probs=199.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CC-ceEEEEEccccCccchHHHHHHHHHHccCCCCC------cceeEeEEeeCCe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SG-QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN------LVTLIGYCTSGDQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~ 130 (375)
.++|++.+.||+|+||.||+|... ++ ..||+|++... ......+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 568999999999999999999864 34 68999999653 233556778999998887655 8999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEE--------------
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL-------------- 196 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill-------------- 196 (375)
.++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 99999999 66787877652 2356899999999999999999999988 9999999999999
Q ss_pred -----eCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccc
Q 017246 197 -----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 271 (375)
Q Consensus 197 -----~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 271 (375)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 67789999999999753221 23467999999999999999999999999999999999999999743321
Q ss_pred cccchhhch-----hhhhhhccc--------------------cchhcccc-cCCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 017246 272 GEQNLVSWS-----RPFLKDQKK--------------------FVHLVDPL-LHGRYPRRCLNYAVAVTAMCLNEEANFR 325 (375)
Q Consensus 272 ~~~~~~~~~-----~~~~~~~~~--------------------~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~R 325 (375)
......... ..+...... ......+. .........+..+.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 110000000 000000000 00000000 0001234567789999999999999999
Q ss_pred CCHHHHH
Q 017246 326 PLINDIV 332 (375)
Q Consensus 326 Ps~~eil 332 (375)
|++.+++
T Consensus 326 pt~~e~l 332 (355)
T 2eu9_A 326 ITLAEAL 332 (355)
T ss_dssp CCHHHHT
T ss_pred cCHHHHh
Confidence 9999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=330.99 Aligned_cols=199 Identities=28% Similarity=0.331 Sum_probs=168.9
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC-CC-----CcceeEeEEeeCCe
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HD-----NLVTLIGYCTSGDQ 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~ 130 (375)
..++|++.+.||+|+||.||+|... +++.||||++.... .....+..|+.+++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999865 68899999997532 23456677888887774 44 49999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc--CCCCCcccCCCCCCcEEEe--CCCceEEee
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC--KANPPVIYRDLKSANILLD--NDFNPKLSD 206 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~~~~i~H~Dlkp~Nill~--~~~~vkl~D 206 (375)
.++||||+. ++|.+++... ....+++..++.++.||+.||.|||+ .+ |+||||||+||||+ .++.+||+|
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred eEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999996 5999999763 23568999999999999999999995 45 99999999999995 477899999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccc
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 268 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 268 (375)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999764321 23467899999999999999999999999999999999999999743
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=322.57 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=181.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc--hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
.++|++.+.||+|+||.||+|... +|+.||||++....... ...+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999875 68999999997653322 223444556788889999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
||+ ++.+..+... ....+++..++.++.||+.||.|||++ + |+|+||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5555555533 245689999999999999999999985 8 9999999999999999999999999997532
Q ss_pred CCCCceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||....... ..........
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-- 246 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEE-- 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSC--
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccC--
Confidence 221 223457999999999984 4568899999999999999999999996422110 0000010000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.+.+ .....++..+.++|.+||+.||.+||++.+|++
T Consensus 247 -----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 -----PPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -----CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----CCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0001 111246678999999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=347.63 Aligned_cols=272 Identities=26% Similarity=0.314 Sum_probs=206.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEcccc-CccchHHHHHHHHHHccCCCCCcceeEeEEee------CCe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 130 (375)
.++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999764 6899999998764 22335668899999999999999999998765 677
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc---eEEeec
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDF 207 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~---vkl~Df 207 (375)
.++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999997633 2346888999999999999999999998 999999999999997765 899999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|........
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~ 240 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKS 240 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC---
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhccc
Confidence 9998643322 223467999999999999999999999999999999999999999642111 11100000000
Q ss_pred ---cccchh------ccc--ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHH-----HHHHHhhhhhcc
Q 017246 288 ---KKFVHL------VDP--LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND-----IVVALDYLVSQR 342 (375)
Q Consensus 288 ---~~~~~~------~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e-----il~~L~~l~~~~ 342 (375)
...... ... .....+...++..+.++|.+||+.||++||++.+ +.+.++.+....
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000000 000 1112345678999999999999999999999988 667777777654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=311.51 Aligned_cols=235 Identities=15% Similarity=0.105 Sum_probs=186.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
.++|++.+.||+|+||.||+|... +++.||||++....... ...+.+|+.++..++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999875 58999999997654332 36788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||++|++|.+++.. . .....+..++.||+.||.|||+++ |+||||||+|||++.+|.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999842 2 355678999999999999999998 9999999999999999999998543
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
|++| ++.++|||||||++|||++|+.||............. . ..... .
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--~-~~~~~------~ 222 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--R-DTAGQ------P 222 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--B-CTTSC------B
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--H-HhccC------C
Confidence 3333 6899999999999999999999997543221100000 0 00000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
.........++..+.++|.+||+.||++| |+.++++.|+++.....
T Consensus 223 --~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 223 --IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp --CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred --CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00001123567789999999999999999 99999999999986554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=349.08 Aligned_cols=242 Identities=23% Similarity=0.319 Sum_probs=195.4
Q ss_pred HhhcccccceeccccceEEEEEEEc--CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCe----
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ---- 130 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 130 (375)
..++|++.+.||+|+||.||++.+. +|+.||||++..... .....+.+|+.++..++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3578999999999999999999875 589999999865432 334567899999999999999999999987665
Q ss_pred -eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 131 -RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 131 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
.||||||++|++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 799999999999988763 26899999999999999999999998 9999999999999885 899999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.......
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------- 283 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------- 283 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence 9764322 3467999999999987654 899999999999999999998886311100
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHHhhhhh
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVVALDYLVS 340 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~eil~~L~~l~~ 340 (375)
+ .........+..+.++|.+||+.||++||+ ++++...|..+..
T Consensus 284 ---~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 ---L----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ---C----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ---c----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0 000111234568899999999999999995 6666666766643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.24 Aligned_cols=242 Identities=17% Similarity=0.177 Sum_probs=180.9
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHHHHHHHHccCCC-CCcce--------------
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHH-DNLVT-------------- 120 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~-------------- 120 (375)
..|...++||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.+.| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45888999999999999999854 699999999874322 235678899999999977 22111
Q ss_pred -------eEeEEee-----CCeeEEEEeecCCCCHHHHHhcc---CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcc
Q 017246 121 -------LIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDL---EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185 (375)
Q Consensus 121 -------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~ 185 (375)
+..++.. ....+++|+++ +++|.+++... ...+..+++..++.++.||+.||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 12356777765 67999988532 233556788899999999999999999998 99
Q ss_pred cCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccccccccccccc----------ccCCCCccchhHhHHHHH
Q 017246 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----------MSGKLTLKSDIYSFGVVL 255 (375)
Q Consensus 186 H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~il 255 (375)
||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999875321 1344678 999999999 555688999999999999
Q ss_pred HHHHhCCCCccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 256 LELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 256 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
|||++|+.||........ ...+ +.. ...++..+.+||.+||+.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~----------------~~~~----~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG----------------SEWI----FRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC----------------SGGG----GSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh----------------HHHH----Hhh--cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999964321110 0001 110 1134578999999999999999999777654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=304.88 Aligned_cols=226 Identities=20% Similarity=0.271 Sum_probs=179.1
Q ss_pred hccccc-ceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHH-ccCCCCCcceeEeEEee----CCeeE
Q 017246 60 RNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLML-SLLHHDNLVTLIGYCTS----GDQRL 132 (375)
Q Consensus 60 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~ 132 (375)
++|.+. +.||+|+||.||++... +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 467776 78999999999999864 689999999853 34567788887 66699999999999877 67889
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---CCceEEeecCC
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGL 209 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~vkl~Dfg~ 209 (375)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999762 3457999999999999999999999998 999999999999998 78899999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
+.... +..++.++|||||||++|+|++|+.||............
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~------------ 210 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 210 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS------------
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH------------
Confidence 86421 245688999999999999999999999643221100000
Q ss_pred cchhcccccCCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 290 FVHLVDPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 290 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...+... ...++ ..++..+.+++.+||+.||++||++.++++
T Consensus 211 ~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 211 KTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 00112 346778999999999999999999999995
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=319.32 Aligned_cols=243 Identities=19% Similarity=0.177 Sum_probs=185.6
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCc--------cchHHHHHHHHHHccCC---------CCCcc
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--------QGHQEFIVEVLMLSLLH---------HDNLV 119 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~niv 119 (375)
...++|++.+.||+|+||.||+|+. +|+.||||++..... .....+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3457899999999999999999987 589999999976532 22367888999888885 66666
Q ss_pred eeEeEE-----------------ee-------------CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 017246 120 TLIGYC-----------------TS-------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169 (375)
Q Consensus 120 ~~~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi 169 (375)
++.+.+ .+ .+..+|||||+++|++.+.+. +..+++..++.++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHH
Confidence 666653 32 688999999999998777663 2568999999999999
Q ss_pred HHHHHHhh-cCCCCCcccCCCCCCcEEEeCCC--------------------ceEEeecCCCccCCCCCCceeeeccccc
Q 017246 170 ARGLEYLH-CKANPPVIYRDLKSANILLDNDF--------------------NPKLSDFGLAKLGPVGDNTHVSTRVMGT 228 (375)
Q Consensus 170 ~~~l~~LH-~~~~~~i~H~Dlkp~Nill~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt 228 (375)
+.||.||| +++ |+||||||+||||+.++ .+||+|||+++.... ...+||
T Consensus 171 ~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt 240 (336)
T 2vuw_A 171 TASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFC 240 (336)
T ss_dssp HHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECC
T ss_pred HHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEe
Confidence 99999999 899 99999999999999887 899999999985322 134799
Q ss_pred cccccccccccCCCCccchhHhHHHH-HHHHHhCCCCccccccccccchhhchhhhhhhccccch-hcccccCCCCCHHH
Q 017246 229 YGYCAPEYAMSGKLTLKSDIYSFGVV-LLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH-LVDPLLHGRYPRRC 306 (375)
Q Consensus 229 ~~y~aPE~~~~~~~~~~~DvwslG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 306 (375)
+.|+|||++.+.. +.++|||||+++ .+++++|..||... .|...... ..... ..........+..+
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTD--KMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHH--HHHHTCCCSSCCCSHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHH--hhhhhhccCcccchhhhhhc
Confidence 9999999998766 899999998777 77788899998521 00000000 00000 00001111123578
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 307 LNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 307 ~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
+.++.+||.+||+.| |+.|++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 899999999999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=290.57 Aligned_cols=186 Identities=18% Similarity=0.103 Sum_probs=131.6
Q ss_pred eeccccceEEEEEE-EcCCceEEEEEccccCc----------cchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEEE
Q 017246 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL----------QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 67 ~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 134 (375)
.++.|++|.+..++ .-.|+.|++|++.+... ...+++.+|+.+|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666654 34589999999965421 1235688999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||++|++|.++|.. +..+++. .|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999964 4556653 58899999999999999 9999999999999999999999999998643
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 265 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 265 (375)
.. .......+||+.|||||++.+ .+..++|+|++|+++++|.++..++
T Consensus 391 ~~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QD--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 22 222345789999999999875 4677899999999999887776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=255.50 Aligned_cols=185 Identities=19% Similarity=0.222 Sum_probs=144.9
Q ss_pred cccceeccccceEEEEEEEcCCceEEEEEccccCccc--------hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 63 REANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 63 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
...++||+|+||.||++.. .+..+++|+........ .+.+.+|+.+++.++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 47889998865432211 23478999999999999999666666677888999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++++|.+++.. ++.++.||+.||.|||+++ |+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999943 4689999999999999998 999999999999998 99999999998653
Q ss_pred CCCCce-----eeecccccccccccccccc--CCCCccchhHhHHHHHHHHHhCCCCc
Q 017246 215 VGDNTH-----VSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAM 265 (375)
Q Consensus 215 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf 265 (375)
...... .....+||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 321111 1235789999999999986 66888899999999999988887766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=212.61 Aligned_cols=149 Identities=13% Similarity=0.025 Sum_probs=119.7
Q ss_pred HHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCcc------------------chHHHHHHHHHHccCCCCCc
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ------------------GHQEFIVEVLMLSLLHHDNL 118 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~ni 118 (375)
.....|.+.+.||+|+||.||+|...+|+.||+|+++..... ....+.+|+.+++.++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 334567778999999999999998877999999999653221 2346789999999998 4
Q ss_pred ceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC
Q 017246 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 198 (375)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~ 198 (375)
+++.+++.. +..++||||++|++|.+ +.. .....++.||+.||.|||+++ |+||||||+|||++
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS- 227 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence 666665544 56799999999999988 421 134579999999999999998 99999999999999
Q ss_pred CCceEEeecCCCccCCCCCCceeeecccccccccccccccc
Q 017246 199 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239 (375)
Q Consensus 199 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 239 (375)
++.+||+|||++.. +..++|||++..
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999862 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-22 Score=178.01 Aligned_cols=136 Identities=17% Similarity=0.085 Sum_probs=106.4
Q ss_pred cccccceeccccceEEEEEEE-cCCce--EEEEEccccCccc------------------------hHHHHHHHHHHccC
Q 017246 61 NFREANLIGEGGFGKVYKGRL-ESGQL--VAIKQLNHEGLQG------------------------HQEFIVEVLMLSLL 113 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vaiK~~~~~~~~~------------------------~~~~~~e~~~l~~l 113 (375)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999987 67888 9999875432110 12577899999999
Q ss_pred CCCCc--ceeEeEEeeCCeeEEEEeecCC-C----CHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCcc
Q 017246 114 HHDNL--VTLIGYCTSGDQRLLVYEYMPM-G----SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKANPPVI 185 (375)
Q Consensus 114 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~i~ 185 (375)
.|+++ +.++.+ +..+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88764 344432 356899999932 3 67766532 123467889999999999999 888 99
Q ss_pred cCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 186 YRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 186 H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
||||||+|||++. .++|+|||++..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999988 899999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-20 Score=171.92 Aligned_cols=135 Identities=14% Similarity=0.117 Sum_probs=99.0
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCcc--------------chHH--------HHHHHHHHccCCCCC
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--------------GHQE--------FIVEVLMLSLLHHDN 117 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------------~~~~--------~~~e~~~l~~l~h~n 117 (375)
.-|++...||.|+||.||+|...+|+.||||+++..... .... ...|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 349999999999999999999888999999987542110 0111 123555666664443
Q ss_pred cc--eeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEE
Q 017246 118 LV--TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 195 (375)
Q Consensus 118 iv--~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nil 195 (375)
+. ..++. ...+|||||++|++|..+... .....++.||+.+|.+||+.| ||||||||.|||
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL 237 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL 237 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence 32 22222 234799999999888654311 234678899999999999998 999999999999
Q ss_pred EeCCC----------ceEEeecCCCc
Q 017246 196 LDNDF----------NPKLSDFGLAK 211 (375)
Q Consensus 196 l~~~~----------~vkl~Dfg~a~ 211 (375)
|++++ .+.|+||+-+.
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EeCCCCcccccccccceEEEEeCCcc
Confidence 98876 38999999765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.6e-14 Score=126.10 Aligned_cols=143 Identities=15% Similarity=0.049 Sum_probs=112.9
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
...|++...++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.++++++...+..|+||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 456888899999999999999755 6889999986532233446788999998884 67788999999988999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------------------------------- 180 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------- 180 (375)
++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 92 i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 92 ADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred cCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876411 1123478889999999999810
Q ss_pred -------------------CCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 181 -------------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 181 -------------------~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
...++|+|++|.|||+++++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876566799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=7.5e-13 Score=117.12 Aligned_cols=136 Identities=17% Similarity=0.101 Sum_probs=100.2
Q ss_pred cccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCC--cceeEeEEeeCCeeEEEEeec
Q 017246 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~ 138 (375)
.+.+..+.+.|..+.||++...+|..+++|+.... ....+..|+.+++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 35544444466679999998777888999987554 2245677898888885444 556888888878899999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-------------------------------------- 180 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------- 180 (375)
+|.+|. ... .. ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998884 211 11 2356777888888888642
Q ss_pred -----------------CCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 181 -----------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 181 -----------------~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
...++|+|++|.|||+++++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=7.3e-12 Score=116.45 Aligned_cols=142 Identities=15% Similarity=0.179 Sum_probs=106.2
Q ss_pred ccceeccccceEEEEEEEcCCceEEEEEcc--ccC-ccchHHHHHHHHHHccCC--CCCcceeEeEEeeC---CeeEEEE
Q 017246 64 EANLIGEGGFGKVYKGRLESGQLVAIKQLN--HEG-LQGHQEFIVEVLMLSLLH--HDNLVTLIGYCTSG---DQRLLVY 135 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~ 135 (375)
..+.|+.|.++.||++... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4677899999999999876 4678899876 322 122346778999998886 34578888888766 4488999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA----------------------------------- 180 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------- 180 (375)
||++|..+.+.. ...++......++.+++..|..||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999998775422 234678888999999999999999731
Q ss_pred --------------------CCCcccCCCCCCcEEEeCCCc--eEEeecCCCcc
Q 017246 181 --------------------NPPVIYRDLKSANILLDNDFN--PKLSDFGLAKL 212 (375)
Q Consensus 181 --------------------~~~i~H~Dlkp~Nill~~~~~--vkl~Dfg~a~~ 212 (375)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999987753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.24 E-value=2.8e-12 Score=116.45 Aligned_cols=183 Identities=20% Similarity=0.218 Sum_probs=121.2
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCC-CCC--cceeEeEEeeCC---eeEEEEeec
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDN--LVTLIGYCTSGD---QRLLVYEYM 138 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~ 138 (375)
.+.++.|....||++. ..+++|+.... .....+..|+.+++.+. +.. +.+++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4668999999999863 56889986432 33466788999998873 332 345555443333 347899999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-------------------------------------- 180 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------- 180 (375)
+|.+|.+... ..++..+...++.+++..|..||+..
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988875432 23667777888888888888888521
Q ss_pred -----------------CCCcccCCCCCCcEEEeC--CCceEEeecCCCccCCCCCCceeeecccccccc---ccccccc
Q 017246 181 -----------------NPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY---CAPEYAM 238 (375)
Q Consensus 181 -----------------~~~i~H~Dlkp~Nill~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aPE~~~ 238 (375)
...++|+|++|.||++++ +..+.|+||+.+......... .....+ ..|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHHH
Confidence 134799999999999998 456789999998653221100 000001 1222111
Q ss_pred c-----CC---------CCccchhHhHHHHHHHHHhCCCCc
Q 017246 239 S-----GK---------LTLKSDIYSFGVVLLELITGRKAM 265 (375)
Q Consensus 239 ~-----~~---------~~~~~DvwslG~il~elltg~~pf 265 (375)
. +. .....+.|+++.++|.+.+|..+|
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 00 112368999999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=2.9e-08 Score=89.92 Aligned_cols=136 Identities=20% Similarity=0.171 Sum_probs=95.8
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCC---CcceeEeEEe-eCCeeEEEEeecCC
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD---NLVTLIGYCT-SGDQRLLVYEYMPM 140 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 140 (375)
.+.++.|....||+. |..+++|+... ......+..|+.+|+.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 466888999999987 56788997432 23345788899999998642 3556666664 34567899999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA---------------------------------------- 180 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------- 180 (375)
.+|.+... ..++......++.+++..|..||+..
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88876331 12345555566666666666666432
Q ss_pred -----------------CCCcccCCCCCCcEEEeC---CCce-EEeecCCCcc
Q 017246 181 -----------------NPPVIYRDLKSANILLDN---DFNP-KLSDFGLAKL 212 (375)
Q Consensus 181 -----------------~~~i~H~Dlkp~Nill~~---~~~v-kl~Dfg~a~~ 212 (375)
...++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123699999999999987 4554 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.5e-07 Score=82.01 Aligned_cols=135 Identities=18% Similarity=0.132 Sum_probs=96.6
Q ss_pred eeccccce-EEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 67 LIGEGGFG-KVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 67 ~lg~G~~g-~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
.+..|..| .||+.... ++..+++|+-... ....+..|...|+.+. +-.+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445544 68988755 4677999976432 3456778999888774 33467889999999999999999999888
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------------------------------------- 180 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------- 180 (375)
.+..... ......+..+++..|..||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7765321 1223456666777777777431
Q ss_pred ------------CCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 181 ------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 181 ------------~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01279999999999999877777999998853
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=5.7e-08 Score=89.90 Aligned_cols=80 Identities=8% Similarity=-0.021 Sum_probs=55.5
Q ss_pred ccee-ccccceEEEEEEEc-------CCceEEEEEccccC---ccchHHHHHHHHHHccCCC---CCcceeEeEEeeC--
Q 017246 65 ANLI-GEGGFGKVYKGRLE-------SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHH---DNLVTLIGYCTSG-- 128 (375)
Q Consensus 65 ~~~l-g~G~~g~V~~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~-- 128 (375)
.+.| +.|....+|++... ++..+++|+..... ......+..|+.+++.+.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88989999998754 26678999865432 1112456778888877742 3567788776654
Q ss_pred -CeeEEEEeecCCCCHH
Q 017246 129 -DQRLLVYEYMPMGSLE 144 (375)
Q Consensus 129 -~~~~lv~e~~~~gsL~ 144 (375)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.46 E-value=1.5e-06 Score=79.56 Aligned_cols=142 Identities=16% Similarity=0.246 Sum_probs=78.5
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCC-----CCCcceeE-e--EEeeCCeeEEEEee
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----HDNLVTLI-G--YCTSGDQRLLVYEY 137 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~ 137 (375)
+.|+.|..+.||++...+| .+++|+.... ...+..|..+++.+. .|.++... + +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987655 4899988652 233334555554442 23333311 1 12346778999999
Q ss_pred cCCCCHH--------------HHHhccCC-C--C--C-----CCCHHH-------------------------------H
Q 017246 138 MPMGSLE--------------DHLYDLEP-D--Q--E-----PLSWNT-------------------------------R 162 (375)
Q Consensus 138 ~~~gsL~--------------~~l~~~~~-~--~--~-----~l~~~~-------------------------------~ 162 (375)
++|.++. ..++.... . . . .-.+.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11111100 0 0 0 011111 1
Q ss_pred HHHHHHHHHHHHHhhc--------C--CCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 163 MKIAVGAARGLEYLHC--------K--ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 163 ~~i~~qi~~~l~~LH~--------~--~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
..+..++..++.+|+. . ....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223345666652 0 123499999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=8.2e-07 Score=83.35 Aligned_cols=75 Identities=15% Similarity=0.062 Sum_probs=49.6
Q ss_pred cceeccccceEEEEEEEc-CCceEEEEEccccCc-------cchHHHHHHHHHHccCCC--CC-cceeEeEEeeCCeeEE
Q 017246 65 ANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-------QGHQEFIVEVLMLSLLHH--DN-LVTLIGYCTSGDQRLL 133 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~l 133 (375)
.+.||.|..+.||++... ++..+++|....... .....+..|..+++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999754 467899998653211 123456778888887632 43 4455543 3456789
Q ss_pred EEeecCCC
Q 017246 134 VYEYMPMG 141 (375)
Q Consensus 134 v~e~~~~g 141 (375)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.6e-06 Score=77.54 Aligned_cols=81 Identities=21% Similarity=0.257 Sum_probs=59.9
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCC---CcceeEeEEeeCCeeEEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD---NLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~ 135 (375)
.....-.+.+|.|..+.||+++..+|+.|++|+...........+..|+..|+.|... .+.+++++ +..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 3456667889999999999999999999999987655444455678899988887422 34555554 2347899
Q ss_pred eecCCCCH
Q 017246 136 EYMPMGSL 143 (375)
Q Consensus 136 e~~~~gsL 143 (375)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.29 E-value=5.7e-06 Score=74.80 Aligned_cols=76 Identities=20% Similarity=0.149 Sum_probs=59.9
Q ss_pred ccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCC---CCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 64 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
-.+.|+.|....+|+.... +..+++|+.... ....+..|+..|+.|. ...+.+++.+....+..++||||++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3567899999999999764 678889976543 3556788988888873 35678888888878889999999998
Q ss_pred CCH
Q 017246 141 GSL 143 (375)
Q Consensus 141 gsL 143 (375)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.5e-05 Score=75.27 Aligned_cols=76 Identities=18% Similarity=0.270 Sum_probs=47.5
Q ss_pred CcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeecccc--ccccccccccccC---CCCccchhHhHHHHHHH
Q 017246 183 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG--TYGYCAPEYAMSG---KLTLKSDIYSFGVVLLE 257 (375)
Q Consensus 183 ~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~il~e 257 (375)
.++|+|++|.|||++.++ ++|+||+.+........ . ..... ...|++|+..... .-....++..+...+|+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--l-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--I-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--H-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--H-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 399999999999998876 99999999875321100 0 00111 2346666654311 11223556688888888
Q ss_pred HHhCC
Q 017246 258 LITGR 262 (375)
Q Consensus 258 lltg~ 262 (375)
.+++.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.95 E-value=6.9e-05 Score=62.99 Aligned_cols=100 Identities=16% Similarity=0.084 Sum_probs=66.4
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCce
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 220 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 220 (375)
.+|.+.|.. .+.++++.++|.++.|.+.+|.-+-.... -..+=+-|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 478888876 46789999999999999999877621111 12233457999999999998864 2111
Q ss_pred eeeccccccccccccccccCCCCccchhHhHHHHHHHHHhC
Q 017246 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 261 (375)
Q Consensus 221 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 261 (375)
.....+.|||... ...+.+.=|||||+++|..+--
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123466888763 3456788999999999999873
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.92 E-value=0.00017 Score=65.31 Aligned_cols=143 Identities=14% Similarity=0.108 Sum_probs=76.8
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCC--cceeEeE------EeeCCeeEEEEee
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIGY------CTSGDQRLLVYEY 137 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~ 137 (375)
+.|+.|....+|++...+| .+++|+.... .....+..|+.++..+...+ +.+++.. ....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788899999987655 6889988653 12234555776666553211 2233321 1234667899999
Q ss_pred cCCCCHHH--------------HHhccC-C---CC-CCCC---HHHHHH------------HHHHHHHHHHHhhcC----
Q 017246 138 MPMGSLED--------------HLYDLE-P---DQ-EPLS---WNTRMK------------IAVGAARGLEYLHCK---- 179 (375)
Q Consensus 138 ~~~gsL~~--------------~l~~~~-~---~~-~~l~---~~~~~~------------i~~qi~~~l~~LH~~---- 179 (375)
++|..+.. .++... . .. .... |..... +...+...+..++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865321 011110 0 00 0011 111000 001133344444421
Q ss_pred CCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 180 ~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
....++|+|+++.|||+++++.+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12349999999999999987666899999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.0001 Score=67.19 Aligned_cols=143 Identities=14% Similarity=0.065 Sum_probs=71.7
Q ss_pred ceeccccceE-EEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCC--CCcceeEeEEeeCCeeEEEEeecCCCC
Q 017246 66 NLIGEGGFGK-VYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGS 142 (375)
Q Consensus 66 ~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs 142 (375)
+.|+.|+... +|+....+|..+++|....... ..+..|+.+++.+.. -.+.+++.+.... -+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4566565544 6677654467787876544321 223345666655532 2355666653332 278999997766
Q ss_pred HHHHHhccC---------------------CC-CCCCCHHHHH-------HHH-------------HHHHHHHHHhh---
Q 017246 143 LEDHLYDLE---------------------PD-QEPLSWNTRM-------KIA-------------VGAARGLEYLH--- 177 (375)
Q Consensus 143 L~~~l~~~~---------------------~~-~~~l~~~~~~-------~i~-------------~qi~~~l~~LH--- 177 (375)
+.+++.... .. ...+...... .+. ..+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655442110 00 0112111100 000 01111222221
Q ss_pred cCCCCCcccCCCCCCcEEEeCC----CceEEeecCCCccC
Q 017246 178 CKANPPVIYRDLKSANILLDND----FNPKLSDFGLAKLG 213 (375)
Q Consensus 178 ~~~~~~i~H~Dlkp~Nill~~~----~~vkl~Dfg~a~~~ 213 (375)
......++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1112349999999999999875 67899999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.83 E-value=3.2e-05 Score=73.19 Aligned_cols=73 Identities=21% Similarity=0.307 Sum_probs=49.7
Q ss_pred cceeccccceEEEEEEEcC--------CceEEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEE
Q 017246 65 ANLIGEGGFGKVYKGRLES--------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 135 (375)
.+.|+.|....||++...+ +..+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888899999998653 478999988432 122455678888888753344 566766542 2899
Q ss_pred eecCCCCH
Q 017246 136 EYMPMGSL 143 (375)
Q Consensus 136 e~~~~gsL 143 (375)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00023 Score=64.49 Aligned_cols=143 Identities=14% Similarity=0.111 Sum_probs=80.9
Q ss_pred ceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCC--CcceeEeE-----EeeCCeeEEEEeec
Q 017246 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD--NLVTLIGY-----CTSGDQRLLVYEYM 138 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~ 138 (375)
..|+ |....||++...+|+.+++|...... .....+..|..++..+... .+++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877777789999986432 2345566677777666321 23334332 22345668899999
Q ss_pred CCCCHH-----H------H---HhccCC-----CCCCCCHHH----------------------HHHHHHHHHHHHHHhh
Q 017246 139 PMGSLE-----D------H---LYDLEP-----DQEPLSWNT----------------------RMKIAVGAARGLEYLH 177 (375)
Q Consensus 139 ~~gsL~-----~------~---l~~~~~-----~~~~l~~~~----------------------~~~i~~qi~~~l~~LH 177 (375)
+|.++. . . ++.... ....+.... ....+..++..+..+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 0 0 111000 011122111 0112222222222221
Q ss_pred cC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 178 CK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 178 ~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
.. ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11 123389999999999999 4 899999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.78 E-value=7.7e-05 Score=66.97 Aligned_cols=71 Identities=7% Similarity=-0.011 Sum_probs=44.1
Q ss_pred cceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEEeec-CCCC
Q 017246 65 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYM-PMGS 142 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gs 142 (375)
.+.|+.|....+|++ ..+++|+....... ......|+.+++.+...++ .+++.++ .+.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 577999999999998 56889987653211 1122457777766643233 4555543 33456899999 6654
Q ss_pred H
Q 017246 143 L 143 (375)
Q Consensus 143 L 143 (375)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.0002 Score=68.24 Aligned_cols=74 Identities=16% Similarity=0.054 Sum_probs=47.5
Q ss_pred cceeccccceEEEEEEEcC-CceEEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEEeecCCCC
Q 017246 65 ANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMGS 142 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs 142 (375)
.+.|+.|-...+|++...+ +..+++|+....... .-....|..+++.|...++ .++++.+. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998764 478889987543211 1112468888888865555 56777663 3 25999998754
Q ss_pred H
Q 017246 143 L 143 (375)
Q Consensus 143 L 143 (375)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00016 Score=67.01 Aligned_cols=142 Identities=18% Similarity=0.216 Sum_probs=82.4
Q ss_pred cceeccccceEEEEEEEc--------CCceEEEEEccccCccchHHHHHHHHHHccCCCCC-cceeEeEEeeCCeeEEEE
Q 017246 65 ANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 135 (375)
.+.|..|-...+|++... ++..|++|+.... ........+|..+++.+.-.+ ..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888999999764 2478999986332 234555668988888774222 3566666543 2899
Q ss_pred eecCCCCHHHH--------------Hh---ccCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHh
Q 017246 136 EYMPMGSLEDH--------------LY---DLEP-DQEPL--SWNTRMKIAVGAAR-------------------GLEYL 176 (375)
Q Consensus 136 e~~~~gsL~~~--------------l~---~~~~-~~~~l--~~~~~~~i~~qi~~-------------------~l~~L 176 (375)
||++|.+|..- |. .... ..... -+..+..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99988654311 11 1000 01111 23455555544422 12222
Q ss_pred h----cCC-CCCcccCCCCCCcEEEeCC----CceEEeecCCCc
Q 017246 177 H----CKA-NPPVIYRDLKSANILLDND----FNPKLSDFGLAK 211 (375)
Q Consensus 177 H----~~~-~~~i~H~Dlkp~Nill~~~----~~vkl~Dfg~a~ 211 (375)
. ..+ ...++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 111 2349999999999999876 789999999885
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00013 Score=67.48 Aligned_cols=74 Identities=12% Similarity=0.038 Sum_probs=44.0
Q ss_pred cceeccccceEEEEEEEcC---------CceEEEEEccccCccchHHHHHHHHHHccCCCCC-cceeEeEEeeCCeeEEE
Q 017246 65 ANLIGEGGFGKVYKGRLES---------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv 134 (375)
.+.|+.|....+|++...+ +..+++|+...... .......|..+++.+...+ +.++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888889999997653 26788998754321 1112356777777774333 34666544 2 2689
Q ss_pred EeecCCCCH
Q 017246 135 YEYMPMGSL 143 (375)
Q Consensus 135 ~e~~~~gsL 143 (375)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00051 Score=62.76 Aligned_cols=31 Identities=19% Similarity=0.262 Sum_probs=27.3
Q ss_pred CCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 182 PPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 182 ~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0099 Score=55.78 Aligned_cols=74 Identities=12% Similarity=0.069 Sum_probs=47.5
Q ss_pred cceeccccceEEEEEEEcC--------CceEEEEEccccCccchHHHHHHHHHHccCCCCC-cceeEeEEeeCCeeEEEE
Q 017246 65 ANLIGEGGFGKVYKGRLES--------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 135 (375)
.+.|..|-...+|++...+ +..|++++..... ...-...+|..+++.+...+ ..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778889999998653 5789999865432 11112346777777774323 345665432 26899
Q ss_pred eecCCCCH
Q 017246 136 EYMPMGSL 143 (375)
Q Consensus 136 e~~~~gsL 143 (375)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.15 E-value=0.059 Score=50.14 Aligned_cols=29 Identities=28% Similarity=0.283 Sum_probs=24.5
Q ss_pred cccCCCCCCcEEEe------CCCceEEeecCCCcc
Q 017246 184 VIYRDLKSANILLD------NDFNPKLSDFGLAKL 212 (375)
Q Consensus 184 i~H~Dlkp~Nill~------~~~~vkl~Dfg~a~~ 212 (375)
++|+|+.+.|||+. ++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999993 456799999998863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.64 E-value=0.56 Score=39.17 Aligned_cols=123 Identities=11% Similarity=0.119 Sum_probs=81.8
Q ss_pred HHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcc
Q 017246 106 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185 (375)
Q Consensus 106 e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~ 185 (375)
|+.+|. ..||++++. .+-...+.+.|.++.-+ +...|-. -..++....++++.+|+....+++ . -+
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~--~---r~ 101 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNR--T---RY 101 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGG--S---SE
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhc--C---ce
Confidence 444443 358888876 45566676666665432 2222221 133677899999999998875554 2 47
Q ss_pred cCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCc
Q 017246 186 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 265 (375)
Q Consensus 186 H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 265 (375)
|--|.|+||+++.++.+++.-.|+-.. ++|. ..+...=+-.+=|++..+++++..|
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEEecceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 889999999999999999987776432 2222 1122333456778999999999988
Q ss_pred c
Q 017246 266 D 266 (375)
Q Consensus 266 ~ 266 (375)
+
T Consensus 158 e 158 (215)
T 4ann_A 158 D 158 (215)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.62 E-value=2.2 Score=35.68 Aligned_cols=115 Identities=11% Similarity=0.086 Sum_probs=77.2
Q ss_pred CCCCcceeEeEEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCcccCCCCCC
Q 017246 114 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE-YLHCKANPPVIYRDLKSA 192 (375)
Q Consensus 114 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~i~H~Dlkp~ 192 (375)
.||++ --..-.+++.+.|.++.-+++.=...+ ..++....++++.+|+.... +++ . -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS--S---SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEeCc
Confidence 57888 233346667777766654333223333 23677899999999988766 554 3 688899999
Q ss_pred cEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcc
Q 017246 193 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 266 (375)
Q Consensus 193 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 266 (375)
||+++.++.+++.-.|+-.. ++|.-+ +..-=+-.+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987776432 333321 222224457788899999988875
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.32 E-value=0.16 Score=48.22 Aligned_cols=60 Identities=5% Similarity=0.057 Sum_probs=17.6
Q ss_pred ccceeccccceEEEEEEEcC-CceEEE------EEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEe
Q 017246 64 EANLIGEGGFGKVYKGRLES-GQLVAI------KQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCT 126 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~~-~~~vai------K~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 126 (375)
+.+.|| ||.||++.+.. ..+||+ |....... .....+.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 456676 99999998753 467888 66543222 22345778888888899999999988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 375 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-77 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-65 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-51 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (603), Expect = 7e-77
Identities = 84/287 (29%), Positives = 126/287 (43%), Gaps = 26/287 (9%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH 114
I IG G FG VYKG+ VA+K LN Q Q F EV +L
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 115 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
H N++ +GY T Q +V ++ SL HL+ +E + IA A+G++
Sbjct: 63 HVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMD 118
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
YLH K +I+RDLKS NI L D K+ DFGLA + +H ++ G+ + AP
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 235 EYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291
E + +SD+Y+FG+VL EL+TG+ + + + D K
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV- 234
Query: 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338
C + A CL ++ + RPL I+ +++ L
Sbjct: 235 -----------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-69
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 28/282 (9%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD 116
+ + +G G FG+V+ G VA+K L +G F+ E ++ L H
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
LV L T + ++ EYM GSL D L P L+ N + +A A G+ ++
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
+ I+RDL++ANIL+ + + K++DFGLA+L + + APE
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 181
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGRKA--MDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294
G T+KSD++SFG++L E++T + ++ + QNL R
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336
P C + +C E RP + + L+
Sbjct: 232 --------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (549), Expect = 2e-68
Identities = 74/313 (23%), Positives = 132/313 (42%), Gaps = 41/313 (13%)
Query: 50 FTFRELAIATRNFREA---------NLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEG 96
FTF + A R F + +IG G FG+V G L + VAIK L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 97 L-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE 155
+ ++F+ E ++ H N++ L G T +++ E+M GSL+ L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 156 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215
+ + + G A G++YL ++RDL + NIL++++ K+SDFGL++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 216 GDNTHVSTRV---MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 272
+ T + APE K T SD++S+G+V+ E+++ +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE--------- 231
Query: 273 EQNLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
RP+ + ++ ++ P C + + C ++ N RP I
Sbjct: 232 --------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 332 VVALDYLVSQRDS 344
V LD ++ +S
Sbjct: 284 VNTLDKMIRNPNS 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-68
Identities = 68/277 (24%), Positives = 112/277 (40%), Gaps = 26/277 (9%)
Query: 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 119
++ +G G FG V G+ VAIK + EG EFI E ++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
L G CT ++ EYM G L ++L + +++ +EYL K
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
++RDL + N L+++ K+SDFGL++ D S + PE M
Sbjct: 120 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 240 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLVDPLL 298
K + KSDI++FGV++ E+ + K P+ + + L
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGK-----------------MPYERFTNSETAEHIAQGL 218
Query: 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335
P + C +E+A+ RP ++ +
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 7e-68
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 55 LAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSL 112
+ + +F + + +G G G V+K SG ++A K ++ E + I E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 113 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
+ +V G S + + E+M GSL+ L + K+++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 173 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
L YL K +++RD+K +NIL+++ KL DFG++ ++ +GT Y
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYM 170
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+PE +++SDI+S G+ L+E+ GR
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 2e-67
Identities = 71/297 (23%), Positives = 130/297 (43%), Gaps = 24/297 (8%)
Query: 48 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVE 106
S + + + + + +G G +G+VY+G + VA+K L + ++ +EF+ E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 107 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 166
++ + H NLV L+G CT ++ E+M G+L D+L E +++ +S + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMA 121
Query: 167 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 226
+ +EYL K I+RDL + N L+ + K++DFGL++L GD
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 177
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286
+ APE K ++KSD+++FGV+L E+ T + D
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------ID 221
Query: 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343
+ L++ P C + C + RP +I A + + +
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-67
Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 24/279 (8%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 120
IG G FG V+ G + VAIK + EG ++FI E ++ L H LV
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 121 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
L G C LV+E+M G L D+L + + T + + + G+ YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 181 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 240
VI+RDL + N L+ + K+SDFG+ + D ST + +PE
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 241 KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 300
+ + KSD++SFGV++ E+ + K ++ E V +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VEDISTGFRL 221
Query: 301 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339
PR + + C E RP + ++ L +
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 3e-66
Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 28/297 (9%)
Query: 68 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 127
IG+G FG+V++G+ G+ VA+K + + E+ +L H+N++ I
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 128 GD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--- 180
+ Q LV +Y GSL D+L ++ ++ +K+A+ A GL +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 181 --NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEY 236
P + +RDLKS NIL+ + ++D GLA +T +GT Y APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 237 AMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSK-GQGEQNLVSWSRPFLKDQKK 289
+ ++DIY+ G+V E+ + + Q + S P +++ +K
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 290 FV--HLVDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343
V + P + R+ L + C R I L L Q
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-65
Identities = 69/282 (24%), Positives = 112/282 (39%), Gaps = 32/282 (11%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 117
++ IG G +G+ K R G+++ K+L++ + Q + EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 118 LVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
+V L V EY G L + +++ L +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 176 LHCK--ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
H + V++RDLK AN+ LD N KL DFGLA++ + +T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 234 PEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293
PE KSDI+S G +L EL PF L
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM------------------PPF--TAFSQKEL 222
Query: 294 VDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDIV 332
+ G++ R Y + LN + RP + +I+
Sbjct: 223 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-65
Identities = 77/286 (26%), Positives = 122/286 (42%), Gaps = 27/286 (9%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD 116
I + R +G+G FG+V+ G VAIK L G + F+ E ++ L H+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHE 72
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
LV L + + +V EYM GSL D L + L + +A A G+ Y+
Sbjct: 73 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
++RDL++ANIL+ + K++DFGLA+L + + APE
Sbjct: 130 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEA 185
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLVD 295
A+ G+ T+KSD++SFG++L EL T + P+ ++ + V+
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGR-----------------VPYPGMVNREVLDQVE 228
Query: 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL-DYLVS 340
P C + C +E RP + L DY S
Sbjct: 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (526), Expect = 5e-65
Identities = 72/315 (22%), Positives = 119/315 (37%), Gaps = 48/315 (15%)
Query: 52 FRELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQ-EFI 104
L N IGEG FG+V++ R E +VA+K L E Q +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 105 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD--------------- 149
E +++ + N+V L+G C G L++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 150 -----LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 204
P PLS ++ IA A G+ YL ++RDL + N L+ + K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 205 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 264
+DFGL++ D + PE + T +SD++++GVVL E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL- 240
Query: 265 MDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN 323
+P+ ++ ++ V P C + +C ++
Sbjct: 241 ----------------QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPA 284
Query: 324 FRPLINDIVVALDYL 338
RP I L +
Sbjct: 285 DRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-64
Identities = 72/307 (23%), Positives = 118/307 (38%), Gaps = 40/307 (13%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGH-QEFIVEVLM 109
+G G FGKV + ++ VA+K L + + E+ +
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 110 LS-LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD--------------LEPDQ 154
LS L +H N+V L+G CT G L++ EY G L + L +E D+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 155 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214
L + + A+G+ +L K I+RDL + NILL + K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 274
N V + APE + T +SD++S+G+ L EL + +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-------- 248
Query: 275 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334
P + KF ++ P + C + + RP IV
Sbjct: 249 -------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 335 LDYLVSQ 341
++ +S+
Sbjct: 302 IEKQISE 308
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-64
Identities = 74/281 (26%), Positives = 119/281 (42%), Gaps = 32/281 (11%)
Query: 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 119
+ + IG+G FG V G G VA+K + ++ Q F+ E +++ L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 120 TLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
L+G L +V EYM GSL D+L + L + +K ++ +EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
++RDL + N+L+ D K+SDFGL K +T + APE
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALR 173
Query: 239 SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHLVDPL 297
K + KSD++SFG++L E+ + + P+ + K V V+
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGR-----------------VPYPRIPLKDVVPRVEKG 216
Query: 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338
P C V C + +A RP + L+++
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 7e-64
Identities = 76/295 (25%), Positives = 130/295 (44%), Gaps = 29/295 (9%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRLESGQ-----LVAIKQLNHEGLQGHQ-EFIVEVLML 110
I +IG G FG+VYKG L++ VAIK L + + +F+ E ++
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 111 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 170
H N++ L G + +++ EYM G+L+ L + S + + G A
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIA 120
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY 229
G++YL N ++RDL + NIL++++ K+SDFGL++ L + T+ ++
Sbjct: 121 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 230 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289
+ APE K T SD++SFG+V+ E++T + + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------------WELSNHE 221
Query: 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344
+ ++ P C + + C +E RP DIV LD L+ DS
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-63
Identities = 69/304 (22%), Positives = 124/304 (40%), Gaps = 35/304 (11%)
Query: 53 RELAIATRNFREANL-IGEGGFGKVYKGRL---ESGQLVAIKQLNHEGLQGH-QEFIVEV 107
++L + N A++ +G G FG V +G + VAIK L + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 108 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 167
++ L + +V LIG C + +LV E G L L +E + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 168 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM 226
+ G++YL K ++RDL + N+LL N K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 227 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-K 285
+ APE K + +SD++S+GV + E ++ + +P+
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----------------KPYKKM 216
Query: 286 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY----LVSQ 341
+ + ++ P C A+ + C + RP + + L S+
Sbjct: 217 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
Query: 342 RDSH 345
+ H
Sbjct: 277 VEGH 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 3e-63
Identities = 70/305 (22%), Positives = 117/305 (38%), Gaps = 49/305 (16%)
Query: 61 NFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQE-FIVEV-LMLSL 112
N ++G G FGKV VA+K L + +E + E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 113 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY-------------------DLEPD 153
H+N+V L+G CT L++EY G L ++L + E D
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 154 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213
L++ + A A+G+E+L K ++RDL + N+L+ + K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 273
N V + APE G T+KSD++S+G++L E+ +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV---------- 264
Query: 274 QNLVSWSRPF--LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
P+ + F L+ P + C ++ RP ++
Sbjct: 265 -------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 332 VVALD 336
L
Sbjct: 318 TSFLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-63
Identities = 63/279 (22%), Positives = 112/279 (40%), Gaps = 32/279 (11%)
Query: 64 EANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNL 118
E +G G FG V KG + + VA+K L +E E + E ++ L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
V +IG C + + +LV E +G L +L + +++ + G++YL
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYA 237
++RDL + N+LL K+SDFGL+K L + T + APE
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVDP 296
K + KSD++SFGV++ E + + +P+ + +++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQ-----------------KPYRGMKGSEVTAMLEK 225
Query: 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335
P C + +C + RP + + L
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-63
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 25/274 (9%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNL 118
++ +GEG +G+V + + VA+K ++ + + + E+ + +L+H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
V G+ G+ + L EY G L D + + + G+ YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
+ +RD+K N+LLD N K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 239 SGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297
+ D++S G+VL ++ G D ++ + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKK 223
Query: 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
+ ++ + +A+ L E + R I DI
Sbjct: 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-63
Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 39/284 (13%)
Query: 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 116
R + IG G F VYKG E+ VA +L L Q F E ML L H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 117 NLVTLIGYCTSGDQR----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 172
N+V S + +LV E M G+L+ +L + + +G
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKG 124
Query: 173 LEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
L++LH + PP+I+RDLK NI + + K+ D GLA L + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK-- 289
APE K D+Y+FG+ +LE+ T P+ + Q
Sbjct: 180 MAPEM-YEEKYDESVDVYAFGMCMLEMATSE------------------YPYSECQNAAQ 220
Query: 290 -FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
+ + + + + + + C+ + + R I D++
Sbjct: 221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 3e-62
Identities = 74/303 (24%), Positives = 126/303 (41%), Gaps = 41/303 (13%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQL---VAIKQLNHEGL-QGHQEFIVEV-LMLSLLHH 115
+ + ++IGEG FG+V K R++ L AIK++ H++F E+ ++ L HH
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD------------LEPDQEPLSWNTRM 163
N++ L+G C L EY P G+L D L LS +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 164 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223
A ARG++YL I+RDL + NIL+ ++ K++DFGL++ V T
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 184
Query: 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283
+ A E T SD++S+GV+L E+++ P+
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----------------TPY 227
Query: 284 L-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342
+ + P C + + C E+ RP I+V+L+ ++ +R
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 343 DSH 345
++
Sbjct: 288 KTY 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-62
Identities = 75/289 (25%), Positives = 126/289 (43%), Gaps = 32/289 (11%)
Query: 61 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHH 115
+F E +IG G FG VY G L A+K LN G +F+ E +++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 116 DNLVTLIGYCTSGDQR-LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
N+++L+G C + L+V YM G L + + + + + + A+G++
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMK 144
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 232
+L K ++RDL + N +LD F K++DFGLA+ D+ H T +
Sbjct: 145 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292
A E + K T KSD++SFGV+L EL+T + N + L+ ++
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLL-- 254
Query: 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341
P C + V C + +A RP +++V + + S
Sbjct: 255 ---------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-61
Identities = 63/278 (22%), Positives = 117/278 (42%), Gaps = 31/278 (11%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 119
+ +G+G FGKVYK + E+ L A K ++ + + ++++VE+ +L+ H N+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
L+ + ++ E+ G+++ + +LE PL+ + + L YLH
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN 129
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
+I+RDLK+ NIL D + KL+DFG++ +GT + APE M
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMC 184
Query: 240 -----GKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293
K+D++S G+ L+E+ +L+ + + P L
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-------- 236
Query: 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
P R + CL + + R + +
Sbjct: 237 --------QPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-61
Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 37/278 (13%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHD 116
+F +G+G FG VY R +S ++A+K L L + EV + S L H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
N++ L GY + L+ EY P+G++ L A L Y
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 122
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H K VI+RD+K N+LL + K++DFG + P + T + GT Y PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEM 175
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296
K D++S GV+ E + G+ PF + +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPF--EANTYQETYKR 215
Query: 297 LLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
+ + P A + + L + RP++ +++
Sbjct: 216 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 2e-61
Identities = 70/282 (24%), Positives = 115/282 (40%), Gaps = 38/282 (13%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLH 114
+ F + IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 115 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 174
H N + G LV EY + + ++PL + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 175 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 234
YLH +I+RD+K+ NILL KL DFG A + + +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAP 180
Query: 235 EYAMS---GKLTLKSDIYSFGVVLLELITGRKAM-DLSKGQGEQNLVSWSRPFLKDQKKF 290
E ++ G+ K D++S G+ +EL + + +++ ++ P L+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----- 235
Query: 291 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332
Y CL + RP ++
Sbjct: 236 ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-60
Identities = 62/293 (21%), Positives = 129/293 (44%), Gaps = 31/293 (10%)
Query: 62 FREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHH 115
F++ ++G G FG VYKG + VAIK+L + ++E + E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
++ L+G C + +L + + MP G L D++ + ++ + + V A+G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
L + +++RDL + N+L+ + K++DFGLAKL + + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLV 294
+ T +SD++S+GV + EL+T +P+ + ++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS-----------------KPYDGIPASEISSIL 226
Query: 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 347
+ P C + C +A+ RP ++++ + + V
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-59
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 117
+ + IG+G G VY + +GQ VAI+Q+N + + I E+L++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+V + GD+ +V EY+ GSL D + + + + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
VI+RD+KS NILL D + KL+DFG + + ++GT + APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVV 188
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD---QKKFVHLV 294
K DI+S G++ +E+I G P+L + + ++
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE------------------PPYLNENPLRALYLIAT 230
Query: 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
+ + P + CL+ + R ++
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-58
Identities = 75/289 (25%), Positives = 114/289 (39%), Gaps = 34/289 (11%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGL---QGHQEFIVEVLM 109
I ++ R +G+G FG V +G ++ VA+K L + L + +FI EV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 110 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
+ L H NL+ L G + ++ V E P+GSL D L Q T + AV
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQV 120
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGT 228
A G+ YL + I+RDL + N+LL K+ DFGL + P D+ +V
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 229 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF--LKD 286
+ +CAPE + + SD + FGV L E+ T + P+ L
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----------------EPWIGLNG 220
Query: 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335
+ + P C V C + RP + L
Sbjct: 221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-57
Identities = 61/292 (20%), Positives = 101/292 (34%), Gaps = 38/292 (13%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHD 116
+F+ ++GEG F V R L + + AIK L + E ++S L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
V L ++ Y G L ++ LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H +I+RDLK NILL+ D + +++DFG AK+ + +GT Y +PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296
SD+++ G ++ +L+ G PF +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------------------PPF--RAGNEYLIFQK 221
Query: 297 LLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346
++ Y P + A + L +A R ++ +HP
Sbjct: 222 IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK-----AHP 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-57
Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 34/293 (11%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVEVLM 109
+A + +G+G FG VY+G E VAIK +N ++ EF+ E +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 110 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRM 163
+ + ++V L+G + G L++ E M G L+ +L L P P S + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 164 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 223
++A A G+ YL+ ++RDL + N ++ DF K+ DFG+ + D
Sbjct: 137 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283
+ + + +PE G T SD++SFGVVL E+ T + +P+
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----------------QPY 236
Query: 284 -LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 335
++ + V P C + + MC RP +I+ ++
Sbjct: 237 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-56
Identities = 67/300 (22%), Positives = 123/300 (41%), Gaps = 39/300 (13%)
Query: 61 NFREANLIGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQG-HQEFIVEV-LMLSL 112
+ +G G FG+V + + + VA+K L H+ + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 113 LHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYD------------LEPDQEPLSW 159
HH N+V L+G CT G +++ E+ G+L +L + ++ L+
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 160 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219
+ + A+G+E+L + I+RDL + NILL K+ DFGLA+ +
Sbjct: 134 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 279
+ APE T++SD++SFGV+L E+ + +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------------- 237
Query: 280 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339
P +K ++F + R P C + E + RP +++V L L+
Sbjct: 238 --PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-55
Identities = 75/307 (24%), Positives = 121/307 (39%), Gaps = 43/307 (14%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRL--------ESGQLVAIKQLNHEGLQGH-QEFIVEV 107
+ +GEG FG+V VA+K L + + + I E+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 108 -LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQ 154
+M + H N++ L+G CT ++ EY G+L ++L P +
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 155 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214
E LS + A ARG+EYL + I+RDL + N+L+ D K++DFGLA+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 274
D +T + APE T +SD++SFGV+L E+ T
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG----------- 235
Query: 275 NLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333
P+ ++ L+ P C N + C + + RP +V
Sbjct: 236 ------SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
Query: 334 ALDYLVS 340
LD +V+
Sbjct: 290 DLDRIVA 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 9e-55
Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 29/290 (10%)
Query: 57 IATRNFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGLQGHQE-FIVEVLMLS 111
I IGEG FG V++G VAIK + +E F+ E L +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 112 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
H ++V LIG T + ++ E +G L L + L + + A +
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 119
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
L YL + ++RD+ + N+L+ ++ KL DFGL++ + +++ +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKW 175
Query: 232 CAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291
APE + T SD++ FGV + E++ + D +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVK-------------PFQGVKNNDVIGRI 222
Query: 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341
+ L P C ++ C + + RP ++ L ++ +
Sbjct: 223 ENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 3e-53
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 119
++ +G G FG V++ +G A K + + E+ +S+L H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
L ++ +++YE+M G L + + D + +S + ++ +GL ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 180 ANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
++ DLK NI+ + KL DFGL D GT + APE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVA 197
Query: 238 MSGKLTLKSDIYSFGVVLLELITGR 262
+ +D++S GV+ L++G
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 173 bits (440), Expect = 2e-51
Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 19/231 (8%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH-- 114
+F +IG GGFG+VY R ++G++ A+K L+ + + QG + E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 115 -HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
+V + + D+ + + M G L HL E A GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR----FYAAEIILGL 120
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 233
E++H N V+YRDLK ANILLD + ++SD GLA +GT+GY A
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 234 PEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283
PE G +D +S G +L +L+ G K + + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 5e-51
Identities = 50/274 (18%), Positives = 100/274 (36%), Gaps = 26/274 (9%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 119
+ +G G FG V++ +G++ K +N E+ +++ LHH L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
L + +L+ E++ G L D + + +S + A GL+++H
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 180 ANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+++ D+K NI+ + K+ DFGLA + + T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIV 200
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297
+ +D+++ GV+ L++G ++ + + V D
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP--------------FAGEDDLETLQNVKRCDWE 246
Query: 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
A L +E R ++D
Sbjct: 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-50
Identities = 72/271 (26%), Positives = 111/271 (40%), Gaps = 32/271 (11%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSL-LHH 115
+F ++G+G FGKV+ ++ Q AIK L + + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
L + + + V EY+ G L H+ + A GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQF 118
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
LH K ++YRDLK NILLD D + K++DFG+ K +GD GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295
+ K D +SFGV+L E++ G+ PF ++ +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------------------SPFHGQDEEELFHSI 215
Query: 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 326
+ + YPR A + E R
Sbjct: 216 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 1e-49
Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 9/203 (4%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLV 119
+ +++G G F +V + +LVAIK + + L+G + E+ +L + H N+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
L SG L+ + + G L D + + + + ++ ++YLH
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
+ LD D +SDFGL+K+ D V + GT GY APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQ 183
Query: 240 GKLTLKSDIYSFGVVLLELITGR 262
+ D +S GV+ L+ G
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (420), Expect = 5e-49
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHH 115
++F+ +G G FG+V+ R +G+ A+K L E + ++ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
++ + G Q ++ +Y+ L+ L + A LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
LH + +IYRDLK NILLD + + K++DFG AK P V+ + GT Y APE
Sbjct: 120 LH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGRK 263
+ D +SFG+++ E++ G
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (416), Expect = 6e-49
Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDN 117
+ ++G GG +V+ R L + VA+K L + + + F E + L+H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 118 LVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
+V + + G +V EY+ +L D ++ + P++ +++ A + L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQAL 124
Query: 174 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 232
+ H +I+RD+K ANI++ K+ DFG+A+ + G++ + V+GT Y
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+PE A + +SD+YS G VL E++TG
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (415), Expect = 9e-49
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---------QGHQEFIVEV-LM 109
N+ ++G G V + + + A+K ++ G + + + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 110 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
+ H N++ L + LV++ M G L D+L + + LS KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRAL 119
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 229
+ LH +++RDLK NILLD+D N KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 230 GYCAPEYAMSG------KLTLKSDIYSFGVVLLELITGR 262
Y APE + D++S GV++ L+ G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-48
Identities = 38/199 (19%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
+G G FG V++ S + K + +G E+ +L++ H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 126 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 185
S ++ ++++E++ + + + L+ + L++LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 186 YRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 243
+ D++ NI+ + K+ +FG A+ GDN + + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVS 181
Query: 244 LKSDIYSFGVVLLELITGR 262
+D++S G ++ L++G
Sbjct: 182 TATDMWSLGTLVYVLLSGI 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 4e-48
Identities = 61/283 (21%), Positives = 107/283 (37%), Gaps = 26/283 (9%)
Query: 66 NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG-----HQEFIVEVLMLSLLHHDNLV 119
+ +GEG F VYK R + Q+VAIK++ ++ + E+ +L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 120 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 179
L+ LV+++M D ++ + L+ + + +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 180 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 239
+++RDLK N+LLD + KL+DFGLAK G T + T Y APE
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 240 GKL-TLKSDIYSFGVVLLELITGRKAMD----------LSKGQGEQNLVSWSRPFLKDQK 288
++ + D+++ G +L EL+ + + + G W
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
+ + + + R
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-46
Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 21/290 (7%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHD 116
+ + IGEG +G V + VAIK+++ Q + Q + E+ +L H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
N++ + + + Y+ + LY L Q LS + RGL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPE 235
H V++RDLK +N+LL+ + K+ DFGLA+ P D+T T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 236 YAMSGKLTLKS-DIYSFGVVLLELITGR-------------KAMDLSKGQGEQNLVSWSR 281
++ K KS DI+S G +L E+++ R + + +++L
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 282 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
++ + + + R + A+ + L + R +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-46
Identities = 69/313 (22%), Positives = 114/313 (36%), Gaps = 43/313 (13%)
Query: 52 FRELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH------QEFI 104
FR+ + + +G G F V K R +G A K + + ++
Sbjct: 3 FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 105 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 164
EV +L + H N++TL + +L+ E + G L+D ++E L+ +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATE 117
Query: 165 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTH 220
G+ YLH + + + DLK NI+L + P K+ DFGLA D +
Sbjct: 118 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGN 171
Query: 221 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 280
+ GT + APE L L++D++S GV+ L++G Q
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------- 222
Query: 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV-------V 333
+ V V+ Y A L ++ R I D +
Sbjct: 223 -----ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277
Query: 334 ALDYLVSQRDSHP 346
+S SHP
Sbjct: 278 DTQQALSSAWSHP 290
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-46
Identities = 66/293 (22%), Positives = 107/293 (36%), Gaps = 26/293 (8%)
Query: 58 ATRNFREANLIGEGGFGKVYKGR--LESGQLVAIKQLNHEGLQGHQE--FIVEVLMLSLL 113
A + + IGEG +GKV+K R G+ VA+K++ + + I EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 114 ---HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVG 168
H N+V L CT + ++ L + + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 169 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 228
RGL++LH V++RDLK NIL+ + KL+DFGLA++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 229 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD----------LSKGQGEQNLVS 278
Y APE + D++S G + E+ + + G
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 279 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
W R ++ F H ++ + CL R
Sbjct: 239 WPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-45
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 117
NF++ IGEG +G VYK R +G++VA+K++ + I E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+V L+ + ++ LV+E++ + + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
V++RDLK N+L++ + KL+DFGLA+ V + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILL 175
Query: 238 MSGKLTLKSDIYSFGVVLLELITGR 262
+ DI+S G + E++T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-45
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 61 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 119
++ + +IG G FG VY+ +L +SG+LVAIK++ + + E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 120 TLIGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
L + S ++ LV +Y+P + ++ L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSL 135
Query: 174 EYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
Y+H + +RD+K N+LLD D KL DFG AK + + + Y
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRA 190
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGR 262
+ T D++S G VL EL+ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 2e-45
Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 30/293 (10%)
Query: 54 ELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL 112
EL + R +R IG G FG +Y G + +G+ VAIK + H + +E + +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKM 58
Query: 113 LHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
+ + I +C GD ++V E + + + S T + +A
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMIS 114
Query: 172 GLEYLHCKANPPVIYRDLKSANIL---LDNDFNPKLSDFGLAKLGPVGDNT-----HVST 223
+EY+H K I+RD+K N L + DFGLAK +
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 224 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 283
+ GT Y + + + + + D+ S G VL+ G K ++ +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------Y 225
Query: 284 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336
+ +K + +L YP Y C + + +P + +
Sbjct: 226 ERISEKKMSTPIEVLCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (391), Expect = 3e-45
Identities = 59/284 (20%), Positives = 110/284 (38%), Gaps = 21/284 (7%)
Query: 61 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNL 118
+ IGEG +G VYK + G+ A+K++ E I E+ +L L H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
V L + + +LV+E++ + + L T + G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
+ V++RDLK N+L++ + K++DFGLA+ + + ++ +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMG 174
Query: 239 SGKLTLKSDIYSFGVVLLELITGRK----------AMDLSKGQGEQNLVSWSRPF-LKDQ 287
S K + DI+S G + E++ G M + + G N +W L
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
+ +PL + + + + + L + N R
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-44
Identities = 61/206 (29%), Positives = 86/206 (41%), Gaps = 13/206 (6%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHD 116
+F L+G+G FGKV R +G+ A+K L E + E + E +L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
L L + D+ V EY G L HL E + A + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------RARFYGAEIVSAL 118
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
+ V+YRD+K N++LD D + K++DFGL K G T GT Y APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEV 176
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGR 262
D + GVV+ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (383), Expect = 6e-44
Identities = 45/298 (15%), Positives = 91/298 (30%), Gaps = 31/298 (10%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNL 118
+++ IGEG FG +++G L + Q VAIK + E LL +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGI 63
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
+ + G +LV + + L+ S T A ++ +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 179 KANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAKLGPVGDNT-----HVSTRVMGT 228
K ++YRD+K N L+ + + DFG+ K + GT
Sbjct: 120 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 229 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288
Y + + + + + D+ + G V + + G K + +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------E 226
Query: 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 346
+ N + P + + ++ + ++
Sbjct: 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-43
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE------FIVEVLMLSLLH--HDN 117
L+G GGFG VY G + VAIK + + + E +EV++L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
++ L+ + D +L+ E L+D ++ L + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 178 CKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
V++RD+K NIL+D N KL DFG L V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEW 180
Query: 237 AMSGKL-TLKSDIYSFGVVLLELITGR 262
+ + ++S G++L +++ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-42
Identities = 52/274 (18%), Positives = 89/274 (32%), Gaps = 32/274 (11%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGY 124
++G G GKV + + + A+K L + EV L ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 73
Query: 125 C----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 180
L+V E + G L + D + + +I ++YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 181 NPPVIYRDLKSANILLDNDFNP---KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+ +RD+K N+L + KL+DFG AK ++ T Y APE
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297
K D++S GV++ L+ G L + + +P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPF-----YSNHGLAISPGMKTRIRMGQYEFPNP- 239
Query: 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 331
+ L E R I +
Sbjct: 240 ----EWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-41
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDN 117
+ + IG+G FG+V+K R ++GQ VA+K++ E + + E+ +L LL H+N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 118 LVTLIGYCTSGDQR--------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 169
+V LI C + LV+++ L + + ++
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQML 126
Query: 170 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS--TRVMG 227
GL Y+H +++RD+K+AN+L+ D KL+DFGLA+ + N+ + T +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 228 TYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 262
T Y PE + + D++ G ++ E+ T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-41
Identities = 52/265 (19%), Positives = 104/265 (39%), Gaps = 11/265 (4%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 117
+ + IGEG +G V+K + E+ ++VA+K++ + + E+ +L L H N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 118 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 177
+V L S + LV+E+ D + L +GL + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 178 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 237
+ V++RDLK N+L++ + KL++FGLA+ + S V+ +
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLF 174
Query: 238 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297
+ + D++S G + EL + + +Q + ++++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 298 LHGRYPRRCLNYAVAVTAMCLNEEA 322
+ YP ++ LN
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATG 259
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-40
Identities = 45/204 (22%), Positives = 85/204 (41%), Gaps = 10/204 (4%)
Query: 62 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNL 118
+R+ +G G +G V +G VAIK+L + E+ +L + H+N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 119 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 178
+ L+ T + ++ + E L + + +GL Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 179 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 238
+RDLK N+ ++ D K+ DFGLA+ ++ ++ V+ +
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILN 192
Query: 239 SGKLTLKSDIYSFGVVLLELITGR 262
+ T DI+S G ++ E+ITG+
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 8e-40
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 61 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHD 116
F +G G FG+V + ESG A+K L+ + + ++ + E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 117 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 176
LV L +V EY+ G + HL S A EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL 157
Query: 177 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 236
H +IYRDLK N+L+D +++DFG AK T + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 237 AMSGKLTLKSDIYSFGVVLLELITGR 262
+S D ++ GV++ E+ G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-37
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 61 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSL 112
NF ++G G +GKV+ R ++G+L A+K L + + + E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 113 L-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
+ LVTL + + L+ +Y+ G L HL +E + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVL 140
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 231
LE+LH +IYRD+K NILLD++ + L+DFGL+K V D T + GT Y
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEY 196
Query: 232 CAPEYAMSGK--LTLKSDIYSFGVVLLELITGR 262
AP+ G D +S GV++ EL+TG
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (334), Expect = 2e-36
Identities = 39/241 (16%), Positives = 89/241 (36%), Gaps = 23/241 (9%)
Query: 42 KEKSGARSFTFRELAIATRN---FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL 97
+ + + N ++ +G G + +V++ + + + V +K L
Sbjct: 14 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK- 72
Query: 98 QGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRL--LVYEYMPMGSLEDHLYDLEPDQ 154
++ E+ ++ +L N++TL R LV+E++ +
Sbjct: 73 --KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------- 123
Query: 155 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLG 213
+ L+ + L+Y H +++RD+K N+++D++ +L D+GLA+
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF- 179
Query: 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 273
+ RV Y D++S G +L +I ++ +
Sbjct: 180 -YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 274 Q 274
Q
Sbjct: 239 Q 239
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-34
Identities = 44/207 (21%), Positives = 88/207 (42%), Gaps = 10/207 (4%)
Query: 59 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHH 115
++ + +G G +G V ++G VA+K+L+ + + + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 116 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 175
+N++ L+ T + + L + + L+ + + RGL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 176 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 235
+H +RDLK +N+ ++ D K+ DFGLA+ + ++ V +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEI 189
Query: 236 YAMSGKLTLKSDIYSFGVVLLELITGR 262
DI+S G ++ EL+TGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-34
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 60 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 116
+ ++ IG G G V + VAIK+L+ + E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 117 NLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 170
N+++L+ T LV E M + Q L +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 171 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 230
G+++LH +I+RDLK +NI++ +D K+ DFGLA+ + + T + T
Sbjct: 130 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRY 183
Query: 231 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 262
Y APE + DI+S G ++ E++ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (305), Expect = 3e-32
Identities = 40/223 (17%), Positives = 83/223 (37%), Gaps = 17/223 (7%)
Query: 67 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 125
+G G F V+ + + + VA+K + + + + E+ +L ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 126 TSGDQRLLVYEYMPMGSL------------EDHLYDLEPDQEPLSWNTRMKIAVGAARGL 173
+ +LL + + + + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 174 EYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 232
+Y+H + +I+ D+K N+L++ D L +A LG T + T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 233 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 275
+PE + +DI+S ++ ELITG + +G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 3e-21
Identities = 21/160 (13%), Positives = 43/160 (26%), Gaps = 29/160 (18%)
Query: 66 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL----------QGHQEFIVEVLMLSLLHH 115
L+GEG V+ E +K G F V + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 116 DNLVTLIGYCTSG----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 171
L L G + ++ E + L ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDMILE 114
Query: 172 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211
+ + + +++ DL N+L+ + + DF +
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 375 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.65 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.38 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.22 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=419.96 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=206.8
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 458999999999999999999875 699999999976533 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
||++|+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999984 3567999999999999999999999998 999999999999999999999999999865443
Q ss_pred CCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.........+||+.|+|||++.+..+ +.++|||||||++|||++|++||......... ... ...
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~--------------~~~ 221 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD--------------WKE 221 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHH--------------HHT
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHH--------------Hhc
Confidence 33344456789999999999988776 57899999999999999999999743321110 000 001
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
..........++.++.+||.+||+.||++|||+.|++
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 1111112345678889999999999999999999997
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=418.28 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=210.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||||+++++++.+.+..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999864 69999999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
+||+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998753 46999999999999999999999998 9999999999999999999999999998643222
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... . ...... ....
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~----~~~~~~---------~~~~ 234 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--A----LYLIAT---------NGTP 234 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--H----HHHHHH---------HCSC
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--H----HHHHHh---------CCCC
Confidence 22345689999999999999999999999999999999999999996322110 0 000000 0111
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
....+..++..+.+||.+||+.||++|||+.|++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1233567788999999999999999999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=414.95 Aligned_cols=263 Identities=31% Similarity=0.481 Sum_probs=207.1
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccC--ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..++|++.+.||+|+||.||+|+++ ..||||+++... ....+.+.+|+.+++.++|||||++++++. .+.++|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 3568999999999999999999865 359999987543 334567889999999999999999999875 46789999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||++|+|.+++.. .+..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999964 3456999999999999999999999998 99999999999999999999999999986544
Q ss_pred CCCceeeecccccccccccccccc---CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
...........||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... .... .....
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~----~~~~~----- 225 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIF----MVGRG----- 225 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHH----HHHHT-----
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHH----HHhcC-----
Confidence 444444456789999999999864 358999999999999999999999996432111 0000 00000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
...+. ....+..+++.+.+|+.+||+.||++|||+.+|++.|+.|.+.
T Consensus 226 ~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 226 YLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp SCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 00010 0123456778999999999999999999999999999999754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-59 Score=419.05 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=219.7
Q ss_pred HHhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
+..++|++.+.||+|+||.||+|.+. +++.||||+++... ...+++.+|+.+|+.++|||||++++++.+.+..+|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 44568999999999999999999876 58899999997653 45678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+++|+|.+++.. .....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 93 E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999965 23567999999999999999999999998 99999999999999999999999999986433
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. .........|++.|+|||++.+..|+.++|||||||++|||++|..||...... . .+...+.
T Consensus 168 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~--------------~~~~~i~ 230 (287)
T d1opja_ 168 D-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--S--------------QVYELLE 230 (287)
T ss_dssp S-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H--------------HHHHHHH
T ss_pred C-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--H--------------HHHHHHh
Confidence 2 222333456899999999999999999999999999999999977665321110 0 1111222
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
.......+..++..+.+||.+||+.||++|||+.+|++.|+.+..+.
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 22334456678889999999999999999999999999999886543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=412.27 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=206.1
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.++|++.+.||+|+||.||+|++.+++.||||+++... ...+++.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35799999999999999999999888899999997643 44678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999864 3467899999999999999999999998 99999999999999999999999999976433222
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhC-CCCccccccccccchhhchhhhhhhccccchhcccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 297 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (375)
.......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||..... ..... .+...
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~--------------~i~~~ 218 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVE--------------DISTG 218 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHH--------------HHHHT
T ss_pred -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHH--------------HHHhc
Confidence 223345789999999999999999999999999999999995 555542211 11111 01111
Q ss_pred cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 298 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 298 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
.....|..++..+.+|+.+||+.||++||++++|++.|++|++
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223356677889999999999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=409.76 Aligned_cols=245 Identities=26% Similarity=0.415 Sum_probs=208.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 68999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999965 456999999999999999999999998 99999999999999999999999999975432
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... .. .. +..
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~---~~----------i~~ 218 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TY---KR----------ISR 218 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HH----------HHT
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HH---HH----------HHc
Confidence 2 2234689999999999999999999999999999999999999996422110 00 00 000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
....+|..+++++.+||.+||+.||++|||+.|+++
T Consensus 219 --~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112345667889999999999999999999999984
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-59 Score=416.86 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=198.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc--chHHHHHHHHHHccCCCCCcceeEeEEee--CCeeEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLV 134 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 134 (375)
++|++.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|+.+++.++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999865 6899999999765432 34568899999999999999999999864 4668999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
||||++|+|.+++......+..+++..++.++.||+.||.|||+++ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765445678999999999999999999999864 23499999999999999999999999999986
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
... ........+||+.|+|||++.+..|+.++|||||||++|||+||+.||...... .... .
T Consensus 164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~-------------~ 225 (269)
T d2java1 164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG-------------K 225 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH-------------H
T ss_pred ccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHH-------------H
Confidence 432 222334578999999999999999999999999999999999999999632211 1100 0
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
+.... ....+..+++++.+||.+||+.||++|||+.||+
T Consensus 226 i~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 226 IREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp HHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 11111 1133556778899999999999999999999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=415.48 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=207.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+|+.+++.++||||+++++++.+.+..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 69999999987532 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999865 457999999999999999999999998 99999999999999999999999999986544
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... .. ..+..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~-------------~~i~~ 224 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IF-------------QKIIK 224 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-------------HHHHT
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HH-------------HHHHc
Confidence 433334455789999999999999999999999999999999999999997422110 00 00111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 334 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 334 (375)
. ...+|..+++.+.+||.+||+.||++|||++|++..
T Consensus 225 ~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 225 L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp T--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1 113455677889999999999999999999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-57 Score=413.14 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=204.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CC---ceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SG---QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.++|++.++||+|+||+||+|+++ ++ ..||||.+..... ...+.+.+|+.+|++++|||||++++++...+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 457889999999999999999865 23 3589998866433 345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
|||||++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998864 3457999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCcee---eeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccc
Q 017246 214 PVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 214 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+.
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~------------ 243 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVI------------ 243 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH------------
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHH------------
Confidence 33222111 122457999999999999999999999999999999998 89999633211 111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
..+....+...+..++..+.+|+.+||+.||++||++.+|++.|+++++.
T Consensus 244 --~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 244 --NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11111122334567888999999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-58 Score=412.71 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=208.7
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
+.|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46999999999999999999875 68999999998776667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... .
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 999999998652 456999999999999999999999998 99999999999999999999999999964211 1
Q ss_pred ceeeeccccccccccccccc-----cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 219 THVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
.......+||+.|+|||++. +..|+.++|||||||++|||+||+.||....... .. .....
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~~i~~-------- 229 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---LKIAK-------- 229 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHH--------
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---HHHHc--------
Confidence 12233468999999999984 4568999999999999999999999996432211 00 00000
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........+..++.++.+||.+||+.||++|||+.|+++
T Consensus 230 -~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 -SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111234577889999999999999999999999983
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=407.06 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=212.5
Q ss_pred HhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
..++|++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 456899999999999999999999888899999997643 456789999999999999999999998754 667999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999988542 2345899999999999999999999988 9999999999999999999999999998643322
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCC-ccccccccccchhhchhhhhhhccccchhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
........||+.|+|||++.+..++.++|||||||++|||+||..| |...... ... ..+..
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~--------------~~i~~ 225 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI--------------QNLER 225 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH--------------HHHHT
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHH--------------HHHHh
Confidence 2233446789999999999999999999999999999999996554 4321110 000 01111
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
......|..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 226 ~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 12223456778889999999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-57 Score=400.22 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=215.0
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecC
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 139 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 139 (375)
++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|+.++..++||||+++++++.+++.+++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5799999999999999999999888899999997654 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc
Q 017246 140 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 219 (375)
Q Consensus 140 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 219 (375)
+|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++...... .
T Consensus 83 ~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~ 155 (258)
T d1k2pa_ 83 NGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y 155 (258)
T ss_dssp TEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-C
T ss_pred CCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC-c
Confidence 9999999765 3456889999999999999999999998 9999999999999999999999999997543322 2
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... .. ..+....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~--------------~~i~~~~ 218 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA--------------EHIAQGL 218 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH--------------HHHHTTC
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HH--------------HHHHhCC
Confidence 22334678999999999999999999999999999999998 899997432211 11 0111112
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
....|..++..+.+||.+||+.||++|||+++|++.|..|
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2334567778999999999999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-57 Score=414.86 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=212.1
Q ss_pred HhhcccccceeccccceEEEEEEEcC-C-----ceEEEEEcccc-CccchHHHHHHHHHHccC-CCCCcceeEeEEeeCC
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLES-G-----QLVAIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD 129 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 129 (375)
..++|++.+.||+|+||+||+|++.. + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 45689999999999999999997642 2 36899988654 334456788999999988 8999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEP-------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 190 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlk 190 (375)
..++|||||++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999975321 1235899999999999999999999998 9999999
Q ss_pred CCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccc
Q 017246 191 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSK 269 (375)
Q Consensus 191 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 269 (375)
|+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986544444444455778999999999999999999999999999999998 899996432
Q ss_pred cccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 017246 270 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 336 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 336 (375)
... . +..++....+...|..+++++.+||.+||+.||++|||++||++.|.
T Consensus 272 ~~~--~--------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA--N--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH--H--------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--H--------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 0 11122222333456778889999999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=403.80 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=212.2
Q ss_pred hhcccccce-eccccceEEEEEEEc---CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANL-IGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.++|.+.+. ||+|+||.||+|.++ ++..||||+++.... ...+.+.+|+.+|++++|||||++++++.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 457888885 999999999999754 355799999976432 335678999999999999999999999865 56899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
||||+++|+|.+++.. .+..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999854 3567999999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 214 PVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 214 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~------------- 223 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA------------- 223 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH-------------
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH-------------
Confidence 433322 22334578999999999999999999999999999999998 99999743211 1111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
.+....+...|..++.++.+||.+||+.||++||++.+|++.|+.+..
T Consensus 224 -~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 224 -FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111112234567788999999999999999999999999999987654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-57 Score=414.58 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=206.3
Q ss_pred HhhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++.... .....+.+|+.+|+.++|||||+++++|.+.+.++|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999865 689999999976432 33567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
||++||+|.+++.. ...+++..++.++.||+.||.|||++ + |+||||||+||||+.++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999965 35689999999999999999999974 7 9999999999999999999999999997532
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc-h-------------
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW-S------------- 280 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~------------- 280 (375)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.............. .
T Consensus 157 ~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 157 D----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp H----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred C----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 1 122346899999999999999999999999999999999999999964332111000000 0
Q ss_pred -----hhhhh---hccccchhc----ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 281 -----RPFLK---DQKKFVHLV----DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 281 -----~~~~~---~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
..... ......... ............+.++.+||.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000 000000000 000001111235678999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-56 Score=408.25 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=192.8
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
.+.|++.+.||+|+||.||+|+.. +|+.||||++...... ....+.+|+.+|+.++||||+++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 457999999999999999999875 6899999999765432 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe---CCCceEEeecCCCccC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLG 213 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~---~~~~vkl~Dfg~a~~~ 213 (375)
||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999964 567999999999999999999999998 99999999999994 5789999999999854
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... .. ......
T Consensus 161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~---~~i~~~------- 224 (307)
T d1a06a_ 161 DPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LF---EQILKA------- 224 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHHTT-------
T ss_pred cCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HH---HHHhcc-------
Confidence 322 22344689999999999999999999999999999999999999996322110 00 000000
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........+..+++++.+||.+||+.||++|||+.|+++
T Consensus 225 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 225 -EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011112234567788999999999999999999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=401.39 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=206.7
Q ss_pred hhcccccceeccccceEEEEEEEcC-C----ceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLES-G----QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~-~----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
...|++.++||+|+||.||+|.++. + ..||||++..... .....+.+|+.+++.++|||||++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 3468899999999999999997653 2 3699999865433 23456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+.++++.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998865 3467999999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCC-CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGD-NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..... .........||+.|+|||++.+..++.++|||||||++|||++|..|+...... .. +.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~--------------~~ 223 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE--------------VM 223 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH--------------HH
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH--------------HH
Confidence 43322 222233456899999999999999999999999999999999976655321110 00 11
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
..+....+...+..++..+.+||.+||+.||++||++.+|++.|+.+...
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11122223345667888999999999999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=397.70 Aligned_cols=247 Identities=27% Similarity=0.390 Sum_probs=197.5
Q ss_pred ccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee----CCeeEEE
Q 017246 62 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLV 134 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 134 (375)
|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+|++++|||||++++++.+ ...++||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 467788999999999999875 688999999876432 234568899999999999999999999865 3567999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe-CCCceEEeecCCCccC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLG 213 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~-~~~~vkl~Dfg~a~~~ 213 (375)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ .+|+||||||+||||+ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999965 456899999999999999999999763 4599999999999996 5789999999999753
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchh
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 293 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....... .+.. .+
T Consensus 166 ~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~-------------~i 225 (270)
T d1t4ha_ 166 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR-------------RV 225 (270)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH-------------HH
T ss_pred cCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHH-------------HH
Confidence 221 2234689999999998865 69999999999999999999999996322110 0000 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 294 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
........++..+++++.+||.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0001111123345667999999999999999999999983
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.4e-56 Score=411.79 Aligned_cols=251 Identities=21% Similarity=0.265 Sum_probs=209.4
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999875 69999999998776666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC--CCceEEeecCCCccCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~--~~~vkl~Dfg~a~~~~~~ 216 (375)
+||+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 106 ~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999854 3457999999999999999999999998 999999999999954 578999999999864332
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ... ....... .
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~---~~i~~~~--------~ 242 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETL---RNVKSCD--------W 242 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTC--------C
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCC--------C
Confidence 2 234468999999999999999999999999999999999999999633211 100 0000000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.........++..+.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111122456778999999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.7e-56 Score=410.58 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=210.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
++|++.+.||+|+||.||+|+.. +|+.||||++..........+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999864 79999999998766556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEe--CCCceEEeecCCCccCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--NDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~--~~~~vkl~Dfg~a~~~~~~ 216 (375)
+||+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|......
T Consensus 109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988753 3557999999999999999999999998 99999999999997 5789999999999864332
Q ss_pred CCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
. ......||+.|+|||++.+..|+.++|||||||++|||+||+.||....... .. ..... ...
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~---~~i~~--------~~~ 245 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL---QNVKR--------CDW 245 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHH--------CCC
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHh--------CCC
Confidence 2 2344679999999999999999999999999999999999999996322110 00 00000 001
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
.........++.++.+||.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112233567788999999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-56 Score=406.54 Aligned_cols=248 Identities=28% Similarity=0.358 Sum_probs=210.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 134 (375)
-++|++++.||+|+||.||+|+.. +|+.||||++.+.. ......+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357999999999999999999875 79999999997542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
||||+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999965 457899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|++||....... +. . .+.
T Consensus 157 ~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~---~----------~i~ 218 (337)
T d1o6la_ 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF---E----------LIL 218 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---H----------HHH
T ss_pred cC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HH---H----------HHh
Confidence 22 223345789999999999999999999999999999999999999997432110 00 0 011
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~ 333 (375)
.. ...+|..++.++.+||.+||+.||.+||+ +.||++
T Consensus 219 ~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 219 ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11 12345677888999999999999999995 888886
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-56 Score=403.91 Aligned_cols=245 Identities=28% Similarity=0.381 Sum_probs=202.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc---chHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
..|+..+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999865 6899999999765433 2356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||.+|+|..++.. +..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999776643 467999999999999999999999998 99999999999999999999999999975322
Q ss_pred CCCceeeecccccccccccccccc---CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccch
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... . +..
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~----------~~~ 225 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A----------LYH 225 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------H----------HHH
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------H----------HHH
Confidence 234679999999999864 458999999999999999999999996322110 0 000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+.........+..+++.+.+||.+||+.||++|||+.|+++
T Consensus 226 i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111111123456788999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-56 Score=397.00 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=201.8
Q ss_pred ceeccccceEEEEEEEc---CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeecCC
Q 017246 66 NLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 140 (375)
Q Consensus 66 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 140 (375)
+.||+|+||.||+|.++ .++.||||+++.... ...+.+.+|+.+|++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999764 356899999965432 234678999999999999999999999865 567899999999
Q ss_pred CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCc-
Q 017246 141 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT- 219 (375)
Q Consensus 141 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~- 219 (375)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999964 567999999999999999999999998 999999999999999999999999999864433322
Q ss_pred eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 220 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 220 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+. ..+....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~--------------~~i~~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT--------------AMLEKGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH--------------HHHHTTC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHH--------------HHHHcCC
Confidence 22334678999999999999999999999999999999998 89999743211 111 1111112
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
+...|..++.++.+||.+||+.||++||++.+|++.|+...
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 23456678889999999999999999999999999887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=396.02 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=209.1
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEeec
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 138 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 138 (375)
.++|++.+.||+|+||.||+|+++++..||||++.... ...+.+.+|+.+++.++|||||++++++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 46899999999999999999999888889999997553 45678999999999999999999999985 46689999999
Q ss_pred CCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCCC
Q 017246 139 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 218 (375)
Q Consensus 139 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 218 (375)
++|+|..++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-
Confidence 999999988653 2456999999999999999999999998 9999999999999999999999999997543222
Q ss_pred ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhccccc
Q 017246 219 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 298 (375)
Q Consensus 219 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (375)
........||+.|+|||++.+..++.++|||||||++|||++|..||...... .... ..+....
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~--------------~~i~~~~ 231 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVL--------------DQVERGY 231 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH--------------HHHHTTC
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHH--------------HHHHhcC
Confidence 22233467999999999999999999999999999999999976655321111 0000 1111112
Q ss_pred CCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhcc
Q 017246 299 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 342 (375)
Q Consensus 299 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~ 342 (375)
....+..++.++.+||.+||+.||++||++++|+++|+......
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 23456678889999999999999999999999999999876543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=396.58 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=206.1
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc------cchHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999875 699999999865432 2356789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC----ceEEeec
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDF 207 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~----~vkl~Df 207 (375)
|||||||++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999965 457999999999999999999999998 99999999999998776 4999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhc
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 287 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 287 (375)
|++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. .......
T Consensus 162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~---~~i~~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANVSAVN 232 (293)
T ss_dssp TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHTTC
T ss_pred hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HH---HHHHhcC
Confidence 9998643322 2334679999999999999999999999999999999999999996322111 00 0000000
Q ss_pred cccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. ......+..++..+.+||.+||+.||++|||++|+++
T Consensus 233 ~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 Y--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000112345678899999999999999999999984
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-55 Score=399.44 Aligned_cols=244 Identities=27% Similarity=0.395 Sum_probs=207.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEcccc---CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999875 6999999999653 2344677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
|||+||+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998864 566888999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... . . ..+..
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~----------~~i~~ 215 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---T---Y----------EKILN 215 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---H----------HHHHH
T ss_pred c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---H---H----------HHHHc
Confidence 1 234789999999999999999999999999999999999999996422110 0 0 01111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
. ...+|..++.++.+++.+||+.||.+|| ++++|++
T Consensus 216 ~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 216 A--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1 1134566778899999999999999996 8999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=394.54 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=203.1
Q ss_pred HhhcccccceeccccceEEEEEEEcC----CceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 58 ATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 58 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
..++|++.+.||+|+||.||+|.+.. +..||||.+..... ...+.+.+|+.+++.++||||+++++++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35689999999999999999997642 35689998865433 33567899999999999999999999986 46789
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999998764 3557899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..... ........||+.|+|||++.+..|+.++|||||||++|||+| |.+||....... ...
T Consensus 158 ~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~------------- 220 (273)
T d1mp8a_ 158 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG------------- 220 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH-------------
T ss_pred ccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH-------------
Confidence 43222 223344678999999999999999999999999999999998 899986433211 110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.+........+..++..+.+||.+||+.||++|||+.||++.|+.+..+
T Consensus 221 -~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 221 -RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0011112234667888999999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=401.76 Aligned_cols=258 Identities=25% Similarity=0.437 Sum_probs=207.9
Q ss_pred hcccccceeccccceEEEEEEEc-CCc----eEEEEEcccc-CccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 133 (375)
.+|++.++||+|+||.||+|.+. +|+ .||+|.+... .....+.+.+|+.+++.++|||||++++++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46999999999999999999764 344 5888988653 33456789999999999999999999999986 45678
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
++|++.+|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998865 4567999999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccch
Q 017246 214 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 292 (375)
Q Consensus 214 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (375)
.............||+.|+|||++.++.|+.++|||||||++|||+| |.+||+...... + ..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~--------------~~ 224 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I--------------SS 224 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---H--------------HH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---H--------------HH
Confidence 44444444445678999999999999999999999999999999999 788886432211 1 11
Q ss_pred hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 293 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.+....+...|..++..+.+|+.+||+.||++|||+.+|++.|..+...
T Consensus 225 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1111122344667888999999999999999999999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-56 Score=402.36 Aligned_cols=268 Identities=26% Similarity=0.411 Sum_probs=216.9
Q ss_pred HHHHHHHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCcc-chHHHHHHHHHHccCCCCCcceeEeE
Q 017246 52 FRELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGY 124 (375)
Q Consensus 52 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~ 124 (375)
+.++....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.+++.++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445556788999999999999999999864 3578999999765433 34578999999999999999999999
Q ss_pred EeeCCeeEEEEeecCCCCHHHHHhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 017246 125 CTSGDQRLLVYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 184 (375)
Q Consensus 125 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 184 (375)
+...+..+++|||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 9999999999999999999999965321 2235889999999999999999999998 9
Q ss_pred ccCCCCCCcEEEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCC-C
Q 017246 185 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-K 263 (375)
Q Consensus 185 ~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~ 263 (375)
+||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999997543333333444577899999999999999999999999999999999985 5
Q ss_pred CccccccccccchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhh
Q 017246 264 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 339 (375)
Q Consensus 264 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~ 339 (375)
||...... .... .+... .....+..++.++.+|+.+||+.+|++|||+.||+++|++|.
T Consensus 242 p~~~~~~~---e~~~-------------~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHE---EVIY-------------YVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHH---HHHH-------------HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHH---HHHH-------------HHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 67532211 1110 01111 112345677788999999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=391.13 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=204.3
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEee-CCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 137 (375)
.++|++.+.||+|+||.||+|+++ |..||||+++.. ...+.+.+|+.++++++||||+++++++.+ .+.+++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 467999999999999999999986 788999999764 345778999999999999999999998854 4678999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC--
Confidence 99999999996521 335899999999999999999999988 99999999999999999999999999975322
Q ss_pred CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccccchhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 296 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (375)
......+|+.|+|||++.+..++.++|||||||++|||+| |++||...... .+. ..+..
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~--------------~~i~~ 215 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV--------------PRVEK 215 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH--------------HHHTT
T ss_pred ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHH--------------HHHHc
Confidence 1233568899999999999999999999999999999998 67887632211 111 11112
Q ss_pred ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 297 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 297 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
..+..++..+++.+.+||.+||+.||.+|||+.+|+++|++|+.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 23334566778899999999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=399.08 Aligned_cols=267 Identities=24% Similarity=0.350 Sum_probs=204.6
Q ss_pred HHHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEee
Q 017246 56 AIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS 127 (375)
Q Consensus 56 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 127 (375)
.+..++|++.+.||+|+||.||+|.+. +++.||||+++.... .....+..|..++.++ +|+||+.+++++..
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 345678999999999999999999753 346899999975433 3345677777777666 68999999998765
Q ss_pred C-CeeEEEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 128 G-DQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 128 ~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
. +.+++|||||++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccce
Confidence 4 568999999999999999975321 2345899999999999999999999998 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCC-CCccccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGE 273 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~ 273 (375)
||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||. +||.......
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~- 244 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 244 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 99999999999999998654444333445578999999999999999999999999999999999975 5775322111
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
.+ ...+........+..+++++.+||.+||+.||++|||+.||+++|+.|.+.
T Consensus 245 -~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 -EF--------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -HH--------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HH--------------HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 00 011111122344566788899999999999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=393.46 Aligned_cols=264 Identities=29% Similarity=0.422 Sum_probs=212.5
Q ss_pred HHhhcccccceeccccceEEEEEEEcC--------CceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEe
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLES--------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCT 126 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 126 (375)
+..++|++++.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345689999999999999999997532 24799999977543 2346778888888887 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 127 SGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 127 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
+++..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 99999999999999999999975432 2356899999999999999999999998 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGE 273 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 273 (375)
|++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence 999999999999999986544444444455779999999999999999999999999999999998 68888632211
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
... ..+........|..++..+.+||.+||+.||++|||+.||++.|++|.+
T Consensus 245 -~~~--------------~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 -ELF--------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHH--------------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHH--------------HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111 1111122234456677889999999999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=394.69 Aligned_cols=268 Identities=26% Similarity=0.397 Sum_probs=220.3
Q ss_pred HHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccC-CCCCcceeEeEEeeC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 128 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 128 (375)
+..++|++.++||+|+||.||+|++. +++.||||+++.... .....+.+|+.++..+ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 44578999999999999999999752 467899999976533 3445688999999998 699999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcE
Q 017246 129 DQRLLVYEYMPMGSLEDHLYDLEP--------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 194 (375)
Q Consensus 129 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Ni 194 (375)
+..++|||||++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 999999999999999999976331 2346899999999999999999999998 99999999999
Q ss_pred EEeCCCceEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccc
Q 017246 195 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGE 273 (375)
Q Consensus 195 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 273 (375)
|++.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+| |.+||........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987655555555566789999999999999999999999999999999999 5555543222110
Q ss_pred cchhhchhhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 274 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
+..++....+...+..++..+.+||.+||+.||++|||+.+|+++|+++....+
T Consensus 257 ----------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~ 310 (311)
T d1t46a_ 257 ----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (311)
T ss_dssp ----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ----------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence 111122222334456678899999999999999999999999999998876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-54 Score=388.26 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=203.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc---hHHHHHHHHHHccCCCCCcceeEeEEeeCC----e
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----Q 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 130 (375)
.++|++.+.||+|+||.||+|+.. +|+.||||++......+ ...+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999864 79999999997654332 446889999999999999999999987654 3
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.||||||++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998865 457999999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCC-CceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccc
Q 017246 211 KLGPVGD-NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 211 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
....... ........+||+.|+|||++.+..++.++|||||||++|||+||++||....... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~-- 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVRED-- 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCC--
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcC--
Confidence 6533222 2223445689999999999999999999999999999999999999996432110 000111100
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhhhh
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLV 339 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~eil~~L~~l~ 339 (375)
+.........++..+.++|.+||+.||++|| ++++++..|.++.
T Consensus 231 ------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 ------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0011112345678899999999999999999 8999999998875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-54 Score=398.32 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=207.1
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 135 (375)
++|++.+.||+|+||.||+|+++ +|+.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 69999999986532 244567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 215 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 215 (375)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999965 456999999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ....+||+.|||||++.+..|+.++|||||||++|||+||+.||...... .. .. .+..
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~---~~----------~i~~ 252 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QI---YE----------KIVS 252 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HH----------HHHH
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HH---HH----------HHhc
Confidence 1 23467999999999999999999999999999999999999999632211 00 00 0111
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
. ...++..++.++.+||.+||+.||.+|+ ++++|++
T Consensus 253 ~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 1123556778899999999999999994 8999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=388.70 Aligned_cols=257 Identities=30% Similarity=0.421 Sum_probs=200.3
Q ss_pred hhcccccceeccccceEEEEEEEc--CC--ceEEEEEccccCc---cchHHHHHHHHHHccCCCCCcceeEeEEeeCCee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE--SG--QLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 131 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 131 (375)
.++|++.+.||+|+||.||+|++. ++ ..||||++.+... ...+.+.+|+.+|+.++||||+++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 467999999999999999999754 22 3689999876432 334678999999999999999999999975 577
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 8999999999999988652 456999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCc-eeeeccccccccccccccccCCCCccchhHhHHHHHHHHHh-CCCCccccccccccchhhchhhhhhhccc
Q 017246 212 LGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 289 (375)
Q Consensus 212 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
........ .......|+..|+|||++.+..++.++|||||||++|||+| |.+||....... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~------------ 224 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL------------ 224 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH------------
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HH------------
Confidence 65433322 22334568889999999999999999999999999999998 899996322111 10
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhh
Q 017246 290 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 338 (375)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l 338 (375)
..+.........+..++..+.+||.+||+.||++|||+.+|++.|.+.
T Consensus 225 -~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 -HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111222234566778899999999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.4e-54 Score=398.36 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=202.0
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc---cchHHHH---HHHHHHccCCCCCcceeEeEEeeCCeeE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFI---VEVLMLSLLHHDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~ 132 (375)
++|++.++||+|+||.||+|+.. +|+.||||++.+... .....+. .++.+++.++|||||+++++|.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999875 699999999865322 1222333 3477788889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
||||||+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999965 456889999999999999999999998 99999999999999999999999999985
Q ss_pred CCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccc
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 291 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
..... ....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||..........+..
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------------- 219 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------- 219 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-------------
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------
Confidence 43222 234679999999999974 568999999999999999999999997433221111000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 017246 292 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 333 (375)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~eil~ 333 (375)
. .......++..+++++.+||.+||+.||++||+ ++|+++
T Consensus 220 ~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 M--TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp H--SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred h--cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 001112334567788999999999999999999 688885
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-54 Score=392.47 Aligned_cols=251 Identities=17% Similarity=0.228 Sum_probs=205.7
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.++|++.+.||+|+||+||+|... +|+.||||+++... .....+.+|+.+|+.++||||++++++|.+.+.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367999999999999999999875 68999999997654 3345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC--CceEEeecCCCccCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND--FNPKLSDFGLAKLGPV 215 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~--~~vkl~Dfg~a~~~~~ 215 (375)
|+||+|.+++.. .+..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||++.....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999954 3447999999999999999999999998 9999999999999854 4799999999986433
Q ss_pred CCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 216 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 216 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||....... . ..........
T Consensus 157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~---~~~i~~~~~~------ 221 (321)
T d1tkia_ 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---I---IENIMNAEYT------ 221 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHHTCCC------
T ss_pred C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCCCC------
Confidence 2 22344679999999999999999999999999999999999999996432110 0 0000000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
+.......++.++.+||.+||+.||++|||+.|+++
T Consensus 222 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 --FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001245678899999999999999999999997
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-54 Score=390.14 Aligned_cols=262 Identities=29% Similarity=0.431 Sum_probs=210.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCc--eEEEEEcccc-CccchHHHHHHHHHHccC-CCCCcceeEeEEeeCCeeEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQ--LVAIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 133 (375)
.++|++.++||+|+||.||+|.+. +|. .||||.+... .....+.+.+|+.+|..+ +|||||++++++.+.+.+++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 368999999999999999999765 444 4778887543 233456789999999998 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhcc------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCc
Q 017246 134 VYEYMPMGSLEDHLYDL------------EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 201 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~ 201 (375)
||||+++|+|.+++... ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999999653 123567999999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCC-Cccccccccccchhhch
Q 017246 202 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSWS 280 (375)
Q Consensus 202 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-pf~~~~~~~~~~~~~~~ 280 (375)
+||+|||+++.... ........||..|+|||.+.+..|+.++|||||||++|||++|.. ||....... +.
T Consensus 166 ~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~--- 236 (309)
T d1fvra_ 166 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY--- 236 (309)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---
T ss_pred eEEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HH---
Confidence 99999999975322 122234568999999999999999999999999999999999764 664322110 00
Q ss_pred hhhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
..+....+...+..+++++.+||.+||+.||++||++.+|++.|+++.....
T Consensus 237 -----------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 237 -----------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp -----------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -----------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 1111112234456788899999999999999999999999999999987654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=393.72 Aligned_cols=247 Identities=29% Similarity=0.418 Sum_probs=204.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccC---ccchHHHHHHHHHHc-cCCCCCcceeEeEEeeCCeeEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLS-LLHHDNLVTLIGYCTSGDQRLLV 134 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 134 (375)
++|++++.||+|+||+||+|+.. +|+.||||++.+.. ....+.+..|..++. .++||||+++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 69999999997532 233455666766654 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 214 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 214 (375)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999965 456899999999999999999999998 9999999999999999999999999998543
Q ss_pred CCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhc
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 294 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .+.. . +.
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~---~----------i~ 216 (320)
T d1xjda_ 155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFH---S----------IR 216 (320)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H----------HH
T ss_pred cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHH---H----------HH
Confidence 22 22334568999999999999999999999999999999999999999743211 1100 0 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 017246 295 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 333 (375)
Q Consensus 295 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-eil~ 333 (375)
. -...+|..++..+.+||.+||+.||++||++. ++++
T Consensus 217 ~--~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 217 M--DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp H--CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred c--CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 01234556788899999999999999999995 6764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-53 Score=382.13 Aligned_cols=250 Identities=24% Similarity=0.274 Sum_probs=205.2
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccc---------hHHHHHHHHHHccCC-CCCcceeEeEEee
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---------HQEFIVEVLMLSLLH-HDNLVTLIGYCTS 127 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 127 (375)
.++|++.+.||+|+||+||+|+.. +|+.||||++....... .+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999874 68999999987643221 235778999999997 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
.+..||||||+++|+|.+++.. +..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999965 457999999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCCceeeecccccccccccccccc------CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchh
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 281 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 281 (375)
|+++...... .....+||+.|+|||++.+ ..++.++||||+||++|||++|++||........ . .
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---~---~ 225 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---L---R 225 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---H
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH---H---H
Confidence 9998643322 2344679999999998863 3578899999999999999999999974321110 0 0
Q ss_pred hhhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 282 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
...... ..........+++++.+|+.+||+.||++||++.||+
T Consensus 226 ~i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 226 MIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 001000 0111122346788999999999999999999999997
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=387.70 Aligned_cols=268 Identities=23% Similarity=0.234 Sum_probs=199.9
Q ss_pred ccceeccccceEEEEEEEc-CCceEEEEEccccCccc-----hHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 64 EANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-----HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
.+++||+|+||+||+|+.. +|+.||||+++...... ...+.+|+.+++.++|||||++++++.+.+..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999865 69999999996543221 34688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+.++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 98877765552 4567899999999999999999999998 9999999999999999999999999997543322
Q ss_pred Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh-------hhhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-------LKDQKK 289 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~ 289 (375)
......+||+.|+|||++.. ..|+.++|||||||++|||++|.+||........ +....... ......
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTTS
T ss_pred --ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHHHHHhcCCCChhhccchhc
Confidence 22334679999999999875 4689999999999999999999999964322110 00000000 000000
Q ss_pred cchhcccccCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCCCCccCCCCC
Q 017246 290 FVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGA 353 (375)
Q Consensus 290 ~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 353 (375)
............. ....++++.+||.+||+.||++|||++|++ .|||-++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L-----------~Hp~f~~~p~ 288 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL-----------KMKYFSNRPG 288 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH-----------TSGGGTSSSC
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh-----------CCHhhCCCCC
Confidence 0000000000001 124567899999999999999999999998 5677665443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=389.52 Aligned_cols=250 Identities=20% Similarity=0.217 Sum_probs=198.4
Q ss_pred hhcccccc-eeccccceEEEEEEE-cCCceEEEEEccccCccchHHHHHHHHHHcc-CCCCCcceeEeEEee----CCee
Q 017246 59 TRNFREAN-LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTS----GDQR 131 (375)
Q Consensus 59 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~ 131 (375)
.++|.+.. +||+|+||.||+|+. .+++.||||+++. ...+.+|+.++.+ ++|||||+++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788764 699999999999986 4699999999853 3457789988654 589999999999876 4678
Q ss_pred EEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---CCceEEeecC
Q 017246 132 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFG 208 (375)
Q Consensus 132 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~vkl~Dfg 208 (375)
|||||||+||+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999752 2457999999999999999999999998 999999999999975 4579999999
Q ss_pred CCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 209 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 209 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|+||++||............
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----------- 225 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------- 225 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-----------
Confidence 998643322 234468999999999999999999999999999999999999999643221110000
Q ss_pred ccchhcccc--cCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 289 KFVHLVDPL--LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 289 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
...+.... +.......+++++.+||.+||+.||++||++.|+++
T Consensus 226 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 226 -KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000000 001112356788999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=382.17 Aligned_cols=259 Identities=27% Similarity=0.394 Sum_probs=207.6
Q ss_pred ccceeccccceEEEEEEEcC----CceEEEEEcccc-CccchHHHHHHHHHHccCCCCCcceeEeEEee-CCeeEEEEee
Q 017246 64 EANLIGEGGFGKVYKGRLES----GQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEY 137 (375)
Q Consensus 64 ~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 137 (375)
+.++||+|+||+||+|++.. ...||||+++.. .......+.+|+.++++++||||+++++++.. +...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 36789999999999998643 235899998753 33445679999999999999999999999865 4688999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
|++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999998864 4556788899999999999999999998 9999999999999999999999999998643322
Q ss_pred C--ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhccccchhcc
Q 017246 218 N--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 295 (375)
Q Consensus 218 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
. ........||+.|+|||++....++.++||||||+++|||+||+.||....... .. ... +.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~---~~~-----------i~ 248 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DI---TVY-----------LL 248 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C---HHH-----------HH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HH---HHH-----------HH
Confidence 1 122233568999999999999999999999999999999999887775321110 00 000 01
Q ss_pred cccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccCC
Q 017246 296 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 344 (375)
Q Consensus 296 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~~ 344 (375)
...+...|..++..+.+||.+||+.||++||++.||++.|+.+.+....
T Consensus 249 ~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1112233566778899999999999999999999999999999876444
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-53 Score=382.38 Aligned_cols=276 Identities=25% Similarity=0.310 Sum_probs=203.9
Q ss_pred hhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeCC----eeEEE
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLLV 134 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv 134 (375)
..+|.+.+.||+|+||.||+|++. |+.||||++..... .......|+..+..++||||+++++++...+ .+++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 357889999999999999999874 88999999865421 1122334555666789999999999997654 57899
Q ss_pred EeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 135 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-----ANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 135 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
|||+++|+|.+++.. ..+++..++.++.|++.||.|||+. ...+|+||||||+||||+.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999964 3589999999999999999999963 112399999999999999999999999999
Q ss_pred CccCCCCCCce--eeeccccccccccccccccCC------CCccchhHhHHHHHHHHHhCCCCccccccccccchhh-ch
Q 017246 210 AKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSGK------LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WS 280 (375)
Q Consensus 210 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~-~~ 280 (375)
++......... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||............. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 97643332221 233467999999999987643 5778999999999999999999886443322111000 00
Q ss_pred hhhhhhccccchhcccccCCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC
Q 017246 281 RPFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 343 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~ 343 (375)
..... ...........+..+ +......+.+|+.+||+.||++|||+.||++.|++|..+.+
T Consensus 235 ~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 235 DPSVE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SCCHH--HHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cchHH--HHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 00000 000011122222222 23566789999999999999999999999999999976543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=383.81 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=215.2
Q ss_pred HHhhcccccceeccccceEEEEEEEc------CCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCC
Q 017246 57 IATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 129 (375)
Q Consensus 57 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 129 (375)
+..++|++.+.||+|+||.||+|.+. +++.||||+++.... .....+.+|+.++++++||||+++++++...+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 34578999999999999999999753 357899999976432 33456889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhccC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLE------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
..++||||+++|+|.+++.... .....+++..+..++.|+++||.|||+++ |+||||||+||||+.++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence 9999999999999999986432 22345789999999999999999999988 99999999999999999999
Q ss_pred EeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCC-CCccccccccccchhhchhh
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGEQNLVSWSRP 282 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~ 282 (375)
|+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||....... .
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~------ 244 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---V------ 244 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---H------
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---H------
Confidence 99999998644333333444567899999999999999999999999999999999985 6665321110 0
Q ss_pred hhhhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhh
Q 017246 283 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 340 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~ 340 (375)
...+.. ......+..++..+.+||.+||+.+|++|||+.+|+++|++...
T Consensus 245 -------~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 -------LRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -------HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------HHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 011111 11223456778899999999999999999999999999988754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=379.21 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=199.9
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|+||.||+|++ .+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999986 4799999999965432 235678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
|+.+ .+.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9966 45555543 24567999999999999999999999998 999999999999999999999999999754322
Q ss_pred CCceeeeccccccccccccccccCC-CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh-------hhh--
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-------LKD-- 286 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~~-- 286 (375)
........||+.|+|||++.... ++.++|||||||++|+|++|+.||....... .+....... ...
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGG
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccc
Confidence 22333467999999999887665 5789999999999999999999997432211 000000000 000
Q ss_pred -ccccchhcccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 287 -QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 287 -~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
............... ....++..+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000000000000 01245678899999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=379.60 Aligned_cols=239 Identities=23% Similarity=0.363 Sum_probs=198.0
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCcc------chHHHHHHHHHHccCC--CCCcceeEeEEeeCC
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGD 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 129 (375)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.... ...++.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999865 6999999998754322 1234567999999986 899999999999999
Q ss_pred eeEEEEeecCC-CCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCC-CceEEeec
Q 017246 130 QRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDF 207 (375)
Q Consensus 130 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~-~~vkl~Df 207 (375)
..++||||+.+ +++.+++.. +..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999976 678888754 457999999999999999999999998 9999999999999854 78999999
Q ss_pred CCCccCCCCCCceeeeccccccccccccccccCCC-CccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 208 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 208 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
|+++..... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . ...
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------i~~- 218 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------IIR- 218 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------HHH-
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-------Hhh-
Confidence 999754322 2334689999999999987765 577999999999999999999996321 0 000
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
. ...++..++.++.+||.+||+.||++|||++|++
T Consensus 219 ---------~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 219 ---------G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp ---------C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---------c--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 0 0123445677899999999999999999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=377.67 Aligned_cols=265 Identities=24% Similarity=0.282 Sum_probs=198.3
Q ss_pred hhcccccceeccccceEEEEEEEc-C-CceEEEEEccccCc--cchHHHHHHHHHHccC---CCCCcceeEeEEee----
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-S-GQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL---HHDNLVTLIGYCTS---- 127 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 127 (375)
.++|++.+.||+|+||+||+|++. + ++.||||++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999863 4 66799999865422 2233456777776665 79999999999853
Q ss_pred -CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEee
Q 017246 128 -GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 206 (375)
Q Consensus 128 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~D 206 (375)
....+++|||++++.+...... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3568899999988776544432 4667899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chhhchhh---
Q 017246 207 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRP--- 282 (375)
Q Consensus 207 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~--- 282 (375)
||++.... ........+||+.|+|||++.+..|+.++|||||||++|||++|++||......... .+......
T Consensus 160 fg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99987532 223344578999999999999999999999999999999999999999743321100 00000000
Q ss_pred -hhhhccc-cchhc---ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 283 -FLKDQKK-FVHLV---DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 283 -~~~~~~~-~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
.+..... ..... .......++..+++.+.+||.+||+.||++|||+.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0000000 00000 00011123345677899999999999999999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.4e-52 Score=373.80 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=201.4
Q ss_pred hcccccceeccccceEEEEEEEcCCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 137 (375)
++|++.+.||+|+||+||+|++++|+.||||++..... ...+.+.+|+.+|+.++||||+++++++...+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 47999999999999999999998999999999966432 3356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 217 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 217 (375)
+.++.+..+.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98876666653 4677999999999999999999999988 9999999999999999999999999987532221
Q ss_pred Cceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhh-------hhhhccc
Q 017246 218 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP-------FLKDQKK 289 (375)
Q Consensus 218 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------~~~~~~~ 289 (375)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........ .......
T Consensus 155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhhccchhh
Confidence 22334568999999999875 457899999999999999999999996432111 00000000 0000000
Q ss_pred cch------hcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 290 FVH------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 290 ~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
... ...+.........++..+.+||.+||+.||++|||++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000 0011111122345677899999999999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.4e-50 Score=362.35 Aligned_cols=273 Identities=18% Similarity=0.187 Sum_probs=212.9
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCC-CCcceeEeEEeeCCeeEEEEe
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 136 (375)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|+..++.+.| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999865 68999999886542 23456778888888865 899999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC-----CCceEEeecCCCc
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-----DFNPKLSDFGLAK 211 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-----~~~vkl~Dfg~a~ 211 (375)
|+ +++|.+++.. .+..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 98 7899998865 3456899999999999999999999998 999999999999964 5789999999998
Q ss_pred cCCCCCC-----ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhh
Q 017246 212 LGPVGDN-----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 286 (375)
Q Consensus 212 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 286 (375)
....... .......+||+.|||||++.+..++.++|||||||++|||+||..||.................. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~-~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-HH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-cC
Confidence 6432211 12234468999999999999999999999999999999999999999744332221111100000 00
Q ss_pred ccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhccC---CCCccCC
Q 017246 287 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD---SHPVSRN 350 (375)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~~~---~~~~~~~ 350 (375)
..... .+...+++++.+++..|++.+|++||+++.+.+.|+++..+.. +.+.+|+
T Consensus 234 ~~~~~---------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 234 STPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp HSCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred CCChH---------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence 00000 1123456789999999999999999999999999998876433 3444553
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-49 Score=360.85 Aligned_cols=262 Identities=22% Similarity=0.233 Sum_probs=201.7
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcc-eeEeEEeeCCeeEEEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV-TLIGYCTSGDQRLLVYEY 137 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~ 137 (375)
++|++.+.||+|+||.||+|++. +|+.||||++..... ..++..|+.+++.++|+|++ .+..++...+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999864 689999998876432 34577899999999877654 555666788889999999
Q ss_pred cCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeC---CCceEEeecCCCccCC
Q 017246 138 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGP 214 (375)
Q Consensus 138 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~vkl~Dfg~a~~~~ 214 (375)
+ +++|.+.+.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+++...
T Consensus 85 ~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 5577776654 3567999999999999999999999998 999999999999864 4579999999998643
Q ss_pred CCCC-----ceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hchhhhhhhcc
Q 017246 215 VGDN-----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSRPFLKDQK 288 (375)
Q Consensus 215 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~ 288 (375)
.... ........||+.|+|||++.+..++.++|||||||++|||+||+.||............ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~--- 234 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--- 234 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH---
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC---
Confidence 3221 12234568999999999999999999999999999999999999999754332221111 11000000
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhhhhhc
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 341 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~l~~~ 341 (375)
...+ .....++.++.+++..||+.+|++||++.+|.+.|+.+..+
T Consensus 235 ----~~~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 235 ----TPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----SCHH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----CChh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0000 11235677899999999999999999999999999887643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-50 Score=369.80 Aligned_cols=266 Identities=27% Similarity=0.323 Sum_probs=198.1
Q ss_pred cccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCCCCCcceeEeEEeeC------CeeEE
Q 017246 61 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLL 133 (375)
Q Consensus 61 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 133 (375)
+|...++||+|+||+||+|++. +|+.||||++...... ..+|+.+|+.++||||++++++|... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6999999999999999999875 6999999999765322 23699999999999999999998543 35789
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCcc
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKL 212 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~~ 212 (375)
||||++++ +...+.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999765 44444333335678999999999999999999999988 99999999999999775 899999999976
Q ss_pred CCCCCCceeeecccccccccccccccc-CCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchh-------hhh
Q 017246 213 GPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR-------PFL 284 (375)
Q Consensus 213 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-------~~~ 284 (375)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||....... .+..... ...
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhh
Confidence 43322 2234679999999998875 568999999999999999999999996433211 0000000 000
Q ss_pred h-hccc-----cchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhhhh
Q 017246 285 K-DQKK-----FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYLV 339 (375)
Q Consensus 285 ~-~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~--L~~l~ 339 (375)
. .... .................++++.+||.+||+.||++|||+.|+++. ++.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0 0000 000000001111234567789999999999999999999999963 55554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=362.78 Aligned_cols=267 Identities=24% Similarity=0.310 Sum_probs=194.6
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee--------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-------- 127 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 127 (375)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999864 799999999865432 335678899999999999999999998754
Q ss_pred CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeec
Q 017246 128 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 207 (375)
Q Consensus 128 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Df 207 (375)
.+..++||||+.++.+..+. .....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 35689999999877665444 34667899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCC--ceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhh-chhhh
Q 017246 208 GLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WSRPF 283 (375)
Q Consensus 208 g~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~-~~~~~ 283 (375)
|+++....... .......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+. .....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99975432221 1222335799999999998765 68999999999999999999999996432211110000 00000
Q ss_pred hhh----c--cccchhcccccCCC--CC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 284 LKD----Q--KKFVHLVDPLLHGR--YP-----RRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 284 ~~~----~--~~~~~~~~~~~~~~--~~-----~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
... . .............. .+ ......+.+||.+||+.||++|||++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 000 0 00000000000000 00 11245678999999999999999999999
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=368.31 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=194.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCC------
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------ 129 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 129 (375)
.++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999865 699999999976432 23456889999999999999999999997654
Q ss_pred eeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCC
Q 017246 130 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 209 (375)
Q Consensus 130 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~ 209 (375)
.+|+||||+ +.+|..++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 569999999 667777764 356999999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhc-h----hhh
Q 017246 210 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW-S----RPF 283 (375)
Q Consensus 210 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~----~~~ 283 (375)
++..... .+...||+.|+|||++.+. .++.++|||||||++|+|++|++||.............. . ..+
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 9864322 2346799999999998764 578999999999999999999999964432111000000 0 000
Q ss_pred hhh-----ccccchhcccccC---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 284 LKD-----QKKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 284 ~~~-----~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... .......+..... ......+++.+.+||.+||..||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000001100 1122455678899999999999999999999996
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.3e-49 Score=361.92 Aligned_cols=257 Identities=17% Similarity=0.276 Sum_probs=197.6
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEEee--CCeeEEEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTS--GDQRLLVY 135 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 135 (375)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. ..+.+.+|+.+|+.+. ||||++++++|.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999874 6999999998653 3567889999999995 9999999999874 35689999
Q ss_pred eecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCC-ceEEeecCCCccCC
Q 017246 136 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGP 214 (375)
Q Consensus 136 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~vkl~Dfg~a~~~~ 214 (375)
||+.+++|..+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+++...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987653 35899999999999999999999998 99999999999998765 59999999998643
Q ss_pred CCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccc--hh---------hchhh
Q 017246 215 VGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN--LV---------SWSRP 282 (375)
Q Consensus 215 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~--~~---------~~~~~ 282 (375)
... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .. .+...
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 322 23446799999999998765 47999999999999999999999996433211100 00 00000
Q ss_pred h-hhhccccchhc--------ccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 283 F-LKDQKKFVHLV--------DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 283 ~-~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
. ........... ...........++.++.+||.+||+.||++|||++|++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0 00000000000 11111122345677899999999999999999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=369.30 Aligned_cols=266 Identities=23% Similarity=0.264 Sum_probs=195.4
Q ss_pred hcccccceeccccceEEEEEEE-cCCceEEEEEccccCc-cchHHHHHHHHHHccCCCCCcceeEeEEeeCC----eeEE
Q 017246 60 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLL 133 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l 133 (375)
.+|++++.||+|+||+||+|.. .+|+.||||++.+... ...+.+.+|+.+|+.++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 5799999999999999999976 4799999999976432 33457889999999999999999999986643 2345
Q ss_pred EEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccC
Q 017246 134 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 213 (375)
Q Consensus 134 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 213 (375)
+++++.+|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 5566779999999954 36999999999999999999999998 999999999999999999999999999753
Q ss_pred CCCCC-ceeeeccccccccccccccc-cCCCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhh--hh--c
Q 017246 214 PVGDN-THVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL--KD--Q 287 (375)
Q Consensus 214 ~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~--~ 287 (375)
..... .......+||+.|+|||++. +..++.++||||+||++|+|++|+.||................... .. .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 32221 12234467999999999985 4567899999999999999999999996433211100000000000 00 0
Q ss_pred c---ccchhc--ccccCC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 288 K---KFVHLV--DPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 288 ~---~~~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
. ...... .+.... ...+..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 000000 011234567899999999999999999999995
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=354.44 Aligned_cols=263 Identities=20% Similarity=0.252 Sum_probs=204.3
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeCCeeEEEEe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 136 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 136 (375)
++|++.+.||+|+||+||+|+.. +++.||||+++.... .....+.+|+.+|+.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47999999999999999999864 789999999865433 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCCccCCCC
Q 017246 137 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 216 (375)
Q Consensus 137 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 216 (375)
++.+++|..++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999998888774 3567899999999999999999999998 999999999999999999999999999864332
Q ss_pred CCceeeeccccccccccccccccCC-CCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhh-------h----
Q 017246 217 DNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-------L---- 284 (375)
Q Consensus 217 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~---- 284 (375)
. .......+++.|+|||++.... ++.++|||||||++|||++|+.||........ ......... .
T Consensus 155 ~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGG
T ss_pred C--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHHHHHhhcCCCChhhhhhhh
Confidence 2 2233356788999999988665 68999999999999999999998743221110 000000000 0
Q ss_pred --hhccccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 285 --KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 285 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
......................+..+.+|+.+||+.||.+|||++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000000000001111123455677899999999999999999999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=361.77 Aligned_cols=252 Identities=28% Similarity=0.366 Sum_probs=203.1
Q ss_pred hcccccceeccccceEEEEEEEc----CCceEEEEEccccC----ccchHHHHHHHHHHccCCC-CCcceeEeEEeeCCe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQ 130 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 130 (375)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999752 48899999986542 2335567889999999976 899999999999999
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.+++|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999965 446788999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCceeeeccccccccccccccccC--CCCccchhHhHHHHHHHHHhCCCCccccccccccchhhchhhhhhhcc
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 288 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 288 (375)
+...... ........|++.|+|||.+.+. .++.++|||||||+||||++|..||............ .....
T Consensus 177 ~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~---- 249 (322)
T d1vzoa_ 177 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL---- 249 (322)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH----
T ss_pred hhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcc----
Confidence 7543222 2223446799999999999754 4788999999999999999999999744322211100 00000
Q ss_pred ccchhcccccCCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 017246 289 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 333 (375)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~ 333 (375)
.....++..++..+.+|+.+||+.||++|| +++|+++
T Consensus 250 --------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 --------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011234567888999999999999999999 4788874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=359.82 Aligned_cols=260 Identities=22% Similarity=0.287 Sum_probs=190.2
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEee------CCe
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQ 130 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 130 (375)
++|++.++||+|+||+||+|++. +|+.||||++..... .....+.+|+.+++.++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999875 699999999976432 234568899999999999999999999853 468
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
+|+||||+.++ +.+.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 89999999765 44444 245899999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCcccccccccc-chh--------hch-
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLV--------SWS- 280 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~--------~~~- 280 (375)
+.... .......+||+.|+|||++.+..++.++||||+||++|+|++|+.||......... ... .+.
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 75332 22334467999999999999999999999999999999999999999643211100 000 000
Q ss_pred ------hhhhhhc-----cccchhcccccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 017246 281 ------RPFLKDQ-----KKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIV 332 (375)
Q Consensus 281 ------~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 332 (375)
..+.... .............. .....+..+.+||.+||+.||++|||++|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0000000 00011111111111 1235678899999999999999999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=358.19 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=194.3
Q ss_pred hhcccccceeccccceEEEEEEEc-CCceEEEEEccccCc--cchHHHHHHHHHHccCCCCCcceeEeEEeeC-----Ce
Q 017246 59 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQ 130 (375)
Q Consensus 59 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 130 (375)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999864 799999999976533 2345688999999999999999999998643 33
Q ss_pred eEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceEEeecCCC
Q 017246 131 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 210 (375)
Q Consensus 131 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a 210 (375)
.+++|+++.+|+|.+++. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 466677788999999984 356999999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCceeeeccccccccccccccccC-CCCccchhHhHHHHHHHHHhCCCCccccccccccchh-hch----hhhh
Q 017246 211 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS----RPFL 284 (375)
Q Consensus 211 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~----~~~~ 284 (375)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||...........+ ... ....
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 7532 123346799999999987765 4689999999999999999999999643221110000 000 0000
Q ss_pred hhc--cccchhcc---cccCCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 017246 285 KDQ--KKFVHLVD---PLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 333 (375)
Q Consensus 285 ~~~--~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 333 (375)
... ........ ...... ....++..+.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000 00000000 000000 01245677899999999999999999999994
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-43 Score=325.97 Aligned_cols=264 Identities=17% Similarity=0.206 Sum_probs=190.8
Q ss_pred hcccccceeccccceEEEEEEEc-CCceEEEEEccccCccchHHHHHHHHHHccCC-----------CCCcceeEeEEee
Q 017246 60 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----------HDNLVTLIGYCTS 127 (375)
Q Consensus 60 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 127 (375)
++|+++++||+|+||+||+|+.. +|+.||||++++... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999874 799999999976532 2456778888887775 5789999988754
Q ss_pred --CCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccCCCCCCcEEEeCCCc---
Q 017246 128 --GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFN--- 201 (375)
Q Consensus 128 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~--- 201 (375)
....+++|+++..+........ ......+++..++.++.||+.||.|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 3566677777655443333222 2356778999999999999999999997 77 999999999999986653
Q ss_pred ---eEEeecCCCccCCCCCCceeeeccccccccccccccccCCCCccchhHhHHHHHHHHHhCCCCccccccccccch--
Q 017246 202 ---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-- 276 (375)
Q Consensus 202 ---vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-- 276 (375)
++|+|||.+..... .....+||+.|+|||++....++.++||||+||++++|++|+.||...........
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999975322 22346799999999999999999999999999999999999999975432211110
Q ss_pred --hhchh-------hhhhhccc---------cchhccc----------ccCCCCCHHHHHHHHHHHHhhcCCCCCCCCCH
Q 017246 277 --VSWSR-------PFLKDQKK---------FVHLVDP----------LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 328 (375)
Q Consensus 277 --~~~~~-------~~~~~~~~---------~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 328 (375)
..... ........ ....+.. ......+...+..+.+|+.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 00000 00000000 0000000 01123456788999999999999999999999
Q ss_pred HHHHH
Q 017246 329 NDIVV 333 (375)
Q Consensus 329 ~eil~ 333 (375)
+|+|+
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99983
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=3.4e-27 Score=198.64 Aligned_cols=166 Identities=14% Similarity=0.046 Sum_probs=120.8
Q ss_pred ccccceeccccceEEEEEEEcCCceEEEEEccccCcc------------------chHHHHHHHHHHccCCCCCcceeEe
Q 017246 62 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ------------------GHQEFIVEVLMLSLLHHDNLVTLIG 123 (375)
Q Consensus 62 ~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~~ 123 (375)
+.+++.||+|+||.||+|...+|+.||||+++..... .......|...+..+.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4568999999999999999888999999987542110 0122446888899999999998886
Q ss_pred EEeeCCeeEEEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccCCCCCCcEEEeCCCceE
Q 017246 124 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 203 (375)
Q Consensus 124 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~vk 203 (375)
+. ..+++|||+++..+.+ ++...+..++.|++.+|.|||+++ |+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 63 2379999998865433 223345789999999999999998 9999999999999976 489
Q ss_pred EeecCCCccCCCCCCceeeecccccccccccc-----ccccCCCCccchhHhHHHHHH
Q 017246 204 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----YAMSGKLTLKSDIYSFGVVLL 256 (375)
Q Consensus 204 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwslG~il~ 256 (375)
|+|||.|......... .|.... .+....|+.++|+||+.--+.
T Consensus 143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred EEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 9999999753222111 111110 012466888999999865543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=5.4e-09 Score=90.23 Aligned_cols=148 Identities=16% Similarity=0.057 Sum_probs=102.5
Q ss_pred HHHHHhhcccccceeccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCC-CCCcceeEeEEeeCCeeE
Q 017246 54 ELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRL 132 (375)
Q Consensus 54 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 132 (375)
++......|+..+..+.++.+.||+.... ++.+++|+...........+..|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 34444567777776665666789988654 6667888876554444555677888877663 334677888888889999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-------------------------------
Q 017246 133 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN------------------------------- 181 (375)
Q Consensus 133 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~------------------------------- 181 (375)
+||++++|.++.+.... . . ....++.+++..+..||+..-
T Consensus 87 lv~~~l~G~~~~~~~~~----~--~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED----E--Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTT----C--S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEecccccccccccc----c--c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999888665421 1 1 122345555666666664210
Q ss_pred -------------------------CCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 182 -------------------------PPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 182 -------------------------~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127999999999999987666799999885
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.45 E-value=4e-07 Score=77.66 Aligned_cols=130 Identities=18% Similarity=0.110 Sum_probs=85.5
Q ss_pred eecccc-ceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCC--CCcceeEeEEeeCCeeEEEEeecCCCCH
Q 017246 67 LIGEGG-FGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSL 143 (375)
Q Consensus 67 ~lg~G~-~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL 143 (375)
.+..|. .+.||+....++..+++|....... ..+..|+..++.+.. -.+.+++.+..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 3689999888888899997655432 345667777766633 2366788888888889999999988665
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------
Q 017246 144 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------------------------------------- 180 (375)
Q Consensus 144 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------- 180 (375)
.+.. ... ..++.++...|..||+..
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 3211 111 112223333344444211
Q ss_pred ------------CCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 181 ------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 181 ------------~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
...++|+|+.|.|||++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1127999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=7.9e-06 Score=74.22 Aligned_cols=77 Identities=14% Similarity=0.044 Sum_probs=48.8
Q ss_pred cceeccccceEEEEEEEc-CCceEEEEEcccc------C-ccchHHHHHHHHHHccCC--CC-CcceeEeEEeeCCeeEE
Q 017246 65 ANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE------G-LQGHQEFIVEVLMLSLLH--HD-NLVTLIGYCTSGDQRLL 133 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~l 133 (375)
.+.||.|....||++... +++.+++|.-.+. . .....+...|...|+.+. -| .+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999765 4678999964321 1 113345566887776652 23 35555544 4556689
Q ss_pred EEeecCCCCH
Q 017246 134 VYEYMPMGSL 143 (375)
Q Consensus 134 v~e~~~~gsL 143 (375)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.65 E-value=0.00011 Score=64.56 Aligned_cols=137 Identities=14% Similarity=0.083 Sum_probs=78.4
Q ss_pred ceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCCCCCc-----ceeE--eEEeeCCeeEEEEeecCCCCHHH
Q 017246 73 FGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-----VTLI--GYCTSGDQRLLVYEYMPMGSLED 145 (375)
Q Consensus 73 ~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~--~~~~~~~~~~lv~e~~~~gsL~~ 145 (375)
--.||+++..+|..|++|+.++.. ....++..|...+..|...++ +..- ..+......+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 368999999999999999987653 345667778887776642221 1111 13345677888999987643210
Q ss_pred ----HHh----------c----cC-CCCCC-------------------CCH---HHHHHHHHHHHHHHHHhh-cCCCCC
Q 017246 146 ----HLY----------D----LE-PDQEP-------------------LSW---NTRMKIAVGAARGLEYLH-CKANPP 183 (375)
Q Consensus 146 ----~l~----------~----~~-~~~~~-------------------l~~---~~~~~i~~qi~~~l~~LH-~~~~~~ 183 (375)
.+. . .. ..... ++. ......+.+++..+.-+- ......
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 000 0 00 00011 111 122233333333333221 111234
Q ss_pred cccCCCCCCcEEEeCCCceEEeecCCCcc
Q 017246 184 VIYRDLKSANILLDNDFNPKLSDFGLAKL 212 (375)
Q Consensus 184 i~H~Dlkp~Nill~~~~~vkl~Dfg~a~~ 212 (375)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.38 E-value=0.00027 Score=63.76 Aligned_cols=73 Identities=21% Similarity=0.299 Sum_probs=49.0
Q ss_pred cceeccccceEEEEEEEcC--------CceEEEEEccccCccchHHHHHHHHHHccCCCCCc-ceeEeEEeeCCeeEEEE
Q 017246 65 ANLIGEGGFGKVYKGRLES--------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVY 135 (375)
Q Consensus 65 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 135 (375)
.+.|+.|-.-.+|++...+ ...|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3678889999999998653 34567776642 2333445678888887753344 467777643 5899
Q ss_pred eecCCCCH
Q 017246 136 EYMPMGSL 143 (375)
Q Consensus 136 e~~~~gsL 143 (375)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.22 E-value=0.0022 Score=55.50 Aligned_cols=158 Identities=13% Similarity=-0.030 Sum_probs=80.8
Q ss_pred cHHHHHHHhhccccccee-----ccccceEEEEEEEcCCceEEEEEccccCccchHHHHHHHHHHccCC-----CCCcce
Q 017246 51 TFRELAIATRNFREANLI-----GEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----HDNLVT 120 (375)
Q Consensus 51 ~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~ 120 (375)
+..++...-.+|.++++. ..|---+.|+++..+| .+++|++.... ...++..|..++..|. .|..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 345555556678765443 4566688899987765 48999986532 2334444565555553 222222
Q ss_pred eE---eEEeeCCeeEEEEeecCCCCHHH--------------HHhccCC-CC----CC------------------CCHH
Q 017246 121 LI---GYCTSGDQRLLVYEYMPMGSLED--------------HLYDLEP-DQ----EP------------------LSWN 160 (375)
Q Consensus 121 ~~---~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~-~~----~~------------------l~~~ 160 (375)
.. .+.........++.++.+..... .+..... .. .. ....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 01223455566666665533210 0000000 00 00 0001
Q ss_pred HHHHHHHHHHHHHHHhhcCC-CCCcccCCCCCCcEEEeCCCceEEeecCCCc
Q 017246 161 TRMKIAVGAARGLEYLHCKA-NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 211 (375)
Q Consensus 161 ~~~~i~~qi~~~l~~LH~~~-~~~i~H~Dlkp~Nill~~~~~vkl~Dfg~a~ 211 (375)
.....+..+...+...+..+ ..++||+|+.++||+++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 12222333333333333211 2349999999999999988777899999885
|